<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF
 xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns:owl="http://www.w3.org/2002/07/owl#"
 xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#"
 xml:base="http://www.reactome.org/biopax/91/162582#">
<owl:Ontology rdf:about="">
 <owl:imports rdf:resource="http://www.biopax.org/release/biopax-level3.owl#" />
</owl:Ontology>

<bp:PathwayStep rdf:ID="PathwayStep2802">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2435" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2803">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2436" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2804">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2437" />
 <bp:stepProcess rdf:resource="#Catalysis769" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2805">
 <bp:stepProcess rdf:resource="#Pathway369" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2800">
 <bp:stepProcess rdf:resource="#Pathway367" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2801">
 <bp:stepProcess rdf:resource="#Pathway368" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2806">
 <bp:stepProcess rdf:resource="#Pathway370" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2807">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2438" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2808">
 <bp:stepProcess rdf:resource="#Catalysis770" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2439" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2809">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2440" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis709">
 <bp:controlled rdf:resource="#BiochemicalReaction2262" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis708">
 <bp:controlled rdf:resource="#BiochemicalReaction2261" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis705">
 <bp:controlled rdf:resource="#BiochemicalReaction2257" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis704">
 <bp:controlled rdf:resource="#BiochemicalReaction2256" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis707">
 <bp:controlled rdf:resource="#BiochemicalReaction2259" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis706">
 <bp:controlled rdf:resource="#BiochemicalReaction2258" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis701">
 <bp:controlled rdf:resource="#BiochemicalReaction2251" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis700">
 <bp:controlled rdf:resource="#BiochemicalReaction2250" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis703">
 <bp:controlled rdf:resource="#BiochemicalReaction2254" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis702">
 <bp:controlled rdf:resource="#BiochemicalReaction2252" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis719">
 <bp:controlled rdf:resource="#BiochemicalReaction2279" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis716">
 <bp:controlled rdf:resource="#BiochemicalReaction2275" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis715">
 <bp:controlled rdf:resource="#BiochemicalReaction2274" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis718">
 <bp:controlled rdf:resource="#BiochemicalReaction2278" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis717">
 <bp:controlled rdf:resource="#BiochemicalReaction2276" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis712">
 <bp:controlled rdf:resource="#BiochemicalReaction2268" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis711">
 <bp:controlled rdf:resource="#BiochemicalReaction2267" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis714">
 <bp:controlled rdf:resource="#BiochemicalReaction2272" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis713">
 <bp:controlled rdf:resource="#BiochemicalReaction2271" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis710">
 <bp:controlled rdf:resource="#BiochemicalReaction2266" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1547">
 <bp:stepProcess rdf:resource="#Pathway204" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2879">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2504" />
 <bp:stepProcess rdf:resource="#Catalysis786" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1546">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1344" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1545">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1343" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1544">
 <bp:stepProcess rdf:resource="#Pathway203" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction178">
 <bp:evidence rdf:resource="#Evidence209" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6 phosphorylates ARHGAP35</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2875">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2501" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction177">
 <bp:evidence rdf:resource="#Evidence208" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of RAC1 by the PXN:CRK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2876">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2502" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1549">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1346" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2877">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2503" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction179">
 <bp:evidence rdf:resource="#Evidence210" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated PXN recruits the CRK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1548">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1345" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2878">
 <bp:stepProcess rdf:resource="#Pathway376" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis767">
 <bp:controlled rdf:resource="#BiochemicalReaction2430" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2871">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2497" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis766">
 <bp:controlled rdf:resource="#BiochemicalReaction2428" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2872">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2498" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis769">
 <bp:controlled rdf:resource="#BiochemicalReaction2437" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2873">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2499" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis768">
 <bp:controlled rdf:resource="#BiochemicalReaction2434" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2874">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2500" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1543">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1342" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis763">
 <bp:controlled rdf:resource="#BiochemicalReaction2419" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1542">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1341" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis762">
 <bp:controlled rdf:resource="#BiochemicalReaction2417" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1541">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1340" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis765">
 <bp:controlled rdf:resource="#BiochemicalReaction2425" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1540">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1339" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis764">
 <bp:controlled rdf:resource="#BiochemicalReaction2424" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2870">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2496" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis770">
 <bp:controlled rdf:resource="#BiochemicalReaction2439" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis772">
 <bp:controlled rdf:resource="#BiochemicalReaction2442" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis771">
 <bp:controlled rdf:resource="#BiochemicalReaction2441" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction185">
 <bp:evidence rdf:resource="#Evidence218" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6 phosphorylates DOK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction184">
 <bp:evidence rdf:resource="#Evidence216" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6 phosphorylates CDKN1B</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction187">
 <bp:evidence rdf:resource="#Evidence220" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CBL autoubiquitinates</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction186">
 <bp:evidence rdf:resource="#Evidence219" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6 phosphorylates ARAP1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction181">
 <bp:evidence rdf:resource="#Evidence212" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ARHGAP35 binds RASA1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction180">
 <bp:evidence rdf:resource="#Evidence211" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RASA1 binds RAS:GTP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction183">
 <bp:evidence rdf:resource="#Evidence215" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated PTK6 binds CDKN1B</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction182">
 <bp:evidence rdf:resource="#Evidence213" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RASA1 stimulates RAS GTPase activity</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1558">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1353" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1557">
 <bp:stepProcess rdf:resource="#Pathway206" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1556">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1352" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1555">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1351" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction189">
 <bp:evidence rdf:resource="#Evidence222" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6 binds ARAP1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2886">
 <bp:stepProcess rdf:resource="#Catalysis791" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2509" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction188">
 <bp:evidence rdf:resource="#Evidence221" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6 binds AKT1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2887">
 <bp:stepProcess rdf:resource="#Catalysis792" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2510" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2888">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2511" />
 <bp:stepProcess rdf:resource="#Catalysis793" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1559">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1354" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2889">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2512" />
 <bp:stepProcess rdf:resource="#Catalysis794" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1550">
 <bp:stepProcess rdf:resource="#Pathway205" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis778">
 <bp:controlled rdf:resource="#BiochemicalReaction2457" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2882">
 <bp:stepProcess rdf:resource="#Catalysis789" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2507" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis777">
 <bp:controlled rdf:resource="#BiochemicalReaction2456" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2883">
 <bp:stepProcess rdf:resource="#Pathway377" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2884">
 <bp:stepProcess rdf:resource="#Catalysis790" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2508" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3151">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis779">
 <bp:controlled rdf:resource="#BiochemicalReaction2458" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2885">
 <bp:stepProcess rdf:resource="#Pathway378" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3150">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1554">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1350" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis774">
 <bp:controlled rdf:resource="#BiochemicalReaction2446" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence3153">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1553">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1349" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis773">
 <bp:controlled rdf:resource="#BiochemicalReaction2445" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence3152">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1552">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1348" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis776">
 <bp:controlled rdf:resource="#BiochemicalReaction2454" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2880">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2505" />
 <bp:stepProcess rdf:resource="#Catalysis787" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1551">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1347" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis775">
 <bp:controlled rdf:resource="#BiochemicalReaction2447" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2881">
 <bp:stepProcess rdf:resource="#Catalysis788" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2506" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis781">
 <bp:controlled rdf:resource="#BiochemicalReaction2461" />
</bp:Catalysis>

<bp:Pathway rdf:ID="Pathway393">
 <bp:pathwayOrder rdf:resource="#PathwayStep2967" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2964" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2960" />
 <bp:pathwayComponent rdf:resource="#Pathway395" />
 <bp:pathwayComponent rdf:resource="#Pathway394" />
 <bp:pathwayComponent rdf:resource="#Pathway396" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2960" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFR1 ligand binding and activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The vertebrate fibroblast growth factor receptor 1 (FGFR1) is alternatively spliced generating multiple variants that are differentially expressed during embryo development and in the adult body. The restricted expression patterns of FGFR1 isoforms, together with differential expression and binding of specific ligands, leads to activation of common FGFR1 signal transduction pathways, but may result in distinctively different biological responses as a result of differences in cellular context. FGFR1 isoforms are also present in the nucleus in complex with various fibroblast growth factors where they function to regulate transcription of target genes.   FGFR is probably activated by NCAM very differently from the way by which it is activated by FGFs, reflecting the different conditions for NCAM-FGFR and FGF-FGFR interactions. The affinity of FGF for FGFR is approximately 10e6 times higher than that of NCAM for FGFR. Moreover, in the brain NCAM is constantly present on the cell surface at a much higher (micromolar) concentration than FGFs, which only appear transiently in the extracellular environment in the nanomolar range.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Catalysis rdf:ID="Catalysis780">
 <bp:controlled rdf:resource="#BiochemicalReaction2460" />
</bp:Catalysis>

<bp:Pathway rdf:ID="Pathway392">
 <bp:pathwayOrder rdf:resource="#PathwayStep2945" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2946" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2947" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2948" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2952" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2953" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2954" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2944" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2950" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2951" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2949" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2558" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2557" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2556" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2555" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2554" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2553" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2563" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2562" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2561" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2560" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2559" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2944" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Spry regulation of FGF signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Sprouty was initially characterized as a negative regulator of  FGFR signaling in Drosophila. Human cells contain four genes encoding Sprouty proteins, of which Spry2 is the best studied and most widely expressed.  Spry proteins modulate the duration and extent of signaling through the MAPK cascade after FGF stimulation, although the mechanism appears to depend on the particular biological context.  Some studies have suggested that Sprouty binds to GRB2 and interferes with the recruitment of GRB2-SOS1 to the receptor, while others have shown that Sprouty interferes with the MAPK cascade at the level of RAF activation.  In addition to modulating the MAPK pathway in response to FGF stimulation, Sprouty itself appears to be subject to complex post-translational modification that regulates its activity and stability.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction190">
 <bp:evidence rdf:resource="#Evidence223" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6 phosphorylates CBL</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis783">
 <bp:controlled rdf:resource="#BiochemicalReaction2465" />
</bp:Catalysis>

<bp:Pathway rdf:ID="Pathway395">
 <bp:pathwayOrder rdf:resource="#PathwayStep2965" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2966" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2572" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2571" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2965" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFR1c and Klotho ligand binding and activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGF23 is a member of the endocrine subfamily of FGFs. It is produced in bone tissue and regulates kidney functions. Klotho is essential for endogenous FGF23 function as it converts FGFR1c into a specific FGF23 receptor.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Catalysis rdf:ID="Catalysis782">
 <bp:controlled rdf:resource="#BiochemicalReaction2462" />
</bp:Catalysis>

<bp:Pathway rdf:ID="Pathway394">
 <bp:pathwayOrder rdf:resource="#PathwayStep2963" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2961" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2962" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2569" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2568" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2570" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2961" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFR1c ligand binding and activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">This pathway depicts the binding of an experimentally-verified range of ligands to FGFR1c. While binding affinities may vary considerably within this set, the ligands listed have been established to bring about receptor activation at their reported physiological concentrations.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway391">
 <bp:pathwayOrder rdf:resource="#PathwayStep2956" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2957" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2958" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2943" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2955" />
 <bp:pathwayComponent rdf:resource="#Pathway392" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2567" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2566" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2565" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2564" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2943" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Negative regulation of FGFR1 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Once activated, the FGFR signaling pathway is regulated by numerous negative feedback mechanisms.  These include downregulation of receptors through CBL-mediated ubiquitination and endocytosis, ERK-mediated inhibition of FRS2-tyrosine phosphorylation and the attenuation of ERK signaling through the action of dual-specificity phosphatases, IL17RD/SEF, Sprouty and Spred proteins.  A number of these inhibitors are themselves transcriptional targets of the activated FGFR pathway.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway390">
 <bp:pathwayOrder rdf:resource="#PathwayStep2941" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2940" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2552" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2551" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2940" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFRL1 modulation of FGFR1 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFRL1 is a fifth member of the FGFR family of receptors. The extracellular region has 40% sequence similarity with FGFR1-4, but FGFRL1 lacks the internal kinase domain of the other FGF receptors and how it acts in FGFR signaling is unclear. Some models suggest FGFRL1 restricts canonical FGFR signaling by sequestering ligand away from kinase-active receptors, while other models suggest that FGFRL1 may promote canonical signaling by nucleating signaling complexes or enhancing ERK1/2 activation (reviewed in Trueb, 2011; Trueb et al, 2013).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction196">
 <bp:evidence rdf:resource="#Evidence230" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated KHDRBS1 translocates to the cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction195">
 <bp:evidence rdf:resource="#Evidence229" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6 phosphorylates KHDRBS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction198">
 <bp:evidence rdf:resource="#Evidence232" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6 translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction197">
 <bp:evidence rdf:resource="#Evidence231" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6 phosphorylates KHDRBS3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction192">
 <bp:evidence rdf:resource="#Evidence225" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6 phosphorylates AKT1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway397">
 <bp:pathwayOrder rdf:resource="#PathwayStep2999" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2971" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3004" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3012" />
 <bp:pathwayComponent rdf:resource="#Pathway404" />
 <bp:pathwayComponent rdf:resource="#Pathway407" />
 <bp:pathwayComponent rdf:resource="#Pathway403" />
 <bp:pathwayComponent rdf:resource="#Pathway398" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2971" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by FGFR2</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The 22 members of the fibroblast growth factor (FGF) family of growth factors mediate their cellular responses by binding to and activating the different isoforms encoded by the four receptor tyrosine kinases (RTKs) designated FGFR1, FGFR2, FGFR3 and FGFR4. These receptors are key regulators of several developmental processes in which cell fate and differentiation to various tissue lineages are determined. Unlike other growth factors, FGFs act in concert with heparin or heparan sulfate proteoglycan (HSPG) to activate FGFRs and to induce the pleiotropic responses that lead to the variety of cellular responses induced by this large family of growth factors. An alternative, FGF-independent, source of FGFR activation originates from the interaction with cell adhesion molecules, typically in the context of interactions on neural cell membranes and is crucial for neuronal survival and development.  Upon ligand binding, receptor dimers are formed and their intrinsic tyrosine kinase is activated causing phosphorylation of multiple tyrosine residues on the receptors. These then serve as docking sites for the recruitment of SH2 (src homology-2) or PTB (phosphotyrosine binding) domains of adaptors, docking proteins or signaling enzymes. Signaling complexes are assembled and recruited to the active receptors resulting in a cascade of phosphorylation events.  This leads to stimulation of intracellular signaling pathways that control cell proliferation, cell differentiation, cell migration, cell survival and cell shape, depending on the cell type or stage of maturation. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction191">
 <bp:evidence rdf:resource="#Evidence224" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6 binds DOK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway396">
 <bp:pathwayOrder rdf:resource="#PathwayStep2968" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2969" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2574" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2573" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2968" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFR1b ligand binding and activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">This pathway depicts the binding of an experimentally-verified range of ligands to FGFR1b. While binding affinities may vary considerably within this set, the ligands listed have been established to bring about receptor activation at their reported physiological concentrations.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction194">
 <bp:evidence rdf:resource="#Evidence228" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6 binds KHDRBS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway399">
 <bp:pathwayOrder rdf:resource="#PathwayStep2974" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2975" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2976" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2973" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2578" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2577" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2576" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2575" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2973" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHC-mediated cascade:FGFR2</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The exact role of SHC1 in FGFR signaling remains unclear.   Numerous studies have shown that the p46 and p52 isoforms of SHC1 are phosphorylated in response to FGF stimulation, but direct interaction with the receptor has not been demonstrated. Co-precipitation of p46 and p52 with the FGFR2 IIIc receptor has been reported, but this interaction is thought to be indirect, possibly mediated by SRC.  Consistent with this, co-precipitation of SHC1 and FGFR1 IIIc is seen in mammalian cells expressing v-SRC.  The p66 isoform of SHC1 has also been co-precipitated with FGFR3, but this occurs independently of receptor stimulation, and the p66 isoform not been shown to undergo FGF-dependent phosphorylation.  SHC1 has been shown to associate with GRB2 and SOS1 in response to FGF stimulation, suggesting that the recruitment of SHC1 may contribute to activation of the MAPK cascade downstream of FGFR.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction193">
 <bp:evidence rdf:resource="#Evidence227" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6 phosphorylates KHDRBS2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway398">
 <bp:pathwayOrder rdf:resource="#PathwayStep2977" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2981" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2972" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2991" />
 <bp:pathwayComponent rdf:resource="#Pathway401" />
 <bp:pathwayComponent rdf:resource="#Pathway400" />
 <bp:pathwayComponent rdf:resource="#Pathway402" />
 <bp:pathwayComponent rdf:resource="#Pathway399" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2972" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Downstream signaling of activated FGFR2</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling via FGFRs is mediated via direct recruitment of signaling proteins that bind to tyrosine auto-phosphorylation sites on the activated receptor and via closely linked docking proteins that become tyrosine phosphorylated in response to FGF-stimulation and form a complex with additional complement of signaling proteins.   The activation loop in the catalytic domain of FGFR maintains the PTK domain in an inactive or low activity state. The activation-loop of FGFR1, for instance, contains two tyrosine residues that must be autophosphorylated for maintaining the catalytic domain in an active state. In the autoinhibited configuration, a kinase invariant proline residue at the C-terminal end of the activation loop interferes with substrate binding while allowing access to ATP in the nucleotide binding site. In addition to the catalytic PTK core, the cytoplasmic domain of FGFR contains several regulatory sequences. The juxtamembrane domain of FGFRs is considerably longer than that of other receptor tyrosine kinases. This region contains a highly conserved sequence that serves as a binding site for the phosphotyrosine binding (PTB) domain of FRS2. A variety of signaling proteins are phosphorylated in response to FGF stimulation, including Shc, phospholipase-C gamma and FRS2 leading to stimulation of intracellular signaling pathways that control cell proliferation, cell differentiation, cell migration, cell survival and cell shape.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep1525">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1328" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2857">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2483" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction159">
 <bp:evidence rdf:resource="#Evidence187" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LINC01139 promotes phosphorylation of HIF1A by LRRK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1524">
 <bp:stepProcess rdf:resource="#Catalysis415" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1327" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2858">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2484" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1523">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1326" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2859">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2485" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1522">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1325" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction156">
 <bp:evidence rdf:resource="#Evidence183" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAP2 recruits STAT3 to PTK6</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1529">
 <bp:stepProcess rdf:resource="#Pathway199" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2853">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2479" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction155">
 <bp:evidence rdf:resource="#Evidence182" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT3 binds SOCS3 promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1528">
 <bp:stepProcess rdf:resource="#Catalysis418" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1331" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2854">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2480" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction158">
 <bp:evidence rdf:resource="#Evidence186" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LINC01139 facilitates PTK6 autophosphorylation</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1527">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1330" />
 <bp:stepProcess rdf:resource="#Catalysis417" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2855">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2481" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction157">
 <bp:evidence rdf:resource="#Evidence184" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated PTK6 binds STAP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1526">
 <bp:stepProcess rdf:resource="#Catalysis416" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1329" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2856">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2482" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis789">
 <bp:controlled rdf:resource="#BiochemicalReaction2507" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2850">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2476" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis788">
 <bp:controlled rdf:resource="#BiochemicalReaction2506" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2851">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2477" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2852">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2478" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1521">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1324" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis785">
 <bp:controlled rdf:resource="#BiochemicalReaction2474" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1520">
 <bp:stepProcess rdf:resource="#Pathway198" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis784">
 <bp:controlled rdf:resource="#BiochemicalReaction2471" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis787">
 <bp:controlled rdf:resource="#BiochemicalReaction2505" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis786">
 <bp:controlled rdf:resource="#BiochemicalReaction2504" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis792">
 <bp:controlled rdf:resource="#BiochemicalReaction2510" />
</bp:Catalysis>

<bp:Pathway rdf:ID="Pathway382">
 <bp:pathwayOrder rdf:resource="#PathwayStep2905" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2906" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2907" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2525" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2524" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2526" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2905" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PLC-gamma1 signalling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The activation of phosphlipase C-gamma (PLC-gamma) and subsequent mobilization of calcium from intracellular stores are essential for neurotrophin secretion. PLC-gamma is activated through the phosphorylation by TrkA receptor kinase and this form hydrolyses PIP2 to generate inositol tris-phosphate (IP3) and diacylglycerol (DAG). IP3 promotes the release of Ca2+ from internal stores and this results in activation of enzymes such as protein kinase C and Ca2+ calmodulin-regulated protein kinases.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Catalysis rdf:ID="Catalysis791">
 <bp:controlled rdf:resource="#BiochemicalReaction2509" />
</bp:Catalysis>

<bp:Pathway rdf:ID="Pathway381">
 <bp:pathwayOrder rdf:resource="#PathwayStep2902" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2903" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2523" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2522" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2902" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signalling to ERK5</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The location of neurotrophin stimulation appears to determine the nature of the transcriptional response through differential uses of individual MAP kinases. The ERK5 pathway has a unique function in retrograde signalling; in contrast, ERK1/2, which mediate nuclear responses following direct cell body stimulation, does not transmit a retrograde signal.  Following neurotrophin stimulation of distal axons, phosphorylated TRK receptors are endocytosed and transported to the cell bodies, where MEK5 phosphorylates ERK5, leading to ERK5 nuclear translocation,   phosphorylation of transcription factors, and neuronal survival. In contrast, neurotrophin stimulation of the cell bodies causes concurrent activation and nuclear transport of ERK1/2 as well as ERK5. Several distinctive features of the ERK5 pathway might be important for retrograde signalling. The ERK5 cascade does not depend on activation of the G-protein RAS. Instead, this pathway may use other G-proteins such as RAP that are associated with vesicles, or may not require any G-protein intermediate. Another distinctive feature is that the MEK5 isoform, which is expressed in the nervous system, exhibits a punctate staining pattern, suggesting a vesicular localization. ERK5 itself significantly differs from ERK1/2, and its substrate specificity also differs from ERK1/2. For instance, ERK5 directly activates transcription factors, including MEF2, that are not phosphorylated by ERK1/2. Conversely, ERK1/2, but not ERK5, activate transcription factors such as ELK1 and MITF.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Catalysis rdf:ID="Catalysis794">
 <bp:controlled rdf:resource="#BiochemicalReaction2512" />
</bp:Catalysis>

<bp:Pathway rdf:ID="Pathway384">
 <bp:pathwayOrder rdf:resource="#PathwayStep2959" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2942" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2910" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2939" />
 <bp:pathwayComponent rdf:resource="#Pathway393" />
 <bp:pathwayComponent rdf:resource="#Pathway391" />
 <bp:pathwayComponent rdf:resource="#Pathway390" />
 <bp:pathwayComponent rdf:resource="#Pathway385" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2910" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by FGFR1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The 22 members of the fibroblast growth factor (FGF) family of growth factors mediate their cellular responses by binding to and activating the different isoforms encoded by the four receptor tyrosine kinases (RTKs) designated FGFR1, FGFR2, FGFR3 and FGFR4. These receptors are key regulators of several developmental processes in which cell fate and differentiation to various tissue lineages are determined. Unlike other growth factors, FGFs act in concert with heparin or heparan sulfate proteoglycan (HSPG) to activate FGFRs and to induce the pleiotropic responses that lead to the variety of cellular responses induced by this large family of growth factors. An alternative, FGF-independent, source of FGFR activation originates from the interaction with cell adhesion molecules, typically in the context of interactions on neural cell membranes and is crucial for neuronal survival and development.  Upon ligand binding, receptor dimers are formed and their intrinsic tyrosine kinase is activated causing phosphorylation of multiple tyrosine residues on the receptors. These then serve as docking sites for the recruitment of SH2 (src homology-2) or PTB (phosphotyrosine binding) domains of adaptors, docking proteins or signaling enzymes. Signaling complexes are assembled and recruited to the active receptors resulting in a cascade of phosphorylation events.  This leads to stimulation of intracellular signaling pathways that control cell proliferation, cell differentiation, cell migration, cell survival and cell shape, depending on the cell type or stage of maturation. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Catalysis rdf:ID="Catalysis793">
 <bp:controlled rdf:resource="#BiochemicalReaction2511" />
</bp:Catalysis>

<bp:Pathway rdf:ID="Pathway383">
 <bp:pathwayOrder rdf:resource="#PathwayStep3082" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2909" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2970" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3028" />
 <bp:pathwayComponent rdf:resource="#Pathway409" />
 <bp:pathwayComponent rdf:resource="#Pathway384" />
 <bp:pathwayComponent rdf:resource="#Pathway397" />
 <bp:pathwayComponent rdf:resource="#Pathway420" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2909" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by FGFR</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The 22 members of the fibroblast growth factor (FGF) family of growth factors mediate their cellular responses by binding to and activating the different isoforms encoded by the four receptor tyrosine kinases (RTKs) designated FGFR1, FGFR2, FGFR3 and FGFR4. These receptors are key regulators of several developmental processes in which cell fate and differentiation to various tissue lineages are determined. Unlike other growth factors, FGFs act in concert with heparin or heparan sulfate proteoglycan (HSPG) to activate FGFRs and to induce the pleiotropic responses that lead to the variety of cellular responses induced by this large family of growth factors. An alternative, FGF-independent, source of FGFR activation originates from the interaction with cell adhesion molecules, typically in the context of interactions on neural cell membranes and is crucial for neuronal survival and development.  Upon ligand binding, receptor dimers are formed and their intrinsic tyrosine kinase is activated causing phosphorylation of multiple tyrosine residues on the receptors. These then serve as docking sites for the recruitment of SH2 (src homology-2) or PTB (phosphotyrosine binding) domains of adaptors, docking proteins or signaling enzymes. Signaling complexes are assembled and recruited to the active receptors resulting in a cascade of phosphorylation events.  This leads to stimulation of intracellular signaling pathways that control cell proliferation, cell differentiation, cell migration, cell survival and cell shape, depending on the cell type or stage of maturation. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Catalysis rdf:ID="Catalysis790">
 <bp:controlled rdf:resource="#BiochemicalReaction2508" />
</bp:Catalysis>

<bp:Pathway rdf:ID="Pathway380">
 <bp:pathwayOrder rdf:resource="#PathwayStep2900" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2521" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2900" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signalling to STAT3</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Neurotrophin-induced increase in Signal transducer and activator of transcription 3 (STAT3; acute-phase response factor) activation appears to underly several downstream functions of neurotrophin signalling, such as transcription of immediate early genes, proliferation arrest, and neurite outgrowth.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction163">
 <bp:evidence rdf:resource="#Evidence191" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EGFR phosphorylates GPNMB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction162">
 <bp:evidence rdf:resource="#Evidence190" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LINC01139 promotes phosphorylation of HIF1A by PTK6</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway389">
 <bp:pathwayOrder rdf:resource="#PathwayStep2934" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2935" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2936" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2937" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2930" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2931" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2932" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2933" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2938" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2547" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2546" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2545" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2544" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2543" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2542" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2550" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2549" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2548" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2930" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FRS-mediated FGFR1 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The FRS family of scaffolding adaptor proteins has two members, FRS2 (also known as FRS2 alpha) and FRS3 (also known as FRS2beta or SNT-2).  Activation of FGFR tyrosine kinase allows FRS proteins to become phosphorylated on tyrosine residues and then bind to the adaptor GRB2 and the tyrosine phosphatase PPTN11/SHP2.  Subsequently, PPTN11 activates the RAS-MAP kinase pathway and GRB2 activates the RAS-MAP kinase , PI-3-kinase and ubiquitinations/degradation pathways by binding to SOS, GAB1 and CBL, respectively, via the SH3 domains of GRB2.  FRS2 acts as a central mediator in FGF signaling mainly because it induces sustained levels of activation of ERK with ubiquitous expression.   </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction165">
 <bp:evidence rdf:resource="#Evidence194" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EPAS1 (HIF2A) and activated NR3C1 (GCR) bind PTK6 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction164">
 <bp:evidence rdf:resource="#Evidence193" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HIF1A,EPAS1 bind PTK6 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway386">
 <bp:pathwayOrder rdf:resource="#PathwayStep2912" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2913" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2914" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2529" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2528" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2527" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2912" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phospholipase C-mediated cascade: FGFR1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phospholipase C-gamma (PLC-gamma) is a substrate of the fibroblast growth factor receptor (FGFR) and other receptors with tyrosine kinase activity. It is known that the src homology region 2 (SH2 domain) of PLC-gamma and of other signaling molecules (such as GTPase-activating protein and phosphatidylinositol 3-kinase-associated p85) direct their binding toward autophosphorylated tyrosine residues of the FGFR. Recruitment of PLC-gamma results in its phosphorylation and activation by the receptor.  Activated PLC-gamma hydrolyzes phosphatidyl inositol[4,5] P2 to form the second messengers diacylglycerol (DAG) and Ins [1,4,5]P3, which stimulate calcium release and activation of calcium/calmodulin dependent kinases. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway385">
 <bp:pathwayOrder rdf:resource="#PathwayStep2923" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2924" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2915" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2911" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2929" />
 <bp:pathwayComponent rdf:resource="#Pathway389" />
 <bp:pathwayComponent rdf:resource="#Pathway386" />
 <bp:pathwayComponent rdf:resource="#Pathway388" />
 <bp:pathwayComponent rdf:resource="#Pathway387" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2537" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2911" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Downstream signaling of activated FGFR1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling via FGFRs is mediated via direct recruitment of signaling proteins that bind to tyrosine auto-phosphorylation sites on the activated receptor and via closely linked docking proteins that become tyrosine phosphorylated in response to FGF-stimulation and form a complex with additional complement of signaling proteins.   The activation loop in the catalytic domain of FGFR maintains the PTK domain in an inactive or low activity state. The activation-loop of FGFR1, for instance, contains two tyrosine residues that must be autophosphorylated for maintaining the catalytic domain in an active state. In the autoinhibited configuration, a kinase invariant proline residue at the C-terminal end of the activation loop interferes with substrate binding while allowing access to ATP in the nucleotide binding site. In addition to the catalytic PTK core, the cytoplasmic domain of FGFR contains several regulatory sequences. The juxtamembrane domain of FGFRs is considerably longer than that of other receptor tyrosine kinases. This region contains a highly conserved sequence that serves as a binding site for the phosphotyrosine binding (PTB) domain of FRS2. A variety of signaling proteins are phosphorylated in response to FGF stimulation, including Shc, phospholipase-C gamma and FRS2 leading to stimulation of intracellular signaling pathways that control cell proliferation, cell differentiation, cell migration, cell survival and cell shape.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction161">
 <bp:evidence rdf:resource="#Evidence189" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HBEGF-bound EGFR forms a heterodimer with GPNMB</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway388">
 <bp:pathwayOrder rdf:resource="#PathwayStep2925" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2926" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2927" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2928" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2541" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2540" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2539" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2538" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2925" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHC-mediated cascade:FGFR1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The exact role of SHC1 in FGFR signaling remains unclear.   Numerous studies have shown that the p46 and p52 isoforms of SHC1 are phosphorylated in response to FGF stimulation, but direct interaction with the receptor has not been demonstrated. Co-precipitation of p46 and p52 with the FGFR2 IIIc receptor has been reported, but this interaction is thought to be indirect, possibly mediated by SRC.  Consistent with this, co-precipitation of SHC1 and FGFR1 IIIc is seen in mammalian cells expressing v-SRC.  The p66 isoform of SHC1 has also been co-precipitated with FGFR3, but this occurs independently of receptor stimulation, and the p66 isoform not been shown to undergo FGF-dependent phosphorylation.  SHC1 has been shown to associate with GRB2 and SOS1 in response to FGF stimulation, suggesting that the recruitment of SHC1 may contribute to activation of the MAPK cascade downstream of FGFR.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction160">
 <bp:evidence rdf:resource="#Evidence188" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated GPNMB recruits PTK6 and LRRK2 in the presence of LINC01139</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway387">
 <bp:pathwayOrder rdf:resource="#PathwayStep2920" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2921" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2922" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2916" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2917" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2918" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2919" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2536" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2535" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2534" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2533" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2532" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2531" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2530" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2916" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI-3K cascade:FGFR1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The ability of growth factors to protect from apoptosis is primarily due to the activation of the AKT survival pathway. P-I-3-kinase dependent activation of PDK leads to the activation of AKT which in turn affects the activity or expression of pro-apoptotic factors, which contribute to protection from apoptosis. AKT activation also blocks the activity of GSK-3b which could lead to additional antiapoptotic signals.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep1536">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1335" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2190">
 <bp:evidence rdf:resource="#Evidence2518" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ALK:MDK dimerization</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2868">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2494" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1535">
 <bp:stepProcess rdf:resource="#Pathway202" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2869">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2495" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1534">
 <bp:stepProcess rdf:resource="#Pathway201" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1533">
 <bp:stepProcess rdf:resource="#Pathway200" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction167">
 <bp:evidence rdf:resource="#Evidence197" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTPN1 dephosphorylates PTK6</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2864">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2490" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction166">
 <bp:evidence rdf:resource="#Evidence195" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HIF1A,EPAS1 promote PTK6 gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1539">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1338" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2865">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2491" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction169">
 <bp:evidence rdf:resource="#Evidence199" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTPN1 binds PTK6</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1538">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1337" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2866">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2492" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction168">
 <bp:evidence rdf:resource="#Evidence198" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SRMS phosphorylates PTK6</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1537">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1336" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2867">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2493" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2198">
 <bp:evidence rdf:resource="#Evidence2527" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y705,S727 STAT3 is acetylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2860">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2486" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2197">
 <bp:evidence rdf:resource="#Evidence2525" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active ALK phosphorylates IRS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2861">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2487" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis799">
 <bp:controlled rdf:resource="#BiochemicalReaction2519" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2196">
 <bp:evidence rdf:resource="#Evidence2524" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active ALK phosphorylates SHC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2862">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2488" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2195">
 <bp:evidence rdf:resource="#Evidence2523" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ALK binds ligand midkine (MDK)</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2863">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2489" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1532">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1334" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2194">
 <bp:evidence rdf:resource="#Evidence2522" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ALK:PTN dimerization</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis796">
 <bp:controlled rdf:resource="#BiochemicalReaction2514" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1531">
 <bp:stepProcess rdf:resource="#Catalysis420" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1333" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2193">
 <bp:evidence rdf:resource="#Evidence2521" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTPRZ dephosphorylates ligand-bound ALK dimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis795">
 <bp:controlled rdf:resource="#BiochemicalReaction2513" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1530">
 <bp:stepProcess rdf:resource="#Catalysis419" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1332" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2192">
 <bp:evidence rdf:resource="#Evidence2520" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTN and MDK bind to PTPRZ</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis798">
 <bp:controlled rdf:resource="#BiochemicalReaction2516" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2191">
 <bp:evidence rdf:resource="#Evidence2519" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ALK binds ligand pleiotrophin (PTN)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis797">
 <bp:controlled rdf:resource="#BiochemicalReaction2515" />
</bp:Catalysis>

<bp:Pathway rdf:ID="Pathway371">
 <bp:pathwayOrder rdf:resource="#PathwayStep2824" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2814" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2825" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2815" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2826" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2816" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2820" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2821" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2822" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2823" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2817" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2818" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2819" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2451" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2450" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2448" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2447" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2446" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2445" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2456" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2444" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2455" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2454" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2453" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2452" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2449" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2814" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Frs2-mediated activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The adaptor protein Frs2 (Fibroblast growth factor receptor substrate 2) can mediate the prolonged activation of the MAPK (ERK) cascade. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway370">
 <bp:pathwayOrder rdf:resource="#PathwayStep2810" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2811" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2812" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2807" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2808" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2809" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2443" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2442" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2441" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2440" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2439" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2438" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2807" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ARMS-mediated activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ARMS (Ankyrin-Rich Membrane Spanning/Kidins 220) is a 220kD tetraspanning adaptor protein which becomes rapidly tyrosine phosphorylated by active Trk receptors. ARMS is another adaptor protein which is involved in the activation of Rap1 and the subsequent prolonged activation of the MAPK cascade.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway373">
 <bp:pathwayOrder rdf:resource="#PathwayStep2831" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2832" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2833" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2830" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2829" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2459" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2458" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2457" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2461" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2460" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2829" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38MAPK events</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NGF induces sustained activation of p38, a member of the MAPK family (Morooka T, Nishida E, 1998). Both p38 and the ERKs appear to be involved in neurite outgrowth and differentiation caused by NGF in PC12 cells. As a matter of fact, PC12 cell differentiation appears to involve activation of both ERK/MAPK and p38. Both ERK/MAPK and p38 pathways contribute to the phosphorylation of the transcription factor CREB and the activation of immediate-early genes (Xing J, 1998). p38 activation by NGF may occur by at least two mechanisms, involving SRC or MEK kinases.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway372">
 <bp:pathwayOrder rdf:resource="#PathwayStep2835" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2836" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2837" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2838" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2834" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2828" />
 <bp:pathwayComponent rdf:resource="#Pathway373" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2466" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2465" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2464" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2463" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2462" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2828" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signalling to RAS</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signalling through Shc adaptor proteins appears to be identical for both NGF and EGF. It leads to a fast, but transient, MAPK/ERK activation, which is insufficient to explain the prolonged activation of MAPK found in NGF-treated cells.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2199">
 <bp:evidence rdf:resource="#Evidence2528" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD274 gene expression downstream of ALK signaling</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction174">
 <bp:evidence rdf:resource="#Evidence205" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6 binds PXN</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway379">
 <bp:pathwayOrder rdf:resource="#PathwayStep2897" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2898" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2894" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2895" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2896" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2520" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2519" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2518" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2517" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2516" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2894" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI3K/AKT activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI3K/AKT signalling is a major regulator of  neuron survival. It blocks cell death by both impinging on the cytoplasmic cell death machinery and by regulating the expression of genes involved in cell death and survival. In addition, it may also use metabolic pathways to regulate cell survival.The PI3K/AKT pathway also affects axon diameter and branching (Marcus et al, 2002) and regulates small G proteins like RhoA (Vanhaesebroeck, B and Waterman, MD, 1999), which control the behaviour of the F-actin cytoskeleton. Moreover, through its connection with the TOR pathway, it promotes translation of a subset of mRNAs. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction173">
 <bp:evidence rdf:resource="#Evidence204" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6 binds ARHGAP35</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway378">
 <bp:pathwayOrder rdf:resource="#PathwayStep2886" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2887" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2510" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2509" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2886" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP Kinases are inactivated by a family of protein named MAP Kinase Phosphatases (MKPs). They act through dephosphorylation of threonine and/or tyrosine residues within the signature sequence -pTXpY- located in the activation loop of MAP kinases (pT=phosphothreonine and pY=phosphotyrosine). MKPs are divided into three major categories depending on their preference for dephosphorylating; tyrosine, serine/threonine and both the tyrosine and threonine (dual specificity phoshatases or DUSPs). The tyrosine-specific MKPs include PTP-SL, STEP  and HePTP, serine/threonine-specific MKPs are PP2A and PP2C, and many DUSPs acting on MAPKs are known. Activated MAP kinases trigger activation of transcription of MKP genes. Therefore, MKPs provide a negative feedback regulatory mechanism on MAPK signaling, by inactivating MAPKs via dephosphorylation, in the cytoplasm and the nucleus. Some MKPs are more specific for ERKs, others for JNK or p38MAPK.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction176">
 <bp:evidence rdf:resource="#Evidence207" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6 binds BCAR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction175">
 <bp:evidence rdf:resource="#Evidence206" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6 phosphorylates BCAR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction170">
 <bp:evidence rdf:resource="#Evidence201" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ARHGAP35 stimulates RHOA GTPase activity</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway375">
 <bp:pathwayOrder rdf:resource="#PathwayStep2857" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2858" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2859" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2853" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2875" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2854" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2876" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2855" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2877" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2856" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2871" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2850" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2872" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2851" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2873" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2852" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2874" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2870" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2846" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2868" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2847" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2869" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2848" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2849" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2842" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2864" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2843" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2865" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2844" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2866" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2845" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2867" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2860" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2861" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2862" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2841" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2863" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2484" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2483" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2482" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2481" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2480" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2503" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2469" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2502" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2468" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2501" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2467" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2489" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2500" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2488" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2487" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2486" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2485" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2473" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2495" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2472" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2494" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2471" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2493" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2470" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2492" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2491" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2490" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2479" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2478" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2477" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2499" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2476" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2498" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2475" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2497" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2474" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2496" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2841" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NGF-stimulated transcription</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NGF stimulation induces expression of a wide array of transcriptional targets. In rat PC12 cells, a common model for NGF signaling, stimulation with NGF causes cells to exit the cell cycle and undergo a differentiation program leading to neurite outgrowth. This program is driven by the expression of immediate early genes (IEGs), which frequently encode transcription factors regulating the activity of NGF-specific delayed response genes (reviewed in Sheng and Greenberg, 1990; Flavell and Grennberg, 2008; Santiago and Bashaw, 2014).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway374">
 <bp:pathwayOrder rdf:resource="#PathwayStep2878" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2883" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2840" />
 <bp:pathwayComponent rdf:resource="#Pathway375" />
 <bp:pathwayComponent rdf:resource="#Pathway377" />
 <bp:pathwayComponent rdf:resource="#Pathway376" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2840" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear Events (kinase and transcription factor activation)</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">An important function of the kinase cascade triggered by neurotrophins is to induce the phosphorylation and activation of transcription factors in the nucleus to initiate new programs of gene expression. Transcription factors directly activated by neurotrophin signalling are responsible for induction of immediate-early genes, many of which are transcription factors. These in turn are involved in the induction of delayed-early genes.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction172">
 <bp:evidence rdf:resource="#Evidence203" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6 phosphorylates PXN</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway377">
 <bp:pathwayOrder rdf:resource="#PathwayStep2888" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2889" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2884" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2885" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2890" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2891" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2892" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2514" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2513" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2512" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2511" />
 <bp:pathwayComponent rdf:resource="#Pathway378" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2508" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2515" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2884" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK targets</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK kinases have a number of targets within the nucleus, usually transcription factors or other kinases. The best known targets, ELK1, ETS1, ATF2, MITF, MAPKAPK2, MSK1, RSK1/2/3 and MEF2 are annotated here.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction171">
 <bp:evidence rdf:resource="#Evidence202" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ARHGAP35 binds RHOA:GTP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway376">
 <bp:pathwayOrder rdf:resource="#PathwayStep2879" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2882" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2880" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2881" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2507" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2506" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2505" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2504" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2879" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CREB phosphorylation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nerve growth factor (NGF) activates multiple signalling pathways that mediate the phosphorylation of CREB at the critical regulatory site, serine 133. CREB phosphorylation at serine 133 is a crucial event in neurotrophin signalling, being mediated by ERK/RSK, ERK/MSK1 and p38/MAPKAPK2 pathways. Several kinases, such as MSK1, RSK1/2/3 (MAPKAPK1A/B/C), and MAPKAPK2, are able to directly phosphorylate CREB at S133. MSK1 is also able to activate ATF (Cyclic-AMP-dependent transcription factor). However, the NGF-induced CREB phosphorylation appears to correlate better with activation of MSK1 rather than RSK1/2/3, or MAPKAPK2. In retrograde signalling, activation of CREB occurs within 20 minutes after neurotrophin stimulation of distal axons.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep1503">
 <bp:stepProcess rdf:resource="#Pathway195" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2835">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2463" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3124">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1502">
 <bp:stepProcess rdf:resource="#Catalysis408" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1309" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2836">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2464" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3123">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1501">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1308" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2837">
 <bp:stepProcess rdf:resource="#Catalysis783" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2465" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3126">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1500">
 <bp:stepProcess rdf:resource="#Catalysis407" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1307" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2838">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2466" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3125">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1507">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1312" />
 <bp:stepProcess rdf:resource="#Catalysis411" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis727">
 <bp:controlled rdf:resource="#BiochemicalReaction2298" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2831">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2459" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3128">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1506">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1311" />
 <bp:stepProcess rdf:resource="#Catalysis410" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis726">
 <bp:controlled rdf:resource="#BiochemicalReaction2293" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2832">
 <bp:stepProcess rdf:resource="#Catalysis780" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2460" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3127">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1505">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1310" />
 <bp:stepProcess rdf:resource="#Catalysis409" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis729">
 <bp:controlled rdf:resource="#BiochemicalReaction2303" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2833">
 <bp:stepProcess rdf:resource="#Catalysis781" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2461" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1504">
 <bp:stepProcess rdf:resource="#Pathway196" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis728">
 <bp:controlled rdf:resource="#BiochemicalReaction2301" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2834">
 <bp:stepProcess rdf:resource="#Catalysis782" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2462" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3129">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis723">
 <bp:controlled rdf:resource="#BiochemicalReaction2288" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis722">
 <bp:controlled rdf:resource="#BiochemicalReaction2287" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis725">
 <bp:controlled rdf:resource="#BiochemicalReaction2292" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis724">
 <bp:controlled rdf:resource="#BiochemicalReaction2291" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2830">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2458" />
 <bp:stepProcess rdf:resource="#Catalysis779" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3120">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis721">
 <bp:controlled rdf:resource="#BiochemicalReaction2282" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence3122">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis720">
 <bp:controlled rdf:resource="#BiochemicalReaction2280" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence3121">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep192">
 <bp:stepProcess rdf:resource="#BiochemicalReaction164" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep193">
 <bp:stepProcess rdf:resource="#BiochemicalReaction165" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep190">
 <bp:stepProcess rdf:resource="#BiochemicalReaction163" />
 <bp:stepProcess rdf:resource="#Catalysis75" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep191">
 <bp:stepProcess rdf:resource="#Pathway29" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep198">
 <bp:stepProcess rdf:resource="#BiochemicalReaction169" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1509">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1314" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep199">
 <bp:stepProcess rdf:resource="#Pathway31" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1508">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1313" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep196">
 <bp:stepProcess rdf:resource="#BiochemicalReaction167" />
 <bp:stepProcess rdf:resource="#Catalysis76" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2839">
 <bp:stepProcess rdf:resource="#Pathway374" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep197">
 <bp:stepProcess rdf:resource="#BiochemicalReaction168" />
 <bp:stepProcess rdf:resource="#Catalysis77" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep194">
 <bp:stepProcess rdf:resource="#BiochemicalReaction166" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep195">
 <bp:stepProcess rdf:resource="#Pathway30" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1514">
 <bp:stepProcess rdf:resource="#Pathway197" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2846">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2472" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3113">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1513">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1318" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2847">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2473" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3112">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1512">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1317" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2848">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2474" />
 <bp:stepProcess rdf:resource="#Catalysis785" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3115">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1511">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1316" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2849">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2475" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3114">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1518">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1322" />
 <bp:stepProcess rdf:resource="#Catalysis414" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis738">
 <bp:controlled rdf:resource="#BiochemicalReaction2365" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2842">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2468" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3117">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1517">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1321" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis737">
 <bp:controlled rdf:resource="#BiochemicalReaction2358" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2843">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2469" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3116">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1516">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1320" />
 <bp:stepProcess rdf:resource="#Catalysis413" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2844">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2470" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3119">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1515">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1319" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis739">
 <bp:controlled rdf:resource="#BiochemicalReaction2367" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2845">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2471" />
 <bp:stepProcess rdf:resource="#Catalysis784" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3118">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis734">
 <bp:controlled rdf:resource="#BiochemicalReaction2350" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis733">
 <bp:controlled rdf:resource="#BiochemicalReaction2347" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis736">
 <bp:controlled rdf:resource="#BiochemicalReaction2354" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2840">
 <bp:stepProcess rdf:resource="#Pathway375" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis735">
 <bp:controlled rdf:resource="#BiochemicalReaction2351" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2841">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2467" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1510">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1315" />
 <bp:stepProcess rdf:resource="#Catalysis412" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis730">
 <bp:controlled rdf:resource="#BiochemicalReaction2316" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis732">
 <bp:controlled rdf:resource="#BiochemicalReaction2346" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence3111">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis731">
 <bp:controlled rdf:resource="#BiochemicalReaction2320" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence3110">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep181">
 <bp:stepProcess rdf:resource="#BiochemicalReaction155" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep182">
 <bp:stepProcess rdf:resource="#BiochemicalReaction156" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep180">
 <bp:stepProcess rdf:resource="#BiochemicalReaction154" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep189">
 <bp:stepProcess rdf:resource="#BiochemicalReaction162" />
 <bp:stepProcess rdf:resource="#Catalysis74" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep187">
 <bp:stepProcess rdf:resource="#BiochemicalReaction160" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep188">
 <bp:stepProcess rdf:resource="#BiochemicalReaction161" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1519">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1323" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep185">
 <bp:stepProcess rdf:resource="#Catalysis72" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction158" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep186">
 <bp:stepProcess rdf:resource="#Catalysis73" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction159" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep183">
 <bp:stepProcess rdf:resource="#BiochemicalReaction157" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep184">
 <bp:stepProcess rdf:resource="#Pathway28" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2813">
 <bp:stepProcess rdf:resource="#Pathway371" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3146">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2814">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2444" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3145">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2815">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2445" />
 <bp:stepProcess rdf:resource="#Catalysis773" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3148">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2816">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2446" />
 <bp:stepProcess rdf:resource="#Catalysis774" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3147">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis749">
 <bp:controlled rdf:resource="#BiochemicalReaction2392" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction199">
 <bp:evidence rdf:resource="#Evidence233" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6 phosphorylates SFPQ</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis748">
 <bp:controlled rdf:resource="#BiochemicalReaction2390" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2810">
 <bp:stepProcess rdf:resource="#Catalysis771" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2441" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3149">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2811">
 <bp:stepProcess rdf:resource="#Catalysis772" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2442" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2812">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2443" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis745">
 <bp:controlled rdf:resource="#BiochemicalReaction2381" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis744">
 <bp:controlled rdf:resource="#BiochemicalReaction2379" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis747">
 <bp:controlled rdf:resource="#BiochemicalReaction2386" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence3140">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis746">
 <bp:controlled rdf:resource="#BiochemicalReaction2385" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis741">
 <bp:controlled rdf:resource="#BiochemicalReaction2371" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence3142">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis740">
 <bp:controlled rdf:resource="#BiochemicalReaction2370" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence3141">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis743">
 <bp:controlled rdf:resource="#BiochemicalReaction2376" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence3144">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis742">
 <bp:controlled rdf:resource="#BiochemicalReaction2373" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence3143">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep170">
 <bp:stepProcess rdf:resource="#BiochemicalReaction147" />
 <bp:stepProcess rdf:resource="#Catalysis68" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep171">
 <bp:stepProcess rdf:resource="#BiochemicalReaction148" />
 <bp:stepProcess rdf:resource="#Catalysis69" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis750">
 <bp:controlled rdf:resource="#BiochemicalReaction2393" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep178">
 <bp:stepProcess rdf:resource="#Catalysis71" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction152" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep179">
 <bp:stepProcess rdf:resource="#BiochemicalReaction153" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep176">
 <bp:stepProcess rdf:resource="#Catalysis70" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction150" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep177">
 <bp:stepProcess rdf:resource="#BiochemicalReaction151" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep174">
 <bp:stepProcess rdf:resource="#Pathway27" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2817">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2447" />
 <bp:stepProcess rdf:resource="#Catalysis775" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep175">
 <bp:stepProcess rdf:resource="#BiochemicalReaction149" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2818">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2448" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep172">
 <bp:stepProcess rdf:resource="#Pathway25" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2819">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2449" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep173">
 <bp:stepProcess rdf:resource="#Pathway26" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2824">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2454" />
 <bp:stepProcess rdf:resource="#Catalysis776" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3135">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2825">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2455" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3134">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2826">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2456" />
 <bp:stepProcess rdf:resource="#Catalysis777" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3137">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2827">
 <bp:stepProcess rdf:resource="#Pathway372" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3136">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2820">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2450" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3139">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis759">
 <bp:controlled rdf:resource="#BiochemicalReaction2410" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2821">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2451" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3138">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep169">
 <bp:stepProcess rdf:resource="#Pathway24" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2822">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2452" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2823">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2453" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis756">
 <bp:controlled rdf:resource="#BiochemicalReaction2404" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis755">
 <bp:controlled rdf:resource="#BiochemicalReaction2403" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis758">
 <bp:controlled rdf:resource="#BiochemicalReaction2406" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis757">
 <bp:controlled rdf:resource="#BiochemicalReaction2405" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis752">
 <bp:controlled rdf:resource="#BiochemicalReaction2396" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence3131">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis751">
 <bp:controlled rdf:resource="#BiochemicalReaction2394" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence3130">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis754">
 <bp:controlled rdf:resource="#BiochemicalReaction2400" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence3133">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis753">
 <bp:controlled rdf:resource="#BiochemicalReaction2398" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence3132">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep160">
 <bp:stepProcess rdf:resource="#BiochemicalReaction138" />
 <bp:stepProcess rdf:resource="#Catalysis63" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis761">
 <bp:controlled rdf:resource="#BiochemicalReaction2415" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis760">
 <bp:controlled rdf:resource="#BiochemicalReaction2413" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep167">
 <bp:stepProcess rdf:resource="#BiochemicalReaction145" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep168">
 <bp:stepProcess rdf:resource="#BiochemicalReaction146" />
 <bp:stepProcess rdf:resource="#Catalysis67" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep165">
 <bp:stepProcess rdf:resource="#BiochemicalReaction143" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep166">
 <bp:stepProcess rdf:resource="#BiochemicalReaction144" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep163">
 <bp:stepProcess rdf:resource="#BiochemicalReaction141" />
 <bp:stepProcess rdf:resource="#Catalysis66" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2828">
 <bp:stepProcess rdf:resource="#Pathway373" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep164">
 <bp:stepProcess rdf:resource="#BiochemicalReaction142" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2829">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2457" />
 <bp:stepProcess rdf:resource="#Catalysis778" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep161">
 <bp:stepProcess rdf:resource="#BiochemicalReaction139" />
 <bp:stepProcess rdf:resource="#Catalysis64" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep162">
 <bp:stepProcess rdf:resource="#BiochemicalReaction140" />
 <bp:stepProcess rdf:resource="#Catalysis65" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction215">
 <bp:evidence rdf:resource="#Evidence252" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDC14A,B bind MAPK6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction214">
 <bp:evidence rdf:resource="#Evidence251" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of PAKs by RAC1 and CDC42</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction217">
 <bp:evidence rdf:resource="#Evidence254" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MYC positively regulates MAPKAPK5 gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction216">
 <bp:evidence rdf:resource="#Evidence253" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-T182-MAPKAPK5 phoshphorylates DNAJB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction211">
 <bp:evidence rdf:resource="#Evidence248" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-T182 MAPKAPK5 binds DNAJB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway317">
 <bp:pathwayOrder rdf:resource="#PathwayStep2449" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2453" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2450" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2451" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2452" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2137" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2136" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2135" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2134" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2133" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2449" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MET activates PTK2 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MET receptor activates the focal adhesion kinase PTK2 (FAK1) in a process that depends on the simultaneous interaction of PTK2 with integrins and with MET. SRC is needed for PTK2 to become fully active. Activation of PTK2 is needed for HGF-induced cell motility (Beviglia et al. 1999, Parr et al. 2001, Chen and Chen 2006, Lietha et al. 2007, Chen et al. 2011, Brami-Cherrier et al. 2014).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction210">
 <bp:evidence rdf:resource="#Evidence247" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK4,6 translocate to the cytoplasm</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway316">
 <bp:pathwayOrder rdf:resource="#PathwayStep2446" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2447" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2132" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2131" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2446" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MET interacts with TNS proteins</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of MET with tensin protein TNS4 at focal adhesion sites promotes cell motility through and unknown mechanism. MET also interacts with TNS3, whose expression seems to be inversely correlated with TNS4 (Muharram et al. 2014).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction213">
 <bp:evidence rdf:resource="#Evidence250" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IGF2BP1 represses translation of MAPK4 mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep279">
 <bp:stepProcess rdf:resource="#Pathway39" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway319">
 <bp:pathwayOrder rdf:resource="#PathwayStep2464" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2465" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2461" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2462" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2463" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2147" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2146" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2145" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2144" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2143" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2461" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MET activates PI3K/AKT signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MET binds and phosphorylates the adapter protein GAB1, thus creating a docking site for the regulatory subunit PIK3R1 of the PI3K complex. Recruitment of PI3K to MET-bound phosphorylated GAB1 results in PI3K activation, production of PIP3, and stimulation of downstream AKT signaling (Rodrigues et al. 2000, Schaeper et al. 2000).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction212">
 <bp:evidence rdf:resource="#Evidence249" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK4,6 translocate to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway318">
 <bp:pathwayOrder rdf:resource="#PathwayStep2457" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2458" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2459" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2455" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2456" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2139" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2138" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2142" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2141" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2140" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2455" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MET activates RAP1 and RAC1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The adapter protein GAB1 is involved in recruitment, through CRK and related CRKL proteins, of guanyl nucleotide exchange factors (GEFs) to the activated MET receptor. MET-associated GEFs, such as RAPGEF1 (C3G) and DOCK7, activate RAP1 and RAC1, respectively, leading to morphological changes that contribute to cell motility (Schaeper et al. 2000, Sakkab et al. 2000, Lamorte et al. 2002, Watanabe et al. 2006, Murray et al. 2014).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2143">
 <bp:evidence rdf:resource="#Evidence2462" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MET phosphorylates GAB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2142">
 <bp:evidence rdf:resource="#Evidence2460" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DOCK7 activates RAC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2141">
 <bp:evidence rdf:resource="#Evidence2459" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAPGEF1 binds CRK,CRKL</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2140">
 <bp:evidence rdf:resource="#Evidence2458" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GAB1 recruits CRK,CRKL to MET</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction219">
 <bp:evidence rdf:resource="#Evidence256" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MYC mRNA translation is negatively regulated by miR-34B and C</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction218">
 <bp:evidence rdf:resource="#Evidence255" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK6 is degraded by the 26S proteasome</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep270">
 <bp:stepProcess rdf:resource="#BiochemicalReaction234" />
 <bp:stepProcess rdf:resource="#Catalysis105" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2149">
 <bp:evidence rdf:resource="#Evidence2470" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT3 binds activated MET receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2148">
 <bp:evidence rdf:resource="#Evidence2468" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GAB1 binds PTPN11</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2147">
 <bp:evidence rdf:resource="#Evidence2466" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated MET binds GAB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2146">
 <bp:evidence rdf:resource="#Evidence2465" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MET bound PI3K generates PIP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2145">
 <bp:evidence rdf:resource="#Evidence2464" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated GAB1 recruits PI3K to MET</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2144">
 <bp:evidence rdf:resource="#Evidence2463" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated MET binds GAB1 and GRB2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep277">
 <bp:stepProcess rdf:resource="#Catalysis109" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction241" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway324">
 <bp:pathwayOrder rdf:resource="#PathwayStep2491" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2501" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2502" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2503" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2497" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2498" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2499" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2500" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2494" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2495" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2496" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2179" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2178" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2177" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2176" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2175" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2174" />
 <bp:pathwayComponent rdf:resource="#Pathway325" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2173" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2172" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2171" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2170" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2491" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Negative regulation of MET activity</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by MET receptor is negatively regulated mainly by MET receptor dephosphorylation or MET receptor degradation. Protein tyrosine phosphatase PTPRJ dephosphorylates MET tyrosine residue Y1349, thus removing the docking site for the GAB1 adapter (Palka et al. 2003). Protein tyrosine phosphatases PTPN1 and PTPN2 dephosphorylate MET tyrosines Y1234 and Y1235 in the kinase activation loop, thus attenuating catalytic activity of MET (Sangwan et al. 2008). The E3 ubiquitin ligase CBL promotes ubiquitination of the activated MET receptor and subsequent MET degradation. CBL contains a RING finger domain that engages E2 protein ubiquitin ligases to mediate ubiquitination of MET, which may occur at the cell membrane or in the early endocytic compartment. Ubiquitinated MET is degraded in a late endosomal or lysosomal compartment in a proteasome-dependent manner. The involvement of proteasome in MET degradation seems to be indirect, through an effect on MET endocytic trafficking (Jeffers et al. 1997, Peschard et al. 2001, Hammond et al. 2001, Petrelli et al. 2002). LRIG1 promotes lysosome-dependent degradation of MET in the absence of HGF-mediated activation (Lee et al. 2014, Oh et al. 2014). MET-mediated activation of RAS signaling is inhibited by MET receptor binding to MUC20 (Higuchi et al. 2004) or RANBP10 (Wang et al. 2004).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep278">
 <bp:stepProcess rdf:resource="#Pathway38" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway323">
 <bp:pathwayOrder rdf:resource="#PathwayStep2480" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2481" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2486" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2487" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2488" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2489" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2482" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2483" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2484" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2485" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2159" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2158" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2167" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2166" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2165" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2164" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2163" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2162" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2161" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2160" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2480" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MET activates RAS signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated MET receptor recruits the RAS guanyl nucleotide exchange factor (GEF) SOS1 indirectly, either through the GRB2 adapter (Ponzetto et al. 1994, Fournier et al. 1996, Shen and Novak 1997, Besser et al. 1997), GAB1 (Weidner et al. 1996) or SHC1 and GRB2 (Pelicci et al. 1995), or RANBP9 (Wang et al. 2002, Wang et al. 2004). Association of SOS1 with the activated MET receptor complex leads to exchange of GDP to GTP on RAS and activation of RAS signaling (Pelicci et al. 1995, Besser et al. 1997, Shen and Novak 1997, Wang et al. 2004). PTPN11 (SHP2) may contribute to activation of RAS signaling downstream of MET (Schaeper et al. 2000, Furcht et al. 2014). Sustained activation of MAPK1 (ERK2) and MAPK3 (ERK1) downstream of MET-activated RAS may require MET endocytosis and signaling from endosomes (Peschard et al. 2001, Hammond et al. 2001, Petrelli et al. 2002, Kermorgant and Parker 2008). Binding of MET to MUC20 or RANBP10 interferes with RAS activation (Higuchi et al. 2004, Wang et al. 2004). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction220">
 <bp:evidence rdf:resource="#Evidence257" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S MAPK6,4 phosphorylate MAPKAPK5</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep275">
 <bp:stepProcess rdf:resource="#BiochemicalReaction239" />
 <bp:stepProcess rdf:resource="#Catalysis108" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway326">
 <bp:pathwayOrder rdf:resource="#PathwayStep2505" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2506" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2181" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2180" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2505" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MET receptor recycling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated MET receptor is subject to recycling from the plasma membrane through the endosomal compartment and back to the plasma membrane (Peschard et al. 2001, Hammond et al. 2001, Petrelli et al. 2002). In the recycling process, activated MET receptor is endocytosed, and the GGA3 protein directs it, via a largely unknown mechanism, through the RAB4 positive endosomal compartments back to the plasma membrane (Parachoniak et al. 2011). Endosomal signaling by MET during the recycling process appears to play an important role in sustained activation of ERK1/ERK2 (MAPK3/MAPK1) and STAT3 downstream of MET (Kermorgant and Parker 2008).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep276">
 <bp:stepProcess rdf:resource="#BiochemicalReaction240" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway325">
 <bp:pathwayOrder rdf:resource="#PathwayStep2492" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2493" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2169" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2168" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2492" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Drug-mediated inhibition of MET activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MET receptor tyrosine kinase (RTK) is a proto-oncogene that is frequently aberrantly activated in cancer through gene amplification and/or activating mutations that result in hypersensitivity to HGF stimulation or HGF-independent activation. Oncogenic MET activation can occur as a primary mechanism of malignant transformation or be selected secondarily, as a mechanism of resistance to therapeutics that target related RTKs, such as EGFR. MET targeted anti-cancer therapeutics, either recombinant monoclonal antibodies (MAbs) or small tyrosine kinase inhibitors (TKIs), have shown promise as a first-line agents for the treatment of solid tumors with primary MET activation or as second-line agents for the treatment of solid tumors with acquired MET-mediated resistance to other RTK-targeted therapies (reviewed in Comoglio et al. 2018).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep273">
 <bp:stepProcess rdf:resource="#BiochemicalReaction237" />
 <bp:stepProcess rdf:resource="#Catalysis107" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway320">
 <bp:pathwayOrder rdf:resource="#PathwayStep2467" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2148" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2467" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MET activates PTPN11</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTPN11 (SHP2), recruited to activated MET receptor through GAB1, is phosphorylated in response to HGF treatment, although phosphorylation sites and direct MET involvement have not been examined (Schaeper et al. 2000, Duan et al. 2006). Phosphorylation of PTPN11 in response to HGF treatment is required for the recruitment and activation of sphingosine kinase SPHK1, which may play a role in HGF-induced cell scattering (Duan et al. 2006). While PTPN11 promotes MAPK3/1 (ERK1/2) signaling downstream of MET, it can also dephosphorylate MET on unidentified tyrosine residues (Furcht et al. 2014).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep274">
 <bp:stepProcess rdf:resource="#BiochemicalReaction238" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep271">
 <bp:stepProcess rdf:resource="#BiochemicalReaction235" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway322">
 <bp:pathwayOrder rdf:resource="#PathwayStep2475" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2476" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2477" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2478" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2474" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2157" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2156" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2155" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2154" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2153" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2474" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MET Receptor Activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hepatocyte growth factor (HGF), the ligand for MET receptor tyrosine kinase (RTK), is secreted into the extracellular matrix (ECM) as an inactive single chain precursor (pro-HGF). The biologically active HGF is the heterodimer of alpha and beta chains that are produced via proteolytic cleavage of pro-HGF by the plasma membrane bound serine protease Hepsin (HPN) (Kirchhofer et al. 2005, Owen et al. 2010) or the ECM-associated serine protease Hepatocyte growth factor activator (HGFAC, commonly known as HGFA) (Shia et al. 2005). HGF binds to the extracellular SEMA and PSI domains of MET RTK, inducing a conformational change that enables MET dimerization or oligomerization (Kirchhofer et al. 2004, Stamos et al. 2004, Hays and Watowich 2004, Gherardi et al. 2006). MET dimers trans-autophosphorylate on tyrosine residues in the activation loop, leading to increased kinase activity, and on tyrosine residues at the cytoplasmic tail that serve as docking sites for adapter proteins involved in MET signal transduction (Ferracini et al. 1991, Longati et al. 1994, Rodrigues and Park 1994, Ponzetto et al. 1994). CD44v6 was implicated as a MET co-receptor, but its role has been disputed (Orian-Rousseau et al. 2002, Dortet et al. 2010, Olaku et al. 2011, Hasenauer et al. 2013, Elliot et al. 2014).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep272">
 <bp:stepProcess rdf:resource="#BiochemicalReaction236" />
 <bp:stepProcess rdf:resource="#Catalysis106" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway321">
 <bp:pathwayOrder rdf:resource="#PathwayStep2470" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2469" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2471" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2472" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2149" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2152" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2151" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2150" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2469" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MET activates STAT3</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The STAT3 transcription factor binds to activated MET through phosphorylated tyrosine residue Y1356 of MET. STAT3 may also bind to activated MET indirectly through GAB1, but this interaction has not been studied in detail. Activated MET induces phosphorylation of STAT3 at Y705, triggering STAT3 dimerization and nuclear translocation (Schaper et al. 1997, Boccaccio et al. 1998, Zhang et al. 2002, Cramer et al. 2005). Endocytosis of MET and interaction with STAT3 at endosomes may be required for sustained STAT3 phosphorylation in response to HGF stimulation (Kermorgant and Parker 2008). Activated SRC may also contribute to phosphorylation of STAT3 at Y705. STAT3 may promote HGF transcription in a SRC-dependent way, but this autocrine HGF loop may be limited to breast cancer cells (Wojcik et al. 2006, Sam et al. 2007). MET-mediated activation of STAT3 is implicated in anchorage independent cell growth and invasiveness downstream of HGF (Zhang et al. 2002, Cramer et al. 2005). MET can also interact with STAT1A, STAT1B and STAT5, but the biological importance of these interactions is not known (Runge et al. 1999).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction226">
 <bp:evidence rdf:resource="#Evidence263" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S215 FOXO1 binds RAG gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction225">
 <bp:evidence rdf:resource="#Evidence262" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKA phosphorylates MAPKAPK5</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway309">
 <bp:pathwayOrder rdf:resource="#PathwayStep2391" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2392" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2393" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2085" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2084" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2083" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2391" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EGFR interacts with phospholipase C-gamma</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated epidermal growth factor receptors (EGFR) can stimulate phosphatidylinositol (PI) turnover. Activated EGFR can activate phospholipase C-gamma1 (PLC-gamma1, i.e. PLCG1) which hydrolyses phosphatidylinositol 4,5-bisphosphate (PIP2) to inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG). IP3 is instrumental in the release of calcium from intracellular stores and DAG is involved in protein kinase C activation.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction228">
 <bp:evidence rdf:resource="#Evidence265" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Autophosphorylation of PAK1,2,3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction227">
 <bp:evidence rdf:resource="#Evidence264" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO3 regulates MIR34B,C expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction222">
 <bp:evidence rdf:resource="#Evidence259" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JUN positively regulates MAPK6 gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway306">
 <bp:pathwayOrder rdf:resource="#PathwayStep2349" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2350" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2351" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2046" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2045" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2044" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2349" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRB2 events in EGFR signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Autophosphorylated EGFR tyrosine residues are docking sites for many downstream effectors in EGFR signaling. The adaptor protein GRB2 binds to phosphotyrosine residues in the C-tail of EGFR through its SH2 domain. GRB2 is constitutively associated with SOS, a guanine nucleotide exchange factor of RAS. GRB2 binding to phosphorylated EGFR results in the recruitment of SOS to the plasma membrane where it comes in proximity to RAS. This mechanism has been seen to be the model for RAS activation.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction221">
 <bp:evidence rdf:resource="#Evidence258" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S215 FOXO3 binds MIR34B and C gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway305">
 <bp:pathwayOrder rdf:resource="#PathwayStep2343" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2344" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2345" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2342" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2039" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2038" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2041" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2040" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2342" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHC1 events in EGFR signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRB2 can bind EGFR directly or through another SH2-containing protein, SHC1. This association leads  to RAS activation.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction224">
 <bp:evidence rdf:resource="#Evidence261" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S MAPK6,4 binds MAPKAPK5</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep268">
 <bp:stepProcess rdf:resource="#BiochemicalReaction232" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway308">
 <bp:pathwayOrder rdf:resource="#PathwayStep2369" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2376" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2387" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2377" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2388" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2367" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2378" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2368" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2379" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2372" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2383" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2373" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2384" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2374" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2385" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2375" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2386" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2380" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2370" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2381" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2371" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2382" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2080" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2066" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2077" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2065" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2076" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2064" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2075" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2063" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2074" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2062" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2073" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2061" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2072" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2060" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2071" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2070" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2081" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2069" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2068" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2079" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2067" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2078" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2367" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EGFR downregulation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of receptor tyrosine kinase (RTK) activity is implicated in the control of almost all cellular functions. One of the best understood RTKs is epidermal growth factor receptor (EGFR). Growth factors can bind to EGFR and activate it to initiate signalling cascades within the cell. EGFRs can also be recruited to clathrin-coated pits which can be internalised into endocytic vesicles. From here, EGFRs can either be recycled back to the plasma membrane or directed to lysosomes for destruction.This provides a mechanism by which EGFR signalling is negatively regulated and controls the strength and duration of EGFR-induced signals. It also prevents EGFR hyperactivation as commonly seen in tumorigenesis.  The proto-oncogene Cbl can negatively regulate EGFR signalling. The Cbl family of RING-type ubiquitin ligases are able to poly-ubiquitinate EGFR, an essential step in EGFR degradation. All Cbl proteins have a unique domain that recognises phosphorylated tyrosine residues on activated EGFRs. They also direct the ubiquitination and degradation of activated EGFRs by recruiting ubiquitin-conjugation enzymes. Cbl proteins function by specifically targeting activated EGFRs and mediating their down-regulation, thus providing a means by which signaling processes can be negatively regulated.  Cbl also promotes receptor internalization via it&apos;s interaction with an adaptor protein, CIN85 (Cbl-interacting protein of 85kDa). CIN85 binds to Cbl via it&apos;s SH3 domain and is enhanced by the EGFR-induced tyrosine phosphorylation of Cbl. The proline-rich region of CIN85 interacts with endophilins which are regulatory components of clathrin-coated vesicles (CCVs). Endophilins bind to membranes and induce membrane curvature, in conjunction with other proteins involved in CCV formation. The rapid recruitment of endophilin to the activated receptor complex by CIN85 is the mechanism which controls receptor internalization.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction223">
 <bp:evidence rdf:resource="#Evidence260" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S MAPK6 phosphorylates NCOA3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep269">
 <bp:stepProcess rdf:resource="#BiochemicalReaction233" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway307">
 <bp:pathwayOrder rdf:resource="#PathwayStep2360" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2358" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2359" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2354" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2355" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2356" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2357" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2361" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2362" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2363" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2353" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2049" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2048" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2047" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2057" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2056" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2055" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2054" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2053" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2052" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2051" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2050" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2353" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GAB1 signalosome</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GAB1 is recruited to the activated EGFR indirectly, through GRB2. GAB1 acts as an adaptor protein that enables formation of an active PIK3, through recruitment of PIK3 regulatory subunit PIK3R1 (also known as PI3Kp85), which subsequently recruits PIK3 catalytic subunit PIK3CA (also known as PI3Kp110). PIK3, in complex with EGFR, GRB2 and GAB1, catalyzes phosphorylation of PIP2 and its conversion to PIP3, which leads to the activation of the AKT signaling. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2132">
 <bp:evidence rdf:resource="#Evidence2448" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MET binds TNS3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2131">
 <bp:evidence rdf:resource="#Evidence2447" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MET binds TNS4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2130">
 <bp:evidence rdf:resource="#Evidence2443" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HPN heterodimer cleaves pro-MST1 to form MST1 dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction229">
 <bp:evidence rdf:resource="#Evidence266" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-T182 MAPKAPK5 phosphorylates FOXO3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2139">
 <bp:evidence rdf:resource="#Evidence2457" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAPGEF1 activates RAP1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2138">
 <bp:evidence rdf:resource="#Evidence2456" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CRK,CRKL recruits RAC1 GEF to activated MET</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2137">
 <bp:evidence rdf:resource="#Evidence2454" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y397-PTK2 binds SRC</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2136">
 <bp:evidence rdf:resource="#Evidence2453" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MET phosphorylates PTK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2135">
 <bp:evidence rdf:resource="#Evidence2452" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SRC phosphorylates PTK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2134">
 <bp:evidence rdf:resource="#Evidence2451" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK2 binds activated MET</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2133">
 <bp:evidence rdf:resource="#Evidence2450" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK2 autophosphorylates</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep266">
 <bp:stepProcess rdf:resource="#BiochemicalReaction230" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway313">
 <bp:pathwayOrder rdf:resource="#PathwayStep2439" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2442" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2440" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2441" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2129" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2128" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2127" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2130" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2439" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by MST1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Inflammatory mediators such as growth factors produced by macrophages play an important role in the inflammatory response occurring during bacterial infection, tissue injury and immune responses. Many growth factors and their receptor-type protein tyrosine kinases (RTKs) play a critical role in inflammation, wound healing and tissue remodelling. The growth factor hepatocyte growth factor-like protein (MST1, also known as macrophage-stimulating protein, MSP) binds to a specific receptor, macrophage-stimulating protein receptor (MST1R, also known as RON, recepteur d&apos;origine nantais). MST1 belongs to the kringle protein family, which includes HGF and plasminogen. It is produced by the liver and circulates in the blood as a biologically-inactive single chain precursor (pro-MST1). Proteolytic cleavage of pro-MST1 into the biologically-active MST1 dimer is necessary for receptor binding. Cleavage occurs during blood coagulation and at inflammatory sites, the resultant MST1 dimer then binds MST1R receptors on local macrophages. MST1R is ubiquitously expressed but mainly in epithelial cells.  MST1 binding to MST1R promotes receptor homodimerisation which in turn allows autophosphorylation of two tyrosine residues within the catalytic site which regulates kinase activity and allows phosphorylation of the carboxy-terminal binding site of the receptor. The docking site is essential for downstream signaling through direct and indirect binding of SH2 domain-containing adaptor proteins such as GRB2, PI3K, and SRC. MST1/MST1R signaling plays a dual role in regulating inflammation; initially stimulating chemotaxis and phagocytosis (macrophage activation) and then exerts broad inhibitory effects on macrophages, limiting the extent of inflammtory responses (Wang et al. 2002). MST1R is upregulated in many epithelial cancers where it is thought to play a role in the progression of these types of cancer (Kretschmann et al. 2010).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep267">
 <bp:stepProcess rdf:resource="#BiochemicalReaction231" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway312">
 <bp:pathwayOrder rdf:resource="#PathwayStep2428" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2429" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2435" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2436" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2437" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2431" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2432" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2433" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2434" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2430" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2118" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2117" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2126" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2125" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2124" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2123" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2122" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2121" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2120" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2119" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2428" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by LTK</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Leukocyte tyrosine kinase (LTK) is a transmembrane receptor tyrosine kinase that is a member of the insulin growth factor receptor superfamily. LTK is most closely related to the ALK receptor, and may have originated as a result of a duplication event of the ALK gene (Krowelski and Dalla-Favera, 1991; Dornburg et al, 2021). The extracellular domains of ALK and LTK are characterized by a membrane proximal EGF-like (EGFL) module, a unique 250 amino acid glycine rich (GR) domain that, in Drosophila, is essential for function (Englund et al, 2003), as well as a TNF-like (TNFL) module. The ALK ECD additionally contains two MAM domains, an LDLa domain and a heparin-binding domain (HBD) that are not present in the LTK receptor (Iwahara et al, 1997; Morris et al, 1997; DeMunck et al, 2021). These differences in ECD may contribute to differences in the ligand binding affinities of the two receptors. LTK is activated by the binding of cytokines ALKAL1 and ALKAL2 to the ECD (Zhang et al, 2014; Reshetnyak et al, 2015; Reshetnyak et al, 2018). Ligand binding induces trans-autophosphorylation in the intracellular domain of the receptor and promotes the interaction and activation of downstream signaling molecules such as SHC, IRS1, CBL and PI3K with the phosphorylated receptor (Kozutsumi et al, 1994; Honda et al, 1994; Ueno et al, 1995; Ueno et al, 1996; Ueno et al, 1997; Li et al, 2004; Yamada et al, 2008). Note however that much of the early functional studies on LTK were conducted before the identification of ALKAL1 and 2 as physiological ligands. In consequence, many of these studies were carried out using chimeric receptors consisting of the ECD (and stimulating ligands) of well-characterized receptors fused to the intracellular domain of LTK. The exact role of LTK signaling is likewise not fully elucidated. Expression of the chimeric LTK proteins described above promotes neurite outgrowth and cell survival (Ueno et al, 1997; Yamada et al, 2008). A role for LTK in the regulation of transport from the ER to the Golgi has also been proposed, and one study suggests that LTK may actually bean ER-resident protein (Farhan et al, 2010; Centonze et al, 2019). More recently, fusions of LTK have been identified in non-small cell lung cancer (Izumi et al, 2021).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep264">
 <bp:stepProcess rdf:resource="#BiochemicalReaction228" />
 <bp:stepProcess rdf:resource="#Catalysis103" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction231">
 <bp:evidence rdf:resource="#Evidence268" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S857 NCOA3:ETV4 bind MMP2 and MMP10 promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway315">
 <bp:pathwayOrder rdf:resource="#PathwayStep2448" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2454" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2445" />
 <bp:pathwayComponent rdf:resource="#Pathway317" />
 <bp:pathwayComponent rdf:resource="#Pathway316" />
 <bp:pathwayComponent rdf:resource="#Pathway318" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2445" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MET promotes cell motility</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Direct and indirect interactions of MET with integrins, focal adhesion kinase PTK2 (FAK1), tensin-4 (TNS4) and GTPases RAP1 and RAC1, induce morphological changes that promote cell motility and play an important role in HGF-induced invasiveness of cancer cells (Weidner et al. 1993, Beviglia et al. 1999, Sakkab et al. 2000, Parr et al. 2001, Trusolino et al. 2001, Lamorte et al. 2002, Chen and Chen 2006, Watanabe et al. 2006, Muharram et al. 2014, Murray et al. 2014).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep265">
 <bp:stepProcess rdf:resource="#BiochemicalReaction229" />
 <bp:stepProcess rdf:resource="#Catalysis104" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction230">
 <bp:evidence rdf:resource="#Evidence267" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S215 FOXO1 positively regulates RAG gene expression </bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway314">
 <bp:pathwayOrder rdf:resource="#PathwayStep2490" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2468" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2479" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2504" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2444" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2466" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2460" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2473" />
 <bp:pathwayComponent rdf:resource="#Pathway319" />
 <bp:pathwayComponent rdf:resource="#Pathway324" />
 <bp:pathwayComponent rdf:resource="#Pathway323" />
 <bp:pathwayComponent rdf:resource="#Pathway315" />
 <bp:pathwayComponent rdf:resource="#Pathway326" />
 <bp:pathwayComponent rdf:resource="#Pathway320" />
 <bp:pathwayComponent rdf:resource="#Pathway322" />
 <bp:pathwayComponent rdf:resource="#Pathway321" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2444" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by MET</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MET is a receptor tyrosine kinase (RTK) (Cooper et al. 1984, Park et al. 1984) activated by binding to its ligand, Hepatocyte growth factor/Scatter factor (HGF/SF) (Bottaro et al. 1991, Naldini et al. 1991). Similar to other related RTKs, such as EGFR, ligand binding induces MET dimerization and trans-autophosphorylation, resulting in the active MET receptor complex (Ferracini et al. 1991, Longati et al. 1994, Rodrigues and Park 1994, Kirchhofer et al. 2004, Stamos et al. 2004, Hays and Watowich 2004). Phosphorylated tyrosines in the cytoplasmic tail of MET serve as docking sites for binding of adapter proteins, such as GRB2, SHC1 and GAB1, which trigger signal transduction cascades that activate PI3K/AKT, RAS, STAT3, PTK2, RAC1 and RAP1 signaling (Ponzetto et al. 1994, Pelicci et al. 1995, Weidner et al. 1995, Besser et al. 1997, Shen and Novak 1997, Beviglia and Kramer 1999, Rodrigues et al. 2000, Sakkab et al. 2000, Schaeper et al. 2000, Lamorte et al. 2002, Wang et al. 2002, Chen and Chen 2006, Palamidessi et al. 2008, Chen et al. 2011, Murray et al. 2014). Activation of PLC gamma 1 (PLCG1) signaling by MET remains unclear. It has been reported that PLCG1 can bind to MET directly (Ponzetto et al. 1994) or be recruited by phosphorylated GAB1 (Gual et al. 2000). Tyrosine residue Y307 of GAB1 that serves as docking sites for PLCG1 may be phosphorylated either by activated MET (Watanabe et al. 2006) or SRC (Chan et al. 2010). Another PCLG1 docking site on GAB1, tyrosine residue Y373, was reported as the SRC target, while the kinase for the main PLCG1 docking site, Y407 of GAB1, is not known (Chan et al. 2010). Signaling by MET promotes cell growth, cell survival and motility, which are essential for embryonic development (Weidner et al. 1993, Schmidt et al. 1995, Uehara et al. 1995, Bladt et al. 1995, Maina et al. 1997, Maina et al. 2001, Helmbacher et al. 2003) and tissue regeneration (Huh et al. 2004, Borowiak et al. 2004, Liu 2004, Chmielowiec et al. 2007). MET signaling is frequently aberrantly activated in cancer, through MET overexpression or activating MET mutations (Schmidt et al. 1997, Pennacchietti et al. 2003, Smolen et al. 2006, Bertotti et al. 2009). Considerable progress has recently been made in the development of HGF-MET inhibitors in cancer therapy. These include inhibitors of HGF activators, HGF inhibitors and MET antagonists, which are protein therapeutics that act outside the cell. Kinase inhibitors function inside the cell and have constituted the largest effort towards MET-based therapeutics (Gherardi et al. 2012). Pathogenic bacteria of the species Listeria monocytogenes, exploit MET receptor as an entryway to host cells (Shen et al. 2000, Veiga and Cossart 2005, Neimann et al. 2007). For review of MET signaling, please refer to Birchmeier et al. 2003, Trusolino et al. 2010, Gherardi et al. 2012, Petrini 2015.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep262">
 <bp:stepProcess rdf:resource="#BiochemicalReaction226" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep263">
 <bp:stepProcess rdf:resource="#BiochemicalReaction227" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep260">
 <bp:stepProcess rdf:resource="#BiochemicalReaction224" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway311">
 <bp:pathwayOrder rdf:resource="#PathwayStep2406" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2417" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2407" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2408" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2409" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2402" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2413" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2403" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2414" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2404" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2415" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2405" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2416" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2410" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2411" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2412" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2099" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2098" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2097" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2096" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2095" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2094" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2093" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2092" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2107" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2106" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2105" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2104" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2103" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2102" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2101" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2100" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2402" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Downstream signal transduction</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The role of autophosphorylation sites on PDGF receptors are to provide docking sites for downstream signal transduction molecules which contain SH2 domains. The SH2 domain is a conserved motif of around 100 amino acids that can bind a phosphorylated tyrosine residue. These downstream molecules are activated upon binding to, or phosphorylated by, the receptor kinases intrinsic to PDGF receptors. Some of the dowstream molecules are themselves enzymes, such as phosphatidylinositol 3&apos;-kinase (PI3K), phospholipase C (PLC-gamma), the Src family of tyrosine kinases, the tyrosine phosphatase SHP2, and a GTPase activating protein (GAP) for Ras. Others such as Grb2 are adaptor molecules which link the receptor with downstream catalytic molecules.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep261">
 <bp:stepProcess rdf:resource="#BiochemicalReaction225" />
 <bp:stepProcess rdf:resource="#Catalysis102" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway310">
 <bp:pathwayOrder rdf:resource="#PathwayStep2418" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2419" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2424" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2425" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2426" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2398" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2420" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2399" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2421" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2400" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2422" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2401" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2423" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2395" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2396" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2397" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2091" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2090" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2088" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2110" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2087" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2086" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2116" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2115" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2114" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2113" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2112" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2089" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2111" />
 <bp:pathwayComponent rdf:resource="#Pathway311" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2109" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2108" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2395" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by PDGF</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Platelet-derived Growth Factor (PDGF) is a potent stimulator of growth and motility of connective tissue cells such as fibroblasts and smooth muscle cells as well as other cells such as capillary endothelial cells and neurons.The PDGF family of growth factors is composed of four different polypeptide chains encoded by four different genes. The classical PDGF chains, PDGF-A and PDGF-B, and more recently discovered PDGF-C and PDGF-D. The four PDGF chains assemble into disulphide-bonded dimers via homo- or heterodimerization, and five different dimeric isoforms have been described so far; PDGF-AA, PDGF-AB, PDGF-BB, PDGF-CC and PDGF-DD. It is notable that no heterodimers involving PDGF-C and PDGF-D chains have been described. PDGF exerts its effects by binding to, and activating, two protein tyrosine kinase (PTK) receptors, alpha and beta. These receptors dimerize and undergo autophosphorylation. The phosphorylation sites then attract downstream effectors to transduct the signal into the cell.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence698">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence699">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep259">
 <bp:stepProcess rdf:resource="#Catalysis101" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction223" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence694">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence695">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep257">
 <bp:stepProcess rdf:resource="#BiochemicalReaction221" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence696">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep258">
 <bp:stepProcess rdf:resource="#BiochemicalReaction222" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence697">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence690">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2121">
 <bp:evidence rdf:resource="#Evidence2433" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active LTK phosphorylates IRS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence691">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2120">
 <bp:evidence rdf:resource="#Evidence2432" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active LTK receptor phosphorylates SHC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence692">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence693">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2129">
 <bp:evidence rdf:resource="#Evidence2442" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MST1 binds MST1R</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2128">
 <bp:evidence rdf:resource="#Evidence2441" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MST1 dimer:MST1R dimer binds MST1R dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2127">
 <bp:evidence rdf:resource="#Evidence2440" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MST1R autophosphorylates</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2126">
 <bp:evidence rdf:resource="#Evidence2438" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LTK binds ALKAL ligand</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2125">
 <bp:evidence rdf:resource="#Evidence2437" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active LTK receptor binds SHC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2124">
 <bp:evidence rdf:resource="#Evidence2436" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active LTK binds IRS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2123">
 <bp:evidence rdf:resource="#Evidence2435" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRS1 recruits GRB2 to active LTK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2122">
 <bp:evidence rdf:resource="#Evidence2434" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active LTK recruits GRB2:SOS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep255">
 <bp:stepProcess rdf:resource="#BiochemicalReaction219" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway302">
 <bp:pathwayOrder rdf:resource="#PathwayStep2325" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2326" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2324" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2025" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2024" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2023" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2324" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of AKT2</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC serine/threonine-protein kinases (AKT, PKB) are serine/threonine kinases belonging to the cAMP-dependent protein kinase A/ protein kinase G/ protein kinase C (AGC) superfamily of protein kinases. They share structural homology within their catalytic domains and have similar mechanisms of activation. Mammals have three AKT genes, named RAC-alpha serine/threonine-protein kinase (AKT1, PKB, PKB-alpha), RAC-beta serine/threonine-protein kinase (AKT2, PKB-beta and RAC-gamma serine/threonine-protein kinase (AKT3, PKB-gamma, STK2). All share a conserved domain structure: an amino terminal pleckstrin homology (PH) domain, a central kinase domain and a carboxyl-terminal regulatory domain that contains a hydrophobic motif that is characteristic of AGC kinases. The PH domain interacts with membrane lipid products such as phosphatidylinositol (3,4,5) trisphosphate (PIP3) produced by phosphatidylinositol 3-kinase (PI3-kinase). Biochemical analysis. The PH domain of AKT binds to PIP3 and PIP2 with similar affinity (James et al. 1996, Frech et al. 1997). The kinase catalytic domain of Akt/PKB is highly similar to other AGC kinases (Peterson    Schreiber 1999). Phosphorylation of a conserved threonine residue in this region (T308 in AKT1) results in partial activation (Alessi et al. 1996). The carboxyl terminal extension has the hydrophobic motif FPQFSY. Phosphorylation of serine or threonine residue in this motif is necessary for full kinase activation. Deletion of this motif completely abolishes activity (Andjelkovi&#263; et al. 1997).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep256">
 <bp:stepProcess rdf:resource="#Catalysis100" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction220" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway301">
 <bp:pathwayOrder rdf:resource="#PathwayStep2321" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2322" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2022" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2021" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2321" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PDE3B signalling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT (PKB) is recruited to the plasma membrane by binding phosphatidylinositol (3,4,5)-trisphosphate (PIP3). AKT is then activated by phosphorylation. Activated AKT in turn phosphorylates Phosphodiesterase 3B (PDE3B) which hydrolyzes 3&apos;,5&apos;-cyclic AMP (cAMP) (reviewed in Manning and Toker 2017).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep253">
 <bp:stepProcess rdf:resource="#BiochemicalReaction217" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway304">
 <bp:pathwayOrder rdf:resource="#PathwayStep2390" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2347" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2348" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2339" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2365" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2366" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2389" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2346" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2340" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2341" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2352" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2364" />
 <bp:pathwayComponent rdf:resource="#Pathway309" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2037" />
 <bp:pathwayComponent rdf:resource="#Pathway306" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2059" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2036" />
 <bp:pathwayComponent rdf:resource="#Pathway305" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2058" />
 <bp:pathwayComponent rdf:resource="#Pathway308" />
 <bp:pathwayComponent rdf:resource="#Pathway307" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2043" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2042" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2082" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2339" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by EGFR</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The epidermal growth factor receptor (EGFR) is one member of the ERBB family of transmembrane glycoprotein tyrosine receptor kinases (RTK). Binding of EGFR to its ligands induces conformational change that unmasks the dimerization interface in the extracellular domain of EGFR, leading to receptor homo- or heterodimerization at the cell surface. Dimerization of the extracellular regions of EGFR triggers additional conformational change of the cytoplasmic EGFR regions, enabling the kinase domains of two EGFR molecules to achieve the catalytically active conformation. Ligand activated EGFR dimers trans-autophosphorylate on tyrosine residues in the cytoplasmic tail of the receptor. Phosphorylated tyrosines serve as binding sites for the recruitment of signal transducers and activators of intracellular substrates, which then stimulate intracellular signal transduction cascades that are involved in regulating cellular proliferation, differentiation, and survival. Recruitment of complexes containing GRB2 and SOS1 to phosphorylated EGFR dimers either directly, through phosphotyrosine residues that serve as GRB2 docking sites, or indirectly, through SHC1 recruitment, promotes GDP to GTP exchange on RAS, resulting in the activation of RAF/MAP kinase cascade. Binding of complexes of GRB2 and GAB1 to phosphorylated EGFR dimers leads to formation of the active PI3K complex, conversion of PIP2 into PIP3, and activation of AKT signaling. Phospholipase C-gamma1 (PLCG1) can also be recruited directly, through EGFR phosphotyrosine residues that serve as PLCG1 docking sites, which leads to PLCG1 phosphorylation by EGFR and activation of DAG and IP3 signaling. EGFR signaling is downregulated by the action of ubiquitin ligase CBL. CBL binds directly to the phosphorylated EGFR dimer through the phosphotyrosine Y1069 (i.e. Y1045 in the mature protein) in the C-tail of EGFR, and after CBL is phosphorylated by EGFR, it becomes active and ubiquitinates phosphorylated EGFR dimers, targeting them for degradation. Positive regulation of EGFR signaling by direct association of EGFR with accessory proteins such as AAMP and FAM83B is being investigated. For review of EGFR signaling, please refer to Carpenter 1999, Wells 1999, Schlessinger 2002, Herbst 2004, Avraham and Yarden, 2011, Bartel et al. 2016, Uribe et al. 2021, Keflee et al. 2022.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep254">
 <bp:stepProcess rdf:resource="#Catalysis99" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction218" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway303">
 <bp:pathwayOrder rdf:resource="#PathwayStep2336" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2332" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2333" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2334" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2335" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2034" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2033" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2032" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2031" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2030" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2332" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHC-related events triggered by IGF1R</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated IGF1R binds and phosphorylates SHC1 (reviewed in Pavelic et al. 2007, Chitnis et al. 2008, Maki et al. 2010, Parrella et al. 2010, Siddle et al. 2012). Phosphorylated SHC then binds GRB:SOS, which activates RAS-RAF-MAPK signaling.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep251">
 <bp:stepProcess rdf:resource="#BiochemicalReaction215" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep252">
 <bp:stepProcess rdf:resource="#BiochemicalReaction216" />
 <bp:stepProcess rdf:resource="#Catalysis98" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway300">
 <bp:pathwayOrder rdf:resource="#PathwayStep2320" />
 <bp:pathwayComponent rdf:resource="#Pathway301" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2320" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKB-mediated events</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKB and PDK1 are activated via membrane-bound PIP3. Activated PDK1 phosphorylates PKB, which in turn phosphorylates PDE3B. The latter hydrolyses cAMP to 5&apos;AMP, depleting cAMP pools.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep250">
 <bp:stepProcess rdf:resource="#BiochemicalReaction214" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction204">
 <bp:evidence rdf:resource="#Evidence241" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDK1 phosphorylates MAPK6</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence687">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction203">
 <bp:evidence rdf:resource="#Evidence240" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDC14A,B dephosphorylate p-3S,T MAPK6</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence688">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction206">
 <bp:evidence rdf:resource="#Evidence243" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S MAPK6,4:p-T182 MAPKAPK5 translocate to the cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence689">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction205">
 <bp:evidence rdf:resource="#Evidence242" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S115 MAPKAPK5 translocates to the cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction200">
 <bp:evidence rdf:resource="#Evidence235" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated ERBB2 binds PTK6 (BRK)</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep248">
 <bp:stepProcess rdf:resource="#BiochemicalReaction212" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence683">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep249">
 <bp:stepProcess rdf:resource="#BiochemicalReaction213" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence684">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction202">
 <bp:evidence rdf:resource="#Evidence239" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S215 FOXO3 translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep246">
 <bp:stepProcess rdf:resource="#BiochemicalReaction210" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence685">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction201">
 <bp:evidence rdf:resource="#Evidence236" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB2 promotes PTK6 autophosphorylation</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep247">
 <bp:stepProcess rdf:resource="#BiochemicalReaction211" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence686">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2110">
 <bp:evidence rdf:resource="#Evidence2421" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PDGF dimer binds two receptors simultaneously</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence680">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence681">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence682">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction208">
 <bp:evidence rdf:resource="#Evidence245" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK6 binds CCND3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction207">
 <bp:evidence rdf:resource="#Evidence244" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S MAPKAPK5 phosphorylates HSPB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction209">
 <bp:evidence rdf:resource="#Evidence246" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JUN binds MAPK6 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2118">
 <bp:evidence rdf:resource="#Evidence2430" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active LTK receptor binds PI3K</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2117">
 <bp:evidence rdf:resource="#Evidence2429" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active LTK binds GRB2:TNK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2116">
 <bp:evidence rdf:resource="#Evidence2427" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PDGFRs bind type I TKI</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2115">
 <bp:evidence rdf:resource="#Evidence2426" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Autophosphorylation of PDGF alpha receptors</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2114">
 <bp:evidence rdf:resource="#Evidence2425" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PDGFRs bind type II TKI</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2113">
 <bp:evidence rdf:resource="#Evidence2424" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PDGF-BB clevage by Furin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2112">
 <bp:evidence rdf:resource="#Evidence2423" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Autophosphorylation of PDGF alpha/beta receptors</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2111">
 <bp:evidence rdf:resource="#Evidence2422" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PDGF-AB clevage by Furin</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep244">
 <bp:stepProcess rdf:resource="#BiochemicalReaction208" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep245">
 <bp:stepProcess rdf:resource="#BiochemicalReaction209" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep242">
 <bp:stepProcess rdf:resource="#BiochemicalReaction206" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep243">
 <bp:stepProcess rdf:resource="#BiochemicalReaction207" />
 <bp:stepProcess rdf:resource="#Catalysis97" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep240">
 <bp:stepProcess rdf:resource="#BiochemicalReaction204" />
 <bp:stepProcess rdf:resource="#Catalysis96" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep241">
 <bp:stepProcess rdf:resource="#BiochemicalReaction205" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2119">
 <bp:evidence rdf:resource="#Evidence2431" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Autophosphorylation of LTK dimer:ALKAL1,2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction259">
 <bp:evidence rdf:resource="#Evidence300" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTPN3 dephosphorylates MAPK12</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence676">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction258">
 <bp:evidence rdf:resource="#Evidence299" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTPN7 binds p-T,Y-MAPK</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence677">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep239">
 <bp:stepProcess rdf:resource="#Catalysis95" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction203" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence678">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1589">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1384" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence679">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1588">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1383" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep237">
 <bp:stepProcess rdf:resource="#Pathway37" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction255">
 <bp:evidence rdf:resource="#Evidence296" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cytosolic DUSPs dephosphorylate MAPKs</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence672">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep238">
 <bp:stepProcess rdf:resource="#BiochemicalReaction202" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction254">
 <bp:evidence rdf:resource="#Evidence295" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTPN3 binds p-T183,Y185 MAPK12</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence673">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep235">
 <bp:stepProcess rdf:resource="#Catalysis94" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction201" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction257">
 <bp:evidence rdf:resource="#Evidence298" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PAQR3 binds inactive RAFs</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence674">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep236">
 <bp:stepProcess rdf:resource="#Pathway36" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction256">
 <bp:evidence rdf:resource="#Evidence297" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTPN7 dephosphorylates p-T,Y-MAPKs</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence675">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1583">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1378" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2187">
 <bp:evidence rdf:resource="#Evidence2514" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTPN6 dephosphorylates JAK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1582">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1377" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2186">
 <bp:evidence rdf:resource="#Evidence2513" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active ALK phosphorylates FRS2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis689">
 <bp:controlled rdf:resource="#BiochemicalReaction2234" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence670">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1581">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1376" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2185">
 <bp:evidence rdf:resource="#Evidence2512" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y705, p-S727 STAT3 dimer translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence671">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1580">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1375" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2184">
 <bp:evidence rdf:resource="#Evidence2511" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y705,S727-STAT3 dimerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1587">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1382" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2183">
 <bp:evidence rdf:resource="#Evidence2510" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MYC/MYCN bind the ALK gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis686">
 <bp:controlled rdf:resource="#BiochemicalReaction2218" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1586">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1381" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2182">
 <bp:evidence rdf:resource="#Evidence2509" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT3 is phosphorylated downstream of active ALK</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis685">
 <bp:controlled rdf:resource="#BiochemicalReaction2213" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1585">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1380" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2181">
 <bp:evidence rdf:resource="#Evidence2507" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GGA3 associates with activated MET receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis688">
 <bp:controlled rdf:resource="#BiochemicalReaction2229" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1584">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1379" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2180">
 <bp:evidence rdf:resource="#Evidence2506" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAB4:GTP promotes recycling of activated MET receptor to the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis687">
 <bp:controlled rdf:resource="#BiochemicalReaction2219" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis693">
 <bp:controlled rdf:resource="#BiochemicalReaction2238" />
</bp:Catalysis>

<bp:Pathway rdf:ID="Pathway360">
 <bp:pathwayOrder rdf:resource="#PathwayStep2778" />
 <bp:pathwayComponent rdf:resource="#Pathway361" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2778" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression and Processing of Neurotrophins</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Neurotrophins function as ligands for receptor tyrosine kinases of the NTRK (TRK) family, as well as the death receptor NGFR (p75NTR). While all four neurotrophins, NGF, BDNF, NTF3 (NT-3) and NTF4 (NT-4, NT-5, NTF5) can bind to and activate NGFR, they show different specificity for NTRKs. NGF exclusively activates NTRK1 (TRKA). BDNF and NTF4 are high affinity ligands for NTRK2 (TRKB). NTF3 is a high affinity ligand for NTRK3 (TRKC) and a low affinity ligand for NTRK2. Neurotrophins play pivotal roles in survival, differentiation, and plasticity of neurons in the peripheral and central nervous system. They are produced, and secreted in minute amounts, by a variety of tissues. For review, please refer to Lessmann et al. 2003, Chao 2003, and Park and Poo 2013. Human NGF, also knowns as the nerve growth factor, is encoded by a gene on chromosome 1, which produces a single transcript. Nascent NGF protein, pre-pro-NGF, is 241 amino acids long. As pre-pro-NGF enters the endoplasmic reticulum (ER), the signal peptide, consisting of eighteen amino acids at the N-terminus, is cleaved, producing pro-NGF. Two molecules of pro-NGF form homodimers in the ER. After transport of pro-NGF homodimers to the Golgi, 103 amino acids at the N-terminus of pro-NGF are cleaved, producing mature NGF homodimers. Both pro-NGF homodimers and mature NGF homodimers are secreted to the extracellular space. Mature NGF homodimers activate NTRK1 signaling, while NGFR signaling can be activated by both mature and pro-NGF homodimers. Secreted pro-NGF homodimers may be cleaved by extracellular matrix proteases to produce mature NGF homodimers. For review, please refer to Poo 2001, Lu et al. 2005, Skaper et al. 2012, Bradshaw et al. 2015. Human BDNF, also known as brain-derived neurotrophic factor, is encoded by a gene on chromosome 11, which, through the use of 9 alternative promoters and alternative splicing, produces 17 protein-coding transcripts. Most BDNF transcripts result in the same pre-pro-BDNF protein of 247 amino acids, but alternative promoters and different 5&apos; and 3&#8217;UTRs allow to fine-tune regulation of BDNF expression at different developmental stages and at different levels of neuronal activity. Similar to NGF, pre-pro-BDNF is processed by proteolytic cleavage in the ER to produce pro-BDNF homodimers. It is unclear whether proteolytic processing of pro-BDNF, to produce mature BDNF homodimers, occurs in the Golgi or in the secretory granules. Extracellular matrix proteases can also cleave secreted pro-BDNF to produce mature BDNF homodimers. Secreted mature BDNF homodimers can activate NTRK2 signaling, while secreted pro-BDNF homodimers can activate NGFR signaling. For review, please refer to Poo 2001, Lu et al. 2005, Skaper et al. 2012, Park and Poo 2013. Human NTF4, also known as neurotrophin-4, is transcribed from a gene on chromosome 19. A single experimentally confirmed transcript produces a pre-pro-NTF4 protein of 210 amino acids. After proteolytic processing in the ER and Golgi, mature NTF4 homodimers are secreted and can activate NTRK2 signaling (Hibbert et al. 2003). For review, please refer to Poo 2001, Skaper et al. 2012. Human NTF3, also known as neurotrophin-3, is transcribed from a gene on chromosome 12. Two NTF3 transcripts have been experimentally confirmed, but only the longer NTF3 splice variant of 270 amino acids has been studied. After proteolytic processing in the ER and Golgi, mature NTF3 homodimers are secreted and can activate NTRK3 signaling (Seidah et al. 1996, Farhadi et al. 2000). For review, please refer to Poo 2001, Skaper et al. 2012. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Catalysis rdf:ID="Catalysis692">
 <bp:controlled rdf:resource="#BiochemicalReaction2237" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis695">
 <bp:controlled rdf:resource="#BiochemicalReaction2242" />
</bp:Catalysis>

<bp:Pathway rdf:ID="Pathway362">
 <bp:pathwayOrder rdf:resource="#PathwayStep2901" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2904" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2789" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2800" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2899" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2893" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2785" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2839" />
 <bp:pathwayComponent rdf:resource="#Pathway382" />
 <bp:pathwayComponent rdf:resource="#Pathway381" />
 <bp:pathwayComponent rdf:resource="#Pathway380" />
 <bp:pathwayComponent rdf:resource="#Pathway379" />
 <bp:pathwayComponent rdf:resource="#Pathway367" />
 <bp:pathwayComponent rdf:resource="#Pathway364" />
 <bp:pathwayComponent rdf:resource="#Pathway363" />
 <bp:pathwayComponent rdf:resource="#Pathway374" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2785" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by NTRK1 (TRKA)</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Trk receptors signal from the plasma membrane and from intracellular membranes, particularly from early endosomes. Signalling from the plasma membrane is fast but transient; signalling from endosomes is slower but long lasting. Signalling from the plasma membrane is annotated here. TRK signalling leads to proliferation in some cell types and neuronal differentiation in others. Proliferation is the likely outcome of short term signalling, as observed following stimulation of  EGFR (EGF receptor). Long term signalling via TRK receptors, instead, was clearly shown to be required for neuronal differentiation in response to neurotrophins.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Catalysis rdf:ID="Catalysis694">
 <bp:controlled rdf:resource="#BiochemicalReaction2239" />
</bp:Catalysis>

<bp:Pathway rdf:ID="Pathway361">
 <bp:pathwayOrder rdf:resource="#PathwayStep2779" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2783" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2780" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2781" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2782" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2423" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2422" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2421" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2420" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2419" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2779" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NGF processing</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">All neurotrophins (NTs) are generated as pre-pro-neurotrophin precursors. The signal peptide is cleaved off as NT is associated with the endoplasmic reticulum (ER). The resulting pro-NT can form a homodimer spontaneously which then transits to the Golgi apparatus and then onto the trans-Golgi network (TGN). Resident protein convertases (PCs) can cleave off the pro-sequence and mature NT is is targeted to constitutively released vesicles. The pro-NT form can also be released to the extracellular region.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep1590">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1385" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2189">
 <bp:evidence rdf:resource="#Evidence2517" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">(PTN,MDK):PTPRZ oligomerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis691">
 <bp:controlled rdf:resource="#BiochemicalReaction2236" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2188">
 <bp:evidence rdf:resource="#Evidence2515" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ALK-stimulated MYCN gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis690">
 <bp:controlled rdf:resource="#BiochemicalReaction2235" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep233">
 <bp:stepProcess rdf:resource="#Pathway35" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction262">
 <bp:evidence rdf:resource="#Evidence303" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PP2A dephosphorylates RAF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway368">
 <bp:pathwayOrder rdf:resource="#PathwayStep2802" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2803" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2804" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2437" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2436" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2435" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2802" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signalling to p38 via RIT and RIN</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RIT and RIN are two small guanine nucleotide binding proteins that share more than 50% sequence identity with RAS, including highly conserved core effector domains. Unlike RAS, the C termini of RIT and RIN lack a typical prenylation motif (CAAX, XXCC, or CXC) required for the association of RAS proteins with the plasma membrane. RIT is expressed in all tissues, whereas RIN is neuron-specific.  They have similar signalling properties and are activated by NGF through unknown exchange factors. They signal to ERKs and p38 MAP kinase. They mainly lead to p38 activation via the BRAF-MEK kinase cascade.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep234">
 <bp:stepProcess rdf:resource="#BiochemicalReaction200" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction261">
 <bp:evidence rdf:resource="#Evidence302" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BRAP autoubiquitinates</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway367">
 <bp:pathwayOrder rdf:resource="#PathwayStep2805" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2827" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2801" />
 <bp:pathwayComponent rdf:resource="#Pathway372" />
 <bp:pathwayComponent rdf:resource="#Pathway368" />
 <bp:pathwayComponent rdf:resource="#Pathway369" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2801" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signalling to ERKs</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Neurotrophins utilize multiple pathways to activate ERKs (ERK1 and ERK2), a subgroup of the large MAP kinase (MAPK) family, from the plasma membrane. The major signalling pathways to ERKs are via RAS, ocurring from caveolae in the plasma membrane or from clathrin-coated vesicles, and via RAP1, taking place in early endosomes. Whereas RAS activation by NGF is transient, RAP1 activation by NGF is sustained for hours.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep231">
 <bp:stepProcess rdf:resource="#BiochemicalReaction198" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction264">
 <bp:evidence rdf:resource="#Evidence305" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BRAP binds RAS:GTP</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep232">
 <bp:stepProcess rdf:resource="#Catalysis93" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction199" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction263">
 <bp:evidence rdf:resource="#Evidence304" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK12 phosphorylates PTPN3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway369">
 <bp:pathwayOrder rdf:resource="#PathwayStep2813" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2806" />
 <bp:pathwayComponent rdf:resource="#Pathway371" />
 <bp:pathwayComponent rdf:resource="#Pathway370" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2806" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Prolonged ERK activation events</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">After NGF binding, activated Trk receptors provide multiple docking sites for adaptor proteins and enzymes. Two docking proteins, the Ankyrin-Rich Membrane Spanning protein (ARMS/Kidins220) and Fibroblast growth factor receptor substrate 2 (Frs2), target signaling molecules in response to NGF stimulation and link receptor activation with the MAP kinase (also called the Extracellular signal-Regulated Kinase cascade, ERK) cascade, an essential process for growth factor-induced cell proliferation and differentiation. A feature of NGF signaling is the sustained activation of the MAPK cascade. This is achieved by the small G protein, Rap1 which binds to and activates B-Raf, an activator of the MAPK cascade. Rap1 is a member of the Ras family of G proteins and like all G proteins, Rap1 is in an inactive state when bound to GDP and is active when bound to GTP. A specific GEF (guanine nucleotide exchange factor) called C3G can activate Rap1 by exchanging GDP for GTP.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway364">
 <bp:pathwayOrder rdf:resource="#PathwayStep2795" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2790" />
 <bp:pathwayComponent rdf:resource="#Pathway366" />
 <bp:pathwayComponent rdf:resource="#Pathway365" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2790" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of TRKA receptors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Trk receptors can either be activated by neurotrophins or by two G-protein-coupled receptors (GPCRs) although the biological relevance of GPCRs remains to be shown.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep230">
 <bp:stepProcess rdf:resource="#Catalysis92" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction197" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway363">
 <bp:pathwayOrder rdf:resource="#PathwayStep2787" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2788" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2786" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2426" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2425" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2424" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2786" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Retrograde neurotrophin signalling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Neurotrophin-TRK complexes can be internalized and enter signalling vesicles, which travel retrogradely over long distances from distal nerve terminals to neuronal cell bodies. Such retrograde signalling by neurotrophin-TRK complexes regulates survival, synaptogenesis and maintenance of proper neural connectivity. The neurotrophin-TRK complex may use three distinct internalization pathways. Although Clathrin-mediated endocytosys appears to be the major internalization route, it is controversial whether it also represents the dominant pathway for retrograde transport and signalling. Pyncher-mediated endocytosis might be more relevant in this regard. Moreover, also caveolin-mediated endocytosis may play a role in NGF-TrkA internalization. Retrograde transport of TRKs is microtubule-dependent: TRKs remain activated and bound to neurotrophins during retrograde transport. The current view is reflected in the signalling endosome model. It is a specialized vesicle containing ligand (NGF, BDNF) bound to its activated TRK receptor, together with activated downstream signalling proteins, transported by motor proteins (dyneins) from nerve terminals to remote cell bodies, where the receptors trigger signalling cascades.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction260">
 <bp:evidence rdf:resource="#Evidence301" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PEBP1 binds activated RAF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway366">
 <bp:pathwayOrder rdf:resource="#PathwayStep2798" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2799" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2796" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2797" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2434" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2433" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2432" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2431" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2796" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRKA activation by NGF</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Neurotrophin functions  are mediated by binding of the secreted neurotrophin homodimers to their common neurotrophin receptor p75NTR, and to their cognate tropomyosin related kinase (TRK) receptor. NGF binds to TRKA, BDNF and NT4 bind to TRKB, NT3 binds to TRKC. A tri-molecular signalling complex (NGF-p75NTR-TRKA) might also be possible.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway365">
 <bp:pathwayOrder rdf:resource="#PathwayStep2794" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2791" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2792" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2793" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2430" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2429" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2428" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2427" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2791" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NGF-independant TRKA activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRK receptors can also be activated by at least two G-protein-coupled receptors (GPCR), the adenosine A2a receptor and the PACAP type I receptor, without involvement of neurotrophins. Activity  of both receptors is mediated by G proteins that activate adenyl cyclase. How this leads to TRKA activation has not been fully elucidated, although a SRC-family tyrosine kinase and intracellular Ca2+ appear to play a role. TRKA activation through GPCRs occurs with slow kinetics (over 1 hr adenosine or PACAP treatment is required) in an intracellular location (probably the Golgi apparatus), and requires transcriptional and protein synthesis events that may influence the processing and activation of the receptors. GPCR-mediated transactivation of TRK receptors causes the preferential activation of AKT versus ERKs. This leads to a cell survival response.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence665">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction269">
 <bp:evidence rdf:resource="#Evidence311" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear DUSPs dephosphorylate MAPKs</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence666">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep228">
 <bp:stepProcess rdf:resource="#Catalysis91" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction195" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence667">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep229">
 <bp:stepProcess rdf:resource="#BiochemicalReaction196" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence668">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1599">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1393" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep226">
 <bp:stepProcess rdf:resource="#Catalysis90" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction193" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction266">
 <bp:evidence rdf:resource="#Evidence308" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated MAPKs phosphorylate BRAF</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence661">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep227">
 <bp:stepProcess rdf:resource="#BiochemicalReaction194" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction265">
 <bp:evidence rdf:resource="#Evidence307" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated MAPKs phosphorylate MAP2K1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence662">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway349">
 <bp:pathwayOrder rdf:resource="#PathwayStep2747" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2758" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2769" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2738" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2754" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2765" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2733" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2751" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2729" />
 <bp:pathwayComponent rdf:resource="#Pathway351" />
 <bp:pathwayComponent rdf:resource="#Pathway350" />
 <bp:pathwayComponent rdf:resource="#Pathway357" />
 <bp:pathwayComponent rdf:resource="#Pathway356" />
 <bp:pathwayComponent rdf:resource="#Pathway359" />
 <bp:pathwayComponent rdf:resource="#Pathway358" />
 <bp:pathwayComponent rdf:resource="#Pathway352" />
 <bp:pathwayComponent rdf:resource="#Pathway355" />
 <bp:pathwayComponent rdf:resource="#Pathway354" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2729" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by NTRK2 (TRKB)</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTRK2 (TRKB) belongs to the family of neurotrophin tyrosine kinase receptors, also known as NTRKs or TRKs. Besides NTRK2, the family includes NTRK1 (TRKA) and NTRK3 (TRKC). Similar to other receptor tyrosine kinases (RTKs), NTRK2 is activated by ligand binding to its extracellular domain. Ligand binding induces receptor dimerization, followed by trans-autophosphorylation of dimerized receptors on conserved tyrosine residues in the cytoplasmic region. Phosphorylated tyrosines in the intracellular domain of the receptor serve as docking sites for adapter proteins, triggering downstream signaling cascaded. Brain-derived neurotrophic factor (BDNF) and neurotrophin-4 (NTF4, also known as NT-4) are two high affinity ligands for NTRK2. Neurotrophin-3 (NTF3, also known as NT-3), a high affinity ligand for NTRK3, binds to NTRK2 with low affinity and it is not clear if it the low level of activation of NTRK2 by NTF3 plays a physiologically relevant role. Nerve growth factor (NGF), a high affinity ligand for NTRK1, does not interact with NTRK2. NTRK2 activation triggers downstream RAS, PI3K, and PLCgamma signaling cascades, thought to be involved in neuronal development in both the peripheral (PNS) and central nervous system (CNS). In addition, NTRK2 plays an important, but poorly elucidated, role in long-term potentiation (LTP) and learning (reviewed by Minichiello 2009). NTRK2 may modify neuronal excitability and synaptic transmission by directly phosphorylating voltage gated channels (Rogalski et al. 2000).  It was recently demonstrated that the protein tyrosine phosphatase PTPN12 negatively regulates NTRK2 signaling and neurite outgrowth. In the presence of PTPN12, NTRK2 phosphorylation at tyrosine Y816 decreases. It has not yet been demonstrated that PTPN12 acts directly to dephosphorylate Y816 (and possibly other phosphotyrosines) of NTRK2 (Ambjorn et al. 2013).  Binding of SH2D1A (SAP) to NTRK2 attenuates NTRK2 trans autophosphorylation and downstream signaling through an unknown mechanism (Lo et al. 2005).  Little is known about downregulation of NTRK2 (TRKB) receptor via ubiquitin dependent pathways (Sanchez Sanchez and Arevalo 2017). CBL, a ubiquitin ligase involved in degradation of many receptor tyrosine kinases, was shown to ubiquitinate and, unexpectedly, increase stability of NTRK2 (Pandya et al. 2014). NTRK2 undergoes ubiquitination by the TRAF6 E3 ubiquitin ligase complex. While ubiquitination by the TRAF6 complex negatively regulates NTRK2 induced AKT activation, the effect of TRAF6 mediated ubiquitination on NTRK2 protein levels has not been examined (Jadhav et al. 2008).  Downregulation of the TRKB receptor may depend on the activating ligand, with BDNF inducing more rapid ubiquitination and degradation compared to NTF4 (NT 4). NTRK2 undergoes both lysosome dependent and proteasome dependent degradation upon stimulation by BDNF, while stimulation by NTF4 may protect NTRK2 from the lysosome degradation route (Proenca et al. 2016).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep224">
 <bp:stepProcess rdf:resource="#Catalysis89" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction192" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction268">
 <bp:evidence rdf:resource="#Evidence310" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BRAP binds KSR1:MARK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence663">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep225">
 <bp:stepProcess rdf:resource="#Pathway34" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction267">
 <bp:evidence rdf:resource="#Evidence309" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated MAPK phosphorylates RAF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence664">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1594">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1389" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2176">
 <bp:evidence rdf:resource="#Evidence2501" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EPS15 and HGS bind ubiquitinated MET</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1593">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1388" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2175">
 <bp:evidence rdf:resource="#Evidence2500" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTPRJ dephosphorylates MET</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1592">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1387" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2174">
 <bp:evidence rdf:resource="#Evidence2499" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CBL monoubiquitinates activated MET</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence660">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1591">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1386" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2173">
 <bp:evidence rdf:resource="#Evidence2498" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MET binds LRIG1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1598">
 <bp:stepProcess rdf:resource="#Pathway207" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2172">
 <bp:evidence rdf:resource="#Evidence2497" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CBL binds MET</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis697">
 <bp:controlled rdf:resource="#BiochemicalReaction2244" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1597">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1392" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2171">
 <bp:evidence rdf:resource="#Evidence2496" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MET phosphorylates CBL</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis696">
 <bp:controlled rdf:resource="#BiochemicalReaction2243" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1596">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1391" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2170">
 <bp:evidence rdf:resource="#Evidence2495" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CBL recruits CIN85:endophilin to ubiquitinated MET</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis699">
 <bp:controlled rdf:resource="#BiochemicalReaction2249" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1595">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1390" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis698">
 <bp:controlled rdf:resource="#BiochemicalReaction2248" />
</bp:Catalysis>

<bp:Pathway rdf:ID="Pathway351">
 <bp:pathwayOrder rdf:resource="#PathwayStep2736" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2737" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2734" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2735" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2387" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2386" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2385" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2384" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2734" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated NTRK2 signals through RAS</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of the neurotrophin receptor NTRK2 (TRKB) by BDNF or NTF4 triggers downstream RAS signaling. The best studied mechanism for activation of RAS signaling downstream of NTRK2 is through SHC1-mediated recruitment of the GRB2:SOS1 complex, triggering SOS1-mediated guanine nucleotide exchange on RAS and formation of active RAS:GTP complexes (Minichiello et al. 1998, McCarthy and Feinstein 1999, Yuen and Mobley 1999).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway350">
 <bp:pathwayOrder rdf:resource="#PathwayStep2732" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2730" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2731" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2383" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2382" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2381" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2730" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTF3 activates NTRK2 (TRKB) signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Neurotrophin receptor tyrosine kinase NTRK2 (TRKB) is a low affinity receptor for neurotrophin-3 (NTF3, also known as NT-3) (Soppet et al. 1991). NTF3 predominantly functions as the ligand for the NTRK3 (TRKC) receptor (Marsh and Palfrey 1996). Binding to NTF3 can trigger NTRK2 dimerization (Ohira et al. 2001) and trans-autophosphorylation of NTRK2 dimers on conserved tyrosine residues in the cytoplasmic tail of the receptor (Middlemas et al. 1994). The efficacy of this process, however, is low in comparison to NTRK2 activation by BDNF and NTF3, and downstream signaling has not been studied.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2179">
 <bp:evidence rdf:resource="#Evidence2504" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LRIG1 undergoes ubiquitination</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2178">
 <bp:evidence rdf:resource="#Evidence2503" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTPN1 and PTPN2 dephosphorylate MET</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2177">
 <bp:evidence rdf:resource="#Evidence2502" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP8 deubiquitinates LRIG1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep222">
 <bp:stepProcess rdf:resource="#BiochemicalReaction190" />
 <bp:stepProcess rdf:resource="#Catalysis88" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction273">
 <bp:evidence rdf:resource="#Evidence315" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PEA15 binds MAPK monomers and dimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway357">
 <bp:pathwayOrder rdf:resource="#PathwayStep2759" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2761" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2762" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2763" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2764" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2760" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2404" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2403" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2408" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2407" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2406" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2405" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2759" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated NTRK2 signals through CDK5</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDK5, in complex with its activator CDK5R1 (p35), binds to BDNF-activated NTRK2 (TRKB). NTRK2 promotes CDK5 catalytic activity by phosphorylating CDK5 at tyrosine residue Y15 (Cheung et al. 2007), although CDK5 can also be phosphorylated at Y15 independently of NTRK2 (Zhao et al. 2009). CDK5 phosphorylates serine residue S479 of NTRK2 (corresponds to S478 in mouse and rat) (Cheung et al. 2007, Zhao et al. 2009). Phosphorylation of NTRK2 at S479 is needed for BDNF-triggered dendritic growth (Cheung et al. 2007), hippocampal long-term potentiation (LTP) and spatial memory (Lai et al. 2012). These processes involve NTRK2-mediated activation of RHO GTPases RAC1 (Lai et al. 2012) and possibly CDC42 (Cheung et al. 2007). In cultured isolated neurons, phosphorylation at S479 affects localization of NTRK2 (Zhao et al. 2009), but this does not appear to be the case in vivo (Lai et al. 2012). CDK5-mediated phosphorylation of NTRK2 was suggested to influence the level of AKT activity, downstream mTOR signaling and DLG4 (PSD-95) expression, but further elucidation is needed (Lai et al. 2012). Signaling by TRKB and CDK5 plays a role in inflammation induced hypersensitivity to heat-triggered pain in rats (Zhang et al. 2014).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep223">
 <bp:stepProcess rdf:resource="#BiochemicalReaction191" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction272">
 <bp:evidence rdf:resource="#Evidence314" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-T,Y MAPKs dimerize</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway356">
 <bp:pathwayOrder rdf:resource="#PathwayStep2755" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2756" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2757" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2402" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2401" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2400" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2755" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated NTRK2 signals through PLCG1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of the neurotrophin receptor NTRK2 (TRKB) by BDNF or NTF4 triggers downstream PLCgamma (PLCG1) signaling, resulting in formation of secondary messengers DAG and IP3 (Eide et al. 1996, Minichiello et al. 1998, McCarthy and Feinstein 1999, Yuen and Mobley 1999, Minichiello et al. 2002, Yamada et al. 2002).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep220">
 <bp:stepProcess rdf:resource="#BiochemicalReaction188" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction275">
 <bp:evidence rdf:resource="#Evidence318" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Deltarasin binds PDE6D</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway359">
 <bp:pathwayOrder rdf:resource="#PathwayStep2776" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2772" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2773" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2774" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2775" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2770" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2771" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2415" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2414" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2413" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2412" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2418" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2417" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2416" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2770" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated NTRK2 signals through FRS2 and FRS3</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Adapter proteins FRS2 and FRS3 can both bind to the cytoplasmic tail of activated NTRK2 (TRKB) receptor, which is followed by NTRK2-mediated phosphorylation of FRS2 and FRS3. NTRK2 signaling through FRS3 has been poorly characterized (Easton et al. 1999, Yuen and Mobley 1999, Dixon et al. 2006, Zeng et al. 2014). Phosphorylated FRS2 is known to recruit GRB2 (presumably in complex with SOS1) and PTPN11 (SHP2) to activated NTRK2, leading to augmentation of RAS signaling (Easton et al. 1999, Easton 2006).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep221">
 <bp:stepProcess rdf:resource="#BiochemicalReaction189" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction274">
 <bp:evidence rdf:resource="#Evidence317" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">mature RAS proteins translocate to plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway358">
 <bp:pathwayOrder rdf:resource="#PathwayStep2766" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2767" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2768" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2411" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2410" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2409" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2766" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BDNF activates NTRK2 (TRKB) signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by the neurotrophin receptor tyrosine kinase NTRK2 (TRKB) can be activated by binding to brain-derived neurotrophic factor (BDNF), which functions as a ligand for NTRK2 (Soppet et al. 1991, Klein et al. 1991). Binding to BDNF triggers NTRK2 dimerization (Ohira et al. 2001) and trans-autophosphorylation of NTRK2 dimers on conserved tyrosine residues in the cytoplasmic tail of the receptor (Guiton et al. 1994, Minichiello et al. 1998, McCarty and Feinstein 1999). Phosphorylated tyrosine residues subsequently serve as docking sites for recruitment of effector proteins that trigger downstream signaling cascades.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence669">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway353">
 <bp:pathwayOrder rdf:resource="#PathwayStep2743" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2742" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2391" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2390" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2742" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTRK2 activates RAC1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DOCK3-mediated activation of RAC1 downstream of BDNF-induced signaling by NTRK2 (TRKB) plays a role in axonal growth and regeneration. DOCK3 can be recruited to the plasma membrane to activate RAC1 by binding to NTRK-associated FYN (Namekata et al. 2010). Alternatively, DOCK3 can, upon poorly elucidated RHOG activation by the BDNF:NTRK2 complex, bind to the RHOG:GTP complex and activate RAC1 in an ELMO1-dependent manner (Namekata et al. 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway352">
 <bp:pathwayOrder rdf:resource="#PathwayStep2739" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2744" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2745" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2746" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2740" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2741" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2389" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2388" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2394" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2393" />
 <bp:pathwayComponent rdf:resource="#Pathway353" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2392" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2739" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated NTRK2 signals through FYN</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In mouse brain, Fyn activation downstream of Bdnf-induced Ntrk2 (TrkB) signaling results in increased protein levels of AMPA receptor subunits Gria2 (GluR2), Gria3 (GluR3) and Gria1 (GluR1) without change in mRNA levels (Narisawa-Saito et al. 1999). BDNF-mediated activation of NTRK2 increases phosphorylation of voltage gated sodium channels by FYN, resulting in decrease of sodium currents (Ahn et al. 2007). FYN activation downstream of NTRK2 is implicated in olygodendrocyte myelination and contributes to BDNF-induced activation of ERK1/2 (MAPK3/1) through an unknown mechanism (Peckham et al. 2015). Besides acting downstream of NTRK2, FYN and other SRC kinases, activated by other receptors such as GPCRs, may phosphorylate NTRK2 and enhance its catalytic activity (Rajagopal and Chao 2006, Huang and McNamara 2010). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction271">
 <bp:evidence rdf:resource="#Evidence313" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MAPKs translocate into the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway355">
 <bp:pathwayOrder rdf:resource="#PathwayStep2752" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2753" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2399" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2398" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2752" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated NTRK2 signals through PI3K</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Neurotrophin receptor NTRK2 (TRKB), activated by BDNF or NTF4, activates PI3K, resulting in formation of the PIP3 secondary messenger. PIP3 activates AKT signaling, and AKT signaling activates mTOR signaling (Yuen and Mobley 1999, Cao et al. 2013).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction270">
 <bp:evidence rdf:resource="#Evidence312" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PP5 dephosphorylates RAF1 S338</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway354">
 <bp:pathwayOrder rdf:resource="#PathwayStep2748" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2749" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2750" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2397" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2396" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2395" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2748" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTF4 activates NTRK2 (TRKB) signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by the neurotrophin receptor tyrosine kinase NTRK2 (TRKB) can be activated by binding to neurotrophin-4 (NTF4, also known as NT-4), which functions as a ligand for NTRK2 (Klein et al. 1992, Ip et al. 1993, Ohira et al. 2001). Binding to NTF4 triggers NTRK2 dimerization (Ohira et al. 2001) and trans-autophosphorylation of NTRK2 dimers on conserved tyrosine residues in the cytoplasmic tail of the receptor (Minichiello et al. 1998). Phosphorylated tyrosine residues subsequently serve as docking sites for recruitment of effector proteins that trigger downstream signaling cascades.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep219">
 <bp:stepProcess rdf:resource="#BiochemicalReaction187" />
 <bp:stepProcess rdf:resource="#Catalysis87" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction237">
 <bp:evidence rdf:resource="#Evidence274" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PAK1,2,3 phosphorylates MAPK6,4</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence654">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1569">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1364" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction236">
 <bp:evidence rdf:resource="#Evidence273" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKAPK5 phosphorylates KALRN</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence655">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1568">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1363" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep217">
 <bp:stepProcess rdf:resource="#BiochemicalReaction185" />
 <bp:stepProcess rdf:resource="#Catalysis85" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction239">
 <bp:evidence rdf:resource="#Evidence276" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-T182 MAPKAPK5 phosphorylates FOXO1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence656">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1567">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1362" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep218">
 <bp:stepProcess rdf:resource="#BiochemicalReaction186" />
 <bp:stepProcess rdf:resource="#Catalysis86" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction238">
 <bp:evidence rdf:resource="#Evidence275" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S189 MAPK6:p-T182 MAPKAPK5 bind KALRN</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence657">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1566">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1361" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep215">
 <bp:stepProcess rdf:resource="#Catalysis84" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction184" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction233">
 <bp:evidence rdf:resource="#Evidence270" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IGF2BP1 binds MAPK4 mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence650">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway339">
 <bp:pathwayOrder rdf:resource="#PathwayStep2684" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2683" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2346" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2345" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2683" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI3K events in ERBB4 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The CYT1 isoforms of ERBB4 possess a C-tail tyrosine residue that, upon trans-autophosphorylation, serves as a docking site for the p85 alpha subunit of PI3K - PIK3R1 (Kaushansky et al. 2008, Cohen et al. 1996). Binding of PIK3R1 to CYT1 isoforms of ERBB4 is followed by recruitment of the p110 catalytic subunit of PI3K (PIK3CA), leading to assembly of an active PI3K complex that converts PIP2 to PIP3 and activates AKT signaling (Kainulainen et al. 2000).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep2897">
 <bp:stepProcess rdf:resource="#Catalysis799" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2519" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep216">
 <bp:stepProcess rdf:resource="#Pathway33" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction232">
 <bp:evidence rdf:resource="#Evidence269" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S857 NCOA3 binds ETV4</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence651">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway338">
 <bp:pathwayOrder rdf:resource="#PathwayStep2659" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2655" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2677" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2656" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2678" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2657" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2679" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2658" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2651" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2673" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2652" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2674" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2653" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2675" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2654" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2676" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2670" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2671" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2650" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2672" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2648" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2649" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2666" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2667" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2668" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2647" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2669" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2662" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2663" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2664" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2665" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2680" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2660" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2661" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2341" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2340" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2327" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2326" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2325" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2324" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2323" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2322" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2321" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2343" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2320" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2342" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2329" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2328" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2330" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2316" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2338" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2315" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2337" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2314" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2336" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2313" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2335" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2312" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2334" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2311" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2333" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2310" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2332" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2331" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2319" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2318" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2317" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2339" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2647" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear signaling by ERBB4</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Besides signaling as a transmembrane receptor, ligand activated homodimers of ERBB4 JM-A isoforms (ERBB4 JM-A CYT1 and ERBB4 JM-A CYT2) undergo proteolytic cleavage by ADAM17 (TACE) in the juxtamembrane region, resulting in shedding of the extracellular domain and formation of an 80 kDa membrane bound ERBB4 fragment known as ERBB4 m80 (Rio et al. 2000, Cheng et al. 2003). ERBB4 m80 undergoes further proteolytic cleavage, mediated by the gamma-secretase complex, which releases the soluble 80 kDa ERBB4 intracellular domain, known as ERBB4 s80 or E4ICD, into the cytosol (Ni et al. 2001). ERBB4 s80 is able to translocate to the nucleus, promote nuclear translocation of various transcription factors, and act as a transcription co-factor. In neuronal precursors, ERBB4 s80 binds the complex of TAB and NCOR1, helps to move the complex into the nucleus, and is a co-factor of TAB:NCOR1-mediated inhibition of expression of astrocyte differentiation genes GFAP and S100B (Sardi et al. 2006). In mammary cells, ERBB4 s80 recruits STAT5A transcription factor in the cytosol, shuttles it to the nucleus, and acts as the STAT5A co-factor in binding to and promoting transcription from the beta-casein (CSN2) promoter, and may be involved in the regulation of other lactation-related genes (Williams et al. 2004, Muraoka-Cook et al. 2008). ERBB4 s80 was also shown to bind activated estrogen receptor in the nucleus and act as its transcriptional co-factor in promoting transcription of some estrogen-regulated genes, such as progesterone receptor gene NR3C3 and CXCL12 i.e. SDF1 (Zhu et al. 2006). ERBB4s80 may inhibit transcription of telomerase reverse transcriptase (TERT) by increasing methylation of the TERT gene promoter through an unknown mechanism (Ishibashi et al. 2012).  The C-tail of ERBB4 possesses several WW-domain binding motifs (three in CYT1 isoform and two in CYT2 isoform), which enable interaction of ERBB4 with WW-domain containing proteins. ERBB4 s80, through WW-domain binding motifs, interacts with YAP1 transcription factor, a known proto-oncogene, and may be a co-regulator of YAP1-mediated transcription (Komuro et al. 2003, Omerovic et al. 2004). The tumor suppressor WWOX, another WW-domain containing protein, competes with YAP1 in binding to ERBB4 s80 and prevents translocation of ERBB4 s80 to the nucleus (Aqeilan et al. 2005). ERBB4 s80 is also able to translocate to the mitochondrial matrix, presumably when its nuclear translocation is inhibited. Once in the mitochondrion, the BH3 domain of ERBB4, characteristic of BCL2 family members, may enable it to act as a pro-apoptotic factor (Naresh et al. 2006).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep2898">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2520" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep213">
 <bp:stepProcess rdf:resource="#Pathway32" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction235">
 <bp:evidence rdf:resource="#Evidence272" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SEPT7 binds p-S189 MAPK6 and p-T182 MAPKAPK5</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence652">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2899">
 <bp:stepProcess rdf:resource="#Pathway380" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep214">
 <bp:stepProcess rdf:resource="#BiochemicalReaction183" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction234">
 <bp:evidence rdf:resource="#Evidence271" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SEPT7:p-S189 MAPK6:p-T182 MAPKAPK5 phosphorylates CDC42EPs</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence653">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1561">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1356" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2165">
 <bp:evidence rdf:resource="#Evidence2488" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHC1-2 bound to MET recruits GRB2:SOS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2893">
 <bp:stepProcess rdf:resource="#Pathway379" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1560">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1355" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2164">
 <bp:evidence rdf:resource="#Evidence2487" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated MET recruits GRB2-1:SOS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2894">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2516" />
 <bp:stepProcess rdf:resource="#Catalysis798" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2163">
 <bp:evidence rdf:resource="#Evidence2486" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MET binds SHC1-2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2895">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2517" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2162">
 <bp:evidence rdf:resource="#Evidence2485" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MET phosphorylates SHC1-2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2896">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2518" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1565">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1360" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2161">
 <bp:evidence rdf:resource="#Evidence2484" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MUC20 binds MET and inhibits GRB2 binding</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1564">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1359" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2160">
 <bp:evidence rdf:resource="#Evidence2483" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated MET binds RANBP9 and SOS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2890">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2513" />
 <bp:stepProcess rdf:resource="#Catalysis795" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1563">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1358" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2891">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2514" />
 <bp:stepProcess rdf:resource="#Catalysis796" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1562">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1357" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2892">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2515" />
 <bp:stepProcess rdf:resource="#Catalysis797" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway340">
 <bp:pathwayOrder rdf:resource="#PathwayStep2690" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2688" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2689" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2691" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2349" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2352" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2351" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2350" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2688" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHC1 events in ERBB4 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">All splicing isoforms of ERBB4 possess two tyrosine residues in the C-tail that serve as docking sites for SHC1 (Kaushansky et al. 2008, Pinkas-Kramarski et al. 1996, Cohen et al. 1996). Once bound to ERBB4, SHC1 becomes phosphorylated on tyrosine residues by the tyrosine kinase activity of ERBB4, which enables it to recruit the complex of GRB2 and SOS1, resulting in the guanyl-nucleotide exchange on RAS and activation of RAF and MAP kinase cascade (Kainulainen et al. 2000).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2169">
 <bp:evidence rdf:resource="#Evidence2494" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Anti-MET recombinant therapeutic antibodies bind MET</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2168">
 <bp:evidence rdf:resource="#Evidence2493" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Anti-MET small tyrosine kinase inhibitors bind MET</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2167">
 <bp:evidence rdf:resource="#Evidence2490" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MET binds RANBP10</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2166">
 <bp:evidence rdf:resource="#Evidence2489" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAS guanyl nucleotide exchange by SOS1 bound to GRB2, SCH1-2 and MET</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep211">
 <bp:stepProcess rdf:resource="#BiochemicalReaction181" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction240">
 <bp:evidence rdf:resource="#Evidence277" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MYC binds MAPKAPK5 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway346">
 <bp:pathwayOrder rdf:resource="#PathwayStep2717" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2718" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2373" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2372" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2717" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTF3 activates NTRK3 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTRK3 (TRKC) is activated by binding to its ligand neurotrophin-3 (NTF3, also known as NT-3). Ligand binding induces dimerization of NTRK3 and trans-autophosphorylation of dimerized receptors on conserved tyrosine residues in the cytoplasmic tail. Autophosphorylated tyrosines serve as docking sites for binding of adaptor proteins that mediate downstream signaling (Lamballe et al. 1991, Philo et al. 1994, Tsoulfas et al. 1996, Huang and Reichardt 2001, Werner et al. 2014).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep212">
 <bp:stepProcess rdf:resource="#Catalysis83" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction182" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway345">
 <bp:pathwayOrder rdf:resource="#PathwayStep2714" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2710" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2711" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2712" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2713" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2369" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2368" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2367" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2366" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2370" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2710" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated NTRK3 signals through PI3K</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The PI3K complex, composed of PIK3R1 and PIK3CA, co-immunoprecipitates with NTRK3 (TRKC), activated by NTF3 (NT-3) treatment (Yuen and Mobley 1999). Activation of NTRK3 correlates with activating phosphorylation of AKT, the main mediator of PI3K signaling (Tognon et al. 2001, Jin et al. 2008), and is dependent on PI3K activity (Tognon et al. 2001). NTRK3-mediated activation of PI3K signaling depends on SRC activation and the adaptor protein IRS1, but the exact mechanism is not known (Morrison et al. 2002, Lannon et al. 2004, Jin et al. 2008).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction242">
 <bp:evidence rdf:resource="#Evidence282" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dual mechanism MAPK inhibitors bind MAPKs</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway348">
 <bp:pathwayOrder rdf:resource="#PathwayStep2725" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2726" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2727" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2379" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2378" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2380" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2725" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated NTRK3 signals through PLCG1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The receptor tyrosine kinase NTRK3 (TRKC), when activated by its ligand NTF3 (NT-3), induces PLCG1 phosphorylation, triggering PLCG1 signaling (Marsh and Palfrey 1996, Yuen and Mobley 1999).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep210">
 <bp:stepProcess rdf:resource="#BiochemicalReaction180" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction241">
 <bp:evidence rdf:resource="#Evidence278" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK6 is ubiquitinated at the N-terminal</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway347">
 <bp:pathwayOrder rdf:resource="#PathwayStep2721" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2722" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2723" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2720" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2377" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2376" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2375" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2374" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2720" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTRK3 as a dependence receptor</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">When neuronal cells are deprived of the NTRK3 (TRKC) ligand NTF3 (NT-3), NTRK3 functions as a dependence receptor, promoting apoptosis. The pro-apoptotic activity of NTRK3 is implicated in proper nervous system development, by dictating the number of surviving sensory neurons (Tauszig-Delamasure et al. 2007). In the absence of its ligand, NTRK3 undergoes caspase-dependent cleavage (Tauszig-Delamasure et al. 2007), resulting in release of the NTRK3 killer fragment (KF). The NTRK3 KF, in complex with NELFB (COBRA1), inserts into the mitochondrial membrane, promoting cytochrome c release and apoptosome-mediated apoptosis (Ichim et al. 2013).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence658">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway342">
 <bp:pathwayOrder rdf:resource="#PathwayStep2703" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2728" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2777" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2784" />
 <bp:pathwayComponent rdf:resource="#Pathway360" />
 <bp:pathwayComponent rdf:resource="#Pathway362" />
 <bp:pathwayComponent rdf:resource="#Pathway349" />
 <bp:pathwayComponent rdf:resource="#Pathway343" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2703" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by NTRKs</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Neurotrophins (NGF, BDNF, NTF3 and NTF4) play pivotal roles in survival, differentiation, and plasticity of neurons in the peripheral and central nervous system. They are produced, and secreted in minute amounts, by a variety of tissues. They signal through two types of receptors: NTRK (TRK) tyrosine kinase receptors (TRKA, TRKB, TRKC), which differ in their preferred neurotrophin ligand, and p75NTR death receptor, which interacts with all neurotrophins. Besides the nervous system, TRK receptors and p75NTR are expressed in a variety of other tissues. For review, please refer to Bibel and Barde 2000, Poo 2001, Lu et al. 2005, Skaper 2012, Park and Poo 2013. NTRK receptors, NTRK1 (TRKA), NTRK2 (TRKB) and NTRK3 (TRKC) are receptor tyrosine kinases activated by ligand binding to their extracellular domain. Ligand binding induces receptor dimerization, followed by trans-autophosphorylation of dimerized receptors on conserved tyrosine residues in the cytoplasmic region. Phosphorylated tyrosines in the intracellular domain of the receptor serve as docking sites for adapter proteins, triggering downstream signaling cascades. NTRK1 (TRKA) is the receptor for the nerve growth factor (NGF). NGF is primarily secreted by tissues that are innervated by sensory and sympathetic neurons. NTRK1 signaling promotes growth and survival of neurons during embryonic development and maintenance of neuronal cell integrity in adulthood (reviewed by Marlin and Li 2015). Brain-derived neurotrophic factor (BDNF) and neurotrophin-4 (NTF4, also known as NT-4) are two high affinity ligands for NTRK2 (TRKB). Neurotrophin-3 (NTF3, also known as NT-3) binds to NTRK2 with low affinity and may not be a physiologically relevant ligand. Nerve growth factor (NGF), a high affinity ligand for NTRK1, does not interact with NTRK2. NTRK2 signaling is implicated in neuronal development in both the peripheral (PNS) and central nervous system (CNS) and may play a role in long-term potentiation (LTP) and learning (reviewed by Minichiello 2009). NTRK2 may modify neuronal excitability and synaptic transmission by directly phosphorylating voltage gated channels (Rogalski et al. 2000). NTF3 (NT-3) is the ligand for NTRK3 (TRKC). Signaling downstream of activated NTRK3, regulates cell survival, proliferation and motility. In the absence of its ligand, NTRK3 functions as a dependence receptor and triggers BAX and CASP9-dependent cell death (Tauszig-Delamasure et al. 2007, Ichim et al. 2013). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence659">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway341">
 <bp:pathwayOrder rdf:resource="#PathwayStep2695" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2696" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2697" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2698" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2694" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2358" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2357" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2356" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2355" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2354" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2694" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Downregulation of ERBB4 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WW-domain binding motifs in the C-tail of ERBB4 play an important role in the downregulation of ERBB4 receptor signaling, enabling the interaction of intact ERBB4, ERBB4 m80 and ERBB4 s80 with NEDD4 family of E3 ubiquitin ligases WWP1 and ITCH. The interaction of WWP1 and ITCH with intact ERBB4 is independent of receptor activation and autophosphorylation. Binding of WWP1 and ITCH ubiquitin ligases leads to ubiquitination of ERBB4 and its cleavage products, and subsequent degradation through both proteasomal and lysosomal routes (Omerovic et al. 2007, Feng et al. 2009). In addition, the s80 cleavage product of ERBB4 JM-A CYT-1 isoform is the target of NEDD4 ubiquitin ligase. NEDD4 binds ERBB4 JM-A CYT-1 s80 (ERBB4jmAcyt1s80) through its PIK3R1 interaction site and mediates ERBB4jmAcyt1s80 ubiquitination, thereby decreasing the amount of ERBB4jmAcyt1s80 that reaches the nucleus (Zeng et al. 2009).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway344">
 <bp:pathwayOrder rdf:resource="#PathwayStep2705" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2706" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2707" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2708" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2365" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2364" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2363" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2362" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2705" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated NTRK3 signals through RAS</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Upon activation by NTF3 (NT-3), the receptor tyrosine kinase NTRK3 (TRKC) triggers RAS signaling through adaptor proteins SHC1 and GRB2 (Marsh and Palfrey 1996, Gunn-Moore et al. 1997, Yuen and Mobley 1999). ERK activation downstream of NTRK3 may increase cell motility through WAVE. The mechanism is not known (Gromnitza et al. 2018).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway343">
 <bp:pathwayOrder rdf:resource="#PathwayStep2704" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2715" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2716" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2724" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2719" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2709" />
 <bp:pathwayComponent rdf:resource="#Pathway346" />
 <bp:pathwayComponent rdf:resource="#Pathway345" />
 <bp:pathwayComponent rdf:resource="#Pathway348" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2371" />
 <bp:pathwayComponent rdf:resource="#Pathway347" />
 <bp:pathwayComponent rdf:resource="#Pathway344" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2704" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by NTRK3 (TRKC)</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTRK3 (TRKC) belongs to the family of neurotrophin receptor tyrosine kinases, which also includes NTRK1 (TRKA) and NTRK2 (TRKB). Neurotrophin-3 (NTF3, also known as NT-3) is the ligand for NTRK3. Similar to other NTRK receptors and receptor tyrosine kinases in general, ligand binding induces receptor dimerization followed by trans-autophosphorylation on conserved tyrosines in the intracellular (cytoplasmic) domain of the receptor (Lamballe et al. 1991, Philo et al. 1994, Tsoulfas et al. 1996, Yuen and Mobley 1999, Werner et al. 2014). These conserved tyrosines serve as docking sites for adaptor proteins that trigger downstream signaling cascades. Signaling through PLCG1 (Marsh and Palfrey 1996, Yuen and Mobley 1999, Huang and Reichardt 2001), PI3K (Yuen and Mobley 1999, Tognon et al. 2001, Huang and Reichardt 2001, Morrison et al. 2002, Lannon et al. 2004, Jin et al. 2008) and RAS (Marsh and Palfrey 1996, Gunn-Moore et al. 1997, Yuen and Mobley 1999, Gromnitza et al. 2018), downstream of activated NTRK3, regulates cell survival, proliferation and motility. In the absence of its ligand, NTRK3 functions as a dependence receptor and triggers BAX and CASP9-dependent cell death (Tauszig-Delamasure et al. 2007, Ichim et al. 2013). NTRK3 was reported to activate STAT3 through JAK2, but the exact mechanism has not been elucidated (Kim et al. 2016). NTRK3 was reported to interact with the adaptor protein SH2B2, but the biological role of this interaction has not been determined (Qian et al. 1998). Receptor protein tyrosine phosphatases PTPRO and PTPRS (PTPsigma) negatively regulate NTRK3 signaling by dephosphorylating NTRK3 (Beltran et al. 2003, Faux et al. 2007, Hower et al. 2009, Tchetchelnitski et al. 2014). In addition to dephosphorylation of NTRK3 in-cis, the extracellular domain of pre-synaptic PTPRS can bind in-trans to extracellular domain of post-synaptic NTRK3, contributing to synapse formation (Takahashi et al. 2011, Coles et al. 2014).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep208">
 <bp:stepProcess rdf:resource="#Catalysis82" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction178" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction248">
 <bp:evidence rdf:resource="#Evidence288" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Single mechanism MAP2K inhibitors bind phosphorylated MAP2Ks</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence643">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep209">
 <bp:stepProcess rdf:resource="#BiochemicalReaction179" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction247">
 <bp:evidence rdf:resource="#Evidence287" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP2Ks and MAPKs are phosphorylated at the endosome membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence644">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1579">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1374" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep206">
 <bp:stepProcess rdf:resource="#BiochemicalReaction176" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence645">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1578">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1373" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep207">
 <bp:stepProcess rdf:resource="#Catalysis81" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction177" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction249">
 <bp:evidence rdf:resource="#Evidence289" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL17RD binds p-2S MAP2Ks and MAPKs</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence646">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1577">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1372" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep204">
 <bp:stepProcess rdf:resource="#BiochemicalReaction174" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction244">
 <bp:evidence rdf:resource="#Evidence284" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WDR83:LAMTOR2:LAMTOR3 binds MAPK components</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway328">
 <bp:pathwayOrder rdf:resource="#PathwayStep2516" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2517" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2518" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2519" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2520" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2521" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2522" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2190" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2189" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2195" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2194" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2193" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2192" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2191" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2516" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MDK and PTN in ALK signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The cytokines pleiotrophin (PTN) and midikine (MDK) were initially proposed to act as ligands for ALK (Stoica et al, 2001; Stoica et al, 2002; reviewed in Wellstein et al, 2012; Winkler et al, 2014; Herradon and Perez-Garcia, 2014). Binding of PTN or MDK to ALK either in cell-free assays or in intact cells was shown to stimulate signaling through IRS, SHC, PLC and PI3K and to support neurite outgrowth, growth and survival (Stoica et al, 2001; Stoica et al, 2002; reviewed in Wellstein et al, 2012; Winkler et al, 2014; Herradon and Perez-Garcia, 2014). The activating effects of PTN and MDK on the ALK receptor were not universally reproducible, however, despite eliciting similar downstream signaling to those with anti-ALK monoclonal antibodies (Mathivet et al, 2007; Moog-Lutz et al, 2005; Motegi et al, 2004; Dirks et al, 2002; Miyake et al, 2002). More recently, ALKAL1 and ALKAL2 have been identified as the physiologically relevant ALK ligands (Zhang et al, 2014; Guan et al, 2015; Reshetnyak et al, 2015; Reshetnyak et al, 2018).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep205">
 <bp:stepProcess rdf:resource="#Catalysis80" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction175" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction243">
 <bp:evidence rdf:resource="#Evidence283" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of RAS:RAF complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence640">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway327">
 <bp:pathwayOrder rdf:resource="#PathwayStep2538" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2539" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2512" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2513" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2514" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2515" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2537" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2510" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2511" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2550" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2551" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2549" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2508" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2523" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2545" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2524" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2546" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2525" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2547" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2548" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2541" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2542" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2543" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2544" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2540" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2509" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2187" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2220" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2186" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2185" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2184" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2183" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2182" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2223" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2222" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2188" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2221" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2209" />
 <bp:pathwayComponent rdf:resource="#Pathway328" />
 <bp:pathwayComponent rdf:resource="#Pathway329" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2197" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2196" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2217" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2216" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2215" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2214" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2213" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2212" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2211" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2210" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2219" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2218" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2508" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by ALK</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The anaplastic lymphoma kinase (ALK) is a transmembrane receptor tyrosine kinase that, along with related receptor LTK (leukocyte tyrosine kinase receptor) is a member of the insulin receptor superfamily (Iwahara et al, 1997). ALK was discovered as an oncogene in anaplastic large cell lymphomas (ALCLs), but also plays an oncogenic role in other cancer types, such as non-small-cell lung cancer (NSCLC), inflammatory myofibroblastic tumours (IMT), melanoma, neuroblastoma and glioblastoma. In cancer, the chromosomal region encoding ALK frequently undergoes genomic rearrangements, resulting in the formation of ALK fusion proteins, such as NPM&#8209;ALK (the result of a translocation event, t(2;5)(p23;q35) which is predominant in ALCL) and EML4&#8209;ALK (an inversion event on chromosome 2) (Morris et al, 1994; Couts et al, 2018). These fusion proteins consist of the C&#8209;terminal region of ALK, encompassing the kinase domain and the effector protein binding domain (with loss of the transmembrane domain), while the N&#8209;terminus of the fusion protein contains the dimerization domain of the partner gene. Fusion proteins of ALK are therefore capable of ligand&#8209;independent dimerization, resulting in constitutive ALK signaling (reviewed in Duyster et al, 2001; Chiarle et al, 2008; Della Corte et al, 2018; Hallberg and Palmer, 2013; Hallberg and Palmer, 2016; Janoueix-Larousey et al, 2018; Ducray et al, 2019). Additionally, amplification of ALK and/or point mutations leading to its constitutive activation have been detected in neuroblastoma (reviewed in McDuff et al, 2011).   Many of the functional studies on ALK have been conducted in the context of oncogenic forms of the protein. In contrast, fewer studies have been conducted on the wild type protein under normal physiological conditions, and indeed, ALK was initially classed as an orphan receptor with no identified ligand. Two small heparin-binding growth factors, pleiotrophin (PTN) and midkine (MDK), were initially identified as potential ligands however subsequent studies failed to support this (Stoica et al, 2001; Stoica et al, 2002; Mathivet et al, 2007; Moog-Lutz et al, 2005; Motegi et al, 2004; reviewed in Wellstein et al, 2012; Winkler et al, 2014; Herradon and Perez-Garcia, 2014). More recently, ALKAL1 and ALKAL2 (also known as FAM150A and FAM150B) have been identified as ligands for both ALK and the related LTK receptor, albeit with differing potencies (Zhang et al, 2014; Guan et al, 2015; Reshetnyak et al, 2015; Reshetnyak et al, 2018; Fadeev et al, 2018; Reshetnyak et al, 2021; De Munck et al, 2021; Borenas et al, 2021; reviewed in Hallberg and Palmer, 2016). Whereas LTK receptor is potently activated by both ALKAL1 and ALKAL2, ALK is only weakly stimulated by ALKAL1 (Reshetnyak et al, 2015; Reshetnyak et al, 2018). Ligand binding induces the dimerization of the receptor and transautophosphorylation, resulting in a fully activated receptor that triggers downstream signaling cascades such as RAS, PI3K and IRS1 signaling. ALK may also undergo ligand-independent activation through RPTPB/RPTPZ (Deuel et al, 2013).   ALK is mainly expressed in the developing central and peripheral nervous system and plays a role in differentiation during development (Souttou et al, 2001; Gouzi et al, 2005; Degoutin et al, 2007). In Drosophila and mice, ALK is a thinness gene involved in the resistance to weight gain (Orthofer et al, 2020). Through activation of STAT3 targets, ALK also appears to play a role in response to ethanol (Hamada et al, 2021). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep202">
 <bp:stepProcess rdf:resource="#Catalysis79" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction172" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction246">
 <bp:evidence rdf:resource="#Evidence286" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAF phosphorylates MAP2K dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence641">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep203">
 <bp:stepProcess rdf:resource="#BiochemicalReaction173" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction245">
 <bp:evidence rdf:resource="#Evidence285" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP2Ks phosphorylate MAPK at the Golgi membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence642">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway329">
 <bp:pathwayOrder rdf:resource="#PathwayStep2527" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2528" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2529" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2534" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2535" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2536" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2526" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2530" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2531" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2532" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2533" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2206" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2205" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2204" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2203" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2202" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2201" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2200" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2199" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2198" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2208" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2207" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2526" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT3 nuclear events downstream of ALK signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of the STAT3 pathway downstream of ALK signaling contributes to cellular survival by modulating expression of a number of genes involved in apoptosis, immune response and angiogenesis (reviewed in Werner et al, 2009). The STAT3 pathway is particularly important in ALK+ cancers that express ALK fusion proteins, where STAT3 contributes to the repression of a number of tumor suppressor genes, highlighting its role as a critical oncogene (reviewed in Yu et al, 2014; Guanizo et al, 2018). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep1572">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1367" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2154">
 <bp:evidence rdf:resource="#Evidence2476" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HGF dimer binds MET</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1571">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1366" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2153">
 <bp:evidence rdf:resource="#Evidence2475" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HPN heterodimer cleaves pro-HGF to form HGF dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1570">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1365" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2152">
 <bp:evidence rdf:resource="#Evidence2473" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated STAT3 Forms Dimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2151">
 <bp:evidence rdf:resource="#Evidence2472" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MET phosphorylates STAT3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1576">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1371" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2150">
 <bp:evidence rdf:resource="#Evidence2471" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated STAT3 Dimer Translocates to the Nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1575">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1370" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1574">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1369" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1573">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1368" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2159">
 <bp:evidence rdf:resource="#Evidence2482" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAS guanyl nucleotide exchange by MET-bound GRB2:SOS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2158">
 <bp:evidence rdf:resource="#Evidence2481" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAS guanyl nucleotide exchange by SOS1 associated with RANBP9 and MET</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2157">
 <bp:evidence rdf:resource="#Evidence2479" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MET dimers autophosphorylate</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2156">
 <bp:evidence rdf:resource="#Evidence2478" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MET receptor dimerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2155">
 <bp:evidence rdf:resource="#Evidence2477" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HGFAC cleaves pro-HGF to form HGF dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep200">
 <bp:stepProcess rdf:resource="#Catalysis78" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction170" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction251">
 <bp:evidence rdf:resource="#Evidence291" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP2Ks phosphorylate MAPKs</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway335">
 <bp:pathwayOrder rdf:resource="#PathwayStep2644" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2640" />
 <bp:pathwayComponent rdf:resource="#Pathway336" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2309" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2640" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">VEGF ligand-receptor interactions</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The VEGF family is encoded by seven genes (VEGF-A, B, C, D, E: PLGF (Placenta Growth Factor)-1, 2). Six isoforms of VEGF-A protein, containing 121, 145, 165, 183, 189, and 206 amino acid residues, and two isoforms of VEGF-B (167 and 186 residues) are specified by alternatively spliced mRNAs. The active form of each of these proteins is a homodimer. The specificities of the three VEGF tyrosine kinase receptors, VEGFR-1, VEGFR-2 and VEGFR-3, for these ligands are shown in the figure (Hicklin and Ellis 2005). All VEGF-A isoforms bind both VEGFR-1 and VEGFR-2; PLGF-1 and -2, and VEGF-B isoforms bind only VEGFR-1; VEGF-E binds VEGFR-2; and VEGF-C and -D bind both VEGFR-2 and -3. VEGF-D undergoes a complex series of post-translational modifications that results in secreted forms with increased activity toward VEGFR-3 and VEGFR-2.  Two co-receptor proteins in the cell membrane, neuropilin (NRP)-1 and NRP-2, interact with VEGFR proteins to increase the affinity of the latter for their ligands (Neufeld et al.,2002). They differ from VEGFR proteins in not having intracellular signaling domains. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep201">
 <bp:stepProcess rdf:resource="#BiochemicalReaction171" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction250">
 <bp:evidence rdf:resource="#Evidence290" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP2Ks and MAPKs bind to the activated RAF complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway334">
 <bp:pathwayOrder rdf:resource="#PathwayStep2589" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2585" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2596" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2586" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2587" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2588" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2592" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2582" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2593" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2583" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2594" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2584" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2595" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2590" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2591" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2253" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2252" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2263" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2251" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2262" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2250" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2261" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2260" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2249" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2259" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2258" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2257" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2256" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2255" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2254" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2582" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">VEGFR2 mediated vascular permeability</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The free radical nitric oxide (NO), produced by endothelial NO synthase (eNOS), is an important vasoactive substance in normal vascular biology and pathophysiology. It plays an important role in vascular functions such as vascular dilation and angiogenesis (Murohara et al. 1998, Ziche at al. 1997). NO has been reported to be a downstream mediator in the angiogenic response mediated by VEGF, but the mechanism by which NO promotes neovessel formation is not clear (Babaei    Stewart 2002). Persistent vasodilation and increase in vascular permeability in the existing vasculature is observed during the early steps of angiogenesis, suggesting that  these hemodynamic changes are indispensable during an angiogenic processes. NO production by VEGF can occur either through the activation of PI3K or through a PLC-gamma dependent manner. Once activated both pathways converge on AKT phosphorylation of eNOS, releasing NO (Lin    Sessa 2006). VEGF also regulates vascular permeability by promoting VE-cadherin endocytosis at the cell surface through a VEGFR-2-Src-Vav2-Rac-PAK signalling axis.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction253">
 <bp:evidence rdf:resource="#Evidence293" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dual mechanism MAP2K inhibitors bind MAP2Ks</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway337">
 <bp:pathwayOrder rdf:resource="#PathwayStep2699" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2700" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2646" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2701" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2685" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2686" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2687" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2681" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2692" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2682" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2693" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2348" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2359" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2347" />
 <bp:pathwayComponent rdf:resource="#Pathway340" />
 <bp:pathwayComponent rdf:resource="#Pathway339" />
 <bp:pathwayComponent rdf:resource="#Pathway338" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2344" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2353" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2361" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2360" />
 <bp:pathwayComponent rdf:resource="#Pathway341" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2646" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by ERBB4</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB4, also known as HER4, belongs to the ERBB family of receptors, which also includes ERBB1 (EGFR/HER1), ERBB2 (HER2/NEU) and ERBB3 (HER3). Similar to EGFR, ERBB4 has an extracellular ligand binding domain, a single transmembrane domain and a cytoplasmic domain which contains an active tyrosine kinase and a C-tail with multiple phosphorylation sites. At least three and possibly four splicing isoforms of ERBB4 exist that differ in their C-tail and/or the extracellular juxtamembrane regions: ERBB4 JM-A CYT1, ERBB4 JM-A CYT2 and ERBB4 JM-B CYT1 (the existence of ERBB4 JM-B CYT2 has not been confirmed).   ERBB4 becomes activated by binding one of its seven ligands, three of which, HB-EGF, epiregulin EPR and betacellulin BTC, are EGF-like (Elenius et al. 1997, Riese et al. 1998), while four, NRG1, NRG2, NRG3 and NRG4, belong to the related neuregulin family (Tzahar et al. 1994, Carraway et al. 1997, Zhang et al. 1997, Hayes et al. 2007). Upon ligand binding, ERBB4 forms homodimers (Sweeney et al. 2000) or it heterodimerizes with ERBB2 (Li et al. 2007). Dimers of ERBB4 undergo trans-autophosphorylation on tyrosine residues in the C-tail (Cohen et al. 1996, Kaushansky et al. 2008, Hazan et al. 1990, Li et al. 2007), triggering downstream signaling cascades. The pathway Signaling by ERBB4 only shows signaling by ERBB4 homodimers. Signaling by heterodimers of ERBB4 and ERBB2 is shown in the pathway Signaling by ERBB2. Ligand-stimulated ERBB4 is also able to form heterodimers with ligand-stimulated EGFR (Cohen et al. 1996) and ligand-stimulated ERBB3 (Riese et al. 1995). Dimers of ERBB4 with EGFR and dimers of ERBB4 with ERBB3 were demonstrated in mouse cell lines in which human ERBB4 and EGFR or ERBB3 were exogenously expressed. These heterodimers undergo trans-autophosphorylation. The promiscuous heteromerization of ERBBs adds combinatorial diversity to ERBB signaling processes. As ERBB4 binds more ligands than other ERBBs, but has restricted expression, ERBB4 expression channels responses to ERBB ligands. The signaling capabilities of the four receptors have been compared (Schulze et al. 2005).  As for other receptor tyrosine kinases, ERBB4 signaling effectors are largely dictated through binding of effector proteins to ERBB4 peptides that are phosphorylated upon ligand binding. All splicing isoforms of ERBB4 possess two tyrosine residues in the C-tail that serve as docking sites for SHC1 (Kaushansky et al. 2008, Pinkas-Kramarski et al. 1996, Cohen et al. 1996). Once bound to ERBB4, SHC1 becomes phosphorylated on tyrosine residues by the tyrosine kinase activity of ERBB4, which enables it to recruit the complex of GRB2 and SOS1, resulting in the guanyl-nucleotide exchange on RAS and activation of RAF and MAP kinase cascade (Kainulainen et al. 2000).   The CYT1 isoforms of ERBB4 also possess a C-tail tyrosine residue that, upon trans-autophosphorylation, serves as a docking site for the p85 alpha subunit of PI3K (Kaushansky et al. 2008, Cohen et al. 1996), leading to assembly of an active PI3K complex that converts PIP2 to PIP3 and activates AKT signaling (Kainulainen et al. 2000).   Besides signaling as a conventional transmembrane receptor kinase, ERBB4 differs from other ERBBs in that JM-A isoforms signal through efficient release of a soluble intracellular domain. Ligand activated homodimers of ERBB4 JM-A isoforms (ERBB4 JM-A CYT1 and ERBB4 JM-A CYT2) undergo proteolytic cleavage by ADAM17 (TACE) in the juxtamembrane region, resulting in shedding of the extracellular domain and formation of an 80 kDa membrane bound ERBB4 fragment known as ERBB4 m80 (Rio et al. 2000, Cheng et al. 2003). ERBB4 m80 undergoes further proteolytic cleavage, mediated by the gamma-secretase complex, which releases the soluble 80 kDa ERBB4 intracellular domain, known as ERBB4 s80 or E4ICD, into the cytosol (Ni et al. 2001). ERBB4 s80 is able to translocate to the nucleus, promote nuclear translocation of various transcription factors, and act as a transcription co-factor. For example, in mammary cells, ERBB4 binds SH2 transcription factor STAT5A. ERBB4 s80 shuttles STAT5A to the nucleus, and actsa as a STAT5A co-factor in binding to and promoting transcription from the beta-casein (CSN2) promoter, and may be involved in the regulation of other lactation-related genes (Jones et al. 1999, Williams et al. 2004, Muraoka-Cook et al. 2008). ERBB4 s80 binds activated estrogen receptor in the nucleus and acts as a transcriptional co-factor in promoting transcription of some estrogen-regulated genes, including progesterone receptor gene NR3C3 and CXCL12 (SDF1) (Zhu et al. 2006). In neuronal precursors, ERBB4 s80 binds the complex of TAB and NCOR1, helps to move the complex into the nucleus, and is a co-factor of TAB:NCOR1-mediated inhibition of expression of astrocyte differentiation genes GFAP and S100B (Sardi et al. 2006).  The C-tail of ERBB4 possesses several WW-domain binding motifs (three in CYT1 isoform and two in CYT2 isoform), which enable interaction of ERBB4 with WW-domain containing proteins. ERBB4 s80, through WW-domain binding motifs, interacts with YAP1 transcription factor, a known proto-oncogene, and is a co-regulator of YAP1-mediated transcription in association with TEAD transcription factors (Komuro et al. 2003, Omerovic et al. 2004). Hence, the WW binding motif couples ERBB4 to the major effector arm of the HIPPO signaling pathway. The tumor suppressor WWOX, another WW-domain containing protein, competes with YAP1 in binding to ERBB4 s80 and prevents translocation of ERBB4 s80 to the nucleus (Aqeilan et al. 2005).  WW-domain binding motifs in the C-tail of ERBB4 play an important role in the downregulation of ERBB4 receptor signaling, enabling the interaction of intact ERBB4, ERBB4 m80 and ERBB4 s80 with NEDD4 family of E3 ubiquitin ligases WWP1 and ITCH. The interaction of WWP1 and ITCH with intact ERBB4 is independent of receptor activation and autophosphorylation. Binding of WWP1 and ITCH ubiquitin ligases leads to ubiquitination of ERBB4 and its cleavage products, and subsequent degradation through both proteasomal and lysosomal routes (Omerovic et al. 2007, Feng et al. 2009). In addition, the s80 cleavage product of ERBB4 JM-A CYT-1 isoform is the target of NEDD4 ubiquitin ligase. NEDD4 binds ERBB4 JM-A CYT-1 s80 (ERBB4jmAcyt1s80) through its PIK3R1 interaction site and mediates ERBB4jmAcyt1s80 ubiquitination, thereby decreasing the amount of ERBB4jmAcyt1s80 that reaches the nucleus (Zeng et al. 2009).  ERBB4 also binds the E3 ubiquitin ligase MDM2, and inhibitor of p53 (Arasada et al. 2005). Other proteins that bind to ERBB4 intracellular domain have been identified by co-immunoprecipitation and mass spectrometry (Gilmore-Hebert et al., 2010), and include transcriptional co-repressor TRIM28/KAP1, which promotes chromatin compaction. DNA damage signaling through ATM releases TRIM28-associated heterochromatinization. Interactions of ERBB4 with TRIM28 and MDM2 may be important for integration of growth factor responses and DNA damage responses.  In human breast cancer cell lines, ERBB4 activation enhances anchorage-independent colony formation in soft agar but inhibits cell growth in a monolayer culture. Different ERBB4 ligands induce different gene expression changes in breast cancer cell lines. Some of the genes induced in response to ERBB4 signaling in breast cancer cell lines are RAB2, EPS15R and GATA4. It is not known if these gene are direct transcriptional targets of ERBB4 (Amin et al. 2004).  Transcriptome and ChIP-seq comparisons of full-length and intracellular domain isoforms in isogenic MCF10A mammary cell background have revealed the diversification of ERBB4 signaling engendered by alternative splicing and cleavage (Wali et al., 2014). ERBB4 broadly affected protease expression, cholesterol biosynthesis, HIF1-alpha signaling, and HIPPO signaling pathways, and other pathways were differentially activated by CYT1 and CYT2 isoforms. For example, CYT1 promoted expression of transcription factors TWIST1 and SNAIL1 that promote epithelial-mesenchymal transition. HIF1-alpha and HIPPO signaling are mediated, respectively, by binding of ERBB4 to HIF1-alpha and to YAP (Paatero et al., 2012, Komuro et al., 2003). ERBB4 increases activity of the transcription factor SREBF2, resulting in increased expression of SREBF2-target genes involved in cholesterol biosynthesis. The mechanism is not known and may involve facilitation of SREBF2 cleavage through ERBB4-mediated PI3K signaling (Haskins et al. 2016).  In some contexts, ERBB4 promotes growth suppression or apoptosis (Penington et al., 2002). Activation of ERBB4 in breast cancer cell lines leads to JNK dependent increase in BRCA1 mRNA level and mitotic cell cycle delay, but the exact mechanism has not been elucidated (Muraoka Cook et al. 2006). The nature of growth responses may be connected with the spliced isoforms expressed. In comparisons of CYT1 vs CYT2 (full-length and ICD) expression in mammary cells, CYT1 was a weaker growth inducer, associated with attenuated MAPK signaling relative to CYT2 (Wali et al., 2014). ERBB4 s80 is also able to translocate to the mitochondrial matrix, presumably when its nuclear translocation is inhibited. Once in the mitochondrion, the BH3 domain of ERBB4, characteristic of BCL2 family members, may enable it to act as a pro apoptotic factor (Naresh et al. 2006).  ERBB4 plays important roles in the developing and adult nervous system. Erbb4 deficiency in somatostatin-expressing neurons of the thalamic reticular nucleus alters behaviors dependent on sensory selection (Ahrens et al. 2015). NRG1-activated ERBB4 signaling enhances AMPA receptor responses through PKC-dependent AMPA receptor exocytosis. This results in an increased excitatory input to parvalbumin-expressing inhibitory neurons in the visual cortex and regulates visual cortical plasticity (Sun et al. 2016). NRG1-activated ERBB4 signaling is involved in GABAergic activity in amygdala which mediates fear conditioning (fear memory) (Lu et al. 2014). Conditional Erbb4 deletion from fast-spiking interneurons, chandelier and basket cells of the cerebral cortex leads to synaptic defects associated with increased locomotor activity and abnormal emotional, social and cognitive function that can be linked to some of the schizophrenia features. The level of GAD1 (GAD67) protein is reduced in the cortex of conditional Erbb4 mutants. GAD1 is a GABA synthesizing enzyme. Cortical mRNA levels of GAD67 are consistently decreased in schizophrenia (Del Pino et al. 2014). Erbb4 is expressed in the GABAergic neurons of the bed nucleus stria terminalis, a part of the extended amygdala. Inhibition of NRG1-triggered ERBB4 signaling induces anxiety-like behavior, which depends on GABAergic neurotransmission. NRG1-ERBB4 signaling stimulates presynaptic GABA release, but the exact mechanism is not known (Geng et al. 2016). NRG1 protects cortical interneurons against ischemic brain injury through ERBB4-mediated increase in GABAergic transmission (Guan et al. 2015). NRG2-activated ERBB4 can reduce the duration of GABAergic transmission by binding to GABA receptors at the postsynaptic membrane via their GABRA1 subunit and promoting endocytosis of GABA receptors (Mitchell et al. 2013). NRG1 promotes synchronization of prefrontal cortex interneurons in an ERBB4 dependent manner (Hou et al. 2014). NRG1-ERBB4 signaling protects neurons from the cell death induced by a mutant form of the amyloid precursor protein (APP) (Woo et al. 2012).  Clinical relevance of ERBB4 has been identified in several contexts. In cancer, putative and validated gain-of-function mutations or gene amplification that may be drivers have been identified at modest frequencies, and may also contribute to resistance to EGFR and ERBB2-targeted therapies. This is noteworthy as ERBB4 kinase activity is inhibited by pan-ERBB tyrosine kinase inhibitors, including lapatinib, which is approved by the US FDA. The reduced prevalence relative to EGFR and ERBB2 in cancer may reflect more restricted expression of ERBB4, or differential signaling, as specific ERBB4 isoforms have been linked to growth inhibition or apoptosis in experimental systems. ERBB2/ERBB4 heterodimers protect cardiomyocytes, so reduced activity of ERBB4 in patients treated with the ERBB2-targeted therapeutic antibody trastuzumab may contribute to the cardiotoxicity of this agent when used in combination with (cardiotoxic) anthracyclines.  With the importance of ERBB4 in developing and adult nervous system, NRG1 and/or ERBB4 polymorphisms, splicing aberrations and mutations have been linked to nervous system disorders including schizophrenia and amyotrophic lateral sclerosis, although these findings are not yet definitive.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction252">
 <bp:evidence rdf:resource="#Evidence292" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Single mechanism MAPK inhibitors bind phosphorylated MAPK</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway336">
 <bp:pathwayOrder rdf:resource="#PathwayStep2641" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2642" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2643" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2308" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2307" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2306" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2641" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">VEGF binds to VEGFR leading to receptor dimerization</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The binding of VEGF ligands to VEGFR receptors in the cell membrane induces dimerization and activation of the latter, initiating intracellular signaling cascades that result in proliferation, survival, migration and increased permeability of vascular endothelial cells (Matsumoto and Mugishima, 2006). The receptors predominantly form homodimers but heterodimers between VEGFR-1 and -2 have been observed. Although both VEGFR-1 and -2 are expressed in the vascular endothelium, the angiogenic activities of VEGFs are transduced mainly through VEGFR-2 in vivo.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence647">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway331">
 <bp:pathwayOrder rdf:resource="#PathwayStep2554" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2555" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2225" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2224" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2554" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Neurophilin interactions with VEGF and VEGFR</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The plasma membrane-associated Neuropilin receptors NRP-1 and -2 bind some of the VEGF proteins and associate with VEGF receptor proteins. NRP-1 binds VEGF-A165, -B, and PLGF-2; NRP-2 also binds VEGF-A165 and PLGF-2, as well as VEGF-A145 and -C. The Neurolipin receptors appear to act as cofactors for the VEGF receptors, increasing their affinities for specific VEGF ligands, although the importance of this function in vivo remains unclear (Neufeld et al. 2002).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence648">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway330">
 <bp:pathwayOrder rdf:resource="#PathwayStep2638" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2639" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2556" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2553" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2305" />
 <bp:pathwayComponent rdf:resource="#Pathway335" />
 <bp:pathwayComponent rdf:resource="#Pathway331" />
 <bp:pathwayComponent rdf:resource="#Pathway332" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2553" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by VEGF</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In normal development vascular endothelial growth factors (VEGFs) are crucial regulators of vascular development during embryogenesis (vasculogenesis) and blood-vessel formation in the adult (angiogenesis). In tumor progression, activation of VEGF pathways promotes tumor vascularization, facilitating tumor growth and metastasis. Abnormal VEGF function is also associated with inflammatory diseases including atherosclerosis, and hyperthyroidism. The members of the VEGF and VEGF-receptor protein families have distinct but overlapping ligand-receptor specificities, cell-type expression, and function. VEGF-receptor activation in turn regulates a network of signaling processes in the body that promote endothelial cell growth, migration and survival (Hicklin and Ellis, 2005; Shibuya and Claesson-Welsh, 2006). Molecular features of the VGF signaling cascades are outlined in the figure below (from Olsson et al. 2006; Nature Publishing Group). Tyrosine residues in the intracellular domains of VEGF receptors 1, 2,and 3 are indicated by dark blue boxes; residues susceptible to phosphorylation are numbered. A circled R indicates that phosphorylation is regulated by cell state (VEGFR2), by ligand binding (VEGFR1), or by heterodimerization (VEGFR3). Specific phosphorylation sites (boxed numbers) bind signaling molecules (dark blue ovals), whose interaction with other cytosolic signaling molecules (light blue ovals) leads to specific cellular (pale blue boxes) and tissue-level (pink boxes) responses in vivo. Signaling cascades whose molecular details are unclear are indicated by dashed arrows. DAG, diacylglycerol; EC, endothelial cell; eNOS, endothelial nitric oxide synthase; FAK, focal adhesion kinase; HPC, hematopoietic progenitor cell; HSP27, heat-shock protein-27; MAPK, mitogen-activated protein kinase; MEK, MAPK and ERK kinase; PI3K, phosphatidylinositol 3&apos; kinase; PKC, protein kinase C; PLCgamma, phospholipase C-gamma; Shb, SH2 and beta-cells; TSAd, T-cell-specific adaptor. In the current release, the first events in these cascades - the interactions between VEGF proteins and their receptors - are annotated.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence649">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway333">
 <bp:pathwayOrder rdf:resource="#PathwayStep2580" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2578" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2579" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2569" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2574" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2575" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2576" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2577" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2570" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2571" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2572" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2573" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2239" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2238" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2237" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2248" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2247" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2246" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2245" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2244" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2243" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2242" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2241" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2240" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2569" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">VEGFR2 mediated cell proliferation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">VEGFR2 stimulates ERK not via GRB2-SOS-RAS, but via pY1175-dependent phosphorylation of PLC gamma and subsequent activation of PKCs. PKC plays an important mediatory role in the proliferative Ras/Raf/MEK/ERK pathway. PKC alpha can intersect the Ras/Raf/MEK/ERK cascade at the level of Ras (Clark et al. 2004) or downstream of Ras through direct phosphorylation of Raf (Kolch et al. 1993). VEGF stimulation leads to Ras activation in a Ras-guanine nucleotide exchange factor (GEF) independent mechanism. It rather relies on modulating the regulation of Ras-GTPase activating protein (GAP) than regulation of Ras-GEFS (Wu et al. 2003).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway332">
 <bp:pathwayOrder rdf:resource="#PathwayStep2637" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2633" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2557" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2634" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2558" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2635" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2559" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2636" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2597" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2630" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2598" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2631" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2599" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2632" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2604" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2605" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2606" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2607" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2567" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2600" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2568" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2601" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2602" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2603" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2563" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2564" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2565" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2566" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2560" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2561" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2562" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2608" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2609" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2615" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2616" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2617" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2618" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2611" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2612" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2613" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2614" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2610" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2619" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2626" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2627" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2628" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2629" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2622" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2623" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2624" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2625" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2620" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2621" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2581" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2264" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2228" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2227" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2304" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2226" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2303" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2269" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2302" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2268" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2301" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2267" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2300" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2266" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2265" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2229" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2297" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2296" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2295" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2294" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2293" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2292" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2291" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2290" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2299" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2298" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2286" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2285" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2284" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2283" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2282" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2281" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2280" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2289" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2288" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2287" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2231" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2275" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2230" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2274" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2273" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2272" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2271" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2270" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2236" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2235" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2279" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2234" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2278" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2233" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2277" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2232" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2276" />
 <bp:pathwayComponent rdf:resource="#Pathway334" />
 <bp:pathwayComponent rdf:resource="#Pathway333" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2557" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">VEGFA-VEGFR2 Pathway</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Angiogenesis is the formation of new blood vessels from preexisting vasculature. One of the most important proangiogenic factors is vascular endothelial growth factor (VEGF). VEGF exerts its biologic effect through interaction with transmembrane tyrosine kinase receptors VEGFR, selectively expressed on vascular endothelial cells. VEGFA signaling through VEGFR2 is the major pathway that activates angiogenesis by inducing the proliferation, survival, sprouting and migration of endothelial cells (ECs), and also by increasing endothelial permeability (Lohela et al. 2009, Shibuya    Claesson-Welsh 2006, Claesson-Welsh    Welsh, 2013). The critical role of VEGFR2 in vascular development is highlighted by the fact that VEGFR2-/- mice die at E8.5-9.5 due to defective development of blood islands, endothelial cells and haematopoietic cells (Shalaby et al. 1995).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence632">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence633">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence634">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence635">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence630">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence631">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence636">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence637">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence638">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence639">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence621">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence622">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence623">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence624">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence620">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence629">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence625">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence626">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence627">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence628">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence610">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence611">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence612">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence613">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence618">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence619">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence614">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence615">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence616">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence617">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence600">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence601">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence602">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence607">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence608">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence609">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence603">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence604">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence605">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence606">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2107">
 <bp:evidence rdf:resource="#Evidence2418" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI3-kinase binds to the active receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2106">
 <bp:evidence rdf:resource="#Evidence2417" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHP2 binds to the active receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2105">
 <bp:evidence rdf:resource="#Evidence2416" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI3K catalyses the phosphorylation of PIP2 to PIP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2104">
 <bp:evidence rdf:resource="#Evidence2415" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SOS-mediated nucleotide exchange on RAS (PDGF receptor:GRB2:SOS)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2103">
 <bp:evidence rdf:resource="#Evidence2414" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nck binds to the active PDGF receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2102">
 <bp:evidence rdf:resource="#Evidence2413" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PLC-gamma binds to the active receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2101">
 <bp:evidence rdf:resource="#Evidence2412" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Crk binds to the active PDGF receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2100">
 <bp:evidence rdf:resource="#Evidence2411" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of PLCgamma by PDGFR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2109">
 <bp:evidence rdf:resource="#Evidence2420" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Olaratumab binds PDGFRA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2108">
 <bp:evidence rdf:resource="#Evidence2419" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Release of novel PDGFs as latent factors</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis808">
 <bp:controlled rdf:resource="#BiochemicalReaction2545" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis807">
 <bp:controlled rdf:resource="#BiochemicalReaction2541" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis809">
 <bp:controlled rdf:resource="#BiochemicalReaction2546" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis804">
 <bp:controlled rdf:resource="#BiochemicalReaction2534" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis803">
 <bp:controlled rdf:resource="#BiochemicalReaction2528" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis806">
 <bp:controlled rdf:resource="#BiochemicalReaction2538" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis805">
 <bp:controlled rdf:resource="#BiochemicalReaction2535" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis800">
 <bp:controlled rdf:resource="#BiochemicalReaction2521" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis802">
 <bp:controlled rdf:resource="#BiochemicalReaction2526" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis801">
 <bp:controlled rdf:resource="#BiochemicalReaction2522" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis819">
 <bp:controlled rdf:resource="#BiochemicalReaction2568" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis818">
 <bp:controlled rdf:resource="#BiochemicalReaction2566" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis815">
 <bp:controlled rdf:resource="#BiochemicalReaction2561" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis814">
 <bp:controlled rdf:resource="#BiochemicalReaction2560" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis817">
 <bp:controlled rdf:resource="#BiochemicalReaction2565" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis816">
 <bp:controlled rdf:resource="#BiochemicalReaction2563" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis811">
 <bp:controlled rdf:resource="#BiochemicalReaction2550" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis810">
 <bp:controlled rdf:resource="#BiochemicalReaction2549" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis813">
 <bp:controlled rdf:resource="#BiochemicalReaction2556" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis812">
 <bp:controlled rdf:resource="#BiochemicalReaction2555" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis829">
 <bp:controlled rdf:resource="#BiochemicalReaction2591" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis826">
 <bp:controlled rdf:resource="#BiochemicalReaction2584" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis825">
 <bp:controlled rdf:resource="#BiochemicalReaction2583" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis828">
 <bp:controlled rdf:resource="#BiochemicalReaction2587" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis827">
 <bp:controlled rdf:resource="#BiochemicalReaction2585" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis822">
 <bp:controlled rdf:resource="#BiochemicalReaction2575" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis821">
 <bp:controlled rdf:resource="#BiochemicalReaction2573" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis824">
 <bp:controlled rdf:resource="#BiochemicalReaction2581" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis823">
 <bp:controlled rdf:resource="#BiochemicalReaction2577" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis820">
 <bp:controlled rdf:resource="#BiochemicalReaction2572" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis837">
 <bp:controlled rdf:resource="#BiochemicalReaction2617" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis836">
 <bp:controlled rdf:resource="#BiochemicalReaction2615" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis839">
 <bp:controlled rdf:resource="#BiochemicalReaction2620" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis838">
 <bp:controlled rdf:resource="#BiochemicalReaction2619" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis833">
 <bp:controlled rdf:resource="#BiochemicalReaction2609" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis832">
 <bp:controlled rdf:resource="#BiochemicalReaction2605" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis835">
 <bp:controlled rdf:resource="#BiochemicalReaction2614" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis834">
 <bp:controlled rdf:resource="#BiochemicalReaction2610" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis831">
 <bp:controlled rdf:resource="#BiochemicalReaction2602" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis830">
 <bp:controlled rdf:resource="#BiochemicalReaction2592" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence3083">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3082">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3085">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3084">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3087">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3086">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3089">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3088">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3090">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3092">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3091">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3079">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3072">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3071">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3074">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3073">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3076">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3075">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3078">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3077">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3081">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3080">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3094">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3093">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3096">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3095">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3098">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3097">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3099">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1426">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1238" />
 <bp:stepProcess rdf:resource="#Catalysis382" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2758">
 <bp:stepProcess rdf:resource="#Pathway357" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3047">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1425">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1237" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2759">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2403" />
 <bp:stepProcess rdf:resource="#Catalysis755" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3046">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1424">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1236" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3049">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1423">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1235" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3048">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2754">
 <bp:stepProcess rdf:resource="#Pathway356" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1429">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1241" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2755">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2400" />
 <bp:stepProcess rdf:resource="#Catalysis754" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1428">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1240" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2756">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2401" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1427">
 <bp:stepProcess rdf:resource="#Catalysis383" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1239" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2757">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2402" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2750">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2397" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2751">
 <bp:stepProcess rdf:resource="#Pathway355" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2752">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2398" />
 <bp:stepProcess rdf:resource="#Catalysis753" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3041">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2753">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2399" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3040">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1422">
 <bp:stepProcess rdf:resource="#Pathway189" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3043">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1421">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1234" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3042">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1420">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1233" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3045">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3044">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway283">
 <bp:pathwayOrder rdf:resource="#PathwayStep2308" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2266" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2273" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2274" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2265" />
 <bp:pathwayComponent rdf:resource="#Pathway285" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1983" />
 <bp:pathwayComponent rdf:resource="#Pathway284" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2016" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1990" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2265" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by Insulin receptor</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Insulin binding to its receptor results in receptor autophosphorylation on tyrosine residues and the tyrosine phosphorylation of insulin receptor substrates (e.g. IRS and Shc) by the insulin receptor tyrosine kinase.  This allows association of IRSs with downstream effectors such as PI-3K via its Src homology 2 (SH2) domains leading to end point events such as Glut4 (Slc2a4) translocation.  Shc when tyrosine phosphorylated associates with Grb2 and can thus activate the Ras/MAPK pathway independent of the IRSs. Signal transduction by the insulin receptor is not limited to its activation at the cell surface.  The activated ligand-receptor complex initially at the cell surface, is internalised into endosomes itself a process which is dependent on tyrosine autophosphorylation.  Endocytosis of activated receptors has the dual effect of concentrating receptors within endosomes and allows the insulin receptor tyrosine kinase to phosphorylate substrates that are spatially distinct from those accessible at the plasma membrane.  Acidification of the endosomal lumen, due to the presence of proton pumps, results in dissociation of insulin from its receptor.  (The endosome constitutes the major site of insulin degradation).   This loss of the ligand-receptor complex attenuates any further insulin-driven receptor re-phosphorylation events and leads to receptor dephosphorylation by extra-lumenal endosomally-associated protein tyrosine phosphatases (PTPs). The identity of these PTPs is not clearly established yet.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway282">
 <bp:pathwayOrder rdf:resource="#PathwayStep2261" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2262" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1981" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1980" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2261" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB2 Activates PTK6 Signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6 (BRK) is activated downstream of ERBB2 (HER) (Xiang et al. 2008, Peng et al. 2015) and other receptor tyrosine kinases, such as EGFR (Kamalati et al. 1996) and MET (Castro and Lange 2010). However, it is not clear if MET and EGFR activate PTK6 directly or act through ERBB2, since it is known that ERBB2 forms heterodimers with EGFR (Spivak-Kroizman et al. 1992), and MET can heterodimerize with both EGFR and ERBB2 (Tanizaki et al. 2011).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway285">
 <bp:pathwayOrder rdf:resource="#PathwayStep2291" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2307" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2304" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2305" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2290" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2306" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2299" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2300" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2275" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2008" />
 <bp:pathwayComponent rdf:resource="#Pathway293" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2015" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2014" />
 <bp:pathwayComponent rdf:resource="#Pathway292" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2013" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2012" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2000" />
 <bp:pathwayComponent rdf:resource="#Pathway286" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2275" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Insulin receptor signalling cascade</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Autophosphorylation of the insulin receptor triggers a series of signalling events, mediated by SHC or IRS, and resulting in activation of the Ras/RAF and MAP kinase cascades. A second effect of the autophosphorylation of the insulin receptor is its internalisation into an endosome, which downregulates its signalling activity.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway284">
 <bp:pathwayOrder rdf:resource="#PathwayStep2270" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2271" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2272" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2267" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2268" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2269" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1986" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1985" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1984" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1989" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1988" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1987" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2267" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Insulin receptor recycling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Triggered by acidification of the endosome, insulin dissociates from the receptor and is degraded. The receptor is dephosphorylated and re-integrated into the plasma membrane, ready to be activated again by the binding of insulin molecules.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway281">
 <bp:pathwayOrder rdf:resource="#PathwayStep2257" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2258" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1978" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1977" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2257" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB2 Regulates Cell Motility</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated ERBB2 heterodimers regulate cell motility through association with MEMO1. MEMO1 retains activated RHOA GTPase and its associated protein DIAPH1 at the plasma membrane, thus linking ERBB2 activation with the microtubule and actin dynamics downstream of the RHOA:GTP:DIAPH1 complex (Marone et al. 2004, Qiu et al. 2008, Zaoui et al. 2008, Zaoui et al. 2010).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway280">
 <bp:pathwayOrder rdf:resource="#PathwayStep2255" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1976" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2255" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRB7 events in ERBB2 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Heterodimers of ERBB2 and ERBB3 are able to bind GRB7 (Fiddes et al. 1998) through phosphorylated tyrosine residues in the C-tail of ERBB3 (Y1199 and Y1262) (Fiddes et al. 1998), but the exact downstream signaling of this complex has not been elucidated. GRB7 can recruit SHC1 to the active ERBB2 complex, and contributes to ERBB2 signaling-induced RAS activation, which promotes cellular proliferation, but the exact mechanism has not been elucidated (Pradip et al. 2013). In addition, GRB7 can be phosphorylated by the integrin-activated PTK2 (FAK), leading to VAV2-dependent activation of RAC1 and promotion of cell migration. The exact mechanistic details of GRB7-induced RAC1 activation are not known (Pradip et al. 2013).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway287">
 <bp:pathwayOrder rdf:resource="#PathwayStep2277" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2278" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1992" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1991" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2277" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SOS-mediated signalling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SOS is recruited to the plasma membrane and mediates activation of Ras.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway286">
 <bp:pathwayOrder rdf:resource="#PathwayStep2289" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2279" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2276" />
 <bp:pathwayComponent rdf:resource="#Pathway287" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1999" />
 <bp:pathwayComponent rdf:resource="#Pathway288" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2276" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRS-mediated signalling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Release of phospho-IRS from the insulin receptor triggers a cascade of signalling events via PI3K, SOS, RAF and the MAP kinases.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway289">
 <bp:pathwayOrder rdf:resource="#PathwayStep2281" />
 <bp:pathwayComponent rdf:resource="#Pathway290" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2281" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKB-mediated events</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKB and PDK1 are activated via membrane-bound PIP3. Activated PDK1 phosphorylates PKB, which in turn phosphorylates PDE3B. The latter hydrolyses cAMP to 5&apos;AMP, depleting cAMP pools.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway288">
 <bp:pathwayOrder rdf:resource="#PathwayStep2280" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2288" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2284" />
 <bp:pathwayComponent rdf:resource="#Pathway291" />
 <bp:pathwayComponent rdf:resource="#Pathway289" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1998" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2280" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI3K Cascade</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The PI3K (Phosphatidlyinositol-3-kinase) - AKT signaling pathway stimulates cell growth and survival.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep1437">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1248" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2769">
 <bp:stepProcess rdf:resource="#Pathway359" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3036">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1436">
 <bp:stepProcess rdf:resource="#Pathway190" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3035">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1435">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1247" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3038">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1434">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1246" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3037">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2765">
 <bp:stepProcess rdf:resource="#Pathway358" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2766">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2409" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3039">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1439">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1250" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2767">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2410" />
 <bp:stepProcess rdf:resource="#Catalysis759" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1438">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1249" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2768">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2411" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2761">
 <bp:stepProcess rdf:resource="#Catalysis757" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2405" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2762">
 <bp:stepProcess rdf:resource="#Catalysis758" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2406" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2763">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2407" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3030">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2764">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2408" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1433">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1245" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3032">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1432">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1244" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3031">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1431">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1243" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3034">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1430">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1242" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2760">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2404" />
 <bp:stepProcess rdf:resource="#Catalysis756" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3033">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway272">
 <bp:pathwayOrder rdf:resource="#PathwayStep2208" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2209" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2215" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2237" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2259" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2222" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2234" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2256" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2230" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2263" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2253" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2210" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2254" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2260" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1975" />
 <bp:pathwayComponent rdf:resource="#Pathway282" />
 <bp:pathwayComponent rdf:resource="#Pathway274" />
 <bp:pathwayComponent rdf:resource="#Pathway273" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1982" />
 <bp:pathwayComponent rdf:resource="#Pathway281" />
 <bp:pathwayComponent rdf:resource="#Pathway280" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1938" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1937" />
 <bp:pathwayComponent rdf:resource="#Pathway276" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1979" />
 <bp:pathwayComponent rdf:resource="#Pathway275" />
 <bp:pathwayComponent rdf:resource="#Pathway278" />
 <bp:pathwayComponent rdf:resource="#Pathway277" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2208" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by ERBB2</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB2, also known as HER2 or NEU, is a receptor tyrosine kinase (RTK) belonging to the EGFR family. ERBB2 possesses an extracellular domain that does not bind any known ligand, contrary to other EGFR family members, a single transmembrane domain, and an intracellular domain consisting of an active kinase and a C-tail with multiple tyrosine phosphorylation sites. Inactive ERBB2 is associated with a chaperone heat shock protein 90 (HSP90) and its co-chaperone CDC37 (Xu et al. 2001, Citri et al. 2004, Xu et al. 2005). In addition, ERBB2 is associated with ERBB2IP (also known as ERBIN or LAP2), a protein responsible for proper localization of ERBB2. In epithelial cells, ERBB2IP restricts expression of ERBB2 to basolateral plasma membrane regions (Borg et al. 2000).   ERBB2 becomes activated by forming a heterodimer with another ligand-activated EGFR family member, either EGFR, ERBB3 or ERBB4, which is accompanied by dissociation of chaperoning proteins HSP90 and CDC37 (Citri et al. 2004), as well as ERBB2IP (Borg et al. 2000) from ERBB2. ERBB2 heterodimers function to promote cell proliferation, cell survival and differentiation, depending on the cellular context. ERBB2 can also be activated by homodimerization when it is overexpressed, in cancer for example.    In cells expressing both ERBB2 and EGFR, EGF stimulation of EGFR leads to formation of both ERBB2:EGFR heterodimers (Wada et al. 1990, Karunagaran et al. 1996) and EGFR homodimers. Heterodimers of ERBB2 and EGFR trans-autophosphorylate on twelve tyrosine residues, six in the C-tail of EGFR and six in the C-tail of ERBB2 - Y1023, Y1139, Y1196, Y1221, Y1222 and Y1248 (Margolis et al. 1989, Hazan et al. 1990,Walton et  al. 1990, Helin et al. 1991, Ricci et al. 1995, Pinkas-Kramarski 1996). Phosphorylated tyrosine residues in the C-tail of EGFR and ERBB2 serve as docking sites for downstream signaling molecules. Three key signaling pathways activated by ERBB2:EGFR heterodimers are RAF/MAP kinase cascade, PI3K-induced AKT signaling, and signaling by phospholipase C gamma (PLCG1). Downregulation of EGFR signaling is mediated by ubiquitin ligase CBL, and is shown under Signaling by EGFR.   In cells expressing ERBB2 and ERBB3, ERBB3 activated by neuregulin NRG1 or NRG2 binding (Tzahar et al. 1994) forms a heterodimer with ERBB2 (Pinkas-Kramarski et al. 1996, Citri et al. 2004). ERBB3 is the only EGFR family member with no kinase activity, and can only function in heterodimers, with ERBB2 being its preferred heterodimerization partner. After heterodimerization, ERBB2 phosphorylates ten tyrosine residues in the C-tail of ERBB3, Y1054, Y1197, Y1199, Y1222, Y1224, Y1260, Y1262, Y1276, Y1289 and Y1328 (Prigent et al. 1994, Pinkas-Kramarski et al. 1996, Vijapurkar et al. 2003, Li et al. 2007) that subsequently serve as docking sites for downstream signaling molecules, resulting in activation of PI3K-induced AKT signaling and RAF/MAP kinase cascade. Signaling by ERBB3 is downregulated by the action of RNF41 ubiquitin ligase, also known as NRDP1.    In cells expressing ERBB2 and ERBB4, ligand stimulated ERBB4 can either homodimerize or form heterodimers with ERBB2 (Li et al. 2007), resulting in trans-autophosphorylation of ERBB2 and ERBB4 on C-tail tyrosine residues that will subsequently serve as docking sites for downstream signaling molecules, leading to activation of RAF/MAP kinase cascade and, in the case of ERBB4 CYT1 isoforms, PI3K-induced AKT signaling (Hazan et al. 1990, Cohen et al. 1996, Li et al. 2007, Kaushansky et al. 2008). Signaling by ERBB4 is downregulated by the action of WWP1 and ITCH ubiquitin ligases, and is shown under Signaling by ERBB4.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway271">
 <bp:pathwayOrder rdf:resource="#PathwayStep2170" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2171" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2172" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2173" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2169" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2174" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2175" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2176" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1906" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1905" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1904" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1903" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1902" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1901" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1900" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1899" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2169" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of KIT signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF induced proliferation is negatively regulated by various proteins including SHP1, PKC, CBL, SOCS1, SOCS6 and LNK.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway274">
 <bp:pathwayOrder rdf:resource="#PathwayStep2219" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2216" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2217" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2218" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2220" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2221" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1948" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1947" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1946" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1945" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1944" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1943" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2216" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHC1 events in ERBB2 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">All ERBB2 heterodimers, ERBB2:EGFR, ERBB2:ERBB3 and ERBB2:ERBB4, are able to activate RAF/MAP kinase cascade by recruiting SHC1 (Pinkas-Kramarski et al. 1996, Sepp-Lorenzino et al. 1996) to phosphorylated C-tail tyrosine residues in either EGFR (Y1148 and Y1173), ERBB2 (Y1196, Y1221, Y1222 and Y1248), ERBB3 (Y1328) or ERBB4 (Y1188 and Y1242 in JM-A CYT1 isoform, Y1178 and Y1232 in JM-B CYT1 isoform, Y1172 and Y1226 in JM-A CYT2 isoform). SHC1 recruitment is followed by phosphorylation (Segatto et al. 1993, Soler et al. 1994), and the phosphorylated SHC1 recruits GRB2:SOS1 complex (Xie et al. 1995), which leads to SOS1-mediated guanyl-nucleotide exchange on RAS (Xie et al. 1995) and downstream activation of RAF and MAP kinases.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway273">
 <bp:pathwayOrder rdf:resource="#PathwayStep2211" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2212" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2213" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2214" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1942" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1941" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1940" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1939" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2211" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRB2 events in ERBB2 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB2:EGFR and ERBB2:ERBB4 can directly recruit GRB2:SOS1 complex through phosphorylated C-tail tyrosines of EGFR (Y1068 and Y1086) and ERBB2 (Y1139) that serve as docking sites for GRB2 (Xie et al. 1995, Sepp-Lorenzino et al. 1996), which, again, results in SOS1-mediated guanyl-nucleotide exchange on RAS and activation of RAF and MAP kinases (Janes et al. 1994, Sepp-Lorenzino et al. 1996).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway270">
 <bp:pathwayOrder rdf:resource="#PathwayStep2178" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2179" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2196" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2197" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2198" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2177" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2199" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2181" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2182" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2183" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2184" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2180" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2204" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2205" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2206" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2167" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2189" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2200" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2168" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2201" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2202" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2203" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2185" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2186" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2187" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2188" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2192" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2193" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2194" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2195" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2190" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2191" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1909" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1908" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1907" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1929" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1898" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1931" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1930" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1917" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1916" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1915" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1914" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1936" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1913" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1935" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1912" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1934" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1911" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1933" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1910" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1932" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1919" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1918" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1920" />
 <bp:pathwayComponent rdf:resource="#Pathway271" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1928" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1927" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1926" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1925" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1924" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1923" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1922" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1921" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2167" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by SCF-KIT</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Stem cell factor (SCF) is a growth factor with membrane bound and soluble forms. It is expressed by fibroblasts and endothelial cells throughout the body, promoting proliferation, migration, survival and differentiation of hematopoetic progenitors, melanocytes and germ cells.(Linnekin 1999, Ronnstrand 2004, Lennartsson and Ronnstrand 2006). The receptor for SCF is KIT, a tyrosine kinase receptor (RTK) closely related to the receptors for platelet derived growth factor receptor, colony stimulating factor 1 (Linnekin 1999) and Flt3 (Rosnet et al. 1991).  Four isoforms of c-Kit have been identified in humans. Alternative splicing results in isoforms of KIT differing in the presence or absence of four residues (GNNK) in the extracellular region. This occurs due to the use of an alternate 5&apos; splice donor site. These GNNK+ and GNNK- variants are co-expressed in most tissues; the GNNK- form predominates and was more strongly tyrosine-phosphorylated and more rapidly internalized (Ronnstrand 2004). There are also splice variants that arise from alternative usage of splice acceptor site resulting in the presence or absence of a serine residue (Crosier et al., 1993). Finally, there is an alternative shorter transcript of KIT expressed in postmeiotic germ cells in the testis  which encodes a truncated KIT consisting only of the second part of the kinase domain and thus lackig the extracellular and transmembrane domains as well as the first part of the kinase domain (Rossi et al. 1991). Binding  of SCF homodimers to KIT results in KIT homodimerization followed by activation of its intrinsic tyrosine kinase activity. KIT stimulation activates a wide array of signalling pathways including MAPK, PI3K and JAK/STAT (Reber et al. 2006, Ronnstrand 2004). Defects of KIT in humans are associated with different genetic diseases and also in several types of cancers like mast cell leukaemia, germ cell tumours, certain subtypes of malignant melanoma and gastrointestinal tumours.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway279">
 <bp:pathwayOrder rdf:resource="#PathwayStep2248" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2249" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2244" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2245" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2246" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2247" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2242" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2243" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1964" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1971" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1970" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1969" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1968" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1967" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1966" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1965" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2242" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Downregulation of ERBB2:ERBB3 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Level of plasma membrane ERBB3 is regulated by E3 ubiquitin ligase RNF41 (also known as NRDP1), which binds and ubiquitinates both inactive and activated ERBB3, targeting it for degradation (Cao et al. 2007). RNF41 is subject to self-ubiquitination which keeps its levels low when ERBB3 is not stimulated, and preserves ERBB3 expression on the cell surface (Qiu et al. 2002).  Self-ubiquitination of RNF41 is reversible, through the action of ubiquitin protease USP8, an enzyme stabilized by AKT-mediated phosphorylation.  Therefore, activation of AKT by ERBB2:ERBB3 signaling leads to phosphorylation of USP8 (Cao et al. 2007), which increases level of RNF41 through deubiquitination, and results in degradation of activated ERBB3 (Cao et al. 2007) - a negative feedback loop of ERBB3 signaling. Downregulation of EGFR and ERBB4 signaling is explained in pathways Signaling by EGFR and Signaling by ERBB4.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway276">
 <bp:pathwayOrder rdf:resource="#PathwayStep2233" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2231" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2232" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1958" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1957" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1956" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2231" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Drug-mediated inhibition of ERBB2 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by ERBB2 can be pharmacologically inhibited with tyrosine kinase inhibitors (TKIs) (Nelson and Fry 2001, Xia et al. 2002, Wood et al. 2004, Rabindran et al. 2004, Gandreau et al. 2007,  Jani et al. 2007, Li et al. 2008, Hichkinson et al. 2010, Traxler et al. 2014, Hanker et al. 2017), and therapeutic antibodies, such as trastuzumab (Hudziak et al. 1989, Carter et al. 1992, Pickl and Ries 2009, Maadi et al. 2018) and pertuzumab (Franklin et al. 2004). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway275">
 <bp:pathwayOrder rdf:resource="#PathwayStep2226" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2227" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2228" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2229" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2223" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2224" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2225" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1953" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1952" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1951" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1950" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1949" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1955" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1954" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2223" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI3K events in ERBB2 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB2:ERBB3 and ERBB2:ERBB4cyt1 heterodimers activate PI3K signaling by direct binding of PI3K regulatory subunit p85 (Yang et al. 2007, Cohen et al. 1996, Kaushansky et al. 2008) to phosphorylated tyrosine residues in the C-tail of ERBB3 (Y1054, Y1197, Y1222, Y1224, Y1276 and Y1289) and ERBB4 CYT1 isoforms (Y1056 in JM-A CYT1 isoform and Y1046 in JM-B CYT1 isoform). Regulatory subunit p85 subsequently recruits catalytic subunit p110 of PI3K, resulting in the formation of active PI3K, conversion of PIP2 to PIP3, and PIP3-mediated activation of AKT signaling (Junttila et al. 2009, Kainulainen et al. 2000). Heterodimers of ERBB2 and EGFR recruit PI3K indirectly, through GRB2:GAB1 complex (Jackson et al. 2004), which again leads to PIP3-mediated activation of AKT signaling.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway278">
 <bp:pathwayOrder rdf:resource="#PathwayStep2250" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2238" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2239" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2240" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2251" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2241" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2252" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1963" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1974" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1962" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1973" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1961" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1972" />
 <bp:pathwayComponent rdf:resource="#Pathway279" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2238" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Downregulation of ERBB2 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by ERBB2 can be downregulated by ubiquitination and subsequent proteasome-dependent degradation of ERBB2 or activated ERBB2 heterodimers. In addition, protein tyrosine phosphatases that dephosphorylate tyrosine residues in the C-terminus of ERBB2 prevent the recruitment of adapter proteins involved in signal transduction, thus attenuating ERBB2 signaling. STUB1 (CHIP) and CUL5 are E3 ubiquitin ligases that can target non-activated ERBB2 for proteasome-dependent degradation (Xu et al. 2002, Ehrlich et al. 2009). RNF41 (NRDP1) is an E3 ubiquitin ligase that targets ERBB3 and activated heterodimers of ERBB2 and ERBB3 for proteasome-dependent degradation by ubiquitinating ERBB3 (Cao et al. 2007). Two protein tyrosine phosphatases of the PEST family, PTPN12 and PTPN18, dephosphorylate tyrosine residues in the C-terminus of ERBB2, thus preventing signal transduction to RAS and PI3K effectors (Sun et al. 2011, Wang et al. 2014). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway277">
 <bp:pathwayOrder rdf:resource="#PathwayStep2235" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2236" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1960" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1959" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2235" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PLCG1 events in ERBB2 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of PLCG1 signaling is observed only in the presence of ERBB2:EGFR heterodimers, with PLCG1 binding to phosphorylated tyrosine Y992 and Y1173 in the C-tail of EGFR (Chattopadhyay et al. 1999), and potentially Y1023 in the C-tail of ERBB2 (Fazioli et al. 1991, Cohen et al. 1996).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep1404">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1220" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2736">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2386" />
 <bp:stepProcess rdf:resource="#Catalysis747" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3069">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1403">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1219" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2737">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2387" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3068">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1402">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1218" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2738">
 <bp:stepProcess rdf:resource="#Pathway352" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1401">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1217" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2739">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2388" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1408">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1223" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2732">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2383" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1407">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1222" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2733">
 <bp:stepProcess rdf:resource="#Pathway351" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1406">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1221" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2734">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2384" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1405">
 <bp:stepProcess rdf:resource="#Pathway186" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2735">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2385" />
 <bp:stepProcess rdf:resource="#Catalysis746" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3061">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3060">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2730">
 <bp:stepProcess rdf:resource="#Catalysis745" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2381" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3063">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2731">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2382" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3062">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1400">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1216" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3065">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3064">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3067">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3066">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway261">
 <bp:pathwayOrder rdf:resource="#PathwayStep2087" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2088" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1828" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1827" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2087" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ceramide signalling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In certain cell types, ligand binding to p75NTR leads to ceramide production, which can mediate either cell survival (e.g. in noecotical subplate neurons) or apoptosis (e.g. in oligodendrocytes). Low levels of ceramide are also able to stimulate axonal outgrowth in hippocampal neurons.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway260">
 <bp:pathwayOrder rdf:resource="#PathwayStep2082" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2083" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2084" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2085" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2080" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2081" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1821" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1826" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1825" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1824" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1823" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1822" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2080" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Axonal growth inhibition (RHOA activation)</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p75NTR can also form a receptor complex with the Nogo receptor (NgR). Such complexes mediates axonal outgrowth inhibitory signals of MDGIs (myelin-derived growth-inhibitors), such as Nogo66, myelin-associated glycoprotein (MAG), and oligodendrocyte myelin glycoprotein (OMGP).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway263">
 <bp:pathwayOrder rdf:resource="#PathwayStep2150" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2151" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2149" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2139" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2145" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2158" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2097" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2152" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2153" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2154" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1887" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1886" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1885" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1884" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1892" />
 <bp:pathwayComponent rdf:resource="#Pathway265" />
 <bp:pathwayComponent rdf:resource="#Pathway264" />
 <bp:pathwayComponent rdf:resource="#Pathway267" />
 <bp:pathwayComponent rdf:resource="#Pathway266" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1888" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2097" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TNF signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The inflammatory cytokine tumor necrosis factor alpha (TNF-&#945;) is expressed in immune and nonimmune cell types including macrophages, T cells, mast cells, granulocytes, natural killer (NK) cells, fibroblasts, neurons, keratinocytes and smooth muscle cells as a response to tissue injury or upon immune responses to pathogenic stimuli (K&#246;ck A. et al. 1990; Dubravec DB et al. 1990; Walsh LJ et al. 1991; te Velde AA et al. 1990; Imaizumi T et al. 2000). TNF-&#945; interacts with two receptors, namely TNF receptor 1 (TNFR1) and TNF receptor 2 (TNFR2). Activation of TNFR1 can trigger multiple signal transduction pathways inducing inflammation, proliferation, survival or cell death (Ward C et al. 1999; Micheau O and Tschopp J 2003; Widera D et al. 2006). Whether a TNF-&#945;-stimulated cell will survive or die is dependent on autocrine/paracrine signals, and on the cellular context. TNF binding to TNFR1 results initially in the formation of complex I that consists of TNFR1, TRADD (TNFR1-associated death domain), TRAF2 (TNF receptor associated factor-2), RIPK1 (receptor-interacting serin/threonine protein kinase 1), and E3 ubiquitin ligases BIRC2,BIRC3 (cIAP1/2,cellular inhibitor of apoptosis) and LUBAC (Micheau O and Tschopp J 2003). The conjugation of ubiquitin chains by BIRC2/3 and LUBAC (composed of HOIP, HOIL-1 and SHARPIN ) to RIPK1 allows further recruitment and activation of the TAK1 (also known as mitogen-activated protein kinase kinase kinase 7 (MAP3K7)) complex and I&#954;B kinase (IKK) complex. TAK1 and IKK phosphorylate RIPK1 to limit its cytotoxic activity  and activate both nuclear factor kappa&#8208;light&#8208;chain&#8208;enhancer of activated B cells (NFkappaB) and mitogen&#8208;activated protein (MAP) kinase signaling pathways promoting cell survival by induction of anti-apoptotic proteins such as BIRC, cellular FLICE (FADD-like IL-1&#946;-converting enzyme)-like inhibitory protein (cFLIP) and secretion of pro-inflammatory cytokines (TNF and IL-6). When the survival pathway is inhibited, the TRADD:TRAF2:RIPK1 detaches from the membrane-bound TNFR1 signaling complex and recruits Fas-associated death domain-containing protein (FADD) and procaspase-8 (also known as complex II). Once recruited to FADD, multiple procaspase-8 molecules interact via their tandem death-effector domains (DED), thereby facilitating both proximity-induced dimerization and proteolytic cleavage of procaspase-8, which are required for initiation of apoptotic cell death (Hughes MA et al. 2009; Oberst A et al. 2010). When caspase activity is inhibited under certain pathophysiological conditions (e.g., expression of caspase-8 inhibitory proteins such as CrmA and vICA after infection with cowpox virus or CMV) or by pharmacological agents, deubiquitinated RIPK1 is physically and functionally engaged by its homolog RIPK3 leading to formation of the necrosome, a necroptosis-inducing complex consisting of RIPK1 and RIPK3 (Tewari M    Dixit VM 1995; Fliss PM    Brune W 2012; Sawai H 2013; Moquin DM et al. 2013; Kalai M et al. 2002; Cho YS et al. 2009, He S et al. 2009, Zhang DW et al., 2009). Within the complex II procaspase-8 can also form heterodimers with cFLIP isoforms, FLIP long (L) and FLIP short (S), which are encoded by the NFkappaB target gene CFLAR (Irmler M et al. 1997; Boatright KM et al. 2004; Yu JW et al. 2009; Pop C et al. 2011). FLIP(S) appears to act purely as an antagonist of caspase-8 activity blocking apoptotic but promoting necroptotic cell death (Feoktistova  et al. 2011). The regulatory function of FLIP(L) has been found to differ depending on its expression levels. FLIP(L) was shown to inhibit death receptor (DR)-mediated apoptosis only when expressed at high levels, while low cell levels of FLIP(L) enhanced DR signaling to apoptosis (Boatright KM et al. 2004; Okano H et al. 2003; Yerbes R et al. 2011; Yu JW et al. 2009; Hughes MA et al. 2016). In addition, caspase-8:FLIP(L) heterodimer activity within the TRADD:TRAF2:RIPK1:FADD:CASP8:FLIP(L) complex allowed cleavage of RIPK1 to cause the dissociation of the TRADD:TRAF2:RIP1:FADD:CASP8, thereby inhibiting RIPK1-mediated necroptosis (Feoktistova  et al. 2011, 2012). TNF-&#945; can also activate sphingomyelinase (SMASE, such as SMPD2,3) proteins to catalyze hydrolysis of sphingomyeline into ceramide (Adam D et al.1996; Adam-Klages S et al. 1998; S&#233;gui B et al. 2001). Activation of neutral SMPD2,3 leads to an accumulation of ceramide at the cell surface and has proinflammatory effects. However, TNF can also activate the pro-apoptotic acidic SMASE via caspase-8 mediated activation of caspase-7 which in turn proteolytically cleaves and activates the 72kDa pro-A-SMase form (Edelmann B et al. 2011). Ceramide induces anti-proliferative and pro-apoptotic responses. Further, ceramide can be converted by ceramidase into sphingosine, which in turn is phosphorylated by sphingosine kinase into sphingosine-1-phosphate (S1P). S1P exerts the opposite biological effects to ceramide by activating cytoprotective signaling to promote cell growth counteracting the apoptotic stimuli (Cuvillier O et al. 1996). Thus, TNF-&#945;-induced TNFR1 activation leads to divergent intracellular signaling networks with extensive cross-talk between the pro-apoptotic/necroptotic pathway, and the other NFkappaB, and MAPK pathways providing highly specific cell responses initiated by various types of stimuli.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway262">
 <bp:pathwayOrder rdf:resource="#PathwayStep2093" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2094" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2095" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2090" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2091" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2092" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1832" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1831" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1830" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1829" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1834" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1833" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2090" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAIL  signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tumor necrosis factor-related apoptosis-inducing ligand or Apo 2 ligand (TRAIL/Apo2L) is a member of the tumor necrosis factor (TNF) family. This group of apoptosis induction pathways all work through protein interactions mediated by the intracellular death domain (DD), encoded within the cytoplasmic domain of the receptor. TRAIL selectively induces apoptosis through its interaction with the Fas-associated death domain protein (FADD) and caspase-8/10 (Wang S    el-Deiry WS 2003; Sprick MR et al. 2002). TRAIL and its receptors, TRAIL-R1 and TRAIL-R2, were shown to be rapidly endocytosed via clathrin-dependent and -independent manner in human Burkitt&apos;s lymphoma B cells (BJAB) (Kohlhaas SL et al. 2007). However, FADD and caspase-8 were able to bind TRAIL-R1/R2 in TRAIL-stimulated BJAB cells at 4 o C (at which membrane trafficking is inhibited), suggesting that the endocytosis was not required for an assembly of the functional TRAIL DISC complex. Moreover, blocking of clathrin-dependent endocytosis did not interfere with the capacity of TRAIL to promote apoptosis (Kohlhaas SL et al. 2007). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence3070">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway269">
 <bp:pathwayOrder rdf:resource="#PathwayStep2309" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2507" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2645" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2338" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2207" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2427" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2438" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2702" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2552" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2443" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2394" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2264" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2166" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2908" />
 <bp:pathwayComponent rdf:resource="#Pathway327" />
 <bp:pathwayComponent rdf:resource="#Pathway272" />
 <bp:pathwayComponent rdf:resource="#Pathway283" />
 <bp:pathwayComponent rdf:resource="#Pathway294" />
 <bp:pathwayComponent rdf:resource="#Pathway383" />
 <bp:pathwayComponent rdf:resource="#Pathway270" />
 <bp:pathwayComponent rdf:resource="#Pathway313" />
 <bp:pathwayComponent rdf:resource="#Pathway312" />
 <bp:pathwayComponent rdf:resource="#Pathway304" />
 <bp:pathwayComponent rdf:resource="#Pathway337" />
 <bp:pathwayComponent rdf:resource="#Pathway314" />
 <bp:pathwayComponent rdf:resource="#Pathway342" />
 <bp:pathwayComponent rdf:resource="#Pathway330" />
 <bp:pathwayComponent rdf:resource="#Pathway310" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2166" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by Receptor Tyrosine Kinases</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Receptor tyrosine kinases (RTKs) are a major class of cell surface proteins involved in Signal Transduction.  Human cells contain ~60 RTKs, grouped into 20 subfamilies based on their domain architecture. All RTK subfamilies are characterized by an extracellular ligand-binding domain, a single transmembrane region and an intracellular region consisting of the tyrosine kinase domain and additional regulatory and protein interaction domains. In general, RTKs associate into dimers upon ligand binding and are activated by autophosphorylation on conserved intracellular tyrosine residues. Autophosphorylation increases the catalytic efficiency of the receptor and provides binding sites for the assembly of downstream signaling complexes (reveiwed in Lemmon and Schlessinger, 2010). Common signaling pathways activated downstream of RTK activation include RAF/MAP kinase cascades (reviewed in McKay and Morrison, 2007 and Wellbrock et al 2004), AKT signaling (reviewed in Manning and Cantley, 2007) and PLC-gamma mediated signaling (reviewed in Patterson et al). Activation of these pathways ultimately results in changes in gene expression and cellular metabolism.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway268">
 <bp:pathwayOrder rdf:resource="#PathwayStep2160" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2161" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2162" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2163" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2164" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1897" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1896" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1895" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1894" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1893" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2160" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FasL/ CD95L signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The Fas family of cell surface receptors initiate the apototic pathway through interaction with the external ligand, FasL.  The cytoplasmic domain of Fas interacts with a number of molecules in the transduction of the external signal to the cytoplasmic side of the cell membrane. The most notable cytoplasmic domain is the Death Domain (DD) that is involved in recruiting the FAS-associating death domain-containing protein (FADD). This interaction drives downstream events.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep1409">
 <bp:stepProcess rdf:resource="#Pathway187" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway265">
 <bp:pathwayOrder rdf:resource="#PathwayStep2140" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2141" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2142" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2143" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2144" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1876" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1880" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1879" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1878" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1877" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2140" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TNFR1-induced NF-kappa-B signaling pathway</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of tumor necrosis factor receptor 1 (TNFR1) can trigger multiple signal transduction pathways to induce inflammation, cell proliferation, survival or cell death (Ward C et al. 1999; Micheau O and Tschopp J 2003; Widera D et al. 2006). Whether a TNF-&#945;-stimulated cell will survive or die is dependent on the cellular context. TNF-&#945;-induced signals lead to the activation of transcriptional factors such as nuclear factor-kappa B (NFkappaB) and activator protein-1 (AP1) (Ward C et al. 1999; Widera D et al. 2006; Tsou HK et al. 2012).  The binding of TNF-&#945; to TNFR1 leads to recruitment of the adapter protein TNFR1-associated death domain (TRADD) and of receptor&#8209;interacting protein 1 (RIPK1). TRADD subsequently recruits also TNF receptor-associated factor 2 (TRAF2). RIPK1 is promptly K63-polyubiquitinated which results in the recruitment of the TAB2:TAK1 complex and the IkB kinase (IKK) complex to TNFR1. The activated IKK complex mediates phosphorylation of the inhibitor of NFkappaB (IkB), which targets IkB for ubiquitination and subsequent degradation. Released NFkappaB induces the expression of a variety of genes including inflammation-related genes and anti-apoptotic genes encoding proteins such as inhibitor of apoptosis proteins cIAP1/2, Bcl-2, Bcl-xL or cellular FLICE-like inhibitory protein (FLIP) (Blonska M et al. 2005; Ea CK et al. 2006; Wu CJ et al. 2006; Chen C et al. 2000; Manna SK et al. 2000; Kreuz S et al. 2001; Micheau O et al. 2001). NFkB-mediated inhibition of cell death also involves attenuating TNF-induced activation of c-Jun activating kinase (JNK). Whereas transient activation of JNK upon TNF treatment is associated with cellular survival, prolonged JNK activation contributes to cell death. However, as caspases activate JNK quite efficiently, JNKs are also regularly stimulated in course of apoptosis without being essential for cell death (Wicovsky A et al. 2007). AP1-mediated gene induction results from activation of JNK via TRAF2 (not shown here) (Tsou HK et al. 2012). While pro-survival signaling is initiated and regulated via the activated TNFR1 receptor complex at the cell membrane, cell death signals are induced by internalization-associated fashion upon the release of RIPK1 from the membrane complex (Micheau O and Tschopp J 2003; Schneider-Brachert W et al. 2004; Tchikov V et al. 2011). TNFR1-mediated transcriptional activity of NFkB is both antiapoptotic and highly proinflammatory and thus must be tightly regulated to prevent constitutive activation that leads to persistent inflammation and cancer (Ward C et al. 1999; Fujihara S et al. 2002; Pekalski J et al. 2013; Kankaanranta H et al. 2014; Shukla S and Gupta S 2004; Jackson-Bernitsas DG et al. 2007; Zhang JY et al. 2007). Multiple mechanisms normally ensure the proper control of NFkappaB activation including two negative feedback loops mediated by NFkappaB inducible inhibitors, IkB-alpha (NFKBIA) and ubiquitin-editing protein A20 (He KL    Ting AT 2002; Wertz IE et al. 2004; Vereecke L et al. 2009; Pekalski J et al. 2013).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway264">
 <bp:pathwayOrder rdf:resource="#PathwayStep2116" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2138" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2117" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2118" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2119" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2112" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2134" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2113" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2135" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2114" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2136" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2115" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2137" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2130" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2098" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2131" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2099" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2110" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2132" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2111" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2133" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2109" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2105" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2127" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2106" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2128" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2107" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2129" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2108" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2101" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2123" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2102" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2124" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2103" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2125" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2104" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2126" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2120" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2121" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2100" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2122" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1854" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1853" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1875" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1852" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1874" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1851" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1873" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1850" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1872" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1871" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1870" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1839" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1838" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1837" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1859" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1836" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1858" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1835" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1857" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1856" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1855" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1843" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1865" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1842" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1864" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1841" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1863" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1840" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1862" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1861" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1860" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1849" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1848" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1847" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1869" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1846" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1868" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1845" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1867" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1844" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1866" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2098" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of TNFR1 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tumor necrosis factor-alpha (TNF&#945;) is an inflammatory cytokine, that activates either cell survival (e.g.,inflammation, proliferation) or cell death upon association with TNF receptor 1 (TNFR1). Stimuli and the cellular context dictate cell fate decisions between survival and death which rely on tightly regulated mechanisms with checkpoints on many levels. The TNFR1 signaling is controlled by the interplay between post-translational modifications such as proteolytic processing by active caspases or ubiquitination/deubiquitination by LUBAC or CYLD ubiquitin-editing complexes. TNFR1-mediated NFkappaB activation leads to the pro-survival transcriptional program that is both anti-apoptotic and highly proinflammatory. The constitutive NFkappaB or AP1 activation may lead to excessive inflammation which has been associated with a variety of aggressive tumor types (Jackson-Bernitsas DG et al. 2007; Zhang JY et al. 2007). Thus, the tight regulation of TNF&#945;:TNFR1 signaling is required to ensure the appropriate cell response to stimuli. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway267">
 <bp:pathwayOrder rdf:resource="#PathwayStep2156" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2157" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2155" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1891" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1890" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1889" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2155" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TNFR1-induced proapoptotic signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of tumor necrosis factor receptor 1 (TNFR1) can trigger multiple signal transduction pathways to induce cell survival or cell death (Ward C et al. 1999; Micheau O and Tschopp J 2003; Widera D et al. 2006). While pro-survival signaling is initiated and regulated via the activated TNFR1 receptor complex at the cell membrane, cell death signals are induced upon the release of TRADD:TRAF2:RIP1 complex from the membrane to the cytosol where it forms death-inducing signaling complex (DISC) (Micheau O and Tschopp J 2003; Schneider-Brachert W et al. 2004). Upon apoptotic stimulation procaspase-8 or 10 is recruited into the DISC, and close proximity promotes the dimerization, autocatalytic processing, and activation of the initiator caspase-8 (and/or caspase-10) (Wang J et al. 2001; Boatright KM and Salvesen GS 2003). The initiator caspases then process and activate the downstream effector caspases such as caspase-3 in a proteolytic cascade (Stennicke HR et al. 1998). The effector caspases in turn cleave many diverse substrates, ultimately inducing cell death. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway266">
 <bp:pathwayOrder rdf:resource="#PathwayStep2146" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2147" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2148" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1883" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1882" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1881" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2146" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TNFR1-mediated ceramide production</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TNF-alpha activates sphingomyelinase (SMASE) proteins to catalyze hydrolysis of sphingomyeline into ceramide. Two types of SMASE can be distinguished downstream of TNFR1 signaling, acid and neutral SMASEs (Adam-Klages S et al. 1996, 1998). Neutral SMASE (such as SMPD2,3) has a pH optimum of 7.4, requires Mg2+ ions and is found at the plasma membrane (Rao BG and Spence MW 1976). Acid SMASE is active at pH 4-5, is Zn2+-dependent and is mainly localized in the lysosomes. The death domain of TNFR1 that is responsible for the initiation of the apoptotic pathway also mediates activation of an acid SMASE. The two proapoptotic adaptor proteins TRADD and FADD are also involved in the activation of acid SMASE signaling events (Schwandner R et al. 1998). TNF-alpha can also activate the pro-apoptotic  acidic SMASE via caspase-8 mediated activation of caspase-7 which in turn proteolytically cleaves and activates the 72kDa pro-acid SMASE form (Edelmann B et al. 2011). Neutral SMASE(SMPD) binds to adaptor protein NSMAF (FAN), which bridges it to NSMASE-activating domain (NSD) of TNFR1 (Adam D et al. 1996; Adam-Klages S et al. 1996; S&#233;gui B et al. 2001). Activation of SMPD2,3 leads to an accumulation of ceramide at the cell surface. Ceramide metabolism generates a cascade of bioactive lipids, all of which carry a specific signaling capacity. Ceramide can be converted by ceramidase into sphingosine, which in turn is phosphorylated by sphingosine kinase into sphingosine-1-phosphate (S1P). These lipids exert opposite biological effects: ceramide and sphingosine are able to induce anti-proliferative and pro-apoptotic responses, whereas S1P is a cytoprotective molecule that promotes cell growth and counteracts apoptotic stimuli (Cuvillier O et al.1996) </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep1415">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1229" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2747">
 <bp:stepProcess rdf:resource="#Pathway354" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3058">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1414">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1228" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2748">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2395" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3057">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1413">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1227" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2749">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2396" />
 <bp:stepProcess rdf:resource="#Catalysis752" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1412">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1226" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3059">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1419">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1232" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2743">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2391" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1418">
 <bp:stepProcess rdf:resource="#Pathway188" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2744">
 <bp:stepProcess rdf:resource="#Catalysis749" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2392" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1417">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1231" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2745">
 <bp:stepProcess rdf:resource="#Catalysis750" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2393" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1416">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1230" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2746">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2394" />
 <bp:stepProcess rdf:resource="#Catalysis751" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3050">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2740">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2389" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2741">
 <bp:stepProcess rdf:resource="#Pathway353" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3052">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2742">
 <bp:stepProcess rdf:resource="#Catalysis748" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2390" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3051">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1411">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1225" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3054">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1410">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1224" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3053">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3056">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3055">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway250">
 <bp:pathwayOrder rdf:resource="#PathwayStep2040" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2035" />
 <bp:pathwayComponent rdf:resource="#Pathway252" />
 <bp:pathwayComponent rdf:resource="#Pathway251" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2035" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p75NTR signals via NF-kB</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The NF-kB pathway is an important pro-survival signalling pathway activated by mature NGF, but not BDNF or NT-3, through p75NTR. It is unclear whether TRKA activity also affects NF-kB activation.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway252">
 <bp:pathwayOrder rdf:resource="#PathwayStep2041" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2046" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2047" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2048" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2049" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2042" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2043" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2044" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2045" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1798" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1797" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1796" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1795" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1794" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1793" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1792" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1791" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1790" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2041" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p75NTR recruits signalling complexes</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kB activation involves recruitment at the cell membrane of several proteins such as RIP2, MYD88, IRAK1, TRAF6, p62 and atypical PKC by the NGF:p75NTR complex.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway251">
 <bp:pathwayOrder rdf:resource="#PathwayStep2039" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2036" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2037" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2038" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1788" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1787" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1786" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1789" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2036" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kB is activated and signals survival</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Upon activation in response to NGF, NF-kB moves to the nucleus, where it turns on genes that promote survival, and triggers the expression of HES1/5 to modulate dendritic growth.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway258">
 <bp:pathwayOrder rdf:resource="#PathwayStep2079" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2076" />
 <bp:pathwayComponent rdf:resource="#Pathway260" />
 <bp:pathwayComponent rdf:resource="#Pathway259" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2076" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p75NTR regulates axonogenesis</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p75NTR modulates axonal growth by regulating the activity of small GTPases like RHOA and RHOB, that control the state of actin polymerization. The best studied is RHOA. In its active, GTP-bound form, RHOA rigidifies the actin cytoskeleton, thereby inhibiting axonal elongation and causing growth cone collapse. Depending on the ligand that binds to it, p75NTR can either promote or inhibit axonal growth, Neurotrophin binding leads to inhibition of RHOA activity and  axonal growth. Axonal growth inhibition is caused by myelin molecules named MDGIs (myelin-derived growth inhibitors), such as NOGO, MAG, OMGP. MDGIs bind to a complex made up of p75NTR and the NOGO receptor, causing RHOA activation and axonal growth inhibition.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway257">
 <bp:pathwayOrder rdf:resource="#PathwayStep2072" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2073" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2074" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1818" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1817" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1816" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2072" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p75NTR negatively regulates cell cycle via SC1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SC1 (Schwann Cell factor 1; also called PR domain zinc finger protein 4, PRDM4) interacts with an NGF:p75NTR complex and signals cell cycle arrest by regulating the levels of cyclin E.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway259">
 <bp:pathwayOrder rdf:resource="#PathwayStep2077" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2078" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1820" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1819" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2077" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Axonal growth stimulation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Complex formation between p75NTR and RHOA can leads to inhibition of RHOA activity and axonal growth.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway254">
 <bp:pathwayOrder rdf:resource="#PathwayStep2052" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2053" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2054" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1799" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1801" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1800" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2052" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NADE modulates death signalling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NADE protein (p75NTR-associated cell death executor) may induce cell death upon NGF binding, but not BDNF, NT3, or NT4/5 binding, to p75NTR. The NADE-dependent apoptosis is modulated by the 14-3-3-epsilon protein (Kimura MT et al, 2001).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway253">
 <bp:pathwayOrder rdf:resource="#PathwayStep2051" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2063" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2055" />
 <bp:pathwayComponent rdf:resource="#Pathway254" />
 <bp:pathwayComponent rdf:resource="#Pathway256" />
 <bp:pathwayComponent rdf:resource="#Pathway255" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2051" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cell death signalling via NRAGE, NRIF and NADE</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p75NTR is a key regulator of neuronal apoptosis, both during development and after injury. Apoptosis is triggered  by binding of either mature neurotrophin or proneurotrophin (proNGF, proBDNF). ProNGF is at least 10 times more potent than mature NGF in inducing apoptosis. TRKA signalling protects neurons from apoptosis. The molecular mechanisms involved in p75NTR-apoptosis are not well understood. The death signalling requires activation of c-JUN N-terminal Kinase (JNK), as well as transcriptional events. JNK activation appears to involve the receptor interacting proteins TRAF6, NRAGE, and Rac. The transcription events are thought to be regulated by another p75-interacting protein, NRIF. Two other p75-interacting proteins, NADE and Necdin, have been implicated in apoptosis, but their role is less clear.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway256">
 <bp:pathwayOrder rdf:resource="#PathwayStep2070" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2068" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2069" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2064" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2065" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2066" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2067" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1810" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1809" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1815" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1814" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1813" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1812" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1811" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2064" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NRIF signals cell death from the nucleus</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NRIF (nuclear receptor-interacting factor) is a DNA binding protein that is essential for p75-mediated apoptosis in retina and sympathetic neurons. Neurotrophin or proneurotrophin binding to p75TR induces nuclear translocation of NRIF, which involves gamma-secretase cleavage of p75NTR ICD (Intra Cellular Domain). Once in the nucleus, NRIF mediates apoptosis, probably by acting as transcription factor.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway255">
 <bp:pathwayOrder rdf:resource="#PathwayStep2060" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2061" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2062" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2057" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2058" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2059" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2056" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1808" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1807" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1806" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1805" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1804" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1803" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1802" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2056" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NRAGE signals death through JNK</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Once bound by either NGF or proNGF, p75NTR interacts with NRAGE, thus leading to phosphorylation and activation of JUN Kinase (JNK). JNK controls apoptosis in two ways: it induces transcription of pro-apoptotic genes, and directly activates the cell death machinery. Only NGF-bound p75NTR is shown here.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep2714">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2370" />
 <bp:stepProcess rdf:resource="#Catalysis740" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3003">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2715">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2371" />
 <bp:stepProcess rdf:resource="#Catalysis741" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3002">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2716">
 <bp:stepProcess rdf:resource="#Pathway346" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3005">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2717">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2372" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3004">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2710">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2366" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3007">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis848">
 <bp:controlled rdf:resource="#BiochemicalReaction2639" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2711">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2367" />
 <bp:stepProcess rdf:resource="#Catalysis739" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3006">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis847">
 <bp:controlled rdf:resource="#BiochemicalReaction2637" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2712">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2368" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3009">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2713">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2369" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3008">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis849">
 <bp:controlled rdf:resource="#BiochemicalReaction2640" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis844">
 <bp:controlled rdf:resource="#BiochemicalReaction2630" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis843">
 <bp:controlled rdf:resource="#BiochemicalReaction2629" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis846">
 <bp:controlled rdf:resource="#BiochemicalReaction2635" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis845">
 <bp:controlled rdf:resource="#BiochemicalReaction2634" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis840">
 <bp:controlled rdf:resource="#BiochemicalReaction2623" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence3001">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis842">
 <bp:controlled rdf:resource="#BiochemicalReaction2626" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence3000">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis841">
 <bp:controlled rdf:resource="#BiochemicalReaction2624" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2718">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2373" />
 <bp:stepProcess rdf:resource="#Catalysis742" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2719">
 <bp:stepProcess rdf:resource="#Pathway347" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2725">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2378" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2726">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2379" />
 <bp:stepProcess rdf:resource="#Catalysis744" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2727">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2380" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2728">
 <bp:stepProcess rdf:resource="#Pathway349" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2721">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2375" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis859">
 <bp:controlled rdf:resource="#BiochemicalReaction2666" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2722">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2376" />
 <bp:stepProcess rdf:resource="#Catalysis743" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis858">
 <bp:controlled rdf:resource="#BiochemicalReaction2663" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2723">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2377" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2724">
 <bp:stepProcess rdf:resource="#Pathway348" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis855">
 <bp:controlled rdf:resource="#BiochemicalReaction2655" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis854">
 <bp:controlled rdf:resource="#BiochemicalReaction2651" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis857">
 <bp:controlled rdf:resource="#BiochemicalReaction2660" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2720">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2374" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis856">
 <bp:controlled rdf:resource="#BiochemicalReaction2656" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis851">
 <bp:controlled rdf:resource="#BiochemicalReaction2643" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis850">
 <bp:controlled rdf:resource="#BiochemicalReaction2641" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis853">
 <bp:controlled rdf:resource="#BiochemicalReaction2650" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis852">
 <bp:controlled rdf:resource="#BiochemicalReaction2645" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis860">
 <bp:controlled rdf:resource="#BiochemicalReaction2667" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2729">
 <bp:stepProcess rdf:resource="#Pathway350" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3025">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3024">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3027">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3026">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3029">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3028">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis869">
 <bp:controlled rdf:resource="#BiochemicalReaction2685" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis866">
 <bp:controlled rdf:resource="#BiochemicalReaction2680" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis865">
 <bp:controlled rdf:resource="#BiochemicalReaction2677" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis868">
 <bp:controlled rdf:resource="#BiochemicalReaction2684" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis867">
 <bp:controlled rdf:resource="#BiochemicalReaction2681" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence3021">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis862">
 <bp:controlled rdf:resource="#BiochemicalReaction2672" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence3020">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis861">
 <bp:controlled rdf:resource="#BiochemicalReaction2671" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence3023">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis864">
 <bp:controlled rdf:resource="#BiochemicalReaction2675" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence3022">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis863">
 <bp:controlled rdf:resource="#BiochemicalReaction2674" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep291">
 <bp:stepProcess rdf:resource="#BiochemicalReaction252" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep292">
 <bp:stepProcess rdf:resource="#BiochemicalReaction253" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis871">
 <bp:controlled rdf:resource="#BiochemicalReaction2689" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep290">
 <bp:stepProcess rdf:resource="#Catalysis112" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction251" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis870">
 <bp:controlled rdf:resource="#BiochemicalReaction2688" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep299">
 <bp:stepProcess rdf:resource="#BiochemicalReaction259" />
 <bp:stepProcess rdf:resource="#Catalysis115" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep297">
 <bp:stepProcess rdf:resource="#BiochemicalReaction257" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep298">
 <bp:stepProcess rdf:resource="#BiochemicalReaction258" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep295">
 <bp:stepProcess rdf:resource="#BiochemicalReaction255" />
 <bp:stepProcess rdf:resource="#Catalysis113" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep296">
 <bp:stepProcess rdf:resource="#BiochemicalReaction256" />
 <bp:stepProcess rdf:resource="#Catalysis114" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep293">
 <bp:stepProcess rdf:resource="#Pathway41" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep294">
 <bp:stepProcess rdf:resource="#BiochemicalReaction254" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2703">
 <bp:stepProcess rdf:resource="#Pathway343" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3014">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2704">
 <bp:stepProcess rdf:resource="#Pathway344" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3013">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2705">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2362" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3016">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2706">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2363" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3015">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3018">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2700">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2360" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3017">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2701">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2361" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2702">
 <bp:stepProcess rdf:resource="#Pathway342" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3019">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis877">
 <bp:controlled rdf:resource="#BiochemicalReaction2706" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis876">
 <bp:controlled rdf:resource="#BiochemicalReaction2704" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis879">
 <bp:controlled rdf:resource="#BiochemicalReaction2720" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis878">
 <bp:controlled rdf:resource="#BiochemicalReaction2717" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence3010">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis873">
 <bp:controlled rdf:resource="#BiochemicalReaction2694" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis872">
 <bp:controlled rdf:resource="#BiochemicalReaction2692" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence3012">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis875">
 <bp:controlled rdf:resource="#BiochemicalReaction2701" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence3011">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis874">
 <bp:controlled rdf:resource="#BiochemicalReaction2700" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep280">
 <bp:stepProcess rdf:resource="#Pathway40" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway294">
 <bp:pathwayOrder rdf:resource="#PathwayStep2337" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2310" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2311" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2017" />
 <bp:pathwayComponent rdf:resource="#Pathway295" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2035" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2310" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of IGF1 (IGF-I) or IGF2 (IGF-II) to the extracellular alpha peptides of the type 1 insulin-like growth factor receptor (IGF1R) triggers the activation of two major signaling pathways: the SOS-RAS-RAF-MAPK (ERK) pathway and the PI3K-PKB (AKT) pathway (recently reviewed in Pavelic et al. 2007, Chitnis et al. 2008, Maki et al. 2010, Parella et al. 2010, Annunziata et al. 2011, Siddle et al. 2012, Holzenberger 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Catalysis rdf:ID="Catalysis880">
 <bp:controlled rdf:resource="#BiochemicalReaction2721" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep281">
 <bp:stepProcess rdf:resource="#BiochemicalReaction242" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway293">
 <bp:pathwayOrder rdf:resource="#PathwayStep2303" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2301" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2302" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2011" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2010" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2009" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2301" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRS activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRS is one of the mediators of insulin signalling events. It is activated by phosphorylation and triggers a cascade of events involving PI3K, SOS, RAF and the MAP kinases. The proteins mentioned under IRS are examples of IRS family members acting as indicated. More family members are to be confirmed and added in the future. Using receptor mutagenesis studies it is known that IRS1 via its PTB domain binds to the insulin receptor at the juxtamembrane region at tyrosine 972. The interaction is further stabilized by the PH domain of IRS1 which interacts with the phospholipids of the plasma membrane. This allows the receptor to phosphorylate IRS1 on up to 13 of its tyrosine residues. Once phosphorylated the IRS1 falls away from the receptor. Now in a tyrosine phosphorylated and hence activated state other proteins can interact with the IRS proteins.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway296">
 <bp:pathwayOrder rdf:resource="#PathwayStep2329" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2314" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2313" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2330" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2018" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2029" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2028" />
 <bp:pathwayComponent rdf:resource="#Pathway297" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2313" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRS-related events triggered by IGF1R</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The phosphorylated type 1 insulin-like growth factor receptor phosphorylates IRS1, IRS2, IRS4 and possibly other IRS/DOK family members (reviewed in Pavelic et al. 2007, Chitnis et al. 2008, Maki et al. 2010, Parrella et al. 2010, Siddle et al. 2012). The phosphorylated IRS proteins serve as scaffolds that bind the effector molecules PI3K and GRB2:SOS. PI3K then activates PKB (AKT) signaling while GRB2:SOS activates RAS-RAF-MAPK signaling.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway295">
 <bp:pathwayOrder rdf:resource="#PathwayStep2312" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2331" />
 <bp:pathwayComponent rdf:resource="#Pathway296" />
 <bp:pathwayComponent rdf:resource="#Pathway303" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2312" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IGF1R signaling cascade</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">After autophosphorylation the type 1 insulin-like growth factor receptor (IGF1R) binds and phosphorylates scaffold proteins, IRS1/2/4 and SHC1, which in turn bind effectors possessing enzymatic activity (recently reviewed in Pavelic et al. 2007, Chitnis et al. 2008, Maki et al. 2010, Parrella et al. 2010, and Siddle et al. 2012). IRS1/2/4 can bind both PI3K (via the p85 subunit of PI3K) and the GRB2:SOS complex. PI3K activates PKB (AKT, AKT1) signaling. GRB:SOS stimulates RAS to exchange GDP for GTP leading to activation of RAF and MAPK.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Catalysis rdf:ID="Catalysis881">
 <bp:controlled rdf:resource="#BiochemicalReaction2722" />
</bp:Catalysis>

<bp:Pathway rdf:ID="Pathway290">
 <bp:pathwayOrder rdf:resource="#PathwayStep2282" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2283" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1994" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1993" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2282" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PDE3B signalling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT (PKB) is recruited to the plasma membrane by binding phosphatidylinositol (3,4,5)-trisphosphate (PIP3). AKT is then activated by phosphorylation. Activated AKT in turn phosphorylates Phosphodiesterase 3B (PDE3B) which hydrolyzes 3&apos;,5&apos;-cyclic AMP (cAMP) (reviewed in Manning and Toker 2017).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway292">
 <bp:pathwayOrder rdf:resource="#PathwayStep2292" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2293" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2294" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2295" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2296" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2297" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2298" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2007" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2006" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2005" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2004" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2003" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2002" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2001" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2292" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signal attenuation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Now with the complete receptor-ligand dissociation and subsequent degradation of insulin in the endosomal lumen, the endosomally associated protein tyrosine phosphatases (PTPs) complete the receptor dephosphorylation. So too are all the receptor substrates dephosphorylated leading to the collapse of the signalling complexes and signal attenuation.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway291">
 <bp:pathwayOrder rdf:resource="#PathwayStep2285" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2286" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2287" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1997" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1996" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1995" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2285" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of AKT2</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC serine/threonine-protein kinases (AKT, PKB) are serine/threonine kinases belonging to the cAMP-dependent protein kinase A/ protein kinase G/ protein kinase C (AGC) superfamily of protein kinases. They share structural homology within their catalytic domains and have similar mechanisms of activation. Mammals have three AKT genes, named RAC-alpha serine/threonine-protein kinase (AKT1, PKB, PKB-alpha), RAC-beta serine/threonine-protein kinase (AKT2, PKB-beta and RAC-gamma serine/threonine-protein kinase (AKT3, PKB-gamma, STK2). All share a conserved domain structure: an amino terminal pleckstrin homology (PH) domain, a central kinase domain and a carboxyl-terminal regulatory domain that contains a hydrophobic motif that is characteristic of AGC kinases. The PH domain interacts with membrane lipid products such as phosphatidylinositol (3,4,5) trisphosphate (PIP3) produced by phosphatidylinositol 3-kinase (PI3-kinase). Biochemical analysis. The PH domain of AKT binds to PIP3 and PIP2 with similar affinity (James et al. 1996, Frech et al. 1997). The kinase catalytic domain of Akt/PKB is highly similar to other AGC kinases (Peterson    Schreiber 1999). Phosphorylation of a conserved threonine residue in this region (T308 in AKT1) results in partial activation (Alessi et al. 1996). The carboxyl terminal extension has the hydrophobic motif FPQFSY. Phosphorylation of serine or threonine residue in this motif is necessary for full kinase activation. Deletion of this motif completely abolishes activity (Andjelkovi&#263; et al. 1997).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep288">
 <bp:stepProcess rdf:resource="#BiochemicalReaction249" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep289">
 <bp:stepProcess rdf:resource="#BiochemicalReaction250" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep286">
 <bp:stepProcess rdf:resource="#BiochemicalReaction247" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep287">
 <bp:stepProcess rdf:resource="#BiochemicalReaction248" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep284">
 <bp:stepProcess rdf:resource="#Catalysis110" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction245" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway298">
 <bp:pathwayOrder rdf:resource="#PathwayStep2316" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2317" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2019" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2020" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2316" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SOS-mediated signalling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SOS is recruited to the plasma membrane and mediates activation of Ras.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep2707">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2364" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep285">
 <bp:stepProcess rdf:resource="#Catalysis111" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction246" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway297">
 <bp:pathwayOrder rdf:resource="#PathwayStep2318" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2315" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2328" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2027" />
 <bp:pathwayComponent rdf:resource="#Pathway298" />
 <bp:pathwayComponent rdf:resource="#Pathway299" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2315" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRS-mediated signalling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Release of phospho-IRS from the insulin receptor triggers a cascade of signalling events via PI3K, SOS, RAF and the MAP kinases.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep2708">
 <bp:stepProcess rdf:resource="#Catalysis738" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2365" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep282">
 <bp:stepProcess rdf:resource="#BiochemicalReaction243" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2709">
 <bp:stepProcess rdf:resource="#Pathway345" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep283">
 <bp:stepProcess rdf:resource="#BiochemicalReaction244" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway299">
 <bp:pathwayOrder rdf:resource="#PathwayStep2319" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2327" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2323" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2026" />
 <bp:pathwayComponent rdf:resource="#Pathway302" />
 <bp:pathwayComponent rdf:resource="#Pathway300" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2319" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI3K Cascade</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The PI3K (Phosphatidlyinositol-3-kinase) - AKT signaling pathway stimulates cell growth and survival.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence599">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence595">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence596">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence597">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence598">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence591">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2264">
 <bp:evidence rdf:resource="#Evidence2598" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AXL binds SRC-1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence592">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2263">
 <bp:evidence rdf:resource="#Evidence2597" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT binds PDPK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence593">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2262">
 <bp:evidence rdf:resource="#Evidence2596" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Caveolin-1 dissociates from eNOS:CaM:HSP90 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence594">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2261">
 <bp:evidence rdf:resource="#Evidence2595" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">eNOS synthesizes NO</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2260">
 <bp:evidence rdf:resource="#Evidence2594" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PIP3 recruits PDPK1 to the membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence590">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep390">
 <bp:stepProcess rdf:resource="#BiochemicalReaction336" />
 <bp:stepProcess rdf:resource="#Catalysis151" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep391">
 <bp:stepProcess rdf:resource="#BiochemicalReaction337" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2269">
 <bp:evidence rdf:resource="#Evidence2603" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK2 binds p-S-SHB and is recruited to p-6Y-VEGFR2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2268">
 <bp:evidence rdf:resource="#Evidence2602" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of SRC-1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2267">
 <bp:evidence rdf:resource="#Evidence2601" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-MAPK2/3 phosphorylates HSP27</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2266">
 <bp:evidence rdf:resource="#Evidence2600" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38 MAPK phosphorylates MAPKAPK2, MAPKAPK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2265">
 <bp:evidence rdf:resource="#Evidence2599" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-VAV family:PIP3 binds RAC1:GDP</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep398">
 <bp:stepProcess rdf:resource="#Catalysis155" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction344" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway203">
 <bp:pathwayOrder rdf:resource="#PathwayStep1546" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1545" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1344" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1343" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1545" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NR1H2 &amp; NR1H3 regulate gene expression linked to gluconeogenesis </bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of liver X receptor &#945; (LXR&#945;, NR1H3) alters the expression of genes in liver and adipose tissue that collectively may limit hepatic glucose output and improve peripheral glucose uptake (Laffitte BA et al. 2003). In the liver, activation of NR1H3 led to the suppression of the expression of genes involved in gluconeogenesis including glucose-6-phosphatase (G6Pase) and phosphoenolpyruvate carboxykinase (PCK1 or PEPCK) (Laffitte BA et al. 2003; Dalen KT et al. 2003; Herzog B et al. 2007; Commerford et al. 2007). In adipose tissue, activation of NR1H3 led to the transcriptional induction of the insulin-sensitive glucose transporter, GLUT4 (Laffitte BA et al. 2003; Dalen KT et al. 2003). In contrast, basal expression of LXR&#946; (NR1H2) has been shown to be essential for the regulation of PCK1 by another nuclear receptor, the glucocorticoid receptor GR (NR3C1) (Patel et al. 2011; Patel et. al. 2017). The LXRs appear to have somewhat opposing roles in the regulation of PCK1 in the liver since NR1H3 (LXR&#945;) activation represses PCK1 mRNA expression induced by glucocorticoids (Nader et al. 2012) and NR1H2 (LXR&#946;) antagonism reduces glucocorticoid-induced PCK1 mRNA expression (Patel et al. 2017).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep399">
 <bp:stepProcess rdf:resource="#Catalysis156" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction345" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway202">
 <bp:pathwayOrder rdf:resource="#PathwayStep1536" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1539" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1538" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1537" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1543" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1542" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1541" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1540" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1337" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1336" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1335" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1342" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1341" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1340" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1339" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1338" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1536" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NR1H2 &amp; NR1H3 regulate gene expression linked to lipogenesis</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The liver X receptor &#945; (LXR&#945; or NR1H3) and LXR&#946; (NR1H2) are nuclear receptors that are activated by endogenous oxidized derivatives of cholesterol known as oxysterols (Janowski BA et al. 1999; Jakobsson T et al. 2012). NR1H2 and NR1H3 act as whole-body cholesterol sensors and their activation results in a net elimination of cholesterol from the body and amelioration of the plasma lipoprotein profile by mobilizing cholesterol from the periphery (Venkateswaran A et al. 2000; Repa JJ et al. 2000a; Ishibashi M et al. 2013). NR1H3 (LXR&#945;) and NR1H2 (LXR&#946;) also contribute to lowering of whole-body cholesterol levels by shifting acetyl-CoA units from cholesterol de novo biosynthesis to fatty acid synthesis. NR1H2 or 3-induced hepatic lipogenesis in rodents and humans is mediated by direct upregulation of sterol regulatory element-binding protein 1 (SREBF1), the main regulator of hepatic lipogenesis that controls the transcription of genes involved in fatty acid biosynthesis (Schultz JR et al. 2000). NR1H2    NR1H3 may activate lipogenic gene transcription directly by biding LXR responsive element (LXRE) found in the promoter regions of several genes, such as fatty acid synthase (FAS or FASN) and stearoyl-CoA desaturase 1 (SCD1) (Repa JJ et al. 2000b; Yoshikawa T et al. 2001; Joseph SB et al. 2002; Chu K et al. 2006). Mice carrying a targeted disruption in the NR1H3 (LXR&#945;) gene were deficient in expression of FAS, SCD1, ACC, and SREBF1 (Peet DJ et al. 1998). Mice ablated of both NR1H3 and NR1H2 showed defective hepatic lipid metabolism decreasing lipogenesis by 80% and were resistant to obesity (Repa JJ et al. 2000; Kalaany NY et al. 2005; Beaven SW et al. 2013). Further, the administration of the synthetic NR1H2 or NR1H3 ligands to mice triggered induction of the lipogenic pathway and raised plasma triglyceride levels (Schultz JR et al. 2000). These studies demonstrate the role of NR1H3 (LXR&#945;) and NR1H2 (LXR&#946;) in the control of lipogenesis.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep396">
 <bp:stepProcess rdf:resource="#Catalysis154" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction342" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway205">
 <bp:pathwayOrder rdf:resource="#PathwayStep1556" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1555" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1554" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1553" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1552" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1551" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1348" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1347" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1352" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1351" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1350" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1349" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1551" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NR1H2 &amp; NR1H3 regulate gene expression to control bile acid homeostasis</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Liver X receptors NR1H3 (LXR alpha) and NR1H2 (LXR beta) are sterol-responsive transcription factors that become activated upon the engagement with their cognate oxysterol ligands. Besides inducing a genetic program aimed to reduce the cellular sterol load, ligand-activated NR1H2    NR1H3 also modulate the expression and activity of genes controlling bile acid synthesis, transport and metabolism such as bile acid-glucuronidating enzyme UGT1A3 which converts hydrophobic bile acids into polar metabolites that can be excreted in the urine (Verreault M et al. 2006). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep397">
 <bp:stepProcess rdf:resource="#BiochemicalReaction343" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway204">
 <bp:pathwayOrder rdf:resource="#PathwayStep1549" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1548" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1346" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1345" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1548" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NR1H2 &amp; NR1H3 regulate gene expression to limit cholesterol uptake </bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Liver X receptors NR1H3 (LXR alpha) and NR1H2 (LXR beta) are sterol-responsive transcription factors that become activated upon the engagement with their cognate oxysterol ligands. Ligand-activated NR1H2    NR1H3 induce a genetic program aimed at reducing the cellular sterol load by limiting cholesterol uptake, attenuating cholesterol biosynthesis and promoting cholesterol efflux. This Reactome module describes the NR1H2    NR1H3-regulated expression of MYLIP (IDOL) gene, an E3 ubiquitin ligase, that triggers ubiquitination of the low-density lipoprotein receptor (LDLR) on its cytoplasmic domain, targeting it for degradation and thereby limiting cholesterol uptake (Zelcer N et al. 2009; Zhang L et al. 2012). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep394">
 <bp:stepProcess rdf:resource="#Catalysis152" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction340" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep395">
 <bp:stepProcess rdf:resource="#Catalysis153" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction341" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep392">
 <bp:stepProcess rdf:resource="#BiochemicalReaction338" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway201">
 <bp:pathwayOrder rdf:resource="#PathwayStep1547" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1535" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1557" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1544" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1550" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1598" />
 <bp:pathwayComponent rdf:resource="#Pathway207" />
 <bp:pathwayComponent rdf:resource="#Pathway206" />
 <bp:pathwayComponent rdf:resource="#Pathway203" />
 <bp:pathwayComponent rdf:resource="#Pathway202" />
 <bp:pathwayComponent rdf:resource="#Pathway205" />
 <bp:pathwayComponent rdf:resource="#Pathway204" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1535" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NR1H2 and NR1H3-mediated signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The liver X receptors LXR&#945; (NR1H3) and LXR&#946; (NR1H2) are members of the nuclear receptor superfamily and function as ligand-activated transcription factors. The natural ligands of NR1H2 and NR1H3 are oxysterols (e.g., 24(S),25-epoxycholesterol, 24(S)-hydroxycholesterol (OH), 25-OH, and 27-OH) that are produced endogenously by enzymatic reactions, by reactive oxygen species (ROS)-dependent oxidation of cholesterol and by the alimentary processes (reviewed in:Jakobsson T et al. 2012; Huang C 2014; Komati R et al. 2017). It has been shown that these oxysterols bind directly to the ligand-binding domain of LXRs with Kd values ranging from 0.1 to 0.4&#8202;microM. 24(S), 25-epoxycholesterol was found to be the most potent endogenous agonist (Janowski BA et al. 1999). NR1H3 (LXR&#945;) and NR1H2 (LXR&#946;) showed similar affinities for these compounds (Janowski BA et al. 1999). In physiological conditions, oxysterols are formed in amounts proportional to cholesterol content in the cell and therefore the LXRs operate as cholesterol sensors to alter gene expression and protect the cells from cholesterol overload via: (1) inhibiting intestinal cholesterol absorption; (2) stimulating cholesterol efflux from cells to high-density lipoproteins through the ATP-binding cassette transporters ABCA1 and ABCG1: (3) activating the conversion of cholesterol to bile acids in the liver; and (4) activating biliary cholesterol and bile acid excretion (reviewed in: W&#243;jcicka G et al. 2007; Baranowski M 2008; Laurencikiene J    Ryd&#233;n M 2012; Edwards PA et al. 2002; Zelcer N    Tontonoz P 2006; Zhao C    Dahlman-Wright K 2010). In addition, LXR agonists enhance de novo fatty acid synthesis by stimulating the expression of a lipogenic transcription factor, sterol regulatory element-binding protein-1c (SREBP-1c), leading to the elevation of plasma triglycerides and hepatic steatosis (W&#243;jcicka G et al. 2007; Baranowski M 2008; Laurencikiene J    Ryd&#233;n M 2012). In addition to their function in lipid metabolism, NR1H2,3 have also been found to modulate immune and inflammatory responses in macrophages (Zelcer N    Tontonoz P 2006). The NR1H2 and NR1H3 molecules can be viewed as having four functional domains: (1) an amino-terminal ligand-independent activation function domain (AF-1), which may stimulate transcription in the absence of ligand; (2) a DNA-binding domain (DBD) containing two zinc fingers; (3) a hydrophobic ligand-binding domain (LBD) required for ligand binding and receptor dimerization; and, (4) a carboxy-terminal ligand-dependent transactivation sequence (also referred to as the activation function-2 (AF-2) domain) that stimulates transcription in response to ligand binding (Robinson-Rechavi M et al. 2003; Jakobsson T et al. 2012; F&#228;rnegardh M et al. 2003; Lin CY    Gustafsson JA 2015). Although both NR1H3 and NR1H2 are activated by the same ligands and are structurally similar, their tissue expression profiles are very different. NR1H3 is selectively expressed in specific tissues and cell types, such as the liver, intestine, adrenal gland, adipose tissue and macrophages, whereas NR1H2 is ubiquitously expressed (Nishimura M et al. 2004; Bookout AL et al. 2006). Upon activation NR1H2 or NR1H3 heterodimerizes with retinoid X receptors (RXR) and binds to LXR-response elements (LXREs) consisting of a direct repeat of the core sequence 5&apos;-AGGTCA-3&apos; separated by 4 nucleotides (DR4) in the DNA of target genes (Wiebel FF    Gustafsson JA 1997). An inverted repeat of the same consensus sequence with no spacer region(IR-0) and an inverted repeat of the same consensus sequence separated by a 1 bp spacer (IR-1) have also been shown to mediate LXR transactivation (Mak PA et al. 2002, Landrier JF et al. 2003). NR1H3 and NR1H2 have been shown to regulate gene expression via LXREs in the promoter regions of their target genes such as UDP glucuronosyltransferase 1 family, polypeptide A3 (UGT1A3) (Verreault M et al. 2006), fatty acid synthase (FAS) (Joseph SB et al. 2002a), carbohydrate response element binding protein (ChREBP, also known as MLX-interacting protein-like or MLXIPL) (Cha JY    Repa JJ 2007) and phospholipid transfer protein (PLTP) (Mak PA et al. 2002). LXREs have also been reported to be present in introns of target genes such as the ATP-binding cassette transporter G1 (ABCG1) (Sabol SL et al. 2005). NR1H3 has been shown to activate gene expression via the FXR-responsive element found in the proximal promoter of the human ileal bile acid-binding protein (FABP6) (Landrier JF et al. 2003). The NR1H2,3:RXR heterodimers are permissive, in that they can be activated by ligands for either NR1H2,3 (LXR) or RXR (Willy PJ et al. 1995).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep393">
 <bp:stepProcess rdf:resource="#BiochemicalReaction339" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway200">
 <bp:pathwayOrder rdf:resource="#PathwayStep1624" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1601" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1534" />
 <bp:pathwayComponent rdf:resource="#Pathway208" />
 <bp:pathwayComponent rdf:resource="#Pathway210" />
 <bp:pathwayComponent rdf:resource="#Pathway201" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1534" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by Nuclear Receptors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear receptors (NRs) are ligand-activated transcription factors that bind to small lipid based molecules to regulate gene expression and other cellular process. This family includes receptors for steroid hormones and derivatives (such as estrogen, progesterone,  glucocorticoids, Vitamin D, oxysterols and bile acids, among others) as well as receptors for retinoic acids, thyroid hormones and fatty acids and their derivatives. These ligands are able to diffuse directly through cellular membranes as a result of their lipophilic nature (reviewed in Beato et al, 1996; Holzer et al, 2017).  The 48 human nuclear receptors share a conserved modular structure that consists of a sequence specific DNA-binding domain and a ligand-binding domain, in addition to various other protein-protein interaction domains. Upon interaction with ligand, NRs bind to the regulatory regions of target genes as homo- or heterodimers, or more rarely, as monomers.  At the promoter, NRs interact with other activators and repressors to regulate gene expression (reviewed Beato et al, 1996; Simons et al, 2014; Hah and Kraus, 2010). A number of nuclear receptors are cytoplasmic in the absence of ligand and exist as part of a heat shock protein complex that regulates their cellular location, protein stability, competency to bind steroid hormones and transcriptional activity (Echeverria and Picard, 2010). Ligand-binding to these receptors promotes dimerization and nuclear translocation.  Other nuclear receptors are contstitutively nuclear and their chromatin-modifying activities are regulated by ligand binding (reviewed in Beato et al, 1996).  In addition to the classic transcriptional response, NRs also have a role in rapid, non-nuclear signaling originating from receptors localized at the plasma membrane. Ligand-binding to these receptors intitiates downstream phospholipase- and kinase-based signaling cascades (reviewed in Schwartz et al, 2016; Levin and Hammes, 2016). Signaling by estrogen, liver X and retinoic acid receptors are currently described here.  </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction105">
 <bp:evidence rdf:resource="#Evidence122" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CaMKK phosphorylates CAMK4</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence588">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction104">
 <bp:evidence rdf:resource="#Evidence121" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Calmodulin binds CAMK4</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence589">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction107">
 <bp:evidence rdf:resource="#Evidence124" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CaMKII binds activated calmodulin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction106">
 <bp:evidence rdf:resource="#Evidence123" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CAMK4 binds KPNA2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction101">
 <bp:evidence rdf:resource="#Evidence118" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerization of p-S133-CREB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence584">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction100">
 <bp:evidence rdf:resource="#Evidence117" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CAMK4 enters the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence585">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction103">
 <bp:evidence rdf:resource="#Evidence120" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CaMK4 phosphorylates CREB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep389">
 <bp:stepProcess rdf:resource="#BiochemicalReaction335" />
 <bp:stepProcess rdf:resource="#Catalysis150" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence586">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction102">
 <bp:evidence rdf:resource="#Evidence119" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CAMK4 autophosphorylates</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence587">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence580">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2253">
 <bp:evidence rdf:resource="#Evidence2587" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC1 binds PAK1-3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence581">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2252">
 <bp:evidence rdf:resource="#Evidence2586" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT1 binds eNOS complex via HSP90</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence582">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2251">
 <bp:evidence rdf:resource="#Evidence2585" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT1 phosphorylates eNOS</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence583">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2250">
 <bp:evidence rdf:resource="#Evidence2584" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PDPK1 phosphorylates AKT at T308</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction109">
 <bp:evidence rdf:resource="#Evidence127" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKA phosphorylates CREB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction108">
 <bp:evidence rdf:resource="#Evidence125" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated calmodulin dissociates from CaMKII-gamma</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep380">
 <bp:stepProcess rdf:resource="#BiochemicalReaction330" />
 <bp:stepProcess rdf:resource="#Catalysis147" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2259">
 <bp:evidence rdf:resource="#Evidence2593" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The cofactor BH4 is required for electron transfer in the eNOS catalytic cycle</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2258">
 <bp:evidence rdf:resource="#Evidence2592" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PAK1-3 autophosphorylates</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2257">
 <bp:evidence rdf:resource="#Evidence2591" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HSP90 binds eNOS:Caveolin-1:CaM complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2256">
 <bp:evidence rdf:resource="#Evidence2590" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TORC2 (mTOR) phosphorylates AKT at S473</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2255">
 <bp:evidence rdf:resource="#Evidence2589" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PAK1-3 dimer disassociates</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2254">
 <bp:evidence rdf:resource="#Evidence2588" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PAK1-3 phosphorylates VE-cadherin</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep387">
 <bp:stepProcess rdf:resource="#Pathway54" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep388">
 <bp:stepProcess rdf:resource="#Pathway55" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction110">
 <bp:evidence rdf:resource="#Evidence128" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerization of p-S133-CREB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep385">
 <bp:stepProcess rdf:resource="#BiochemicalReaction334" />
 <bp:stepProcess rdf:resource="#Catalysis149" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep386">
 <bp:stepProcess rdf:resource="#Pathway53" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep383">
 <bp:stepProcess rdf:resource="#BiochemicalReaction332" />
 <bp:stepProcess rdf:resource="#Catalysis148" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep384">
 <bp:stepProcess rdf:resource="#BiochemicalReaction333" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep381">
 <bp:stepProcess rdf:resource="#BiochemicalReaction331" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep382">
 <bp:stepProcess rdf:resource="#Pathway52" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence577">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3102">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence578">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3101">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence579">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3104">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1489">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1297" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3103">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence573">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3106">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence574">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3105">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep378">
 <bp:stepProcess rdf:resource="#Pathway51" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence575">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3108">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep379">
 <bp:stepProcess rdf:resource="#BiochemicalReaction329" />
 <bp:stepProcess rdf:resource="#Catalysis146" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence576">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence3107">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1484">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1292" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2242">
 <bp:evidence rdf:resource="#Evidence2575" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKC phosphorylates sphingosine kinase 1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence570">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1483">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1291" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2241">
 <bp:evidence rdf:resource="#Evidence2574" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PLCG1 disassociates from VEGFR2 and translocate to PM</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence571">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1482">
 <bp:stepProcess rdf:resource="#Catalysis400" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1290" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2240">
 <bp:evidence rdf:resource="#Evidence2573" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-6Y-VEGFR2 binds PLCG1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence572">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1481">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1289" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1488">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1296" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1487">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1295" />
 <bp:stepProcess rdf:resource="#Catalysis402" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1486">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1294" />
 <bp:stepProcess rdf:resource="#Catalysis401" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3100">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1485">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1293" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2249">
 <bp:evidence rdf:resource="#Evidence2583" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">eNOS:Caveolin-1 complex binds to CaM</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2248">
 <bp:evidence rdf:resource="#Evidence2581" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IP3R:I(1,4,5)P3 tetramer transports Ca2+ from ER lumen to cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2247">
 <bp:evidence rdf:resource="#Evidence2580" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Calcium binds calmodulin</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1491">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1299" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2246">
 <bp:evidence rdf:resource="#Evidence2579" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IP3 binds to the IP3 receptor, opening the endoplasmic reticulum Ca2+ channel</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1490">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1298" />
 <bp:stepProcess rdf:resource="#Catalysis403" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2245">
 <bp:evidence rdf:resource="#Evidence2578" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DAG and Ca+2 bind to PKC and tether it to membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2244">
 <bp:evidence rdf:resource="#Evidence2577" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-SPHK1 phosphorylates sphingosine to sphingosine 1-phosphate</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2243">
 <bp:evidence rdf:resource="#Evidence2576" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active PLCG1 hydrolyses PIP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep376">
 <bp:stepProcess rdf:resource="#Pathway49" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep377">
 <bp:stepProcess rdf:resource="#Pathway50" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3109">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep374">
 <bp:stepProcess rdf:resource="#BiochemicalReaction327" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep375">
 <bp:stepProcess rdf:resource="#Catalysis145" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction328" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep372">
 <bp:stepProcess rdf:resource="#BiochemicalReaction325" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep373">
 <bp:stepProcess rdf:resource="#BiochemicalReaction326" />
 <bp:stepProcess rdf:resource="#Catalysis144" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep370">
 <bp:stepProcess rdf:resource="#BiochemicalReaction324" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep371">
 <bp:stepProcess rdf:resource="#Pathway48" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence566">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence567">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence568">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence569">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep369">
 <bp:stepProcess rdf:resource="#Catalysis143" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction323" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence562">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence563">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep367">
 <bp:stepProcess rdf:resource="#Catalysis142" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction321" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence564">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep368">
 <bp:stepProcess rdf:resource="#BiochemicalReaction322" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence565">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1495">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1303" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2231">
 <bp:evidence rdf:resource="#Evidence2563" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ROCK1,ROCK2 are activated</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1494">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1302" />
 <bp:stepProcess rdf:resource="#Catalysis406" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2230">
 <bp:evidence rdf:resource="#Evidence2562" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC1:GTP and PIP3 bind WAVE Regulatory Complex (WRC)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence560">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1493">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1301" />
 <bp:stepProcess rdf:resource="#Catalysis405" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence561">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1492">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1300" />
 <bp:stepProcess rdf:resource="#Catalysis404" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1499">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1306" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1498">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1305" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1497">
 <bp:stepProcess rdf:resource="#Pathway194" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1496">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1304" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2239">
 <bp:evidence rdf:resource="#Evidence2572" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SFKs phosphorylate PLCG1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2238">
 <bp:evidence rdf:resource="#Evidence2571" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PDK1 phosphorylates PKC</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2237">
 <bp:evidence rdf:resource="#Evidence2570" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKC autophosphorylates</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2236">
 <bp:evidence rdf:resource="#Evidence2568" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AXL autophosphorylates on Y779 and Y821</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2235">
 <bp:evidence rdf:resource="#Evidence2567" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SRC-1 phosphorylates p-Y397-PTK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2234">
 <bp:evidence rdf:resource="#Evidence2566" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK2 autophosphorylates</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2233">
 <bp:evidence rdf:resource="#Evidence2565" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HSP90AA1 binds p-6Y-VEGFR2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2232">
 <bp:evidence rdf:resource="#Evidence2564" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SRC-1 binds p-Y397-PTK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep365">
 <bp:stepProcess rdf:resource="#BiochemicalReaction320" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep366">
 <bp:stepProcess rdf:resource="#Pathway47" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep363">
 <bp:stepProcess rdf:resource="#BiochemicalReaction318" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep364">
 <bp:stepProcess rdf:resource="#Catalysis141" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction319" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep361">
 <bp:stepProcess rdf:resource="#Pathway46" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep362">
 <bp:stepProcess rdf:resource="#BiochemicalReaction317" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep360">
 <bp:stepProcess rdf:resource="#BiochemicalReaction316" />
 <bp:stepProcess rdf:resource="#Catalysis140" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction138">
 <bp:evidence rdf:resource="#Evidence161" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of cytosolic AMPK by phosphorylation</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence555">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction137">
 <bp:evidence rdf:resource="#Evidence160" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHEB in mTORC1:RHEB:GTP hydrolyses GTP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence556">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1469">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1279" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence557">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1468">
 <bp:stepProcess rdf:resource="#Catalysis397" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1278" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction139">
 <bp:evidence rdf:resource="#Evidence162" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AMPK phosphorylates Raptor in the mTORC1 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence558">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1467">
 <bp:stepProcess rdf:resource="#Catalysis396" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1277" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction134">
 <bp:evidence rdf:resource="#Evidence157" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LKB1 forms a trimeric complex with STRAD and MO25</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep358">
 <bp:stepProcess rdf:resource="#BiochemicalReaction314" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence551">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2798">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2433" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction133">
 <bp:evidence rdf:resource="#Evidence155" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GTP loading by Rheb</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep359">
 <bp:stepProcess rdf:resource="#BiochemicalReaction315" />
 <bp:stepProcess rdf:resource="#Catalysis139" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence552">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway239">
 <bp:pathwayOrder rdf:resource="#PathwayStep1951" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1949" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1948" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1950" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1711" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1710" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1713" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1712" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1948" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GLI proteins bind promoters of Hh responsive genes to promote transcription</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GLI proteins are bifunctional DNA-binding proteins that recognize consensus GLI sites 5&apos;-GACCACCC-3&apos; in the promoters of target genes (Kinzler and Vogelstein, 1990).  Pathway induction upon ligand-binding diverts the GLI proteins from the processing/degradation pathway that generates the truncated repressor form and promotes the formation of the full-length transcriptional activator (reviewed in Hui and Angers, 2011; Briscoe and Therond, 2013). GLI-dependent target genes have been identified by a number of ChIP based screens, and well-established, direct targets include a number of Hh pathway members including PTCH1, PTCH2, GLI1, HHIP and BOC (Lee et al, 2010; Vokes et al, 2007; Vokes et al, 2008; Agren et al, 2004; Bai et al, 2004; Bai et al, 2002; Dai et al, 1999).  Full-length GLI proteins nucleate the assembly of a transcriptional activation complex at target gene promoters, but the details of interacting partners are not well known.  The C-terminus of GLI3 has been shown to interact with a number of transcriptional activators including the histone acetyltransferase CBP, the Mediator component Med12 and the TATA-box recognition protein TAF31, but the detail of how and when these binding partners interact is not known (Dai et al, 1999; Zhou et al, 2006; Yoon et al, 1998; reviewed in Hui and Angers, 2011).  Each of the GLI proteins has been shown to bind to CDC 73, a component of the PAF complex that has roles in RNA polymerase II-mediated transcription (Mosimann et al, 2009; reviewed in Tomson and Arndt, 2013).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep2799">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2434" />
 <bp:stepProcess rdf:resource="#Catalysis768" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction136">
 <bp:evidence rdf:resource="#Evidence159" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated AMPK binds AMP</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep356">
 <bp:stepProcess rdf:resource="#BiochemicalReaction312" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence553">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction135">
 <bp:evidence rdf:resource="#Evidence158" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-AMPK phosphorylates TSC1:TSC2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep357">
 <bp:stepProcess rdf:resource="#BiochemicalReaction313" />
 <bp:stepProcess rdf:resource="#Catalysis138" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence554">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1462">
 <bp:stepProcess rdf:resource="#Catalysis393" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1272" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2794">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2430" />
 <bp:stepProcess rdf:resource="#Catalysis767" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1461">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1271" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2795">
 <bp:stepProcess rdf:resource="#Pathway366" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1460">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1270" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2796">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2431" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence550">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2797">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2432" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1466">
 <bp:stepProcess rdf:resource="#Catalysis395" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1276" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2790">
 <bp:stepProcess rdf:resource="#Pathway365" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1465">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1275" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2791">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2427" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1464">
 <bp:stepProcess rdf:resource="#Catalysis394" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1274" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2792">
 <bp:stepProcess rdf:resource="#Catalysis766" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2428" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1463">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1273" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2793">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2429" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway241">
 <bp:pathwayOrder rdf:resource="#PathwayStep1976" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1975" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1974" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1973" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1979" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1978" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1977" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1972" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1971" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1733" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1732" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1731" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1739" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1738" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1737" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1736" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1735" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1734" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1971" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of SMO</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of the transmembrane protein SMO in response to Hh stimulation is a major control point in the Hh signaling pathway (reviewed in Ayers and Therond, 2010; Jiang and Hui, 2008). In the absence of ligand, SMO is inhibited in an unknown manner by the Hh receptor PTCH. PTCH regulates SMO in a non-stoichiometric manner and there is little evidence that endogenous PTCH and SMO interact directly (Taipale et al, 2002; reviewed in Huangfu and Anderson, 2006). PTCH may regulate SMO activity by controlling the flux of sterol-related SMO agonists and/or antagonists, although this has not been fully substantiated (Khaliullina et al, 2009; reviewed in Rohatgi and Scott, 2007; Briscoe and Therond, 2013).  PTCH-mediated inhibition of SMO is relieved upon ligand stimulation of PTCH, but the mechanisms for this relief are again unknown. SMO and PTCH appear to have opposing localizations in both the &apos;off&apos; and &apos;on&apos; state, with PTCH exiting and SMO entering the cilium upon Hh pathway activation (Denef et al, 2000; Rohatgi et al, 2007; reviewed in Goetz and Anderson, 2010; Hui and Angers, 2011). Activation of SMO involves a conserved phosphorylation-mediated conformational change in the C-terminal tails that destabilizes an intramolecular interaction and promotes the interaction between adjacent tails in the SMO dimer.  In Drosophila, this phosphorylation is mediated by PKA and CK1, while in vertebrates it appears to involve ADRBK1/GRK2 and CSNK1A1. Sequential phosphorylations along multiple serine and threonine motifs in the SMO C-terminal tail appear to allow a graded response to Hh ligand concentration in both flies and vertebrates (Zhao et al, 2007; Chen et al, 2010; Chen et al, 2011).  In flies, Smo C-terminal tail phosphorylation promotes an association with the Hedgehog signaling complex (HSC) through interaction with the scaffolding kinesin-2 like protein Cos2, activating the Fu kinase and ultimately releasing uncleaved Ci from the complex (Zhang et al, 2005; Ogden et al, 2003; Lum et al, 2003; reviewed in Mukhopadhyay and Rohatgi, 2014). In vertebrates, SMO C-terminal tail phosphorylation and conformational change is linked to its KIF7-dependent ciliary accumulation  (Chen et al, 2011; Zhao et al, 2007; Chen et al, 2010).  In the cilium, SMO is restricted to a transition-zone proximal region known as the EvC zone (Yang et al, 2012; Blair et al, 2011; Pusapati et al, 2014; reviewed in Eggenschwiler 2012). Both SMO phosphorylation and its ciliary localization are required to promote the Hh-dependent dissociation of the GLI:SUFU complex, ultimately allowing full-length GLI transcription factors to translocate to the nucleus to activate Hh-responsive genes (reviewed in Briscoe and Therond, 2013).   </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway240">
 <bp:pathwayOrder rdf:resource="#PathwayStep1954" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1957" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1956" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1955" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1718" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1717" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1716" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1715" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1954" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ligand-receptor interactions</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Repression of Hh signaling in the absence of ligand depends on the transmembrane receptor protein Patched (PTCH), which inhibits Smoothened (SMO) activity by an unknown mechanism. This promotes the proteolytic processing and/or degradation of the GLI family of transcription factors and maintains the pathway in a transcriptionally repressed state (reviewed in Briscoe and Therond, 2013). In the absence of ligand, PTCH is localized in the cilium, while SMO is largely concentrated in intracellular compartments.  Upon binding of Hh to the PTCH receptor, PTCH is endocytosed, relieving SMO inhibition and allowing it to accumulate in the primary cilium (Marigo et al, 1996; Chen and Struhl, 1996; Stone et al, 1996; Rohatgi et al, 2007; Corbit et al, 2005; reviewed in Goetz and Anderson, 2010).  In the cilium, SMO is activated by an unknown mechanism, allowing the full length transcriptional activator forms of the GLI proteins to accumulate and translocate to the nucleus, where they bind to the promoters of Hh-responsive genes (reviewed in Briscoe and Therond, 2013).  In addition to PTCH, three additional membrane proteins have been shown to bind Hh and to be required for Hh-dependent signaling in vertebrates: CDON (CAM-related/downregulated by oncogenes), BOC (brother of CDO) and GAS1 (growth arrest specific 1) (Yao et al, 2006; Okada et al, 2006; Tenzen et al, 2006; McLellan et al, 2008; reviewed in Kang et al, 2007; Beachy et al, 2010; Sanchez-Arrones et al, 2012).  CDON and BOC, homologues of Drosophila Ihog and Boi respectively, are evolutionarily conserved transmembrane glycoproteins that have been shown to bind both to Hh ligand and to the canonical receptor PTCH to promote Hh signaling (Okada et al, 2006; Yao et al, 2006; Tenzen et al, 2006, McLellan et al, 2008; Izzi et al, 2011; reviewed in Sanchez-Arrones et al, 2012).  Despite the evolutionary conservation, the mode of ligand binding by CDON/Ihog and BOC/Boi is distinct in vertebrates and invertebrates.  High affinity ligand-binding by CDON and BOC requires Ca2+, while invertebrate ligand-binding is heparin-dependent (Okada et al, 2006; Tenzen et al, 2006; McLellan et al, 2008; Yao et al, 2006; Kavran et al, 2010). GAS1 is a vertebrate-specific GPI-anchored protein that similarly binds both to Hh ligand and to the PTCH receptor to promote Hh signaling (Martinelli and Fan, 2007; Izzi et al, 2011; reviewed in Kang et al, 2007).  CDON, BOC and GAS1 have partially overlapping but not totally redundant roles, and knock-out of all three is required to abrogate Hh signaling in mice (Allen et al, 2011; Izzi et al, 2011; reviewed in Briscoe and Therond, 2013). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction141">
 <bp:evidence rdf:resource="#Evidence164" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">mTORC1 phosphorylates AKT1S1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep354">
 <bp:stepProcess rdf:resource="#BiochemicalReaction310" />
 <bp:stepProcess rdf:resource="#Catalysis137" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway247">
 <bp:pathwayOrder rdf:resource="#PathwayStep2071" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2050" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2025" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2031" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2075" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2086" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2034" />
 <bp:pathwayComponent rdf:resource="#Pathway250" />
 <bp:pathwayComponent rdf:resource="#Pathway261" />
 <bp:pathwayComponent rdf:resource="#Pathway258" />
 <bp:pathwayComponent rdf:resource="#Pathway257" />
 <bp:pathwayComponent rdf:resource="#Pathway249" />
 <bp:pathwayComponent rdf:resource="#Pathway248" />
 <bp:pathwayComponent rdf:resource="#Pathway253" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2025" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p75 NTR receptor-mediated signalling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Besides signalling through the tyrosine kinase receptors TRK A, B, and C, the mature neurotrophins NGF, BDNF, and NT3/4 signal through their common receptor p75NTR. NGF binding to p75NTR activates a number of downstream signalling events controlling survival, death, proliferation, and axonogenesis, according to the cellular context. p75NTR is devoid of enzymatic activity, and signals by recruiting other proteins to its own intracellular domain. p75 interacting proteins include NRIF, TRAF2, 4, and 6, NRAGE, necdin, SC1, NADE, RhoA, Rac, ARMS, RIP2, FAP and PLAIDD. Here we annotate only the proteins for which a clear involvement in p75NTR signalling was demonstrated. A peculiarity of p75NTR is the ability to bind the pro-neurotrophins proNGF and proBDNF. Proneurotrophins do not associate with TRK receptors, whereas they efficiently signal cell death by apoptosis through p75NTR. The biological action of neurotrophins is thus regulated by proteolytic cleavage, with proforms preferentially activating p75NTR, mediating apoptosis, and mature forms activating TRK receptors, to promote survival. Moreover, the two receptors are utilised to differentially modulate neuronal plasticity. For instance, proBDNF-p75NTR signalling  facilitates LTD, long term depression, in the hippocampus (Woo NH, et al, 2005), while BDNF-TRKB signalling promotes LTP (long term potentiation). Many biological observations indicate  a functional interaction between p75NTR and TRKA signaling pathways.  </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction140">
 <bp:evidence rdf:resource="#Evidence163" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AMPK is dephosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep355">
 <bp:stepProcess rdf:resource="#BiochemicalReaction311" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway246">
 <bp:pathwayOrder rdf:resource="#PathwayStep2096" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2024" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2159" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2089" />
 <bp:pathwayComponent rdf:resource="#Pathway263" />
 <bp:pathwayComponent rdf:resource="#Pathway262" />
 <bp:pathwayComponent rdf:resource="#Pathway247" />
 <bp:pathwayComponent rdf:resource="#Pathway268" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2024" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Death Receptor Signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The death receptors (DR), all cell-surface receptors, that belong to the TNF receptor superfamily (TNFRSF). The term death receptor refers to those members of the TNFRSF that contain a &quot;death domain&quot; (DD) within their cytoplasmic tail which provides the capacity for protein&#8211;protein interactions with other DD-containing proteins suach as FADD. The main signals transmitted from TNF death receptors such as TNFR1, TRAIL-R, and CD95/FAS in response to their cognate ligand binding result in an apoptotic signaling pathway characterized by direct activation of intracellular cysteine proteases (caspases), without directly involving the mitochondrial death pathway. However, these death receptors have also been shown to initiate survival signals via the activation of transcription factors NF&#954;appaB and AP1. This project describes an assembly of the death-inducing signaling complex (DISC) downstream of TNFR1, TRAIL-R, and CD95/FAS and shows protein composition and stoichiometry within the DISC. However, the DISC signaling complex may vary in its components stoichiometry. DR signaling may trigger formation of higher order receptor structures or signaling through rearrangement of receptor chains, which is not reflected here. The project also describes neuron-type-specific signaling by the p75NTR death receptor (also known as NGFR) that can regulate a number of different biological activities in response to ligand binding, including cell death and/or survival, axonal growth and synaptic plasticity.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction143">
 <bp:evidence rdf:resource="#Evidence166" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of active mTORC1 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep352">
 <bp:stepProcess rdf:resource="#Catalysis136" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction308" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway249">
 <bp:pathwayOrder rdf:resource="#PathwayStep2032" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2033" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1785" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1784" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2032" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NFG and proNGF binds to p75NTR</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">When the co-receptor sortilin is present at the cell surface, proNGF preferentially interacts with a p75NTR:sortilin complex. Thus, proNGF, which does not bind TRKA, discriminates between TRKA and p75NTR, in cells that express both receptors. The same is true for proBDNF. Pro-neurotrophin binding to p75NTR:sortilin activates an apoptotic cascade, which may be involved in cell death after injury, and in neurodegenerative diseases such as Alzheimer&apos;s dementia.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction142">
 <bp:evidence rdf:resource="#Evidence165" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated AKT1S1:mTORC1 binds YWHAB</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep353">
 <bp:stepProcess rdf:resource="#BiochemicalReaction309" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway248">
 <bp:pathwayOrder rdf:resource="#PathwayStep2030" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2028" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2029" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2026" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2027" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1783" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1782" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1781" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1780" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1779" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2026" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulated proteolysis of p75NTR</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p75NTR undergoes a process of regulated intramembrane proteolysis (RIP) similar to other transmembrane proteins such as NOTCH, beta-amyloid precursor protein (APP), and ERBB4. Each of these proteins is subjected  to two sequential cleavages. The first one occurs in the extracellular part of the protein and is mediated by the metalloproteinase alpha-secretase which causes shedding of the extracellular domain. The second cleavage occurs in the intramembrane region and is mediated by gamma-secretase and causes release of the intracellular domain, ICD, and of a small peptide. The ICD often traffics to the nucleus and, in some instances (e.g. NOTCH), was found to act as  transcriptional regulator. Whether the p75NTR ICD does translocate to the nucleus to regulate gene expression in a way similar to the NOTCH receptor remains to be seen. The alpha- and gamma-secretase mediated cleavage of p75 appears to be regulated by neurotrophin (NGF, BDNF) binding to TRKA or TRKB. p75NTR processing also occurs in response to MAG in cerebellar granule neurons.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep350">
 <bp:stepProcess rdf:resource="#BiochemicalReaction306" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence559">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway243">
 <bp:pathwayOrder rdf:resource="#PathwayStep1998" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1997" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1999" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2000" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2001" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1755" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1759" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1758" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1757" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1756" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1997" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GLI3 is processed to GLI3R by the proteasome</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In the absence of Hh signaling, the majority of full-length GLI3 is partially processed by the proteasome to a shorter form that serves as the principal repressor of Hh target genes (Wang et al, 2000).  Processing depends on phosphorylation at 6 sites by PKA, which primes the protein for subsequent phosphorylation at adjacent sites by CK1 and GSK3.  The hyperphosphorylated protein is then a direct target for betaTrCP-dependent ubiquitination and proteasome-dependent processing (Wang and Li, 2006; Tempe et al, 2006; Wen et al, 2010; Schrader et al, 2011; Pan and Wang, 2007).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep351">
 <bp:stepProcess rdf:resource="#BiochemicalReaction307" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway242">
 <bp:pathwayOrder rdf:resource="#PathwayStep1996" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1995" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2006" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2007" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1989" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2008" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1988" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1990" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2002" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2003" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2014" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2004" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2005" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1994" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1993" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2021" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1992" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2022" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1991" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1777" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1754" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1765" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1753" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1764" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1752" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1763" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1751" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1762" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1750" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1761" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1760" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1749" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1748" />
 <bp:pathwayComponent rdf:resource="#Pathway243" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1747" />
 <bp:pathwayComponent rdf:resource="#Pathway245" />
 <bp:pathwayComponent rdf:resource="#Pathway244" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1778" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1988" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hedgehog &apos;off&apos; state</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hedgehog is a secreted morphogen that has evolutionarily conserved roles in body organization by regulating the activity of the Ci/Gli transcription factor family. In Drosophila in the absence of Hh signaling, full-length Ci is partially degraded by the proteasome to generate a truncated repressor form that translocates to the nucleus to represses Hh-responsive genes. Binding of Hh ligand to the Patched (PTC) receptor allows the 7-pass transmembrane protein Smoothened (SMO) to be activated in an unknown manner, disrupting the partial proteolysis of Ci and allowing the full length activator form to accumulate (reviewed in Ingham et al, 2011; Briscoe and Therond, 2013).   While many of the core components of Hh signaling are conserved from flies to humans, the pathways do show points of significant divergence. Notably, the human genome encodes three Ci homologues, GLI1, 2 and 3 that each play slightly different roles in regulating Hh responsive genes. GLI3 is the primary repressor of Hh signaling in vertebrates, and is converted to the truncated GLI3R repressor form in the absence of Hh. GLI2 is a potent activator of transcription in the presence of Hh but contributes only minimally to the repression function. While a minor fraction of GLI2 protein is processed into the repressor form in the absence of Hh, the majority is either fully degraded by the proteasome or sequestered in the full-length form in the cytosol by protein-protein interactions. GLI1 lacks the repression domain and appears to be an obligate transcriptional activator (reviewed in Briscoe and Therond, 2013).  Vertebrate but not fly Hh signaling also depends on the movement of pathway components through the primary cilium. The primary cilium is a non-motile microtubule based structure whose construction and maintenance depends on intraflagellar transport (IFT). Anterograde IFT moves molecules from the ciliary base along the axoneme to the ciliary tip in a manner that requires the microtubule-plus-end directed kinesin KIF3 motor complex and the IFT-B protein complex, while retrograde IFT back to the ciliary base depends on the minus-end directed dynein motor and the IFT-A complex. Genetic screens have identified a number of cilia-related proteins that are required both to maintain Hh in the &apos;off&apos; state and to transduce the signal when the pathway is activated (reviewed in Hui and Angers, 2011; Goetz and Anderson, 2010).    </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway245">
 <bp:pathwayOrder rdf:resource="#PathwayStep2017" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2018" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2019" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2015" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2016" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2020" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1776" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1775" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1774" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1773" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1772" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1771" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2015" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Degradation of GLI1 by the proteasome</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GLI1 is the most divergent of the 3 mammalian GLI transcription factors and lacks a transcriptional repressor domain.  Although GLI1 is dispensible for development, the gene is an early transcriptional target of Hh signaling and the protein contributes a minor activation function in mammals (Dai et al, 1999; Bai et al, 2002; Park et al, 2000). In the absence of Hh signaling, GLI1 is completely degraded by the proteasome, in contrast to the partial processing that occurs with GLI3. This differential response reflects the absence in GLI1 of two of the three elements identified in GLI3 that promote partial proteolysis; these are the zinc finger region, present in all GLI proteins, and an adjacent linker sequence and the degron, neither of which are found in the GLI1 protein (Schrader et al, 2011; Pan and Wang, 2007).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway244">
 <bp:pathwayOrder rdf:resource="#PathwayStep2009" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2013" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2010" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2011" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2012" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1766" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1770" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1769" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1768" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1767" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2009" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Degradation of GLI2 by the proteasome</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The primary role of the GLI2 protein is as an activator of Hh-dependent signaling upon pathway stimulation; in the absence of Hh ligand, a small fraction of GLI2 appears to be processed to a repressor form, but the bulk of the protein is completely degraded by the proteasome (reviewed in Briscoe and Therond, 2013).  Both the processing and the degradation of GLI2 is dependent upon sequential phosphorylation of multiple serine residues by PKA, CK1 and GSK3, analagous to the requirement for these kinases in the processing of GLI3 (Pan et al, 2009; Pan et al, 2006; Pan and Wang, 2007).  The differential processing of GLI2 and GLI3 depends on the processing determinant domain (PDD) in the C-terminal of the proteins, which directs the partial proteolysis of GLI3 in the absence of Hh signal.  Substitution of 2 amino-acids from GLI3 into the GLI2 protein is sufficient to promote efficient processing of GLI2 to the repressor form (Pan and Wang, 2007).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction149">
 <bp:evidence rdf:resource="#Evidence176" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated STAT3 Dimer Translocates to the Nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence544">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction148">
 <bp:evidence rdf:resource="#Evidence172" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of TSC2 by PKB</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence545">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep349">
 <bp:stepProcess rdf:resource="#BiochemicalReaction305" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence546">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1479">
 <bp:stepProcess rdf:resource="#Pathway193" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence547">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1478">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1287" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction145">
 <bp:evidence rdf:resource="#Evidence168" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT1S1 (PRAS40) binds mTORC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep347">
 <bp:stepProcess rdf:resource="#BiochemicalReaction304" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence540">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway229">
 <bp:pathwayOrder rdf:resource="#PathwayStep1866" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1865" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1864" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1869" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1868" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1867" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1641" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1640" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1639" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1638" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1637" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1636" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1864" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Negative regulation of NOTCH4 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH4 signaling can be negatively regulated at the level of nuclear translocation of the NOTCH4 intracellular domain fragment (NICD4). AKT-mediated phosphorylation of NICD4 promotes binding of NICD4 with 14-3-3-zeta (YWHAZ), leading to retention of NICD4 in the cytosol (Ramakrishnan et al. 2015).  The E3 ubiquitin ligase FBXW7, a component of the SCF ubiquitin ligase complex, binds to and ubiquitinates phosphorylated NICD4, targeting it for proteasome-mediated degradation (Wu et al. 2001). The level of NICD4 is significantly increased in Fbxw7 knockout mouse embryos, which die in utero and have impaired development of the vascular system (Tsunematsu et al. 2004).  Binding of NOTCH4 to ELOC (elongin C) is involved in proteasome-mediated degradation of NOTCH4, but the exact mechanism has not been elucidated (Cummins et al. 2011). MDM2, a TP53-induced ubiquitin ligase, was reported to ubiquitinate NICD4 and target it for degradation in response to TP53 activation (Sun et al. 2011).  NOTCH4 signaling is inhibited by binding of NICD4 to the transforming acidic coiled-coil protein-3, but he mechanism is not known (Bargo et al. 2010).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction144">
 <bp:evidence rdf:resource="#Evidence167" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Rag dimer formation</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep348">
 <bp:stepProcess rdf:resource="#Pathway45" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence541">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway228">
 <bp:pathwayOrder rdf:resource="#PathwayStep1863" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1880" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1870" />
 <bp:pathwayComponent rdf:resource="#Pathway230" />
 <bp:pathwayComponent rdf:resource="#Pathway229" />
 <bp:pathwayComponent rdf:resource="#Pathway231" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1863" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by NOTCH4</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The NOTCH4 gene locus was discovered as a frequent site of insertion for the proviral genome of the mouse mammary tumor virus (MMTV) (Gallahan and Callahan 1987). MMTV-insertion results in aberrant expression of the mouse mammary tumor gene int-3, which was subsequently discovered to represent the intracellular domain of Notch4 (Robbins et al. 1992, Uyttendaele et al. 1996).  NOTCH4 is prevalently expressed in endothelial cells (Uyttendaele et al. 1996). DLL4 and JAG1 act as ligands for NOTCH4 in human endothelial cells (Shawber et al. 2003, Shawber et al. 2007), but DLL4- and JAG1-mediated activation of NOTCH4 have not been confirmed in all cell types tested (Aste-Amezaga et al. 2010, James et al. 2014). The gamma secretase complex cleaves activated NOTCH4 receptor to release the intracellular domain fragment (NICD4) (Saxena et al. 2001, Das et al. 2004). NICD4 traffics to the nucleus where it acts as a transcription factor and stimulates expression of NOTCH target genes HES1, HES5, HEY1 and HEY2, as well as VEGFR3 and ACTA2 (Lin et al. 2002, Raafat et al.2004, Tsunematsu et al. 2004, Shawber et al. 2007, Tang et al. 2008, Bargo et al. 2010). NOTCH4 signaling can be downregulated by AKT1 phosphorylation-induced cytoplasmic retention (Ramakrishnan et al. 2015) as well as proteasome-dependent degradation upon FBXW7-mediated ubiquitination (Wu et al. 2001, Tsunematsu et al. 2004).  NOTCH4 was reported to inhibit NOTCH1 signaling in-cis, by binding to NOTCH1 and interfering with the S1 cleavage of NOTCH1, thus preventing production of functional NOTCH1 heterodimers at the cell surface (James et al. 2014).  NOTCH4 is involved in development of the vascular system. Overexpression of constitutively active Notch4 in mouse embryonic vasculature results in abnormal vessel structure and patterning (Uyttendaele et al. 2001). NOTCH4 may act to inhibit apoptosis of endothelial cells (MacKenzie et al. 2004).  Expression of int-3 interferes with normal mammary gland development in mice and promotes tumorigenesis. The phenotype of mice expressing int-3 in mammary glands is dependent on the presence of Rbpj (Raafat et al. 2009). JAG1 and NOTCH4 are upregulated in human ER+ breast cancers resistant to anti-estrogen therapy, which correlates with elevated expression of NOTCH target genes HES1, HEY1 and HEY2,  and is associated with increased population of breast cancer stem cells and distant metastases (Simoes et al. 2015). Development of int-3-induced mammary tumours  in mice depends on Kit and Pdgfra signaling (Raafat et al. 2006) and on int-3-induced activaton of NFKB signaling (Raafat et al. 2017). In head and neck squamous cell carcinoma (HNSCC), high NOTCH4 expression correlates with elevated HEY1 levels, increased cell proliferation and survival, epithelial-to-mesenchymal transition (EMT) phenotype and cisplatin resistance (Fukusumi et al. 2018). In melanoma, however, exogenous NOTCH4 expression correlates with mesenchymal-to-epithelial-like transition and reduced invasiveness (Bonyadi Rad et al. 2016). NOTCH4 is frequently overexpressed in gastric cancer. Increased NOTCH4 levels correlate with activation of WNT signaling and gastric cancer progression (Qian et al. 2015).  NOTCH4 is expressed in adipocytes and may promote adipocyte differentiation (Lai et al. 2013).  During Dengue virus infection, DLL1, DLL4, NOTCH4 and HES1 are upregulated in interferon-beta (INFB) dependent manner (Li et al. 2015). NOTCH4 signaling may be affected by Epstein-Barr virus (EBV) infection, as the EBV protein BARF0 binds to NOTCH4 (Kusano and Raab-Traub 2001). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction147">
 <bp:evidence rdf:resource="#Evidence171" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of complexed TSC2 by PKB</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep345">
 <bp:stepProcess rdf:resource="#BiochemicalReaction302" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence542">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction146">
 <bp:evidence rdf:resource="#Evidence169" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SLC38A9 transports L-Arg from lysosomal lumen to cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep346">
 <bp:stepProcess rdf:resource="#BiochemicalReaction303" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence543">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1473">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1283" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2297">
 <bp:evidence rdf:resource="#Evidence2631" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDC42:GTP binds PAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1472">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1282" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2296">
 <bp:evidence rdf:resource="#Evidence2630" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">VEGFA-165 dimer binds VEGFR2 dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1471">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1281" />
 <bp:stepProcess rdf:resource="#Catalysis399" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2295">
 <bp:evidence rdf:resource="#Evidence2629" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK2beta binds alphaVbeta3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1470">
 <bp:stepProcess rdf:resource="#Catalysis398" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1280" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2294">
 <bp:evidence rdf:resource="#Evidence2628" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PXN binds p-6Y,S732-PTK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1477">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1286" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2293">
 <bp:evidence rdf:resource="#Evidence2627" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DOCK180:ELMO exchanges GTP for GDP, activating RAC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1476">
 <bp:stepProcess rdf:resource="#Pathway192" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2292">
 <bp:evidence rdf:resource="#Evidence2626" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NADPH oxidase 2 generates superoxide from oxygen</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1475">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1285" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2291">
 <bp:evidence rdf:resource="#Evidence2625" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">VEGFR2 autophosphorylates</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1474">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1284" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2290">
 <bp:evidence rdf:resource="#Evidence2624" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PAK2 binds NCK</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway230">
 <bp:pathwayOrder rdf:resource="#PathwayStep1877" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1876" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1875" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1874" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1879" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1878" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1873" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1872" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1871" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1645" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1644" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1643" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1642" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1650" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1649" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1648" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1647" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1646" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1871" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH4 Intracellular Domain Regulates Transcription</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In the nucleus, NOTCH4 intracellular domain fragment (NICD4) binds transcription factors RBPJ (CSL) and mastermind family members (MAML1, MAML2 or MAML3) to form the NOTCH4 co-activator complex (Lin et al. 2002). The NOTCH4 coactivator complex stimulates transcription of well-established NOTCH targets HES1, HES5, HEY1 and HEY2 in a cellular context-dependent manner (Lin et al. 2002, Raafat et al.2004, Tsunematsu et al. 2004, Bargo et al. 2010). NOTCH4 also stimulates transcription of the FLT4 (VEGFR3) gene, encoding vascular endothelial growth factor receptor-3 (Shawber et al. 2007) and ACTA2 gene, encoding smooth muscle alpha actin (Tang et al. 2008).  NICD4 inhibits TGF-beta-induced SMAD-mediated transcription via binding of NICD4 to TGF-beta activated SMAD3 (Sun et al. 2005, Grabias and Konstantopoulos 2013).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep1480">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1288" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2299">
 <bp:evidence rdf:resource="#Evidence2633" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">VEGFA-165 dimer binds VEGFA inhibitors</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2298">
 <bp:evidence rdf:resource="#Evidence2632" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SRC-1 phosphorylates SHB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction152">
 <bp:evidence rdf:resource="#Evidence179" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6 phosphorylates STAP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep343">
 <bp:stepProcess rdf:resource="#BiochemicalReaction300" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway236">
 <bp:pathwayOrder rdf:resource="#PathwayStep1943" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1942" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1930" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1941" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1940" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1936" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1945" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1944" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1939" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1938" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1937" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1700" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1709" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1708" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1707" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1706" />
 <bp:pathwayComponent rdf:resource="#Pathway237" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1705" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1704" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1703" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1702" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1701" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1930" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hedgehog ligand biogenesis</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Mammalian genomes encode three Hedgehog ligands, Sonic Hedgehog (SHH), Indian Hedgehog (IHH) and Desert Hedgehog (DHH).  These secreted morphogens can remain associated with lipid rafts on the surface of the secreting cell and affect developmental processes in adjacent cells. Alternatively, they can be released by proteolysis or packaging into vesicles or lipoprotein particles and dispersed to act on distant cells. SHH activity is required for organization of the limb bud, notochord and neural plate, IHH regulates bone and cartilage development and is partially redundant with SHH, and DHH contributes to germ cell development in the testis and formation of the peripheral nerve sheath (reviewed in Pan et al, 2013).    Despite divergent biological roles, all Hh ligands are subject to proteolytic processing and lipid modification during transit to the surface of the secreting cell (reviewed in Gallet, 2011).  Precursor Hh undergoes autoproteolytic cleavage mediated by the C-terminal region to yield an amino-terminal peptide Hh-Np (also referred to as Hh-N) (Chen et al, 2011).  No other well defined role for the C-terminal region of Hh has been identified, and the secreted Hh-Np is responsible for all Hh signaling activity.  Hh-Np is modified with cholesterol and palmitic acid during transit through the secretory system, and both modifications contribute to the activity of the ligand (Porter et al, 1996; Pepinsky et al, 1998; Chamoun et al, 2001).    At the cell surface, Hh-Np remains associated with the secreting cell membrane by virtue of its lipid modifications, which promote clustering of Hh-Np into lipid rafts (Callejo et al, 2006; Peters et al, 2004).  Long range dispersal of Hh-Np depends on the untethering of the ligand from the membrane through a variety of mechanisms.  These include release of monomers through the combined activity of the transmembrane protein Dispatched (DISP2) and the secreted protein SCUBE2, assembly into soluble multimers or apolipoprotein particles or release on the surface of exovesicles (Vyas et al, 2008; Tukachinsky et al, 2012; Chen 2004; Zeng et al, 2001; reviewed in Briscoe and Therond, 2013).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction151">
 <bp:evidence rdf:resource="#Evidence178" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated STAT3 Forms Dimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep344">
 <bp:stepProcess rdf:resource="#BiochemicalReaction301" />
 <bp:stepProcess rdf:resource="#Catalysis135" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway235">
 <bp:pathwayOrder rdf:resource="#PathwayStep1987" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1946" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1929" />
 <bp:pathwayComponent rdf:resource="#Pathway236" />
 <bp:pathwayComponent rdf:resource="#Pathway238" />
 <bp:pathwayComponent rdf:resource="#Pathway242" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1929" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by Hedgehog</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hedgehog (Hh) is a secreted morphogen that regulates developmental processes in vertebrates including limb bud formation, neural tube patterning, cell growth and differentiation (reviewed in Hui and Angers, 2011).  Hh signaling also contributes to stem cell homeostasis in adult tissues.  Downregulation of Hh signaling can lead to neonatal abnormalities, while upregulation of signaling is associated with the development of various cancers (Beachy et al, 2004; Jiang and Hui, 2008; Hui and Angers, 2011).  Hh signaling is switched between &apos;off&apos; and an &apos;on&apos; states to differentially regulate an intracellular signaling cascade that targets the Gli transcription factors.  In the absence of Hh ligand, cytosolic Gli proteins are cleaved to yield a truncated form that translocates into the nucleus and represses target gene transcription.  Binding of Hh to the Patched (PTC) receptor on the cell surface stabilizes the Gli proteins in their full-length transcriptional activator form, stimulating Hh-dependent gene expression (reviewed in Hui and Angers, 2011; Briscoe and Therond, 2013).  </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction154">
 <bp:evidence rdf:resource="#Evidence181" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT3 stimulates SOCS3 expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep341">
 <bp:stepProcess rdf:resource="#Catalysis133" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction298" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway238">
 <bp:pathwayOrder rdf:resource="#PathwayStep1965" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1953" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1964" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1986" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1952" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1963" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1985" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1962" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1984" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1947" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1958" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1969" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1968" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1967" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1966" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1961" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1983" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1960" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1982" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1970" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1981" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1980" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1959" />
 <bp:pathwayComponent rdf:resource="#Pathway239" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1722" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1744" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1721" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1743" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1720" />
 <bp:pathwayComponent rdf:resource="#Pathway241" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1742" />
 <bp:pathwayComponent rdf:resource="#Pathway240" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1730" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1741" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1740" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1719" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1729" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1728" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1727" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1726" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1714" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1725" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1724" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1746" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1723" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1745" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1947" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hedgehog &apos;on&apos; state</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hedgehog is a secreted morphogen that has evolutionarily conserved roles in body organization by regulating the activity of the Ci/Gli transcription factor family. In Drosophila in the absence of Hh signaling, full-length Ci is partially degraded by the proteasome to generate a truncated repressor form that translocates to the nucleus to represses Hh-responsive genes. Binding of Hh ligand to the Patched (PTC) receptor allows the 7-pass transmembrane protein Smoothened (SMO) to be activated in an unknown manner, disrupting the partial proteolysis of Ci and allowing the full length activator form to accumulate (reviewed in Ingham et al, 2011; Briscoe and Therond, 2013).   While many of the core components of Hh signaling are conserved from flies to humans, the pathways do show points of significant divergence. Notably, the human genome encodes three Ci homologues, GLI1, 2 and 3 that each play slightly different roles in regulating Hh responsive genes. GLI3 is the primary repressor of Hh signaling in vertebrates, and is converted to the truncated GLI3R repressor form in the absence of Hh. GLI2 is a potent activator of transcription in the presence of Hh but contributes only minimally to the repression function. While a minor fraction of GLI2 protein is processed into the repressor form in the absence of Hh, the majority is either fully degraded by the proteasome or sequestered in the full-length form in the cytosol by protein-protein interactions. GLI1 lacks the repression domain and appears to be an obligate transcriptional activator (reviewed in Briscoe and Therond, 2013).  Vertebrate but not fly Hh signaling also depends on the movement of pathway components through the primary cilium. The primary cilium is a non-motile microtubule based structure whose construction and maintenance depends on intraflagellar transport (IFT). Anterograde IFT moves molecules from the ciliary base along the axoneme to the ciliary tip in a manner that requires the microtubule-plus-end directed kinesin KIF3 motor complex and the IFT-B protein complex, while retrograde IFT back to the ciliary base depends on the minus-end directed dynein motor and the IFT-A complex. Genetic screens have identified a number of cilia-related proteins that are required both to maintain Hh in the &apos;off&apos; state and to transduce the signal when the pathway is activated (reviewed in Hui and Angers, 2011; Goetz and Anderson, 2010).    </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction153">
 <bp:evidence rdf:resource="#Evidence180" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SOCS3 binds activated PTK6</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep342">
 <bp:stepProcess rdf:resource="#Catalysis134" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction299" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway237">
 <bp:pathwayOrder rdf:resource="#PathwayStep1932" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1931" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1935" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1934" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1933" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1699" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1698" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1697" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1696" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1695" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1931" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Release of Hh-Np from the secreting cell</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cholesterol and palmitoyl-modification of Hh-Np render the ligand highly hydrophobic and results in its close association with the plasma membrane of the producing cell after secretion.  Hh-Np tethered in this way may cluster in sterol-rich lipid rafts where it is competent for short-range signaling.  Cell surface Hh-Np also interacts with glypican components of the extracellular matrix and this interaction stabilizes the ligand and is required for its lateral spread.  Together, clustering into lipid rafts and interaction with HSPGs may favour packaging of ligand into higher order forms required for ligand dispersal.  Long-range signaling requires release of Hh-Np from the secreting cell.  Release is achieved through a number of possibly overlapping mechanisms.  These include oligomerization into micelle-like structures, packaging into lipoprotein particles and interaction with cholesterol-binding adaptor proteins such as DISP and SCUBE2.  In addition, Hh-Np can be released from the plasma membrane through proteolytic cleavage: NOTUM is a secreted enzyme that is thought to promote the release of Hh-Np by cleaving the GPI anchor of Hh-associated glypicans, while the transmembrane metalloprotease ADAM17 promotes long-range Hh signaling by removing the palmitoyl- and cholesterol-modified N- and C-termini of the membrane-associated ligand.  How all these mechanisms are coordinated remains to be elucidated (reviewed in Briscoe and Therond, 2013; Gallet, 2011).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence548">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway232">
 <bp:pathwayOrder rdf:resource="#PathwayStep1887" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1906" />
 <bp:pathwayComponent rdf:resource="#Pathway234" />
 <bp:pathwayComponent rdf:resource="#Pathway233" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1887" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by NOTCH1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH1 functions as both a transmembrane receptor presented on the cell surface and as a transcriptional regulator in the nucleus.  NOTCH1 receptor presented on the plasma membrane is activated by a membrane bound ligand expressed in trans on the surface of a neighboring cell. In trans, ligand binding triggers proteolytic cleavage of NOTCH1 and results in release of the NOTCH1 intracellular domain, NICD1, into the cytosol.  NICD1 translocates to the nucleus where it associates with RBPJ (also known as CSL or CBF) and mastermind-like (MAML) proteins (MAML1, MAML2 or MAML3; possibly also MAMLD1) to form NOTCH1 coactivator complex. NOTCH1 coactivator complex activates transcription of genes that possess RBPJ binding sites in their promoters.   </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep340">
 <bp:stepProcess rdf:resource="#Pathway44" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence549">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway231">
 <bp:pathwayOrder rdf:resource="#PathwayStep1885" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1884" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1883" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1882" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1881" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1655" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1654" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1653" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1652" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1651" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1881" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH4 Activation and Transmission of Signal to the Nucleus</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH4 is co-expressed with DLL4 (Delta-4) and JAG1 (Jagged-1) in the vascular system (Shutter et al. 2000, Uyttendaele et al. 2000). NOTCH4 can be activated by DLL4 and JAG1 when HMVECd cells (human primary endothelial cell line derived from neonatal dermal microvasculature) or HUVEC cells (human umbilical venous endothelial cell line) expressing recombinant mouse Notch4 are co-cultured with HMVECd or HUVEC cells expressing recombinant human or mouse DLL4 (Shawber et al. 2003, Shawber et al. 2007) or mouse Jag1 (Shawber et al. 2007). Activation of NOTCH4 by DLL4 and JAG1 could not be reproduced when the mouse fibroblast cell line NIH 3T3 or human embryonic kidney cell line HEK293 was transduced with Notch4- or either Dll4- or Jag1-expressing vectors and used in co-culture experiments (Aste-Amezaga et al. 2010, James et al. 2014).  Signaling by NOTCH4, similar to other NOTCH family proteins, involves proteolytic cleavage of the membrane-bound NOTCH4 receptor and release of the NOTCH4 intracellular domain fragment (NICD4) into the cytosol (Saxena et al. 2001, Das et al. 2004). NICD4 traffics from the cytosol to the nucleus, where it acts as a transcription factor (Lin et al. 2002).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction150">
 <bp:evidence rdf:resource="#Evidence177" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6 phosphorylates STAT3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway234">
 <bp:pathwayOrder rdf:resource="#PathwayStep1910" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1921" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1920" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1914" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1925" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1913" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1924" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1912" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1923" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1911" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1922" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1907" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1918" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1917" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1916" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1927" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1915" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1926" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1909" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1908" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1919" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1681" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1692" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1680" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1691" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1690" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1678" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1689" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1677" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1688" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1676" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1687" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1675" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1686" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1674" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1685" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1684" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1683" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1694" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1682" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1693" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1679" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1907" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated NOTCH1 Transmits Signal to the Nucleus</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Mature NOTCH1 heterodimer on the cell surface is activated by one of its ligands: DLL1 (Cordle et al. 2008, Jarriault et al. 1998), DLL4 (Benedito et al. 2009), JAG1 (Li et al. 1998, Benedito et al. 2009) or JAG2 (Luo et al. 1997, Shimizu et al. 2000), expressed in trans on a neighboring cell. Thus, a ligand-expressing cell is a signal-sending cell, while the NOTCH1 expressing cell is a signal-receiving cell. If NOTCH1 has undergone Fringe modification in the Golgi, it is preferentially activated by Delta ligands (Yang et al. 2005), DLL1 and DLL4.    Upon binding to NOTCH1 on a neighboring cell, NOTCH ligands are ubiquitinated by Mindbomb (MIB1 and MIB2) and/or Neuralized (NEURL and NEURL1B) E3 ubiquitin ligases and endocytosed (Koo et al. 2007, Koo et al. 2005, Itoh et al. 2003, Lai et al. 2001, Koutelou et al. 2008, Song et al. 2006). Endocytosis of ubiquitinated ligands is thought to mechanically stretch the bound NOTCH1 receptor, exposing a cleavage site S2 that is recognized by ADAM10 and/or ADAM17 metalloprotease (van Tetering et al. 2009, Brou et al. 2000, Hartmann et al. 2002, Pan et al. 1997). S2 cleavage of NOTCH1 produces the NEXT1 fragment which is further cleaved at an S3 cleavage site by the gamma-secretase complex, resulting in release of the NOTCH1 intracellular domain (NICD1) into the cytosol (de Strooper et al. 1999, Schroeter et al. 1998, Huppert et al. 2000). NICD1 produced by activation of NOTCH1 in response to in trans presented Delta and Jagged ligands (DLL/JAG) traffics to the nucleus where it acts as a transcription regulator.   NOTCH1 signaling can also be activated by ligands other than DLL1, DLL4, JAG1 and JAG2. CNTN1 (Contactin-1), transiently expressed during central and peripheral nervous system development, activates NOTCH1 and NOTCH2 in trans, promoting oligodendrocyte maturation and myelination (Hu et al. 2003). DNER (Delta and Notch-like epidermal growth factor-related receptor) is a transmembrane protein specifically expressed in dendrites and cell bodies of postmitotic neurons. Activation of NOTCH1 by DNER in trans may play an important role in development of the central nervous system by influencing differentiation of astrocytes (Eiraku et al. 2005). Activation of NOTCH1 by both CNTN1 and DNER is Deltex (DTX)-dependent and results in gamma-secretase mediated release of NICD1. Three members of the Deltex protein family: DTX1, DTX2 and DTX4 possess a domain involved in binding cdc10/ankyrin repeats of NOTCH. DTX proteins are considered as positive regulators of NOTCH signaling, although the exact mechanism has not been elucidated (Matsuno et al. 1998, Kishi et al. 2001).In addition, DTX can mediate downregulation of NOTCH signaling by recruiting non-visual beta-arrestins to NOTCH (Mukherjee et al. 2005), thereby trigerring NOTCH ubiquitination. DTX proteins are negatively regulated by ITCH (AIP4) ubiquitin ligase (Chastagner et al. 2006).  NOTCH1 signaling in the signal-receiving cell can be turned off in cis by expression of NOTCH ligands DLL/JAG (Cordle et al. 2008, Sprinzak et al. 2010), as well as DLK1 (Baladron et al. 2005, Bray et al. 2008). Formation of NOTCH1:ligand complexes in cis prevents interaction of NOTCH1 with ligands expressed in trans, resulting in the inhibition of NOTCH signaling. In the signal-sending cell, NOTCH signaling can be negatively regulated by the protein NUMB, which is asymmetrically distributed during cell division (Rhyu et al. 1994). NUMB recruits ITCH ubiquitin ligase to NOTCH1 and promotes sorting of NOTCH1 through late endosomes for degradation (McGill et al. 2009, Chastagner et al. 2008). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway233">
 <bp:pathwayOrder rdf:resource="#PathwayStep1888" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1899" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1898" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1897" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1896" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1903" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1902" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1901" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1889" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1900" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1891" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1890" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1895" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1894" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1893" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1892" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1905" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1904" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1670" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1656" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1667" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1666" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1665" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1664" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1663" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1662" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1673" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1661" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1672" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1660" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1671" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1659" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1658" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1669" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1657" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1668" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1888" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH1 Intracellular Domain Regulates Transcription</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NICD1 produced by activation of NOTCH1 in response to Delta and Jagged ligands (DLL/JAG) presented in trans, traffics to the nucleus where it acts as a transcription regulator. In the nucleus, NICD1 displaces the NCOR corepressor complex from RBPJ (CSL). When bound to the co-repressor complex that includes NCOR proteins (NCOR1 and NCOR2) and HDAC histone deacetylases, RBPJ (CSL) represses transcription of NOTCH target genes (Kao et al. 1998, Zhou et al. 2000, Perissi et al. 2004, Perissi et al. 2008). Once the co-repressor complex is displaced, NICD1 recruits MAML (mastermind-like) to RBPJ, while MAML recruits histone acetyltransferases EP300 (p300) and PCAF, resulting in formation of the NOTCH coactivator complex that activates transcription from NOTCH regulatory elements. The minimal functional NOTCH coactivator complex that activates transcription from NOTCH regulatory elements is a heterotrimer composed of NICD, MAML and RBPJ (Fryer et al. 2002, Wallberg et al. 2002, Nam et al. 2006).     NOTCH1 coactivator complex is known to activate transcription of HES1 (Jarriault et al. 1995), HES5 (Arnett et al. 2010), HEY genes (Fischer et al. 2004, Leimeister et al. 2000, Maier et al. 2000, Arnett et al. 2010) and MYC (Palomero et al. 2006) and likely regulates transcription of many other genes (Wang et al. 2011). NOTCH1 coactivator complex on any specific regulatory element may involve additional transcriptional regulatory proteins. HES1 binds TLE proteins, forming an evolutionarily conserved transcriptional corepressor involved in regulation of neurogenesis, segmentation and sex determination (Grbavec et al. 1996, Fisher et al. 1996, Paroush et al. 1994).   After NOTCH1 coactivator complex is assembled on a NOTCH-responsive promoter, MAML (mastermind-like) recruits CDK8 in complex with cyclin C, triggering phosphorylation of conserved serine residues in TAD and PEST domains of NICD1 by CDK8. Phosphorylated NICD1 is recognized by the E3 ubiquitin ligase FBXW7 which ubiquitinates NICD1, leading to degradation of NICD1 and downregulation of NOTCH1 signaling. FBXW7-mediated ubiquitination and degradation of NOTCH1 depend on C-terminally located PEST domain sequences in NOTCH1 (Fryer et al. 2004, Oberg et al. 2001, Wu et al. 2001). The PEST domain of NOTCH1 and the substrate binding WD40 domain of FBXW7 are frequent targets of mutations in T-cell acute lymphoblastic leukemia - T-ALL (Welcker and Clurman 2008).    NICD1, which normally has a short half-life, can be stabilized by binding to the hypoxia-inducable factor 1-alpha (HIF1A) which accumulates in the nucleus when oxygen levels are low. This results in HIF1A-induced inhibition of cellular differentiation that is NOTCH-dependent (Gustafsson et al. 2005).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction116">
 <bp:evidence rdf:resource="#Evidence136" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Calmodulin activates Cam-PDE 1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence533">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1448">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1258" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction115">
 <bp:evidence rdf:resource="#Evidence134" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKA catalytic subunit translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence534">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1447">
 <bp:stepProcess rdf:resource="#Catalysis385" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1257" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction118">
 <bp:evidence rdf:resource="#Evidence138" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKC phosphorylates GRK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep338">
 <bp:stepProcess rdf:resource="#BiochemicalReaction296" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence535">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1446">
 <bp:stepProcess rdf:resource="#Catalysis384" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1256" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction117">
 <bp:evidence rdf:resource="#Evidence137" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">cAMP hydrolysis by Cam-PDE 1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep339">
 <bp:stepProcess rdf:resource="#Catalysis132" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction297" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence536">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1445">
 <bp:stepProcess rdf:resource="#Pathway191" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction112">
 <bp:evidence rdf:resource="#Evidence131" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Adenylate cyclase produces cAMP</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep336">
 <bp:stepProcess rdf:resource="#BiochemicalReaction294" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway218">
 <bp:pathwayOrder rdf:resource="#PathwayStep1767" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1766" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1765" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1764" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1768" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1763" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1762" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1761" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1760" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1546" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1545" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1544" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1543" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1551" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1550" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1549" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1548" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1547" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1760" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH2 intracellular domain regulates transcription</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In the nucleus, NICD2 forms a complex with RBPJ (CBF1, CSL) and MAML (mastermind). NICD2:RBPJ:MAML complex activates transcription from RBPJ-binding promoter elements (RBEs) (Wu et al. 2000). Besides NICD2, RBPJ and MAML, NOTCH2 coactivator complex likely includes other proteins, shown as components of the NOTCH1 coactivator complex.   NOTCH2 coactivator complex directly stimulates transcription of HES1 and HES5 genes (Shimizu et al. 2002), both of which are known NOTCH1 targets.  The promoter of FCER2 (CD23A) contains several RBEs that are occupied by NOTCH2 but not NOTCH1 coactivator complexes, and NOTCH2 activation stimulates FCER2 transcription. Overexpression of FCER2 (CD23A) is a hallmark of B-cell chronic lymphocytic leukemia (B-CLL) and correlates with the malfunction of apoptosis, which is thought be an underlying mechanism of B-CLL development. The Epstein-Barr virus protein EBNA2 can also activate FCER2 transcription through RBEs, possibly by mimicking NOTCH2 signaling (Hubmann et al. 2002).  NOTCH2 coactivator complex occupies the proximal RBE of the GZMB (granzyme B) promoter and at the same time interacts with phosphorylated CREB1, bound to an adjacent CRE site. EP300 transcriptional coactivator is also recruited to this complex through association with CREB1 (Maekawa et al. 2008). NOTCH2 coactivator complex together with CREBP1 and EP300 stimulates transcription of GZMB (granzyme B), which is important for the cytotoxic function of CD8+ T-cells (Maekawa et al. 2008).  There are indications that NOTCH2 genetically interacts with hepatocyte nuclear factor 1-beta (HNF1B) in kidney development (Massa et al. 2013, Heliot et al. 2013) and with hepatocyte nuclear factor 6 (HNF6) in bile duct formation (Vanderpool et al. 2012), but the exact nature of these genetic interactions has not been defined.  </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep2776">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2418" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction111">
 <bp:evidence rdf:resource="#Evidence130" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NBEA binds PRKAR2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep337">
 <bp:stepProcess rdf:resource="#Catalysis131" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction295" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence530">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway217">
 <bp:pathwayOrder rdf:resource="#PathwayStep1756" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1755" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1754" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1753" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1749" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1748" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1747" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1758" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1746" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1757" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1752" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1751" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1750" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1535" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1534" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1533" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1532" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1531" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1542" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1530" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1541" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1540" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1539" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1538" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1537" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1536" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1746" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH2 Activation and Transmission of Signal to the Nucleus</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Similar to NOTCH1, NOTCH2 is activated by Delta-like and Jagged ligands (DLL/JAG) expressed in trans on a neighboring cell (Shimizu et al. 1999, Shimizu et al. 2000, Hicks et al. 2000, Ji et al. 2004). The activation triggers cleavage of NOTCH2, first by ADAM10 at the S2 cleavage site (Gibb et al. 2010, Shimizu et al. 2000), then by gamma-secretase at the S3 cleavage site (Saxena et al. 2001, De Strooper et al. 1999), resulting in the release of the intracellular domain of NOTCH2, NICD2, into the cytosol. NICD2 subsequently traffics to the nucleus where it acts as a transcription regulator.   While DLL and JAG ligands are well established, canonical NOTCH2 ligands, there is limited evidence that NOTCH2, similar to NOTCH1, can be activated by CNTN1 (contactin 1), a protein involved in oligodendrocyte maturation (Hu et al. 2003). MDK (midkine), which plays an important role in epithelial to mesenchymal transition, can also activate NOTCH2 signaling and is able to bind to the extracellular domain of NOTCH2, but the exact mechanism of MDK-induced NOTCH2 activation has not been elucidated (Huang et al. 2008, Gungor et al. 2011).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep2777">
 <bp:stepProcess rdf:resource="#Pathway360" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction114">
 <bp:evidence rdf:resource="#Evidence133" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">cAMP induces dissociation of inactive PKA tetramers</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep334">
 <bp:stepProcess rdf:resource="#BiochemicalReaction292" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence531">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2778">
 <bp:stepProcess rdf:resource="#Pathway361" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction113">
 <bp:evidence rdf:resource="#Evidence132" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">cAMP binds PKA tetramer</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep335">
 <bp:stepProcess rdf:resource="#BiochemicalReaction293" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence532">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1449">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1259" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway219">
 <bp:pathwayOrder rdf:resource="#PathwayStep1770" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1793" />
 <bp:pathwayComponent rdf:resource="#Pathway221" />
 <bp:pathwayComponent rdf:resource="#Pathway220" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1770" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by NOTCH3</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Similar to NOTCH1, NOTCH3 is activated by delta-like and jagged ligands (DLL/JAG) expressed in trans on a neighboring cell. The activation triggers cleavage of NOTCH3, first by ADAM10 at the S2 cleavage site, then by gamma-secretase at the S3 cleavage site, resulting in the release of the intracellular domain of NOTCH3, NICD3, into the cytosol. NICD3 subsequently traffics to the nucleus where it acts as a transcriptional regulator. NOTCH3 expression pattern is more restricted than the expression patterns of NOTCH1 and NOTCH2, with predominant expression of NOTCH3 in vascular smooth muscle cells, lymphocytes and the nervous system (reviewed by Bellavia et al. 2008). Based on the study of Notch3 knockout mice, Notch3 is not essential for embryonic development or fertility (Krebs et al. 2003).  Germline gain-of-function NOTCH3 mutations are an underlying cause of the CADASIL syndrome - cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. CADASIL is characterized by degeneration and loss of vascular smooth muscle cells from the arterial wall, predisposing affected individuals to an early onset stroke (Storkebaum et al. 2011). NOTCH3 promotes survival of vascular smooth muscle cells at least in part by induction of CFLAR (c FLIP), an inhibitor of FASLG activated death receptor signaling. The mechanism of NOTCH3 mediated upregulation of CFLAR is unknown; it is independent of the NOTCH3 coactivator complex and involves an unelucidated crosstalk with the RAS/RAF/MAPK pathway (Wang et al. 2002).  In rat brain, NOTCH3 and NOTCH1 are expressed at sites of adult neurogenesis, such as the dentate gyrus (Irvin et al. 2001). NOTCH3, similar to NOTCH1, promotes differentiation of the rat adult hippocampus derived multipotent neuronal progenitors into astroglia (Tanigaki et al. 2001). NOTCH1, NOTCH2, NOTCH3, and their ligand DLL1 are expressed in neuroepithelial precursor cells in the neural tube of mouse embryos. Together, they signal to inhibit neuronal differentiation of neuroepithelial precursors. Expression of NOTCH3 in mouse neuroepithelial precursors is stimulated by growth factors BMP2, FGF2, Xenopus TGF beta5 - homologous to TGFB1, LIF, and NTF3 (Faux et al. 2001). In mouse telencephalon, NOTCH3, similar to NOTCH1, promotes radial glia and neuronal progenitor phenotype. This can, at least in part be attributed to NOTCH mediated activation of RBPJ-dependent and HES5-dependent transcription (Dang et al. 2006). In mouse spinal cord, Notch3 is involved in neuronal differentiation and maturation. Notch3 knockout mice have a decreased number of mature inhibitory interneurons in the spinal cord, which may be involved in chronic pain conditions (Rusanescu and Mao 2014).  NOTCH3 amplification was reported in breast cancer, where NOTCH3 promotes proliferation and survival of ERBB2 negative breast cancer cells (Yamaguchi et al. 2008), and it has also been reported in ovarian cancer (Park et al. 2006). NOTCH3 signaling is involved in TGF beta (TGFB1) signaling-induced eptihelial to mesenchimal transition (EMT) (Ohashi et al. 2011, Liu et al. 2014)  NOTCH3 indirectly promotes development of regulatory T cells (Tregs). NOTCH3 signaling activates pre-TCR-dependent and PKC-theta (PRKCQ)-dependent NF-kappaB (NFKB) activation, resulting in induction of FOXP3 expression (Barbarulo et al. 2011). Deregulated NOTCH3 and pre-TCR signaling contributes to development of leukemia and lymphoma (Bellavia et al. 2000, Bellavia et al. 2002).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep2779">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2419" />
 <bp:stepProcess rdf:resource="#Catalysis763" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1440">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1251" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2286">
 <bp:evidence rdf:resource="#Evidence2620" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI(3,4,5)P3 binds VAV1,2,3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2772">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2414" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2285">
 <bp:evidence rdf:resource="#Evidence2619" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CRK binds BCAR1 and or PXN</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2773">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2415" />
 <bp:stepProcess rdf:resource="#Catalysis761" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2284">
 <bp:evidence rdf:resource="#Evidence2618" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-6Y-VEGFR2 binds SHC-transforming protein 2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2774">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2416" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2283">
 <bp:evidence rdf:resource="#Evidence2617" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-6Y-VEGFR2 binds FYN</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2775">
 <bp:stepProcess rdf:resource="#Catalysis762" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2417" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1444">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1255" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2282">
 <bp:evidence rdf:resource="#Evidence2616" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active ROCK1,ROCK2 phosphorylates p-5Y-PTK2 on S732</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction119">
 <bp:evidence rdf:resource="#Evidence139" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Calcium binds calmodulin</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1443">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1254" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2281">
 <bp:evidence rdf:resource="#Evidence2615" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NADPH oxidase 2 (NOX2) complex binds RAC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1442">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1253" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2280">
 <bp:evidence rdf:resource="#Evidence2614" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK2/SRC-1 phosphorylates BCAR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2770">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2412" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1441">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1252" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2771">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2413" />
 <bp:stepProcess rdf:resource="#Catalysis760" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2289">
 <bp:evidence rdf:resource="#Evidence2623" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Integrin alphaVbeta3 binds p-6Y-VEGFR2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2288">
 <bp:evidence rdf:resource="#Evidence2622" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">VEGFA dimer:p-6Y-VEGFR2 dimer:PI3K phosphorylates PIP2 to PIP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2287">
 <bp:evidence rdf:resource="#Evidence2621" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Src kinases phosphorylate VAV</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep332">
 <bp:stepProcess rdf:resource="#BiochemicalReaction290" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway225">
 <bp:pathwayOrder rdf:resource="#PathwayStep1822" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1844" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1821" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1843" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1820" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1842" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1841" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1826" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1848" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1825" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1847" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1824" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1846" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1823" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1845" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1840" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1827" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1849" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1852" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1815" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1837" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1851" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1850" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1819" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1818" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1817" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1839" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1816" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1838" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1593" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1592" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1591" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1612" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1599" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1598" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1597" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1596" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1595" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1594" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1619" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1618" />
 <bp:pathwayComponent rdf:resource="#Pathway226" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1617" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1616" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1615" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1614" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1613" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1601" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1623" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1600" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1622" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1621" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1620" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1627" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1626" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1625" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1602" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1624" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1815" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pre-NOTCH Transcription and Translation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string"> In humans, the NOTCH protein family has four members: NOTCH1, NOTCH2, NOTCH3 and NOTCH4. NOTCH1 protein was identified first, as the product of a chromosome 9 gene translocated in T-cell acute lymphoblastic leukemia that was homologous to Drosophila Notch (Ellisen et al. 1991). At the same time, rat Notch1 was cloned (Weinmaster et al. 1991), followed by cloning of mouse Notch1, named Motch (Del Amo et al. 1992). NOTCH2 protein is the product of a gene on chromosome 1 (Larsson et al. 1994). NOTCH2 expression is differentially regulated during B-cell development (Bertrand et al. 2000). NOTCH2 mutations are a rare cause of Alagille syndrome (McDaniell et al. 2006). NOTCH3 is the product of a gene on chromosome 19. NOTCH3 mutations are the underlying cause of CADASIL, cerebral arteriopathy with subcortical infarcts and leukoencephalopathy (Joutel et al. 1996). NOTCH4, the last NOTCH protein discovered, is the product of a gene on chromosome 6 (Li et al. 1998).   MicroRNAs play an important negative role in translation and/or stability of NOTCH mRNAs. MicroRNAs miR-34 (miR-34A, miR-34B and mi-R34C), whose transcription is directly induced by the tumor suppressor protein p53 (Chang et al. 2007, Raver-Shapira et al. 2007, He et al. 2007, Corney et al. 2007) bind and negatively regulate translation of NOTCH1 mRNA (Li et al. 2009, Pang et al. 2010, Ji et al. 2009) and NOTCH2 mRNA (Li et al. 2009). NOTCH1 mRNA translation is also negatively regulated by microRNAs miR-200B and miR-200C (Kong et al. 2010), as well as miR-449A, miR-449B and miR-449C (Marcet et al. 2011). Translation of NOTCH3 mRNA is negatively regulated by microRNAs miR-150 (Ghisi et al. 2011) and miR-206 (Song et al. 2009). Translation of NOTCH4 mRNA is negatively regulated by microRNAs miR-181C (Hashimoto et al. 2010) and miR-302A (Costa et al. 2009).   The  NOTCH2NL  (Notch homolog 2 N-terminal-like) gene family includes four genes,  NOTCH2NLA  (Notch homolog 2 N-terminal-like A),  NOTCH2NLB  (Notch homolog 2 N-terminal-like B),  NOTCH2NLC  (Notch homolog 2 N-terminal-like), and  NOTCH2NLR  (Notch homolog 2 N-terminal-like R), which originated from the partial duplication of the first four exons and introns of the  NOTCH2  gene and function to modulate NOTCH signaling (Fiddes et al. 2018, Florio et al. 2018, Suzuki et al. 2018, Lodewijk et al. 2020).  Nascent NOTCH peptides are co-translationally targeted to the endoplasmic reticulum for further processing, followed by modification in the Golgi apparatus, before trafficking to the plasma membrane. Endoplasmic reticulum calcium ATPases, positively regulate NOTCH trafficking, possibly by contributing to accurate folding of NOTCH precursors (Periz et al. 1999). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep333">
 <bp:stepProcess rdf:resource="#BiochemicalReaction291" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway224">
 <bp:pathwayOrder rdf:resource="#PathwayStep1813" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1812" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1589" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1590" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1812" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pre-NOTCH Processing in the Endoplasmic Reticulum</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In the endoplasmic reticulum, glycosyl transferases modify NOTCH precursors by glycosylating conserved serine and threonine residues in EGF repeats of NOTCH.    O-fucosyl transferase POFUT1 fucosylates NOTCH serine and threonine residues that conform to the consensus sequence C2-X(4-5)-S/T-C3, where C2 and C3 are the second and third cysteine residue within the EGF repeat, and X(4-5) is four to five amino acid residues of any type (Yao et al. 2011, Stahl et al. 2008, Wang et al. 2001, Shao et al. 2003).    O-glucosyl transferase POGLUT1, mammalian homolog of the Drosophila enzyme Rumi, adds a glucosyl group to conserved serine residues within the EGF repeats of NOTCH. The consensus sequence for POGLUT1-mediated glucosylation is C1-X-S-X-P-C2, where C1 and C2 are the first and second cysteine residue in the EGF repeat, respectively, while X represents any amino acid (Acar et al. 2008, Fernandez-Valdivia et al. 2011). Both fucosylation and glucosylation of NOTCH receptor precursors are essential for functionality.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction121">
 <bp:evidence rdf:resource="#Evidence143" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of phosphorylated 4EBP1 from eIF4E</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep330">
 <bp:stepProcess rdf:resource="#BiochemicalReaction288" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway227">
 <bp:pathwayOrder rdf:resource="#PathwayStep1855" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1854" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1859" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1858" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1857" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1856" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1861" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1860" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1634" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1633" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1632" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1631" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1630" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1629" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1628" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1635" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1854" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pre-NOTCH Processing in Golgi</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH undergoes final posttranslational processing in the Golgi apparatus (Lardelli et al. 1994, Blaumueller et al. 1997, Weinmaster et al. 1991, Weinmaster et al. 1992, Uyttendaele et al. 1996). Movement of NOTCH precursors from the endoplasmic reticulum to Golgi is controlled by SEL1L protein, a homolog of C. elegans sel-1. SEL1L localizes to the endoplasmic reticulum membrane and prevents translocation of misfolded proteins, therefore serving as a quality control check (Li et al. 2010, Sundaram et al. 1993, Francisco et al. 2010). Similarly, C. elegans sel-9 and its mammalian homolog TMED2 are Golgi membrane proteins that participate in quality control of proteins transported from Golgi to the plasma membrane. Translocation of a mutant C. elegans NOTCH homolog lin-12 from the Golgi to the plasma membrane is negatively regulated by sel-9 (Wen et al. 1999). A GTPase RAB6 positively controls NOTCH trafficking through Golgi (Purcell et al. 1999).     Processing of mammalian NOTCH precursors in the Golgi typically involves the cleavage by FURIN convertase. Pre-NOTCH is a ~300 kDa protein, and cleavage by FURIN produces two fragments with approximate sizes of 110 kDa and 180 kDa. The 110 kDa fragment contains the transmembrane and intracellular domains of NOTCH and is known as NTM or NTMICD. The 189 kDa fragment contains NOTCH extracellular sequence and is known as NEC or NECD. The NTM and NEC fragments heterodimerize (Blaumueller et al. 1997, Logeat et al. 1998, Chan et al. 1998) and are held together by disulfide bonds and calcium ions (Rand et al. 2000, Gordon et al. 2009).      An optional step in Pre-NOTCH processing in the Golgi is modification by fringe enzymes. Fringe enzymes are glycosyl transferases that initiate elongation of O-linked fucose on fucosylated peptides by addition of a beta 1,3 N-acetylglucosaminyl group, resulting in formation of disaccharide chains on NOTCH EGF repeats (GlcNAc-bet1,3-fucitol). Three fringe enzymes are known in mammals: LFNG (lunatic fringe), MFNG (manic fringe) and RFNG (radical fringe). LFNG shows the highest catalytic activity in modifying NOTCH (Bruckner et al. 2000, Moloney et al. 2000). Fringe-created disaccharide chains on NOTCH EGF repeats are further extended by B4GALT1 (beta-1,4-galactosyltransferase 1), which adds galactose to the N-acetylglucosaminyl group, resulting in formation of trisaccharide Gal-beta1,4-GlcNAc-beta1,3-fucitol chains (Moloney et al. 2000, Chen et al. 2001). Formation of trisaccharide chains is the minimum requirement for fringe-mediated modulation of NOTCH signaling, although fringe-modified NOTCH expressed on the cell surface predominantly contains tetrasaccharide chains on EGF repeats. The tetrasaccharide chains are formed by sialyltransferase(s) that add sialic acid to galactose, resulting in formation of Sia-alpha2,3-Gal-beta1,4-GlcNAc-beta1,3-fucitol (Moloney et al. 2000). Three known Golgi membrane sialyltransferases could be performing this function: ST3GAL3, ST3GAL4 and ST3GAL6 (Harduin-Lepers et al. 2001). The modification of NOTCH by fringe enzymes modulates NOTCH-signaling by increasing the affinity of NOTCH receptors for delta-like ligands, DLL1 and DLL4, while decreasing affinity for jagged ligands, JAG1 and JAG2. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction120">
 <bp:evidence rdf:resource="#Evidence141" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ragulator binds Rag dimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep331">
 <bp:stepProcess rdf:resource="#Catalysis130" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction289" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway226">
 <bp:pathwayOrder rdf:resource="#PathwayStep1833" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1832" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1831" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1830" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1836" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1835" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1834" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1829" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1828" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1611" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1610" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1609" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1608" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1607" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1606" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1605" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1604" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1603" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1828" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of NOTCH2NL genes</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string"> The  NOTCH2NL  gene family includes four genes,  NOTCH2NLA ,  NOTCH2NLB ,  NOTCH2NLC , and  NOTCH2NLR , which originated from the partial duplication of the first four exons and introns of the  NOTCH2  gene. Three of the duplicated genes,  NOTCH2NLA ,  NOTCH2NLB , and  NOTCH2NLC , reside at the chromosomal band 1q21.1, while  NOTCH2NLR  resides at 1p12, in the vicinity of  NOTCH2 .  NOTCH2NLA  was originally cloned as a gene highly expressed in white blood cells (Duan et al. 2004). Several studies suggest that , NOTCH2NL  genes may have played a role in the evolutionary expansion of the human brain (Florio et al. 2018, Fiddes et al. 2018, Suzuki et al. 2018, Lodewijk et al. 2020).  NOTCH2NL  genes are present only in the Hominidae family and, while they are functional in humans, they exist as pseudogenes in chimpanzees and gorillas. In addition, these genes are highly expressed during brain development (Florio et al. 2018) and have the ability to delay differentiation of neuronal progenitors (Fiddes et al. 2018, Suzuki et al. 2018). The study of sequence polymorphism and copy number variation in  NOTCH2NL  genes in modern humans (Fiddes et al. 2018, Lodewijk et al. 2020), and comparative analysis of  NOTCH2NL  gene sequences between modern humans, Denisovans and Neanderthals (Lodewijk et al. 2020), is suggestive of an ongoing adaptive evolution of modern human  NOTCH2NL  genes trending toward lower levels of NOTCH2NL proteins. Downstream of each of the  NOTCH2NL  genes is an  NBPF  gene in the same orientation as its  NOTCH2NL  partner and co-expressed with it ( NBPF10  downstream of  NOTCH2NLA ,  NBPF14  downstream of  NOTCH2NLB ,  NBPF19  downstream of  NOTCH2NLC , and  NBPF26  downstream of  NOTCH2NLR ), and these  NOTCH2NL-NBPF  pairs likely function in a coordinated, complementary fashion to promote neurogenesis and human brain expansion (Fiddes et al. 2019).  The neurodevelopmental disorder known as 1q21.1 distal deletion/duplication syndrome involves copy number gain or loss of the 1q21.1 chromosomal region that includes  NOTCH2NLA  and  NOTCH2NLB  genes. Copy number loss is associated with microcephaly, while copy number gain is associated with macrocephaly (Fiddes et al. 2018), and both gain and loss are accompanied with severe neurological disorders (Fiddes et al. 2018, Lodewijk et al. 2020). Breakpoints within  NOTCH2NL  gene loci are also associated with neurological disorders (Lodewijk et al. 2020).  Expansion of the GGC repeat in the 5&#8217;UTR of the  NOTCH2NLC  gene was identified as an important contributor to neuronal intranuclear inclusion disease (NIID) and may play a role in other neurodegenerative disorders such as Parkinson&#8217;s disease, Alzheimer&#8217;s disease, frontotemporal dementia (FTD), and amyotrophic lateral sclerosis (ALS), to name a few. The underlying pathogenic mechanism has not been elucidated. For review of  NOTCH2NLC -related trinucleotide expansion disorders, please refer to Cao et al. 2021 and Huang et al. 2021.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence537">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway221">
 <bp:pathwayOrder rdf:resource="#PathwayStep1800" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1799" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1798" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1797" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1804" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1803" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1802" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1801" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1796" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1795" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1794" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1807" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1806" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1805" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1582" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1581" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1580" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1579" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1578" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1577" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1576" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1575" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1586" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1574" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1585" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1584" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1583" />
 <bp:pathwayComponent rdf:resource="#Pathway222" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1794" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH3 Activation and Transmission of Signal to the Nucleus</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH3 receptor can be activated by DLL/JAG ligands DLL1, JAG1, and JAG2 (Shimizu et al. 2000), as well as DLL4 (Claxton and Fruttiger 2004, Indraccolo et al. 2009). Ligand binding induces a conformational change in NOTCH3, which exposes the S2 site in the extracellular region of NOTCH3. The S2 site is cleaved by ADAM10 metalloprotease, generating the membrane anchored NOTCH3 fragment NEXT3. The NEXT3 fragment of NOTCH3 is further cleaved at the S3 site by the gamma secretase complex, releasing the intracellular domain NICD3 into the cytosol (Groot et al. 2014). Besides DLL/JAG ligands, NOTCH3 signaling can also be activated by binding of NOTCH3 to YBX1 (YB 1) (Rauen et al. 2009). NICD3 traffics to the nucleus where it acts as a transcription factor. WWP2, an E3 ubiquitin ligase, negatively regulates NOTCH3 signaling by ubiquitinating NEXT3 and NICD3 in the cytosol and targeting them for lysosome-mediated degradation (Jung et al. 2014). NOTCH3 signaling is also negatively regulated by binding to TACC3 (Bargo et al. 2010) and by EGFR-mediated phosphorylation (Arasada et al. 2014).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence538">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway220">
 <bp:pathwayOrder rdf:resource="#PathwayStep1778" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1789" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1777" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1788" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1776" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1787" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1775" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1786" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1779" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1781" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1792" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1780" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1791" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1790" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1774" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1785" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1773" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1784" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1772" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1783" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1771" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1782" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1560" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1571" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1570" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1557" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1568" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1556" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1567" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1555" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1566" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1554" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1565" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1553" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1564" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1552" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1563" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1562" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1573" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1561" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1572" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1559" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1558" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1569" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1771" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH3 Intracellular Domain Regulates Transcription</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In the nucleus, NICD3 forms a complex with RBPJ (CBF1, CSL) and MAML (mastermind) proteins MAML1, MAML2 or MAML3 (possibly also MAMLD1). NICD3:RBPJ:MAML complex, also known as the NOTCH3 coactivator complex, activates transcription from RBPJ-binding promoter elements (Lin et al. 2002). While NOTCH1 prefers paired RBPJ binding sites, NOTCH3 preferentially binds to single RBPJ binding sites (Ong et al. 2006).   NOTCH3 coactivator complex induces transcription of the well established NOTCH target genes HES1 (Lin et al. 2002, Boelens et al. 2014), HEYL (Maier and Gessler 2000, Geimer Le Lay et al. 2014), HES5 (Lin te al. 2002, Shimizu et al. 2002), and HEY2 (Wang et al. 2002).  NOTCH3 positively regulates transcription of the pre-T-cell receptor alpha chain (PTCRA, commonly known as pT-alpha or pre-TCRalpha) (Talora et al. 2003, Bellavia et al. 2007). IK1, splicing isoform of the transcription factor Ikaros (IKZF1), competes with RBPJ for binding to the PTCRA promoter and inhibits PTCRA transcription. NOTCH3, through pre-TCR signaling, stimulates expression of the RNA binding protein HuD, which promotes splicing of IKZF1 into dominant negative isoforms. These dominant negative isoforms of IKZF1 heterodimerize with IK1, preventing its binding to target DNA sequences and thus contributing to sustained transcription of PTCRA (Bellavia et al. 2007, reviewed by Bellavia, Mecarrozzi, Campese, Grazioli, Gulino and Screpanti 2007).  NOTCH3-triggered pre-TCR-signaling downregulates the activity of the transcription factor TCF3 (E2A), through ERK-dependent induction of ID1. Inhibition of TCF3-mediated transcription downstream of NOTCH3 contributes to development of T-cell lymphomas in transgenic mice expressing NICD3 (Talora et al. 2003). Activation of ERKs downstream of NOTCH3-stimulated pre-TCR signaling leads to phosphorylation of the transcription factor TAL1, formation of the TAL1:SP1 complex, and activation of cyclin D1 (CCND1) transcription, which stimulates cell division (Talora et al. 2006). NOTCH3 signaling can activate NF-kappaB (NFKB)-mediate transcription either indirectly, through activation of pre-TCR signaling, or directly, through association of NOTCH3 with IKKA. NFKB is constitutively active in T lymphoma cells derived from NOTCH3 transgenic mice (Vacca et al. 2006).  Transcription of the PLXND1 gene, encoding the semaphorin receptor Plexin D1, is directly stimulated by NOTCH1 and NOTCH3 coactivator complexes. PLXND1 is involved in neuronal migration and cancer cell invasiveness (Rehman et al. 2016). Expression of FABP7 (BLBP) in radial glia is positively regulated by NOTCH1 and NOTCH3 during neuronal migration (Anthony et al. 2005, Keilani and Sugaya 2008).   NOTCH3 gene is frequently amplified in ovarian cancer (Park et al. 2006). NOTCH3 coactivator complex directly stimulates DLGAP5 transcription. DLGAP5 is involved in G2/M transition and is overexpressed in ovarian cancer cells. (Chen et al. 2012). Another gene overexpressed in ovarian cancer whose transcription is directly stimulated by NOTCH3 is PBX1 (Park et al. 2008). The NOTCH3 coactivator complex directly stimulates WWC1 gene transcription. WWC1 gene encodes protein Kibra, involved in Hippo signaling. NOTCH3-mediated induction of WWC1  positively regulates Hippo signaling and inhibits epithelial-to-mesenchymal transition (EMT) in triple negative breast cancer cells (Zhang et al. 2016). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence539">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway223">
 <bp:pathwayOrder rdf:resource="#PathwayStep1811" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1853" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1814" />
 <bp:pathwayComponent rdf:resource="#Pathway225" />
 <bp:pathwayComponent rdf:resource="#Pathway224" />
 <bp:pathwayComponent rdf:resource="#Pathway227" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1811" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pre-NOTCH Expression and Processing</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In humans and other mammals the NOTCH gene family has four members, NOTCH1, NOTCH2, NOTCH3 and NOTCH4, encoded on four different chromosomes. Their transcription is developmentally regulated and tissue specific, but very little information exists on molecular mechanisms of transcriptional regulation. Translation of NOTCH mRNAs is negatively regulated by a number of recently discovered microRNAs (Li et al. 2009, Pang et al.2010, Ji et al. 2009, Kong et al. 2010, Marcet et al. 2011, Ghisi et al. 2011, Song et al. 2009, Hashimoto et al. 2010, Costa et al. 2009).     The nascent forms of NOTCH precursors, Pre-NOTCH1, Pre-NOTCH2, Pre-NOTCH3 and Pre-NOTCH4, undergo extensive posttranslational modifications in the endoplasmic reticulum and Golgi apparatus to become functional. In the endoplasmic reticulum, conserved serine and threonine residues in the EGF repeats of NOTCH extracellular domain are fucosylated and glucosylated by POFUT1 and POGLUT1, respectively (Yao et al. 2011, Stahl et al. 2008, Wang et al. 2001, Shao et al. 2003, Acar et al. 2008, Fernandez Valdivia et al. 2011).     In the Golgi apparatus, fucose groups attached to NOTCH EGF repeats can be elongated by additional glycosylation steps initiated by fringe enzymes (Bruckner et al. 2000, Moloney et al. 2000, Cohen et al. 1997, Johnston et al. 1997, Chen et al. 2001). Fringe-mediated modification modulates NOTCH signaling but is not an obligatory step in Pre-NOTCH processing. Typically, processing of Pre-NOTCH in the Golgi involves cleavage by FURIN convertase (Blaumueller et al. 1997, Logeat et al. 1998, Gordon et al. 2009, Rand et al. 2000, Chan et al. 1998). The cleavage of NOTCH results in formation of mature NOTCH heterodimers that consist of NOTCH extracellular domain (NEC i.e. NECD) and NOTCH transmembrane and intracellular domain (NTM i.e. NTMICD). NOTCH heterodimers translocate to the cell surface where they function in cell to cell signaling.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway222">
 <bp:pathwayOrder rdf:resource="#PathwayStep1808" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1809" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1588" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1587" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1808" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Noncanonical activation of NOTCH3</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Besides DLL/JAG ligands, NOTCH3 signaling can also be activated by binding of NOTCH3 to YBX1 (YB 1) (Rauen et al. 2009). YBX1, a protein involved in mRNA processing, is secreted by mesangial cells and monocytes during inflammation and acts as an extracellular mitogen (Frye et al. 2009). YBX1 triggers the gamma secretase complex mediated cleavage of NOTCH3, resulting in release of NOTCH3 intracellular domain (NICD3) and activation of NOTCH3 target genes (Rauen et al. 2009).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction127">
 <bp:evidence rdf:resource="#Evidence149" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">mTORC1 phosphorylation of RPS6KB1 (S6K)</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep329">
 <bp:stepProcess rdf:resource="#BiochemicalReaction287" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence522">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1459">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1269" />
 <bp:stepProcess rdf:resource="#Catalysis392" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction126">
 <bp:evidence rdf:resource="#Evidence148" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation and activation of eIF4G by activated S6K1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence523">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1458">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1268" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction129">
 <bp:evidence rdf:resource="#Evidence151" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SLC38A9 binds Ragulator:Rag dimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep327">
 <bp:stepProcess rdf:resource="#Catalysis128" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction285" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence524">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1457">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1267" />
 <bp:stepProcess rdf:resource="#Catalysis391" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction128">
 <bp:evidence rdf:resource="#Evidence150" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation and activation of eIF4B by activated S6K1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep328">
 <bp:stepProcess rdf:resource="#Catalysis129" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction286" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence525">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1456">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1266" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction123">
 <bp:evidence rdf:resource="#Evidence145" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation and inactivation of eEF2K by activated S6K1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep325">
 <bp:stepProcess rdf:resource="#BiochemicalReaction283" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway207">
 <bp:pathwayOrder rdf:resource="#PathwayStep1600" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1599" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1394" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1393" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1599" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NR1H2 &amp; NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Adipose tissue triglycerides (TGs) represent the major energy store of the body. During adipocyte lipolysis triglycerides (TGs) are hydrolyzed into free fatty acids (FFAs) and glycerol by the action of adipose triglyceride lipase (ATGL, encoded by PNPLA2), then hormone-sensitive lipase (HSL), which is activated by glucagon and adrenaline (epinephrine) and inhibited by insulin. Both isoforms of liver X receptor, LXR&#945; (NR1H3) and LXR&#946; (NR1H2), are expressed in mature mouse and human adipocytes (Juvet LK et al. 2003). Expression of NR1H3 is up-regulated during adipocyte differentiation (Juvet LK et al. 2003; Darimont C et al. 2006). Ligand activation of LXRs (NR1H2 or NR1H3) can induce adipocyte lipolysis and FFA oxidation (Stenson BM et al. 2011; Ross SE et al. 2002). For instance, in mouse 3T3L1 adipocytes and human primary adipocytes, LXR activation led to an increase in basal, but not hormone-stimulated, lipolysis as measured by glycerol release (Ross SE et al. 2002; Stenson BM et al. 2011). Another study showed that administration of synthetic ligands of NR1H2/ NR1H3, T0901317 or GW3965, to mice resulted in smaller adipocytes and increased serum free fatty acid and glycerol concentrations, suggesting increased adipocyte lipolysis (Commerford SR et al. 2007). Further, microarray analysis of human adipocytes following NR1H3 or NR1H2 activation revealed altered gene expression of several lipolysis-regulating proteins such as perilipin1 (PLIN1), which was also confirmed by quantitative real-time PCR (Stenson BM et al. 2011). Selective knockdown of either NR1H2 or NR1H3 showed that NR1H3 (LXR&#945;) was the major isoform mediating the lipolysis-related effects of LXR agonists (Stenson BM et al. 2011). In addition, the absence of NR1H3 (LXR&#945;) in mouse adipose tissue resulted in elevated adiposity through a decrease of both lipolytic and oxidative capacities in white adipose tissue (Dib L et al. 2014).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep2787">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2425" />
 <bp:stepProcess rdf:resource="#Catalysis765" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction122">
 <bp:evidence rdf:resource="#Evidence144" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of 4E-BP1 by activated mTORC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep326">
 <bp:stepProcess rdf:resource="#BiochemicalReaction284" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway206">
 <bp:pathwayOrder rdf:resource="#PathwayStep1569" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1568" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1567" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1589" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1566" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1588" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1561" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1583" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1560" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1582" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1581" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1580" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1565" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1587" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1564" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1586" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1563" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1585" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1562" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1584" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1590" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1558" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1579" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1578" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1577" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1559" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1572" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1594" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1571" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1593" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1570" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1592" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1591" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1576" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1575" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1597" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1574" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1596" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1573" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1595" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1373" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1372" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1371" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1370" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1392" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1391" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1390" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1359" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1358" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1357" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1379" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1356" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1378" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1355" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1377" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1354" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1376" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1353" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1375" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1374" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1362" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1384" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1361" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1383" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1360" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1382" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1381" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1380" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1369" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1368" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1367" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1389" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1366" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1388" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1365" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1387" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1364" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1386" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1363" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1385" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1558" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NR1H3 &amp; NR1H2 regulate gene expression linked to cholesterol transport and efflux</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The liver X receptors (LXRs), LXR&#945; (NR1H3) and LXR&#946; (NR1H2), are nuclear receptors that are activated by endogenous oxysterols, oxidized derivatives of cholesterol (Janowski BA et al. 1996). When cellular oxysterols accumulate as a result of increasing concentrations of cholesterol, NR1H2,3 induce the transcription of genes that protect cells from cholesterol overload (Zhao C    Dahlman&#8209;Wright K 2010; Ma Z et al. 2017). In peripheral cells such as macrophages, NR1H2 and NR1H3 increase cholesterol efflux by inducing expression of ATP-binding cassette subfamily A type 1 (ABCA1), ABCG1, and apolipoprotein APOE (Jakobsson T et al. 2009; Laffitte BA et al. 2001; Mak PA et al. 2002). In the intestine, LXR agonists decrease cholesterol absorption through induction of ABCA1, ABCG5, and ABCG8 (Repa JJ et al. 2000; Back SS et al. 2013). Cholesterol removal from non-hepatic peripheral cells, such as lipid-laden macrophages, and its delivery back to the liver for catabolism and excretion are processes collectively known as reverse cholesterol transport (RCT) (Francis GA 2010; Rosenson RS et al. 2012). This Reactome module describes the activation of several direct NR1H2,3 target genes that are closely associated with the RCT pathway, including genes encoding membrane lipid transporters, such ABCA1, ABCG1, ABCG5, ABCG8 and a cluster of apolipoprotein genes APOE, APOC1, APOC2 and APOC4 (Jakobsson T et al. 2009; Back SS et al. 2013; Mak PA et al. 2002).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep2788">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2426" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction125">
 <bp:evidence rdf:resource="#Evidence147" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FKBP1A binds sirolimus</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep323">
 <bp:stepProcess rdf:resource="#BiochemicalReaction281" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence520">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway209">
 <bp:pathwayOrder rdf:resource="#PathwayStep1613" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1612" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1611" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1610" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1606" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1605" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1615" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1614" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1609" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1608" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1607" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1403" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1402" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1401" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1400" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1399" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1398" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1397" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1407" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1406" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1405" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1404" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1605" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RA biosynthesis pathway</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The major activated retinoid, all-trans-retinoic acid (atRA) is produced by the dehydrogenation of all-trans-retinol (atROL) by members of the short chain dehydrogenase/reductase (SDR) and aldehyde dehydrogenase (RALDH) gene families (Das et al. 2014, Napoli 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep2789">
 <bp:stepProcess rdf:resource="#Pathway364" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction124">
 <bp:evidence rdf:resource="#Evidence146" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of Ribosomal protein S6 by activated S6K1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep324">
 <bp:stepProcess rdf:resource="#BiochemicalReaction282" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence521">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway208">
 <bp:pathwayOrder rdf:resource="#PathwayStep1602" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1623" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1622" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1621" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1617" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1616" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1604" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1603" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1619" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1618" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1620" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1414" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1413" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1412" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1411" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1410" />
 <bp:pathwayComponent rdf:resource="#Pathway209" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1396" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1395" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1409" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1408" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1415" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1602" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by Retinoic Acid</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Vitamin A (retinol) can be metabolised into active retinoid metabolites that function either as a chromophore in vision or in regulating gene expression transcriptionally and post-transcriptionally. Genes regulated by retinoids are essential for reproduction, embryonic development, growth, and multiple processes in the adult, including energy balance, neurogenesis, and the immune response. The retinoid used as a cofactor in the visual cycle  is 11-cis-retinal (11cRAL). The non-visual cycle effects of retinol are mediated by retinoic acid (RA), generated by two-step conversion from retinol (Napoli 2012).  All-trans-retinoic acid (atRA) is the major activated metabolite of retinol. An isomer, 9-cis-retinoic acid (9cRA) has biological activity, but has not been detected in vivo, except in the pancreas. An alternative route involves BCO1 cleavage of carotenoids into retinal, which is then reduced into retinol in the intestine (Harrison 2012). The two isomers of RA serve as ligands for  retinoic acid receptors (RAR) that regulate gene expression. (Das et al. 2014). RA is catabolised to oxidised metabolites such as 4-hydroxy-, 18-hydroxy-  or 4-oxo-RA by CYP family enzymes, these metabolites then becoming substrates for Phase II conjugation enzymes (Ross    Zolfaghari 2011).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep1451">
 <bp:stepProcess rdf:resource="#Catalysis387" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1261" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2275">
 <bp:evidence rdf:resource="#Evidence2609" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FYN autophosphorylates</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2783">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2423" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1450">
 <bp:stepProcess rdf:resource="#Catalysis386" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1260" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2274">
 <bp:evidence rdf:resource="#Evidence2608" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK2 and SRC-1 phosphorylate PXN on Y31 and Y118</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2784">
 <bp:stepProcess rdf:resource="#Pathway362" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2273">
 <bp:evidence rdf:resource="#Evidence2607" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DOCK180:ELMO binds CRK</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2785">
 <bp:stepProcess rdf:resource="#Pathway363" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2272">
 <bp:evidence rdf:resource="#Evidence2606" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FYN phosphorylates PAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2786">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2424" />
 <bp:stepProcess rdf:resource="#Catalysis764" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1455">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1265" />
 <bp:stepProcess rdf:resource="#Catalysis390" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2271">
 <bp:evidence rdf:resource="#Evidence2605" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PAK2 autophorylates</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1454">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1264" />
 <bp:stepProcess rdf:resource="#Catalysis389" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2270">
 <bp:evidence rdf:resource="#Evidence2604" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-6Y-VEGFR2 binds NCK</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2780">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2420" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1453">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1263" />
 <bp:stepProcess rdf:resource="#Catalysis388" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2781">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2421" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1452">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1262" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2782">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2422" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2279">
 <bp:evidence rdf:resource="#Evidence2613" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">VEGF induces CDC42 activation by unknown mechanism</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2278">
 <bp:evidence rdf:resource="#Evidence2612" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SRC-1 phosphorylates PTK2-beta</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2277">
 <bp:evidence rdf:resource="#Evidence2611" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-6Y-VEGFR2 binds SHB </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2276">
 <bp:evidence rdf:resource="#Evidence2610" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38 MAPK activation by VEGFR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction130">
 <bp:evidence rdf:resource="#Evidence152" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Ragulator complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep321">
 <bp:stepProcess rdf:resource="#BiochemicalReaction279" />
 <bp:stepProcess rdf:resource="#Catalysis127" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway214">
 <bp:pathwayOrder rdf:resource="#PathwayStep1734" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1733" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1732" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1731" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1727" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1738" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1737" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1736" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1735" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1729" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1728" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1730" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1524" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1523" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1522" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1521" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1520" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1519" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1518" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1517" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1516" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1515" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1514" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1525" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1727" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Estrogen-dependent nuclear events downstream of ESR-membrane signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Although membrane-localized estrogen receptors stimulate rapid, transcription-independent responses such as calcium mobilization and alterations to the fibronectin matrix to affect cell migration, among others, the pathways activated by rapid signaling may also ultimately affect nuclear events. Activation of MAPK and PI3K/AKT pathways downstream of membrane-localized ESR1 contributes to estrogen-responsive changes in cellular proliferation and survival in part through changes in gene expression (reviewed in Levin et al, 2005; Lange et al, 2007; Le Romancer et al, 2011).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep322">
 <bp:stepProcess rdf:resource="#BiochemicalReaction280" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway213">
 <bp:pathwayOrder rdf:resource="#PathwayStep1721" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1720" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1716" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1719" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1718" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1717" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1509" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1508" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1507" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1506" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1505" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1504" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1716" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Estrogen-stimulated signaling through PRKCZ</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Atypical protein kinases lack the calcium binding C2 domain and are unresponsive to diacylglycerol and phorbol ester, but instead respond to PIP3 generation downstream of PI3K signaling. Atypical protein kinase C zeta (PRKCZ) is activated downstream of estrogen stimulation is MCF7 breast cancer cells and contributes estrogen-dependent proliferation through MAPK pathway activation (Castoria et al, 2004).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction132">
 <bp:evidence rdf:resource="#Evidence154" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated Akt1 phosphorylates AKT1S1 (PRAS40)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway216">
 <bp:pathwayOrder rdf:resource="#PathwayStep1745" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1759" />
 <bp:pathwayComponent rdf:resource="#Pathway218" />
 <bp:pathwayComponent rdf:resource="#Pathway217" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1745" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by NOTCH2</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH2 is activated by binding Delta-like and Jagged ligands (DLL/JAG) expressed in trans on neighboring cells (Shimizu et al. 1999, Shimizu et al. 2000, Hicks et al. 2000, Ji et al. 2004). In trans ligand-receptor binding is followed by ADAM10 mediated (Gibb et al. 2010, Shimizu et al. 2000) and gamma secretase complex mediated cleavage of NOTCH2 (Saxena et al. 2001, De Strooper et al. 1999), resulting in the release of the intracellular domain of NOTCH2, NICD2, into the cytosol. NICD2 traffics to the nucleus where it acts as a transcriptional regulator. For a recent review of the cannonical NOTCH signaling, please refer to Kopan and Ilagan 2009, D&apos;Souza et al. 2010, Kovall and Blacklow 2010. CNTN1 (contactin 1), a protein involved in oligodendrocyte maturation (Hu et al. 2003) and MDK (midkine) (Huang et al. 2008, Gungor et al. 2011), which plays an important role in epithelial-to-mesenchymal transition, can also bind NOTCH2 and activate NOTCH2 signaling.  In the nucleus, NICD2 forms a complex with RBPJ (CBF1, CSL) and MAML (mastermind). The NICD2:RBPJ:MAML complex activates transcription from RBPJ binding promoter elements (RBEs) (Wu et al. 2000). NOTCH2 coactivator complexes directly stimulate transcription of HES1 and HES5 genes (Shimizu et al. 2002), both of which are known NOTCH1 targets. NOTCH2 but not NOTCH1 coactivator complexes, stimulate FCER2 transcription. Overexpression of FCER2 (CD23A) is a hallmark of B-cell chronic lymphocytic leukemia (B-CLL) and correlates with the malfunction of apoptosis, which is thought be an underlying mechanism of B-CLL development (Hubmann et al. 2002). NOTCH2 coactivator complexes together with CREBP1 and EP300 stimulate transcription of GZMB (granzyme B), which is important for the cytotoxic function of CD8+ T cells (Maekawa et al. 2008).  NOTCH2 gene expression is differentially regulated during human B-cell development, with NOTCH2 transcripts appearing at late developmental stages (Bertrand et al. 2000).   NOTCH2 mutations are a rare cause of Alagille syndrome (AGS). AGS is a dominant congenital multisystem disorder characterized mainly by hepatic bile duct abnormalities. Craniofacial, heart and kidney abnormalities are also frequently observed in the Alagille spectrum (Alagille et al. 1975). AGS is predominantly caused by mutations in JAG1, a NOTCH2 ligand (Oda et al. 1997, Li et al. 1997), but it can also be caused by mutations in NOTCH2 (McDaniell et al. 2006).   Hajdu-Cheney syndrome, an autosomal dominant disorder characterized by severe and progressive bone loss, is caused by NOTCH2 mutations that result in premature C-terminal NOTCH2 truncation, probably leading to increased NOTCH2 signaling (Simpson et al. 2011, Isidor et al. 2011, Majewski et al. 2011). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction131">
 <bp:evidence rdf:resource="#Evidence153" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ragulator:Rag dimers:SLC38A9 bind mTORC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep320">
 <bp:stepProcess rdf:resource="#BiochemicalReaction278" />
 <bp:stepProcess rdf:resource="#Catalysis126" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway215">
 <bp:pathwayOrder rdf:resource="#PathwayStep1744" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1810" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1886" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1769" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1862" />
 <bp:pathwayComponent rdf:resource="#Pathway228" />
 <bp:pathwayComponent rdf:resource="#Pathway219" />
 <bp:pathwayComponent rdf:resource="#Pathway216" />
 <bp:pathwayComponent rdf:resource="#Pathway232" />
 <bp:pathwayComponent rdf:resource="#Pathway223" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1744" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by NOTCH</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The Notch Signaling Pathway (NSP) is a highly conserved pathway  for cell-cell communication. NSP is involved in the regulation of cellular differentiation, proliferation, and specification. For example, it is utilised by continually renewing adult tissues such as blood, skin, and gut epithelium not only to maintain stem cells in a proliferative, pluripotent, and undifferentiated state but also to direct the cellular progeny to adopt different developmental cell fates. Analogously, it is used during embryonic development to create fine-grained patterns of differentiated cells, notably during neurogenesis where the NSP controls patches such as that of the vertebrate inner ear where individual hair cells are surrounded by supporting cells. This process is known as lateral inhibition: a molecular mechanism whereby individual cells within a field are stochastically selected to adopt particular cell fates and the NSP inhibits their direct neighbours from doing the same. The NSP has been adopted by several other biological systems for binary cell fate choice. In addition, the NSP is also used during vertebrate segmentation to divide the growing embryo into regular blocks called somites which eventually form the vertebrae. The core of this process relies on regular pulses of Notch signaling generated from a molecular oscillator in the presomatic mesoderm. The Notch receptor is synthesized in the rough endoplasmic reticulum as a single polypeptide precursor.  Newly synthesized Notch receptor is proteolytically cleaved in the trans-golgi network, creating a heterodimeric mature receptor comprising of non-covalently associated extracellular and transmembrane subunits. This assembly travels to the cell surface ready to interact with specific ligands. Following ligand activation and further proteolytic cleavage,  an intracellular domain is released and translocates to the nucleus where it regulates gene expression.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence526">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway210">
 <bp:pathwayOrder rdf:resource="#PathwayStep1699" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1698" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1742" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1626" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1625" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1693" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1697" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1741" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1696" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1695" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1694" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1488" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1487" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1486" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1485" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1484" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1483" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1529" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1528" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1416" />
 <bp:pathwayComponent rdf:resource="#Pathway212" />
 <bp:pathwayComponent rdf:resource="#Pathway211" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1625" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ESR-mediated signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Estrogens are a class of hormones that play a role in physiological processes such as development, reproduction, metabolism of liver, fat and bone, and neuronal and cardiovascular function (reviewed in Arnal et al, 2017; Haldosen et al, 2014). Estrogens bind estrogen receptors, members of the nuclear receptor superfamily. Ligand-bound estrogen receptors act as nuclear transcription factors to regulate expression of genes that control cellular proliferation and differentiation, among other processes, but also play a non-genomic role in rapid signaling from the plasma membrane (reviewed in Hah et al, 2014;Schwartz et al, 2016).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence527">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence528">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway212">
 <bp:pathwayOrder rdf:resource="#PathwayStep1701" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1712" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1723" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1700" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1711" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1722" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1710" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1705" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1704" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1715" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1726" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1703" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1714" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1725" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1702" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1713" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1724" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1740" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1709" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1708" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1707" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1706" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1739" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1494" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1493" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1492" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1491" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1490" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1502" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1513" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1501" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1512" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1489" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1500" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1511" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1499" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1510" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1498" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1497" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1496" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1495" />
 <bp:pathwayComponent rdf:resource="#Pathway214" />
 <bp:pathwayComponent rdf:resource="#Pathway213" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1527" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1526" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1503" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1700" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Extra-nuclear estrogen signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In addition to its well-characterized role in estrogen-dependent transcription, estrogen (beta-estradiol, also known as E2) also plays a rapid, non-genomic role through interaction with receptors localized at the plasma membrane by virtue of dynamic palmitoylation. Estrogen receptor palmitoylation is a prerequisite for the E2-dependent activation of extra-nuclear signaling both in vitro and in animal models (Acconcia et al, 2004; Acconcia et al, 2005; Marino et al, 2006; Marino and Ascenzi, 2006). Non-genomic signaling through the estrogen receptor ESR1 also depends on receptor arginine methylation by PMRT1 (Pedram et al, 2007; Pedram et al, 2012; Le Romancer et al, 2008; reviewed in Arnal, 2017; Le Romancer et al, 2011 ).  E2-evoked extra-nuclear signaling is independent of the transcriptional activity of estrogen receptors and occurs within seconds to minutes following E2 administration to target cells. Extra-nuclear signaling consists of the activation of a plethora of signaling pathways including the RAF/MAP kinase cascade and the PI3K/AKT signaling cascade and governs processes such as  apoptosis, cellular proliferation and metastasis (reviewed in Hammes et al, 2007; Handa et al, 2012; Lange et al, 2007; Losel et al, 2003; Arnal et al, 2017; Le Romancer et al, 2011). ESR-mediated signaling also cross-talks with receptor tyrosine kinase, NF- kappa beta and GPCR signaling pathways by modulating the post-translational modification of enzymes and other proteins and regulating second messengers (reviewed in Arnal et al, 2017; Schwartz et al, 2016; Boonyaratanakornkit, 2011; Biswas et al, 2005). In the nervous system, E2 affects neural functions such as cognition, behaviour, stress responses and reproduction in part by inducing such rapid extra-nuclear responses (Farach-Carson and Davis, 2003; Losel et al, 2003), while in endothelial cells, non-genomic ESR-dependent signaling also regulates vasodilation through the eNOS pathway (reviewed in Levin, 2011).  Extra-nuclear signaling additionally cross-talks with nuclear estrogen receptor signaling and is required to control ER protein stability (La Rosa et al, 2012) Recent data have demonstrated that the membrane ESR1 can interact with various endocytic proteins to traffic and signal within the cytoplasm. This receptor intracellular trafficking appears to be dependent on the phyical interaction of ESR1 with specific trans-membrane receptors such as IGR-1R and beta 1-integrin (Sampayo et al, 2018)</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence529">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway211">
 <bp:pathwayOrder rdf:resource="#PathwayStep1668" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1667" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1666" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1665" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1628" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1627" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1669" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1660" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1664" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1663" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1662" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1661" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1629" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1635" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1679" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1634" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1678" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1633" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1677" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1632" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1676" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1639" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1638" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1637" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1636" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1671" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1670" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1631" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1675" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1630" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1674" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1673" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1672" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1646" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1645" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1689" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1644" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1688" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1643" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1687" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1649" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1648" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1647" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1682" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1681" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1680" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1642" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1686" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1641" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1685" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1640" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1684" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1683" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1657" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1656" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1655" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1654" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1659" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1658" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1692" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1691" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1690" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1653" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1652" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1651" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1650" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1450" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1458" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1457" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1456" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1455" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1454" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1453" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1452" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1451" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1419" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1418" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1417" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1459" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1482" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1481" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1480" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1447" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1446" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1445" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1444" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1443" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1442" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1441" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1440" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1449" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1448" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1472" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1471" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1470" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1436" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1435" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1479" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1434" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1478" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1433" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1477" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1432" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1476" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1431" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1475" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1430" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1474" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1473" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1439" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1438" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1437" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1461" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1460" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1425" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1469" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1424" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1468" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1423" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1467" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1422" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1466" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1421" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1465" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1420" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1464" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1463" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1462" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1429" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1428" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1427" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1426" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1627" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Estrogen-dependent gene expression</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Estrogens mediate their transcriptional effects through interaction with the estrogen receptors, ESR1 (also known as ER alpha) and ESR2 (ER beta). ESR1 and ESR2 share overlapping but distinct functions, with ESR1 playing the primary role in transcriptional activation in most cell types (Hah and Krauss, 2014; Haldos&#233;n et al, 2014. The receptors function as ligand-dependent dimers and can activate target genes either through direct binding to an estrogen responsive element (ERE) in the target gene promoter, or indirectly through interaction with another DNA-binding protein such as RUNX1, SP1, AP1 or NF-kappa beta (reviewed in Bai and Gust, 2009; Hah and Krause, 2014). Binding of estrogen receptors to the DNA promotes the assembly of higher order transcriptional complexes containing methyltransferases, histone acetyltransferases and other transcriptional activators, which promote transcription by establishing active chromatin marks and by recruiting general transcription factors and RNA polymerase II. ESR1- and estrogen-dependent recruitment of up to hundreds of coregulators has been demonstrated by varied co-immunoprecipitation and proteomic approaches (Kittler et al, 2013; Mohammed et al, 2013; Foulds et al, 2013; Mohammed et al, 2015; Liu et al, 2014; reviewed in Magnani and Lupien, 2014; Arnal, 2017). In some circumstances, ligand-bound receptors can also promote the assembly of a repression complex at a target gene, and in some cases, heterodimers of ESR1 and ESR2 serve as repressors of ESR1-mediated target gene activation (reviewed in Hah and Kraus, 2014; Arnal et al, 2017).  Phosphorylation of the estrogen receptor also modulates its activity, and provides cross-talk between nuclear estrogen-dependent signaling and non-genomic estrogen signaling from the plasma membrane (reviewed in Anbalagan and Rowan, 2015; Halods&#232;n et al, 2014; Schwartz et al, 2016)   A number of recent genome wide studies highlight the breadth of the transcriptional response to estrogen. The number of predicted estrogen-dependent target genes ranges from a couple of hundred (based on microarray studies) to upwards of 10000, based on ChIP-chip or ChIP-seq (Cheung and Kraus, 2010; Kinnis and Kraus, 2008; Lin et al, 2004; Welboren et al, 2009; Ikeda et al, 2015; Lin et al, 2007; Carroll et al, 2006). Many of these predicted sites may not represent transcriptionally productive binding events, however. A study examining ESR1 binding by ChIP-seq in 20 primary breast cancers identified a core of 484 ESR-binding events that were conserved in at least 75% of ER+ tumors, which may represent a more realistic estimate (Ross-Innes et al, 2012). These studies also highlight the long-range effect of estrogen receptor-binding, with distal enhancer or promoter elements regulating the expression of many target genes, often through looping or other higher order chromatin structures (Kittler et al, 2013; reviewed in Dietz and Carroll, 2008; Liu and Cheung, 2014; Magnani and Lupien, 2014). Transcription from a number of estrogen-responsive target genes also appears to be primed by the binding of pioneering transcription factors such as FOXA1, GATA3, PBX1 among others. These factors bind to heterochromatin by virtue of their winged helix domains and promote chromatin opening, allowing subsequent recruitment of other transcription factors (reviewed in Zaret and Carroll, 2011; Fiorito et al, 2013; Arnal et al, 2017; Magnani et al, 2011)</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep318">
 <bp:stepProcess rdf:resource="#BiochemicalReaction276" />
 <bp:stepProcess rdf:resource="#Catalysis124" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence511">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep319">
 <bp:stepProcess rdf:resource="#BiochemicalReaction277" />
 <bp:stepProcess rdf:resource="#Catalysis125" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence512">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep316">
 <bp:stepProcess rdf:resource="#BiochemicalReaction274" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence513">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep317">
 <bp:stepProcess rdf:resource="#BiochemicalReaction275" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence514">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep314">
 <bp:stepProcess rdf:resource="#BiochemicalReaction273" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep315">
 <bp:stepProcess rdf:resource="#Pathway43" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep312">
 <bp:stepProcess rdf:resource="#BiochemicalReaction271" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep313">
 <bp:stepProcess rdf:resource="#BiochemicalReaction272" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence510">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep310">
 <bp:stepProcess rdf:resource="#BiochemicalReaction269" />
 <bp:stepProcess rdf:resource="#Catalysis122" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence519">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep311">
 <bp:stepProcess rdf:resource="#Catalysis123" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction270" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence515">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence516">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence517">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence518">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep307">
 <bp:stepProcess rdf:resource="#Catalysis120" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction266" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence500">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep308">
 <bp:stepProcess rdf:resource="#Catalysis121" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction267" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence501">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep305">
 <bp:stepProcess rdf:resource="#Pathway42" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence502">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep306">
 <bp:stepProcess rdf:resource="#BiochemicalReaction265" />
 <bp:stepProcess rdf:resource="#Catalysis119" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence503">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep303">
 <bp:stepProcess rdf:resource="#Catalysis118" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction263" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep304">
 <bp:stepProcess rdf:resource="#BiochemicalReaction264" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep301">
 <bp:stepProcess rdf:resource="#BiochemicalReaction261" />
 <bp:stepProcess rdf:resource="#Catalysis116" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep302">
 <bp:stepProcess rdf:resource="#BiochemicalReaction262" />
 <bp:stepProcess rdf:resource="#Catalysis117" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep309">
 <bp:stepProcess rdf:resource="#BiochemicalReaction268" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence508">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep300">
 <bp:stepProcess rdf:resource="#BiochemicalReaction260" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence509">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence504">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence505">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence506">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence507">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2220">
 <bp:evidence rdf:resource="#Evidence2549" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ALK binds ALKAL ligand</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2228">
 <bp:evidence rdf:resource="#Evidence2560" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SRC1-1 binds SH2D2A and is recruited to VEGFR2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2227">
 <bp:evidence rdf:resource="#Evidence2559" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-AXL binds PI3K</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2226">
 <bp:evidence rdf:resource="#Evidence2558" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOA:GTP:Mg2+ binds ROCK1,ROCK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2225">
 <bp:evidence rdf:resource="#Evidence2556" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NRP-1 forms a ternary complex with VEGF165 and VEGFR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2224">
 <bp:evidence rdf:resource="#Evidence2555" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NRP-2 associates with VEGFR1 forming complexes on  cell surface</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2223">
 <bp:evidence rdf:resource="#Evidence2552" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active ALK binds SRC</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2222">
 <bp:evidence rdf:resource="#Evidence2551" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active ALK binds FRS2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2221">
 <bp:evidence rdf:resource="#Evidence2550" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active ALK binds JAK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2229">
 <bp:evidence rdf:resource="#Evidence2561" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">VAV exchanges GTP for GDP on RAC1, activating it</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2217">
 <bp:evidence rdf:resource="#Evidence2546" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active ALK binds SHC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2216">
 <bp:evidence rdf:resource="#Evidence2545" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ALK gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2215">
 <bp:evidence rdf:resource="#Evidence2544" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active ALK recruits PI3K</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2214">
 <bp:evidence rdf:resource="#Evidence2543" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active ALK dimer binds IRS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2213">
 <bp:evidence rdf:resource="#Evidence2542" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI3K synthesizes PIP3 downstream of ALK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2212">
 <bp:evidence rdf:resource="#Evidence2541" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active ALK phosphorylates JAK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2211">
 <bp:evidence rdf:resource="#Evidence2540" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Liganded-ALK dimer binds type I ALK-binding TKIs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2210">
 <bp:evidence rdf:resource="#Evidence2539" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active ALK binds PLCG1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2219">
 <bp:evidence rdf:resource="#Evidence2548" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active ALK phosphorylates SRC</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2218">
 <bp:evidence rdf:resource="#Evidence2547" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ALK autophosphorylation </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2206">
 <bp:evidence rdf:resource="#Evidence2535" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AcK685 p-Y705, S727 STAT3 dimer and DNMT1 bind IL2RG gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2205">
 <bp:evidence rdf:resource="#Evidence2534" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ALK- and STAT3-dependent HIF1A gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2204">
 <bp:evidence rdf:resource="#Evidence2533" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y705, S727 STAT3 dimer binds CD274 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2203">
 <bp:evidence rdf:resource="#Evidence2532" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRDM1 gene expression downstream of ALK signaling</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2202">
 <bp:evidence rdf:resource="#Evidence2531" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HDACs deacetylate p-STAT3 dimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2201">
 <bp:evidence rdf:resource="#Evidence2530" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AcK685-p-Y705,S727 STAT3 and SIN3A bind the PDRM1 promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2200">
 <bp:evidence rdf:resource="#Evidence2529" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y705, S727 STAT3 dimer binds HIF1A gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2209">
 <bp:evidence rdf:resource="#Evidence2538" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active ALK phosphorylates PLCG1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2208">
 <bp:evidence rdf:resource="#Evidence2537" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL2RG gene expression downstream of ALK signaling</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2207">
 <bp:evidence rdf:resource="#Evidence2536" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AcK685-p-Y705,S727 STAT3 and SIN3A bind the IL2RG promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1305">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1134" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2637">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2304" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1304">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1133" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2638">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2305" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1303">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1132" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2639">
 <bp:stepProcess rdf:resource="#Pathway335" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1302">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1131" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1309">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1138" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2633">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2300" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1308">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1137" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2634">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2301" />
 <bp:stepProcess rdf:resource="#Catalysis728" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1307">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1136" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2635">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2302" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1306">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1135" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2636">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2303" />
 <bp:stepProcess rdf:resource="#Catalysis729" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2630">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2297" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2631">
 <bp:stepProcess rdf:resource="#Catalysis727" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2298" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2632">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2299" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1301">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1130" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1300">
 <bp:stepProcess rdf:resource="#Pathway172" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway162">
 <bp:pathwayOrder rdf:resource="#PathwayStep1316" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1327" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1404" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1315" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1204" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1314" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1369" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1203" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1379" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1408" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1318" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1317" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1405" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1385" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1296" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1295" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1294" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1202" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1201" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1200" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1199" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1375" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1386" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1042" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1041" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1040" />
 <bp:pathwayComponent rdf:resource="#Pathway173" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1039" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1127" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1204" />
 <bp:pathwayComponent rdf:resource="#Pathway183" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1038" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1126" />
 <bp:pathwayComponent rdf:resource="#Pathway186" />
 <bp:pathwayComponent rdf:resource="#Pathway163" />
 <bp:pathwayComponent rdf:resource="#Pathway174" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1146" />
 <bp:pathwayComponent rdf:resource="#Pathway180" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1223" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1145" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1144" />
 <bp:pathwayComponent rdf:resource="#Pathway182" />
 <bp:pathwayComponent rdf:resource="#Pathway170" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1143" />
 <bp:pathwayComponent rdf:resource="#Pathway181" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1220" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1199" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Class A/1 (Rhodopsin-like receptors)</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Rhodopsin-like receptors (class A/1) are the largest group of GPCRs and are the best studied group from a functional and structural point of view. They show great diversity at the sequence level and thus, can be subdivided into 19 subfamilies (Subfamily A1-19) based on a phylogenetic analysis (Joost P and  Methner A, 2002). They represent members which include hormone, light and neurotransmitter receptors and encompass a wide range of functions including many autocrine, paracrine and endocrine processes.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway161">
 <bp:pathwayOrder rdf:resource="#PathwayStep1418" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1198" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1409" />
 <bp:pathwayComponent rdf:resource="#Pathway162" />
 <bp:pathwayComponent rdf:resource="#Pathway188" />
 <bp:pathwayComponent rdf:resource="#Pathway187" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1198" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GPCR ligand binding</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">There are more than 800 G-protein coupled receptor (GPCRs) in the human genome, making it the largest receptor superfamily. GPCRs are also the largest class of drug targets, involved in virtually all physiological processes (Frederiksson 2003). GPCRs are receptors for a diverse range of ligands from large proteins to photons (Kristiansen et al. 2004) and have an equal diversity of ligand-binding mechanisms (Gether et al. 2002). Classical GPCR signaling involves signal transduction via heterotrimeric G-proteins, though G-protein independent mechanisms have been reported.  Rhodopsin-like receptors (class A/1) are by far the largest group of GPCRs and the best studied, though a large proportion of the functional and structural studies have focused on a very few members; many remain functionally uncharacterized. This large family can be subdivided into at least 19 subfamilies (Subfamily A1-19) based on phylogenetic analysis (Joost    Methner 2002). Family A includes receptors for a wide variety of ligands including hormones, light and neurotransmitters, encompassing a wide range of functions including many autocrine, paracrine and endocrine processes. The secretin-like family B/2 GPCRs includes receptors for many hormone-like peptides, such as secretin, calcitonin, parathyroid hormone/parathyroid hormone-related peptides and vasoactive intestinal peptide, which activate adenylyl cyclase and the phosphatidyl-inositol-calcium pathway (Harmar 2001). The class C/3 GPCRs include the metabotropic glutamate receptors and taste receptors (Brauner-Osborne et al. 2007).  All have a large extracellular N-terminus that structurally resembles a clamshell and has an important role in ligand binding. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway164">
 <bp:pathwayOrder rdf:resource="#PathwayStep1209" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1208" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1211" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1210" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1048" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1047" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1046" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1045" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1208" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Orexin and neuropeptides FF and QRFP bind to their respective receptors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The orphan G protein-coupled receptors mentioned here regulate sleep and appetite.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway163">
 <bp:pathwayOrder rdf:resource="#PathwayStep1228" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1227" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1226" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1225" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1269" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1229" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1220" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1224" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1268" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1223" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1267" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1222" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1266" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1221" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1271" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1270" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1239" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1275" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1230" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1274" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1273" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1272" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1235" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1279" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1234" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1278" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1277" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1276" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1282" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1281" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1280" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1206" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1205" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1207" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1242" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1241" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1285" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1240" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1284" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1283" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1246" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1245" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1244" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1243" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1293" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1217" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1219" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1218" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1212" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1054" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1053" />
 <bp:pathwayComponent rdf:resource="#Pathway164" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1059" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1058" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1057" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1056" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1055" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1099" />
 <bp:pathwayComponent rdf:resource="#Pathway169" />
 <bp:pathwayComponent rdf:resource="#Pathway166" />
 <bp:pathwayComponent rdf:resource="#Pathway165" />
 <bp:pathwayComponent rdf:resource="#Pathway168" />
 <bp:pathwayComponent rdf:resource="#Pathway167" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1043" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1125" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1044" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1076" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1075" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1074" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1073" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1117" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1116" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1115" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1114" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1113" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1079" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1112" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1078" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1111" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1077" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1110" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1065" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1064" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1063" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1062" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1061" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1060" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1106" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1105" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1104" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1103" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1069" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1102" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1101" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1100" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1109" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1108" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1107" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1205" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Peptide ligand-binding receptors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">These receptors, a subset of the Class A/1 (Rhodopsin-like) family, all bind peptide ligands which include the chemokines, opioids and somatostatins.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway160">
 <bp:pathwayOrder rdf:resource="#PathwayStep1183" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1182" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1181" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1180" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1176" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1185" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1184" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1179" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1178" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1177" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1018" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1017" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1026" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1025" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1024" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1023" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1022" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1021" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1020" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1019" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1176" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GPER1 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GPER1 (also known as GPR30) is an orphan G-protein coupled receptor that has been suggested to act as an alternate estrogen receptor (Revankar et al, 2005; Filardo et al, 2007; reviewed in Prossnitz and Barton, 2011; Gaudet et al, 2015). In support of this, a number of studies have shown that GPER1 stimulates MAPK and cAMP activation in response to estrogen in ESR1 negative breast cancer cells. Similar to classical ESR1-mediated signaling, this estrogen-responsive GPER1 is suggested to act through G beta gamma and to involve EGFR transactivation (Filardo et al, 2000; Filardo et al, 2002; reviewed in Filardo and Thomas, 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway169">
 <bp:pathwayOrder rdf:resource="#PathwayStep1292" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1291" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1290" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1286" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1289" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1288" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1287" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1124" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1123" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1122" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1121" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1120" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1119" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1118" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1286" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Vasopressin-like receptors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The vasopressins are peptide hormones consisting of nine amino acids (nonapeptides). They include arginine vasopressin (AVP; anti-diuretic hormone, ADH) and oxytocin. They are synthesized in the hypothalamus from a precursor and released from stores in the posterior pituitary into the blood stream. One of the most important roles of vasopressins is the regulation of water retention in the body. Oxytocin is important in uterine contraction during birth. The vasopressins act via AVP and oxytocin receptors. These are connected to G proteins which act as second messengers and convey the signal inside the cell.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway166">
 <bp:pathwayOrder rdf:resource="#PathwayStep1231" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1233" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1232" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1068" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1067" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1066" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1231" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tachykinin receptors bind tachykinins</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tachykinin peptides are one of the largest family of neuropeptides, so named due to their ability to rapidly induce contraction of gut tissue. Tachykinins excite neurons, elicit behavioural responses, are potent vasodilators and contract many smooth muscles. The tachykinin family is characterized by a common C-terminal sequence, Phe-X-Gly-Leu-Met-NH2 (where X can be either an aromatic or an aliphatic amino acid) and are ten to twelve residues long.  These peptides elicit their effects via the tachykinin receptors, of which there are three types in humans (NK1,2 and 3). There are two human tachykinin peptide genes in humans, TAC1 and TAC3. TAC1 encodes substance P and substance K while TAC3 encodes neurokinin B.  Antagonists of these receptors are promising candidates for classes of antidepressants, anxiolytics and antipsychotics.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway165">
 <bp:pathwayOrder rdf:resource="#PathwayStep1216" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1215" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1214" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1213" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1049" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1052" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1051" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1050" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1213" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Relaxin receptors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Relaxins are part of a family of peptide hormones that diverged from insulin in early vertebrate evolution to form the insulin-like peptides and relaxins, now often referred to as the relaxin peptide family. All are heterodimers; both chains are cleaved from a common propeptide and cross-linked by 2 disulphide bonds. Humans have 3 true relaxins encoded by 3 related genes, plus several more distantly related insulin-like peptide genes. Non-primates have 2 relaxin genes. The major circulating form of relaxin in humans is relaxin-2, equivalent to relaxin-1 in non-primates. Relaxin-3 is very highly conserved. Little is known about human relaxin-1; several of the insulin-like peptides have no known receptor or function.   There are 4 human G-protein coupled receptors for relaxin family peptides. Relaxin receptor 1 (RXFP1) and relaxin receptor 2 (RXFP2) are also known as LGR7 and LGR8 respectively, members of the LRR-containing G protein-coupled receptors (LGRs). Relaxin-3 receptor 1 (RXFP3) and Relaxin-3 receptor 2 (RXFP4) are unrelated, having more homology with small peptide receptors such as the somatostatin receptors.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway168">
 <bp:pathwayOrder rdf:resource="#PathwayStep1249" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1248" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1259" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1247" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1258" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1253" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1264" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1252" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1263" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1251" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1262" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1250" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1261" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1257" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1256" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1255" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1254" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1265" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1260" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1090" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1087" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1098" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1086" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1097" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1085" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1096" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1084" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1095" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1083" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1094" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1082" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1093" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1081" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1092" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1080" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1091" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1089" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1088" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1247" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Chemokine receptors bind chemokines</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Chemokine receptors are cytokine receptors found on the surface of certain cells, which interact with a type of cytokine called a chemokine. Following interaction, these receptors trigger a flux of intracellular calcium which leads to chemotaxis. Chemokine receptors are divided into different families, CXC chemokine receptors, CC chemokine receptors, CX3C chemokine receptors and XC chemokine receptors that correspond to the 4 distinct subfamilies of chemokines they bind.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway167">
 <bp:pathwayOrder rdf:resource="#PathwayStep1238" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1237" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1236" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1072" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1071" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1070" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1236" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formyl peptide receptors bind formyl peptides and many other ligands</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The formyl peptide receptor (FPR) was defined pharmacologically in 1976 as a high affinity binding site on the surface of neutrophils for the peptide N-formyl-methionine-leucine-phenylalanine (fMLF). FPR was cloned in 1990 and the cDNA used as a probe to identify two additional genes, FPRL1 and FPRL2. The three genes for a cluster on 19q13.3. All are coupled to the Gi family of G proteins.   All 3 receptors can be activated by formyl peptides but also display affinities for a range of structurally diverse ligands. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep1316">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1145" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2648">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2311" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1315">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1144" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2649">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2312" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1314">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1143" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1313">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1142" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2644">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2309" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1319">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1147" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2645">
 <bp:stepProcess rdf:resource="#Pathway337" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1318">
 <bp:stepProcess rdf:resource="#Pathway173" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2646">
 <bp:stepProcess rdf:resource="#Pathway338" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1317">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1146" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2647">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2310" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2640">
 <bp:stepProcess rdf:resource="#Pathway336" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2641">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2306" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2642">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2307" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2643">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2308" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1312">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1141" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1311">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1140" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1310">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1139" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway151">
 <bp:pathwayOrder rdf:resource="#PathwayStep1110" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1113" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1112" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1111" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction963" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction962" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction961" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction960" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1110" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G beta:gamma signalling through PI3Kgamma</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI3K gamma (PI3KG) is a heterodimer consisting of a p110 catalytic subunit associated with a regulatory p101 or p84 subunit. PI3KG is most highly expressed in neutrophils, where the p101 form predominates (approximately 95%). G beta:gamma recruits PI3KG to the plasma membrane, both activating PI3KG and providing access to its substrate PIP2, which is converted to PIP3.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway150">
 <bp:pathwayOrder rdf:resource="#PathwayStep1107" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1108" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction959" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction958" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1107" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G beta:gamma signalling through PLC beta</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phospholipase C beta (PLCbeta) isoforms are activated by G-protein beta:gamma in the order PLCB3 &gt; PLCB2 &gt; PLCB1. Gbeta:gamma binds to the pleckstrin homology domain of PLC beta,  increasing phospholipase activity and leading to increased hydrolysis of PIP2 to DAG and IP3.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway153">
 <bp:pathwayOrder rdf:resource="#PathwayStep1119" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1121" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1120" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1124" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1123" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1122" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction970" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction972" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction971" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction967" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction969" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction968" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1119" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G beta:gamma signalling through CDC42</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G-Protein Coupled Receptors (GPCR) sense extracellular signals and activate different Guanine nucleotide binding proteins (G-proteins) that have alpha, beta and gamma subunits. Upon activation, the alpha subunit of G-proteins dissociates from beta-gamma and the both are then free to regulate downstream effectors. Serine/threonine-protein kinase PAK 1 binds with Rho guanine nucleotide exchange factor 6 (ARHGEF6, PIX-Alpha) in the cytosol and is subsequently translocated by the G-protein beta-gamma complex to the plasma membrane. Here, ARHGEF6 activates Cell division control protein 42 homolog (CDC42) by acting as a GEF. Once active, CDC42 can facilitate the activation of PAK1. CDC42 is known to be involved in epithelial cell polarization processes.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway152">
 <bp:pathwayOrder rdf:resource="#PathwayStep1117" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1116" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1115" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction965" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction964" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction966" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1115" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G beta:gamma signalling through BTK</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G-Protein Coupled Receptors (GPCR) sense extracellular signals and activate different Guanine nucleotide binding proteins (G-proteins) that have alpha, beta and gamma subunits. Upon activation, the alpha subunit of G-proteins dissociates from beta-gamma and the both are then free to regulate downstream effectors. G-protein beta-gamma complex, along with phosphatidylinositol 3,4,5-trisphosphate (PIP3), recruits the non-receptor Tyrosine-protein kinase BTK to the cell membrane. Here, the G-protein beta-gamma complex activates BTK. Subsequently, active BTK dissociates from the complex to phosphorylate downstream substrates. Physiologically, BTK plays a key role in B lymphocyte development, differentiation and signalling.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway159">
 <bp:pathwayOrder rdf:resource="#PathwayStep1187" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1175" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1186" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1174" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1196" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1173" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1195" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1169" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1168" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1167" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1189" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1166" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1188" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1190" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1172" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1194" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1171" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1193" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1170" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1192" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1191" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1010" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1032" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1031" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1030" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1029" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1028" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1016" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1027" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1015" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1037" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1014" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1036" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1013" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1035" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1012" />
 <bp:pathwayComponent rdf:resource="#Pathway160" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1034" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1011" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1033" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1009" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1008" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1166" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G alpha (s) signalling events</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The general function of the G alpha (s) subunit (Gs) is to activate adenylate cyclase (Tesmer et al. 1997), which in turn produces cAMP, leading to the activation of cAMP-dependent protein kinases (often referred to collectively as Protein Kinase A). The signal from the ligand-stimulated GPCR is amplified because the receptor can activate several Gs heterotrimers before it is inactivated. Another downstream effector of G alpha (s) is the protein tyrosine kinase c-Src (Ma et al. 2000).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway158">
 <bp:pathwayOrder rdf:resource="#PathwayStep1159" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1161" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1160" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1163" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1162" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1158" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1006" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1005" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1004" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1003" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1002" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1001" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1158" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EGFR Transactivation by Gastrin</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Gastrin, through the action of diacylglycerol produced from downstream G alpha (q) events, transactivates EGFR via a PKC-mediated pathway by activation of MMP3 (Matrix Metalloproteinase 3) which allows formation of mature HBEGF (heparin-binding epidermal growth factor) by cleaving pro-HBEGF. Mature HBEGF is then free to bind the EGFR, resulting in EGFR activation (Dufresne et al. 2006, Liebmann 2011).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway155">
 <bp:pathwayOrder rdf:resource="#PathwayStep1139" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1138" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1143" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1142" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1141" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1140" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1147" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction985" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction984" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction987" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction986" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction992" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction988" />
 <bp:pathwayComponent rdf:resource="#Pathway156" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1138" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Effects of PIP2 hydrolysis</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hydrolysis of phosphatidyl inositol-bisphosphate (PIP2) by phospholipase C (PLC) produces diacylglycerol (DAG) and inositol triphosphate (IP3). Both are potent second messengers. IP3 diffuses into the cytosol, but as DAG is a hydrophobic lipid it remains within the plasma membrane. IP3 stimulates the release of calcium ions from the smooth endoplasmic reticulum, while DAG activates the conventional and unconventional protein kinase C (PKC) isoforms, facilitating the translocation of PKC from the cytosol to the plasma membrane. The effects of DAG are mimicked by tumor-promoting phorbol esters. DAG is also a precursor for the biosynthesis of prostaglandins, the endocannabinoid 2-arachidonoylglycerol and an activator of a subfamily of TRP-C (Transient Receptor Potential Canonical) cation channels 3, 6, and 7.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway154">
 <bp:pathwayOrder rdf:resource="#PathwayStep1129" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1128" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1127" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1149" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1126" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1137" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1148" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1132" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1154" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1131" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1153" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1130" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1152" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1151" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1136" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1135" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1134" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1133" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1150" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction974" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction996" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction973" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction995" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction976" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction998" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction975" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction997" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction981" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction980" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction983" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction994" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction982" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction993" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction978" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction977" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction979" />
 <bp:pathwayComponent rdf:resource="#Pathway155" />
 <bp:pathwayComponent rdf:resource="#Pathway157" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1126" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G alpha (q) signalling events</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The classic signalling route for G alpha (q) is activation of phospholipase C beta thereby triggering phosphoinositide hydrolysis, calcium mobilization and protein kinase C activation. This provides a path to calcium-regulated kinases and phosphatases, GEFs, MAP kinase cassettes and other proteins that mediate cellular responses ranging from granule secretion, integrin activation, and aggregation in platelets. Gq participates in many other signalling events including direct interaction with RhoGEFs that stimulate RhoA activity and inhibition of PI3K. Both in vitro and in vivo, the G-protein Gq seems to be the predominant mediator of the activation of platelets. Moreover, G alpha (q) can stimulate the activation of Burton tyrosine kinase (Ma Y C et al. 1998). Regulator of G-protein Signalling (RGS) proteins can regulate the activity of G alpha (z) (Soundararajan M et al. 2008).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway157">
 <bp:pathwayOrder rdf:resource="#PathwayStep1164" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1157" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1156" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1155" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1007" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1000" />
 <bp:pathwayComponent rdf:resource="#Pathway158" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction999" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1155" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Gastrin-CREB signalling pathway via PKC and MAPK</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Gastrin is a hormone whose main function is to stimulate secretion of hydrochloric acid by the gastric mucosa, which results in gastrin formation inhibition. This hormone also acts as a mitogenic factor for gastrointestinal epithelial cells. Gastrin has two biologically active peptide forms, G34 and G17.Gastrin gene expression is upregulated in both a number of pre-malignant conditions and in established cancer through a variety of mechanisms. Depending on the tissue where it is expressed and the level of expression, differential processing of the polypeptide product leads to the production of different biologically active peptides. In turn, acting through the classical gastrin cholecystokinin B receptor CCK-BR, its isoforms and alternative receptors, these peptides trigger signalling pathways which influence the expression of downstream genes that affect cell survival, angiogenesis and invasion (Wank 1995, de Weerth et al. 1999, Grabowska    Watson 2007)</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway156">
 <bp:pathwayOrder rdf:resource="#PathwayStep1146" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1145" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1144" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction991" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction990" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction989" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1144" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Arachidonate production from DAG</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Diacylglycerol (DAG) is an important source of arachidonic acid, a signalling molecule and the precursor of the prostaglandins. In human platelet almost all the DAG produced from phosphatidylinositol degradation contains arachidonate (Takamura et al. 1987). DAG is hydrolysed by DAG lipase to 2-arachidonylglycerol (2-AG) which is further hydrolysed by monoacylglycerol lipase. 2-AG is an agonist of cannabinoid receptor 1.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep2615">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2282" />
 <bp:stepProcess rdf:resource="#Catalysis721" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2616">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2283" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2617">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2284" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2618">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2285" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction398">
 <bp:evidence rdf:resource="#Evidence458" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ROCK activation by RHO</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2611">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2278" />
 <bp:stepProcess rdf:resource="#Catalysis718" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction397">
 <bp:evidence rdf:resource="#Evidence456" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated RHOA, RHOG, RAC1 and CDC42 bind KTN1 (kinectin)</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2612">
 <bp:stepProcess rdf:resource="#Catalysis719" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2279" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2613">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2280" />
 <bp:stepProcess rdf:resource="#Catalysis720" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction399">
 <bp:evidence rdf:resource="#Evidence459" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Myosin phosphatase inactivation by ROCK</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2614">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2281" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2610">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2277" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway140">
 <bp:pathwayOrder rdf:resource="#PathwayStep1065" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1036" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction921" />
 <bp:pathwayComponent rdf:resource="#Pathway141" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1036" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CaM pathway</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Calmodulin (CaM) is a small acidic protein that contains four EF-hand motifs, each of which can bind a calcium ion, therefore it can bind up to four calcium ions. The protein has two approximately symmetrical domains, separated by a flexible hinge region. Calmodulin is the prototypical example of the EF-hand family of Ca2+-sensing proteins. Changes in intracellular Ca2+ concentration regulate calmodulin in three distinct ways. First, by directing its subcellular distribution. Second, by promoting association with different target proteins. Third, by directing a variety of conformational states in calmodulin that result in target-specific activation. Calmodulin binds and activates several effector protein (e.g. the CaM-dependent adenylyl cyclases, phosphodiesterases,  protein kinases and the protein phosphatase calcineurin).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway142">
 <bp:pathwayOrder rdf:resource="#PathwayStep1039" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1049" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1044" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1043" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1042" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1041" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1048" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1047" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1046" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1045" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1040" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1051" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1050" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction899" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction910" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction898" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction905" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction904" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction907" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction906" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction901" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction900" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction903" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction902" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction909" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction908" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1039" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CaMK IV-mediated phosphorylation of CREB</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The Ca2+-calmodulin-dependent protein kinase (CaM kinase) cascade includes three kinases: CaM-kinase kinase (CaMKK); and the CaM kinases CaMKI and CaMKIV, which are phosphorylated and activated by CaMKK. Members of this cascade respond to elevation of intracellular Ca2+ levels. CaMKK and CaMKIV localize both to the nucleus and to the cytoplasm, whereas CaMKI is only cytosolic. Nuclear CaMKIV regulates transcription through phosphorylation of several transcription factors, including CREB. In the cytoplasm, there is extensive cross-talk between CaMKK, CaMKIV and other signaling cascades, including those that involve the cAMP-dependent kinase (PKA), MAP kinases and protein kinase B (PKB/Akt).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway141">
 <bp:pathwayOrder rdf:resource="#PathwayStep1038" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1061" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1064" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1052" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1037" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction897" />
 <bp:pathwayComponent rdf:resource="#Pathway142" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction920" />
 <bp:pathwayComponent rdf:resource="#Pathway143" />
 <bp:pathwayComponent rdf:resource="#Pathway145" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1037" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Calmodulin induced events</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">One important physiological role for Calmodulin is the regulation of adenylylcyclases. Four of the nine known adenylylcyclases are calcium sensitive, in particular type 8 (AC8).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway148">
 <bp:pathwayOrder rdf:resource="#PathwayStep1104" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1099" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1098" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1097" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1096" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1103" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1102" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1101" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1100" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1091" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1090" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1095" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1094" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1093" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1092" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction952" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction951" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction943" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction954" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction953" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction950" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction949" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction948" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction945" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction956" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction944" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction955" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction947" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction946" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction957" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1090" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G alpha (12/13) signalling events</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The G12/13 family is probably the least well characterized subtype, partly because G12/13 coupling is difficult to determine when compared with the other subtypes which predominantly rely on assay technologies that measure intracellular calcium. The G12/13 family are best known for their involvement in the processes of cell proliferation and morphology, such as stress fiber and focal adhesion formation. Interactions with Rho guanine nucleotide exchange factors (RhoGEFs)  are thought to mediate many of these processes. (Buhl et al.1995, Sugimoto et al. 2003). Activation of Rho or the regulation of events through Rho is often taken as evidence of G12/13 signaling. Receptors that are coupled with G12/13 invariably couple with one or more other G protein subtypes, usually Gq.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway147">
 <bp:pathwayOrder rdf:resource="#PathwayStep1077" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1076" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1075" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1078" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction930" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction932" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction931" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction929" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1075" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Adenylate cyclase activating pathway</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Stimulatory G proteins activate adenylate cyclase, which drives the conversion of cAMP from ATP and in turn activates cAMP-dependent protein kinase and subsequent kinase pathways.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway149">
 <bp:pathwayOrder rdf:resource="#PathwayStep1118" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1106" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1109" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1114" />
 <bp:pathwayComponent rdf:resource="#Pathway151" />
 <bp:pathwayComponent rdf:resource="#Pathway150" />
 <bp:pathwayComponent rdf:resource="#Pathway153" />
 <bp:pathwayComponent rdf:resource="#Pathway152" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1106" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G-protein beta:gamma signalling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The classical role of the G-protein beta/gamma dimer was believed to be the inactivation of the alpha subunit, Gbeta/gamma was viewed as a negative regulator of Galpha signalling. It is now known that Gbeta/gamma subunits can directly modulate many effectors, including some also regulated by G alpha.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway144">
 <bp:pathwayOrder rdf:resource="#PathwayStep1059" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1058" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1057" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1056" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction916" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction915" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction914" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction913" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1056" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKA activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">A number of inactive tetrameric PKA holoenzymes are produced by the combination of homo- or heterodimers of the different regulatory subunits associated with two catalytic subunits. When cAMP binds to two specific binding sites on the regulatory subunits, these undergo a conformational change that causes the dissociation of a dimer of regulatory subunits bound to four cAMP from two monomeric, catalytically active PKA subunits.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep2619">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2286" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway143">
 <bp:pathwayOrder rdf:resource="#PathwayStep1060" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1055" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1054" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1053" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction917" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction912" />
 <bp:pathwayComponent rdf:resource="#Pathway144" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction911" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1053" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKA-mediated phosphorylation of CREB</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cyclic adenosine 3&apos;,5&apos;-monophosphate (cAMP) induces gene transcription through activation of cAMP-dependent protein kinase (PKA), and subsequent phosphorylation of the transcription factor cAMP response element-binding protein, CREB, at serine-133.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway146">
 <bp:pathwayOrder rdf:resource="#PathwayStep1069" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1068" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1067" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction923" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction922" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction924" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1067" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">phospho-PLA2 pathway</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phospholipase A2 (PLA2) enzymes hydrolyze arachidonic acid (AA) from the sn-2 position of phospholipids. AA is a precursor of eicosanoids, lipid mediators involved in inflammtory responses. PLA2 enzymes function as regulators of phospholipid acyl turnover, either as housekeepers for membrane repair or for the production of imflammatory lipid mediators. There are diverse forms of PLA2 enyzmes including secretory (sPLA2), calcium-independent and cytosolic (cPLA2). The cPLA2 form which mediates arachidonic acid release is annotated here.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway145">
 <bp:pathwayOrder rdf:resource="#PathwayStep1062" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1063" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction919" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction918" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1062" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cam-PDE 1 activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Human Ca2+/calmodulin-dependent phosphodiesterase PDE1 is  activated by the binding of calmodulin in the presence of Ca(2+).  PDE1 has three subtypes PDE1A, PDE1B and PDE1C and their role is to hydrolyze both cGMP and cAMP. Their role is to antagonize the increased concentration of the intracellular second messengers determined by the synthetic activity of the adenylate cyclase enzymes thus governing intracellular cAMP dynamics in response to changes in the cytosolic Ca2+ concentration. PDE1 are mainly cytosolic but different isoforms are expressed in different tissues.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep2626">
 <bp:stepProcess rdf:resource="#Catalysis726" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2293" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2627">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2294" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2628">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2295" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2629">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2296" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2622">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2289" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway129">
 <bp:pathwayOrder rdf:resource="#PathwayStep1197" />
 <bp:pathwayOrder rdf:resource="#PathwayStep980" />
 <bp:pathwayComponent rdf:resource="#Pathway161" />
 <bp:pathwayComponent rdf:resource="#Pathway130" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence980" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by GPCR</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G protein-coupled receptors (GPCRs; 7TM receptors; seven transmembrane domain receptors; heptahelical receptors; G protein-linked receptors [GPLR]) are the largest family of transmembrane receptors in humans, accounting for more than 1% of the protein-coding capacity of the human genome. All known GPCRs share a common architecture of seven membrane-spanning helices connected by intra- and extracellular loops. The extracellular loops contain two highly-conserved cysteine residues that form disulphide bonds to stabilize the structure of the receptor. They recognize diverse messengers such as light, odorants, small molecules, hormones and neurotransmitters. Most GPCRs act as guanine nucleotide exchange factors; activated by ligand binding, they promote GDP-GTP exchange on associated heterotrimeric guanine nucleotide-binding (G) proteins. There are two models for GPCR-G Protein interactions: 1) ligand-GPCR binding first, then binding to G Proteins; 2) &quot;Pre-coupling&quot; of GPCRs and G Proteins before ligand binding (review Oldham WM and Hamm HE, 2008). These in turn activate effector enzymes or ion channels. GPCRs are involved in a range of physiological roles which include the visual sense, smell, behavioural regulation, functions of the autonomic nervous system and regulation of the immune system and inflammation. GPCRs are divided into  classes based on sequence homology and functional similarity.  The main mammalian classes, in order of size, are the Rhodopsin-like family A, the Secretin receptor family B, and the Metabotropic glutamate/pheromone receptor family C. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep2623">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2290" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2624">
 <bp:stepProcess rdf:resource="#Catalysis724" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2291" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2625">
 <bp:stepProcess rdf:resource="#Catalysis725" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2292" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2620">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2287" />
 <bp:stepProcess rdf:resource="#Catalysis722" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2621">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2288" />
 <bp:stepProcess rdf:resource="#Catalysis723" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway131">
 <bp:pathwayOrder rdf:resource="#PathwayStep989" />
 <bp:pathwayOrder rdf:resource="#PathwayStep987" />
 <bp:pathwayOrder rdf:resource="#PathwayStep988" />
 <bp:pathwayOrder rdf:resource="#PathwayStep985" />
 <bp:pathwayOrder rdf:resource="#PathwayStep986" />
 <bp:pathwayOrder rdf:resource="#PathwayStep983" />
 <bp:pathwayOrder rdf:resource="#PathwayStep994" />
 <bp:pathwayOrder rdf:resource="#PathwayStep984" />
 <bp:pathwayOrder rdf:resource="#PathwayStep992" />
 <bp:pathwayOrder rdf:resource="#PathwayStep982" />
 <bp:pathwayOrder rdf:resource="#PathwayStep993" />
 <bp:pathwayOrder rdf:resource="#PathwayStep990" />
 <bp:pathwayOrder rdf:resource="#PathwayStep991" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction853" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction864" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction852" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction863" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction855" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction854" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction860" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction862" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction861" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction857" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction856" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction859" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction858" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence982" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G alpha (z) signalling events</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The heterotrimeric G protein G alpha (z), is a member of the G (i) family. Unlike other G alpha (i) family members it lacks an ADP ribosylation site cysteine four residues from the carboxyl terminus and is thus pertussis toxin-insensitive. It inhibits adenylyl cyclase types I, V and VI (Wong Y H et al. 1992). G alpha (z) interacts with the Rap1 GTPase activating protein (Rap1GAP) to attenuate Rap1 signaling. Like all G-proteins G alpha (z) has an intrinsic GTPase activity, but this activity tends to be lower for the pertussis toxin insensitive G-proteins, most strikingly so for G alpha (z), whose kcat value for GTP hydrolysis is 200-fold lower than those of G alpha (s) or G alpha (i) (Grazziano et al. 1989). G alpha (z) knockout mice have disrupted platelet aggregation at physiological concentrations of epinephrine and responses to several neuroactive drugs are altered (Yang et al. 2000). Regulator of G-protein Signalling (RGS) proteins can regulate the activity of G alpha (z) (Soundararajan M et al. 2008).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway130">
 <bp:pathwayOrder rdf:resource="#PathwayStep1105" />
 <bp:pathwayOrder rdf:resource="#PathwayStep995" />
 <bp:pathwayOrder rdf:resource="#PathwayStep981" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1165" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1125" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1089" />
 <bp:pathwayComponent rdf:resource="#Pathway131" />
 <bp:pathwayComponent rdf:resource="#Pathway148" />
 <bp:pathwayComponent rdf:resource="#Pathway159" />
 <bp:pathwayComponent rdf:resource="#Pathway149" />
 <bp:pathwayComponent rdf:resource="#Pathway132" />
 <bp:pathwayComponent rdf:resource="#Pathway154" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence981" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GPCR downstream signalling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G protein-coupled receptors (GPCRs) are classically defined as the receptor, G-protein and downstream effectors, the alpha subunit of the G-protein being the primary signaling molecule. However, it has become clear that this greatly oversimplifies the complexities of GPCR signaling (Gurevich    Gurevich 2008). The beta:gamma G-protein dimer is also involved in downstream signaling (Smrcka 2008) and some receptors form metastable complexes with accessory proteins such as the arrestins.  GPCRs are involved in many diverse signaling events (Kristiansen 2004), using a variety of pathways that include modulation of adenylyl cyclase, phospholipase C, the mitogen activated protein kinases (MAPKs), extracellular signal regulated kinase (ERK) c-Jun-NH2-terminal kinase (JNK) and p38 MAPK. Regulator of G-protein Signalling (RGS) proteins can directly inhibit the activity of the G-alpha subunit (Soundararajan et al. 2008). The general function of the G alpha-s subunit (Gs) is to activate adenylate cyclase (Tesmer et al. 1997), which in turn produces cyclic-AMP (cAMP), leading to the activation of cAMP-dependent protein kinases (often referred to collectively as Protein Kinase A). The signal from the ligand-stimulated GPCR is amplified because the receptor can activate several Gs heterotrimers before it is inactivated.  The classical signalling mechanism for G alpha-i (Gi) is inhibition of the cAMP dependent pathway through inhibition of adenylate cyclase (Dessauer et al. 2002). Decreased production of cAMP results in decreased activity of cAMP-dependent protein kinases.  G alpha-z (Gz) is a member of the Gi family. Unlike other Gi family members it is pertussis toxin-insensitive. Gz interacts with Rap1 GTPase activating protein (RAP1GAP) to attenuate Rap1 signaling. The classic signalling route for G alpha-q (Gq) is activation of phospholipase C beta, leading to phosphoinositide hydrolysis, calcium mobilization and protein kinase C activation. This provides a path to calcium-regulated kinases and phosphatases, GEFs, MAP kinases and many other proteins. The G-alpha-12/13 (G12/13) family is probably the least well characterized, at least in part because G12/13 coupling is more difficult to determine than for other subtypes, G12/13 is best known for involvement in the processes of cell proliferation and morphology, such as stress fiber and focal adhesion formation. Interactions with Rho guanine nucleotide exchange factors (RhoGEFs)  are thought to mediate many of these processes. (Buhl et al.1995, Sugimoto et al. 2003). Activation of Rho or the regulation of events through Rho is often taken as evidence of G12/13 signaling. Receptors that are coupled with G12/13 invariably couple with one or more other G protein subtypes, usually Gq. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway137">
 <bp:pathwayOrder rdf:resource="#PathwayStep1029" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1028" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1027" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1031" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1030" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction893" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction892" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction895" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction894" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction891" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1027" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Adenylate cyclase inhibitory pathway</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Guanine nucleotide-binding protein G(i) alpha (Gi-alpha) inhibits adenylate cyclase, thus inhibiting the production of cAMP from ATP and ultimately decreasing the activity of cAMP-dependent protein kinase.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway136">
 <bp:pathwayOrder rdf:resource="#PathwayStep1032" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1074" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1026" />
 <bp:pathwayComponent rdf:resource="#Pathway137" />
 <bp:pathwayComponent rdf:resource="#Pathway147" />
 <bp:pathwayComponent rdf:resource="#Pathway138" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1026" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G-protein mediated events</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">When dissociated Galpha-GTP and Gbeta-gamma can activate or inhibit different signalling cascades and effector proteins. The precise pathways depends on the identity of the alpha and beta/gamma subtypes.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway139">
 <bp:pathwayOrder rdf:resource="#PathwayStep1066" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1035" />
 <bp:pathwayComponent rdf:resource="#Pathway140" />
 <bp:pathwayComponent rdf:resource="#Pathway146" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1035" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ca-dependent events</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Calcium, as the ion Ca2+, is essential in many biological processes. The majority of Ca2+ in many organisms is bound to phosphates which form skeletal structures and also buffer Ca2+ levels in extracellular fluids (typically 1 millimolar). Intracellular free Ca2+, by contrast, is 10,000 times lower than the outside of the cell (typically 10 micromolar). This concentration gradient is used to import Ca2+ into cells where it acts as a second messenger.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway138">
 <bp:pathwayOrder rdf:resource="#PathwayStep1073" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1072" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1071" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1070" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1033" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1034" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction896" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction927" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction926" />
 <bp:pathwayComponent rdf:resource="#Pathway139" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction928" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction925" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1033" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PLC beta mediated events</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The phospholipase C (PLC) family of enzymes is both diverse and complex. The isoforms beta, gamma and delta (each have subtypes) make up the members of this family. PLC hydrolyzes phosphatidylinositol bisphosphate (PIP2) into two second messengers, inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). IP3 mobilizes intracellular calcium stores while DAG activates protein kinase C isoforms which are involved in regulatory functions.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway133">
 <bp:pathwayOrder rdf:resource="#PathwayStep1011" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1004" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1025" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1079" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1012" />
 <bp:pathwayComponent rdf:resource="#Pathway136" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction878" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction933" />
 <bp:pathwayComponent rdf:resource="#Pathway135" />
 <bp:pathwayComponent rdf:resource="#Pathway134" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1004" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Opioid Signalling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Opioids are chemical substances similar to opiates, the active substances found in opium  (morphine, codeine etc.). Opioid action is mediated by the receptors for endogenous opioids; peptides such as the enkephalins, the endorphins or the dynorphins.  Opioids possess powerful analgesic and sedative effects, and are widely used as pain-killers. Their main side-effect is the rapid establishment of a strong addiction.  Opioids receptors are G-protein coupled receptors (GPCR). There are four classes of receptors:  mu (MOR), kappa (KOR) and delta (DOR), and the nociceptin receptor (NOP). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway132">
 <bp:pathwayOrder rdf:resource="#PathwayStep998" />
 <bp:pathwayOrder rdf:resource="#PathwayStep999" />
 <bp:pathwayOrder rdf:resource="#PathwayStep996" />
 <bp:pathwayOrder rdf:resource="#PathwayStep997" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1000" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1088" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1087" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1086" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1085" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1003" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1002" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1001" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1080" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1084" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1083" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1082" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1081" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction941" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction940" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction866" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction865" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction942" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction871" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction870" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction938" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction937" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction939" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction868" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction934" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction867" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction936" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction869" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction935" />
 <bp:pathwayComponent rdf:resource="#Pathway133" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence996" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G alpha (i) signalling events</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The classical signalling mechanism for G alpha (i) is inhibition of the cAMP dependent pathway through inhibition of adenylate cyclase (Dessauer C W et al. 2002). Decreased production of cAMP from ATP results in decreased activity of cAMP-dependent protein kinases. Other functions of G alpha (i) includes activation of the protein tyrosine kinase c-Src (Ma Y C et al. 2000). Regulator of G-protein Signalling (RGS) proteins can regulate the activity of G alpha (i) (Soundararajan et al. 2008).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway135">
 <bp:pathwayOrder rdf:resource="#PathwayStep1019" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1018" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1017" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1016" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1022" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1021" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1020" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1015" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1014" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1013" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1024" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1023" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction886" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction885" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction888" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction887" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction882" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction881" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction884" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction883" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction880" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction890" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction879" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction889" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1013" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DARPP-32 events</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dopamine- and cAMP-regulated phosphoprotein, Mr 32 kDa (DARPP-32), was identified as a major target for dopamine and protein kinase A (PKA) in striatum. Recent advances now indicate that regulation DARPP-32 phosphorylation provides a mechanism for integrating information arriving at dopaminoceptive neurons, in multiple brain regions, via a variety of neurotransmitters, neuromodulators, neuropeptides, and steroid hormones. Activation of PKA or PKG stimulates DARPP-32 phosphorylation at Thr34, converting DARPP-32 into a potent inhibitor of protein phosphatase-1 (PP-1). DARPP-32 is also phosphorylated at Thr75 by Cdk5, converting DARPP-32 into an inhibitor of PKA. Thus, DARPP-32 has the unique property of being a dual-function protein, acting either as an inhibitor of PP-1 or of PKA.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway134">
 <bp:pathwayOrder rdf:resource="#PathwayStep1008" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1007" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1006" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1005" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1009" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1010" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction875" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction874" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction877" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction876" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction873" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction872" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1005" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G-protein activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Receptor activated heterotrimeric G proteins consist of the Galpha and the tightly associated Gbeta-gamma subunits.  When a ligand binds to a G protein-coupled receptor, it stabilises a conformation with an high affinity for the G-protein bound to GDP. GDP is then exchanged for GTP on the Galpha subunit. This exchange triggers the dissociation of the Galpha subunit from the Gbeta-gamma dimer and the receptor. Galpha-GTP and Gbeta-gamma, can then modulate different signalling cascades and effector proteins, while the receptor is able to activate another G protein, resulting in an amplification cascade. The Galpha subunit will eventually hydrolyze the attached GTP to GDP by its inherent enzymatic activity, allowing it to reassociate with Gbeta-gamma and start a new cycle.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep2604">
 <bp:stepProcess rdf:resource="#Catalysis713" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2271" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2605">
 <bp:stepProcess rdf:resource="#Catalysis714" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2272" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2606">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2273" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway99">
 <bp:pathwayOrder rdf:resource="#PathwayStep699" />
 <bp:pathwayOrder rdf:resource="#PathwayStep700" />
 <bp:pathwayOrder rdf:resource="#PathwayStep697" />
 <bp:pathwayOrder rdf:resource="#PathwayStep698" />
 <bp:pathwayOrder rdf:resource="#PathwayStep695" />
 <bp:pathwayOrder rdf:resource="#PathwayStep696" />
 <bp:pathwayOrder rdf:resource="#PathwayStep707" />
 <bp:pathwayOrder rdf:resource="#PathwayStep708" />
 <bp:pathwayOrder rdf:resource="#PathwayStep705" />
 <bp:pathwayOrder rdf:resource="#PathwayStep706" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction600" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction599" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction601" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction598" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction597" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction608" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction607" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction609" />
 <bp:pathwayComponent rdf:resource="#Pathway100" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction606" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence695" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of the beta-catenin:TCF transactivating complex</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Once in the nucleus, beta-catenin is recruited to WNT target genes through interaction with TCF/LEF transcription factors. This family, which consists of TCF7 (also known as TCF1), TCF7L1 (also known as TCF3), TCF7L2 (also known as TCF4) and TCF7L3 (also known as LEF1), are HMG-containing transcription factors that bind to the WNT responsive elements in target gene promoters (reviewed in Brantjes et al, 2002).  In the absence of WNT signal, TCF/LEF proteins recruit Groucho/TLE repressors to inhibit transcription; upon WNT stimulation, beta-catenin can displace Groucho/TLE from TCF/LEF proteins to initiate transcriptional activation (reviewed in Chen and Courey, 2000).  Although this model for WNT-dependent activation of target genes is widely accepted, it is important to note that TCF/LEF proteins are not redundant and can contribute to WNT target gene expression in a number of different ways (reviewed in Brantjes et al, 2002; MacDonald et al, 2009).  In particular, TCF7L1 (TCF3) is thought to have a more pronounced repressor function than other TCF/LEF family members.  A couple of recent studies in Xenopus and mammalian cells show that WNT- and beta-catenin-dependent phosphorylation of TCF7L1(TCF3) promotes its dissociation from the promoter of target genes and allows gene expression through relief of this repression activity (Hikasa et al, 2010; Hikasa et al, 2011).   The role of beta-catenin at WNT promoters hinges upon its ability to act as a scaffold for the recruitment of other proteins. The structure of beta-catenin consists of 12 imperfect ARM repeats (R1-12) flanked by an N-terminal and C-terminal extension (NTD and CTD respectively), with a conserved Helix C located between R12 and the CTD.  Nuclear beta-catenin interacts with TCF/LEF at WNT target genes through ARM domains 3-9 (Graham et al, 2000; Poy et al, 2001; Xing et al, 2008).  The N and the C terminal regions are important for the recruitment of transcriptional activator and repressors that contribute to WNT target gene expression (reviewed in Mosimann et al, 2009; Valenta et al, 2012).  The N-terminal ARM domains 1-4 recruit the WNT-pathway specific activators BCL9:PYGO while the C-terminal region (R11-CTD) interacts with a wide range of general transcriptional activators that are involved in chromatin remodelling and transcription initiation. These include HATs such as P300, CBP and TIP60, histone methyltransferases such as MLL1 and 2, SWI/SNF factors BRG1 and ISWI and components of the PAF complex (reviewed in Mosimann et al, 2009; Valenta et al, 2012).  Although many binding partners have been identified for the C-terminal region of beta-catenin, in many cases the timing and relationship of these interactions and indeed, the exact complex composition remains to be elucidated.  Moreover, because many of the interacting partners appear to bind to overlapping regions of beta-catenin, it is unlikely that they all bind simultaneously.  For simplicity, the interactions have been depicted as though they occur independently of one another; more accurately they are likely to cycle successively on and off beta-catenin to promote an active chromatin structure (reviewed in Willert and Jones, 2006; Valenta et al, 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep2607">
 <bp:stepProcess rdf:resource="#Catalysis715" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2274" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2600">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2267" />
 <bp:stepProcess rdf:resource="#Catalysis711" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2601">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2268" />
 <bp:stepProcess rdf:resource="#Catalysis712" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2602">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2269" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2603">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2270" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway94">
 <bp:pathwayOrder rdf:resource="#PathwayStep659" />
 <bp:pathwayOrder rdf:resource="#PathwayStep657" />
 <bp:pathwayOrder rdf:resource="#PathwayStep658" />
 <bp:pathwayOrder rdf:resource="#PathwayStep655" />
 <bp:pathwayOrder rdf:resource="#PathwayStep656" />
 <bp:pathwayOrder rdf:resource="#PathwayStep654" />
 <bp:pathwayOrder rdf:resource="#PathwayStep660" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction567" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction566" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction563" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction562" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction565" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction564" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction561" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence654" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Disassembly of the destruction complex and recruitment of AXIN to the membrane</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Upon stimulation with WNT ligand, AXIN and GSK3beta are recruited to the plasma membrane through interaction with DVL (Tamai et al, 2004; Mao et al, 2001; reviewed in He et al, 2004).  Polymerization of membrane-associated DVL and GSK3beta- and CSNK1-mediated phosphorylation of LRP5/6 establish a feed-forward mechanism for enhanced membrane recruitment of AXIN upon WNT signaling (Tamai et al, 2004; Cong et al, 2004; Zeng et al, 2005; Bilic et al, 2007).   In Xenopus oocytes, but not necessarily all sytems, AXIN is present in limiting concentrations and is considered rate limiting for the assembly of the destruction complex (Lee et al, 2003; Benchabane et al, 2008;  Tan et al, 2012; reviewed in MacDonald et al, 2009).  The recruitment of AXIN away from the destruction complex upon WNT stimulation effectively destabilizes the destruction complex and contributes to the accumulation of free beta-catenin (Kikuchi, 1999; Lee et al, 2003).  AXIN association with the destruction complex is also regulated by phosphorylation.  In the active destruction complex, AXIN is phosphorylated by GSK3beta; dephosphorylation by protein phosphatase 1 (PP1) or protein phosphatase 2A (PP2A) destabilizes the interaction of AXIN with the other components of the destruction complex and promotes its disassembly (Luo et al, 2007; Willert et al, 1999; Jho et al, 1999).  Free AXIN is also subject to degradation by the 26S proteasome in a manner that depends on the poly-ADP-ribosylating enzymes tankyrase 1 and 2 (Huang et al, 2009).   </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway93">
 <bp:pathwayOrder rdf:resource="#PathwayStep651" />
 <bp:pathwayOrder rdf:resource="#PathwayStep652" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction560" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction559" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence651" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Negative regulation of TCF-dependent signaling by DVL-interacting proteins</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DVL is a central component of WNT signaling that plays roles in both canonical and non-canonical pathways (reviewed in Gao and Chen, 2010).  In the canonical pathway, DVL recruits AXIN from the destruction complex upon WNT stimulation, allowing cytosolic beta-catenin to accumulate (reviewed in MacDonald et al, 2009).  DVL activity is regulated by phosphorylation as well as by regulated proteasomal or lysosomal degradation (reviewed in Gao and Chen, 2010).  In addition, DVL activity can be regulated by interaction with other proteins; both CXXC4 and CCDC88C were identified as negative regulators of WNT signaling that interact directly with DVL, although the role of these proteins in limiting WNT signaling remain to be fully worked out (Hino et al, 2001; Oshita et al, 2003; Ekici et al, 2010; Ishida-Takagishi et al, 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway92">
 <bp:pathwayOrder rdf:resource="#PathwayStep637" />
 <bp:pathwayOrder rdf:resource="#PathwayStep648" />
 <bp:pathwayOrder rdf:resource="#PathwayStep638" />
 <bp:pathwayOrder rdf:resource="#PathwayStep635" />
 <bp:pathwayOrder rdf:resource="#PathwayStep646" />
 <bp:pathwayOrder rdf:resource="#PathwayStep636" />
 <bp:pathwayOrder rdf:resource="#PathwayStep647" />
 <bp:pathwayOrder rdf:resource="#PathwayStep644" />
 <bp:pathwayOrder rdf:resource="#PathwayStep645" />
 <bp:pathwayOrder rdf:resource="#PathwayStep642" />
 <bp:pathwayOrder rdf:resource="#PathwayStep643" />
 <bp:pathwayOrder rdf:resource="#PathwayStep639" />
 <bp:pathwayOrder rdf:resource="#PathwayStep640" />
 <bp:pathwayOrder rdf:resource="#PathwayStep641" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction545" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction556" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction544" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction555" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction547" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction546" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction557" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction552" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction551" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction554" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction553" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction549" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction548" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction550" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence635" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Deactivation of the beta-catenin transactivating complex</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The mechanisms involved in downregulation of TCF-dependent transcription are not yet very well understood. beta-catenin is known to recruit a number of transcriptional repressors, including Reptin, SMRT and NCoR, to the TCF/LEF complex, allowing the transition from activation to repression (Bauer et al, 2000; Weiske et al, 2007; Song and Gelmann, 2008).  CTNNBIP1 (also known as ICAT) and Chibby are inhibitors of TCF-dependent signaling that function by binding directly to beta-catenin and preventing interactions with critical components of the transactivation machinery (Takemaru et al, 2003; Li et al, 2008; Tago et al, 2000; Graham et al, 2002; Daniels and Weiss, 2002).  Chibby additionally promotes the nuclear export of beta-catenin in conjunction with 14-3-3/YWHAZ proteins (Takemura et al, 2003; Li et al, 2008).  A couple of recent studies have also suggested a role for nuclear APC in the disassembly of the beta-catenin activation complex (Hamada and Bienz, 2004; Sierra et al, 2006). It is worth noting that while some of the players involved in the disassembly of the beta-catenin transactivating complex are beginning to be worked out in vitro, the significance of their role in vivo is not yet fully understood, and some can be knocked out with little effect on endogenous WNT signaling (see for instance Voronina et al, 2009).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway91">
 <bp:pathwayOrder rdf:resource="#PathwayStep714" />
 <bp:pathwayOrder rdf:resource="#PathwayStep649" />
 <bp:pathwayOrder rdf:resource="#PathwayStep679" />
 <bp:pathwayOrder rdf:resource="#PathwayStep669" />
 <bp:pathwayOrder rdf:resource="#PathwayStep688" />
 <bp:pathwayOrder rdf:resource="#PathwayStep634" />
 <bp:pathwayOrder rdf:resource="#PathwayStep678" />
 <bp:pathwayOrder rdf:resource="#PathwayStep653" />
 <bp:pathwayOrder rdf:resource="#PathwayStep709" />
 <bp:pathwayOrder rdf:resource="#PathwayStep662" />
 <bp:pathwayOrder rdf:resource="#PathwayStep650" />
 <bp:pathwayOrder rdf:resource="#PathwayStep661" />
 <bp:pathwayOrder rdf:resource="#PathwayStep694" />
 <bp:pathwayOrder rdf:resource="#PathwayStep670" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction558" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction568" />
 <bp:pathwayComponent rdf:resource="#Pathway99" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction575" />
 <bp:pathwayComponent rdf:resource="#Pathway94" />
 <bp:pathwayComponent rdf:resource="#Pathway93" />
 <bp:pathwayComponent rdf:resource="#Pathway92" />
 <bp:pathwayComponent rdf:resource="#Pathway98" />
 <bp:pathwayComponent rdf:resource="#Pathway97" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction614" />
 <bp:pathwayComponent rdf:resource="#Pathway96" />
 <bp:pathwayComponent rdf:resource="#Pathway95" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction583" />
 <bp:pathwayComponent rdf:resource="#Pathway101" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence634" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TCF dependent signaling in response to WNT</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">19 WNT ligands and 10 FZD receptors have been identified in human cells; interactions amongst these ligands and receptors vary in a developmental and tissue-specific manner and lead to activation of so-called &apos;canonical&apos; and &apos;non-canonical&apos; WNT signaling.  In the canonical WNT signaling pathway, binding of a WNT ligand to the Frizzled (FZD) and lipoprotein receptor-related protein (LRP) receptors results in the inactivation of the destruction complex, the stabilization and nuclear translocation of beta-catenin and subsequent activation of T-cell factor/lymphoid enhancing factor (TCF/LEF)-dependent transcription. Transcriptional activation in response to canonical WNT signaling controls processes such as cell fate, proliferation and self renewal of stem cells, as well as contributing to oncogenesis (reviewed in MacDonald et al, 2009; Saito-Diaz et al, 2013; Kim et al, 2013).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway98">
 <bp:pathwayOrder rdf:resource="#PathwayStep689" />
 <bp:pathwayOrder rdf:resource="#PathwayStep693" />
 <bp:pathwayOrder rdf:resource="#PathwayStep691" />
 <bp:pathwayOrder rdf:resource="#PathwayStep692" />
 <bp:pathwayOrder rdf:resource="#PathwayStep690" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction596" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction595" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction592" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction594" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction593" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence689" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Negative regulation of TCF-dependent signaling by WNT ligand antagonists</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Several unrelated families of secreted proteins antagonize WNT signaling.  Secreted frizzled-related proteins (sFRPs) have a cysteine rich domain (CRD) that is also found in FZD and ROR receptors, while WNT inhibitory factor (WIF) proteins contain a WIF domain also present in the WNT-receptor RYK.  Both these classes of secreted WNT antagonists inhibit signaling by binding to WNTs and preventing their interaction with the FZD receptors.  sFRPs may also able to bind the receptors, blocking ligand binding (Bafico et al, 1999; reviewed in Kawano and Kypta, 2003).  The interaction of WIF and sFRPs with WNT ligand may also play a role in regulating WNT diffusion and gradient formation (reviewed in Boloventa et al, 2008).  Dickkopf (DKK) and Sclerostin (SOST) family members, in contrast, antagonize WNT signaling by binding to LRP5/6.  There are four DKK family members in vertebrates; the closely related DKK1, 2 and 4 proteins have been shown to have roles in WNT signaling, while the more divergent DKK3 appears not to (Glinka et al, 1998; Fedi et al, 1999; Mao et al, 2001; Semenov et al, 2001; reviewed in Niehrs, 2006).  Secreted DKK proteins bind to LRP6 in conjunction with the single-pass transmembrane proteins Kremen 1 and 2, and this interaction is thought to disrupt the WNT-induced FZD-LRP5/6 complex.  In some cases, DKK2 has also been shown to function as a WNT agonist (reviewed in N (reviewed in Niehrs, 2006).   Like DKK proteins, SOST binds LRP5/6 and disrupts WNT-dependent receptor activation (Semenov et al, 2005).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway97">
 <bp:pathwayOrder rdf:resource="#PathwayStep686" />
 <bp:pathwayOrder rdf:resource="#PathwayStep687" />
 <bp:pathwayOrder rdf:resource="#PathwayStep684" />
 <bp:pathwayOrder rdf:resource="#PathwayStep685" />
 <bp:pathwayOrder rdf:resource="#PathwayStep682" />
 <bp:pathwayOrder rdf:resource="#PathwayStep683" />
 <bp:pathwayOrder rdf:resource="#PathwayStep680" />
 <bp:pathwayOrder rdf:resource="#PathwayStep681" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction589" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction588" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction585" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction584" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction587" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction586" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction591" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction590" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence680" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Degradation of AXIN</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AXIN is present in low concentrations in the cell and is considered to be the limiting component of the beta-catenin destruction complex in Xenopus; this may not be the case in mammalian cells, however (Lee et al, 2003; Tan et al, 2012).  Cellular levels of AXIN are regulated in part through ubiquitin-mediated turnover.  E3 ligases SMURF2 and RNF146 have both been shown to play a role in promoting the degradation of AXIN by the 26S proteasome (Kim and Jho, 2010; Callow et al, 2011; Zhang et al, 2011).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway96">
 <bp:pathwayOrder rdf:resource="#PathwayStep677" />
 <bp:pathwayOrder rdf:resource="#PathwayStep675" />
 <bp:pathwayOrder rdf:resource="#PathwayStep676" />
 <bp:pathwayOrder rdf:resource="#PathwayStep673" />
 <bp:pathwayOrder rdf:resource="#PathwayStep674" />
 <bp:pathwayOrder rdf:resource="#PathwayStep671" />
 <bp:pathwayOrder rdf:resource="#PathwayStep672" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction578" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction577" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction579" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction576" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction581" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction580" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction582" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence671" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Degradation of DVL</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DVL protein levels are regulated by both proteasomal and lysosomal degradation (reviewed in Gao and Chen, 2010). The E3 ligases HECF1, ITCH and KLHL12:CUL3 have all been shown to contribute to the polyubiquitination and subsequent degradation of DVL (Angers et al, 2006; Miyazaki et al, 2004; Wei et al, 2012).  DVL stability is also regulated by its interaction with DACT1, which promotes degradation of DVL in the lysosome (Cheyette et al, 2002; Zhang et al, 2006).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway95">
 <bp:pathwayOrder rdf:resource="#PathwayStep668" />
 <bp:pathwayOrder rdf:resource="#PathwayStep666" />
 <bp:pathwayOrder rdf:resource="#PathwayStep667" />
 <bp:pathwayOrder rdf:resource="#PathwayStep664" />
 <bp:pathwayOrder rdf:resource="#PathwayStep665" />
 <bp:pathwayOrder rdf:resource="#PathwayStep663" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction569" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction574" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction573" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction570" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction572" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction571" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence663" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of FZD by ubiquitination</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WNT responsiveness is influenced by expression levels of FZD and LRP proteins.  Levels of these receptors at the cell surface are regulated in part by endocytosis, but the mechanisms are not fully elucidated (Garliardi et al, 2008).  A number of recent studies have identified a role for ubiquitination in the localization and turnover of WNT receptors at the plasma membrane.  ZNRF3 and RNF43 are E3 ligases that have been shown to ubiquitinate FZD proteins and promote their lysosomal degradation, while the deubiquitinating enzyme USP8 promotes recycling of the receptor back to the plasma membrane (Hao et al, 2012; Mukai et al, 2010).  This balance of ubiquitination and deubiquitination is in turn regulated by the R-spondin (RSPO) proteins, agonists of WNT signaling which appear to act by downregulating ZNRF3 and RNF43, thus potentiating both canonical and non-canonical pathways (Hao et al, 2012; reviewed in Abo and Clevers, 2012; Fearon and Spence, 2012, Papartriantafyllou, 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway195">
 <bp:pathwayOrder rdf:resource="#PathwayStep1514" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1513" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1518" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1529" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1528" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1504" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1519" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1520" />
 <bp:pathwayComponent rdf:resource="#Pathway197" />
 <bp:pathwayComponent rdf:resource="#Pathway196" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1323" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1322" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1331" />
 <bp:pathwayComponent rdf:resource="#Pathway199" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1318" />
 <bp:pathwayComponent rdf:resource="#Pathway198" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1504" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by Erythropoietin</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Erythropoietin (EPO) is a cytokine that serves as the primary regulator of erythropoiesis, the differentiation of erythrocytes from stem cells in the liver of the fetus and the bone marrow of adult mammals (reviewed in Ingley 2012, Zhang et al. 2014, Kuhrt and Wojchowski 2015). EPO is produced in the kidneys in response to low oxygen tension and binds a receptor, EPOR, located on progenitor cells: burst forming unit-erythroid (BFU-e) cells and colony forming unit-erythroid (CFU-e) cells. The erythropoietin receptor (EPOR) exists in lipid rafts (reviewed in McGraw and List 2017) as a dimer pre-associated with proteins involved in downstream signaling: the tyrosine kinase JAK2, the tyrosine kinase LYN, and the scaffold protein IRS2. Binding of EPO to the EPOR dimer causes a change in conformation (reviewed in Watowich et al. 2011, Corbett et al. 2016) that activates JAK2, which then transphosphorylates JAK2 and phosphorylates the cytoplasmic domain of EPOR. The phosphorylated EPOR serves directly or indirectly as a docking site for signaling molecules such as STAT5, phosphatidylinositol 4,5-bisphosphate 3-kinase (PI3K), phospholipase C gamma (PLCG1, PLCG2), and activators of RAS (SHC1, GRB2:SOS1, GRB2:VAV1). EPO activates 4 major signaling pathways: STAT5-activated transcription, PI3K-AKT, RAS-RAF-ERK, and PLC-PKC. JAK2-STAT5 activates expression of BCL2L1 (Bcl-xL) and therefore appears to be important for anti-apoptosis. PI3K-AKT appears to be important for both anti-apoptosis and proliferation. The roles of other signaling pathways are controversial but both RAS-RAF-MEK-ERK and PLCgamma-PKC have mitogenic effects. Phosphatases such as SHP1 are also recruited and downregulate the EPO signal. EPO also has effects outside of erythropoiesis. The EPOR is expressed in various tissues such as endothelium where it can act to stimulate growth and promote cell survival (Debeljak et al. 2014, Kim&#225;kov&#225; et al. 2017). EPO and EPOR in the neurovascular system act via Akt, Wnt1, mTOR, SIRT1, and FOXO proteins to prevent apoptotic cell injury (reviewed in  Ostrowski and Heinrich 2018, Maiese 2016) and EPO may have therapeutic value in the nervous system (Ma et al. 2016).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway194">
 <bp:pathwayOrder rdf:resource="#PathwayStep1499" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1498" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1306" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1305" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1498" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRB2:SOS provides linkage to MAPK signaling for Integrins </bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Integrin signaling is linked to the MAP kinase pathway by recruiting Grb2 to the FADK1/SRC activation complex.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway197">
 <bp:pathwayOrder rdf:resource="#PathwayStep1517" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1516" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1515" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1321" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1320" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1319" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1515" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Erythropoietin activates STAT5</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT5 (STAT5A or STAT5B) directly binds the phosphorylated cytoplasmic domain of EPOR, where it is phosphorylated by JAK2 and LYN (Oda et al. 1998, inferred from mouse homologs, reviewed in Kuhrt and Wojchowski 2015). Phosphorylated STAT5 then dissociates from EPOR, dimerizes, and transits to the nucleus where it activates gene expression.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway196">
 <bp:pathwayOrder rdf:resource="#PathwayStep1512" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1511" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1507" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1506" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1505" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1509" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1508" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1510" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1315" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1314" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1313" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1312" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1311" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1310" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1317" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1316" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1505" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Erythropoietin activates RAS</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The RAS guanine nucleotide exchange factors SOS1 and VAV1 bind indirectly to the phosphorylated EPOR via CRKL, SHC1, and GRB2 (Miura et al. 1994, Hanazono et al. 1996, Odai et al. 1997, Arai et al. 2001, reviewed in Kuhrt et al. 2015) . The phosphorylated cytoplasmic domain of EPOR binds CRKL, which is then phosphorylated (Arai et al. 2001). Phosphorylated CRKL binds SHC1, which is then phosphorylated and binds either GRB2:SOS1 (Barber et al. 1997) or GRB2:VAV1 (Hanazono et al. 1996). SOS1 and phosphorylated VAV1 catalyze the exchange of GDP for GTP bound to RAS, that is, RAS:GDP is converted to RAS:GTP.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway90">
 <bp:pathwayOrder rdf:resource="#PathwayStep715" />
 <bp:pathwayOrder rdf:resource="#PathwayStep633" />
 <bp:pathwayOrder rdf:resource="#PathwayStep798" />
 <bp:pathwayOrder rdf:resource="#PathwayStep772" />
 <bp:pathwayComponent rdf:resource="#Pathway108" />
 <bp:pathwayComponent rdf:resource="#Pathway91" />
 <bp:pathwayComponent rdf:resource="#Pathway111" />
 <bp:pathwayComponent rdf:resource="#Pathway102" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence633" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by WNT</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WNT signaling pathways control a wide range of developmental and adult process in metozoans including cell proliferation, cell fate decisions, cell polarity and stem cell maintenance (reviewed in Saito-Diaz et al, 2013; MacDonald et al, 2009).  The pathway is named for the WNT ligands, a large family of secreted cysteine-rich glycoproteins. At least 19 WNT members have been identified in humans and mice with distinct expression patterns during development (reviewed in Willert and Nusse, 2012).  These ligands can activate at least three different downstream signaling cascades depending on which receptors they engage.    In the so-called &apos;canonical&apos; WNT signaling pathway, WNT ligands bind one of the 10 human Frizzled (FZD) receptors in conjunction with the LRP5/6 co-receptors to activate a transcriptional cascade that controls processes such as cell fate, proliferation and self-renenwal of stem cells.  Engagement of the FZD-LRP receptor by WNT ligand results in the stabilization and translocation of cytosolic beta-catenin to the nucleus where it is a co-activator for LEF (lymphoid enhancer-binding factor)- and TCF (T cell factor) -dependent transcription.  In the absence of WNT ligand, cytosolic beta-catenin is phosphorylated by a degradation complex consisting of glycogen synthase kinase 3 (GSK3), casein kinase 1 (CK1), Axin and Adenomatous polyposis coli (APC), and subsequently ubiquitinated and degraded by the 26S proteasome (reviewed in Saito-Diaz et al, 2013; Kimmelman and Xu, 2006).    In addition to the beta-catenin-dependent transcriptional response, WNT signaling can also activate distinct non-transcriptional pathways that regulate cell migration and polarity.  These beta-catenin-independent &apos;non-canonical&apos; pathways signal through Frizzled receptors independently of LRP5/6, or occur through the tyrosine kinase receptors ROR and RYK (reviewed in Veeman et al, 2003; James et al, 2009).  Non-canonical WNT pathways are best studied in Drosophila where the planar cell polarity (PCP) pathway controls the orientation of wing hairs and eye facets, but are also involved in processes such as convergent extension, neural tube closure, inner ear development and hair orientation in vertebrates and mammals(reviewed in Seifert and Mlodzik, 2007; Simons and Mlodzik, 2008). In the PCP pathway, binding of WNT ligand to the FZD receptor leads to activation of small Rho GTPases and JNK, which regulate the cytoskeleton and coordinate cell migration and polarity (reviewed in Lai et al, 2009; Schlessinger et al, 2009).  In some cases, a FZD-WNT interaction increases intracellular calcium concentration and activates CaMK II and PKC; this WNT calcium pathway promotes cell migration and inhibits the canonical beta-catenin dependent transcriptional pathway (reviewed in Kuhl et al, 2000; Kohn and Moon, 2005; Rao et al 2010).  Binding of WNT to ROR or RYK receptors also regulates cell migration, apparently through activation of JNK or SRC kinases, respectively, however the details of these pathways remain to be worked out (reviewed in Minami et al, 2010).  Although the WNT signaling pathways were originally viewed as discrete, linear pathways controlled by defined subsets of &apos;canonical&apos; or &apos;non-canonical&apos; ligands and receptors, the emerging evidence is challenging this notion.  Instead, the specificity and the downstream response appear to depend on the particular cellular context and vary with species, tissue and stage of development (reviewed in van Amerongen and Nusse, 2009; Rao et al, 2010).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway191">
 <bp:pathwayOrder rdf:resource="#PathwayStep1448" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1447" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1469" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1446" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1468" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1467" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1449" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1462" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1461" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1460" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1466" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1465" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1464" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1463" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1459" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1458" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1457" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1456" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1451" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1473" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1450" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1472" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1471" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1470" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1455" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1454" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1453" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1475" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1452" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1474" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1274" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1273" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1272" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1271" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1270" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1259" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1258" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1257" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1279" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1256" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1278" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1277" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1276" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1275" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1263" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1285" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1262" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1284" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1261" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1283" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1260" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1282" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1281" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1280" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1269" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1268" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1267" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1266" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1265" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1264" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1446" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by Hippo</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Human Hippo signaling is a network of reactions that regulates cell proliferation and apoptosis, centered on a three-step kinase cascade. The cascade was discovered by analysis of Drosophila mutations that lead to tissue overgrowth, and human homologues of its components have since been identified and characterized at a molecular level. Data from studies of mice carrying knockout mutant alleles of the genes as well as from studies of somatic mutations in these genes in human tumors are consistent with the conclusion that in mammals, as in flies, the Hippo cascade is required for normal regulation of cell proliferation and defects in the pathway are associated with cell overgrowth and tumorigenesis (Oh and Irvine 2010; Pan 2010; Zhao et al. 2010). This group of reactions is also notable for its abundance of protein:protein interactions mediated by WW domains and PPxY sequence motifs (Sudol and Harvey 2010). There are two human homologues of each of the three Drosophila kinases, whose functions are well conserved: expression of human proteins rescues fly mutants. The two members of each pair of human homologues have biochemically indistinguishable functions. Autophosphorylated STK3 (MST2) and STK4 (MST1) (homologues of Drosophila Hippo) catalyze the phosphorylation and activation of LATS1 and LATS2 (homologues of Drosophila Warts) and of the accessory proteins MOB1A and MOB1B (homologues of Drosophila Mats). LATS1 and LATS2 in turn catalyze the phosphorylation of the transcriptional co-activators YAP1 and WWTR1 (TAZ) (homologues of Drosophila Yorkie). In their unphosphorylated states, YAP1 and WWTR1 freely enter the nucleus and function as transcriptional co-activators. In their phosphorylated states, however, YAP1 and WWTR1 are instead bound by 14-3-3 proteins, YWHAB and YWHAE respectively, and sequestered in the cytosol. Several accessory proteins are required for the three-step kinase cascade to function. STK3 (MST2) and STK4 (MST1) each form a complex with SAV1 (homologue of Drosophila Salvador), and LATS1 and LATS2 form complexes with MOB1A and MOB1B (homologues of Drosophila Mats). In Drosophila a complex of three proteins, Kibra, Expanded, and Merlin, can trigger the Hippo cascade. A human homologue of Kibra, WWC1, has been identified and indirect evidence suggests that it can regulate the human Hippo pathway (Xiao et al. 2011). A molecular mechanism for this interaction has not yet been worked out and the molecular steps that trigger the Hippo kinase cascade in humans are unknown. Four additional processes related to human Hippo signaling, although incompletely characterized, have been described in sufficient detail to allow their annotation. All are of physiological interest as they are likely to be parts of mechanisms by which Hippo signaling is modulated or functionally linked to other signaling processes. First, the caspase 3 protease cleaves STK3 (MST2) and STK4 (MST1), releasing inhibitory carboxyterminal domains in each case, leading to increased kinase activity and YAP1 / TAZ phosphorylation (Lee et al. 2001). Second, cytosolic AMOT (angiomotin) proteins can bind YAP1 and WWTR1 (TAZ) in their unphosphorylated states, a process that may provide a Hippo-independent mechanism to down-regulate the activities of these proteins (Chan et al. 2011). Third, WWTR1 (TAZ) and YAP1 bind ZO-1 and 2 proteins (Remue et al. 2010; Oka et al. 2010). Fourth, phosphorylated WWTR1 (TAZ) binds and sequesters DVL2, providing a molecular link between Hippo and Wnt signaling (Varelas et al. 2010).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway190">
 <bp:pathwayOrder rdf:resource="#PathwayStep1437" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1439" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1438" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1440" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1444" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1443" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1442" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1441" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1249" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1248" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1255" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1254" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1253" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1252" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1251" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1250" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1437" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Calcitonin-like ligand receptors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The calcitonin peptide family comprises calcitonin, amylin, calcitonin gene-related peptide (CGRP), adrenomedullin (AM) and intermedin (AM2). Calcitonin is a 32 amino acid peptide, involved in bone homeostasis (Sexton PM et al, 1999). Amylin is a product of the islet beta-cell (Cooper GJ et al, 1987), along with insulin and probably has a hormonal role in the regulation of nutrient intake (Young A and Denaro M, 1998). Adrenomedullin (AM) is a ubiquitously expressed peptide initially isolated from phaechromocytoma (a tumour of the adrenal medulla) (Kitamura K et al, 1993). Both AM and AM2 (Takei Y et al, 2004) belong to a family of calcitonin-related peptide hormones important for regulating diverse physiologic functions and the chemical composition of fluids and tissues. The receptor family for these peptides consists of two class B GPCRs, the calcitonin receptor (CT) and calcitonin receptor-like receptor (CL) (Poyner DR er al, 2002). Whilst the receptor for calcitonin is a conventional class B GPCR, the receptors for CGRP, AM and amylin require additional proteins, called the receptor activity modifying proteins (RAMPs). There are three RAMPs in mammals; they interact with the CT receptor to convert it to receptors for amylin. For CGRP and AM, the related CL interacts with RAMP1 to give a CGRP receptor and RAMP2 or 3 to give AM receptors. CL by itself will bind no known endogenous ligand.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway193">
 <bp:pathwayOrder rdf:resource="#PathwayStep1480" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1482" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1481" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1289" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1288" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1290" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1480" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p130Cas linkage to MAPK signaling for integrins</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Integrin signaling is linked to the MAP kinase pathway by recruiting p130cas and Crk to the FAK/Src activation complex.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway192">
 <bp:pathwayOrder rdf:resource="#PathwayStep1502" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1479" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1501" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1478" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1489" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1500" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1484" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1495" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1483" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1494" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1493" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1492" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1477" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1488" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1487" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1486" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1497" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1485" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1496" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1491" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1490" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1296" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1295" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1294" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1293" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1292" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1291" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1304" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1303" />
 <bp:pathwayComponent rdf:resource="#Pathway194" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1302" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1301" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1300" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1299" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1287" />
 <bp:pathwayComponent rdf:resource="#Pathway193" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1298" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1286" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1297" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1309" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1308" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1307" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1477" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Integrin signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Integrins are a major family of cell surface receptors that modulate cell adhesion, migration, proliferation and survival through interaction with the extracellular matrix (ECM) and the actin cytoskeleton.  Integrins are type 1 transmembrane proteins that exist at the cell surface as heterodimers of alpha and beta subunits, of which there are 18 and 8 different isoforms, respectively, in human cells. In addition to their mechanical role in mediating contact between the ECM and the cytoskeleton, integrins also modulate intracellular signaling pathways governing cytoskeletal rearrangements and pro-survival and mitogenic signaling (reviewed in Hehlgans et al, 2007; Harburger and Calderwood, 2009; Ata and Antonescu, 2017).  In this pathway, we describe signaling through integrin alphaIIb beta3 as a representative example.  At the sites of vascular injury bioactive molecules such as thrombin, ADP, collagen, fibrinogen and thrombospondin are generated, secreted or exposed. These stimuli activate platelets, converting the major platelet integrin alphaIIbbeta3 from a resting state to an active conformation, in a process termed integrin priming or &apos;inside-out signalling&apos;. Integrin activation refers to the change required to enhance ligand-binding activity. The activated alphaIIbbeta3 interacts with the fibrinogen and links platelets together in an aggregate to form a platelet plug. AlphaIIbbeta3 bound to fibrin generates more intracellular signals (outside-in signalling), causing further platelet activation and platelet-plug retraction.  In the resting state the alpha and beta tails are close together.  This interaction keeps the membrane proximal regions in a bent conformation that maintains alphaIIbbeta3 in a low affinity state.  Integrin alphaIIbbeta3 is released from its inactive state by interaction with the protein talin. Talin interacts with the beta3 cytoplasmic domain and disrupts the salt bridge between the alpha and beta chains. This separation in the cytoplasmic regions triggers the conformational change in the extracellular domain that increases its affinity to fibrinogen.  Much of talin exists in an inactive cytosolic pool, and the Rap1 interacting adaptor molecule (RIAM) is implicated in talin activation and translocation to beta3 integrin cytoplasmic domain. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway199">
 <bp:pathwayOrder rdf:resource="#PathwayStep1532" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1531" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1530" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1334" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1333" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1332" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1530" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Erythropoietin activates Phospholipase C gamma (PLCG)</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PLCG1 (Phospholipase C gamma1) or PLCG2 bound to the activated EPOR is phosphorylated on tyrosine residues by the kinase LYN (Ren et al. 1994, and inferred from mouse homologs). PLCG1 and PLCG2 produce inositol 1,4,5-trisphosphate which then activates calcium signaling, and diacylglycerol (DAG) which then activates protein kinase C (PKC).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep2608">
 <bp:stepProcess rdf:resource="#Catalysis716" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2275" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway198">
 <bp:pathwayOrder rdf:resource="#PathwayStep1525" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1524" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1523" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1522" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1527" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1526" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1521" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1326" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1325" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1324" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1330" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1329" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1328" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1327" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1521" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Erythropoietin activates Phosphoinositide-3-kinase (PI3K)</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI3K can bind the activated EPO receptor (EPOR) by three different mechanisms: direct binding to phospho-Y479 of the EPOR, indirect binding via phosphorylated IRS2 bound to the EPOR, and indirect binding via phosphorylated GAB1 bound to the EPOR (Bouscary et al. 2003, Schmidt et al. 2004, reviewed in Kuhrt and Wojchowski 2015). PI3K phosphorylates phosphatidylinositol 4,5-bisphosphate to yield phosphatidylinositol 3,4,5-trisphosphate which recruits AKT1 to the membrane.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep2609">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2276" />
 <bp:stepProcess rdf:resource="#Catalysis717" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway89">
 <bp:pathwayOrder rdf:resource="#PathwayStep631" />
 <bp:pathwayOrder rdf:resource="#PathwayStep630" />
 <bp:pathwayOrder rdf:resource="#PathwayStep629" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction541" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction543" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction542" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence629" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOBTB3 ATPase cycle</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOBTB3 is a member of the Ras-like superfamily of proteins that is phylogenetically distinct from other related Ras-like families, which include, besides RHOBTB3, Rho, Miro, Ras, Ran, Arf and Rab (Boureux et al. 2007). Due to its similarity with RHOBTB1 and RHOBTB2 Rho GTPases, RHOBTB3 is sometimes classified as an atypical member of the RHO GTPase family. However, the GTPase domain of RHOBTB3 is divergent from other Ras-like superfamily members and actually displays ATPase activity (Espinosa et al. 2009). All three RHOBTBs possess other conserved domains in addition to the GTPase domain. The GTPase domain at the N terminus is followed by a proline rich region, a tandem of two BTB (broad complex, tramtrack, bric &#224; brac) domains, and a conserved C terminal BACK (BTB and C terminal Kelch). Unlike RHOBTB1 and RHOBTB2, RHOBTB3 has a CAAX box (prenylation motif) domain (Berthold et al. 2008, Ji and Rivero 2016). RHOBTB proteins can form homo and heterodimers, but the role of dimerization in RHOBTB function is not known (Berthold et al. 2008, Ji and Rivero 2016). RHOBTB3 is ubiquitously expressed, with high levels in placenta, testis, pancreas, adrenal and salivary glands and neural and cardiac tissues (Berthold et al. 2016). RHOBTB3 is involved in CUL3-dependent protein ubiquitination (Berthold et al. 2008; Ji and Rivero 2016). RHOBTB3 is involved in retrograde transport from endosomes to the Golgi apparatus (Espinosa et al. 2009). RHOBTB3 participates in regulation of the cell cycle and in modulating the adaptive response to hypoxia (Ji and Rivero 2016). RHOBTB3 level is decreased in many tumor types and it is proposed to act as a tumor suppressor, although no pathogenic mutations have been reported (Berthold et al. 2008; Ji and Rivero 2016).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway88">
 <bp:pathwayOrder rdf:resource="#PathwayStep626" />
 <bp:pathwayOrder rdf:resource="#PathwayStep627" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction540" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction539" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence626" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RND2 GTPase cycle</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RND2 (RHON) is an atypical RHO GTPase and the least studied member of the RND subfamily. RND2 is constitutively bound to GTP and lacks GTPase activity. No guanine nucleotide exchange factors (GEFs), GTPase activator proteins (GAPs) or guanine nucleotide dissociation inhibitors (GDIs) act on RND2. RND2 is predominantly expressed in brain, testis and liver (Nobes et al. 1998; Nishi et al. 1999). RND2 regulates neurite outgrowth and branching (Fujita et al. 2002; Kakimoto et al. 2004; Tanaka et al. 2006; Wakita et al. 2011) and migration of newborn neurons within the embryonic cerebral cortex (Nakamura et al. 2006; Heng et al. 2008; Alfano et al. 2011; Pacary et al. 2011; Gladwyn-Ng et al. 2015; Heng et al. 2015). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence496">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence497">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence498">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence499">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence492">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway83">
 <bp:pathwayOrder rdf:resource="#PathwayStep604" />
 <bp:pathwayOrder rdf:resource="#PathwayStep603" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction522" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction521" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence603" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOBTB1 GTPase cycle</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOBTB1 is an atypical member of the RHO GTPase family that is predicted not to cycle between a GTP-bound form and a GDP-bound form (Berthold et al. 2008). RHOBTB family proteins, in contrast to other RHO GTPases, possess other conserved domains in addition to the GTPase domain. The GTPase domain at the N-terminus is followed by a proline-rich region, a tandem of two BTB (broad-complex, tramtrack, bric &#224; brac) domains, and a conserved C-terminal BACK (BTB and C-terminal Kelch) domain (Berthold et al. 2008, Ji and Rivero 2016). RHOBTB proteins can form homo- and heterodimers, but the role of dimerization in RHOBTB function is not known (Berthold et al. 2008, Ji and Rivero 2016). RHOBTB1 is highly expressed in skeletal muscle, placenta, stomach, kidney, testis, ovary, uterus and adrenal gland (Berthold et al. 2008). RHOBTB1 is a component of a signaling cascade that regulates vascular function and blood pressure (Ji and Rivero 2016). RHOBTB1 level is decreased in many cancer types and it is proposed to function as a tumor suppressor, but no mutations in RHOBTB1 have been detected in cancer (Berthold et al. 2008; Ji and Rivero 2016). RHOBTB1 localizes at early endosomes and participates in the architecture of the endosomal-lysosomal system (Long et al. 2020).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence493">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway82">
 <bp:pathwayOrder rdf:resource="#PathwayStep605" />
 <bp:pathwayOrder rdf:resource="#PathwayStep602" />
 <bp:pathwayComponent rdf:resource="#Pathway83" />
 <bp:pathwayComponent rdf:resource="#Pathway84" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence602" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOBTB GTPase Cycle</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHO BTB family belongs to atypical RHO GTPases, which are characterized by the absence of GTPase activity. RhoBTB family includes RHOBTB1 and RHOBTB2. RHOBTB3 is sometimes classified as the third RhoBTB family member, but it is divergent from the other two RHOBTBs and from Rho GTPases in general. RHOBTB1 is a component of a signaling cascade that regulates vascular function and blood pressure (Ji and Rivero 2016). RHOBTB2 is involved in COP9 signalosome-regulated and CUL3-dependent protein ubiquitination (Berthold et al. 2008; Ji and Rivero 2016).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence494">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway81">
 <bp:pathwayOrder rdf:resource="#PathwayStep600" />
 <bp:pathwayOrder rdf:resource="#PathwayStep599" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction520" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction519" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence599" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOV GTPase cycle</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOV (also known as Chp) is an atypical RHO GTPase that is thought to be constitutively active due to its high intrinsic guanine nucleotide exchange activity. No guanine nucleotide exchange factors (GEFs) nor GTPase activator proteins (GAPs) that act on RHOV have been identified. RHOV is expressed at very low levels. The expression of RHOV is detected during embryonic development in fish (Tay et al. 2010), frog (Gu&#233;mar et al. 2007) and chicken (Notarnicola et al. 2008). RHOV is involved in neural crest formation, where its expression is induced downstream of WNT signaling. RHOV is thought to regulate cell adhesion, as its zebrafish orthologue is required for proper localization of E-cadherin and beta-catenin at adherens junctions. RHOV activates JNK and induces apoptosis in rat pheochromocytoma cell line PC12 (Shepelev et al 2011) and in macrophages (Song et al. 2015).  RHOV gene overexpression is a molecular marker of human lung adenocarcinoma (Shepelev and Korobko 2013, Shukla et al. 2017, Ma et al. 2020, Zhang et al. 2020), where RHOV is likely to act as an oncogene (Chen et al. 2021).  For review, please refer to Faure and Fort 2015, and Hodge and Ridley 2020.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence495">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway80">
 <bp:pathwayOrder rdf:resource="#PathwayStep596" />
 <bp:pathwayOrder rdf:resource="#PathwayStep597" />
 <bp:pathwayOrder rdf:resource="#PathwayStep594" />
 <bp:pathwayOrder rdf:resource="#PathwayStep595" />
 <bp:pathwayOrder rdf:resource="#PathwayStep593" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction514" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction516" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction515" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction518" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction517" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence593" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOQ GTPase cycle</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">This pathway catalogues RHOQ (also known as TC10) guanine nucleotide exchange factors (GEFs), GTPase activator proteins (GAPs), and RHOQ effectors. No GDP dissociation inhibitors (GDIs) have been shown to interact with RHOQ. Two GDIs, ARHGDIA (also known as Rho-GDI alpha) (Michaelson et al. 2001; Murphy et al. 2001) and ARHGDIB (also known as D4-GDI) (Zhang et al. 2009), were specifically shown not to interact with RHOQ. RHOQ, together with RHOJ (TCL), belongs to the CDC42 subfamily of RHO GTPases, with the three family members sharing 65-85% of homology (Murphy et al. 1999, Vignal et al. 2000, Donnelly et al. 2014; Shi et al. 2016). RHOQ is highly activated on exocytosing vesicles and recycling endosomes. RHOQ GTPase activity is necessary for fusion of vesicles with the plasma membrane (Kawase et al. 2006, Donnelly et al. 2014). RHOQ is required for insulin-stimulated glucose uptake (Kanzaki and Pessin 2003; Saltiel and Pessin 2003) and is involved in insulin signaling in adipocytes (Satoh 2014). While some studies reported RHOQ involvement in neurite outgrowth (Abe et al. 2003, Gonzalez&#8208;Billault et al. 2012) and regulation of membrane addition during axon formation (Dupraz et al. 2009, Gonzalez&#8208;Billault et al. 2012), other studies failed to identify RHOQ as a regulator of neurite outgrowth (Murphy et al. 1999, Murphy et al. 2001).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway87">
 <bp:pathwayOrder rdf:resource="#PathwayStep624" />
 <bp:pathwayOrder rdf:resource="#PathwayStep622" />
 <bp:pathwayOrder rdf:resource="#PathwayStep623" />
 <bp:pathwayOrder rdf:resource="#PathwayStep620" />
 <bp:pathwayOrder rdf:resource="#PathwayStep621" />
 <bp:pathwayOrder rdf:resource="#PathwayStep619" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction534" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction533" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction536" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction535" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction538" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction537" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence619" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOA GTPase cycle</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">This pathway catalogues RHOA guanine nucleotide exchange factors (GEFs), GTPase activator proteins (GAPs), GDP dissociation inhibitors (GDIs) and RHOA effectors. RHOA is one of the three best characterized RHO GTPases, the other two being RAC1 and CDC42, and is the founding member of the RHO GTPase family (Zhou and Zheng 2013). RHOA regulates the cytoskeleton and cell contractility (Lessey et al. 2012), thus playing a role in a number of cellular functions, such as adhesion, migration, survival, division, vesicle trafficking and gene expression (Zhou and Zheng 2013). RHOA-regulated processes are involved in mechanotransduction (Lessey et al. 2012; Marjoram et al. 2014), neuronal development (Zhou and Zheng 2013; Fujita and Yamashita 2014; Hu and Selzer 2017), immune system development (Zhou and Zheng 2013; Ricker et al. 2016; Bros et al. 2019), and cardiovascular regulation (Zhou and Zheng 2013; Cai et al. 2016; Shimokawa et al. 2016). RHOA mutations are frequently found in cancer (Kataoka and Ogawa 2016). Toxins of numerous pathogens target RHOA to hijack the host cytoskeleton (Jamilloux et al. 2018).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway86">
 <bp:pathwayOrder rdf:resource="#PathwayStep616" />
 <bp:pathwayOrder rdf:resource="#PathwayStep617" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction532" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction531" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence616" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RND3 GTPase cycle</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RND3 (RHOE) is an atypical RHO GTPase from the RND subfamily. RND3 is constitutively bound to GTP and lacks GTPase activity. No guanine nucleotide exchange factors (GEFs), GTPase activator proteins (GAPs) or guanine nucleotide dissociation inhibitors (GDIs) act on RND3. RND3 is a direct antagonist of ROCK1 kinase activity. RND3 prevents phosphorylation of ROCK1 targets and, similar to RND1, induces stress fiber disassembly. RND3 regulates cell migration, establishment of neuronal polarity, heart development, and myometrium changes during pregnancy. Defective RND3 function is related to cardiomyopathy, hydrocephalus and cancer. Like RND1, RND3 is implicated both as a tumor suppressor and an oncogene in cancer, and can both increase and decrease sensitivity to chemotherapeutic agents, which depends on cancer type and stage. For review, please refer to Jie et al. 2015 and Paysan et al. 2016.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence490">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway85">
 <bp:pathwayOrder rdf:resource="#PathwayStep613" />
 <bp:pathwayOrder rdf:resource="#PathwayStep614" />
 <bp:pathwayOrder rdf:resource="#PathwayStep611" />
 <bp:pathwayOrder rdf:resource="#PathwayStep612" />
 <bp:pathwayOrder rdf:resource="#PathwayStep610" />
 <bp:pathwayOrder rdf:resource="#PathwayStep609" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction525" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction530" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction527" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction526" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction529" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction528" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence609" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOC GTPase cycle</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">This pathway catalogues RHOC guanine nucleotide exchange factors (GEFs), GTPase activator proteins (GAPs), GDP dissociation inhibitors (GDIs) and RHOC effectors. RHOC belongs to the RHOA subfamily of RHO GTPases and shares 85% sequence identity with RHOA and RHOB (Wheeler and Ridley 2004). Like RHOA and RHOB, RHOC regulates the cytoskeleton and is involved in cell adhesion and migration (Guan et al. 2018). RHOC contributes to invasiveness and metastatic potential of cancer cells (Bravo-Cordero et al. 2014; Guan et al. 2018; Thomas et al. 2019).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence491">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway84">
 <bp:pathwayOrder rdf:resource="#PathwayStep606" />
 <bp:pathwayOrder rdf:resource="#PathwayStep607" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction523" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction524" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence606" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOBTB2 GTPase cycle</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOBTB2 is an atypical member of the RHO GTPase family that is predicted not to cycle between a GTP-bound form and a GDP-bound form (Berthold et al. 2008). RHOBTB family proteins, in contrast to other RHO GTPases, possess other conserved domains in addition to the GTPase domain. The GTPase domain at the N terminus is followed by a proline rich region, a tandem of two BTB (broad complex, tramtrack, bric &#224; brac) domains, and a conserved C terminal BACK (BTB and C terminal Kelch) domain (Berthold et al. 2008, Ji and Rivero 2016). RHOBTB proteins can form homo- and heterodimers, but the role of dimerization in RHOBTB function is not known (Berthold et al. 2008, Ji and Rivero 2016). RHOBTB2 is usually expressed weakly (Berthold et al. 2008), at a lower level than RHOBTB1 (Ji and Rivero 2016). Relatively high levels of RHOBTB2 can be detected in neural and cardiac tissues (Berthold et al. 2016). RHOBTB2 is involved in COP9 signalosome-regulated and CUL3-dependent protein ubiquitination (Berthold et al. 2008; Ji and Rivero 2016). RHOBTB2 suppresses cellular proliferation and promotes apoptosis (Ji and Rivero 2016). RHOBTB2 takes part in vesicle transport (Ji and Rivero 2016). RHOBTB2 was initially discovered as the gene homozygously deleted in breast cancer and was named DBC2 (deleted in breast cancer 2) (Berthold et al. 2008). RHOBTB2 level is decreased in many tumor types and it is proposed to act as a tumor suppressor. Genomic deletions and a small number of pathogenic mutations in RHOBTB2 have been reported in cancer (Berthold et al. 2008; Ji and Rivero 2016). Mutations of RHOBTB2 that result in impaired interaction with CUL3 have been found to cause epileptic encephalopathy (Belal et al. 2018).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway184">
 <bp:pathwayOrder rdf:resource="#PathwayStep1392" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1391" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1390" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1389" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1388" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1205" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1209" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1208" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1207" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1206" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1388" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Leukotriene receptors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Leukotriene receptors bind leukotriene ligands. There are four types of receptor in humans; two for leukotriene B4 and two for cysteinyl leukotrienes (Brink C et al, 2003).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway183">
 <bp:pathwayOrder rdf:resource="#PathwayStep1394" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1393" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1387" />
 <bp:pathwayComponent rdf:resource="#Pathway184" />
 <bp:pathwayComponent rdf:resource="#Pathway185" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1210" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1387" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Eicosanoid ligand-binding receptors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Eicosanoids, derived from polyunsaturated 20-carbon fatty acids, are paracrine and autocrine regulators of inflammation, smooth muscle contraction, and blood coagulation. The actions of eicosanoids are mediated by eicosanoid receptors, most of which are GPCRs. There are four types of eicosanoid GPCRs in humans; leukotriene, lipoxin (Brink C et al, 2003), prostanoid (Coleman RA et al, 1994) and oxoeicosanoid (Brink C et al, 2004) receptors. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway186">
 <bp:pathwayOrder rdf:resource="#PathwayStep1407" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1406" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1222" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1221" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1406" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Opsins</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Opsins are light-sensitive, 35-55 kDa membrane-bound G protein-coupled receptors of the retinylidene protein family found in photoreceptor cells of the retina. Five classical groups of opsins are involved in vision, mediating the conversion of a photon of light into an electrochemical signal, the first step in the visual transduction cascade (Terakita A, 2005; Nickle B and Robinson PR, 2007). Another opsin found in the mammalian retina, melanopsin, is involved in circadian rhythms and pupillary reflex but not in image-forming (Hankins MW et al, 2008; Kumbalasiri T and Provencio I, 2005). Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in various transmembrane signaling systems. The G protein transducin, encoded by GNAT genes, is one of the transducers of a visual impulse that performs the coupling between rhodopsin and cGMP-phosphodiesterase. Defects in GNAT1 are the cause of congenital stationary night blindness autosomal dominant type 3, also known as congenital stationary night blindness Nougaret type. Congenital stationary night blindness is a non-progressive retinal disorder characterized by impaired night vision (Dryja TP et al, 1996). Defects in GNAT2 are the cause of achromatopsia type 4 (ACHM4). Achromatopsia is an autosomal recessively inherited visual disorder that is present from birth and that features the absence of color discrimination (Kohl S et al, 2002).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway185">
 <bp:pathwayOrder rdf:resource="#PathwayStep1403" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1402" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1401" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1396" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1395" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1400" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1399" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1398" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1397" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1216" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1215" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1214" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1213" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1212" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1211" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1219" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1218" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1217" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1395" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Prostanoid ligand receptors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Fatty acid cyclo-oxygenase (COX) converts arachidonic acid to prostaglandin H2 (PGH2) from which the prostanoids PGD2, PGE2, PGF2alpha, PGI2 (prostacyclin) and thromboxane A2 (TXA2) are derived. Based on the agonist potencies, five prostanoid receptors are recognized and correspondingly named DP, EP, FP, IP and TP receptors (Coleman RA et al, 1994). Additionally, EP receptors contains four subtypes, termed EP1, EP2, EP3 and EP4; the DP receptor also has two subtypes, DP1 and DP2 (CRTH2).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway180">
 <bp:pathwayOrder rdf:resource="#PathwayStep1370" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1374" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1373" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1372" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1371" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1195" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1194" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1193" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1192" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1191" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1370" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Lysosphingolipid and LPA receptors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The Lysophospholipid receptor (LPLR) group are members of the G protein-coupled receptor family of integral membrane proteins that are important for lipid signaling. In humans there are eight LPL receptors, each encoded by a separate gene (these genes also sometimes referred to as &quot;Edg&quot; or endothelial differentiation gene). The ligands for LPLRs are the lysophospholipid extracellular signaling molecules, lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P). The primary effects are inhibition of adenylyl cyclase and release of calcium from the endoplasmic reticulum, as well as secondary effects of preventing apoptosis and increasing cell proliferation (Contos JJ et al, 2000; An S et al, 1998; Fukushima N and Chun J, 2001).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway182">
 <bp:pathwayOrder rdf:resource="#PathwayStep1381" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1380" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1384" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1383" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1382" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1203" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1202" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1201" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1200" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1199" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1380" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Free fatty acid receptors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Fatty acids are the ligands for a small family of G-protein-coupled receptors, the Free Fatty Acid receptors, and an unrelated receptor GPR120.   Free fatty acid receptor 1 (FFAR1/GPR40) is activated by both saturated and unsaturated medium to long-chain fatty acids while FFAR2 (GPR43) and FFAR3 (GPR41) are activated by short-chain fatty acids (carboxylates) with six or fewer carbon molecules. A fourth highly homologous receptor GPR42 is believed to be a pseudogene with intact open reading frame, but could be a functional gene in a significant fraction of the human population.   GPR120 is activated by long chain (C16-22) fatty acids.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway181">
 <bp:pathwayOrder rdf:resource="#PathwayStep1378" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1377" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1376" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1198" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1197" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1196" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1376" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hydroxycarboxylic acid-binding receptors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The G-protein-coupled receptors Hydroxy-carboxylic acid receptor 1 (HCAR1, GPR81), HCAR2 (GPR109A), and HCAR3 (GPR109B) have significant sequence homology and are encoded by clustered genes. Their endogenous ligands are hydroxy-carboxylic acid metabolites. HCAR1 is activated by lactate (2-hydroxy-propanoic acid). HCAR2 is a receptor for 3-hydroxy-butyric acid. HCAR3 is activated by 3-hydroxy-octanoic acid. HCAR1 and HCAR2 are found in most mammalian species; HCA3 is found only in higher primates. All three receptors are expressed in adipocytes and are coupled to Gi-type G-proteins, mediating antilipolytic effects in fat cells. HCAR2 and HCAR3 are also expressed in a variety of immune cells. HCAR2 is a receptor for the antidyslipidemic drug nicotinic acid (niacin) and related natural and synthetic compounds.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway188">
 <bp:pathwayOrder rdf:resource="#PathwayStep1436" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1435" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1434" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1419" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1422" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1433" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1421" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1432" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1420" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1431" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1247" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1246" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1234" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1245" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1233" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1244" />
 <bp:pathwayComponent rdf:resource="#Pathway190" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1232" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1243" />
 <bp:pathwayComponent rdf:resource="#Pathway189" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1419" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Class B/2 (Secretin family receptors)</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">This family is known as Family B (secretin-receptor family, family 2) G-protein-coupled receptors. Family B GPCRs include secretin, calcitonin, parathyroid hormone/parathyroid hormone-related peptides and vasoactive intestinal peptide receptors; all of which activate adenylyl cyclase and the phosphatidyl-inositol-calcium pathway (Harmar AJ, 2001).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway187">
 <bp:pathwayOrder rdf:resource="#PathwayStep1415" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1414" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1413" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1412" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1417" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1416" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1411" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1410" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1227" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1226" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1225" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1224" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1231" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1230" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1229" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1228" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1410" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Class C/3 (Metabotropic glutamate/pheromone receptors)</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The class C G-protein-coupled receptors are a class of G-protein coupled receptors that include the metabotropic glutamate receptors and several additional receptors (Brauner-Osborne H et al, 2007). Family C GPCRs have a large extracellular N-terminus which binds the orthosteric (endogenous) ligand. The shape of this domain is often likened to a clam. Several allosteric ligands to these receptors have been identified and these bind within the seven transmembrane region.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway189">
 <bp:pathwayOrder rdf:resource="#PathwayStep1426" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1425" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1424" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1423" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1429" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1428" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1427" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1430" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1238" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1237" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1236" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1235" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1242" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1241" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1240" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1239" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1423" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Glucagon-type ligand receptors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The glucagon hormone family regulates the activity of GPCRs from the secretin receptor subfamily in Class II/B (Mayo KE et al, 2003).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence489">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway79">
 <bp:pathwayOrder rdf:resource="#PathwayStep589" />
 <bp:pathwayOrder rdf:resource="#PathwayStep590" />
 <bp:pathwayOrder rdf:resource="#PathwayStep591" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction512" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction511" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction513" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence589" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOH GTPase cycle</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOH is constitutively bound to GTP and does not require a guanine nucleotide exchange factor (GEF) for activation (Li et al. 2002). RHOH does not possess a GTPase activity (Li et al. 2002), but has been reported to bind to a small number of GTPase activator proteins (GAPs) (Bagci et al. 2020), which possibly function as RHOH effectors. While RHOH is not found in the GDP bound state, GDP dissociation inhibitors (GDIs), still interact with RHOH, presumably affecting its translocation to the site of activity by sequestering it in the cytosol (Li et al. 2002). Similar to RAC2, RHOH expression is also restricted to hematopoietic cells. RHOH function is required for T cell development and RHOH activity is regulated by posttranslational modifications downstream of activated T cell receptor (TCR). Following TCR activation, RhoH is degraded in lysosomes (Schmidt-Mende et al. 2010). In blood neutrophils from patients suffering from cystic fibrosis or eosinophils from patients with hypereosinophilic syndromes, an upregulation of RhoH expression has been found (Daryadel et al., 2009; Stoeckle et al., 2016). RHOH is subject to mutations and translocations in lymphoma (Suzuki and Oda 2008; Troeger and Williams 2013). Mutations in RHOH are associated with abnormal susceptibility to human beta-papillomavirus (beta-HPV) skin infections, which leads to epidermodysplasia verruciformis, a condition characterized by persistent flat warts or beta-HPV associated skin lesions (Przybyszewska et al. 2017).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway78">
 <bp:pathwayOrder rdf:resource="#PathwayStep587" />
 <bp:pathwayOrder rdf:resource="#PathwayStep585" />
 <bp:pathwayOrder rdf:resource="#PathwayStep586" />
 <bp:pathwayOrder rdf:resource="#PathwayStep583" />
 <bp:pathwayOrder rdf:resource="#PathwayStep584" />
 <bp:pathwayOrder rdf:resource="#PathwayStep582" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction510" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction509" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction508" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction505" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction507" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction506" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence582" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDC42 GTPase cycle</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">This pathway catalogues CDC42 guanine nucleotide exchange factors (GEFs), GTPase activator proteins (GAPs), GDP dissociation inhibitors (GDIs) and CDC42 effectors. CDC42 is one of the three best characterized RHO GTPases, the other two being RHOA and RAC1. By regulating the cytoskeleton, CDC42 regulates cell polarity across different species, from yeast to humans (Pichaud et al. 2019, Woods and Lew 2019). CDC42 is an essential regulator of polarized morphogenesis in epithelial cells, where it coordinates formation of the apical membrane and lumen formation, as well as junction maturation (Pichaud et al. 2019). CDC42 plays a role in cell-to-cell adhesion and cell cycle regulation (Xiao et al. 2018). CDC42 takes part in the regulation of membrane trafficking. Dysfunction of several CDC42-specific GEFs has been shown to impair intracellular trafficking (Egorov and Polishchuk 2017). CDC42 participates in insulin synthesis and secretion and contributes to the pathogenesis of insulin resistance and diabetic nephropathy (Huang et al. 2019). CDC42 is often dysregulated in cancer because a number of GEFs and GEF activators that act upstream of RAC1 and CDC42 are known oncogenes (Aguilar et al. 2017; Maldonado et al. 2018; Zhang et al. 2019; Maldonado et al. 2020). CDC4 promotes cancer cell proliferation, survival, invasion, migration and metastasis (Xiao et al. 2018), especially under hyperglycemia (Huang et al. 2019).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway77">
 <bp:pathwayOrder rdf:resource="#PathwayStep578" />
 <bp:pathwayOrder rdf:resource="#PathwayStep579" />
 <bp:pathwayOrder rdf:resource="#PathwayStep576" />
 <bp:pathwayOrder rdf:resource="#PathwayStep577" />
 <bp:pathwayOrder rdf:resource="#PathwayStep574" />
 <bp:pathwayOrder rdf:resource="#PathwayStep575" />
 <bp:pathwayOrder rdf:resource="#PathwayStep572" />
 <bp:pathwayOrder rdf:resource="#PathwayStep573" />
 <bp:pathwayOrder rdf:resource="#PathwayStep571" />
 <bp:pathwayOrder rdf:resource="#PathwayStep580" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction501" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction500" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction503" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction502" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction497" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction496" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction499" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction498" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction495" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction504" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence571" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC2 GTPase cycle</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">This pathway catalogues RAC2 guanine nucleotide exchange factors (GEFs), GTPase activator proteins (GAPs), GDP dissociation inhibitors (GDIs) and RAC2 effectors. RAC2 is exclusively expressed in hematopoietic cells (Troeger and Williams 2013). RAC2 is a component of the phagocytic oxidase complex in neutrophils (Troeger and Williams 2013). RAC2 is required for adhesion and mobilization of hematopoietic stem cells and progenitor cells (Troeger and Williams 2013). RAC2 is also needed for adhesion, migration and degranulation of mast cells (Troeger and Williams 2013). Mutations in RAC2 have been found in a small number of patients with primary immunodeficiencies (Gu and Williams 2002; Troeger and Williams 2013; Lougaris et al. 2020). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence485">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence486">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence487">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence488">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence481">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway72">
 <bp:pathwayOrder rdf:resource="#PathwayStep538" />
 <bp:pathwayOrder rdf:resource="#PathwayStep539" />
 <bp:pathwayOrder rdf:resource="#PathwayStep536" />
 <bp:pathwayOrder rdf:resource="#PathwayStep537" />
 <bp:pathwayOrder rdf:resource="#PathwayStep541" />
 <bp:pathwayOrder rdf:resource="#PathwayStep540" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction468" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction467" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction469" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction466" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction465" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction470" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence536" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOG GTPase cycle</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">This pathway catalogues RHOG guanine nucleotide exchange factors (GEFs), GTPase activator proteins (GAPs), GDP dissociation inhibitors (GDIs) and RHOG effectors. RHOG is a RAC-related RHO GTPase, ~70% identical to RAC1 (Vincent et al. 1992, de Curtis 2008). RHOG is broadly expressed in different tissue types. It regulates the cytoskeleton, acting either upstream of or in parallel to RAC1. RHOG regulates cell polarity, adhesion, migration and invasion, contributing to the formation of lamellipodia and invadopodia (Gauthier-Rouvi&#232;re et al. 1998, Al-Koussa et al. 2020). The ortholog of RHOG is required for neuronal development in C. elegans (de Curtis 2008). RHOG is involved in VEGF signaling and angiogenesis (El Baba et al. 2020). RHOG cooperates with RAC1 and CDC42 in malignant cell transformation (Roux et al. 1997) and may contribute to invasiveness of cancer cells (Al-Koussa et al. 2020).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence482">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway71">
 <bp:pathwayOrder rdf:resource="#PathwayStep534" />
 <bp:pathwayOrder rdf:resource="#PathwayStep532" />
 <bp:pathwayOrder rdf:resource="#PathwayStep533" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction464" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction463" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction462" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence532" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOJ GTPase cycle</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">This pathway catalogues RHOJ (also known as TCL or RHOI) guanine nucleotide exchange factors (GEFs), GTPase activator proteins (GAPs), and RHOJ effectors. No GDP dissociation inhibitors (GDIs) have been shown to interact with RHOJ. RHOJ, together with RHOQ (TC10), belongs to the CDC42 subfamily of RHO GTPases and shares 85% and 78% amino acid similarity with RHOQ and CDC42, respectively (Vignal et al. 2000). RHOJ regulates the cytoskeleton, including formation of lamellipodia and actin filaments (Vignal et al. 2000, Abe et al. 2003, Aspenstrom et al. 2004, Shi et al. 2016). RHOJ is highly expressed in endothelial cells, regulating their motility and, consequently, vascular morphogenesis (Leszczynska et al. 2011; Shi et al. 2016). As a part of the VEGF signaling cascade, RHOJ promotes retinal angiogenesis (Fukushima et al. 2013). RHOJ plays a role in cancer cell migration and cancer-related angiogenesis (Shi et al. 2016). RHOJ is involved in adipocyte differentiation (Nishizuka 2003; Shi et al. 2016).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence483">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway70">
 <bp:pathwayOrder rdf:resource="#PathwayStep527" />
 <bp:pathwayOrder rdf:resource="#PathwayStep528" />
 <bp:pathwayOrder rdf:resource="#PathwayStep525" />
 <bp:pathwayOrder rdf:resource="#PathwayStep526" />
 <bp:pathwayOrder rdf:resource="#PathwayStep530" />
 <bp:pathwayOrder rdf:resource="#PathwayStep529" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction457" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction456" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction459" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction458" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction460" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction461" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence525" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC3 GTPase cycle</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">This pathway catalogues RAC3 guanine nucleotide exchange factors (GEFs), GTPase activator proteins (GAPs), GDP dissociation inhibitors (GDIs) and RAC3 effectors. RAC3 is highly similar to RAC1 (92% amino acid sequence identity), but it is expressed in fewer tissues than RAC1. RAC3 orthologues only exist in vertebrates (de Curtis 2019). RAC3 is highly expressed in neurons and plays an important role in neuronal and brain development (de Curtis 2014, de Curtis 2019). RAC3 mutations have been reported in patients with intellectual disability and brain malformations (de Curtis 2019). RAC3 is frequently overexpressed in cancer and contributes to proliferation, migration and invasiveness of cancer cells (de Curtis 2019).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence484">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway76">
 <bp:pathwayOrder rdf:resource="#PathwayStep569" />
 <bp:pathwayOrder rdf:resource="#PathwayStep567" />
 <bp:pathwayOrder rdf:resource="#PathwayStep568" />
 <bp:pathwayOrder rdf:resource="#PathwayStep565" />
 <bp:pathwayOrder rdf:resource="#PathwayStep566" />
 <bp:pathwayOrder rdf:resource="#PathwayStep563" />
 <bp:pathwayOrder rdf:resource="#PathwayStep564" />
 <bp:pathwayOrder rdf:resource="#PathwayStep561" />
 <bp:pathwayOrder rdf:resource="#PathwayStep562" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction489" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction486" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction488" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction487" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction493" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction492" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction494" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction491" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction490" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence561" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOD GTPase cycle</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">This pathway catalogues RHOD GTPase activator proteins (GAPs) and RHOD effectors. RHOD possesses GTPase activity and is therefore grouped with classical RHO GTPases but it is atypical in the sense that no known guanine nucleotide exchange factors (GEFs) and no GDP dissociation inhibitors (GDIs) (Blom et al. 2017) are involved in the regulation of RHOD activity. RHOD possesses an elevated intrinsic guanine nucleotide exchange activity and auto-activates (Jaiswal, Fansa et al. 2013). RHOD regulates cytoskeletal dynamics and intracellular transport of vesicles (Gad and Aspenstrom 2010; Aspenstrom et al. 2014), especially actin-dependent movement of endosomes (Gasman et al. 2003, reviewed in Randazzo 2003).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway75">
 <bp:pathwayOrder rdf:resource="#PathwayStep558" />
 <bp:pathwayOrder rdf:resource="#PathwayStep559" />
 <bp:pathwayOrder rdf:resource="#PathwayStep556" />
 <bp:pathwayOrder rdf:resource="#PathwayStep557" />
 <bp:pathwayOrder rdf:resource="#PathwayStep554" />
 <bp:pathwayOrder rdf:resource="#PathwayStep555" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction485" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction482" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction481" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction484" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction483" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction480" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence554" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC1 GTPase cycle</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">This pathway catalogues RAC1 guanine nucleotide exchange factors (GEFs), GTPase activator proteins (GAPs), GDP dissociation inhibitors (GDIs) and RAC1 effectors (reviewed by Payapilli and Malliri 2018). RAC1 is one of the three best characterized RHO GTPases, the other two being RHOA and CDC42. RAC1 regulates the cytoskeleton and the production of reactive oxygen species (ROS) (Acevedo and Gonzalez-Billault 2018) and is involved in cell adhesion and cell migration (Marei and Malliri 2017). RAC1 is involved in neuronal development (de Curtis et al. 2014). In neurons, RAC1 activity is regulated by synaptic activation and RAC1-mediated changes in actin cytoskeleton are implicated in dendritic spine morphogenesis, which plays a role in memory formation and learning (Tajeda-Simon 2015; Costa et al. 2020). RAC1 is involved in metabolic regulation of pancreatic islet &#946;-cells and in diabetes pathophysiology (Kowluru 2017; Kowluru et al. 2020). RAC1-mediated activation of NOX2 contributes to mitochondrial damage and the development of retinopathy in patients with diabetes (Sahajpal et al. 2019). RAC1 is important for exercise and contraction-stimulated glucose uptake in skeletal muscles (Sylow et al. 2014). RAC1 plays an important role in the maintenance of intestinal barrier integrity under physiological conditions and during tissue repair after resolution of colitis. Toxins of many diarrhea-causing bacteria target RAC1 (Kotelevets and Chastre 2020). RAC1 is important for skin homeostasis and wound healing and is involved in the pathogenesis of psoriasis (Winge and Marinkovich 2019). RAC1 is essential to vascular homeostasis and chronically elevated RAC1 signaling contributes to vascular pathology (Marinkovic et al. 2015). RAC1 hyperactivation, mutation and copy-number gain are frequently observed in solid tumors (Zou et al. 2017; De et al. 2019; De et al. 2020; Cannon et al. 2020; Kotelevets and Chastre 2020).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway74">
 <bp:pathwayOrder rdf:resource="#PathwayStep552" />
 <bp:pathwayOrder rdf:resource="#PathwayStep550" />
 <bp:pathwayOrder rdf:resource="#PathwayStep551" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction479" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction478" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction477" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence550" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOF GTPase cycle</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">This pathway catalogues RHOF (RIF) GTPase activator proteins (GAPs) and RHOF effectors. RHOF GTPase is thought to exist in the active GTP-bound state in the absence of any GEF activity (Tian et al. 2017). No GDP dissociation inhibitors (GDIs) have been shown to interact with RHOF. RHOF is only found in vertebrates (Gad and Aspenstrom 2010; Fan and Mellor 2012). RHOF regulates cytoskeletal dynamics (Gad and Aspenstrom 2010; Aspenstrom et al. 2014) and promotes the formation of filopodia and stress fibers (Fan and Mellor 2012). RHOF may be involved in actin remodelling in lymphocyte microvilli (Fan and Mellor 2012). In neurons, RHOF contributes to the formation of dendritic spines (Fan and Mellor 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence480">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway73">
 <bp:pathwayOrder rdf:resource="#PathwayStep547" />
 <bp:pathwayOrder rdf:resource="#PathwayStep548" />
 <bp:pathwayOrder rdf:resource="#PathwayStep545" />
 <bp:pathwayOrder rdf:resource="#PathwayStep546" />
 <bp:pathwayOrder rdf:resource="#PathwayStep543" />
 <bp:pathwayOrder rdf:resource="#PathwayStep544" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction475" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction474" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction476" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction471" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction473" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction472" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence543" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOB GTPase cycle</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">This pathway catalogues RHOB guanine nucleotide exchange factors (GEFs), GTPase activator proteins (GAPs), GDP dissociation inhibitors (GDIs) and RHOB effectors. RHOB belongs to the RHOA subfamily of RHO GTPases and shares 85% sequence identity with RHOA and RHOC. Posttranslational modifications of the unique C-terminus of RHOB regulate its subcellular localization. Similar to RHOA and RHOC, RHOB regulates the cytoskeleton and plays a role in cell migration. RHOB plays a role in regulation of membrane trafficking (Vega and Ridley 2018), cell proliferation (Vega and Ridley 2018), cell adhesion (Vega and Ridley 2018), DNA repair (Vega and Ridley 2018), and apoptosis (Prendergast 2001; Vega and Ridley 2018). RHOB-regulated cellular processes are important for the immune system function (Vega and Ridley 2018), pulmonary gas exchange (Wojciak-Stothard et al. 2012; Vega and Ridley 2018), and angiogenesis and vascular function (Vega and Ridley 2018). RHOB has been implicated both as a tumor suppressor and as an oncogene in cancer (Prendergast 2001; Huang and Prendergast 2006; Ju and Gilkes 2018; Calvayrac et al. 2018).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway173">
 <bp:pathwayOrder rdf:resource="#PathwayStep1326" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1325" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1324" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1319" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1323" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1322" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1321" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1320" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1149" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1148" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1147" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1154" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1153" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1152" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1151" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1150" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1319" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hormone ligand-binding receptors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The class A (rhodopsin-like) GPCRs that bind to hormone ligands are annotated here. The hormones follicle-stimulating hormone (FSH), luteinizing hormone (LH), thyroid-stimulating hormone (TSH) and human chorionic gonadotrophin (hCG) are dimeric glycoproteins, sharing an identical alpha subunit and varying beta subunits. Their actions are mediated by the respective GPCRs, influencing reproductive processes and thyroid hormone release.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway172">
 <bp:pathwayOrder rdf:resource="#PathwayStep1305" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1304" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1303" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1302" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1313" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1309" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1308" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1307" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1306" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1301" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1312" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1311" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1310" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1131" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1142" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1130" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1141" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1140" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1139" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1138" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1137" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1136" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1135" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1134" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1133" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1132" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1301" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">P2Y receptors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">P2Y receptors are a family of purinergic receptors, G protein-coupled receptors stimulated by nucleotides such as ATP, ADP, UTP, UDP and UDP-glucose. To date, 12 P2Y receptors have been cloned in humans (Abbracchio MP et al, 2006; Fischer W and Krugel U, 2007). P2Y receptors are present in almost all human tissues where they exert various biological functions based on their G-protein coupling. Purine nucleotides are involved in a large number of intermediate metabolic pathways, taking part as substrates, products or allosteric factors.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway175">
 <bp:pathwayOrder rdf:resource="#PathwayStep1329" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1330" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1334" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1333" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1332" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1331" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1159" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1158" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1157" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1156" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1155" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1160" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1329" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Serotonin receptors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Serotonin (5-HT) is a monoamine neurotransmitter that plays an important role as a modulator of anger, aggression, body temperature, mood, sleep, sexuality, appetite, metabolism, as well as stimulating vomiting. Several classes of drugs target the 5-HT system including some antidepressants, antipsychotics, anxiolytics, antiemetics and antimigraine drugs. The activity of 5-HT is modulated by 5-HT receptors, made up of seven families (5-HT1-7). All but 5-HT3 (ligand-gated ion channel) are GPCRs and these receptors bind different G proteins resulting in differing outcomes (Hoyer D et al, 1994; Kitson SL, 2007).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway174">
 <bp:pathwayOrder rdf:resource="#PathwayStep1349" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1335" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1368" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1328" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1362" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1344" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1343" />
 <bp:pathwayComponent rdf:resource="#Pathway175" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1168" />
 <bp:pathwayComponent rdf:resource="#Pathway177" />
 <bp:pathwayComponent rdf:resource="#Pathway176" />
 <bp:pathwayComponent rdf:resource="#Pathway179" />
 <bp:pathwayComponent rdf:resource="#Pathway178" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1190" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1328" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Amine ligand-binding receptors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The class A (rhodopsin-like) GPCRs that bind to classical biogenic amine ligands are annotated here. The amines involved  (acetylcholine, adrenaline, noradrenaline, dopamine, serotonin and histamine) can all act as neurotransmitters in humans. The so-called &apos;trace amines&apos;, used when referring to p-tyramine, beta-phenylethylamine, tryptamine and octopamine, can also bind to recently-discovered GPCRs.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway171">
 <bp:pathwayOrder rdf:resource="#PathwayStep1299" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1298" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1128" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1129" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1298" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Adenosine P1 receptors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The adenosine receptors (P1 receptors) are a class of purinergic receptors, G-protein coupled receptors with adenosine as their endogenous ligand.In humans, there are four adenosine receptors. Each is encoded by a separate gene and the four receptors have distinct, though overlapping, functions. For instance, both A1 and A2A receptors play roles in the heart, regulating myocardial oxygen consumption and coronary blood flow. They also have important roles in the brain, regulating the release of other neurotransmitters such as dopamine and glutamate. The A2B and A3 receptors are located peripherally and are involved in processes such as inflammation and immune responses. Fredholm BB et al, 2001).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway170">
 <bp:pathwayOrder rdf:resource="#PathwayStep1297" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1300" />
 <bp:pathwayComponent rdf:resource="#Pathway172" />
 <bp:pathwayComponent rdf:resource="#Pathway171" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1297" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nucleotide-like (purinergic) receptors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Purinergic receptors (Burnstock G, 2006; Abbracchio MP et al, 2009) are a family of newly characterized plasma membrane molecules involved in several cellular functions such as vascular reactivity, apoptosis and cytokine secretion. The functions of these receptors are as yet only partially characterized. The family includes the GPCR P2Y purinergic receptors and adenosine P1 receptors. A third family member, the P2X receptor, is a ligand-gated ion channel. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway177">
 <bp:pathwayOrder rdf:resource="#PathwayStep1348" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1347" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1346" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1345" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1169" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1172" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1171" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1170" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1345" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dopamine receptors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dopamine receptors play vital roles in processes such as the control of learning, motivation, fine motor control and modulation of neuroendocrine signaling (Giralt JA and Greengard P, 2004). Abnormalities in dopamine receptor signaling may lead to neuropsychiatric disorders such as Parkinson&apos;s disease and schizophrenia. Dopamine receptors are prominent in the CNS and the neurotransmitter dopamine is the primary endogenous ligand for these receptors. In humans, there are five distinct types of dopamine receptor, D1-D5. They are subdivided into two families; D1-like family (D1 and D5) which couple with the G protein alpha-s and are excitatory and D2-like family (D2,D3 and D4) which couple with the G protein alpha-i and are inhibitory (Kebabian JW and Calne DB, 1979).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway176">
 <bp:pathwayOrder rdf:resource="#PathwayStep1338" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1337" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1336" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1339" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1341" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1340" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1342" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1167" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1166" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1165" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1164" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1163" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1162" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1161" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1336" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Histamine receptors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Histamine is a biogenic amine involved in local immune responses, regulation of gut function and neurotransmission. It exerts its actions by binding to histamine receptors. There are four receptors in humans, H1-H4 (Hill SJ et al, 1997).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway179">
 <bp:pathwayOrder rdf:resource="#PathwayStep1363" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1367" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1366" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1365" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1364" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1189" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1188" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1187" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1186" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1185" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1363" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Muscarinic acetylcholine receptors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Muscarinic acetylcholine (mAChRs) receptors were so named because they are more sensitive to muscarine than to nicotine (Ishii M and Kurachi Y, 2006). Their counterparts are nicotinic acetylcholine receptors (nAChRs), ion channels receptors that are also important in the autonomic nervous system. Many drugs can manipulate these two distinct receptors by acting as selective agonists or antagonists. mAChRs bind to the bioamine acetylcholine, have a widespread tissue distribution and are involved in the control of numerous central and peripheral physiological responses, particularly voluntary muscle contraction. They are also major targets for drugs in human diseases such as Alzheimer&apos;s, Parkinson&apos;s and schizophrenia. This family of G-protein coupled receptors consists of five members designated M1-M5 and are sub-divided into two groups based on their primary coupling to G proteins. M2 and M4 receptors couple to Gi/o proteins and M1, M3 and M5 receptors couple to Gq/11 proteins (Caulfield MP and Birdsall NJ, 1998).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway178">
 <bp:pathwayOrder rdf:resource="#PathwayStep1359" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1358" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1357" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1352" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1351" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1350" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1361" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1360" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1356" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1355" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1354" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1353" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1179" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1178" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1177" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1176" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1175" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1174" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1173" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1184" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1183" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1182" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1181" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1180" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1350" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Adrenoceptors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The adrenoceptors (adrenergic receptors) are targets for the catecholamines adrenaline (epinephrine) and noradrenaline (norepinephrine). These receptors are widespread in the body and binding of catecholamines produces a sympathetic response (&apos;flight-or-fight response&apos;) resulting in increased heart rate, pupil dilation and energy mobilization amongst other responses. There are three major types of adrenoceptor, alpha1, alpha2 and beta. Each type is thought to have three subtypes; alpha1 (1A,1B,1D), alpha2 (2A,2B,2C) and beta (1,2,3) (Bylund DB et al, 1994).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence478">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway69">
 <bp:pathwayOrder rdf:resource="#PathwayStep523" />
 <bp:pathwayOrder rdf:resource="#PathwayStep521" />
 <bp:pathwayOrder rdf:resource="#PathwayStep522" />
 <bp:pathwayOrder rdf:resource="#PathwayStep520" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction453" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction452" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction455" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction454" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence520" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOU GTPase cycle</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHO GTPase RHOU (Wrch-1) possesses a high intrinsic guanine nucleotide exchange activity and is constitutively present in the active GTP-bound state in the absence of guanine nucleotide exchange factors (GEFs) (Shutes et al. 2004, Saras et al. 2004). RHOU does not possess a GTPase activity (Saras et al. 2004). RHOU has been reported to interact with some GTPase activator proteins (GAPs) (Bagci et al. 2020), which may serve as effectors that enable cross-talk with other RHO GTPases. RHOU was shown to regulate cytoskeletal dynamics, cell migration and adhesion. RHOU is expressed during embryonic development and regulates cardiac (Dickover et al. 2014) and intestinal (Slaymi et al. 2019) development. RHOU activates JNK and AKT signaling during cell migration (Chuang et al. 2007). For review, please refer to Faure and Fort 2015, and Hodge and Ridley 2020.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction457">
 <bp:evidence rdf:resource="#Evidence527" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC3 GDIs block activation of RAC3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence479">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway68">
 <bp:pathwayOrder rdf:resource="#PathwayStep517" />
 <bp:pathwayOrder rdf:resource="#PathwayStep518" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction451" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction450" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence517" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RND1 GTPase cycle</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RND1 is an atypical RHO GTPase from the RND subfamily. RND1 is constitutively bound to GTP and lacks GTPase activity. No guanine nucleotide exchange factors (GEFs), GTPase activator proteins (GAPs) or guanine nucleotide dissociation inhibitors (GDIs) act on RND1. RND1 localizes to the plasma membrane, but can be extracted from the plasma membrane and sequestered to the cytosol upon phosphorylation-induced binding to 14-3-3 protein. RND1 antagonizes RHOA, leading to reduced actomyosin contractility and loss of stress fibers and focal adhesions, which results in a rounded cell phenotype. RND1 plays a role in embryogenesis, neuronal development, myometrium changes during pregnancy, and angiogenesis. RND1 is frequently downregulated in cancer and is implicated as a tumor suppressor, but may play an oncogenic role in some cancer types. RND1 expression increases in response to anti-cancer agents and in may be involved in resistance to treatment. For review, please refer to Mouly et al. 2019.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction456">
 <bp:evidence rdf:resource="#Evidence526" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC3 GAPs stimulate RAC3 GTPase activity</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway67">
 <bp:pathwayOrder rdf:resource="#PathwayStep516" />
 <bp:pathwayOrder rdf:resource="#PathwayStep549" />
 <bp:pathwayOrder rdf:resource="#PathwayStep615" />
 <bp:pathwayOrder rdf:resource="#PathwayStep625" />
 <bp:pathwayOrder rdf:resource="#PathwayStep524" />
 <bp:pathwayOrder rdf:resource="#PathwayStep535" />
 <bp:pathwayOrder rdf:resource="#PathwayStep601" />
 <bp:pathwayOrder rdf:resource="#PathwayStep598" />
 <bp:pathwayOrder rdf:resource="#PathwayStep588" />
 <bp:pathwayOrder rdf:resource="#PathwayStep608" />
 <bp:pathwayOrder rdf:resource="#PathwayStep519" />
 <bp:pathwayOrder rdf:resource="#PathwayStep618" />
 <bp:pathwayOrder rdf:resource="#PathwayStep531" />
 <bp:pathwayOrder rdf:resource="#PathwayStep542" />
 <bp:pathwayOrder rdf:resource="#PathwayStep553" />
 <bp:pathwayOrder rdf:resource="#PathwayStep570" />
 <bp:pathwayOrder rdf:resource="#PathwayStep581" />
 <bp:pathwayOrder rdf:resource="#PathwayStep592" />
 <bp:pathwayOrder rdf:resource="#PathwayStep560" />
 <bp:pathwayComponent rdf:resource="#Pathway69" />
 <bp:pathwayComponent rdf:resource="#Pathway68" />
 <bp:pathwayComponent rdf:resource="#Pathway79" />
 <bp:pathwayComponent rdf:resource="#Pathway78" />
 <bp:pathwayComponent rdf:resource="#Pathway77" />
 <bp:pathwayComponent rdf:resource="#Pathway88" />
 <bp:pathwayComponent rdf:resource="#Pathway72" />
 <bp:pathwayComponent rdf:resource="#Pathway71" />
 <bp:pathwayComponent rdf:resource="#Pathway82" />
 <bp:pathwayComponent rdf:resource="#Pathway70" />
 <bp:pathwayComponent rdf:resource="#Pathway81" />
 <bp:pathwayComponent rdf:resource="#Pathway80" />
 <bp:pathwayComponent rdf:resource="#Pathway76" />
 <bp:pathwayComponent rdf:resource="#Pathway87" />
 <bp:pathwayComponent rdf:resource="#Pathway75" />
 <bp:pathwayComponent rdf:resource="#Pathway86" />
 <bp:pathwayComponent rdf:resource="#Pathway74" />
 <bp:pathwayComponent rdf:resource="#Pathway85" />
 <bp:pathwayComponent rdf:resource="#Pathway73" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence516" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHO GTPase cycle</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHO family of GTPases is large and diverse, with many of its members considered to be master regulators of actin cytoskeleton. RHO GTPases are involved in the regulation of many cellular processes that depend on dynamic reorganization of the cytoskeleton, including cell migration, cell adhesion, cell division, establishment of cellular polarity and intracellular transport. As a consequence, RHO GTPases play important roles in neuronal development, immunity and cardio-vascular homeostasis. RHO GTPases are involved in the etiology of infectious diseases, congenital immunodeficiencies, neurodegenerative diseases and cancer. For review, please refer to Jaffe and Hall 2005, Lemichez and Aktories 2013, Ridley 2015, Hodge and Ridley 2016, Haga and Ridley 2016, Olson 2018, and Kalpachidou et al. 2019.  Phylogenetically, RHO GTPases can be grouped into four clusters. The first cluster consists of three subfamilies: Rho, RhoD/RhoF and Rnd. The second cluster consists of three subfamilies: Rac, Cdc42 and RhoU/RhoV. The third cluster consists of the RhoH subfamily. The fourth cluster consists of the RhoBTB subfamily. Miro GTPases and RHOBTB3 ATPase are sometimes described as Rho family members, but they are phylogenetically distant from the Rho family and constitute two separate families of Ras-like GTPases, which, besides Rho, Miro and RHOBTB3 also includes Ran, Arf, Rab and Ras families (Boureux et al. 2007). Based on their activation type, RHO GTPases can be divided into classical (typical) and atypical (reviewed by Haga and Ridley 2016, and Kalpachidou et al. 2019). Classical RHO GTPases cycle between active GTP-bound states and inactive GDP-bound states through steps that are tightly controlled by members of three classes of proteins: (1) guanine nucleotide dissociation inhibitors or GDIs, which maintain Rho proteins in an inactive state in the cytoplasm, (2) guanine nucleotide exchange factors or GEFs, which destabilize the interaction between Rho proteins and their bound nucleotide, the net result of which is the exchange of bound GDP for the more abundant GTP, and (3) GTPase activating proteins or GAPs, which stimulate the low intrinsic GTP hydrolysis activity of Rho family members, thus promoting their inactivation. GDIs, GEFs, and GAPs are themselves subject to tight regulation, and the overall level of Rho activity reflects the balance of their activities. Many of the Rho-specific GEFs, GAPs, and GDIs act on multiple Rho GTPases, so that regulation of these control proteins can have complex effects on the functions of multiple Rho GTPases (reviewed by Van Aelst and D&apos;Souza-Schorey 1997, and Hodge and Ridley 2016). The classical Rho GTPase cycle is diagrammed in the figure below. External or internal cues promote the release of Rho GTPases from the GDI inhibitory complexes, which allows them to associate with the plasma membrane, where they are activated by GEFs (1), and can signal to effector proteins (4). Then, GAPs inactivate the GTPases by accelerating the intrinsic GTPase activity, leading to the GDP bound form (2). Once again, the GDI molecules stabilize the inactive GDP bound form in the cytoplasm, waiting for further instructions (3) (Tcherkezian and Lamarche-Vane, 2007). Classical RHO GTPases include four subfamilies: Rho (includes RHOA, RHOB and RHOC), Rac (includes RAC1, RAC2, RAC3 and RHOG), Cdc42 (includes CDC42, RHOJ and RHOQ) and RhoD/RhoF (includes RHOD and RHOF) (reviewed in Haga and Ridley 2016). RHOA, the founding member of the RHO GTPase family, regulates the actin cytoskeleton, formation of stress fibers and cell contractility, which is implicated in cell adhesion and migration (Lessey et al. 2012). RHOB and RHOC functions resemble RHOA (Vega and Ridley 2018; Guan et al. 2018). RHOB is also involved in membrane trafficking and DNA repair (Vega and Ridley 2018). RAC1 regulates the cytoskeleton and the production of reactive oxygen species (ROS) (Acevedo and Gonzalez-Billault 2018), and is involved in cell adhesion and cell migration (Marei and Malliri 2017). RAC2 expression is restricted to hematopoietic cells and RAC2 is a component of the phagocytic oxidase complex in neutrophils (Troeger and Williams 2013). RAC3 shares 92% sequence identity with RAC1 and is highly expressed in neurons (de Curtis 2019). CDC42 regulate the cytoskeleton and cell polarity, and is involved in cell adhesion and migration as well as in intracellular membrane trafficking (Egorov and Polishchuk 2017; Xiao et al. 2018; Pichaud et al. 2019; Woods and Lew 2019). RHOJ is highly expressed in endothelial cells, regulating their motility and vascular morphogenesis (Leszczynska et al. 2011; Shi et al. 2016). RHOQ (also known as TC10) is highly activated on exocytosing vesicles and recycling endosomes (Donnelly et al. 2014) and is involved in trafficking of CFTR (cystic fibrosis transmembrane conductance regulator) (Cheng et al. 2005). RHOD regulates cytoskeletal dynamics and intracellular transport of vesicles (Randazzo 2003; Gad and Aspenstrom 2010; Aspenstrom et al. 2014, Aspenstrom et al. 2020). RHOF regulates cytoskeletal dynamics (Gad and Aspenstrom 2010; Aspenstrom et al. 2014, Aspenstrom et al. 2020) and promotes the formation of filopodia and stress fibers (Fan and Mellor 2012). RHOD and RHOF do possess GTPase activity and are therefore grouped with classical RHO GTPases, but they are atypical in the sense that they possess high intrinsic guanine nucleotide exchange activity and do not require GEFs for activation (Aspenstrom et al. 2020).  Atypical RHO GTPases do not possess GTPase activity. They therefore constitutively exist in the active GTP-bound state. Atypical RHO GTPases include three subfamilies: Rnd (includes RND1, RND2 and RND3), RhoBTB (includes RHOBTB1 and RHOBTB2), RhoH (RHOH is the only member) and RhoU/RhoV (includes RHOU and RHOV). RND1 and RND3 can antagonize RHOA activity, leading to loss of stress fibers and cell rounding (Haga and Ridley 2016). RND1, RND2 and RND3 regulate cell migration (Ridley 2015; Mouly et al. 2019). RHOBTB1 is a component of a signaling cascade that regulates vascular function and blood pressure (Ji and Rivero 2016). RHOBTB2 is involved in COP9 signalosome-regulated and CUL3-dependent protein ubiquitination (Berthold et al. 2008; Ji and Rivero 2016). RHOH expression is restricted to hematopoietic cells, and it is known to be involved in T cell receptor (TCR) signaling and T cell development (Suzuki and Oda 2008; Troeger and Williams 2013). RHOU and RHOV expression is induced by WNT signaling and they are involved in regulation of cell shape and cell adhesion (Faure and Fort 2015; and Hodge and Ridley 2016).  Almost every classical RHO GTPase interacts with multiple GEFs, GAPs and GDIs, and every RHO GTPase activates multiple downstream effectors. There are 82 Rho GEFs (71 Dbl, reviewed in Fort and Blangy 2017, and 11 DOCK, reviewed in Meller et al. 2005), 66 Rho GAPs (Amin et al. 2016) and 3 Rho GDIs (Dransart et al. 2005) encoded by the human genome. To keep our reaction annotations compact, we have grouped the GEF, GAP, GDI and effector proteins associated with each RHO GTPase into sets. Within a set, we have distinguished full set members from candidate members on the basis of the amount of experimental evidence supporting the member&#8217;s molecular function. Note that members of a set can otherwise be functionally quite diverse. Annotation of upstream activators of GEFs, GAPs and GDIs was outside the scope of this catalogue pathway and is or will be shown elsewhere in Reactome. Signaling through downstream effectors is shown in more detail in the Reactome pathway &#8220;RHO GTPase Effectors&#8221;.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction459">
 <bp:evidence rdf:resource="#Evidence529" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC3 binds ER effectors</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway66">
 <bp:pathwayOrder rdf:resource="#PathwayStep514" />
 <bp:pathwayOrder rdf:resource="#PathwayStep512" />
 <bp:pathwayOrder rdf:resource="#PathwayStep513" />
 <bp:pathwayOrder rdf:resource="#PathwayStep510" />
 <bp:pathwayOrder rdf:resource="#PathwayStep511" />
 <bp:pathwayOrder rdf:resource="#PathwayStep509" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction446" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction445" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction448" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction447" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction444" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction449" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence509" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHO GTPases Activate Rhotekin and Rhophilins</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Rhotekin (RTKN) is a protein with an N-terminally located RHO GTPase binding domain, that shares a limited sequence homology with PKNs and rhophilins. RTKN binds to GTP-bound RHOA, RHOB and RHOC and can inhibit their GTPase activity (Reid et al. 1996, Fu et al. 2000), which can be corroborated by protein kinase D-mediated phosphorylation of RTKN (Pusapati et al. 2012). RTKN is implicated in the establishment of cell polarity (Sudo et al. 2006), septin organization (Ito et al. 2005, Sudo et al. 2007) and stimulation of SRF-mediated transcription (Reynaud et al. 2000). RTKN can have an anti-apoptotic effect that depends on the activation of NFKB (NF-kappaB) (Liu et al. 2004). RTKN2 (rhotekin-2) is another rhotekin exclusively expressed in lymphocytes (Collier et al. 2004). The function and the mechanism of action of RTKN2 are unknown. Rhophillins include two family members - rhophilin-1 (RHNP1) and rhophilin-2 (RHPN2) with ~75% sequence identity. A RHO GTPase binding domain is located at the N-terminus of rhophilins, followed by a BRO1 domain (characteristic of proteins involved in protein kinase C signaling) and a C-terminal PDZ domain. RHOA:GTP binds both RHPN1 and RHPN2 and these interactions may be involved in organization of the actin cytoskeleton and/or cell motility (Watanabe et al. 1996, Fujita et al. 2000, Peck et al. 2002). RHOB:GTP recruits RHPN2 to endosomes which may be involved in the function of thyroid cells (Mircescu et al. 2002).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction458">
 <bp:evidence rdf:resource="#Evidence528" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC3 GEFs activate RAC3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence474">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction453">
 <bp:evidence rdf:resource="#Evidence522" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOU auto-activates</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence475">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction452">
 <bp:evidence rdf:resource="#Evidence521" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated RHOU translocates to the endosome membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence476">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction455">
 <bp:evidence rdf:resource="#Evidence524" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SRC phosphorylates RHOU</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence477">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction454">
 <bp:evidence rdf:resource="#Evidence523" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOU binds effectors at the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway61">
 <bp:pathwayOrder rdf:resource="#PathwayStep468" />
 <bp:pathwayOrder rdf:resource="#PathwayStep469" />
 <bp:pathwayOrder rdf:resource="#PathwayStep466" />
 <bp:pathwayOrder rdf:resource="#PathwayStep467" />
 <bp:pathwayOrder rdf:resource="#PathwayStep465" />
 <bp:pathwayOrder rdf:resource="#PathwayStep473" />
 <bp:pathwayOrder rdf:resource="#PathwayStep485" />
 <bp:pathwayOrder rdf:resource="#PathwayStep471" />
 <bp:pathwayOrder rdf:resource="#PathwayStep472" />
 <bp:pathwayOrder rdf:resource="#PathwayStep470" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction424" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction412" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction411" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction410" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction409" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction406" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction405" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction408" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction407" />
 <bp:pathwayComponent rdf:resource="#Pathway62" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence465" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHO GTPases activate PKNs</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Protein kinases N (PKN), also known as protein kinase C-related kinases (PKR) feature a C-terminal serine/threonine kinase domain and three RHO-binding motifs at the N-terminus. RHO GTPases RHOA, RHOB, RHOC and RAC1 bind PKN1, PKN2 and PKN3 (Maesaki et al. 1999, Zhong et al. 1999, Owen et al. 2003, Modha et al. 2008, Hutchinson et al. 2011, Hutchinson et al. 2013), bringing them in proximity to the PIP3-activated co-activator PDPK1 (PDK1) (Flynn et al. 2000, Torbett et al. 2003). PDPK1 phosphorylates PKNs on a highly conserved threonine residue in the kinase activation loop, which is a prerequisite for PKN activation. Phosphorylation of other residues might also be involved in activation (Flynn et al. 2000, Torbett et al. 2003, Dettori et al. 2009). PKNs are activated by fatty acids like arachidonic acid and phospholipids in vitro, but the in vivo significance of this activation remains unclear (Palmer et al. 1995, Yoshinaga et al. 1999). PKNs play important roles in diverse functions, including regulation of cell cycle, receptor trafficking, vesicle transport and apoptosis. PKN is also involved in the ligand-dependent transcriptional activation by the androgen receptor. More than 20 proteins and several peptides have been shown to be phosphorylated by PKN1 and PKN2, including CPI-17 (Hamaguchi et al. 2000), alpha-actinin (Mukai et al. 1997), adducin (Collazos et al. 2011), CDC25C (Misaki et al. 2001), vimentin (Matsuzawa et al. 1997), TRAF1 (Kato et al. 2008), CLIP170 (Collazos et al. 2011) and EGFR (Collazos et al. 2011). There are no known substrates for PKN3 (Collazos et al. 2011).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence470">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1054">
 <bp:evidence rdf:resource="#Evidence1219" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Neurolysin degrades neurotensin</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1385">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1204" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2385">
 <bp:evidence rdf:resource="#Evidence2736" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTRK2 phosphorylates SHC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway60">
 <bp:pathwayOrder rdf:resource="#PathwayStep459" />
 <bp:pathwayOrder rdf:resource="#PathwayStep457" />
 <bp:pathwayOrder rdf:resource="#PathwayStep458" />
 <bp:pathwayOrder rdf:resource="#PathwayStep462" />
 <bp:pathwayOrder rdf:resource="#PathwayStep463" />
 <bp:pathwayOrder rdf:resource="#PathwayStep460" />
 <bp:pathwayOrder rdf:resource="#PathwayStep461" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction402" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction401" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction404" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction403" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction398" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction400" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction399" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence457" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHO GTPases Activate ROCKs</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHO associated, coiled-coil containing protein kinases ROCK1 and ROCK2 consist of a serine/threonine kinase domain, a coiled-coil region, a RHO-binding domain and a plekstrin homology (PH) domain interspersed with a cysteine-rich region. The PH domain inhibits the kinase activity of ROCKs by an intramolecular fold. ROCKs are activated by binding of the GTP-bound RHO GTPases RHOA, RHOB and RHOC to the RHO binding domain of ROCKs (Ishizaki et al. 1996, Leung et al. 1996), which disrupts the autoinhibitory fold. Once activated, ROCK1 and ROCK2 phosphorylate target proteins, many of which are involved in the stabilization of actin filaments and generation of actin-myosin contractile force. ROCKs phosphorylate LIM kinases LIMK1 and LIMK2, enabling LIMKs to phosphorylate cofilin, an actin depolymerizing factor, and thereby regulate the reorganization of the actin cytoskeleton (Ohashi et al. 2000, Sumi et al. 2001). ROCKs phosphorylate MRLC (myosin regulatory light chain), which stimulates the activity of non-muscle myosin II (NMM2), an actin-based motor protein involved in cell migration, polarity formation and cytokinesis (Amano et al. 1996, Riento and Ridley 2003, Watanabe et al. 2007, Amano et al. 2010). ROCKs also phosphorylate the myosin phosphatase targeting subunit (MYPT1) of MLC phosphatase, inhibiting the phosphatase activity and preventing dephosphorylation of MRLC. This pathway acts synergistically with phosphorylation of MRLC by ROCKs towards stimulation of non-muscle myosin II activity (Kimura et al. 1996, Amano et al. 2010). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence471">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1053">
 <bp:evidence rdf:resource="#Evidence1218" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Prokineticin receptors bind prokineticin</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1384">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1203" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2384">
 <bp:evidence rdf:resource="#Evidence2735" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y516 of p-5Y-NTRK2 recruits SHC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence472">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1052">
 <bp:evidence rdf:resource="#Evidence1217" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Relaxin receptor 1 binds relaxin 2 and 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1383">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1202" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2383">
 <bp:evidence rdf:resource="#Evidence2733" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTF3 binds NTRK2 (TRKB)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence473">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1051">
 <bp:evidence rdf:resource="#Evidence1216" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Relaxin 3 receptor 1 binds relaxin 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1382">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1201" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2382">
 <bp:evidence rdf:resource="#Evidence2732" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTF3-bound NTRK2 dimerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway65">
 <bp:pathwayOrder rdf:resource="#PathwayStep505" />
 <bp:pathwayOrder rdf:resource="#PathwayStep506" />
 <bp:pathwayOrder rdf:resource="#PathwayStep507" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction442" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction441" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction443" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence505" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHO GTPases regulate CFTR trafficking</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated RHO GTPase RHOQ (TC10) regulates the trafficking of CFTR (cystic fibrosis transmembrane conductance regulator) by binding to GOPC (Golgi-associated and PDZ and coiled-coil motif-containing protein) also known as PIST, FIG or CAL. GOPC is a Golgi resident protein that binds several membrane proteins, thereby modulating their expression. In the absence of RHOQ, GOPC bound to CFTR directs CFTR for lysosomal degradation, while GTP-bound RHOQ directs GOPC:CFTR complex to the plasma membrane, thereby rescuing CFTR (Neudauer et al. 2001, Cheng et al. 2005).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1050">
 <bp:evidence rdf:resource="#Evidence1215" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Relaxin receptor 2 binds relaxin 2 and INSL3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1389">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1206" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2381">
 <bp:evidence rdf:resource="#Evidence2731" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTF3-bound NTRK2 dimers trans-autophosphorylate</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway64">
 <bp:pathwayOrder rdf:resource="#PathwayStep503" />
 <bp:pathwayOrder rdf:resource="#PathwayStep501" />
 <bp:pathwayOrder rdf:resource="#PathwayStep502" />
 <bp:pathwayOrder rdf:resource="#PathwayStep499" />
 <bp:pathwayOrder rdf:resource="#PathwayStep500" />
 <bp:pathwayOrder rdf:resource="#PathwayStep497" />
 <bp:pathwayOrder rdf:resource="#PathwayStep498" />
 <bp:pathwayOrder rdf:resource="#PathwayStep495" />
 <bp:pathwayOrder rdf:resource="#PathwayStep496" />
 <bp:pathwayOrder rdf:resource="#PathwayStep494" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction435" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction434" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction437" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction436" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction431" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction433" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction432" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction440" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction439" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction438" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence494" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHO GTPases Activate WASPs and WAVEs</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WASP and WAVE proteins belong to the Wiskott-Aldrich Syndrome protein family, with recessive mutations in the founding member WASP being responsible for the X-linked recessive immunodeficieny known as the Wiskott-Aldrich Syndrome. WASP proteins include WASP and WASL (N-WASP). WAVE proteins include WASF1 (WAVE1), WASF2 (WAVE2) and WASF3 (WAVE3). WASPs and WAVEs contain a VCA domain (consisting of WH2 and CA subdomains) at the C-terminus, responsible for binding to G-actin (WH2 subdomain) and the actin-associated ARP2/3 complex (CA subdomain). WASPs contain a WH1 (WASP homology 1) domain at the N-terminus, responsible for binding to WIPs (WASP-interacting proteins). A RHO GTPase binding domain (GBD) is located in the N-terminal half of WASPs and C-terminally located in WAVEs. RHO GTPases activate WASPs by disrupting the autoinhibitory interaction between the GBD and VCA domains, which allows WASPs to bind actin and the ARP2/3 complex and act as nucleation promoting factors in actin polymerization. WAVEs have the WAVE/SCAR homology domain (WHD/SHD) at the N-terminus, which binds ABI, NCKAP1, CYFIP2 and BRK1 to form the WAVE regulatory complex (WRC). Binding of the RAC1:GTP to the GBD of WAVEs most likely induces a conformational change in the WRC that allows activating phosphorylation of WAVEs by ABL1, thus enabling them to function as nucleation promoting factors in actin polymerization through binding G-actin and the ARP2/3 complex (Reviewed by Lane et al. 2014).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep1388">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1205" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2380">
 <bp:evidence rdf:resource="#Evidence2728" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated NTRK3 binds PLCG1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway63">
 <bp:pathwayOrder rdf:resource="#PathwayStep490" />
 <bp:pathwayOrder rdf:resource="#PathwayStep488" />
 <bp:pathwayOrder rdf:resource="#PathwayStep489" />
 <bp:pathwayOrder rdf:resource="#PathwayStep487" />
 <bp:pathwayOrder rdf:resource="#PathwayStep491" />
 <bp:pathwayOrder rdf:resource="#PathwayStep492" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction426" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction425" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction430" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction428" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction427" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction429" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence487" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHO GTPases activate CIT</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Citron kinase (CIT) or citron RHO-interacting kinase (CRIK) shares similarities with ROCK kinases. Like ROCK, it consists of a serine/threonine kinase domain, a coiled-coil region, a RHO-binding domain, a cysteine rich region and a plekstrin homology (PH) domain, but additionally features a proline-rich region and a PDZ-binding domain. A shorter splicing isoform of CIT, citron-N, is specifically expressed in the nervous system and lacks the kinase domain. Citron-N is a component of the post-synaptic density, where it binds to the PDZ domains of the scaffolding protein PDS-95/SAP90 (Zhang et al. 2006). While the binding of CIT to RHO GTPases RHOA, RHOB, RHOC and RAC1 is well established (Madaule et al. 1995), the mechanism of CIT activation by GTP-bound RHO GTPases has not been elucidated. There are indications that CIT may be activated through autophosphorylation in the presence of active forms of RHO GTPases (Di Cunto et al. 1998). CIT appears to phosphorylate the myosin regulatory light chain (MRLC), the only substrate identified to date, on the same residues that are phosphorylated by ROCKs, but it has not been established yet how this relates to activation by RHO GTPases (Yamashiro et al. 2003). CIT and RHOA are implicated to act together in Golgi apparatus organization through regulation of the actin cytoskeleton (Camera et al. 2003). CIT is also involved in the regulation of cytokinesis through its interaction with KIF14 (Gruneberg et al. 2006, Bassi et al. 2013, Watanabe et al. 2013) and p27(Kip1) (Serres et al. 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep1387">
 <bp:stepProcess rdf:resource="#Pathway184" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway62">
 <bp:pathwayOrder rdf:resource="#PathwayStep479" />
 <bp:pathwayOrder rdf:resource="#PathwayStep477" />
 <bp:pathwayOrder rdf:resource="#PathwayStep478" />
 <bp:pathwayOrder rdf:resource="#PathwayStep475" />
 <bp:pathwayOrder rdf:resource="#PathwayStep476" />
 <bp:pathwayOrder rdf:resource="#PathwayStep484" />
 <bp:pathwayOrder rdf:resource="#PathwayStep474" />
 <bp:pathwayOrder rdf:resource="#PathwayStep482" />
 <bp:pathwayOrder rdf:resource="#PathwayStep483" />
 <bp:pathwayOrder rdf:resource="#PathwayStep480" />
 <bp:pathwayOrder rdf:resource="#PathwayStep481" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction413" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction423" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction415" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction414" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction420" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction422" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction421" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction417" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction416" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction419" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction418" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence474" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKN1, activated by phosphorylation at threonine T774, binds activated AR (androgen receptor) and promotes transcription from AR-regulated promoters. On one hand, phosphorylated PKN1 promotes the formation of a functional complex of AR with the transcriptional coactivator NCOA2 (TIF2) (Metzger et al. 2003). On the other hand, binding of phosphorylated PKN1, in complex with the activated AR, to androgen-reponsive promoters of KLK2 and KLK3 (PSA) genes, leads to PKN1-mediated histone phosphorylation. PKN1-phosphorylated histones recruit histone demethylases KDM4C (JMJD2C) and KDM1A (LSD1), and the ensuing demethylation of histones associated with the promoter regions of KLK2 and KLK3 genes increases their transcription (Metzger et al. 2005, Metzger et al. 2008).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep1386">
 <bp:stepProcess rdf:resource="#Pathway183" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1059">
 <bp:evidence rdf:resource="#Evidence1224" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GPR37 binds prosaptide</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1058">
 <bp:evidence rdf:resource="#Evidence1223" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Galanin receptors can bind galanin</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1392">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1209" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2389">
 <bp:evidence rdf:resource="#Evidence2741" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated NTRK2 binds FYN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1057">
 <bp:evidence rdf:resource="#Evidence1222" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Neurotensin receptors can bind neurotensins</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1391">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1208" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2388">
 <bp:evidence rdf:resource="#Evidence2740" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FYN binds GRIN2B</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1056">
 <bp:evidence rdf:resource="#Evidence1221" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Opioid receptors bind opioid peptides</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1390">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1207" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2387">
 <bp:evidence rdf:resource="#Evidence2738" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHC1 bound to activated NTRK2 recruits GRB2:SOS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1055">
 <bp:evidence rdf:resource="#Evidence1220" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AGT(34-41) binds to AGTR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2386">
 <bp:evidence rdf:resource="#Evidence2737" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTRK2 activates RAS signaling through SHC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction460">
 <bp:evidence rdf:resource="#Evidence530" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC3 translocates to the endoplasmic reticulum membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction462">
 <bp:evidence rdf:resource="#Evidence533" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOJ binds effectors at the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction461">
 <bp:evidence rdf:resource="#Evidence531" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC3 binds effectors at the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway58">
 <bp:pathwayOrder rdf:resource="#PathwayStep448" />
 <bp:pathwayOrder rdf:resource="#PathwayStep449" />
 <bp:pathwayOrder rdf:resource="#PathwayStep451" />
 <bp:pathwayOrder rdf:resource="#PathwayStep452" />
 <bp:pathwayOrder rdf:resource="#PathwayStep450" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction394" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction393" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction395" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction392" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction391" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence448" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHO GTPases activate IQGAPs</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IQGAPs constitute a family of scaffolding proteins characterized by a calponin homology (CH) domain, a polyproline binding region (WW domain), a tandem of four IQ (isoleucine and glutamine-rich) repeats and a RAS GTPase-activating protein-related domain (GRD). Three IQGAPs have been identified in human, IQGAP1, IQGAP2 and IQGAP3. The best characterized is IQGAP1 and over 90 proteins have been reported to bind to it. IQGAPs integrate multiple signaling pathways and coordinate a large variety of cellular activities (White et al. 2012). IQGAP proteins IQGAP1, IQGAP2 and IQGAP3, bind activated RHO GTPases RAC1 and CDC42 via their GRD and stabilize them in their GTP-bound state (Kuroda et al. 1996, Swart-Mataraza et al. 2002, Wang et al. 2007). IQGAPs bind F-actin filaments via the CH domain and modulate cell shape and motility through regulation of G-actin/F-actin equilibrium (Brill et al. 1996, Fukata et al. 1997, Bashour et al. 1997, Wang et al. 2007, Pelikan-Conchaudron et al. 2011). Binding of IQGAPs to F-actin is inhibited by calmodulin binding to the IQ repeats (Bashour et al. 1997, Pelikan-Conchaudron et al. 2011). Based on IQGAP1 studies, IQGAPs presumably function as homodimers (Bashour et al. 1997). IQGAP1 is involved in the regulation of adherens junctions through its interaction with E-cadherin (CDH1) and catenins (CTTNB1 and CTTNA1) (Kuroda et al. 1998, Hage et al. 2009). IQGAP1 contributes to cell polarity and lamellipodia formation through its interaction with microtubules (Fukata et al. 2002, Suzuki and Takahashi 2008). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence467">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction468">
 <bp:evidence rdf:resource="#Evidence540" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOG binds effectors at the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway57">
 <bp:pathwayOrder rdf:resource="#PathwayStep439" />
 <bp:pathwayOrder rdf:resource="#PathwayStep437" />
 <bp:pathwayOrder rdf:resource="#PathwayStep438" />
 <bp:pathwayOrder rdf:resource="#PathwayStep435" />
 <bp:pathwayOrder rdf:resource="#PathwayStep446" />
 <bp:pathwayOrder rdf:resource="#PathwayStep436" />
 <bp:pathwayOrder rdf:resource="#PathwayStep433" />
 <bp:pathwayOrder rdf:resource="#PathwayStep444" />
 <bp:pathwayOrder rdf:resource="#PathwayStep434" />
 <bp:pathwayOrder rdf:resource="#PathwayStep445" />
 <bp:pathwayOrder rdf:resource="#PathwayStep442" />
 <bp:pathwayOrder rdf:resource="#PathwayStep432" />
 <bp:pathwayOrder rdf:resource="#PathwayStep443" />
 <bp:pathwayOrder rdf:resource="#PathwayStep440" />
 <bp:pathwayOrder rdf:resource="#PathwayStep441" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction379" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction376" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction387" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction386" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction378" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction389" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction377" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction388" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction383" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction382" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction385" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction384" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction390" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction381" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction380" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence432" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHO GTPases activate PAKs</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The PAKs (p21-activated kinases) are a family of serine/threonine kinases mainly implicated in cytoskeletal rearrangements. All PAKs share a conserved catalytic domain located at the carboxyl terminus and a highly conserved motif in the amino terminus known as p21-binding domain (PBD) or Cdc42/Rac interactive binding (CRIB) domain. There are six mammalian PAKs that can be divided into two classes: class I (or conventional) PAKs (PAK1-3) and class II PAKs (PAK4-6). Conventional PAKs are important regulators of cytoskeletal dynamics and cell motility and are additionally implicated in transcription through MAPK (mitogen-activated protein kinase) cascades, death and survival signaling and cell cycle progression (Chan and Manser 2012). PAK1, PAK2 and PAK3 are direct effectors of RAC1 and CDC42 GTPases. RAC1 and CDC42 bind to the CRIB domain. This binding induces a conformational change that disrupts inactive PAK homodimers and relieves autoinhibition of the catalytic carboxyl terminal domain (Manser et al. 1994, Manser et al. 1995, Zhang et al. 1998, Lei et al. 2000, Parrini et al. 2002; reviewed by Daniels and Bokoch 1999, Szczepanowska 2009). Autophosphorylation of a conserved threonine residue in the catalytic domain of PAKs (T423 in PAK1, T402 in PAK2 and T436 in PAK3) is necessary for the kinase activity of PAK1, PAK2 and PAK3. Autophosphorylation of PAK1 serine residue S144, PAK2 serine residue S141, and PAK3 serine residue S154 disrupts association of PAKs with RAC1 or CDC42 and enhances kinase activity (Lei et al. 2000, Chong et al. 2001, Parrini et al. 2002, Jung and Traugh 2005, Wang et al. 2011). LIMK1 is one of the downstream targets of PAK1 and is activated through PAK1-mediated phosphorylation of the threonine residue T508 within its activation loop (Edwards et al. 1999). Further targets are the myosin regulatory light chain (MRLC), myosin light chain kinase (MLCK), filamin, cortactin, p41Arc (a subunit of the Arp2/3 complex), caldesmon, paxillin and RhoGDI, to mention a few (Szczepanowska 2009). Class II PAKs also have a CRIB domain, but lack a defined autoinhibitory domain and proline-rich regions. They do not require GTPases for their kinase activity, but their interaction with RAC or CDC42 affects their subcellular localization. Only conventional PAKs will be annotated here. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence468">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction467">
 <bp:evidence rdf:resource="#Evidence539" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOG binds effectors at the ER membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway56">
 <bp:pathwayOrder rdf:resource="#PathwayStep417" />
 <bp:pathwayOrder rdf:resource="#PathwayStep418" />
 <bp:pathwayOrder rdf:resource="#PathwayStep415" />
 <bp:pathwayOrder rdf:resource="#PathwayStep416" />
 <bp:pathwayOrder rdf:resource="#PathwayStep413" />
 <bp:pathwayOrder rdf:resource="#PathwayStep414" />
 <bp:pathwayOrder rdf:resource="#PathwayStep411" />
 <bp:pathwayOrder rdf:resource="#PathwayStep412" />
 <bp:pathwayOrder rdf:resource="#PathwayStep419" />
 <bp:pathwayOrder rdf:resource="#PathwayStep410" />
 <bp:pathwayOrder rdf:resource="#PathwayStep430" />
 <bp:pathwayOrder rdf:resource="#PathwayStep406" />
 <bp:pathwayOrder rdf:resource="#PathwayStep428" />
 <bp:pathwayOrder rdf:resource="#PathwayStep407" />
 <bp:pathwayOrder rdf:resource="#PathwayStep429" />
 <bp:pathwayOrder rdf:resource="#PathwayStep404" />
 <bp:pathwayOrder rdf:resource="#PathwayStep426" />
 <bp:pathwayOrder rdf:resource="#PathwayStep405" />
 <bp:pathwayOrder rdf:resource="#PathwayStep427" />
 <bp:pathwayOrder rdf:resource="#PathwayStep424" />
 <bp:pathwayOrder rdf:resource="#PathwayStep425" />
 <bp:pathwayOrder rdf:resource="#PathwayStep422" />
 <bp:pathwayOrder rdf:resource="#PathwayStep423" />
 <bp:pathwayOrder rdf:resource="#PathwayStep408" />
 <bp:pathwayOrder rdf:resource="#PathwayStep409" />
 <bp:pathwayOrder rdf:resource="#PathwayStep420" />
 <bp:pathwayOrder rdf:resource="#PathwayStep421" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction358" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction357" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction359" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction354" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction353" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction375" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction356" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction355" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction361" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction360" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction363" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction362" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction369" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction368" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction349" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction365" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction364" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction367" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction366" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction350" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction372" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction371" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction352" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction374" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction351" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction373" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction370" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence404" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHO GTPases Activate Formins</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formins are a family of proteins with 15 members in mammals, organized into 8 subfamilies. Formins are involved in the regulation of actin cytoskeleton. Many but not all formin family members are activated by RHO GTPases. Formins that serve as effectors of RHO GTPases belong to different formin subfamilies but they all share a structural similarity to Drosophila protein diaphanous and are hence named diaphanous-related formins (DRFs). DRFs activated by RHO GTPases contain a GTPase binding domain (GBD) at their N-terminus, followed by formin homology domains 3, 1, and 2 (FH3, FH1, FH2) and a diaphanous autoregulatory domain (DAD) at the C-terminus. Most DRFs contain a dimerization domain (DD) and a coiled-coil region (CC) in between FH3 and FH1 domains (reviewed by Kuhn and Geyer 2014). RHO GTPase-activated DRFs are autoinhibited through the interaction between FH3 and DAD which is disrupted upon binding to an active RHO GTPase (Li and Higgs 2003, Lammers et al. 2005, Nezami et al. 2006). Since formins dimerize, it is not clear whether the FH3-DAD interaction is intra- or intermolecular. FH2 domain is responsible for binding to the F-actin and contributes to the formation of head-to-tail formin dimers (Xu et al. 2004). The proline-rich FH1 domain interacts with the actin-binding proteins profilins, thereby facilitating actin recruitment to formins and accelerating actin polymerization (Romero et al. 2004, Kovar et al. 2006). Different formins are activated by different RHO GTPases in different cell contexts. FMNL1 (formin-like protein 1) is activated by binding to the RAC1:GTP and is involved in the formation of lamellipodia in macrophages (Yayoshi-Yamamoto et al. 2000) and is involved in the regulation of the Golgi complex structure (Colon-Franco et al. 2011). Activation of FMNL1 by CDC42:GTP contributes to the formation of the phagocytic cup (Seth et al. 2006). Activation of FMNL2 (formin-like protein 2) and FMNL3 (formin-like protein 3) by RHOC:GTP is involved in cancer cell motility and invasiveness (Kitzing et al. 2010, Vega et al. 2011). DIAPH1, activated by RHOA:GTP, promotes elongation of actin filaments and activation of SRF-mediated transcription which is inhibited by unpolymerized actin (Miralles et al. 2003). RHOF-mediated activation of DIAPH1 is implicated in formation of stress fibers (Fan et al. 2010). Activation of DIAPH1 and DIAPH3 by RHOB:GTP leads to actin coat formation around endosomes and regulates endosome motility and trafficking (Fernandez-Borja et al. 2005, Wallar et al. 2007). Endosome trafficking is also regulated by DIAPH2 transcription isoform 3 (DIAPH2-3) which, upon activation by RHOD:GTP, recruits SRC kinase to endosomes (Tominaga et al. 2000, Gasman et al. 2003). DIAPH2 transcription isoform 2 (DIAPH2-2) is involved in mitosis where, upon being activated by CDC42:GTP, it facilitates the capture of astral microtubules by kinetochores (Yasuda et al. 2004, Cheng et al. 2011). DIAPH2 is implicated in ovarian maintenance and premature ovarian failure (Bione et al. 1998). DAAM1, activated by RHOA:GTP, is involved in linking WNT signaling to cytoskeleton reorganization (Habas et al. 2001). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence469">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway55">
 <bp:pathwayOrder rdf:resource="#PathwayStep402" />
 <bp:pathwayOrder rdf:resource="#PathwayStep389" />
 <bp:pathwayOrder rdf:resource="#PathwayStep400" />
 <bp:pathwayOrder rdf:resource="#PathwayStep401" />
 <bp:pathwayOrder rdf:resource="#PathwayStep390" />
 <bp:pathwayOrder rdf:resource="#PathwayStep391" />
 <bp:pathwayOrder rdf:resource="#PathwayStep398" />
 <bp:pathwayOrder rdf:resource="#PathwayStep399" />
 <bp:pathwayOrder rdf:resource="#PathwayStep396" />
 <bp:pathwayOrder rdf:resource="#PathwayStep397" />
 <bp:pathwayOrder rdf:resource="#PathwayStep394" />
 <bp:pathwayOrder rdf:resource="#PathwayStep395" />
 <bp:pathwayOrder rdf:resource="#PathwayStep392" />
 <bp:pathwayOrder rdf:resource="#PathwayStep393" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction336" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction347" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction335" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction346" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction338" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction337" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction348" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction343" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction342" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction345" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction344" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction339" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction341" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction340" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence389" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHO GTPases Activate NADPH Oxidases</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NADPH oxidases (NOX) are membrane-associated enzymatic complexes that use NADPH as an electon donor to reduce oxygen and produce superoxide (O2-) that serves as a secondary messenger (Brown and Griendling 2009). NOX2 complex consists of CYBB (NOX2), CYBA (p22phox), NCF1 (p47phox), NCF2 (p67phox) and NCF4 (p40ohox). RAC1:GTP binds NOX2 complex in response to VEGF signaling by directly interracting with CYBB and NCF2, leading to enhancement of VEGF-signaling through VEGF receptor VEGFR2, which plays a role in angiogenesis (Price et al. 2002, Bedard and Krause 2007). RAC2:GTP can also activate the NOX2 complex by binding to CYBB and NCF2, leading to production of superoxide in phagosomes of neutrophils which is necessary fo the microbicidal activity of neutrophils (Knaus et al. 1991, Roberts et al. 1999, Kim and Dinauer 2001, Jyoti et al. 2014). NOX1 complex (composed of NOX1, NOXA1, NOXO1 and CYBA) and NOX3 complex (composed of NOX3, CYBA, NCF1 amd NCF2 or NOXA1) can also be activated by binding to RAC1:GTP to produce superoxide (Cheng et al. 2006, Miyano et al. 2006, Ueyama et al. 2006).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction469">
 <bp:evidence rdf:resource="#Evidence541" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOG GEFs activate RHOG</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence463">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction464">
 <bp:evidence rdf:resource="#Evidence535" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOJ GAPs stimulate RHOJ GTPase activity</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence464">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction463">
 <bp:evidence rdf:resource="#Evidence534" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOJ GEFs activate RHOJ</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence465">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction466">
 <bp:evidence rdf:resource="#Evidence538" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOG GAPs stimulate RHOG GTPase activity</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway59">
 <bp:pathwayOrder rdf:resource="#PathwayStep455" />
 <bp:pathwayOrder rdf:resource="#PathwayStep454" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction397" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction396" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence454" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHO GTPases activate KTN1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GTP-bound active forms of RHO GTPases RHOA, RHOG, RAC1 and CDC42 bind kinectin (KTN1), a protein inserted in endoplasmic reticulum membranes that interacts with the cargo-binding site of kinesin and activates its microtubule-stimulated ATPase activity required for vesicle motility (Vignal et al. 2001, Hotta et al. 1996). The effect of RHOG activity on cellular morphology, exhibited in the formation of microtubule-dependent cellular protrusions, depends both on RHOG interaction with KTN1, as well as on the kinesin activity (Vignal et al. 2001). RHOG and KTN1 also cooperate in microtubule-dependent lysosomal transport (Vignal et al. 2001). The precise mechanism of kinectin-mediated Rho GTPase signaling cascade needs further elucidation, and only the first two steps, KTN1-activated RHO GTPase binding, and KTN1-kinesin-1 binding are annotated here.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence466">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction465">
 <bp:evidence rdf:resource="#Evidence537" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOG translocates to the ER membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway50">
 <bp:pathwayOrder rdf:resource="#PathwayStep378" />
 <bp:pathwayOrder rdf:resource="#PathwayStep382" />
 <bp:pathwayComponent rdf:resource="#Pathway52" />
 <bp:pathwayComponent rdf:resource="#Pathway51" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence378" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Miro GTPase Cycle</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Miro GTPases are a separate family of Ras-related GTPases that are sometimes included in the atypical RHO GTPases group, but are phylogenetically distinct from the Rho family (Jaffe and Hall 2005; Boureux et al. 2007; Devine et al. 2016; Liu et al. 2017). Miro GTPases possess an additional GTPase domain more closely related to Rheb (Klosowiak et al. 2013). Miro family of RAS-like GTPases includes two members, RHOT1 and RHOT2. RHOT1 and RHOT2 regulate the movement of mitochondria (Schwarz 2013; Devine et al. 2016) and peroxisomes (Castro et al. 2018, Okumoto et al. 2018, Covill-Cooke et al. 2020).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1043">
 <bp:evidence rdf:resource="#Evidence1206" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ARBs bind AGRT1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1396">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1212" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2374">
 <bp:evidence rdf:resource="#Evidence2721" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTRK3(496-641) binds NELFB</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence460">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1042">
 <bp:evidence rdf:resource="#Evidence1204" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G-protein coupled bile acid receptor binds lithocholic acid</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1395">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1211" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2373">
 <bp:evidence rdf:resource="#Evidence2719" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTRK3 dimers trans-autophosphorylate</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence461">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1041">
 <bp:evidence rdf:resource="#Evidence1203" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">N-arachidonyl glycine receptor GPR18 binds N-arachidonyl glycine</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1394">
 <bp:stepProcess rdf:resource="#Pathway185" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2372">
 <bp:evidence rdf:resource="#Evidence2718" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTF3 binds NTRK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence462">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1040">
 <bp:evidence rdf:resource="#Evidence1202" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SUCNR1 binds SUCCA</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1393">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1210" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2371">
 <bp:evidence rdf:resource="#Evidence2716" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Protein tyrosine phosphatases dephosphorylate NTRK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway54">
 <bp:pathwayOrder rdf:resource="#PathwayStep504" />
 <bp:pathwayOrder rdf:resource="#PathwayStep403" />
 <bp:pathwayOrder rdf:resource="#PathwayStep447" />
 <bp:pathwayOrder rdf:resource="#PathwayStep456" />
 <bp:pathwayOrder rdf:resource="#PathwayStep431" />
 <bp:pathwayOrder rdf:resource="#PathwayStep453" />
 <bp:pathwayOrder rdf:resource="#PathwayStep464" />
 <bp:pathwayOrder rdf:resource="#PathwayStep486" />
 <bp:pathwayOrder rdf:resource="#PathwayStep388" />
 <bp:pathwayOrder rdf:resource="#PathwayStep493" />
 <bp:pathwayOrder rdf:resource="#PathwayStep508" />
 <bp:pathwayComponent rdf:resource="#Pathway58" />
 <bp:pathwayComponent rdf:resource="#Pathway57" />
 <bp:pathwayComponent rdf:resource="#Pathway56" />
 <bp:pathwayComponent rdf:resource="#Pathway55" />
 <bp:pathwayComponent rdf:resource="#Pathway66" />
 <bp:pathwayComponent rdf:resource="#Pathway59" />
 <bp:pathwayComponent rdf:resource="#Pathway61" />
 <bp:pathwayComponent rdf:resource="#Pathway60" />
 <bp:pathwayComponent rdf:resource="#Pathway65" />
 <bp:pathwayComponent rdf:resource="#Pathway64" />
 <bp:pathwayComponent rdf:resource="#Pathway63" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence388" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHO GTPase Effectors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHO GTPases regulate cell behaviour by activating a number of downstream effectors that regulate cytoskeletal organization, intracellular trafficking and transcription (reviewed by Sahai and Marshall 2002). One of the best studied RHO GTPase effectors are protein kinases ROCK1 and ROCK2, which are activated by binding RHOA, RHOB or RHOC. ROCK1 and ROCK2 phosphorylate many proteins involved in the stabilization of actin filaments and generation of actin-myosin contractile force, such as LIM kinases and myosin regulatory light chains (MRLC) (Amano et al. 1996, Ishizaki et al. 1996, Leung et al. 1996, Ohashi et al. 2000, Sumi et al. 2001, Riento and Ridley 2003, Watanabe et al. 2007). PAK1, PAK2 and PAK3, members of the p21-activated kinase family, are activated by binding to RHO GTPases RAC1 and CDC42 and subsequent autophosphorylation and are involved in cytoskeleton regulation (Manser et al. 1994, Manser et al. 1995, Zhang et al. 1998, Edwards et al. 1999, Lei et al. 2000, Parrini et al. 2002; reviewed by Daniels and Bokoch 1999, Szczepanowska 2009). RHOA, RHOB, RHOC and RAC1 activate protein kinase C related kinases (PKNs) PKN1, PKN2 and PKN3 (Maesaki et al. 1999, Zong et al. 1999, Owen et al. 2003, Modha et al. 2008, Hutchinson et al. 2011, Hutchinson et al. 2013), bringing them in proximity to the PIP3-activated PDPK1 (PDK1) and thus enabling PDPK1-mediated phosphorylation of PKN1, PKN2 and PKN3 (Flynn et al. 2000, Torbett et al. 2003). PKNs play important roles in cytoskeleton organization (Hamaguchi et al. 2000), regulation of cell cycle (Misaki et al. 2001), receptor trafficking (Metzger et al. 2003) and apoptosis (Takahashi et al. 1998). PKN1 is also involved in the ligand-dependent transcriptional activation by the androgen receptor (Metzger et al. 2003, Metzger et al. 2005, Metzger et al. 2008). Citron kinase (CIT) binds RHO GTPases RHOA, RHOB, RHOC and RAC1 (Madaule et al. 1995), but the mechanism of CIT activation by GTP-bound RHO GTPases has not been elucidated. CIT and RHOA are implicated to act together in Golgi apparatus organization through regulation of the actin cytoskeleton (Camera et al. 2003). CIT is also involved in the regulation of cytokinesis through its interaction with KIF14 (Gruneberg et al. 2006, Bassi et al. 2013, Watanabe et al. 2013). RHOA, RHOG, RAC1 and CDC42 bind kinectin (KTN1), a kinesin anchor protein involved in kinesin-mediated vesicle motility (Vignal et al. 2001, Hotta et al. 1996). The effect of RHOG activity on cellular morphology, exhibited in the formation of microtubule-dependent cellular protrusions, depends both on RHOG interaction with KTN1, as well as on the kinesin activity (Vignal et al. 2001). RHOG and KTN1 also cooperate in microtubule-dependent lysosomal transport (Vignal et al. 2001). IQGAP proteins IQGAP1, IQGAP2 and IQGAP3, bind RAC1 and CDC42 and stabilize them in their GTP-bound state (Kuroda et al. 1996, Swart-Mataraza et al. 2002, Wang et al. 2007). IQGAPs bind F-actin filaments and modulate cell shape and motility through regulation of G-actin/F-actin equilibrium (Brill et al. 1996, Fukata et al. 1997, Bashour et al. 1997, Wang et al. 2007, Pelikan-Conchaudron et al. 2011). Binding of IQGAPs to F-actin is inhibited by calmodulin (Bashour et al. 1997, Pelikan-Conchaudron et al. 2011). IQGAP1 is involved in the regulation of adherens junctions through its interaction with E-cadherin (CDH1) and catenins (CTTNB1 and CTTNA1) (Kuroda et al. 1998, Hage et al. 2009). IQGAP1 contributes to cell polarity and lamellipodia formation through its interaction with microtubules (Fukata et al. 2002, Suzuki and Takahashi 2008). RHOQ (TC10) regulates the trafficking of CFTR (cystic fibrosis transmembrane conductance regulator) by binding to the Golgi-associated protein GOPC (also known as PIST, FIG and CAL). In the absence of RHOQ, GOPC bound to CFTR directs CFTR for lysosomal degradation, while GTP-bound RHOQ directs GOPC:CFTR complex to the plasma membrane, thereby rescuing CFTR (Neudauer et al. 2001, Cheng et al. 2005). RAC1 and CDC42 activate WASP and WAVE proteins, members of the Wiskott-Aldrich Syndrome protein family. WASPs and WAVEs simultaneously interact with G-actin and the actin-related ARP2/3 complex, acting as nucleation promoting factors in actin polymerization (reviewed by Lane et al. 2014). RHOA, RHOB, RHOC, RAC1 and CDC42 activate a subset of formin family members. Once activated, formins bind G-actin and the actin-bound profilins and accelerate actin polymerization, while some formins also interact with microtubules. Formin-mediated cytoskeletal reorganization plays important roles in cell motility, organelle trafficking and mitosis (reviewed by Kuhn and Geyer 2014). Rhotekin (RTKN) and rhophilins (RHPN1 and RHPN2) are effectors of RHOA, RHOB and RHOC and have not been studied in detail. They regulate the organization of the actin cytoskeleton and are implicated in the establishment of cell polarity, cell motility and possibly endosome trafficking (Sudo et al. 2006, Watanabe et al. 1996, Fujita et al. 2000, Peck et al. 2002, Mircescu et al. 2002). Similar to formins (Miralles et al. 2003), cytoskeletal changes triggered by RTKN activation may lead to stimulation of SRF-mediated transcription (Reynaud et al. 2000). RHO GTPases RAC1 and RAC2 are needed for activation of NADPH oxidase complexes 1, 2 and 3 (NOX1, NOX2 and NOX3), membrane associated enzymatic complexes that use NADPH as an electron donor to reduce oxygen and produce superoxide (O2-). Superoxide serves as a secondary messenger and also directly contributes to the microbicidal activity of neutrophils (Knaus et al. 1991, Roberts et al. 1999, Kim and Dinauer 2001, Jyoti et al. 2014, Cheng et al. 2006, Miyano et al. 2006, Ueyama et al. 2006).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2370">
 <bp:evidence rdf:resource="#Evidence2715" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated NTRK3 stimulates PI3K activity</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway53">
 <bp:pathwayOrder rdf:resource="#PathwayStep515" />
 <bp:pathwayOrder rdf:resource="#PathwayStep387" />
 <bp:pathwayComponent rdf:resource="#Pathway67" />
 <bp:pathwayComponent rdf:resource="#Pathway54" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence387" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by Rho GTPases</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The Rho family of small guanine nucleotide binding proteins is one of seven phylogenetic branches of the Ras superfamily (Bernards 2005), which, besides Rho, Miro and RHOBTB3 also includes Ran, Arf, Rab and Ras families (Boureux et al. 2007). Miro GTPases and RHOBTB3 ATPase are sometimes described as Rho family members, but they are phylogenetically distinct (Boureux et al. 2007). Phylogenetically, RHO GTPases can be grouped into four clusters. The first cluster consists of three subfamilies: Rho, RhoD/RhoF and Rnd. The second cluster consists of three subfamilies: Rac, Cdc42 and RhoU/RhoV. The third cluster consists of the RhoH subfamily. The fourth cluster consists of the RhoBTB subfamily. Based on their activation type, RHO GTPases can be divided into classical (typical) and atypical (reviewed by Haga and Ridley 2016, and Kalpachidou et al. 2019). Classical RHO GTPases cycle between active GTP-bound states and inactive GDP-bound states through steps that are tightly controlled by members of three classes of proteins: (1) guanine nucleotide dissociation inhibitors or GDIs, which maintain Rho proteins in an inactive state in the cytoplasm, (2) guanine nucleotide exchange factors or GEFs, which destabilize the interaction between Rho proteins and their bound nucleotide, the net result of which is the exchange of bound GDP for the more abundant GTP, and (3) GTPase activating proteins or GAPs, which stimulate the low intrinsic GTP hydrolysis activity of Rho family members, thus promoting their inactivation. GDIs, GEFs, and GAPs are themselves subject to tight regulation, and the overall level of Rho activity reflects the balance of their activities. Many of the Rho-specific GEFs, GAPs, and GDIs act on multiple Rho GTPases, so that regulation of these control proteins can have complex effects on the functions of multiple Rho GTPases (reviewed by Van Aelst and D&apos;Souza-Schorey 1997, Schmidt and Hall 2002, Jaffe and Hall 2005, Bernards 2005, and Hodge and Ridley 2016). Classical RHO GTPases include four subfamilies: Rho (includes RHOA, RHOB and RHOC), Rac (includes RAC1, RAC2, RAC3 and RHOG), Cdc42 (includes CDC42, RHOJ and RHOQ) and RhoD/RhoF (includes RHOD and RHOF) (reviewed in Haga and Ridley 2016). Atypical RHO GTPases do not possess GTPase activity. They therefore constitutively exist in the active GTP-bound state. Atypical RHO GTPases include three subfamilies: Rnd (includes RND1, RND2 and RND3), RhoBTB (includes RHOBTB1 and RHOBTB2), RhoH (RHOH is the only member) and RhoU/RhoV (includes RHOU and RHOV). Members of the Rho family have been identified in all eukaryotes. Among Rho GTPases, RHOA, RAC1 and CDC42 have been most extensively studied.  RHO GTPases regulate cell behavior by activating a number of downstream effectors that regulate cytoskeletal organization, intracellular trafficking and transcription (reviewed by Sahai and Marshall 2002). They are best known for their ability to induce dynamic rearrangements of the plasma membrane-associated actin cytoskeleton (Aspenstrom et al. 2004; Murphy et al. 1999; Govek et al. 2005). Beyond this function, Rho GTPases also regulate actomyosin contractility and microtubule dynamics. Rho mediated effects on transcription and membrane trafficking are believed to be secondary to these functions. At the more macroscopic level, Rho GTPases have been implicated in many important cell biological processes, including cell growth control, cytokinesis, cell motility, cell-cell and cell-extracellular matrix adhesion, cell transformation and invasion, and development (Govek et al., 2005). One of the best studied RHO GTPase effectors are protein kinases ROCK1 and ROCK2, which phosphorylate many proteins involved in the stabilization of actin filaments and generation of actin-myosin contractile force, such as LIM kinases and myosin regulatory light chains (MRLC) (reviewed in Riento and Ridley 2003). The p21-activated kinase family, which includes PAK1, PAK2 and PAK3, is another well characterized family of RHO GTPase effectors involved in cytoskeleton regulation (reviewed in Daniels and Bokoch 1999, Szczepanowska 2009). Protein kinase C related kinases (PKNs), PKN1, PKN2 and PKN3 play important roles in cytoskeleton organization (Hamaguchi et al. 2000), regulation of cell cycle (Misaki et al. 2001), receptor trafficking (Metzger et al. 2003), apoptosis (Takahashi et al. 1998), and transcription (Metzger et al. 2003, Metzger et al. 2005, Metzger et al. 2008). Citron kinase (CIT) is involved in Golgi apparatus organization through regulation of the actin cytoskeleton (Camera et al. 2003) and in the regulation of cytokinesis (Gruneberg et al. 2006, Bassi et al. 2013, Watanabe et al. 2013). Kinectin (KTN1), a kinesin anchor protein, is a RHO GTPase effector involved in kinesin-mediated vesicle motility (Vignal et al. 2001, Hotta et al. 1996), including microtubule-dependent lysosomal transport (Vignal et al. 2001). IQGAP proteins, IQGAP1, IQGAP2 and IQGAP3, are RHO GTPase effectors that modulate cell shape and motility through regulation of G-actin/F-actin equilibrium (Brill et al. 1996, Fukata et al. 1997, Bashour et al. 1997, Wang et al. 2007, Pelikan-Conchaudron et al. 2011), regulate adherens junctions (Kuroda et al. 1998, Hage et al. 2009), and contribute to cell polarity and lamellipodia formation (Fukata et al. 2002, Suzuki and Takahashi 2008). WASP and WAVE proteins (reviewed by Lane et al. 2014), as well as formins (reviewed by Kuhn and Geyer 2014), are RHO GTPase effectors that regulate actin polymerization and play important roles in cell motility, organelle trafficking and mitosis. Rhotekin (RTKN) and rhophilins (RHPN1 and RHPN2) are RHO GTPase effectors that regulate the organization of the actin cytoskeleton and are implicated in the establishment of cell polarity, cell motility and possibly endosome trafficking (Sudo et al. 2006, Watanabe et al. 1996, Fujita et al. 2000, Peck et al. 2002, Mircescu et al. 2002). Cytoskeletal changes triggered by the activation of formins (Miralles et al. 2003) and RTKN (Reynaud et al. 2000) may lead to stimulation of SRF-mediated transcription. NADPH oxidase complexes 1, 2 and 3 (NOX1, NOX2 and NOX3), membrane associated enzymatic complexes that use NADPH as an electron donor to reduce oxygen and produce superoxide (O2-), are also regulated by RHO GTPases (Knaus et al. 1991, Roberts et al. 1999, Kim and Dinauer 2001, Jyoti et al. 2014, Cheng et al. 2006, Miyano et al. 2006, Ueyama et al. 2006). Every RHO GTPase activates multiple downstream effectors and most effectors are regulated by multiple RHO GTPases, resulting in an elaborate cross-talk.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep1399">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1215" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway52">
 <bp:pathwayOrder rdf:resource="#PathwayStep385" />
 <bp:pathwayOrder rdf:resource="#PathwayStep383" />
 <bp:pathwayOrder rdf:resource="#PathwayStep384" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction332" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction334" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction333" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence383" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOT2 GTPase cycle</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">This pathway catalogues guanine nucleotide exchange factors (GEFs) and effectors of RHOT2 (also known as MIRO-2). RHOT2 possesses a high intrinsic GTP-ase activity and does not require a GTPase activator protein (GAP) (Peters et al. 2018). No GDP dissociation inhibitors (GDIs) have been reported to interact with RHOT2. RHOT2 is a mitochondrial RHO GTPase. Like related RHOT1 (MIRO-1), RHOT2 localizes to the outer mitochondrial membrane. Similar to RHOT1, RHOT2 regulates mitochondrial movement by coupling mitochondria to kinesin and dynein motors that transport them along microtubules (Devine et al. 2016). RHOT2 is also localized to peroxisomes and it is involved in peroxisomal dynamics (Covill-Cooke et al. 2020).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep1398">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1214" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway51">
 <bp:pathwayOrder rdf:resource="#PathwayStep380" />
 <bp:pathwayOrder rdf:resource="#PathwayStep379" />
 <bp:pathwayOrder rdf:resource="#PathwayStep381" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction331" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction330" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction329" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence379" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOT1 GTPase cycle</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">This pathway catalogues guanine nucleotide exchange factors (GEFs) and effectors of RHOT1 (also known as MIRO-1). RHOT1 possesses a high intrinsic GTP-ase activity and does not require a GTPase activator protein (GAP) (Peters et al. 2018). No GDP dissociation inhibitors (GDIs) have been reported to interact with RHOT1. RHOT1 is a mitochondrial RHO GTPase. Like related RHOT2 (MIRO-2), RHOT1 localizes to the outer mitochondrial membrane. RHOT1 is implicated in mitochondrial movement inside the cells (Schwarz 2013), including the axonal transport of mitochondria in neurons (Saxton and Hollenbeck 2012; Birsa et al. 2013; Devine et al. 2016), as well as mitochondrial fission and fusion (Saxton and Hollenbeck 2012). RHOT1/RHOT2-mediated mitochondrial turnover is affected in neurodegenerative diseases (Birsa et al. 2013; Devine et al. 2016). RHOT1 can localize to peroxisomes and regulate peroxisome motility and fission (Castro et al. 2018, Okumoto et al. 2018, Covill-Cooke et al. 2020). RHOT1 is also involved in the regulation of ER-mitochondria membrane contact sites (Grossmann et al. 2019, Modi et al. 2019). Upregulation of RHOT1 has a neuroprotective effect in ischemic stroke (Wei et al. 2019). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep1397">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1213" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1049">
 <bp:evidence rdf:resource="#Evidence1214" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Relaxin 3 receptor 2 binds relaxin 3 and INSL5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1048">
 <bp:evidence rdf:resource="#Evidence1212" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The orphan QRFP receptor can bind neuropeptide QRFP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2379">
 <bp:evidence rdf:resource="#Evidence2727" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTRK3 phosphorylates PLCG1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1047">
 <bp:evidence rdf:resource="#Evidence1211" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Two NPFF receptors can bind neuropeptide FF</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2378">
 <bp:evidence rdf:resource="#Evidence2726" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated PCLG1 dissociates from NTRK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1046">
 <bp:evidence rdf:resource="#Evidence1210" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Orexin 2 receptor can bind orexin-B neuropeptide</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2377">
 <bp:evidence rdf:resource="#Evidence2724" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTRK3(496-641):NELFB translocates to mitochondrion</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1045">
 <bp:evidence rdf:resource="#Evidence1209" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Orexin 1 receptor can bind orexin-A neuropeptide</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2376">
 <bp:evidence rdf:resource="#Evidence2723" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Unknown caspase cleaves NTRK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1044">
 <bp:evidence rdf:resource="#Evidence1207" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GPCR neuropeptide receptor binds neuropeptides B and W</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2375">
 <bp:evidence rdf:resource="#Evidence2722" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BAX activation is stimulated by NTRK3(495-641) and NELFB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction471">
 <bp:evidence rdf:resource="#Evidence544" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOB binds effectors on endosomes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction470">
 <bp:evidence rdf:resource="#Evidence542" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GDIs block activation of RHOG</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction473">
 <bp:evidence rdf:resource="#Evidence546" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOB binds effectors at the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction472">
 <bp:evidence rdf:resource="#Evidence545" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOB translocates to the endosome membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway47">
 <bp:pathwayOrder rdf:resource="#PathwayStep369" />
 <bp:pathwayOrder rdf:resource="#PathwayStep367" />
 <bp:pathwayOrder rdf:resource="#PathwayStep368" />
 <bp:pathwayOrder rdf:resource="#PathwayStep370" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction324" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction321" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction323" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction322" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence367" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK3 (ERK1) activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Mitogen-activated protein kinase kinase MAP2K1 (also known as MEK1) is a dual threonine and tyrosine recognition kinase that phosphorylates and activates MAPK3 (ERK1) (Ohren et al. 2004; Roskoski 2012a). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence456">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction435">
 <bp:evidence rdf:resource="#Evidence499" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC1:GTP and PIP3 bind WAVE Regulatory Complex (WRC)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway46">
 <bp:pathwayOrder rdf:resource="#PathwayStep365" />
 <bp:pathwayOrder rdf:resource="#PathwayStep366" />
 <bp:pathwayOrder rdf:resource="#PathwayStep363" />
 <bp:pathwayOrder rdf:resource="#PathwayStep364" />
 <bp:pathwayOrder rdf:resource="#PathwayStep375" />
 <bp:pathwayOrder rdf:resource="#PathwayStep362" />
 <bp:pathwayOrder rdf:resource="#PathwayStep371" />
 <bp:pathwayComponent rdf:resource="#Pathway47" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction320" />
 <bp:pathwayComponent rdf:resource="#Pathway48" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction318" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction317" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction328" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction319" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence362" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAF-independent MAPK1/3 activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Depending upon the stimulus and cell type mitogen-activated protein kinases (MAPK) signaling pathway can transmit signals to regulate many different biological processes by virtue of their ability to target multiple effector proteins (Kyriakis JM    Avruch J 2012; Yoon and Seger 2006; Shaul YD    Seger R 2007; Arthur JS    Ley SC 2013). In particular, the extracellular signal-regulated kinases MAPK3(ERK1) and MAPK1 (ERK2) are involved in diverse cellular processes such as proliferation, differentiation, regulation of inflammatory responses, cytoskeletal remodeling, cell motility and invasion through the increase of matrix metalloproteinase production (Viala E    Pouyssegur J 2004; Hsu MC et al. 2006; Dawson CW et al.2008; Kuriakose T et al. 2014).The canonical RAF:MAP2K:MAPK1/3 cascade is stimulated by various extracellular stimuli including hormones, cytokines, growth factors, heat shock and UV irradiation triggering the GEF-mediated activation of RAS at the plasma membrane and leading to the activation of the RAF MAP3 kinases. However, many physiological and pathological stimuli have been found to activate MAPK1/3 independently of RAF and RAS (Dawson CW et al. 2008; Wang J et al. 2009; Kuriakose T et al. 2014). For example, AMP-activated protein kinase (AMPK), but not RAF1, was reported to regulate MAP2K1/2 and MAPK1/3 (MEK and ERK) activation in rat hepatoma H4IIE and human erythroleukemia K562 cells in response to autophagy stimuli (Wang J et al. 2009). Tumor progression locus 2 (TPL2, also known as MAP3K8 and COT) is another MAP3 kinase which promotes MAPK1/3 (ERK)-regulated immune responses downstream of toll-like receptors (TLR), TNF receptor and IL1beta signaling pathways (Gantke T et al. 2011). In response to stimuli the cell surface receptors transmit signals inducing MAP3 kinases, e.g., TPL2, MEKK1, which in turn phosphorylate MAP2Ks (MEK1/2). MAP2K then phosphorylate and activate the MAPK1/3 (ERK1 and ERK2 MAPKs). Activated MAPK1/3 phosphorylate and regulate the activities of an ever growing pool of substrates that are estimated to comprise over 160 proteins (Yoon and Seger 2006). The majority of ERK substrates are nuclear proteins, but others are found in the cytoplasm and other organelles. Activated MAPK1/3 can translocate to the nucleus, where they phosphorylate and regulate various transcription factors, such as Ets family transcription factors (e.g., ELK1), ultimately leading to changes in gene expression (Zuber J et al. 2000).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence457">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction434">
 <bp:evidence rdf:resource="#Evidence498" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WIP binds WASP,N-WASP, activating them</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway45">
 <bp:pathwayOrder rdf:resource="#PathwayStep349" />
 <bp:pathwayOrder rdf:resource="#PathwayStep358" />
 <bp:pathwayOrder rdf:resource="#PathwayStep359" />
 <bp:pathwayOrder rdf:resource="#PathwayStep356" />
 <bp:pathwayOrder rdf:resource="#PathwayStep357" />
 <bp:pathwayOrder rdf:resource="#PathwayStep354" />
 <bp:pathwayOrder rdf:resource="#PathwayStep355" />
 <bp:pathwayOrder rdf:resource="#PathwayStep352" />
 <bp:pathwayOrder rdf:resource="#PathwayStep353" />
 <bp:pathwayOrder rdf:resource="#PathwayStep350" />
 <bp:pathwayOrder rdf:resource="#PathwayStep351" />
 <bp:pathwayOrder rdf:resource="#PathwayStep360" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction314" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction313" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction305" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction316" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction315" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction310" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction312" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction311" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction307" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction306" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction309" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction308" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence349" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAF activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Mammals have three RAF isoforms, A, B and C, that are activated downstream of RAS and stimulate the MAPK pathway. Although CRAF (also known as RAF-1) was the first identified and remains perhaps the best studied, BRAF is most similar to the RAF expressed in other organisms. Notably, MAPK (ERK) activation is more compromised in BRAF-deficient cells than in CRAF or ARAF deficient cells (Bonner et al, 1985; Mikula et al, 2001, Huser et al, 2001, Mercer et al, 2002; reviewed in Leicht et al, 2007; Matallanas et al, 2011; Cseh et al, 2014). Consistent with its important role in MAPK pathway activation, mutations in the BRAF gene, but not in those for A- or CRAF, are associated with cancer development (Davies et al, 2002; reviewed in Leicht et al, 2007). ARAF and CRAF may have arisen through gene duplication events, and may play additional roles in MAPK-independent signaling (Hindley and Kolch, 2002; Murakami and Morrison, 2001). Despite divergences in function, all mammalian RAF proteins share three conserved regions (CRs) and each interacts with RAS and MEK proteins, although with different affinities. The N-terminal CR1 contains a RAS-binding domain (RBD) and a cysteine-rich domain (CRD) that mediate interactions with RAS and the phospholipid membrane. CR2 contains inhibitory phosphorylation sites that impact RAS binding and RAF activation, while the C-terminal CR3 contains the bi-lobed kinase domain with its activation loop, and an adjacent upstream &quot;N-terminal acidic motif&quot; -S(S/G)YY in C- and A-RAF,respectively, and SSDD in B-RAF - that is required for RAF activation (Tran et al, 2005; Dhillon et al, 2002; Chong et al, 2001; Cutler et al, 1998; Chong et al, 2003; reviewed in Matallanas et al, 2011).  Regulation of RAF activity involves multiple phosphorylation and dephosphorylation events, intramolecular conformational changes, homo- and heterodimerization between RAF monomers and changes to protein binding partners, including scaffolding proteins which bring pathway members together (reviewed in Matallanas et al, 2011; Cseh et al, 2014). The details of this regulation are not completely known and differ slightly from one RAF isoform to another. Briefly, in the inactive state, RAF phosphorylation on conserved serine residues in CR2 promote an interaction with 14-3-3 dimers, maintaining the kinase in a closed conformation. Upon RAS activation, these sites are dephosphorylated, allowing the RAF CRD and RBD to bind RAS and phospholipids, facilitating membrane recruitment.  RAF activation requires homo- or heterodimerization, which promotes autophosphorylation in the activation loop of the receiving monomer.  Of the three isoforms, only BRAF is able to initiate this allosteric activation of other RAF monomers (Hu et al, 2013; Heidorn et al, 2010; Garnett et al, 2005). This activity depends on negative charge in the N-terminal acidic region (NtA; S(S/G)YY or SSDD) adjacent to the kinase domain. In BRAF, this region carries permanent negative charge due to the presence of the two aspartate residues in place of the tyrosine residues of A- and CRAF.  In addition, unique to BRAF, one of the serine residues of the NtA is constitutively phosphorylated.  In A- and CRAF, residues in this region are subject to phosphorylation by activated MEK downstream of RAF activation, establishing a positive feedback loop and allowing activated A- and CRAF monomers to act as transactivators in turn (Hu et al, 2013; reviewed in Cseh et al, 2014). RAF signaling is terminated through dephosphorylation of the NtA region and phosphorylation of the residues that mediate the inhibitory interaction with 14-3-3, promoting a return to the inactive state (reviewed in Matallanas et al, 2011; Cseh et al, 2014). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence458">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction437">
 <bp:evidence rdf:resource="#Evidence501" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">(WASPs, WAVE):G-actin:ARP2/3 binds F-actin</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1369">
 <bp:stepProcess rdf:resource="#Pathway180" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway44">
 <bp:pathwayOrder rdf:resource="#PathwayStep345" />
 <bp:pathwayOrder rdf:resource="#PathwayStep343" />
 <bp:pathwayOrder rdf:resource="#PathwayStep344" />
 <bp:pathwayOrder rdf:resource="#PathwayStep341" />
 <bp:pathwayOrder rdf:resource="#PathwayStep342" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction302" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction299" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction298" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction301" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction300" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence341" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of RAS by GAPs</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The intrinsic GTPase activity of RAS proteins is stimulated by the GAP proteins, of which there are at least 10 in the human genome (reviewed in King et al, 2013).   </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence459">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction436">
 <bp:evidence rdf:resource="#Evidence500" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WASPs or WAVEs activate the ARP2/3 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1368">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1190" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence452">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction431">
 <bp:evidence rdf:resource="#Evidence495" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Branching and elongation of mother and daughter filaments</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2699">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2359" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence453">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction430">
 <bp:evidence rdf:resource="#Evidence493" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CIT binds CDKN1B</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway49">
 <bp:pathwayOrder rdf:resource="#PathwayStep377" />
 <bp:pathwayOrder rdf:resource="#PathwayStep386" />
 <bp:pathwayOrder rdf:resource="#PathwayStep628" />
 <bp:pathwayComponent rdf:resource="#Pathway89" />
 <bp:pathwayComponent rdf:resource="#Pathway50" />
 <bp:pathwayComponent rdf:resource="#Pathway53" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence377" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by Rho GTPases, Miro GTPases and RHOBTB3</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAS-like proteins are small GTP binding proteins characterized structurally by 5 G boxes that are involved in nucleotide binding and hydrolysis. RAS-like proteins are typically active when bound to GTP and inactive when bound to GDP. Conversion between the two states is mediated by effector proteins: among others, GTPase activating proteins (GAPs) enable hydrolysis of bound GTP to form GDP, which remains bound, and guanine nucleotide exchange factors (GEFs) enable exchange of bound GDP for free GTP (intracellular GTP concentrations are typically an order of magnitude higher than GDP concentrations) (reviewed in Tetlow and Tamanoi, 2013).  The human genome includes over 150 members of the RAS superfamily grouped into five main subfamilies: RAS, RHO, ARF, RAB and RAN. These small GTPases affect a wide range of critical processes including gene expression, signal transduction, cell morphology, vesicle and nuclear trafficking, cellular proliferation and motility, among others (reviewed in Tetlow and Tamanoi, 2013).  The RHO family of GTPases is large and diverse, with many of its members considered to be master regulators of actin cytoskeleton, involved in the regulation of cellular processes that depend on dynamic reorganization of the cytoskeleton, including cell migration, cell adhesion, cell division, establishment of cellular polarity and intracellular transport (reviewed in Hodge and Ridley 2016, and Olson 2018).  MIRO proteins and RHOBTB3 protein, sometimes called atypical RHO proteins, show a high degree of overall sequence similarity to members of the five RAS-like subfamilies but diverge in their functions enough to constitute two separate subfamilies (Boureux et al. 2007). MIRO proteins have intrinsically high GTPase activity and do not require GTPase activator proteins (Peters et al. 2018). They play an important role mitochondrial biogenesis, maintenance and organization (reviewed in Birsa et al. 2013). The GTPase domain of RHOBTB3 is divergent from other Ras like superfamily members and displays ATPase activity (Espinosa et al. 2009). RHOBTB3 is involved in CUL3 dependent protein ubiquitination (Berthold et al. 2008; Ji and Rivero 2016), retrograde transport from endosomes to the Golgi apparatus (Espinosa et al. 2009), regulation of the cell cycle and in modulating the adaptive response to hypoxia (Ji and Rivero 2016). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence454">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction433">
 <bp:evidence rdf:resource="#Evidence497" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Detachment of WASP/WAVE</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep499">
 <bp:stepProcess rdf:resource="#BiochemicalReaction436" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway48">
 <bp:pathwayOrder rdf:resource="#PathwayStep374" />
 <bp:pathwayOrder rdf:resource="#PathwayStep372" />
 <bp:pathwayOrder rdf:resource="#PathwayStep373" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction325" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction327" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction326" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence372" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK1 (ERK2) activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Mitogen-activated protein kinase kinase MAP2K2 (also known as MEK2) is a dual threonine and tyrosine recognition kinase that phosphorylates and activates MAPK1 (ERK2) (Ohren et al. 2004; Roskoski 2012). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence455">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction432">
 <bp:evidence rdf:resource="#Evidence496" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of WASP and N-WASP by CDC42</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1032">
 <bp:evidence rdf:resource="#Evidence1192" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRKs bind ADRB2:Catecholamine</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1363">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1185" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2695">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2355" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2363">
 <bp:evidence rdf:resource="#Evidence2707" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated NTRK3 binds SHC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1031">
 <bp:evidence rdf:resource="#Evidence1191" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Liganded Gs-activating GPCRs bind inactive heterotrimeric Gs</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1362">
 <bp:stepProcess rdf:resource="#Pathway179" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2696">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2356" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2362">
 <bp:evidence rdf:resource="#Evidence2706" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTRK3 binds GRB2:SOS1 through SHC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence450">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1030">
 <bp:evidence rdf:resource="#Evidence1190" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PDE3A hydrolyses cAMP to AMP</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1361">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1184" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2697">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2357" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2361">
 <bp:evidence rdf:resource="#Evidence2702" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Homodimerization of ERBB4</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence451">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1360">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1183" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2698">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2358" />
 <bp:stepProcess rdf:resource="#Catalysis737" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2360">
 <bp:evidence rdf:resource="#Evidence2701" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NRG2-activated ERBB4 binds GABA receptors through GABRA1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway43">
 <bp:pathwayOrder rdf:resource="#PathwayStep318" />
 <bp:pathwayOrder rdf:resource="#PathwayStep329" />
 <bp:pathwayOrder rdf:resource="#PathwayStep319" />
 <bp:pathwayOrder rdf:resource="#PathwayStep316" />
 <bp:pathwayOrder rdf:resource="#PathwayStep327" />
 <bp:pathwayOrder rdf:resource="#PathwayStep317" />
 <bp:pathwayOrder rdf:resource="#PathwayStep328" />
 <bp:pathwayOrder rdf:resource="#PathwayStep325" />
 <bp:pathwayOrder rdf:resource="#PathwayStep336" />
 <bp:pathwayOrder rdf:resource="#PathwayStep326" />
 <bp:pathwayOrder rdf:resource="#PathwayStep323" />
 <bp:pathwayOrder rdf:resource="#PathwayStep334" />
 <bp:pathwayOrder rdf:resource="#PathwayStep324" />
 <bp:pathwayOrder rdf:resource="#PathwayStep335" />
 <bp:pathwayOrder rdf:resource="#PathwayStep321" />
 <bp:pathwayOrder rdf:resource="#PathwayStep332" />
 <bp:pathwayOrder rdf:resource="#PathwayStep322" />
 <bp:pathwayOrder rdf:resource="#PathwayStep333" />
 <bp:pathwayOrder rdf:resource="#PathwayStep330" />
 <bp:pathwayOrder rdf:resource="#PathwayStep320" />
 <bp:pathwayOrder rdf:resource="#PathwayStep331" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction277" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction288" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction276" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction287" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction279" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction278" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction289" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction284" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction283" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction294" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction275" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction286" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction274" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction285" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction280" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction291" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction290" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction282" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction293" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction281" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction292" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence316" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAS processing</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAS proteins undergo several processing steps during maturation including farnesylation, carboxy-terminal cleavage and carboxymethylation, among others. These steps are required for their membrane localization and function and ultimately for their ability to activate RAF (reviewed in Gysin et al, 2011; Ahearn et al, 2018).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction439">
 <bp:evidence rdf:resource="#Evidence503" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Src phosphorylate WASP,N-WASP</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1367">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1189" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2691">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2352" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway42">
 <bp:pathwayOrder rdf:resource="#PathwayStep307" />
 <bp:pathwayOrder rdf:resource="#PathwayStep308" />
 <bp:pathwayOrder rdf:resource="#PathwayStep306" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction266" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction265" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction267" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence306" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Negative feedback regulation of MAPK pathway</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK pathway activation is limited by a number of negative feedback loops established by MAPK-dependent phosphorylations.  Known substrates of activated MAPK proteins that lie upstream in the RAF/MAPK pathway include SOS, RAF1, BRAF, and MAP2K1 (Buday et al, 1995; Dong et al, 1996; Dougherty et al, 2005; Sturm et al, 2010; Fritsche-Guenther et al, 2011; Rushworth et al, 2006; Brummer et al, 2003; Ritt et al, 2010; Catalanotti et al, 2009)</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction438">
 <bp:evidence rdf:resource="#Evidence502" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-ERK phosphorylates WAVEs and ABI</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1366">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1188" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2692">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2353" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway41">
 <bp:pathwayOrder rdf:resource="#PathwayStep305" />
 <bp:pathwayOrder rdf:resource="#PathwayStep303" />
 <bp:pathwayOrder rdf:resource="#PathwayStep304" />
 <bp:pathwayOrder rdf:resource="#PathwayStep301" />
 <bp:pathwayOrder rdf:resource="#PathwayStep302" />
 <bp:pathwayOrder rdf:resource="#PathwayStep309" />
 <bp:pathwayOrder rdf:resource="#PathwayStep299" />
 <bp:pathwayOrder rdf:resource="#PathwayStep310" />
 <bp:pathwayOrder rdf:resource="#PathwayStep300" />
 <bp:pathwayOrder rdf:resource="#PathwayStep311" />
 <bp:pathwayOrder rdf:resource="#PathwayStep297" />
 <bp:pathwayOrder rdf:resource="#PathwayStep298" />
 <bp:pathwayOrder rdf:resource="#PathwayStep295" />
 <bp:pathwayOrder rdf:resource="#PathwayStep296" />
 <bp:pathwayOrder rdf:resource="#PathwayStep294" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction259" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction258" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction269" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction255" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction254" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction257" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction268" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction256" />
 <bp:pathwayComponent rdf:resource="#Pathway42" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction262" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction261" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction264" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction263" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction260" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction270" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence294" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Negative regulation of MAPK pathway</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The duration and extent of activated MAPK signaling is regulated at many levels through mechanisms that include phosphorylation and dephosphorylation, changes to protein interacting partners and subcellular localization (reviewed in Matallanas et al, 2011).    Activated RAF proteins are subject to MAPK-dependent phosphorylation that promotes the subsequent dephosphorylation of the activation loop and NtA region, terminating RAF kinase activity. This dephosphorylation, catalyzed by PP2A and PP5, primes the RAF proteins for PKA or AKT-mediated phosphorylation of residues S259 and S621, restoring the 14-3-3 binding sites and returning the RAF proteins to the inactive state (von Kriegsheim et al, 2006;  Dougherty et al, 2005; reviewed in Matallanas et al, 2011). The phosphorylated RAF1 NtA is also subject to additional regulation through binding to the PEBP1 protein, which promotes its dissociation from MAP2K substrates (Shin et al, 2009).   Activated MAPK proteins also phosphorylate T292 of MAP2K1; this phosphorylation limits the activity of MAP2K1, and indirectly affects MAP2K2 activity through by modulating the activity of the MAP2K heterodimer (Catalanotti et al, 2009; reviewed in Matallanas et al, 2011).  Dephosphorylation of MAPKs by the dual specificity MAPK phosphatases (DUSPs) plays a key role in limiting the extent of pathway activation (Owens et al, 2007; reviewed in Roskoski, 2012b).  Class I DUSPs are localized in the nucleus and are induced by activation of the MAPK pathway, establishing a negative feedback loop, while class II DUSPs dephosphorylate cytoplasmic MAPKs (reviewed in Rososki, 2012b). MAPK signaling is also regulated by the RAS GAP-mediated stimulation of intrinsic RAS GTPase activity which returns RAS to the inactive, GDP bound state (reviewed in King et al, 2013).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep1365">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1187" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2693">
 <bp:stepProcess rdf:resource="#Pathway341" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway40">
 <bp:pathwayOrder rdf:resource="#PathwayStep291" />
 <bp:pathwayOrder rdf:resource="#PathwayStep281" />
 <bp:pathwayOrder rdf:resource="#PathwayStep292" />
 <bp:pathwayOrder rdf:resource="#PathwayStep290" />
 <bp:pathwayOrder rdf:resource="#PathwayStep288" />
 <bp:pathwayOrder rdf:resource="#PathwayStep289" />
 <bp:pathwayOrder rdf:resource="#PathwayStep286" />
 <bp:pathwayOrder rdf:resource="#PathwayStep287" />
 <bp:pathwayOrder rdf:resource="#PathwayStep284" />
 <bp:pathwayOrder rdf:resource="#PathwayStep285" />
 <bp:pathwayOrder rdf:resource="#PathwayStep282" />
 <bp:pathwayOrder rdf:resource="#PathwayStep283" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction248" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction247" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction249" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction244" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction243" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction246" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction245" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction251" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction250" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction242" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction253" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction252" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence281" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP2K and MAPK activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated RAF proteins are restricted substrate kinases whose primary downstream targets are the two MAP2K proteins, MAPK2K1 and MAP2K2 (also known as MEK1 and MEK2) (reviewed in Roskoski, 2010, Roskoski, 2012a).  Phosphorylation of the MAPK2K activation loop primes them to phosphorylate the primary effector of the activated MAPK pathway, the two MAPK proteins MAPK3 and MAPK1 (also known as ERK1 and 2).  Unlike their upstream counterparts, MAPK3 and MAPK1 catalyze the phosphorylation of hundreds of cytoplasmic and nuclear targets including transcription factors and regulatory molecules (reviewed in Roskoski, 2012b).  Activation of MAP2K and MAPK proteins downstream of activated RAF generally occurs in the context of a higher order scaffolding complex that regulates the specificity and localization of the pathway (reviewed in Brown and Sacks, 2009; Matallanas et al, 2011).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep1364">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1186" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2694">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2354" />
 <bp:stepProcess rdf:resource="#Catalysis736" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep490">
 <bp:stepProcess rdf:resource="#BiochemicalReaction428" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1039">
 <bp:evidence rdf:resource="#Evidence1201" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cannabinoid receptors can bind cannabinoids</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1038">
 <bp:evidence rdf:resource="#Evidence1200" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Melatonin receptors can bind melatonin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2369">
 <bp:evidence rdf:resource="#Evidence2714" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated NTRK3 binds SRC</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1037">
 <bp:evidence rdf:resource="#Evidence1197" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G alpha (s) auto-inactivates by hydrolysing GTP to GDP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2368">
 <bp:evidence rdf:resource="#Evidence2713" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated NTRK3 binds PI3K</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1036">
 <bp:evidence rdf:resource="#Evidence1196" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">cAMP degradation by Phosphodiesterases</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1370">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1191" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2367">
 <bp:evidence rdf:resource="#Evidence2712" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated NTRK3 promotes SRC autophosphorylation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1035">
 <bp:evidence rdf:resource="#Evidence1195" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G protein alpha (s):GTP binds SRC</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2366">
 <bp:evidence rdf:resource="#Evidence2711" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated NTRK3 binds IRS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1034">
 <bp:evidence rdf:resource="#Evidence1194" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PDE3A inhibitors bind PDE3A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2365">
 <bp:evidence rdf:resource="#Evidence2709" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTRK3 phosphorylates SHC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1033">
 <bp:evidence rdf:resource="#Evidence1193" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The Ligand:GPCR:Gs complex dissociates</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2364">
 <bp:evidence rdf:resource="#Evidence2708" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTRK3 activates RAS through SHC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep497">
 <bp:stepProcess rdf:resource="#BiochemicalReaction434" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep498">
 <bp:stepProcess rdf:resource="#BiochemicalReaction435" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep495">
 <bp:stepProcess rdf:resource="#BiochemicalReaction432" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction440">
 <bp:evidence rdf:resource="#Evidence504" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ABL phosphorylates WAVEs</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep496">
 <bp:stepProcess rdf:resource="#BiochemicalReaction433" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep493">
 <bp:stepProcess rdf:resource="#Pathway64" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep494">
 <bp:stepProcess rdf:resource="#BiochemicalReaction431" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep491">
 <bp:stepProcess rdf:resource="#BiochemicalReaction429" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep492">
 <bp:stepProcess rdf:resource="#BiochemicalReaction430" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway36">
 <bp:pathwayOrder rdf:resource="#PathwayStep237" />
 <bp:pathwayOrder rdf:resource="#PathwayStep278" />
 <bp:pathwayComponent rdf:resource="#Pathway38" />
 <bp:pathwayComponent rdf:resource="#Pathway37" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence237" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK family signaling cascades</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The mitogen activated protein kinases (MAPKs) are a family of conserved protein serine threonine kinases that respond to varied extracellular stimuli to activate intracellular processes including gene expression, metabolism, proliferation, differentiation and apoptosis, among others.    The classic MAPK cascades, including the ERK1/2 pathway, the p38 MAPK pathway, the JNK pathway and the ERK5 pathway are characterized by three tiers of sequentially acting, activating kinases (reviewed in Kryiakis and Avruch, 2012; Cargnello and Roux, 2011).  The MAPK kinase kinase kinase (MAPKKK), at the top of the cascade, is phosphorylated on serine and threonine residues in response to external stimuli; this phosphorylation often occurs in the context of an interaction between the MAPKKK protein and a member of the RAS/RHO family of small GTP-binding proteins.  Activated MAPKKK proteins in turn phosphorylate the dual-specificity MAPK kinase proteins (MAPKK), which ultimately phosphorylate the MAPK proteins in a conserved Thr-X-Tyr motif in the activation loop.  Less is known about the activation of the atypical families of MAPKs, which include the ERK3/4 signaling cascade, the ERK7 cascade and the NLK cascade.  Although the details are not fully worked out, these MAPK proteins don&apos;t appear to be phosphorylated downstream of a 3-tiered kinase system as described above (reviewed in Coulombe and Meloche, 2007; Cargnello and Roux, 2011) .   Both conventional and atypical MAPKs are proline-directed serine threonine kinases and, once activated, phosphorylate substrates in the consensus P-X-S/T-P site. Both cytosolic and nuclear targets of MAPK proteins have been identified and upon stimulation, a proportion of the phosphorylated MAPKs relocalize from the cytoplasm to the nucleus. In some cases, nuclear translocation may be accompanied by dimerization, although the relationship between these two events is not fully elaborated (reviewed in Kryiakis and Avruch, 2012; Cargnello and Roux, 2011; Plotnikov et al, 2010).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence445">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction446">
 <bp:evidence rdf:resource="#Evidence512" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ROPN1 binds RHOA:GTP:RHPN1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway35">
 <bp:pathwayOrder rdf:resource="#PathwayStep235" />
 <bp:pathwayOrder rdf:resource="#PathwayStep234" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction200" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction201" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence234" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB2 Activates PTK6 Signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6 (BRK) is activated downstream of ERBB2 (HER) (Xiang et al. 2008, Peng et al. 2015) and other receptor tyrosine kinases, such as EGFR (Kamalati et al. 1996) and MET (Castro and Lange 2010). However, it is not clear if MET and EGFR activate PTK6 directly or act through ERBB2, since it is known that ERBB2 forms heterodimers with EGFR (Spivak-Kroizman et al. 1992), and MET can heterodimerize with both EGFR and ERBB2 (Tanizaki et al. 2011).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence446">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction445">
 <bp:evidence rdf:resource="#Evidence511" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHPN2 binds RHOB:GTP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway34">
 <bp:pathwayOrder rdf:resource="#PathwayStep228" />
 <bp:pathwayOrder rdf:resource="#PathwayStep229" />
 <bp:pathwayOrder rdf:resource="#PathwayStep226" />
 <bp:pathwayOrder rdf:resource="#PathwayStep227" />
 <bp:pathwayOrder rdf:resource="#PathwayStep231" />
 <bp:pathwayOrder rdf:resource="#PathwayStep232" />
 <bp:pathwayOrder rdf:resource="#PathwayStep230" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction199" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction196" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction195" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction198" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction197" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction194" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction193" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence226" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6 Regulates Proteins Involved in RNA Processing</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6 binds and phosphorylates several nuclear RNA-binding proteins, including SAM68 family members (KHDRSB1, KHDRSB2 and KHDRSB3) (Derry et al. 2000, Haegebarth et al. 2004, Lukong et al. 2005) and SFPQ (PSF) (Lukong et al. 2009). The biological role of PTK6 in RNA processing is not known.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence447">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction448">
 <bp:evidence rdf:resource="#Evidence514" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RTKN binds RHOA, RHOC or RHOB</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway33">
 <bp:pathwayOrder rdf:resource="#PathwayStep219" />
 <bp:pathwayOrder rdf:resource="#PathwayStep217" />
 <bp:pathwayOrder rdf:resource="#PathwayStep218" />
 <bp:pathwayOrder rdf:resource="#PathwayStep224" />
 <bp:pathwayOrder rdf:resource="#PathwayStep222" />
 <bp:pathwayOrder rdf:resource="#PathwayStep223" />
 <bp:pathwayOrder rdf:resource="#PathwayStep220" />
 <bp:pathwayOrder rdf:resource="#PathwayStep221" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction190" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction189" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction188" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction185" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction187" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction186" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction192" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction191" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence217" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6 enhances EGFR signaling by inhibiting EGFR down-regulation (Kang et al. 2010, Li et al. 2012, Kang and Lee 2013). PTK6 may also enhance signaling by other receptor tyrosine kinases (RTKs), such as IGF1R (Fan et al. 2013) and ERBB3 (Kamalati et al. 2000). PTK6 affects AKT1 activation (Zhang et al. 2005, Zheng et al. 2010) and targets negative regulator of RTKs, DOK1, for degradation (Miah et al. 2014). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence448">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction447">
 <bp:evidence rdf:resource="#Evidence513" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOA:GTP binds RHPN1 or RHPN2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1379">
 <bp:stepProcess rdf:resource="#Pathway182" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence441">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction442">
 <bp:evidence rdf:resource="#Evidence507" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOQ positively regulates trafficking of GOPC:CFTR to the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway39">
 <bp:pathwayOrder rdf:resource="#PathwayStep338" />
 <bp:pathwayOrder rdf:resource="#PathwayStep339" />
 <bp:pathwayOrder rdf:resource="#PathwayStep314" />
 <bp:pathwayOrder rdf:resource="#PathwayStep347" />
 <bp:pathwayOrder rdf:resource="#PathwayStep315" />
 <bp:pathwayOrder rdf:resource="#PathwayStep337" />
 <bp:pathwayOrder rdf:resource="#PathwayStep348" />
 <bp:pathwayOrder rdf:resource="#PathwayStep312" />
 <bp:pathwayOrder rdf:resource="#PathwayStep313" />
 <bp:pathwayOrder rdf:resource="#PathwayStep346" />
 <bp:pathwayOrder rdf:resource="#PathwayStep280" />
 <bp:pathwayOrder rdf:resource="#PathwayStep340" />
 <bp:pathwayOrder rdf:resource="#PathwayStep293" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction303" />
 <bp:pathwayComponent rdf:resource="#Pathway45" />
 <bp:pathwayComponent rdf:resource="#Pathway44" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction304" />
 <bp:pathwayComponent rdf:resource="#Pathway43" />
 <bp:pathwayComponent rdf:resource="#Pathway41" />
 <bp:pathwayComponent rdf:resource="#Pathway40" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction273" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction295" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction272" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction297" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction296" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction271" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence280" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAF/MAP kinase cascade</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The RAS-RAF-MEK-ERK pathway regulates processes such as proliferation, differentiation, survival, senescence and cell motility in response to growth factors, hormones and cytokines, among others. Binding of these stimuli to receptors in the plasma membrane promotes the GEF-mediated activation of RAS at the plasma membrane and initiates the three-tiered kinase cascade of the conventional MAPK cascades.  GTP-bound RAS recruits RAF (the MAPK kinase kinase), and promotes its dimerization and activation (reviewed in Cseh et al, 2014; Roskoski, 2010; McKay and Morrison, 2007; Wellbrock et al, 2004).  Activated RAF phosphorylates the MAPK kinase proteins MEK1 and MEK2 (also known as MAP2K1 and MAP2K2), which in turn phophorylate the proline-directed kinases ERK1 and 2 (also known as MAPK3 and MAPK1) (reviewed in Roskoski, 2012a, b; Kryiakis and Avruch, 2012).  Activated ERK proteins may undergo dimerization and have identified targets in both the nucleus and the cytosol; consistent with this, a proportion of activated ERK protein relocalizes to the nucleus in response to stimuli (reviewed in Roskoski 2012b; Turjanski et al, 2007; Plotnikov et al, 2010; Cargnello et al, 2011).  Although initially seen as a linear cascade originating at the plasma membrane and culminating in the nucleus, the RAS/RAF MAPK cascade is now also known to be activated from various intracellular location.  Temporal and spatial specificity of the cascade is achieved in part through the interaction of pathway components with numerous scaffolding proteins (reviewed in McKay and Morrison, 2007; Brown and Sacks, 2009).   The importance of the RAS/RAF MAPK cascade is highlighted by the fact that components of this pathway are mutated with high frequency in a large number of human cancers.  Activating mutations in RAS are found in approximately one third of human cancers, while ~8% of tumors express an activated form of BRAF (Roberts and Der, 2007; Davies et al, 2002; Cantwell-Dorris et al, 2011).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence442">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction441">
 <bp:evidence rdf:resource="#Evidence506" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GOPC promotes translocation of CFTR to lysosomes</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway38">
 <bp:pathwayOrder rdf:resource="#PathwayStep279" />
 <bp:pathwayOrder rdf:resource="#PathwayStep361" />
 <bp:pathwayComponent rdf:resource="#Pathway46" />
 <bp:pathwayComponent rdf:resource="#Pathway39" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence279" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK1/MAPK3 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The extracellular signal regulated kinases (ERKs) 1 and 2, also known as MAPK3 and MAPK1, are phosphorylated by the MAP2Ks 1 and 2 in response to a wide range of extracellular stimuli to promote differentiation, proliferation, cell motility, cell survivial, metabolism and transcription, among others (reviewed in Roskoski, 2012b; McKay and Morrison, 2007; Raman et al, 2007). In the classical pathway, MAPK1/3 activation is triggered by the GEF-mediated activation of RAS at the plasma membrane, leading to the activation of the RAF MAP3Ks (reviewed in McKay and Morrison, 2007; Matallanas et al, 2011; Wellbrock et al, 2004). However, many physiological and pathological stimuli have been found to activate MAPK1/3 independently of RAF and RAS, acting instead through MAP3Ks such as MOS, TPL2 and AMPK (Dawson et al, 2008; Wang et al, 2009; Kuriakose et al, 2014; Awane et al, 1999).  Activated MAPK1/3 phosphorylate numerous targets in both the nucleus and cytoplasm (reviewed in Yoon and Seger, 2006; Roskoski 2012b).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence443">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep488">
 <bp:stepProcess rdf:resource="#BiochemicalReaction426" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction444">
 <bp:evidence rdf:resource="#Evidence510" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOA:GTP:RTKN binds TAX1BP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway37">
 <bp:pathwayOrder rdf:resource="#PathwayStep239" />
 <bp:pathwayOrder rdf:resource="#PathwayStep259" />
 <bp:pathwayOrder rdf:resource="#PathwayStep238" />
 <bp:pathwayOrder rdf:resource="#PathwayStep257" />
 <bp:pathwayOrder rdf:resource="#PathwayStep258" />
 <bp:pathwayOrder rdf:resource="#PathwayStep270" />
 <bp:pathwayOrder rdf:resource="#PathwayStep255" />
 <bp:pathwayOrder rdf:resource="#PathwayStep277" />
 <bp:pathwayOrder rdf:resource="#PathwayStep256" />
 <bp:pathwayOrder rdf:resource="#PathwayStep253" />
 <bp:pathwayOrder rdf:resource="#PathwayStep275" />
 <bp:pathwayOrder rdf:resource="#PathwayStep254" />
 <bp:pathwayOrder rdf:resource="#PathwayStep276" />
 <bp:pathwayOrder rdf:resource="#PathwayStep251" />
 <bp:pathwayOrder rdf:resource="#PathwayStep273" />
 <bp:pathwayOrder rdf:resource="#PathwayStep252" />
 <bp:pathwayOrder rdf:resource="#PathwayStep274" />
 <bp:pathwayOrder rdf:resource="#PathwayStep271" />
 <bp:pathwayOrder rdf:resource="#PathwayStep250" />
 <bp:pathwayOrder rdf:resource="#PathwayStep272" />
 <bp:pathwayOrder rdf:resource="#PathwayStep248" />
 <bp:pathwayOrder rdf:resource="#PathwayStep249" />
 <bp:pathwayOrder rdf:resource="#PathwayStep246" />
 <bp:pathwayOrder rdf:resource="#PathwayStep268" />
 <bp:pathwayOrder rdf:resource="#PathwayStep247" />
 <bp:pathwayOrder rdf:resource="#PathwayStep269" />
 <bp:pathwayOrder rdf:resource="#PathwayStep244" />
 <bp:pathwayOrder rdf:resource="#PathwayStep266" />
 <bp:pathwayOrder rdf:resource="#PathwayStep245" />
 <bp:pathwayOrder rdf:resource="#PathwayStep267" />
 <bp:pathwayOrder rdf:resource="#PathwayStep242" />
 <bp:pathwayOrder rdf:resource="#PathwayStep264" />
 <bp:pathwayOrder rdf:resource="#PathwayStep243" />
 <bp:pathwayOrder rdf:resource="#PathwayStep265" />
 <bp:pathwayOrder rdf:resource="#PathwayStep240" />
 <bp:pathwayOrder rdf:resource="#PathwayStep262" />
 <bp:pathwayOrder rdf:resource="#PathwayStep241" />
 <bp:pathwayOrder rdf:resource="#PathwayStep263" />
 <bp:pathwayOrder rdf:resource="#PathwayStep260" />
 <bp:pathwayOrder rdf:resource="#PathwayStep261" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction215" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction237" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction214" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction236" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction217" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction239" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction216" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction238" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction211" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction233" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction210" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction232" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction213" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction235" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction212" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction234" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction219" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction218" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction240" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction220" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction241" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction204" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction226" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction203" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction225" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction206" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction228" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction205" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction227" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction222" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction221" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction202" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction224" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction223" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction208" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction207" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction229" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction209" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction231" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction230" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence238" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK6/MAPK4 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK6 and MAPK4 (also known as ERK3 and ERK4) are vertebrate-specific atypical MAP kinases.  Atypical MAPK are less well characterized than their conventional counterparts, and are generally classified as such based on their lack of activation by MAPKK family members. Unlike the conventional MAPK proteins, which contain a Thr-X-Tyr motif in the activation loop, MAPK6 and 4 have a single Ser-Glu-Gly phospho-acceptor motif (reviewed in Coulombe and Meloche, 2007; Cargnello et al, 2011).  MAPK6 is also distinct in being an unstable kinase, whose turnover is mediated by ubiquitin-dependent degradation (Coulombe et al, 2003; Coulombe et al, 2004). The biological functions and pathways governing MAPK6 and 4 are not well established.  MAPK6 and 4 are phosphorylated downstream of class I p21 activated kinases (PAKs) in a RAC- or CDC42-dependent manner (Deleris et al, 2008; Perander et al, 2008; Deleris et al, 2011; De La Mota-Peynado et al, 2011). One of the only well established substrates of MAPK6 and 4 is MAPKAPK5, which contributes to cell motility by promoting the HSBP1-dependent rearrangement of F-actin (Gerits et al, 2007; Kostenko et al, 2009a; reviewed in Kostenko et al, 2011b).  The atypical MAPKs also contribute to cell motility and invasiveness through the NCOA3:ETV4-dependent regulation of MMP gene expression (Long et al, 2012; Yan et al, 2008; Qin et al, 2008).  Both of these pathways may be misregulated in human cancers (reviewed in Myant and Sansom, 2011; Kostenko et al, 2012)</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence444">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep489">
 <bp:stepProcess rdf:resource="#Catalysis183" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction427" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction443">
 <bp:evidence rdf:resource="#Evidence508" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOQ binds GOPC:CFTR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1021">
 <bp:evidence rdf:resource="#Evidence1181" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKA catalytic subunit translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1374">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1195" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2352">
 <bp:evidence rdf:resource="#Evidence2692" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHC1 binds P-ERBB4 isoform dimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1020">
 <bp:evidence rdf:resource="#Evidence1180" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">cAMP binds PKA tetramer</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1373">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1194" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2351">
 <bp:evidence rdf:resource="#Evidence2691" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAS guanyl-nucleotide exchange mediated by SOS1 in complex with GRB2 and p-Y349,350-SHC1:p-ERBB4</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1372">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1193" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2350">
 <bp:evidence rdf:resource="#Evidence2690" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of SHC1 by ERBB4 homodimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence440">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1371">
 <bp:stepProcess rdf:resource="#Catalysis381" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1192" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway32">
 <bp:pathwayOrder rdf:resource="#PathwayStep215" />
 <bp:pathwayOrder rdf:resource="#PathwayStep214" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction184" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction183" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence214" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6 Regulates Cell Cycle</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6 promotes cell cycle progression by phosphorylating and inactivating CDK inhibitor CDKN1B (p27) (Patel et al. 2015). PTK6 also negatively modulates CDKN1B expression via regulation of the activity of the FOXO3 (FOXO3A) transcription factor (Chan and Nimnual 2010). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep1378">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1198" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway31">
 <bp:pathwayOrder rdf:resource="#PathwayStep208" />
 <bp:pathwayOrder rdf:resource="#PathwayStep209" />
 <bp:pathwayOrder rdf:resource="#PathwayStep206" />
 <bp:pathwayOrder rdf:resource="#PathwayStep207" />
 <bp:pathwayOrder rdf:resource="#PathwayStep204" />
 <bp:pathwayOrder rdf:resource="#PathwayStep205" />
 <bp:pathwayOrder rdf:resource="#PathwayStep202" />
 <bp:pathwayOrder rdf:resource="#PathwayStep203" />
 <bp:pathwayOrder rdf:resource="#PathwayStep200" />
 <bp:pathwayOrder rdf:resource="#PathwayStep211" />
 <bp:pathwayOrder rdf:resource="#PathwayStep201" />
 <bp:pathwayOrder rdf:resource="#PathwayStep212" />
 <bp:pathwayOrder rdf:resource="#PathwayStep210" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction178" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction177" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction179" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction174" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction173" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction176" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction175" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction170" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction181" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction180" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction172" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction171" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction182" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence200" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6 promotes cell motility and migration by regulating the activity of RHO GTPases RAC1 (Chen et al. 2004) and RHOA (Shen et al. 2008). PTK6 inhibits RAS GTPase activating protein RASA1 (Shen et al. 2008) and may be involved in MAPK7 (ERK5) activation (Ostrander et al. 2007, Zheng et al. 2012)</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction449">
 <bp:evidence rdf:resource="#Evidence515" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOA:GTP:RTKN binds LIN7B</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1377">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1197" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway30">
 <bp:pathwayOrder rdf:resource="#PathwayStep198" />
 <bp:pathwayOrder rdf:resource="#PathwayStep196" />
 <bp:pathwayOrder rdf:resource="#PathwayStep197" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction167" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction169" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction168" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence196" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6 Down-Regulation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The kinase activity of PTK6 is negatively regulated by both PTPN1 phosphatase (Fan et al. 2013), which dephosphorylates tyrosine Y342 of PTK6, and SRMS kinase (Fan et al. 2015), which phosphorylates PTK6 on tyrosine residue Y447. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep1376">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1196" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1375">
 <bp:stepProcess rdf:resource="#Pathway181" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1029">
 <bp:evidence rdf:resource="#Evidence1189" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ADRB2:GRK complex dissociates to Phosphorylated ADRB2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1028">
 <bp:evidence rdf:resource="#Evidence1188" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G alpha (s):GTP:SRC dissociates</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2359">
 <bp:evidence rdf:resource="#Evidence2700" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB4 binds NRGs or EGF-like ligands</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1027">
 <bp:evidence rdf:resource="#Evidence1187" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PDE3B hydrolyses cAMP to AMP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2358">
 <bp:evidence rdf:resource="#Evidence2699" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB4 ubiquitination by WWP1/ITCH</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1026">
 <bp:evidence rdf:resource="#Evidence1186" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G alpha (s) activates adenylate cyclase</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2357">
 <bp:evidence rdf:resource="#Evidence2698" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB4 binds WWP1/ITCH ubiquitin ligases</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1025">
 <bp:evidence rdf:resource="#Evidence1185" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-SHC1 binds integrin alpha5beta1:fibronectin</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1381">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1200" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2356">
 <bp:evidence rdf:resource="#Evidence2697" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB4s80 binds to SRC</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1024">
 <bp:evidence rdf:resource="#Evidence1184" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ESTG stimulates GTP exchange on GPER:heterotrimeric G-protein s</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1380">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1199" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2355">
 <bp:evidence rdf:resource="#Evidence2696" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NEDD4 binds ERBB4jmAcyt1s80 dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1023">
 <bp:evidence rdf:resource="#Evidence1183" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Adenylate cyclase converts ATP to 3&apos;,5&apos;-cyclic AMP (cAMP) and pyrophosphate</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2354">
 <bp:evidence rdf:resource="#Evidence2695" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NEDD4 ubiquitinates ERBB4jmAcyt1s80 dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1022">
 <bp:evidence rdf:resource="#Evidence1182" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">cAMP induces dissociation of inactive PKA tetramers</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2353">
 <bp:evidence rdf:resource="#Evidence2693" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB4 forms heterodimers with EGFR</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep486">
 <bp:stepProcess rdf:resource="#Pathway63" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep487">
 <bp:stepProcess rdf:resource="#BiochemicalReaction425" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep484">
 <bp:stepProcess rdf:resource="#BiochemicalReaction423" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction451">
 <bp:evidence rdf:resource="#Evidence519" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RND1 binds GTP</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep485">
 <bp:stepProcess rdf:resource="#BiochemicalReaction424" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction450">
 <bp:evidence rdf:resource="#Evidence518" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RND1 binds effectors</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence449">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep482">
 <bp:stepProcess rdf:resource="#BiochemicalReaction421" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep483">
 <bp:stepProcess rdf:resource="#Catalysis182" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction422" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep480">
 <bp:stepProcess rdf:resource="#BiochemicalReaction419" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep481">
 <bp:stepProcess rdf:resource="#BiochemicalReaction420" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway25">
 <bp:pathwayOrder rdf:resource="#PathwayStep173" />
 <bp:pathwayComponent rdf:resource="#Pathway26" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence173" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by Non-Receptor Tyrosine Kinases</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In addition to receptor tyrosine kinases, the human genome encodes at least 32 non-receptor tyrosine kinases (non-RTKs). These cytosolic tyrosine kinases lack a transmembrane domain but are recruited into signal transduction cascades through interaction with other plasma-bound receptors, which may or may not themselves have intrinsic catalytic activity. In this way, non-RTKs essentially function as an (additional) enzymatic subunit of the signaling complex and contribute to many of the same downstream signaling pathways. The non-RTKs can be grouped into 9 families (ABL, SYK, JAK, TEC, FAK, ACK, SRC, BRK/PTK6 and CSK) based on their domain structure (reviewed in Neet and Hunter, 1996).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence434">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1090">
 <bp:evidence rdf:resource="#Evidence1258" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Receptor CXCR2 binds ligands CXCL1 to 7</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1349">
 <bp:stepProcess rdf:resource="#Pathway178" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway24">
 <bp:pathwayOrder rdf:resource="#PathwayStep170" />
 <bp:pathwayOrder rdf:resource="#PathwayStep171" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction148" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction147" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence170" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Inhibition of TSC complex formation by PKB</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of TSC2 by PKB disrupts TSC1/TSC2 heterodimer formation (Hay    Sonenberg 2004). TSC2 function is affected in at least two ways: first, phosphorylation decreases the activity of TSC2; second, phosphorylation destabilizes the TSC2 protein. This destabilization is achieved by disrupting complex formation between TSC1 and TSC2 and inducing ubiquination of the free TSC2 (Inoki et al. 2002).  Phosphorylation of complexed TSC2 by PKB may result in the dissociation of the TSC1:TSC2 complex (Proud 2002).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence435">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1348">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1172" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway23">
 <bp:pathwayOrder rdf:resource="#PathwayStep160" />
 <bp:pathwayOrder rdf:resource="#PathwayStep158" />
 <bp:pathwayOrder rdf:resource="#PathwayStep159" />
 <bp:pathwayOrder rdf:resource="#PathwayStep156" />
 <bp:pathwayOrder rdf:resource="#PathwayStep157" />
 <bp:pathwayOrder rdf:resource="#PathwayStep161" />
 <bp:pathwayOrder rdf:resource="#PathwayStep162" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction138" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction137" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction139" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction134" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction136" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction135" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction140" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence156" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Energy dependent regulation of mTOR by LKB1-AMPK</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Upon formation of a trimeric LKB1:STRAD:MO25 complex, LKB1 phosphorylates and activates AMPK. This phosphorylation is immediately removed in basal conditions by PP2C, but if the cellular AMP:ATP ratio rises, this activation is maintained, as AMP binding by AMPK inhibits the dephosphorylation. AMPK then activates the TSC complex by phosphorylating TSC2. Active TSC activates the intrinsic GTPase activity of Rheb, resulting in GDP-loaded Rheb and inhibition of mTOR pathway.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence436">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1347">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1171" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway22">
 <bp:pathwayOrder rdf:resource="#PathwayStep149" />
 <bp:pathwayOrder rdf:resource="#PathwayStep147" />
 <bp:pathwayOrder rdf:resource="#PathwayStep148" />
 <bp:pathwayOrder rdf:resource="#PathwayStep145" />
 <bp:pathwayOrder rdf:resource="#PathwayStep146" />
 <bp:pathwayOrder rdf:resource="#PathwayStep143" />
 <bp:pathwayOrder rdf:resource="#PathwayStep144" />
 <bp:pathwayOrder rdf:resource="#PathwayStep142" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction127" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction126" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction128" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction123" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction122" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction125" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction124" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction121" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence142" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">mTORC1-mediated signalling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">mTORC1 integrates four major signals &#8211; growth factors, energy status, oxygen and amino acids &#8211; to regulate many processes that are involved in the promotion of cell growth. Growth factors stimulate mTORC1 through the activation of the canonical insulin and Ras signaling pathways. The energy status of the cell is signaled to mTORC1 through AMP-activated protein kinase (AMPK), a key sensor of intracellular energy status (Hardie 2007). Energy depletion (low ATP:ADP ratio) activates AMPK which phosphorylates TSC2, increasing its GAP activity towards Rheb which reduces mTORC1 activation (Inoki et al. 2003). AMPK can reduce mTORC1 activity by directly phosphorylating Raptor (Gwinn et al. 2008). Amino acids positively regulate mTORC1 (reviewed by Guertin    Sabatini 2007). In the presence of amino acids, Rag proteins bind Raptor to promote the relocalization of mTORC1 from the cytoplasm to lysosomal membranes (Puertollano 2014) where it is activated by Rheb (Saucedo et al. 2003, Stocker et al. 2003). Translocation of mTOR to the lysosome requires active Rag GTPases and a complex known as Ragulator, a pentameric protein complex that anchors the Rag GTPases to lysosomes (Sancak et al. 2008, 2010, Bar-Peled et al. 2012). Rag proteins function as heterodimers, consisting of GTP-bound RagA or RagB complexed with GDP-bound RagC or RagD. Amino acids may trigger the GTP loading of RagA/B, thereby promoting binding to raptor and assembly of an activated mTORC1 complex, though a recent study suggested that the activation of mTORC1 is not dependent on Rag GTP charging (Oshiro et al. 2014).  The activity of Rheb is regulated by a complex consisting of tuberous sclerosis complex 1 (TSC1), TSC2, and TBC1 domain family member 7 (TBC1D7) (Huang et al. 2008, Dibble et al. 2012). This complex localizes to lysosomes and functions as a GTPase-activating protein (GAP) that inhibits the activity of Rheb (Menon et al. 2014, Demetriades et al. 2014). In the presence of growth factors or insulin, TSC releases its inhibitory activity on Rheb, thus allowing the activation of mTORC1.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence437">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1346">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1170" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway29">
 <bp:pathwayOrder rdf:resource="#PathwayStep192" />
 <bp:pathwayOrder rdf:resource="#PathwayStep193" />
 <bp:pathwayOrder rdf:resource="#PathwayStep194" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction166" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction165" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction164" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence192" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6 Expression</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Levels of PTK6 increase under hypoxic conditions due to direct transcriptional regulation of PTK6 gene by hypoxia inducible transcription factors (HIFs) (Regan Anderson et al. 2013). PTK6 protein levels are also rapidly stabilized in hypoxic conditions in a HIF-independent manner (Pires et al. 2014). It has also been shown that PTK6 is ubiquitinated in normoxic conditions by a so far unknown E3 ligase (Pires et al. 2014). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence430">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep479">
 <bp:stepProcess rdf:resource="#Catalysis181" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction418" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction497">
 <bp:evidence rdf:resource="#Evidence574" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC2 translocates to the phagocytic vesicle membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway119">
 <bp:pathwayOrder rdf:resource="#PathwayStep846" />
 <bp:pathwayOrder rdf:resource="#PathwayStep847" />
 <bp:pathwayOrder rdf:resource="#PathwayStep842" />
 <bp:pathwayOrder rdf:resource="#PathwayStep843" />
 <bp:pathwayOrder rdf:resource="#PathwayStep851" />
 <bp:pathwayOrder rdf:resource="#PathwayStep852" />
 <bp:pathwayOrder rdf:resource="#PathwayStep850" />
 <bp:pathwayOrder rdf:resource="#PathwayStep848" />
 <bp:pathwayOrder rdf:resource="#PathwayStep849" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction732" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction731" />
 <bp:pathwayComponent rdf:resource="#Pathway120" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction733" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction730" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction729" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction728" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction724" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction727" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence842" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by Activin</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activin was initially discovered as an activator of follicle stimulating hormone in the pituitary gland. It has since been shown to be an important participant in the differentiation of embryonic cells into mesodermal and endodermal layers. Activin binds the Activin receptor and triggers downstream events: phosphorylation of SMAD2 and SMAD3 followed by activation of gene expression (reviewed in Attisano et al. 1996, Willis et al. 1996, Chen et al. 2006, Hinck 2012).  Activins are dimers comprising activin A (INHBA:INHBA), activin AB (INHBA:INHBB), and activin B (INHBB:INHBB). Activin first binds the type II receptor (ACVR2A, ACVR2B) and this complex then interacts with the type I receptor (ACVR1B, ACVR1C) (Attisano et al. 1996). The type II receptor phosphorylates the type I receptor and then the phosphorylated type I receptor phosphorylates SMAD2 and SMAD3. Dimers of phosphorylated SMAD2/3 bind SMAD4 and the resulting ternary complex enters the nucleus and activates target genes.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep2677">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2340" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway28">
 <bp:pathwayOrder rdf:resource="#PathwayStep190" />
 <bp:pathwayOrder rdf:resource="#PathwayStep189" />
 <bp:pathwayOrder rdf:resource="#PathwayStep187" />
 <bp:pathwayOrder rdf:resource="#PathwayStep188" />
 <bp:pathwayOrder rdf:resource="#PathwayStep185" />
 <bp:pathwayOrder rdf:resource="#PathwayStep186" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction159" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction158" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction163" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction162" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction161" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction160" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence185" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6 promotes HIF1A stabilization</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HBEGF-stimulated formation of EGFR heterodimers with GPNMB triggers PTK6-mediated phosphorylation and stabilization of the hypoxia inducible factor 1 alpha (HIF1A) under normoxic conditions. This process depends on the presence of a long non-coding RNA LINC01139 (LINK-A) (Lin et al. 2016).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence431">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction496">
 <bp:evidence rdf:resource="#Evidence573" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC2 GAPs stimulate RAC2 GTPase activity</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway118">
 <bp:pathwayOrder rdf:resource="#PathwayStep840" />
 <bp:pathwayOrder rdf:resource="#PathwayStep839" />
 <bp:pathwayOrder rdf:resource="#PathwayStep838" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction721" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction723" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction722" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence838" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TGFBR3 PTM regulation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">This subpathway includes the post-translation modification reactions of TGFBR3 including its plasma membrane localization and extracellular regulation by MT-MMPs and Gamma-secretase (Knappenberger et al.,2017, Velasco-loyden et al.,2004, Blari et al.,2011).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep2678">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2341" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway27">
 <bp:pathwayOrder rdf:resource="#PathwayStep181" />
 <bp:pathwayOrder rdf:resource="#PathwayStep182" />
 <bp:pathwayOrder rdf:resource="#PathwayStep180" />
 <bp:pathwayOrder rdf:resource="#PathwayStep178" />
 <bp:pathwayOrder rdf:resource="#PathwayStep179" />
 <bp:pathwayOrder rdf:resource="#PathwayStep176" />
 <bp:pathwayOrder rdf:resource="#PathwayStep177" />
 <bp:pathwayOrder rdf:resource="#PathwayStep175" />
 <bp:pathwayOrder rdf:resource="#PathwayStep183" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction149" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction156" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction155" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction157" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction152" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction151" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction154" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction153" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction150" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence175" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6 Activates STAT3</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6-mediated phosphorylation activates STAT3 transcription factor via STAP2 adapter protein. STAT3 transcriptional target SOCS3 is a negative regulator of PTK6 and inhibits PTK6-mediated phosphorylation of STAT3, thus creating a negative feedback loop (Liu et al. 2006, Ikeda et al. 2009, Ikeda et al. 2010). PTK6 may also activate STAT5-mediated transcription (Ikeda et al. 2011).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence432">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep477">
 <bp:stepProcess rdf:resource="#Catalysis180" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction416" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction499">
 <bp:evidence rdf:resource="#Evidence576" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC2 binds effectors at the mitochondrial outer membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2679">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2342" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway26">
 <bp:pathwayOrder rdf:resource="#PathwayStep191" />
 <bp:pathwayOrder rdf:resource="#PathwayStep216" />
 <bp:pathwayOrder rdf:resource="#PathwayStep213" />
 <bp:pathwayOrder rdf:resource="#PathwayStep225" />
 <bp:pathwayOrder rdf:resource="#PathwayStep233" />
 <bp:pathwayOrder rdf:resource="#PathwayStep199" />
 <bp:pathwayOrder rdf:resource="#PathwayStep174" />
 <bp:pathwayOrder rdf:resource="#PathwayStep184" />
 <bp:pathwayOrder rdf:resource="#PathwayStep195" />
 <bp:pathwayComponent rdf:resource="#Pathway35" />
 <bp:pathwayComponent rdf:resource="#Pathway34" />
 <bp:pathwayComponent rdf:resource="#Pathway33" />
 <bp:pathwayComponent rdf:resource="#Pathway29" />
 <bp:pathwayComponent rdf:resource="#Pathway28" />
 <bp:pathwayComponent rdf:resource="#Pathway27" />
 <bp:pathwayComponent rdf:resource="#Pathway32" />
 <bp:pathwayComponent rdf:resource="#Pathway31" />
 <bp:pathwayComponent rdf:resource="#Pathway30" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence174" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by PTK6</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK6 (BRK) is an oncogenic non-receptor tyrosine kinase that functions downstream of ERBB2 (HER2) (Xiang et al. 2008, Peng et al. 2015) and other receptor tyrosine kinases, such as EGFR (Kamalati et al. 1996) and MET (Castro and Lange 2010). Since ERBB2 forms heterodimers with EGFR and since MET can heterodimerize with both ERBB2 and EGFR (Tanizaki et al. 2011), it is not clear if MET and EGFR activate PTK6 directly or act through ERBB2. Levels of PTK6 increase under hypoxic conditions (Regan Anderson et al. 2013, Pires et al. 2014). The kinase activity of PTK6 is negatively regulated by PTPN1 phosphatase (Fan et al. 2013) and SRMS kinase (Fan et al. 2015), as well as the STAT3 target SOCS3 (Gao et al. 2012). PTK6 activates STAT3-mediated transcription (Ikeda et al. 2009, Ikeda et al. 2010) and may also activate STAT5-mediated transcription (Ikeda et al. 2011). PTK6 promotes cell motility and migration by regulating the activity of RHO GTPases RAC1 (Chen et al. 2004) and RHOA (Shen et al. 2008), and possibly by affecting motility-related kinesins (Lukong and Richard 2008). PTK6 crosstalks with AKT1 (Zhang et al. 2005, Zheng et al. 2010) and RAS signaling cascades (Shen et al. 2008, Ono et al. 2014) and may be involved in MAPK7 (ERK5) activation (Ostrander et al. 2007, Zheng et al. 2012). PTK6 enhances EGFR signaling by inhibiting EGFR down-regulation (Kang et al. 2010, Li et al. 2012, Kang and Lee 2013). PTK6 may also enhance signaling by IGF1R (Fan et al. 2013) and ERBB3 (Kamalati et al. 2000). PTK6 promotes cell cycle progression by phosphorylating and inactivating CDK inhibitor CDKN1B (p27) (Patel et al. 2015). PTK6 activity is upregulated in osteopontin (OPN or SPP1)-mediated signaling, leading to increased VEGF expression via PTK6/NF-kappaB/ATF4 signaling path. PTK6 may therefore play a role in VEGF-dependent tumor angiogenesis (Chakraborty et al. 2008). PTK6 binds and phosphorylates several nuclear RNA-binding proteins, including SAM68 family members (KHDRSB1, KHDRSB2 and KHDRSB3) (Derry et al. 2000, Haegebarth et al. 2004, Lukong et al. 2005) and SFPQ (PSF) (Lukong et al. 2009). The biological role of PTK6 in RNA processing is not known. For a review of PTK6 function, please refer to Goel and Lukong 2015. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence433">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep478">
 <bp:stepProcess rdf:resource="#BiochemicalReaction417" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction498">
 <bp:evidence rdf:resource="#Evidence575" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC2 GDIs block activation of RAC2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1098">
 <bp:evidence rdf:resource="#Evidence1266" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Receptors CCR3, 4 and 5 bind CCL5 ligand</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1341">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1166" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2673">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2336" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1097">
 <bp:evidence rdf:resource="#Evidence1265" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Receptors CXCR4 and 7 bind CXCL12 ligand</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1340">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1165" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2674">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2337" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1096">
 <bp:evidence rdf:resource="#Evidence1264" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Receptor CCR7 binds CCL19 and 21 ligands</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2675">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2338" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1095">
 <bp:evidence rdf:resource="#Evidence1263" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CCR2, CCR3 bind CCL13</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2676">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2339" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway21">
 <bp:pathwayOrder rdf:resource="#PathwayStep169" />
 <bp:pathwayOrder rdf:resource="#PathwayStep167" />
 <bp:pathwayOrder rdf:resource="#PathwayStep168" />
 <bp:pathwayOrder rdf:resource="#PathwayStep154" />
 <bp:pathwayOrder rdf:resource="#PathwayStep165" />
 <bp:pathwayOrder rdf:resource="#PathwayStep155" />
 <bp:pathwayOrder rdf:resource="#PathwayStep166" />
 <bp:pathwayOrder rdf:resource="#PathwayStep141" />
 <bp:pathwayOrder rdf:resource="#PathwayStep152" />
 <bp:pathwayOrder rdf:resource="#PathwayStep163" />
 <bp:pathwayOrder rdf:resource="#PathwayStep153" />
 <bp:pathwayOrder rdf:resource="#PathwayStep164" />
 <bp:pathwayOrder rdf:resource="#PathwayStep150" />
 <bp:pathwayOrder rdf:resource="#PathwayStep140" />
 <bp:pathwayOrder rdf:resource="#PathwayStep151" />
 <bp:pathwayComponent rdf:resource="#Pathway24" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction129" />
 <bp:pathwayComponent rdf:resource="#Pathway23" />
 <bp:pathwayComponent rdf:resource="#Pathway22" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction145" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction133" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction144" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction146" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction130" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction141" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction132" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction143" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction120" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction131" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction142" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence140" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MTOR signalling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Target of rapamycin (mTOR) is a highly-conserved serine/threonine kinase that regulates cell growth and division in response to energy levels, growth signals, and nutrients (Zoncu et al. 2011). Control of mTOR activity is critical for the cell since its dysregulation leads to cancer, metabolic disease, and diabetes (Laplante    Sabatini 2012). In cells, mTOR exists as two structurally distinct complexes termed mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2), each one with specificity for different sets of effectors. mTORC1 couples energy and nutrient abundance to cell growth and proliferation by balancing anabolic (protein synthesis and nutrient storage) and catabolic (autophagy and utilization of energy stores) processes.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1094">
 <bp:evidence rdf:resource="#Evidence1262" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Receptor CXCR6 binds CXCL16 ligand</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1345">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1169" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway20">
 <bp:pathwayOrder rdf:resource="#PathwayStep136" />
 <bp:pathwayOrder rdf:resource="#PathwayStep135" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction116" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction117" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence135" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cam-PDE 1 activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Human Ca2+/calmodulin-dependent phosphodiesterase PDE1 is  activated by the binding of calmodulin in the presence of Ca(2+).  PDE1 has three subtypes PDE1A, PDE1B and PDE1C and their role is to hydrolyze both cGMP and cAMP. Their role is to antagonize the increased concentration of the intracellular second messengers determined by the synthetic activity of the adenylate cyclase enzymes thus governing intracellular cAMP dynamics in response to changes in the cytosolic Ca2+ concentration. PDE1 are mainly cytosolic but different isoforms are expressed in different tissues.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1093">
 <bp:evidence rdf:resource="#Evidence1261" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Receptor CCR11 binds CCL19, CCL21 &amp; CCL25</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1344">
 <bp:stepProcess rdf:resource="#Pathway177" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2670">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2333" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1092">
 <bp:evidence rdf:resource="#Evidence1260" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Receptor CXCR3 binds ligands CXCL9 to 11</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1343">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1168" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2671">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2334" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1091">
 <bp:evidence rdf:resource="#Evidence1259" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CXCR5 binds CXCL13</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1342">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1167" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2672">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2335" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway120">
 <bp:pathwayOrder rdf:resource="#PathwayStep844" />
 <bp:pathwayOrder rdf:resource="#PathwayStep845" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction725" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction726" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence844" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Antagonism of Activin by Follistatin</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Both Follistatin (FST) and Follistatin-like-3 (FSTL3) irreversibly bind Activin dimers and prevent Activin from interacting with its receptor (reviewed in Schneyer et al. 2004, Xia and Schneyer 2009). Though functionally similar in vitro, FST and FSTL3 do not function identically in vivo. Mice lacking FST die shortly after birth due to defects in muscle and bone (Matzuk et al. 1995); mice lacking FSTL3 are viable but have altered glucose metabolism (Mukherjee et al. 2007).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1099">
 <bp:evidence rdf:resource="#Evidence1267" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Neuropeptide S receptor binds neuropeptide S</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep475">
 <bp:stepProcess rdf:resource="#BiochemicalReaction414" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway126">
 <bp:pathwayOrder rdf:resource="#PathwayStep934" />
 <bp:pathwayOrder rdf:resource="#PathwayStep935" />
 <bp:pathwayOrder rdf:resource="#PathwayStep932" />
 <bp:pathwayOrder rdf:resource="#PathwayStep933" />
 <bp:pathwayOrder rdf:resource="#PathwayStep930" />
 <bp:pathwayOrder rdf:resource="#PathwayStep941" />
 <bp:pathwayOrder rdf:resource="#PathwayStep931" />
 <bp:pathwayOrder rdf:resource="#PathwayStep942" />
 <bp:pathwayOrder rdf:resource="#PathwayStep940" />
 <bp:pathwayOrder rdf:resource="#PathwayStep929" />
 <bp:pathwayOrder rdf:resource="#PathwayStep927" />
 <bp:pathwayOrder rdf:resource="#PathwayStep938" />
 <bp:pathwayOrder rdf:resource="#PathwayStep928" />
 <bp:pathwayOrder rdf:resource="#PathwayStep939" />
 <bp:pathwayOrder rdf:resource="#PathwayStep936" />
 <bp:pathwayOrder rdf:resource="#PathwayStep937" />
 <bp:pathwayOrder rdf:resource="#PathwayStep971" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction811" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction810" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction806" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction805" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction816" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction808" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction807" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction802" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction813" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction812" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction845" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction804" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction815" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction803" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction814" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction809" />
 <bp:pathwayComponent rdf:resource="#Pathway127" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence927" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TGF-beta receptor signaling activates SMADs</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of transforming growth factor beta 1 (TGF beta 1, i.e. TGFB1) to TGF beta receptor type 2 (TGFBR2) activates TGF beta receptor signaling cascade. TGFB1 is posttranslationally processed by furin (Dubois et al. 1995) to form a homodimer and secreted to the extracellular space as part of the large latent complex (LLC). After the LLC disassembles in the extracellular space, dimeric TGFB1 becomes capable of binding to TGFBR2 (Annes et al. 2003, Keski Oja et al. 2004). Formation of TGFB1:TGFBR2 complex creates a binding pocket for TGF-beta receptor type-1 (TGFBR1) and TGFBR1 is recruited to the complex by binding to both TGFB1 and TGFBR2. This results in an active heterotetrameric TGF-beta receptor complex that consists of TGFB1 homodimer bound to two heterodimers of TGFBR1 and TGFBR2 (Wrana et al. 1992, Moustakas et al. 1993, Franzen et al. 1993). TGF-beta signaling can also occur through a single heterodimer of TGFBR1 and TGFBR2, although with decreased efficiency (Huang et al. 2011). TGFBR1 and TGFBR2 interact through their extracellular domains, which brings their cytoplasmic domains together. Ligand binding to extracellular receptor domains is cooperative, but no conformational change is seen from crystal structures of either TGFB1- or TGFB3-bound heterotetrameric receptor complexes (Groppe et al. 2008, Radaev et al. 2010).  Activation of TGFBR1 by TGFBR2 in the absence of ligand is prevented by FKBP1A (FKBP12), a peptidyl-prolyl cis-trans isomerase. FKBP1A forms a complex with inactive TGFBR1 and dissociates from it only after TGFBR1 is recruited by TGFB1-bound TGFBR2 (Chen et al. 1997).   Both TGFBR1 and TGFBR2 are receptor serine/threonine kinases. Formation of the hetero-tetrameric TGF-beta receptor complex (TGFBR) in response to TGFB1 binding induces receptor rotation, so that TGFBR2 and TGFBR1 cytoplasmic kinase domains face each other in a catalytically favourable configuration. TGFBR2 trans-phosphorylates serine residues at the conserved Gly-Ser-rich juxtapositioned domain (GS domain) of TGFBR1 (Wrana et al. 1994, Souchelnytskyi et al. 1996), activating TGFBR1. In addition to phosphorylation, TGFBR1 may also be sumoylated in response to TGF-beta stimulation. Sumoylation enhances TGFBR1 kinase activity (Kang et al. 2008).   The activated TGFBR complex is internalized by clathrin-mediated endocytosis into early endosomes. With the assistance of SARA, an early endosome membrane protein, phosphorylated TGFBR1 within TGFBR complex recruits SMAD2 and/or SMAD3 , i.e. R-SMADs (Tsukazaki et al. 1998). TGFBR1 phosphorylates recruited SMAD2/3 on two C-terminal serine residues (Souchelnytskyi et al. 2001). The phosphorylation changes the conformation of SMAD2/3 MH2 domain, promoting dissociation of SMAD2/3 from SARA and TGFBR1 (Souchelnytskyi et al. 1997, Macias-Silva et al. 1996, Nakao et al. 1997) and formation of SMAD2/3 trimers (Chacko et al. 2004). The phosphorylated C-terminal tail of SMAD2/3 has high affinity for SMAD4 (Co-SMAD), inducing formation of SMAD2/3:SMAD4 heterotrimers, composed of two phosphorylated R-SMADs (SMAD2 and/or SMAD3) and SMAD4 (Co-SMAD). SMAD2/3:SMAD4 heterotrimers are energetically favored over R-SMAD trimers (Nakao et al. 1997, Qin et al. 2001, Kawabata et al. 1998, Chacko et al. 2004).  SMAD2/3:SMAD4 heterotrimers translocate to the nucleus where they act as transcriptional regulators. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep476">
 <bp:stepProcess rdf:resource="#BiochemicalReaction415" />
 <bp:stepProcess rdf:resource="#Catalysis179" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway125">
 <bp:pathwayOrder rdf:resource="#PathwayStep912" />
 <bp:pathwayOrder rdf:resource="#PathwayStep913" />
 <bp:pathwayOrder rdf:resource="#PathwayStep899" />
 <bp:pathwayOrder rdf:resource="#PathwayStep910" />
 <bp:pathwayOrder rdf:resource="#PathwayStep911" />
 <bp:pathwayOrder rdf:resource="#PathwayStep918" />
 <bp:pathwayOrder rdf:resource="#PathwayStep919" />
 <bp:pathwayOrder rdf:resource="#PathwayStep916" />
 <bp:pathwayOrder rdf:resource="#PathwayStep917" />
 <bp:pathwayOrder rdf:resource="#PathwayStep914" />
 <bp:pathwayOrder rdf:resource="#PathwayStep915" />
 <bp:pathwayOrder rdf:resource="#PathwayStep901" />
 <bp:pathwayOrder rdf:resource="#PathwayStep923" />
 <bp:pathwayOrder rdf:resource="#PathwayStep902" />
 <bp:pathwayOrder rdf:resource="#PathwayStep924" />
 <bp:pathwayOrder rdf:resource="#PathwayStep921" />
 <bp:pathwayOrder rdf:resource="#PathwayStep900" />
 <bp:pathwayOrder rdf:resource="#PathwayStep922" />
 <bp:pathwayOrder rdf:resource="#PathwayStep920" />
 <bp:pathwayOrder rdf:resource="#PathwayStep909" />
 <bp:pathwayOrder rdf:resource="#PathwayStep907" />
 <bp:pathwayOrder rdf:resource="#PathwayStep908" />
 <bp:pathwayOrder rdf:resource="#PathwayStep905" />
 <bp:pathwayOrder rdf:resource="#PathwayStep906" />
 <bp:pathwayOrder rdf:resource="#PathwayStep903" />
 <bp:pathwayOrder rdf:resource="#PathwayStep925" />
 <bp:pathwayOrder rdf:resource="#PathwayStep904" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction776" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction798" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction775" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction797" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction778" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction777" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction799" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction794" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction793" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction796" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction795" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction779" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction781" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction780" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction787" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction786" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction789" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction800" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction788" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction783" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction782" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction785" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction784" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction801" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction790" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction792" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction791" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence899" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Downregulation of SMAD2/3:SMAD4 transcriptional activity</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transcriptional activity of SMAD2/3:SMAD4 heterotrimer can be inhibited by formation of a complex with SKI or SKIL (SNO), where SKI or SKIL recruit NCOR and possibly other transcriptional repressors to SMAD-binding promoter elements (Sun et al. 1999, Luo et al. 1999, Strochein et al. 1999). Higher levels of phosphorylated SMAD2 and SMAD3, however, may target SKI and SKIL for degradation (Strochein et al. 1999, Sun et al. 1999 PNAS, Bonni et al. 2001) through recruitment of SMURF2 (Bonni et al. 2001) or RNF111 i.e. Arkadia (Levy et al. 2007) ubiquitin ligases to SKI/SKIL by SMAD2/3. Therefore,the ratio of SMAD2/3 and SKI/SKIL determines the outcome: inhibition of SMAD2/3:SMAD4-mediated transcription or degradation of SKI/SKIL. SKI and SKIL are overexpressed in various cancer types and their oncogenic effect is connected with their ability to inhibit signaling by TGF-beta receptor complex.  SMAD4 can be monoubiquitinated by a nuclear ubiquitin ligase TRIM33 (Ecto, Ectodermin, Tif1-gamma). Monoubiquitination of SMAD4 disrupts SMAD2/3:SMAD4 heterotrimers and leads to SMAD4 translocation to the cytosol. In the cytosol, SMAD4 can be deubiquitinated by USP9X (FAM), reversing TRIM33-mediated negative regulation (Dupont et al. 2009). Phosphorylation of the linker region of SMAD2 and SMAD3 by CDK8 or CDK9 primes SMAD2/3:SMAD4 complex for ubiquitination by NEDD4L and SMURF ubiquitin ligases. NEDD4L ubiquitinates SMAD2/3 and targets SMAD2/3:SMAD4 heterotrimer for degradation (Gao et al. 2009). SMURF2 monoubiquitinates SMAD2/3, leading to disruption of SMAD2/3:SMAD4 complexes (Tang et al. 2011).  Transcriptional repressors TGIF1 and TGIF2 bind SMAD2/3:SMAD4 complexes and inhibit SMAD-mediated transcription by recruitment of histone deacetylase HDAC1 to SMAD-binding promoter elements (Wotton et al. 1999, Melhuish et al. 2001). PARP1 can attach poly ADP-ribosyl chains to SMAD3 and SMAD4 within SMAD2/3:SMAD4 heterotrimers. PARylated SMAD2/3:SMAD4 complexes are unable to bind SMAD-binding DNA elements (SBEs) (Lonn et al. 2010).  Phosphorylated SMAD2 and SMAD3 can be dephosphorylated by PPM1A protein phosphatase, leading to dissociation of SMAD2/3 complexes and translocation of unphosphorylated SMAD2/3 to the cytosol (Lin et al. 2006). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep473">
 <bp:stepProcess rdf:resource="#Pathway62" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway128">
 <bp:pathwayOrder rdf:resource="#PathwayStep978" />
 <bp:pathwayOrder rdf:resource="#PathwayStep976" />
 <bp:pathwayOrder rdf:resource="#PathwayStep977" />
 <bp:pathwayOrder rdf:resource="#PathwayStep974" />
 <bp:pathwayOrder rdf:resource="#PathwayStep975" />
 <bp:pathwayOrder rdf:resource="#PathwayStep973" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction851" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction850" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction849" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction846" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction848" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction847" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence973" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In normal cells and in the early stages of cancer development, signaling by TGF-beta plays a tumor suppressive role, as SMAD2/3:SMAD4-mediated transcription inhibits cell division by downregulating MYC oncogene transcription and stimulating transcription of CDKN2B tumor suppressor gene. In advanced cancers however, TGF-beta signaling promotes metastasis by stimulating epithelial to mesenchymal transition (EMT).  TGFBR1 is recruited to tight junctions by binding PARD6A, a component of tight junctions. After TGF-beta stimulation, activated TGFBR2 binds TGFBR1 at tight junctions, and phosphorylates both TGFBR1 and PARD6A. Phosphorylated PARD6A recruits SMURF1 to tight junctions. SMURF1 is able to ubiquitinate RHOA, a component of tight junctions needed for tight junction maintenance, leading to disassembly of tight junctions, an important step in EMT (Wang et al. 2003, Ozdamar et al. 2005).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway19">
 <bp:pathwayOrder rdf:resource="#PathwayStep129" />
 <bp:pathwayOrder rdf:resource="#PathwayStep132" />
 <bp:pathwayOrder rdf:resource="#PathwayStep130" />
 <bp:pathwayOrder rdf:resource="#PathwayStep131" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction112" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction111" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction114" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction113" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence129" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKA activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">A number of inactive tetrameric PKA holoenzymes are produced by the combination of homo- or heterodimers of the different regulatory subunits associated with two catalytic subunits. When cAMP binds to two specific binding sites on the regulatory subunits, these undergo a conformational change that causes the dissociation of a dimer of regulatory subunits bound to four cAMP from two monomeric, catalytically active PKA subunits.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep474">
 <bp:stepProcess rdf:resource="#BiochemicalReaction413" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway127">
 <bp:pathwayOrder rdf:resource="#PathwayStep956" />
 <bp:pathwayOrder rdf:resource="#PathwayStep957" />
 <bp:pathwayOrder rdf:resource="#PathwayStep954" />
 <bp:pathwayOrder rdf:resource="#PathwayStep955" />
 <bp:pathwayOrder rdf:resource="#PathwayStep952" />
 <bp:pathwayOrder rdf:resource="#PathwayStep953" />
 <bp:pathwayOrder rdf:resource="#PathwayStep950" />
 <bp:pathwayOrder rdf:resource="#PathwayStep951" />
 <bp:pathwayOrder rdf:resource="#PathwayStep958" />
 <bp:pathwayOrder rdf:resource="#PathwayStep959" />
 <bp:pathwayOrder rdf:resource="#PathwayStep970" />
 <bp:pathwayOrder rdf:resource="#PathwayStep945" />
 <bp:pathwayOrder rdf:resource="#PathwayStep967" />
 <bp:pathwayOrder rdf:resource="#PathwayStep946" />
 <bp:pathwayOrder rdf:resource="#PathwayStep968" />
 <bp:pathwayOrder rdf:resource="#PathwayStep943" />
 <bp:pathwayOrder rdf:resource="#PathwayStep965" />
 <bp:pathwayOrder rdf:resource="#PathwayStep944" />
 <bp:pathwayOrder rdf:resource="#PathwayStep966" />
 <bp:pathwayOrder rdf:resource="#PathwayStep963" />
 <bp:pathwayOrder rdf:resource="#PathwayStep964" />
 <bp:pathwayOrder rdf:resource="#PathwayStep961" />
 <bp:pathwayOrder rdf:resource="#PathwayStep962" />
 <bp:pathwayOrder rdf:resource="#PathwayStep949" />
 <bp:pathwayOrder rdf:resource="#PathwayStep947" />
 <bp:pathwayOrder rdf:resource="#PathwayStep969" />
 <bp:pathwayOrder rdf:resource="#PathwayStep948" />
 <bp:pathwayOrder rdf:resource="#PathwayStep960" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction831" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction830" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction833" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction832" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction817" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction839" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction838" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction819" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction818" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction835" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction834" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction837" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction836" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction820" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction842" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction841" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction822" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction844" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction821" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction843" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction840" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction828" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction827" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction829" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction824" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction823" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction826" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction825" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence943" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Downregulation of TGF-beta receptor signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TGF-beta receptor signaling is downregulated by proteasome and lysosome-mediated degradation of ubiquitinated TGFBR1, SMAD2 and SMAD3, as well as by dephosphorylation of TGFBR1, SMAD2 and SMAD3.   In the nucleus, SMAD2/3:SMAD4 complex stimulates transcription of SMAD7, an inhibitory SMAD (I-SMAD). SMAD7 binds phosphorylated TGFBR1 and competes with the binding of SMAD2 and SMAD3 (Hayashi et al. 1997, Nakao et al. 1997). Binding of SMAD7 to TGBR1 can be stabilized by STRAP, a protein that simultaneously binds SMAD7 and TGFBR1 (Datta et al. 2000). BAMBI simultaneously binds SMAD7 and activated TGFBR1, leading to downregulation of TGF-beta receptor complex signaling (Onichtchouk et al. 1999, Yan et al. 2009).   In addition to competing with SMAD2/3 binding to TGFBR1, SMAD7 recruits protein phosphatase PP1 to phosphorylated TGFBR1, by binding to the PP1 regulatory subunit PPP1R15A (GADD34). PP1 dephosphorylates TGFBR1, preventing the activation of SMAD2/3 and propagation of TGF-beta signal (Shi et al. 2004).    SMAD7 associates with several ubiquitin ligases, SMURF1 (Ebisawa et al. 2001, Suzuki et al. 2002, Tajima et al. 2003, Chong et al. 2010), SMURF2 (Kavsak et al. 2000, Ogunjimi et al. 2005), and NEDD4L (Kuratomi et al. 2005), and recruits them to phosphorylated TGFBR1 within TGFBR complex. SMURF1, SMURF2 and NEDD4L ubiquitinate TGFBR1 (and SMAD7), targeting TGFBR complex for proteasome and lysosome-dependent degradation (Ebisawa et al. 2001, Kavsak et al. 2000, Kuratomi et al. 2005). The ubiquitination of TGFBR1 can be reversed by deubiquitinating enzymes, UCHL5 (UCH37) and USP15, which may be recruited to ubiquitinated TGFBR1 by SMAD7 (Wicks et al. 2005, Eichhorn et al. 2012).    Basal levels of SMAD2 and SMAD3 are maintained by SMURF2 and STUB1 ubiquitin ligases. SMURF2 is able to bind and ubiquitinate SMAD2, leading to SMAD2 degradation (Zhang et al. 2001), but this has been questioned by a recent study of Smurf2 knockout mice (Tang et al. 2011). STUB1 (CHIP) binds and ubiquitinates SMAD3, leading to SMAD3 degradation (Li et al. 2004, Xin et al. 2005). PMEPA1 can bind and sequester unphosphorylated SMAD2 and SMAD3, preventing their activation in response to TGF-beta signaling. In addition, PMEPA1 can bind and sequester phosphorylated SMAD2 and SMAD3, preventing formation of SMAD2/3:SMAD4 heterotrimer complexes (Watanabe et al. 2010). A protein phosphatase MTMR4, residing in the membrane of early endosomes, can dephosphorylate activated SMAD2 and SMAD3, preventing formation of SMAD2/3:SMAD4 complexes (Yu et al. 2010).  </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence438">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep471">
 <bp:stepProcess rdf:resource="#BiochemicalReaction411" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway122">
 <bp:pathwayOrder rdf:resource="#PathwayStep972" />
 <bp:pathwayOrder rdf:resource="#PathwayStep872" />
 <bp:pathwayOrder rdf:resource="#PathwayStep926" />
 <bp:pathwayComponent rdf:resource="#Pathway126" />
 <bp:pathwayComponent rdf:resource="#Pathway128" />
 <bp:pathwayComponent rdf:resource="#Pathway123" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence872" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by TGF-beta Receptor Complex</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The TGF-beta/BMP pathway incorporates several signaling pathways that share most, but not all, components of a central signal transduction engine. The general signaling scheme is rather simple: upon binding of a ligand, an activated plasma membrane receptor complex is formed, which passes on the signal towards the nucleus through a phosphorylated receptor SMAD (R-SMAD). In the nucleus, the activated R-SMAD promotes transcription in complex with a closely related helper molecule termed Co-SMAD (SMAD4). However, this simple linear pathway expands into a network when various regulatory components and mechanisms are taken into account. The signaling pathway includes a great variety of different TGF-beta/BMP superfamily ligands and receptors, several types of the R-SMADs, and functionally critical negative feedback loops. The R-SMAD:Co-SMAD complex can interact with a great number of transcriptional co-activators/co-repressors to regulate positively or negatively effector genes, so that the interpretation of a signal depends on the cell-type and cross talk with other signaling pathways such as Notch, MAPK and Wnt. The pathway plays a number of different biological roles in the control of embryonic and adult cell proliferation and differentiation, and it is implicated in a great number of human diseases. TGF beta (TGFB1) is secreted as a homodimer, and as such it binds to TGF beta receptor II (TGFBR2), inducing its dimerization. Binding of TGF beta enables TGFBR2 to form a stable hetero-tetrameric complex with TGF beta receptor I homodimer (TGFBR1). TGFBR2 acts as a serine/threonine kinase and phosphorylates serine and threonine residues within the short GS domain (glycine-serine rich domain) of TGFBR1. The phosphorylated heterotetrameric TGF beta receptor complex (TGFBR) internalizes into clathrin coated endocytic vesicles where it associates with the endosomal membrane protein SARA. SARA facilitates the recruitment of cytosolic SMAD2 and SMAD3, which act as R-SMADs for TGF beta receptor complex. TGFBR1 phosphorylates recruited SMAD2 and SMAD3, inducing a conformational change that promotes formation of R-SMAD trimers and dissociation of R-SMADs from the TGF beta receptor complex.  In the cytosol, phosphorylated SMAD2 and SMAD3 associate with SMAD4 (known as Co-SMAD), forming a heterotrimer which is more stable than the R-SMAD homotrimers. R-SMAD:Co-SMAD heterotrimer translocates to the nucleus where it directly binds DNA and, in cooperation with other transcription factors, regulates expression of genes involved in cell differentiation, in a context-dependent manner.  The intracellular level of SMAD2 and SMAD3 is regulated by SMURF ubiquitin ligases, which target R-SMADs for degradation. In addition, nuclear R-SMAD:Co-SMAD heterotrimer stimulates transcription of inhibitory SMADs (I-SMADs), forming a negative feedback loop. I-SMADs bind the phosphorylated TGF beta receptor complexes on caveolin coated vesicles, derived from the lipid rafts, and recruit SMURF ubiquitin ligases to TGF beta receptors, leading to ubiquitination and degradation of TGFBR1. Nuclear R-SMAD:Co-SMAD heterotrimers are targets of nuclear ubiquitin ligases which ubiquitinate SMAD2/3 and SMAD4, causing heterotrimer dissociation, translocation of ubiquitinated SMADs to the cytosol and their proteasome-mediated degradation. For a recent review of TGF-beta receptor signaling, please refer to Kang et al. 2009.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence439">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep472">
 <bp:stepProcess rdf:resource="#BiochemicalReaction412" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway121">
 <bp:pathwayOrder rdf:resource="#PathwayStep857" />
 <bp:pathwayOrder rdf:resource="#PathwayStep868" />
 <bp:pathwayOrder rdf:resource="#PathwayStep858" />
 <bp:pathwayOrder rdf:resource="#PathwayStep869" />
 <bp:pathwayOrder rdf:resource="#PathwayStep855" />
 <bp:pathwayOrder rdf:resource="#PathwayStep866" />
 <bp:pathwayOrder rdf:resource="#PathwayStep856" />
 <bp:pathwayOrder rdf:resource="#PathwayStep867" />
 <bp:pathwayOrder rdf:resource="#PathwayStep864" />
 <bp:pathwayOrder rdf:resource="#PathwayStep854" />
 <bp:pathwayOrder rdf:resource="#PathwayStep865" />
 <bp:pathwayOrder rdf:resource="#PathwayStep862" />
 <bp:pathwayOrder rdf:resource="#PathwayStep863" />
 <bp:pathwayOrder rdf:resource="#PathwayStep859" />
 <bp:pathwayOrder rdf:resource="#PathwayStep860" />
 <bp:pathwayOrder rdf:resource="#PathwayStep861" />
 <bp:pathwayOrder rdf:resource="#PathwayStep870" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction743" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction742" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction734" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction745" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction744" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction750" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction741" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction740" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction739" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction736" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction747" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction735" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction746" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction738" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction749" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction737" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction748" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence854" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by BMP</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Bone morphogenetic proteins (BMPs) have many biological activities in various tissues, including bone, cartilage, blood vessels, heart, kidney, neurons, liver and lung. They are members of the Transforming growth factor-Beta (TGFB) family. They bind to type II and type I serine-threonine kinase receptors, which transduce signals through SMAD and non-SMAD signalling pathways. BMP signalling is linked to a wide variety of clinical disorders, including vascular diseases, skeletal diseases and cancer. BMPs typically activate BMP type I receptors and signal via SMAD1, 5 and 8. They can be classified into several subgroups, including the BMP2/4 group, the BMP5-8 osteogenic protein-1 (OP1) group, the growth and differentiation factor (GDF) 5-7 group and the BMP9/10 group. Most of the proteins of the BMP2/4, OP1 and BMP9/10 groups induce formation of bone and cartilage tissues in vivo, while the GDF5-7 group induce cartilage and tendon-like, but not bone-like, tissues (Miyazono et al. 2010). Members of the TGFB family bind to two types of serine-threonine kinase receptors, type I and type II (Massagu&#233; 2012). BMPs can bind type I receptors in the absence of type II receptors, but both types are required for signal transduction. The presence of both types dramatically increases binding affinity (Rozenweig et al. 1995). The type II receptor kinase transphosphorylates the type I receptor, which transmits specific intracellular signals. Type I and type II receptors share similar structural properties, comprised of a relatively short extracellular domain, a single membrane-spanning domain and an intracellular domain containing a serine-threonine kinase domain. Seven receptors, collectively referred to as the Activin receptor-like kinases (ALK), have been identified as type I receptors for the TGFB family in mammals. ALKs are classified into three groups based on their structure and function, the BMPRI group (Bone morphogenetic protein receptor type-1A, ALK3, BMPR1A and Bone morphogenetic protein receptor type-1B, ALK6, BMPR1B), the ALK1 group (Serine/threonine-protein kinase receptor R3, ALK1, ACVRL1 and Activin receptor type-1, ALK2, ACVR1) and the TBetaR1 group (Activin receptor type-1B, ALK4, ACVR1B and  TGF-beta receptor type-1, ALK5, TGFBR1 and Activin receptor type-1C, ALK7, ACVR1C) (Kawabata et al. 1998). ALK1 group and BMPRI group activate SMAD1/5/8 and transduce similar intracellular signals. The TBetaR1 group activate SMAD2/3. BMPR1A and ACVR1 are widely expressed. BMPR1B shows a more restricted expression profile. ACVRL1 is limited to endothelial cells and a few other cell types. The binding specificities of BMPs to type I receptors is affected by the type II receptors that are present (Yu et al. 2005). Typically, BMP2 and BMP4 bind to BMPR1A and BMPR1B (ten Dijke et al. 1994). BMP6 and BMP7 bind strongly to ACVR1 and weakly to BMPR1B. Growth/differentiation factor 5 (BMP14, GDF5) preferentially binds to BMPR1B, but not to other type I receptors (Nishitoh et al. 1995). BMP9 and BMP10 bind to ACVRL1 and ACVRL (Scharpfenecker et al. 2007). BMP type I receptors are shared by other members of the TGFB family. Three receptors, Bone morphogenetic protein receptor type-2 (BMPR2), Activin receptor type-2A (ACVR2A) and Activin receptor type-2B (ACVR2B) are the type II receptors for mammalian BMPs. They are widely expressed in various tissues. BMPR2 is specific for BMPs, whereas ACVR2A and ACVR2B are shared with activins and myostatin. BMP binding and signalling can be affected by coreceptors. Glycosylphosphatidylinositol (GPI)-anchored proteins of the repulsive guidance molecule (RGM) family, including RGMA, RGMB (DRAGON) and Hemojuvelin (HFE2, RGMC) are coreceptors for BMP2 and BMP4, enhancing signaling (Samad et al. 2005, Babitt et al. 2005, 2006). They interact with BMP type I and/or type II receptors and bind BMP2 and BMP4, but not BMP7 or TGFB1. BMP2/4 signalling normally involves BMPR2, not ACVR2A or ACVR2B. Cells transfected with RGMA use both BMPR2 and ACVR2A for BMP-2/4 signalling, suggesting that RGMA facilitates the use of ACVR2A by BMP2/4 (Xia et al. 2007). Endoglin (ENG) is a transmembrane protein expressed in proliferating endothelial cells. It binds various ligands including TGFB1/3, Activin-A and BMP2/7 (Barbara et al. 1999). It inhibits TGFB-induced responses and enhances BMP7-induced responses (Scherner et al. 2007). Mutations in ENG result in hereditary haemorrhagic telangiectasia (HHT1), also known as OslerWeberRendu disease, while mutations in ACVRL1 lead to HHT2, suggesting that they act in a common signalling pathway (McAllister et al. 1994, Johnson et al. 1996). BMP2 is a dimeric protein, having two receptor-binding motifs. One is a high-affinity binding site for BMPR1A, the other is a low-affinity binding site for BMPR2 (Kirsch et al. 2000). In the absence of ligand stimulation, small fractions of type II and type I receptors are present as preexisting homodimers and heterodimers on the cell surface. Ligand-binding increases oligomerization. The intracellular domains of type I receptors have a characteristic GS domain (glycine and serine-rich domain) located N-terminal to the serine-threonine kinase domains. Type II receptor kinases are constitutively active in the absence of ligand. Upon ligand binding, the type II receptor kinase phosphorylates the GS domain of the type I receptor, a critical event in signal transduction by the serine/threonine kinase receptors (Miyazono et al. 2010). Activation of the TGFBR1 receptor has been studied in detail. The inactive conformation is maintained by interaction between the GS domain, the N-terminal lobe and the activation loop of the kinase (Huse et al. 1999). When the GS domain is phosphorylated by the type II receptor kinase, the TGFBR1 kinase is converted to an active conformation. Mutations of Thr-204 in TGFBR1 and the corresponding Gln in BMP type I receptors lead to their constitutive activation. The L45 loop, in the kinase domain of  type I receptors, specifically interacts with receptor-regulated Smads (R-Smads). Neurotrophic tyrosine kinase receptor type 3 (NT-3 growth factor receptor, TrkC, NTRK3) directly binds BMPR2, interfereing with its interaction with BMPR1A, which inhibits downstream signalling (Jin et al. 2007). Tyrosine-protein kinase transmembrane receptor ROR2 and BMPR1B form a heteromeric complex in a ligand independent fashion that modulatesGDF5-BMPR1B signalling by inhibition of Smad1/5 signalling (Sammar et al. 2004). Type I receptor kinases activated by the type II receptor kinases, phosphorylate R-Smads. R-Smads then form a complex with common-partner Smad (co-Smad) and translocate to the nucleus. The oligomeric Smad complexes regulate the transcription of target genes through interaction with various transcription factors and transcriptional coactivators or corepressors. Inhibitory Smads (I-Smads) negatively regulate the action of R-Smads and/or co-Smads. Eight different Smads have been identified in mammals. Smad1, Smad5 and Smad8 are R-Smads in BMP signalling pathways (BMP-specific R-Smads). Smad2 and Smad3 are R-Smads in TGFB/activin signalling pathways. BMP receptors can phosphorylate Smad2 in certain types of cells (Murakami et al. 2009). Smad1, Smad5 and Smad8 are structurally highly similar to each other. The functional differences between them are largely unknown. Smad4 is the only co-Smad in mammals, shared by both BMP and TGFB/activin signalling pathways. Smad6 and Smad7 are I-Smads.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway124">
 <bp:pathwayOrder rdf:resource="#PathwayStep879" />
 <bp:pathwayOrder rdf:resource="#PathwayStep877" />
 <bp:pathwayOrder rdf:resource="#PathwayStep888" />
 <bp:pathwayOrder rdf:resource="#PathwayStep878" />
 <bp:pathwayOrder rdf:resource="#PathwayStep889" />
 <bp:pathwayOrder rdf:resource="#PathwayStep875" />
 <bp:pathwayOrder rdf:resource="#PathwayStep886" />
 <bp:pathwayOrder rdf:resource="#PathwayStep897" />
 <bp:pathwayOrder rdf:resource="#PathwayStep876" />
 <bp:pathwayOrder rdf:resource="#PathwayStep887" />
 <bp:pathwayOrder rdf:resource="#PathwayStep884" />
 <bp:pathwayOrder rdf:resource="#PathwayStep895" />
 <bp:pathwayOrder rdf:resource="#PathwayStep874" />
 <bp:pathwayOrder rdf:resource="#PathwayStep885" />
 <bp:pathwayOrder rdf:resource="#PathwayStep896" />
 <bp:pathwayOrder rdf:resource="#PathwayStep882" />
 <bp:pathwayOrder rdf:resource="#PathwayStep893" />
 <bp:pathwayOrder rdf:resource="#PathwayStep883" />
 <bp:pathwayOrder rdf:resource="#PathwayStep894" />
 <bp:pathwayOrder rdf:resource="#PathwayStep880" />
 <bp:pathwayOrder rdf:resource="#PathwayStep891" />
 <bp:pathwayOrder rdf:resource="#PathwayStep881" />
 <bp:pathwayOrder rdf:resource="#PathwayStep892" />
 <bp:pathwayOrder rdf:resource="#PathwayStep890" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction754" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction765" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction753" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction764" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction756" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction767" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction755" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction766" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction761" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction772" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction760" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction771" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction752" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction763" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction774" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction751" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction762" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction773" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction758" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction769" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction757" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction768" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction759" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction770" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence874" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">After phosphorylated SMAD2 and/or SMAD3 form a heterotrimer with SMAD4, SMAD2/3:SMAD4 complex translocates to the nucleus (Xu et al. 2000, Kurisaki et al. 2001, Xiao et al. 2003). In the nucleus, linker regions of SMAD2 and SMAD3 within SMAD2/3:SMAD4 complex can be phosphorylated by CDK8 associated with cyclin C (CDK8:CCNC) or CDK9 associated with cyclin T (CDK9:CCNT). CDK8/CDK9-mediated phosphorylation of SMAD2/3 enhances transcriptional activity of SMAD2/3:SMAD4 complex, but also primes it for ubiquitination and consequent degradation (Alarcon et al. 2009).   The transfer of SMAD2/3:SMAD4 complex to the nucleus can be assisted by other proteins, such as WWTR1. In human embryonic cells, WWTR1 (TAZ) binds SMAD2/3:SMAD4 heterotrimer and mediates TGF-beta-dependent nuclear accumulation of SMAD2/3:SMAD4. The complex of WWTR1 and SMAD2/3:SMAD4 binds promoters of SMAD7 and SERPINE1 (PAI-1 i.e. plasminogen activator inhibitor 1) genes and stimulates their transcription (Varelas et al. 2008). Stimulation of SMAD7 transcription by SMAD2/3:SMAD4 represents a negative feedback loop in TGF-beta receptor signaling. SMAD7 can be downregulated by RNF111 ubiquitin ligase (Arkadia), which binds and ubiquitinates SMAD7, targeting it for degradation (Koinuma et al. 2003).   SMAD2/3:SMAD4 heterotrimer also binds the complex of RBL1 (p107), E2F4/5 and TFDP1/2 (DP1/2). The resulting complex binds MYC promoter and inhibits MYC transcription. Inhibition of MYC transcription contributes to anti-proliferative effect of TGF-beta (Chen et al. 2002). SMAD2/3:SMAD4 heterotrimer also associates with transcription factor SP1. SMAD2/3:SMAD4:SP1 complex stimulates transcription of a CDK inhibitor CDKN2B (p15-INK4B), also contributing to the anti-proliferative effect of TGF-beta (Feng et al. 2000).   MEN1 (menin), a transcription factor tumor suppressor mutated in a familial cancer syndrome multiple endocrine neoplasia type 1, forms a complex with SMAD2/3:SMAD4 heterotrimer, but transcriptional targets of SMAD2/3:SMAD4:MEN1 have not been elucidated (Kaji et al. 2001, Sowa et al. 2004, Canaff et al. 2012).   JUNB is also an established transcriptional target of SMAD2/3:SMAD4 complex (Wong et al. 1999).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep470">
 <bp:stepProcess rdf:resource="#Catalysis178" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction410" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway123">
 <bp:pathwayOrder rdf:resource="#PathwayStep898" />
 <bp:pathwayOrder rdf:resource="#PathwayStep873" />
 <bp:pathwayComponent rdf:resource="#Pathway125" />
 <bp:pathwayComponent rdf:resource="#Pathway124" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence873" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In the nucleus, SMAD2/3:SMAD4 heterotrimer complex acts as a transcriptional regulator. The activity of SMAD2/3 complex is regulated both positively and negatively by association with other transcription factors (Chen et al. 2002, Varelas et al. 2008, Stroschein et al. 1999, Wotton et al. 1999). In addition, the activity of SMAD2/3:SMAD4 complex can be inhibited by nuclear protein phosphatases and ubiquitin ligases (Lin et al. 2006, Dupont et al. 2009).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway14">
 <bp:pathwayOrder rdf:resource="#PathwayStep107" />
 <bp:pathwayOrder rdf:resource="#PathwayStep108" />
 <bp:pathwayOrder rdf:resource="#PathwayStep105" />
 <bp:pathwayOrder rdf:resource="#PathwayStep106" />
 <bp:pathwayOrder rdf:resource="#PathwayStep104" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction91" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction93" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction92" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction94" />
 <bp:pathwayComponent rdf:resource="#Pathway15" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence104" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DAG and IP3 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">This pathway describes the generation of DAG and IP3 by the PLCgamma-mediated hydrolysis of PIP2 and the subsequent downstream signaling events.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence423">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway13">
 <bp:pathwayOrder rdf:resource="#PathwayStep101" />
 <bp:pathwayOrder rdf:resource="#PathwayStep99" />
 <bp:pathwayOrder rdf:resource="#PathwayStep100" />
 <bp:pathwayOrder rdf:resource="#PathwayStep96" />
 <bp:pathwayOrder rdf:resource="#PathwayStep95" />
 <bp:pathwayOrder rdf:resource="#PathwayStep98" />
 <bp:pathwayOrder rdf:resource="#PathwayStep97" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction84" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction83" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction86" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction85" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction88" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction87" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction89" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence95" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphatidylinositol-5-phosphate (PI5P) may modulate PI3K/AKT signaling in several ways. PI5P is used as a substrate for production of phosphatidylinositol-4,5-bisphosphate, PI(4,5)P2 (Rameh et al. 1997, Clarke et al. 2008, Clarke et al. 2010, Clarke and Irvine 2013, Clarke et al. 2015), which serves as a substrate for activated PI3K, resulting in the production of PIP3 (Mandelker et al. 2009, Burke et al. 2011). The majority of PI(4,5)P2 in the cell, however, is produced from the phosphatidylinositol-4-phosphate (PI4P) substrate (Zhang et al. 1997, Di Paolo et al. 2002, Oude Weernink et al. 2004, Halstead et al. 2006, Oude Weernink et al. 2007). PIP3 is necessary for the activating phosphorylation of AKT. AKT1 can be deactivated by the protein phosphatase 2A (PP2A) complex that contains a regulatory subunit B56-beta (PPP2R5B) or B56-gamma (PPP2R5C). PI5P inhibits AKT1 dephosphorylation by PP2A through an unknown mechanism (Ramel et al. 2009). Increased PI5P levels correlate with inhibitory phosphorylation(s) of the PP2A complex. MAPK1 (ERK2) and MAPK3 (ERK1) are involved in inhibitory phosphorylation of PP2A, in a process that involves IER3 (IEX-1) (Letourneux et al. 2006, Rocher et al. 2007). It is uncertain, however, whether PI5P is in any way involved in ERK-mediated phosphorylation of PP2A or if it regulates another PP2A kinase.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence424">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1359">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1182" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway12">
 <bp:pathwayOrder rdf:resource="#PathwayStep92" />
 <bp:pathwayOrder rdf:resource="#PathwayStep94" />
 <bp:pathwayOrder rdf:resource="#PathwayStep93" />
 <bp:pathwayOrder rdf:resource="#PathwayStep102" />
 <bp:pathwayComponent rdf:resource="#Pathway13" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction90" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction82" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction81" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence92" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Negative regulation of the PI3K/AKT network</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The PI3K/AKT network is negatively regulated by phosphatases that dephosphorylate PIP3, thus hampering AKT activation.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence425">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1358">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1181" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway11">
 <bp:pathwayOrder rdf:resource="#PathwayStep81" />
 <bp:pathwayOrder rdf:resource="#PathwayStep80" />
 <bp:pathwayOrder rdf:resource="#PathwayStep83" />
 <bp:pathwayOrder rdf:resource="#PathwayStep82" />
 <bp:pathwayOrder rdf:resource="#PathwayStep78" />
 <bp:pathwayOrder rdf:resource="#PathwayStep77" />
 <bp:pathwayOrder rdf:resource="#PathwayStep79" />
 <bp:pathwayOrder rdf:resource="#PathwayStep85" />
 <bp:pathwayOrder rdf:resource="#PathwayStep84" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction71" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction70" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction73" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction72" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction75" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction74" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction68" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction67" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction69" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence77" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT phosphorylates targets in the cytosol</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Following activation, AKT can phosphorylate an array of target proteins in the cytoplasm, many of which are involved in cell survival control. Phosphorylation of TSC2 feeds positively to the TOR kinase, which, in turn, contributes to AKT activation (positive feedback loop).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence426">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1357">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1180" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway18">
 <bp:pathwayOrder rdf:resource="#PathwayStep127" />
 <bp:pathwayOrder rdf:resource="#PathwayStep128" />
 <bp:pathwayOrder rdf:resource="#PathwayStep126" />
 <bp:pathwayOrder rdf:resource="#PathwayStep133" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction115" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction110" />
 <bp:pathwayComponent rdf:resource="#Pathway19" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction109" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence126" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKA-mediated phosphorylation of CREB</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cyclic adenosine 3&apos;,5&apos;-monophosphate (cAMP) induces gene transcription through activation of cAMP-dependent protein kinase (PKA), and subsequent phosphorylation of the transcription factor cAMP response element-binding protein, CREB, at serine-133.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep468">
 <bp:stepProcess rdf:resource="#Catalysis176" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction408" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway108">
 <bp:pathwayOrder rdf:resource="#PathwayStep789" />
 <bp:pathwayOrder rdf:resource="#PathwayStep779" />
 <bp:pathwayOrder rdf:resource="#PathwayStep787" />
 <bp:pathwayOrder rdf:resource="#PathwayStep788" />
 <bp:pathwayOrder rdf:resource="#PathwayStep774" />
 <bp:pathwayOrder rdf:resource="#PathwayStep785" />
 <bp:pathwayOrder rdf:resource="#PathwayStep786" />
 <bp:pathwayOrder rdf:resource="#PathwayStep783" />
 <bp:pathwayOrder rdf:resource="#PathwayStep773" />
 <bp:pathwayOrder rdf:resource="#PathwayStep784" />
 <bp:pathwayOrder rdf:resource="#PathwayStep781" />
 <bp:pathwayOrder rdf:resource="#PathwayStep782" />
 <bp:pathwayOrder rdf:resource="#PathwayStep790" />
 <bp:pathwayOrder rdf:resource="#PathwayStep780" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction666" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction677" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction676" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction679" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction678" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction673" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction672" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction675" />
 <bp:pathwayComponent rdf:resource="#Pathway109" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction674" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction680" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction671" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction681" />
 <bp:pathwayComponent rdf:resource="#Pathway110" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence773" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Degradation of beta-catenin by the destruction complex</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The beta-catenin destruction complex plays a key role in the canonical Wnt signaling pathway. In the absence of Wnt signaling, this complex controls the levels of cytoplamic beta-catenin. Beta-catenin associates with and is phosphorylated by the destruction complex. Phosphorylated beta-catenin is recognized and ubiquitinated by the SCF-beta TrCP ubiquitin ligase complex and is subsequently degraded by the proteasome (reviewed in Kimelman and Xu, 2006).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep2688">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2349" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway17">
 <bp:pathwayOrder rdf:resource="#PathwayStep118" />
 <bp:pathwayOrder rdf:resource="#PathwayStep119" />
 <bp:pathwayOrder rdf:resource="#PathwayStep116" />
 <bp:pathwayOrder rdf:resource="#PathwayStep117" />
 <bp:pathwayOrder rdf:resource="#PathwayStep114" />
 <bp:pathwayOrder rdf:resource="#PathwayStep115" />
 <bp:pathwayOrder rdf:resource="#PathwayStep112" />
 <bp:pathwayOrder rdf:resource="#PathwayStep123" />
 <bp:pathwayOrder rdf:resource="#PathwayStep113" />
 <bp:pathwayOrder rdf:resource="#PathwayStep124" />
 <bp:pathwayOrder rdf:resource="#PathwayStep121" />
 <bp:pathwayOrder rdf:resource="#PathwayStep122" />
 <bp:pathwayOrder rdf:resource="#PathwayStep120" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction105" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction104" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction107" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction106" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction101" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction100" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction97" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction103" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction96" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction102" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction108" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction99" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction98" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence112" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CaMK IV-mediated phosphorylation of CREB</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The Ca2+-calmodulin-dependent protein kinase (CaM kinase) cascade includes three kinases: CaM-kinase kinase (CaMKK); and the CaM kinases CaMKI and CaMKIV, which are phosphorylated and activated by CaMKK. Members of this cascade respond to elevation of intracellular Ca2+ levels. CaMKK and CaMKIV localize both to the nucleus and to the cytoplasm, whereas CaMKI is only cytosolic. Nuclear CaMKIV regulates transcription through phosphorylation of several transcription factors, including CREB. In the cytoplasm, there is extensive cross-talk between CaMKK, CaMKIV and other signaling cascades, including those that involve the cAMP-dependent kinase (PKA), MAP kinases and protein kinase B (PKB/Akt).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence420">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep469">
 <bp:stepProcess rdf:resource="#Catalysis177" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction409" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway107">
 <bp:pathwayOrder rdf:resource="#PathwayStep758" />
 <bp:pathwayOrder rdf:resource="#PathwayStep759" />
 <bp:pathwayOrder rdf:resource="#PathwayStep756" />
 <bp:pathwayOrder rdf:resource="#PathwayStep757" />
 <bp:pathwayOrder rdf:resource="#PathwayStep754" />
 <bp:pathwayOrder rdf:resource="#PathwayStep755" />
 <bp:pathwayOrder rdf:resource="#PathwayStep752" />
 <bp:pathwayOrder rdf:resource="#PathwayStep753" />
 <bp:pathwayOrder rdf:resource="#PathwayStep750" />
 <bp:pathwayOrder rdf:resource="#PathwayStep751" />
 <bp:pathwayOrder rdf:resource="#PathwayStep770" />
 <bp:pathwayOrder rdf:resource="#PathwayStep771" />
 <bp:pathwayOrder rdf:resource="#PathwayStep747" />
 <bp:pathwayOrder rdf:resource="#PathwayStep769" />
 <bp:pathwayOrder rdf:resource="#PathwayStep748" />
 <bp:pathwayOrder rdf:resource="#PathwayStep745" />
 <bp:pathwayOrder rdf:resource="#PathwayStep767" />
 <bp:pathwayOrder rdf:resource="#PathwayStep746" />
 <bp:pathwayOrder rdf:resource="#PathwayStep768" />
 <bp:pathwayOrder rdf:resource="#PathwayStep765" />
 <bp:pathwayOrder rdf:resource="#PathwayStep766" />
 <bp:pathwayOrder rdf:resource="#PathwayStep763" />
 <bp:pathwayOrder rdf:resource="#PathwayStep764" />
 <bp:pathwayOrder rdf:resource="#PathwayStep749" />
 <bp:pathwayOrder rdf:resource="#PathwayStep761" />
 <bp:pathwayOrder rdf:resource="#PathwayStep762" />
 <bp:pathwayOrder rdf:resource="#PathwayStep760" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction655" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction654" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction657" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction656" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction651" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction650" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction653" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction652" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction659" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction658" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction639" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction660" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction644" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction643" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction665" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction646" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction645" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction640" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction662" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction661" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction642" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction664" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction641" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction663" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction648" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction647" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction649" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence745" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ca2+ pathway</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">A number of so called non-canonical WNT ligands have been shown to promote intracellular calcium release upon FZD binding.  This beta-catenin-independent WNT pathway acts through heterotrimeric G proteins and promotes calcium release through phophoinositol signaling and activation of phosphodiesterase (PDE).  Downstream effectors include the calcium/calmodulin-dependent kinase II (CaMK2) and PKC (reviewed in De, 2011).  The WNT Ca2+ pathway is important in dorsoventral polarity, convergent extension and organ formation in vertebrates and also has roles in negatively regulating &apos;canonical&apos; beta-catenin-dependent transcription.  Non-canonical WNT Ca2+ signaling is also implicated in inflammatory response and cancer (reviewed in Kohn and Moon, 2005; Sugimura and Li, 2010).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep2689">
 <bp:stepProcess rdf:resource="#Catalysis734" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2350" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway16">
 <bp:pathwayOrder rdf:resource="#PathwayStep125" />
 <bp:pathwayOrder rdf:resource="#PathwayStep137" />
 <bp:pathwayOrder rdf:resource="#PathwayStep134" />
 <bp:pathwayOrder rdf:resource="#PathwayStep110" />
 <bp:pathwayOrder rdf:resource="#PathwayStep111" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction118" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction95" />
 <bp:pathwayComponent rdf:resource="#Pathway18" />
 <bp:pathwayComponent rdf:resource="#Pathway17" />
 <bp:pathwayComponent rdf:resource="#Pathway20" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence110" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Calmodulin induced events</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">One important physiological role for Calmodulin is the regulation of adenylylcyclases. Four of the nine known adenylylcyclases are calcium sensitive, in particular type 8 (AC8).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence421">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep466">
 <bp:stepProcess rdf:resource="#Catalysis175" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction406" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway15">
 <bp:pathwayOrder rdf:resource="#PathwayStep109" />
 <bp:pathwayOrder rdf:resource="#PathwayStep138" />
 <bp:pathwayComponent rdf:resource="#Pathway16" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction119" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence109" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CaM pathway</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Calmodulin (CaM) is a small acidic protein that contains four EF-hand motifs, each of which can bind a calcium ion, therefore it can bind up to four calcium ions. The protein has two approximately symmetrical domains, separated by a flexible hinge region. Calmodulin is the prototypical example of the EF-hand family of Ca2+-sensing proteins. Changes in intracellular Ca2+ concentration regulate calmodulin in three distinct ways. First, by directing its subcellular distribution. Second, by promoting association with different target proteins. Third, by directing a variety of conformational states in calmodulin that result in target-specific activation. Calmodulin binds and activates several effector protein (e.g. the CaM-dependent adenylyl cyclases, phosphodiesterases,  protein kinases and the protein phosphatase calcineurin).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence422">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep467">
 <bp:stepProcess rdf:resource="#BiochemicalReaction407" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway109">
 <bp:pathwayOrder rdf:resource="#PathwayStep778" />
 <bp:pathwayOrder rdf:resource="#PathwayStep776" />
 <bp:pathwayOrder rdf:resource="#PathwayStep777" />
 <bp:pathwayOrder rdf:resource="#PathwayStep775" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction668" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction667" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction670" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction669" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence775" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Beta-catenin phosphorylation cascade</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Degradation of beta-catenin is initiated following amino-terminal serine/threonine phosphorylation. Phosphorylation of B-catenin at  S45 by CK1 alpha primes the subsequent sequential GSK-3-mediated phosphorylation at Thr41, Ser37 and Ser33 (Amit et al., 2002 ; Lui et al., 2002).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1087">
 <bp:evidence rdf:resource="#Evidence1255" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Receptor CCR9  binds CCL25 ligand</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1352">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1175" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2684">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2346" />
 <bp:stepProcess rdf:resource="#Catalysis732" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1086">
 <bp:evidence rdf:resource="#Evidence1254" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Receptor CCR6 binds CCL20 ligand</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1351">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1174" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2685">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2347" />
 <bp:stepProcess rdf:resource="#Catalysis733" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1085">
 <bp:evidence rdf:resource="#Evidence1253" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Receptor CXCR1 binds CXCL6 and CXCL8 ligands</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1350">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1173" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2686">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2348" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1084">
 <bp:evidence rdf:resource="#Evidence1252" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Receptor CCR10 binds CCL27 and 28 ligands</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2687">
 <bp:stepProcess rdf:resource="#Pathway340" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway10">
 <bp:pathwayOrder rdf:resource="#PathwayStep70" />
 <bp:pathwayOrder rdf:resource="#PathwayStep72" />
 <bp:pathwayOrder rdf:resource="#PathwayStep71" />
 <bp:pathwayOrder rdf:resource="#PathwayStep73" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction62" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction61" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction64" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction63" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence70" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT phosphorylates targets in the nucleus</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">After translocation into the nucleus, AKT can phosphorylate a number of targets there such as CREB, forkhead transcription factors, SRK and NUR77.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1083">
 <bp:evidence rdf:resource="#Evidence1251" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CX3CR1 binds CX3CL1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1356">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1179" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2680">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2343" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1082">
 <bp:evidence rdf:resource="#Evidence1250" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Receptor CXC1 binds to the ligands lymphotactin and cytokine SCM-1 beta</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1355">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1178" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2681">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2344" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1081">
 <bp:evidence rdf:resource="#Evidence1249" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CCRL2 binds CCL19</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1354">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1177" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2682">
 <bp:stepProcess rdf:resource="#Pathway339" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1080">
 <bp:evidence rdf:resource="#Evidence1248" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CCR8 binds CCL1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1353">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1176" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2683">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2345" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2690">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2351" />
 <bp:stepProcess rdf:resource="#Catalysis735" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1089">
 <bp:evidence rdf:resource="#Evidence1257" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Receptors CCR1, 2 and 8 bind CCL16 ligand</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1088">
 <bp:evidence rdf:resource="#Evidence1256" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Receptor ACKR2 binds most inflammatory CC chemokines</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep464">
 <bp:stepProcess rdf:resource="#Pathway61" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway115">
 <bp:pathwayOrder rdf:resource="#PathwayStep824" />
 <bp:pathwayOrder rdf:resource="#PathwayStep823" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction710" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction709" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence823" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TGFBR3 regulates activin signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">This subpathway describes the regulation of activin signaling by TGFBR3. TGFBR3 binds with Inhibin A, which is also a ligand for TGFBR3 and inhibits activin/BMP signaling by binding competititively to ACVR2A receptor and BMPRII (Esparza-Lopez et al., 2001, Lewis et al., 2000, Wiater et al., 2003).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep465">
 <bp:stepProcess rdf:resource="#BiochemicalReaction405" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway114">
 <bp:pathwayOrder rdf:resource="#PathwayStep814" />
 <bp:pathwayOrder rdf:resource="#PathwayStep820" />
 <bp:pathwayOrder rdf:resource="#PathwayStep821" />
 <bp:pathwayOrder rdf:resource="#PathwayStep819" />
 <bp:pathwayOrder rdf:resource="#PathwayStep817" />
 <bp:pathwayOrder rdf:resource="#PathwayStep818" />
 <bp:pathwayOrder rdf:resource="#PathwayStep815" />
 <bp:pathwayOrder rdf:resource="#PathwayStep816" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction701" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction707" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction706" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction708" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction703" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction702" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction705" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction704" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence814" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TGFBR3 regulates TGF-beta signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">This subpathway describes the activation of TGFBR3 by TGF ligands and the subsequent regulation of TGF signaling by TGFBR3 (L&#243;pez&#8209;Casillas et al.,1991,L&#243;pez&#8209;Casillas et al.,1994, Blobe et al.,2001)</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep462">
 <bp:stepProcess rdf:resource="#BiochemicalReaction403" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway117">
 <bp:pathwayOrder rdf:resource="#PathwayStep835" />
 <bp:pathwayOrder rdf:resource="#PathwayStep836" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction720" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction719" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence835" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TGFBR3 regulates FGF2 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">This subpathway describes the regulation of FGF2:FGFR1  mediated signaling by the TGFBR3 receptor complex. TGFBR3 have binding affinity for FGF2 (Andres et al., 1992) and in presence of GIPC, FGF2/TGFBR3/GPIC enhances FGF2 signaling (Knelson et al.,2013).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep463">
 <bp:stepProcess rdf:resource="#BiochemicalReaction404" />
 <bp:stepProcess rdf:resource="#Catalysis174" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway116">
 <bp:pathwayOrder rdf:resource="#PathwayStep833" />
 <bp:pathwayOrder rdf:resource="#PathwayStep831" />
 <bp:pathwayOrder rdf:resource="#PathwayStep832" />
 <bp:pathwayOrder rdf:resource="#PathwayStep830" />
 <bp:pathwayOrder rdf:resource="#PathwayStep828" />
 <bp:pathwayOrder rdf:resource="#PathwayStep829" />
 <bp:pathwayOrder rdf:resource="#PathwayStep826" />
 <bp:pathwayOrder rdf:resource="#PathwayStep827" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction712" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction711" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction718" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction717" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction714" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction713" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction716" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction715" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence826" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TGFBR3 expression</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">This pathway describes the transcriptional and translational regulation of TGFBR3. Regulation of TGFBR3 expression includes different transcription factors (Sp1, MyoD and RAR) (Lopez-Casillas et al., 2003), epigenetic regulators such as HELLS (Hou et al., 2021) and KLP16 (Chen et al., 2022)), and translational regulation by miRNAs (Wang et al., 2019, Zhu et al., 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence427">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep460">
 <bp:stepProcess rdf:resource="#BiochemicalReaction401" />
 <bp:stepProcess rdf:resource="#Catalysis172" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway111">
 <bp:pathwayOrder rdf:resource="#PathwayStep802" />
 <bp:pathwayOrder rdf:resource="#PathwayStep803" />
 <bp:pathwayOrder rdf:resource="#PathwayStep800" />
 <bp:pathwayOrder rdf:resource="#PathwayStep801" />
 <bp:pathwayOrder rdf:resource="#PathwayStep799" />
 <bp:pathwayOrder rdf:resource="#PathwayStep810" />
 <bp:pathwayOrder rdf:resource="#PathwayStep808" />
 <bp:pathwayOrder rdf:resource="#PathwayStep809" />
 <bp:pathwayOrder rdf:resource="#PathwayStep806" />
 <bp:pathwayOrder rdf:resource="#PathwayStep807" />
 <bp:pathwayOrder rdf:resource="#PathwayStep804" />
 <bp:pathwayOrder rdf:resource="#PathwayStep805" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction699" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction698" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction689" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction700" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction695" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction694" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction697" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction696" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction691" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction690" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction693" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction692" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence799" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WNT ligand biogenesis and trafficking</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">19 WNT proteins have been identified in human cells.  The WNTs are members of a conserved metazoan family of secreted morphogens that activate several signaling pathways in the responding cell: the canonical (beta-catenin) WNT signaling cascade and several non-canonical pathways, including the planar cell polarity (PCP), the regulation of intracellular calcium signaling and  activation of JNK kinases.  WNT proteins exist in a gradient outside the secreting cell and are able to act over both short and long ranges to promote proliferation, changes in cell migration and polarity and tissue homeostasis, among others (reviewed in Saito-Diaz et al, 2012; Willert and Nusse, 2012).     The WNTs are ~40kDa proteins with 23 conserved cysteine residues in the N-terminal that may form intramolecular disulphide bonds. They also contain an N-terminal signal sequence and a number of N-linked glycosylation sites (Janda et al, 2012). In addition to being glycosylated, WNTs are also lipid-modified in the endoplasmic reticulum by a WNT-specific O-acyl-transferase, Porcupine (PORCN), contributing to their characteristic hydrophobicity.  PORCN-dependent palmitoylation is required for the secretion of WNT as well as its signaling activity, as either depletion of PORCN or mutation of the conserved serine acylation site results in the intracellular accumulation of WNT ligand (Takada et al, 2006; Barrott et al, 2011; Biechele et al, 2011; reviewed in Willert and Nusse, 2012).   Secretion of WNT requires a number of other dedicated factors including the sorting receptor Wntless (WLS) (also knownas Evi, Sprinter, and GPR177), which binds WNT and escorts it to the cell surface (Banziger et al, 2006; Bartscherer et al, 2006; Goodman et al, 2006).  A WNT-specific retromer containing SNX3 is subsequently required for the recycling of WLS back to the Golgi (reviewed in Herr et al, 2012; Johannes and Wunder,  2011).   Once at the cell surface, WNT makes extensive contacts with components of the extracellular matrix such as heparan sulphate proteoglycans (HSPGs) and may be bound by any of a number of regulatory proteins, including WIFs and SFRPs. The diffusion of the WNT ligand may be aided by its packing either into WNT multimers, exosomes or onto lipoprotein particles to shield the hydrophobic lipid adducts from the aqueous extracellular environment (Gross et al, 2012; Luga et al, 2012, Korkut et al, 2009; reviewed in Willert and Nusse, 2012).  </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence428">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep461">
 <bp:stepProcess rdf:resource="#BiochemicalReaction402" />
 <bp:stepProcess rdf:resource="#Catalysis173" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway110">
 <bp:pathwayOrder rdf:resource="#PathwayStep796" />
 <bp:pathwayOrder rdf:resource="#PathwayStep797" />
 <bp:pathwayOrder rdf:resource="#PathwayStep794" />
 <bp:pathwayOrder rdf:resource="#PathwayStep795" />
 <bp:pathwayOrder rdf:resource="#PathwayStep792" />
 <bp:pathwayOrder rdf:resource="#PathwayStep793" />
 <bp:pathwayOrder rdf:resource="#PathwayStep791" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction688" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction687" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction684" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction683" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction686" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction685" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction682" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence791" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Repression of WNT target genes</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In the absence of a WNT signal, many WNT target genes are repressed by Groucho/TLE.  Groucho was initially identified in Drosophila, where it has been shown to interact with a variety of proteins to repress transcription (reviewed in Turki-Judeh and Courey, 2012).  Groucho proteins, including the 4 human homologues (transducin-like enhancer of split (TLE) 1-4), do not bind DNA directly but instead are recruited to target genes through interaction with DNA-binding transcription factors including TCF/LEF (Brantjes et al, 2001; reviewed in Chen and Courey, 2000). Groucho proteins are believed to oligomerize in a manner that depends on an N-terminal glutamine-rich Q domain, and oligomerization may be important for function (Song et al, 2004; Pinto and Lobe, 1996).  Groucho/TLE proteins affect levels of gene expression by interacting with the core transcriptional machinery as well as by modfiying chromatin structure through direct interaction with histones and recruitment of histone deacetylases, among other mechanisms (reviewed in Turki-Judeh and Courey, 2012).  In addition to the four TLE proteins, human cells also include a truncated TLE-like protein called amino-terminal enhancer of split (AES) which contains the N-terminal Q domain but lacks much of the C-terminal sequence of TLE proteins, including the WD domain which is important for many protein-protein interactions.  AES is believed to act as a dominant negative, since it is able to heter-oligomerize with full-length TLE proteins to form non-functional complexes (Brantjes et al, 2001; reviewed in Beagle and Johnson, 2010).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence429">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway113">
 <bp:pathwayOrder rdf:resource="#PathwayStep813" />
 <bp:pathwayOrder rdf:resource="#PathwayStep825" />
 <bp:pathwayOrder rdf:resource="#PathwayStep822" />
 <bp:pathwayOrder rdf:resource="#PathwayStep834" />
 <bp:pathwayOrder rdf:resource="#PathwayStep837" />
 <bp:pathwayComponent rdf:resource="#Pathway118" />
 <bp:pathwayComponent rdf:resource="#Pathway115" />
 <bp:pathwayComponent rdf:resource="#Pathway114" />
 <bp:pathwayComponent rdf:resource="#Pathway117" />
 <bp:pathwayComponent rdf:resource="#Pathway116" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence813" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by TGFBR3</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TGFBR3, also known as betaglycan, is a member of the proteoglycan family (Zhang et al., 2020) and plays a key role in regulating TGF-beta receptor-mediated signaling (Esparza-Lopez et al., 2001, Blobe et al., 2001)&#160; as well as TGF-beta-independent signaling (Wiater et al.,2003, Andres et al., 1992). TGFBR3 is expressed in abundance in normal cells (Wang et al, 1991) and is known to be down-regulated in multiple cancers due to its function as a tumor suppressor (Zhang et al.,2020, Fang et al.,2020, Cook et al.,2019). TGFBR3 is a transmembrane protein but lacks kinase activity in its cytoplasmic domain (L&#243;pez-Casillas et al.,1991). TGFBR3 primarily works as a co-receptor for different signaling pathways and can either facilitate or inhibit them (Wiater et al.,2003, Andres et al., 1992, Esparza-Lopez et al., 2001). TGFBR3 binds to TGF-beta ligands, facilitates their presentation to the TGFBR2 receptor, and helps in complex formation between TGFBR2 and TGFBR1 (Esparza-Lopez et al., 2001, Blobe et al., 2001). TGFBR3 also facilitates FGF:FGFR receptor complex stability and functions in FGFR1-mediated signaling as a co-receptor (Andres et al., 1992). TGBFR3 regulates signaling by other TGF-beta family members, including BMP2/7 and Activin (Wiater et al.,2003). Thus, TGFBR3 is involved in normal cell signaling and plays an important role in cancer, inflammatory diseases (Santiago et al, 2020), and Alzheimer&apos;s (Song et al., 2022).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway112">
 <bp:pathwayOrder rdf:resource="#PathwayStep812" />
 <bp:pathwayOrder rdf:resource="#PathwayStep853" />
 <bp:pathwayOrder rdf:resource="#PathwayStep841" />
 <bp:pathwayOrder rdf:resource="#PathwayStep871" />
 <bp:pathwayComponent rdf:resource="#Pathway119" />
 <bp:pathwayComponent rdf:resource="#Pathway122" />
 <bp:pathwayComponent rdf:resource="#Pathway121" />
 <bp:pathwayComponent rdf:resource="#Pathway113" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence812" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by TGFB family members</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The human genome encodes 33 TGF-beta family members, including TGF-beta itself, as well as bone morphogenetic protein (BMP), activin, nodal and growth and differentiation factors (GDFs). This superfamily of ligands generally binds as dimers to hetero-tetrameric cell-surface receptor serine/threonine kinases to activate SMAD-dependent and SMAD-independent signaling (reviewed in Morikawa et al, 2016; Budi et al, 2017). Signaling by the TGF-beta receptor complex is initiated by TGF-beta. TGF-beta (TGFB1), secreted as a homodimer, binds to TGF-beta receptor II (TGFBR2), inducing its dimerization and formation of a stable hetero-tetrameric complex with TGF-beta receptor I homodimer (TGFBR1). TGFBR2-mediated phosphorylation of TGFBR1 triggers internalization of the heterotetrameric TGF beta receptor complex (TGFBR) into clathrin coated endocytic vesicles and recruitment of cytosolic SMAD2 and SMAD3, which act as R-SMADs for TGF beta receptor complex. TGFBR1 phosphorylates SMAD2 and SMAD3, promoting their association with SMAD4 (known as Co-SMAD). In the nucleus, the SMAD2/3:SMAD4 heterotrimer binds target DNA elements and, in cooperation with other transcription factors, regulates expression of genes involved in cell differentiation. For a review of TGF-beta receptor signaling, please refer to Kang et al. 2009.  Signaling by BMP is triggered by bone morphogenetic proteins (BMPs). BMPs can bind type I receptors in the absence of type II receptors, but the presence of both types dramatically increases binding affinity. The type II receptor kinase transphosphorylates the type I receptor, leading to recruitment and phosphorylation of SMAD1, SMAD5 and SMAD8, which function as R-SMADs in BMP signalling pathways. Phosphorylated SMAD1, SMAD5 and SMAD8 form heterotrimeric complexes with SMAD4, the only Co-SMAD in mammals. The SMAD1/5/8:SMAD4 heterotrimer regulates transcription of genes involved in development of many tissues, including bone, cartilage, blood vessels, heart, kidney, neurons, liver and lung. For review of BMP signaling, please refer to Miyazono et al. 2010. Signaling by activin is triggered when an activin dimer (activin A, activin AB or activin B) binds the type II receptor (ACVR2A, ACVR2B). This complex then interacts with the type I receptor (ACVR1B, ACVR1C) and phosphorylates it. The phosphorylated type I receptor phosphorylates SMAD2 and SMAD3. Dimers of phosphorylated SMAD2/3 bind SMAD4 and the resulting ternary complex enters the nucleus and activates target genes. For a review of activin signaling, please refer to Chen et al. 2006.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence412">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction479">
 <bp:evidence rdf:resource="#Evidence553" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOF GAPs stimulate RHOF GTPase activity</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1327">
 <bp:stepProcess rdf:resource="#Pathway174" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2659">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2322" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence413">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction478">
 <bp:evidence rdf:resource="#Evidence552" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOF auto-activates</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1326">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1154" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence414">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep459">
 <bp:stepProcess rdf:resource="#Catalysis171" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction400" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1325">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1153" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence415">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1324">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1152" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep457">
 <bp:stepProcess rdf:resource="#BiochemicalReaction398" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction475">
 <bp:evidence rdf:resource="#Evidence548" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOB GEFs activate RHOB</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2655">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2318" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep458">
 <bp:stepProcess rdf:resource="#BiochemicalReaction399" />
 <bp:stepProcess rdf:resource="#Catalysis170" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction474">
 <bp:evidence rdf:resource="#Evidence547" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOB GAPs stimulate RHOB GTPase activity</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2656">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2319" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence410">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep455">
 <bp:stepProcess rdf:resource="#BiochemicalReaction397" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction477">
 <bp:evidence rdf:resource="#Evidence551" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOF binds effectors at the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1329">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1155" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2657">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2320" />
 <bp:stepProcess rdf:resource="#Catalysis731" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence411">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep456">
 <bp:stepProcess rdf:resource="#Pathway60" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction476">
 <bp:evidence rdf:resource="#Evidence549" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GDIs block activation of RHOB</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1328">
 <bp:stepProcess rdf:resource="#Pathway175" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2658">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2321" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1076">
 <bp:evidence rdf:resource="#Evidence1243" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Apelin receptor binds to apelin</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2651">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2314" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1075">
 <bp:evidence rdf:resource="#Evidence1242" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ECE1 cleaves EDN1(53-90)</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2652">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2315" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1074">
 <bp:evidence rdf:resource="#Evidence1241" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EDNRA binds EDNs</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2653">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2316" />
 <bp:stepProcess rdf:resource="#Catalysis730" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1073">
 <bp:evidence rdf:resource="#Evidence1240" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Urotensin-2 receptor binds urotensin-2 and 2B</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2654">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2317" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1072">
 <bp:evidence rdf:resource="#Evidence1239" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FPR is a receptor for formyl peptides</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1323">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1151" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1071">
 <bp:evidence rdf:resource="#Evidence1238" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FPRL2 receptor binds a wide range of ligands</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1322">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1150" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1070">
 <bp:evidence rdf:resource="#Evidence1237" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FPR2 binds FPR2 ligands</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1321">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1149" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1320">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1148" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2650">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2313" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1079">
 <bp:evidence rdf:resource="#Evidence1246" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NMUR2 binds neuromedin-S</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1078">
 <bp:evidence rdf:resource="#Evidence1245" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nociceptin receptor binds to nociceptin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1077">
 <bp:evidence rdf:resource="#Evidence1244" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C5AR2 binds anaphylatoxins and thier desArginated derivatives</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep453">
 <bp:stepProcess rdf:resource="#Pathway59" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction482">
 <bp:evidence rdf:resource="#Evidence557" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC1 translocates to the endoplasmic reticulum membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway104">
 <bp:pathwayOrder rdf:resource="#PathwayStep725" />
 <bp:pathwayOrder rdf:resource="#PathwayStep723" />
 <bp:pathwayOrder rdf:resource="#PathwayStep724" />
 <bp:pathwayOrder rdf:resource="#PathwayStep721" />
 <bp:pathwayOrder rdf:resource="#PathwayStep722" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction622" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction621" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction620" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction619" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction618" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence721" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WNT5A-dependent internalization of FZD4</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WNT5A induces internalization of FZD4 in a manner that depends upon PKC-mediated phosphorylation of DVL2.  Uptake of FZD4 appears to occur in a clathrin, AP-2 and ARBB2-dependent mannner (Chen et al, 2003; Yu et al, 2007; Yu et al, 2010).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep454">
 <bp:stepProcess rdf:resource="#BiochemicalReaction396" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction481">
 <bp:evidence rdf:resource="#Evidence556" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC1 binds effectors at the ER membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway103">
 <bp:pathwayOrder rdf:resource="#PathwayStep736" />
 <bp:pathwayOrder rdf:resource="#PathwayStep726" />
 <bp:pathwayOrder rdf:resource="#PathwayStep734" />
 <bp:pathwayOrder rdf:resource="#PathwayStep735" />
 <bp:pathwayOrder rdf:resource="#PathwayStep732" />
 <bp:pathwayOrder rdf:resource="#PathwayStep733" />
 <bp:pathwayOrder rdf:resource="#PathwayStep720" />
 <bp:pathwayOrder rdf:resource="#PathwayStep718" />
 <bp:pathwayOrder rdf:resource="#PathwayStep729" />
 <bp:pathwayOrder rdf:resource="#PathwayStep719" />
 <bp:pathwayOrder rdf:resource="#PathwayStep727" />
 <bp:pathwayOrder rdf:resource="#PathwayStep717" />
 <bp:pathwayOrder rdf:resource="#PathwayStep728" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction624" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction623" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction631" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction630" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction629" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction615" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction625" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction617" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction628" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction616" />
 <bp:pathwayComponent rdf:resource="#Pathway104" />
 <bp:pathwayComponent rdf:resource="#Pathway106" />
 <bp:pathwayComponent rdf:resource="#Pathway105" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence717" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PCP/CE pathway</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The planar cell polarity (PCP) pathway controls the establishment of polarity within the plane of a sheet of cells.  PCP was initially characterized in Drosophila, where it controls the arrangement of hair bristles and photoreceptors in the eye (reviewed in Maung and Jenny, 2011). In vertebrates, PCP regulates convergent extension (CE, a process by which a tissue narrows along one axis and lengthens along a perpendicular one), closure of the neural tube, hair orientation and inner ear development, among others (reviewed in Seifert and Mlodzik, 2007).  Studies in Drosophila identified a core group of PCP genes including Frizzled (Fz), Flamingo (Fmi), Van Gogh (Vang), Dishevelled (Dsh), Prickle (Pk) and Diego (Dgo), whose products become asymmetrically localized in the cell upon initiation of PCP (reviewed Maung and Jenny, 2011).  Subsequent studies in vertebrates have shown that many of these PCP genes are conserved.  Unlike in Drosophila, where the upstream signal for the PCP pathway has not been defined, in vertebrates, a number of so-called &apos;non-canonical&apos; WNTs have been shown to have roles in PCP processes.  WNT5B and WNT11 are both required for CE during gastrulation, and WNT5A physically and genetically interacts with VANGL2 in the inner ear and the developing limb bud (Heisenberg et al, 2000; Rauch et al, 1997; Qian et al, 2007; Gao et al, 2011).  WNT ligand can be bound by one of a number of FZD receptors or the single pass transmembrane proteins RYK or ROR, depending on context (reviewed in Green et al, 2008; Fradkin et al, 2010).  Although the downstream pathway is not well established, vertebrate PCP signaling appears to work at least in part through DVL, DAAM1 and small GTPases to remodel the actin cytoskeleton (reviewed in Lai et al, 2009; Gao et al, 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep451">
 <bp:stepProcess rdf:resource="#BiochemicalReaction394" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction484">
 <bp:evidence rdf:resource="#Evidence559" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC1 GAPs stimulate RAC1 GTPase activity</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway106">
 <bp:pathwayOrder rdf:resource="#PathwayStep737" />
 <bp:pathwayOrder rdf:resource="#PathwayStep743" />
 <bp:pathwayOrder rdf:resource="#PathwayStep741" />
 <bp:pathwayOrder rdf:resource="#PathwayStep742" />
 <bp:pathwayOrder rdf:resource="#PathwayStep740" />
 <bp:pathwayOrder rdf:resource="#PathwayStep738" />
 <bp:pathwayOrder rdf:resource="#PathwayStep739" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction633" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction632" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction635" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction634" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction637" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction636" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction638" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence737" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Asymmetric localization of PCP proteins</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">One of the hallmarks of the Planar Cell Polarity pathway is the asymmetric distribution of proteins on opposite membranes of a single cell. In Drosophila, Stbm and Pk (homologues to the human VANGL1/2 and PRICKLE1/2/3) colocalize opposite Fz, Dsh and Dgo (FZD, DVL, and ANKRD6, respectively).  The two complexes antagonize each other, with Fz:Dsh:Dgo acting to promote signaling downstream of Dsh, while the Stbm:Pk complex restricts this signaling (reviewed in Seifert and Mlodzik, 2007).  Asymmetric localization of some PCP proteins is also seen in vertebrates (Montcouquiol et al, 2003, 2006; Wang et al, 2006, Narimatsu et al, 2009) although the patterns of localization differ from that of flies.  The details of how localization is established and how the asymmetrical distribution of proteins is translated into gross morphological processes remain to be fully elucidated.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep452">
 <bp:stepProcess rdf:resource="#BiochemicalReaction395" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction483">
 <bp:evidence rdf:resource="#Evidence558" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC1 GDIs block activation of RAC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway105">
 <bp:pathwayOrder rdf:resource="#PathwayStep730" />
 <bp:pathwayOrder rdf:resource="#PathwayStep731" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction626" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction627" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence730" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WNT5A-dependent internalization of FZD2, FZD5 and ROR2</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Internalization of FZD2, FZD5 and ROR2 after WNT5A binding is thought to occur in a clathrin-dependent manner and is required for the activation of RAC signaling (Kurayoshi et al, 2007; Sato et al, 2010; Hanaki et al, 2012; Yamamoto et al, 2009).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence416">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway100">
 <bp:pathwayOrder rdf:resource="#PathwayStep703" />
 <bp:pathwayOrder rdf:resource="#PathwayStep704" />
 <bp:pathwayOrder rdf:resource="#PathwayStep701" />
 <bp:pathwayOrder rdf:resource="#PathwayStep702" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction602" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction604" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction603" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction605" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence701" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of TCF/LEF:CTNNB1 to target gene promoters</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The genes regulated by beta-catenin and TCF/LEF are involved in a diverse range of functions in cellular proliferation, differentiation, embryogenesis and tissue homeostasis, and include transcription factors, cell cycle regulators, growth factors, proteinases and inflammatory cytokines, among others (reviewed in Vlad et al, 2008).  A number of WNT signaling components are themselves positively or negatively regulated targets of TCF/LEF-dependent transcription, establishing feedback loops to enhance or restrict signaling (see for instance, Khan et al 2007; Chamorro et al, 2005; Roose et al, 1999; Lustig et al, 2002).  Other than a few of these general feedback targets (e.g. Axin2), most target genes are cell- and/or tissue-specific. A list of WNT/beta-catenin-dependent target genes is maintained at http://www.standford.edu/group/nusselab/cgi-bin/wnt/target_genes.  </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence417">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep450">
 <bp:stepProcess rdf:resource="#BiochemicalReaction393" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence418">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction480">
 <bp:evidence rdf:resource="#Evidence555" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC1 GEFs activate RAC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway102">
 <bp:pathwayOrder rdf:resource="#PathwayStep744" />
 <bp:pathwayOrder rdf:resource="#PathwayStep716" />
 <bp:pathwayComponent rdf:resource="#Pathway107" />
 <bp:pathwayComponent rdf:resource="#Pathway103" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence716" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Beta-catenin independent WNT signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Humans and mice have 19 identified WNT proteins that were originally classified as either &apos;canonical&apos; or &apos;non-canonical&apos; depending upon whether they were able to transform the mouse mammary epithelial cell line C57MG and to induce secondary axis formation in Xenopus (Wong et al, 1994; Du et al, 1995).  So-called canonical WNTs, including Wnt1, 3, 3a and 7, initiate signaling pathways that destabilize the destruction complex and allow beta-catenin to accumulate and translocate to the nucleus where it promotes transcription (reviewed in Saito-Diaz et al, 2013).  Non-canonical WNTs, including Wnt 2, 4, 5a, 5b, 6, 7b, and Wnt11 activate beta-catenin-independent responses that regulate many aspects of morphogenesis and development, often by impinging on the cytoskeleton (reviewed in van Amerongen, 2012).  Two of the main beta-catenin-independent pathways are the Planar Cell Polarity (PCP) pathway, which controls the establishment of polarity in the plane of a field of cells, and the WNT/Ca2+ pathway, which promotes the release of intracellular calcium and regulates numerous downstream effectors (reviewed in Gao, 2012; De, 2011).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence419">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway101">
 <bp:pathwayOrder rdf:resource="#PathwayStep712" />
 <bp:pathwayOrder rdf:resource="#PathwayStep713" />
 <bp:pathwayOrder rdf:resource="#PathwayStep710" />
 <bp:pathwayOrder rdf:resource="#PathwayStep711" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction611" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction610" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction613" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction612" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence710" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WNT mediated activation of DVL</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The three human Dishevelled (DVL) proteins play a central and overlapping role in the transduction of the WNT signaling cascade (Lee et al, 2008; reviewed in Gao and Chen 2010).  DVL activity is regulated by phosphorylation, although the details are not completely worked out.  DVL likely exists as a phosphoprotein even in the absence of WNT stimulation, and is further phosphorylated upon ligand binding.  Casein kinase 1epsilon (CSNK1E), casein kinase 2 (CSNK2) and PAR1 have all been reported to phosphorylate DVL (Willert et al, 1997; Sun et al, 2001; Cong et al, 2004; Ossipova et al, 2005).  Upon pathway activation, phosphorylated DVL translocates to the plasma membrane through an interaction between the DVL PDZ domain and the FZD KTxxxW motif (Wong et al, 2003; Umbhauer et al, 2000; Kikuchi et al, 2011).  At the plasma membrane, DVL is believed to oligomerize through its DIX domain, providing a platform for AXIN recruitment; recruitment of AXIN is also facilitated by interaction with LRP (Schwarz-Romond et al, 2007; Mao et al, 2001).  DVL interacts with phosphatidylinositol-4-kinase type II (PI4KII) and phophatidylinositol-4-phosphate 5-kinase type I (PIP5KI) to promote formation of phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) in the membrane, which is required for the clustering and phosphorylation of LRP6 and the recruitment of AXIN (Pan et al, 2008; Qin et al, 2009).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence401">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1338">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1163" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence402">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction489">
 <bp:evidence rdf:resource="#Evidence565" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOD binds effectors at the endosome membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1337">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1162" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence403">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep448">
 <bp:stepProcess rdf:resource="#BiochemicalReaction391" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1336">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1161" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence404">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep449">
 <bp:stepProcess rdf:resource="#BiochemicalReaction392" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1335">
 <bp:stepProcess rdf:resource="#Pathway176" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep446">
 <bp:stepProcess rdf:resource="#BiochemicalReaction390" />
 <bp:stepProcess rdf:resource="#Catalysis169" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction486">
 <bp:evidence rdf:resource="#Evidence562" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOD binds effectors at the mitochondrial outer membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2666">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2329" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep447">
 <bp:stepProcess rdf:resource="#Pathway58" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction485">
 <bp:evidence rdf:resource="#Evidence560" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC1 binds effectors at the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2667">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2330" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep444">
 <bp:stepProcess rdf:resource="#Catalysis167" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction388" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction488">
 <bp:evidence rdf:resource="#Evidence564" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOD translocates to the Golgi membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2668">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2331" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence400">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep445">
 <bp:stepProcess rdf:resource="#BiochemicalReaction389" />
 <bp:stepProcess rdf:resource="#Catalysis168" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction487">
 <bp:evidence rdf:resource="#Evidence563" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOD binds effectors at the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1339">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1164" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2669">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2332" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1065">
 <bp:evidence rdf:resource="#Evidence1230" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G protein-coupled estrogen receptor 1 binds estrogen non-classically</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1330">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1156" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2662">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2325" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2396">
 <bp:evidence rdf:resource="#Evidence2750" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTF4-bound NTRK2 dimers trans-autophosphorylate</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1064">
 <bp:evidence rdf:resource="#Evidence1229" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MLNR (GPR38) is a receptor for motilin</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2663">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2326" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2395">
 <bp:evidence rdf:resource="#Evidence2749" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTF4 binds NTRK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1063">
 <bp:evidence rdf:resource="#Evidence1228" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cholecystokinin receptors bind cholecystokinin</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2664">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2327" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2394">
 <bp:evidence rdf:resource="#Evidence2747" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FYN-mediated phosphorylation of GRIN2B</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1062">
 <bp:evidence rdf:resource="#Evidence1227" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ECE2 cleaves EDN1(53-90)</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2665">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2328" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2393">
 <bp:evidence rdf:resource="#Evidence2746" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SRC,FYN phosphorylate NTRK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1061">
 <bp:evidence rdf:resource="#Evidence1226" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GHSR is a receptor for ghrelin</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1334">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1160" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2392">
 <bp:evidence rdf:resource="#Evidence2745" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTRK2-bound FYN autophosphorylates</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1060">
 <bp:evidence rdf:resource="#Evidence1225" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GPR37L binds prosaposin</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1333">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1159" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2391">
 <bp:evidence rdf:resource="#Evidence2744" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DOCK3 binds FYN associated with NTRK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1332">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1158" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2660">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2323" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2390">
 <bp:evidence rdf:resource="#Evidence2743" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DOCK3 activates RAC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1331">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1157" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2661">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2324" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1069">
 <bp:evidence rdf:resource="#Evidence1235" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Bradykinin receptors B1 and B2 bind to bradykinin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1068">
 <bp:evidence rdf:resource="#Evidence1234" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tachykinin receptor 2 (NK2) binds to nuerokinin A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2399">
 <bp:evidence rdf:resource="#Evidence2754" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated NTRK2 recruits PI3K</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1067">
 <bp:evidence rdf:resource="#Evidence1233" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tachykinin receptor 3 (NK3) binds to neurokinin B</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2398">
 <bp:evidence rdf:resource="#Evidence2753" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTRK2-activated PI3K generates PIP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1066">
 <bp:evidence rdf:resource="#Evidence1232" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tachykinin receptor 1 (NK1) binds to substance P</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2397">
 <bp:evidence rdf:resource="#Evidence2751" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTF4-bound NTRK2 dimerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence409">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep442">
 <bp:stepProcess rdf:resource="#BiochemicalReaction386" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction493">
 <bp:evidence rdf:resource="#Evidence569" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOD auto-activates</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep443">
 <bp:stepProcess rdf:resource="#BiochemicalReaction387" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction492">
 <bp:evidence rdf:resource="#Evidence568" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOD GAPs stimulate RHOD GTPase activity</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep440">
 <bp:stepProcess rdf:resource="#Catalysis166" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction384" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction495">
 <bp:evidence rdf:resource="#Evidence572" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC2 binds effectors at the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep441">
 <bp:stepProcess rdf:resource="#BiochemicalReaction385" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction494">
 <bp:evidence rdf:resource="#Evidence570" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOD binds effectors at the Golgi membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence405">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence406">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence407">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction491">
 <bp:evidence rdf:resource="#Evidence567" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOD translocates to the mitochondrial outer membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence408">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction490">
 <bp:evidence rdf:resource="#Evidence566" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOD:GTP translocates to the endosome membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep439">
 <bp:stepProcess rdf:resource="#BiochemicalReaction383" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep437">
 <bp:stepProcess rdf:resource="#Catalysis164" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction381" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep438">
 <bp:stepProcess rdf:resource="#Catalysis165" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction382" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep435">
 <bp:stepProcess rdf:resource="#BiochemicalReaction379" />
 <bp:stepProcess rdf:resource="#Catalysis162" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep436">
 <bp:stepProcess rdf:resource="#Catalysis163" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction380" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep433">
 <bp:stepProcess rdf:resource="#BiochemicalReaction377" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep434">
 <bp:stepProcess rdf:resource="#Catalysis161" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction378" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2305">
 <bp:evidence rdf:resource="#Evidence2639" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AAMP gene expression is positively regulated by VEGF</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2304">
 <bp:evidence rdf:resource="#Evidence2638" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-6Y-VEGFR2 binds SH2D2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2303">
 <bp:evidence rdf:resource="#Evidence2637" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y402-PTK2B phosphorylates p-5Y,S732-PTK2 on Y407</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2302">
 <bp:evidence rdf:resource="#Evidence2636" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-6Y-VEGFR2 binds PI3K</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2301">
 <bp:evidence rdf:resource="#Evidence2635" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y420-FYN is phosphorylated on S21</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2300">
 <bp:evidence rdf:resource="#Evidence2634" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BCAR1 binds p-7Y-PTK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep431">
 <bp:stepProcess rdf:resource="#Pathway57" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep432">
 <bp:stepProcess rdf:resource="#BiochemicalReaction376" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep430">
 <bp:stepProcess rdf:resource="#BiochemicalReaction375" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2309">
 <bp:evidence rdf:resource="#Evidence2645" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Homodimerization of VEGF proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2308">
 <bp:evidence rdf:resource="#Evidence2644" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">VEGF-A,C,D bind to VEGFR2 leading to receptor dimerization</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2307">
 <bp:evidence rdf:resource="#Evidence2643" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">VEGFA,B,PLGF bind to VEGFR1 leading to receptor dimerization</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2306">
 <bp:evidence rdf:resource="#Evidence2642" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">VEGF-C,D bind to VEGFR3 leading to receptor dimerization</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep428">
 <bp:stepProcess rdf:resource="#BiochemicalReaction373" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep429">
 <bp:stepProcess rdf:resource="#BiochemicalReaction374" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep426">
 <bp:stepProcess rdf:resource="#BiochemicalReaction371" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep427">
 <bp:stepProcess rdf:resource="#BiochemicalReaction372" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep424">
 <bp:stepProcess rdf:resource="#BiochemicalReaction369" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep425">
 <bp:stepProcess rdf:resource="#BiochemicalReaction370" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep422">
 <bp:stepProcess rdf:resource="#BiochemicalReaction367" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep423">
 <bp:stepProcess rdf:resource="#BiochemicalReaction368" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep420">
 <bp:stepProcess rdf:resource="#BiochemicalReaction365" />
 <bp:stepProcess rdf:resource="#Catalysis160" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep421">
 <bp:stepProcess rdf:resource="#BiochemicalReaction366" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep417">
 <bp:stepProcess rdf:resource="#BiochemicalReaction362" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep418">
 <bp:stepProcess rdf:resource="#BiochemicalReaction363" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep415">
 <bp:stepProcess rdf:resource="#BiochemicalReaction360" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep416">
 <bp:stepProcess rdf:resource="#BiochemicalReaction361" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep413">
 <bp:stepProcess rdf:resource="#BiochemicalReaction358" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep414">
 <bp:stepProcess rdf:resource="#BiochemicalReaction359" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep411">
 <bp:stepProcess rdf:resource="#BiochemicalReaction356" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep412">
 <bp:stepProcess rdf:resource="#BiochemicalReaction357" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep419">
 <bp:stepProcess rdf:resource="#BiochemicalReaction364" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep410">
 <bp:stepProcess rdf:resource="#BiochemicalReaction355" />
 <bp:stepProcess rdf:resource="#Catalysis159" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep406">
 <bp:stepProcess rdf:resource="#BiochemicalReaction351" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep407">
 <bp:stepProcess rdf:resource="#BiochemicalReaction352" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep404">
 <bp:stepProcess rdf:resource="#BiochemicalReaction349" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep405">
 <bp:stepProcess rdf:resource="#BiochemicalReaction350" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep402">
 <bp:stepProcess rdf:resource="#BiochemicalReaction348" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep403">
 <bp:stepProcess rdf:resource="#Pathway56" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep400">
 <bp:stepProcess rdf:resource="#BiochemicalReaction346" />
 <bp:stepProcess rdf:resource="#Catalysis157" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep401">
 <bp:stepProcess rdf:resource="#BiochemicalReaction347" />
 <bp:stepProcess rdf:resource="#Catalysis158" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep408">
 <bp:stepProcess rdf:resource="#BiochemicalReaction353" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep409">
 <bp:stepProcess rdf:resource="#BiochemicalReaction354" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction413">
 <bp:evidence rdf:resource="#Evidence475" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-T774-PKN1:AR:Androgen complex translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction412">
 <bp:evidence rdf:resource="#Evidence473" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-T38-PPP1R14A binds MLCP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction415">
 <bp:evidence rdf:resource="#Evidence477" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KDM1A demethylates dimethylated H3K9 (Me2K-10-H3) at KLK2 and KLK3 promoters</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction414">
 <bp:evidence rdf:resource="#Evidence476" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKN1 in complex with AR positively regulates expression of KLK2 and KLK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction411">
 <bp:evidence rdf:resource="#Evidence472" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Association of p-S216-CDC25C with 14-3-3 proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction410">
 <bp:evidence rdf:resource="#Evidence471" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Myosin phosphatase dephosphorylates myosin regulatory light chain</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1010">
 <bp:evidence rdf:resource="#Evidence1169" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G alpha (s) activates adenylate cyclase</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2341">
 <bp:evidence rdf:resource="#Evidence2679" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of ERBB4s80:YAP1 complex to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2340">
 <bp:evidence rdf:resource="#Evidence2678" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB4s80:STAT5A binds CSN2 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction417">
 <bp:evidence rdf:resource="#Evidence479" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Demethylase KDM1A binds KLK2 and KLK3 promoters</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction416">
 <bp:evidence rdf:resource="#Evidence478" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKN1 phosphorylates histone 3 of nucleosomes associate with KLK2 and KLK3 promoters</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction419">
 <bp:evidence rdf:resource="#Evidence481" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKN1:AR complex binds promoters of KLK2 and KLK3 genes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction418">
 <bp:evidence rdf:resource="#Evidence480" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KDM1A demethylates monomethylated H3K9 (MeK-10-H3) at KLK2 and KLK3 promoters</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1018">
 <bp:evidence rdf:resource="#Evidence1178" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHC1 is phosphorylated downstream of estrogen stimulation of GPER1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2349">
 <bp:evidence rdf:resource="#Evidence2689" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of GRB2:SOS1 to phosphorylated SHC1 in complex with phosphorylated ERBB4 homodimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1017">
 <bp:evidence rdf:resource="#Evidence1177" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ESTG-stimulated dissociation of GPER:heterotrimeric G-protein (s) complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2348">
 <bp:evidence rdf:resource="#Evidence2687" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB4 forms heterodimers with ERBB3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1016">
 <bp:evidence rdf:resource="#Evidence1175" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G alpha (s):GTP:SRC catalyzes SRC to p-Y419-SRC</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2347">
 <bp:evidence rdf:resource="#Evidence2686" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Trans-autophosphorylation of ERBB4 homodimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1015">
 <bp:evidence rdf:resource="#Evidence1174" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ADRB2 in ADRB2:GRK complex is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2346">
 <bp:evidence rdf:resource="#Evidence2685" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Conversion of PIP2 into PIP3 by PI3K bound to p-ERBB4cyt1 homodimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1014">
 <bp:evidence rdf:resource="#Evidence1173" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PDE4A hydrolyses cAMP to AMP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2345">
 <bp:evidence rdf:resource="#Evidence2684" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of p85 subunit of PI3K (PIK3R1) to p-ERBB4cyt1 homodimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1013">
 <bp:evidence rdf:resource="#Evidence1172" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Inactive G alpha (s) reassociates with G beta:gamma</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2344">
 <bp:evidence rdf:resource="#Evidence2682" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB4 binds DLG4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1012">
 <bp:evidence rdf:resource="#Evidence1171" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PDE4A binds PDE4A inhibitors</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2343">
 <bp:evidence rdf:resource="#Evidence2681" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of ERBB4s80 to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1011">
 <bp:evidence rdf:resource="#Evidence1170" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Adenylate cyclase converts ATP to 3&apos;,5&apos;-cyclic AMP (cAMP) and pyrophosphate</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2342">
 <bp:evidence rdf:resource="#Evidence2680" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of cytosolic ERBB4s80 to mitochondrial matrix</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1019">
 <bp:evidence rdf:resource="#Evidence1179" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GPER:Heterotrimeric G-protein Gs binds ESTG</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction424">
 <bp:evidence rdf:resource="#Evidence486" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-T774-PKN1 binds CDC25C</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction423">
 <bp:evidence rdf:resource="#Evidence485" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated PKN1 binds androgen receptor (AR)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction426">
 <bp:evidence rdf:resource="#Evidence489" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CIT-3 binds activated RHOA, RHOB, RHOC and RAC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction425">
 <bp:evidence rdf:resource="#Evidence488" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CIT-3 binds DLG4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction420">
 <bp:evidence rdf:resource="#Evidence482" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKN1 stimulates association of AR with NCOA2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction422">
 <bp:evidence rdf:resource="#Evidence484" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KDM4C demethylates Me3K-10-H3 associated with KLK2 and KLK3 promoters</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction421">
 <bp:evidence rdf:resource="#Evidence483" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Demethylase KDM4C binds KLK2 and KLK3 promoters</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2330">
 <bp:evidence rdf:resource="#Evidence2668" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CXCL12 gene expression is stimulated by ERBB4s80:ESR1:estrogen</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction428">
 <bp:evidence rdf:resource="#Evidence491" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CIT (citron kinase) binds activated RHOA, RHOB, RHOC and RAC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction427">
 <bp:evidence rdf:resource="#Evidence490" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated CIT phosphorylates MRLCs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction429">
 <bp:evidence rdf:resource="#Evidence492" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated CIT binds KIF14 and PRC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1007">
 <bp:evidence rdf:resource="#Evidence1165" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Gastrin binds to CCK-B receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2338">
 <bp:evidence rdf:resource="#Evidence2676" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ADAP1 gene expression is inhibited by ERBB4s80</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1006">
 <bp:evidence rdf:resource="#Evidence1164" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated PKC-alpha  activate MMP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2337">
 <bp:evidence rdf:resource="#Evidence2675" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MXD4 gene expression is stimulated by ERBB4s80</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1005">
 <bp:evidence rdf:resource="#Evidence1163" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRB2:SOS1 binds to HBEGF:p-Y-EGFR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2336">
 <bp:evidence rdf:resource="#Evidence2674" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB4 gene expression is stimulated by ERBB4s80:ESR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1004">
 <bp:evidence rdf:resource="#Evidence1162" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Diacylgycerol activates Protein kinase C, alpha type</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2335">
 <bp:evidence rdf:resource="#Evidence2673" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PGR gene expression is stimulated by ERBB4s80:ESR1:estrogen</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1003">
 <bp:evidence rdf:resource="#Evidence1161" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Mature HBEGF binds to EGFR, triggering dimerisation and autophosphorylation of the receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2334">
 <bp:evidence rdf:resource="#Evidence2672" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB4s80:ESR1 binds PGR gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1002">
 <bp:evidence rdf:resource="#Evidence1160" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active MMP3 can cleave pro-HBEGF to form active HBEGF</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2333">
 <bp:evidence rdf:resource="#Evidence2671" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SPARC gene transcription is stimulated by ERBB4s80</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1001">
 <bp:evidence rdf:resource="#Evidence1159" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SOS1-mediated nucleotide exchange of RAS (HB-EFG-initiated)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2332">
 <bp:evidence rdf:resource="#Evidence2670" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB4s80 binds SPARC gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1000">
 <bp:evidence rdf:resource="#Evidence1157" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RSK1/2/3 phosphorylates CREB at Serine 119</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2331">
 <bp:evidence rdf:resource="#Evidence2669" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB4s80 forms a complex with estrogen receptor ESR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1009">
 <bp:evidence rdf:resource="#Evidence1168" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Liganded Gs-activating GPCR acts as a GEF for Gs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1008">
 <bp:evidence rdf:resource="#Evidence1167" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ADRB2:Catecholamine binds ARRB1, ARRB2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2339">
 <bp:evidence rdf:resource="#Evidence2677" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB4s80 binds YAP1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2327">
 <bp:evidence rdf:resource="#Evidence2665" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GFAP gene expression is inhibited by ERBB4:TAB2:NCOR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2326">
 <bp:evidence rdf:resource="#Evidence2664" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB4s80:ESR1 binds CXCL12 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2325">
 <bp:evidence rdf:resource="#Evidence2663" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB4s80:TAB2:NCOR1 complex translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2324">
 <bp:evidence rdf:resource="#Evidence2662" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB4s80:ESR1 binds ERBB4 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2323">
 <bp:evidence rdf:resource="#Evidence2661" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STMN1 gene expression is stimulated by ERBB4s80</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2322">
 <bp:evidence rdf:resource="#Evidence2660" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB4s80 binds STMN1 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2321">
 <bp:evidence rdf:resource="#Evidence2659" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB4s80:TAB2:NCOR1 complex binds S100B gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2320">
 <bp:evidence rdf:resource="#Evidence2658" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cleavage of ERBB4m80 by gamma-scretase complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2329">
 <bp:evidence rdf:resource="#Evidence2667" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB4s80:STAT5A complex translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2328">
 <bp:evidence rdf:resource="#Evidence2666" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB4s80 binds TAB2:NCOR1 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction402">
 <bp:evidence rdf:resource="#Evidence462" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LIM kinase phosphorylation by ROCK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction401">
 <bp:evidence rdf:resource="#Evidence461" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LIMK phosphorylates CFL1, inactivating it</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction404">
 <bp:evidence rdf:resource="#Evidence464" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Myosin phosphatase dephosphorylates myosin regulatory light chain</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction403">
 <bp:evidence rdf:resource="#Evidence463" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ROCK1,2 bind ROCKi</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction400">
 <bp:evidence rdf:resource="#Evidence460" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Myosin regulatory light chain phosphorylation by ROCK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction409">
 <bp:evidence rdf:resource="#Evidence470" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PDPK1 phosphorylates PKN1,2,3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction406">
 <bp:evidence rdf:resource="#Evidence467" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-T774-PKN1 phosphorylates CDC25C</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction405">
 <bp:evidence rdf:resource="#Evidence466" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOA, RHOB, RHOC and RAC1 bind PKN1, PKN2 or PKN3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction408">
 <bp:evidence rdf:resource="#Evidence469" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-T774-PKN1 phosphorylates PPP1R14A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction407">
 <bp:evidence rdf:resource="#Evidence468" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOA,RHOB,RHOC,RAC1:GTP:PKN1,2,3 binds PDPK1:PIP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2316">
 <bp:evidence rdf:resource="#Evidence2654" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cleavage of P-ERBB4jmA isoforms by ADAM17</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2315">
 <bp:evidence rdf:resource="#Evidence2653" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB4s80 binds the MXD4 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2314">
 <bp:evidence rdf:resource="#Evidence2652" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB4s80 binds the APOE gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2313">
 <bp:evidence rdf:resource="#Evidence2651" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">APOE gene transcription is stimulated by ERBB4s80</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2312">
 <bp:evidence rdf:resource="#Evidence2650" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CSN2 gene expression is stimulated by ERBB4s80:STAT5A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2311">
 <bp:evidence rdf:resource="#Evidence2649" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB4s80:TAB2:NCOR1 complex binds GFAP gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2310">
 <bp:evidence rdf:resource="#Evidence2648" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB4s80 binds STAT5A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2319">
 <bp:evidence rdf:resource="#Evidence2657" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB4s80 binds ADAP1 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2318">
 <bp:evidence rdf:resource="#Evidence2656" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WWOX binds ERBB4s80</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2317">
 <bp:evidence rdf:resource="#Evidence2655" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">S100B gene expression is inhibited by ERBB4:TAB2:NCOR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1940">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1941">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1942">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1943">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1944">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1945">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1946">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1947">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1948">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1949">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1930">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1931">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1932">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1933">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1934">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1935">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1936">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1937">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1938">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1939">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1960">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1961">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1962">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1963">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1964">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1965">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1966">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1967">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1968">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1969">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1950">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1951">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1952">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1953">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1954">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1955">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1956">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1957">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1958">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1959">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1907">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2503">
 <bp:evidence rdf:resource="#Evidence2878" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-CREB, ASCL1, TCF12, ATFs and p300 bind the VGF promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1908">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2502">
 <bp:evidence rdf:resource="#Evidence2877" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-4S, T366 ELK1:SRF bind EGR1 and EGR2 gene promoters</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1909">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2501">
 <bp:evidence rdf:resource="#Evidence2876" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NAB2 binds EGR1 to repress CDK5R1 gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2500">
 <bp:evidence rdf:resource="#Evidence2875" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EGR1-dependent CDK5R1 gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1900">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1901">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2509">
 <bp:evidence rdf:resource="#Evidence2887" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by dual-specific phosphatases (DUSPs)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1902">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2508">
 <bp:evidence rdf:resource="#Evidence2885" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38MAPK phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1903">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2507">
 <bp:evidence rdf:resource="#Evidence2883" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RSK1/2/3 phosphorylates CREB at Serine 119</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1904">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2506">
 <bp:evidence rdf:resource="#Evidence2882" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates ATF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1905">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2505">
 <bp:evidence rdf:resource="#Evidence2881" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates CREB</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1906">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2504">
 <bp:evidence rdf:resource="#Evidence2880" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKAPK2 phosphorylates CREB at Serine 133</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1920">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1929">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1921">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1922">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1923">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1924">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1925">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1926">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1927">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1928">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1918">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1919">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1910">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1911">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1912">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1913">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1914">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1915">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1916">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1917">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2516">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2189" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2517">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2190" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2518">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2191" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2519">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2192" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction299">
 <bp:evidence rdf:resource="#Evidence343" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF1 is degraded by the proteasome</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2512">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2186" />
 <bp:stepProcess rdf:resource="#Catalysis676" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction298">
 <bp:evidence rdf:resource="#Evidence342" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KBTBD7:CUL3:RBX1 ubiquitinates NF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2513">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2187" />
 <bp:stepProcess rdf:resource="#Catalysis677" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2514">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2188" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2515">
 <bp:stepProcess rdf:resource="#Pathway328" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2510">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2184" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2511">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2185" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2527">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2199" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2528">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2200" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2529">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2201" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2523">
 <bp:stepProcess rdf:resource="#Catalysis679" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2196" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2524">
 <bp:stepProcess rdf:resource="#Catalysis680" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2197" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2525">
 <bp:stepProcess rdf:resource="#Pathway329" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2526">
 <bp:stepProcess rdf:resource="#Catalysis681" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2198" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2520">
 <bp:stepProcess rdf:resource="#Catalysis678" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2193" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2521">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2194" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2522">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2195" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction277">
 <bp:evidence rdf:resource="#Evidence320" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ICMT methylates S-Farn RAS proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction276">
 <bp:evidence rdf:resource="#Evidence319" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">S-farn Me-HRAS, -NRAS and -KRAS4A are palmitoylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction279">
 <bp:evidence rdf:resource="#Evidence322" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pro-RAS proteins are farnesylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction278">
 <bp:evidence rdf:resource="#Evidence321" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP17L2 deubiquitinates RCE1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction284">
 <bp:evidence rdf:resource="#Evidence327" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PDE6D binds S-Farn-Me KRAS4B:CALM:4 Ca2+</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction283">
 <bp:evidence rdf:resource="#Evidence326" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cysmethynil binds ICMT:Zn2+</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction286">
 <bp:evidence rdf:resource="#Evidence329" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RCE1 cleaves S-Farn proRAS proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction285">
 <bp:evidence rdf:resource="#Evidence328" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KRAS4B is phosphorylated on serine 181</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction280">
 <bp:evidence rdf:resource="#Evidence323" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Mature S-Farn-Me KRAS4B translocates to plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction282">
 <bp:evidence rdf:resource="#Evidence325" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">mature p21 RAS binds GDP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction281">
 <bp:evidence rdf:resource="#Evidence324" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KRAS4B recycles to the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2505">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2180" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2506">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2181" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2507">
 <bp:stepProcess rdf:resource="#Pathway327" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2508">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2182" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction288">
 <bp:evidence rdf:resource="#Evidence331" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Calmodulin dissociates KRAS4B from the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2501">
 <bp:stepProcess rdf:resource="#Catalysis673" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2177" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction287">
 <bp:evidence rdf:resource="#Evidence330" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pS181-S-Farn-Me KRAS4B translocates to the outer mitochondrial membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2502">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2178" />
 <bp:stepProcess rdf:resource="#Catalysis674" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2503">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2179" />
 <bp:stepProcess rdf:resource="#Catalysis675" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction289">
 <bp:evidence rdf:resource="#Evidence332" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAS proteins are depalmitoylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2504">
 <bp:stepProcess rdf:resource="#Pathway326" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2500">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2176" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction295">
 <bp:evidence rdf:resource="#Evidence338" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAS GEFs promote RAS nucleotide exchange</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction294">
 <bp:evidence rdf:resource="#Evidence337" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FNTB inhibitors bind FNTA:FNTB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction297">
 <bp:evidence rdf:resource="#Evidence340" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAS intrinsic GTPase activity hydrolyzes GTP to GDP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction296">
 <bp:evidence rdf:resource="#Evidence339" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Intrinsic nucleotide exchange on RAS</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction291">
 <bp:evidence rdf:resource="#Evidence334" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pS181-S-Farn-Me KRAS4B binds BCL2L1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2509">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2183" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction290">
 <bp:evidence rdf:resource="#Evidence333" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ARL2:GTP bind PDE6D on KRAS4B</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction293">
 <bp:evidence rdf:resource="#Evidence336" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">S-Farn-Me KRAS4B binds calmodulin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction292">
 <bp:evidence rdf:resource="#Evidence335" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Palmostatin B binds RAS depalmitoylases</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence397">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence398">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence399">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence393">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence394">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence395">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence396">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence390">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence391">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence392">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence386">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence387">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence388">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence389">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence382">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence383">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence384">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence385">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence380">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence381">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence379">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence375">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence376">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence377">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence378">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence371">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence372">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence373">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence374">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence370">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence368">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence369">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence364">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence365">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence366">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence367">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence360">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence361">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence362">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence363">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence357">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction336">
 <bp:evidence rdf:resource="#Evidence391" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Production of phagocyte oxygen radicals by NOX2 complex bound to RAC2:GTP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence358">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction335">
 <bp:evidence rdf:resource="#Evidence390" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK1 or MAPK3 phosphorylates NCF1 at Ser345</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence359">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction338">
 <bp:evidence rdf:resource="#Evidence393" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC1:GTP binds NOX3 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction337">
 <bp:evidence rdf:resource="#Evidence392" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NADPH oxidase 2 (NOX2) complex binds RAC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1269">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1102" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence353">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction332">
 <bp:evidence rdf:resource="#Evidence384" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOT2 hydrolyzes GTP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence354">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction331">
 <bp:evidence rdf:resource="#Evidence382" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOT1 binds effectors at the mitochondrial outer membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence355">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction334">
 <bp:evidence rdf:resource="#Evidence386" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOT2 GEFs activate RHOT2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence356">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction333">
 <bp:evidence rdf:resource="#Evidence385" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOT2 binds effectors at the mitochondrial outer membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1264">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1097" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1175">
 <bp:evidence rdf:resource="#Evidence1353" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&#946;-blockers bind ADRB1,2,3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2596">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2263" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence350">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1263">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1096" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1174">
 <bp:evidence rdf:resource="#Evidence1352" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&#946;3-agonists bind ADRB3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2597">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2264" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence351">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1262">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1095" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1173">
 <bp:evidence rdf:resource="#Evidence1351" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ADRB3 bind ADR,NAd</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2598">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2265" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence352">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1261">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1094" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1172">
 <bp:evidence rdf:resource="#Evidence1349" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DRD2 antagonist drugs bind to DRD2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2599">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2266" />
 <bp:stepProcess rdf:resource="#Catalysis710" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1268">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1101" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1171">
 <bp:evidence rdf:resource="#Evidence1348" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DRD1,5 bind DA</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2592">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2259" />
 <bp:stepProcess rdf:resource="#Catalysis707" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction339">
 <bp:evidence rdf:resource="#Evidence394" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC2:GTP binds NOX2 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1267">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1100" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1170">
 <bp:evidence rdf:resource="#Evidence1347" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DRD2 binds DA</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2593">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2260" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1266">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1099" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2594">
 <bp:stepProcess rdf:resource="#Catalysis708" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2261" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1265">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1098" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2595">
 <bp:stepProcess rdf:resource="#Catalysis709" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2262" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1271">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1104" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1179">
 <bp:evidence rdf:resource="#Evidence1357" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&#945;1-antagonists bind ADRA1A,B,D</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1270">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1103" />
 <bp:stepProcess rdf:resource="#Catalysis380" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1178">
 <bp:evidence rdf:resource="#Evidence1356" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ADRB2 bind ADR,NAd</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1177">
 <bp:evidence rdf:resource="#Evidence1355" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&#945;1-agonists bind ADRA1A,B,D</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1176">
 <bp:evidence rdf:resource="#Evidence1354" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&#946;1-agonists bind ADRB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction341">
 <bp:evidence rdf:resource="#Evidence396" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK11 or MAPK14 phosphorylates NCF1 at Ser345</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction340">
 <bp:evidence rdf:resource="#Evidence395" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOX3 complex:RAC1:GTP generates superoxide from oxygen</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence346">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction347">
 <bp:evidence rdf:resource="#Evidence402" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PIK3C3:PIK3R4 phosphorylates PI to PI3P</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence347">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction346">
 <bp:evidence rdf:resource="#Evidence401" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOX1 complex:RAC1:GTP generates superoxide from oxygen</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence348">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction349">
 <bp:evidence rdf:resource="#Evidence405" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FMNL1 binds CDC42:GTP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence349">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction348">
 <bp:evidence rdf:resource="#Evidence403" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC1:GTP binds NOX1 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence342">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction343">
 <bp:evidence rdf:resource="#Evidence398" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">S100A8:S100A9:AA:Ca(2+) binds NOX2 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence343">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction342">
 <bp:evidence rdf:resource="#Evidence397" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PIN1 binds p-S345-NCF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence344">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction345">
 <bp:evidence rdf:resource="#Evidence400" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NADPH oxidase 2 generates superoxide from oxygen</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence345">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction344">
 <bp:evidence rdf:resource="#Evidence399" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKC phosphorylates NCF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis5">
 <bp:controlled rdf:resource="#BiochemicalReaction42" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1275">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1108" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1164">
 <bp:evidence rdf:resource="#Evidence1340" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HRH4 binds Hist</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2495">
 <bp:evidence rdf:resource="#Evidence2870" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EGR2:NAB2 and CHD4 bind the ID2 and ID4 promoter regions</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis6">
 <bp:controlled rdf:resource="#BiochemicalReaction46" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1274">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1107" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1163">
 <bp:evidence rdf:resource="#Evidence1339" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HRH1 binds hist</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2494">
 <bp:evidence rdf:resource="#Evidence2869" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EGR1 gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis3">
 <bp:controlled rdf:resource="#BiochemicalReaction27" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence340">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1273">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1106" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1162">
 <bp:evidence rdf:resource="#Evidence1338" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HRH1 binds HRH1 inverse agonists</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2493">
 <bp:evidence rdf:resource="#Evidence2868" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S133 CREB1, MEF2D and SRF  bind the ARC gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis4">
 <bp:controlled rdf:resource="#BiochemicalReaction29" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence341">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1272">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1105" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1161">
 <bp:evidence rdf:resource="#Evidence1337" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HRH2 binds hist</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2492">
 <bp:evidence rdf:resource="#Evidence2867" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RRAD gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis9">
 <bp:controlled rdf:resource="#BiochemicalReaction51" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1279">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1112" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1160">
 <bp:evidence rdf:resource="#Evidence1335" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HTR1A binds 5HT</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2491">
 <bp:evidence rdf:resource="#Evidence2866" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S133 CREB and p-S103 SRF bind the EGR1 promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1278">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1111" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2490">
 <bp:evidence rdf:resource="#Evidence2865" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerization of p-S133-CREB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis7">
 <bp:controlled rdf:resource="#BiochemicalReaction47" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1277">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1110" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis8">
 <bp:controlled rdf:resource="#BiochemicalReaction48" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1276">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1109" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1169">
 <bp:evidence rdf:resource="#Evidence1346" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">D2D3,4 bind to DA</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1282">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1115" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1168">
 <bp:evidence rdf:resource="#Evidence1344" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Trace amine-associated receptors can bind trace amines</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2499">
 <bp:evidence rdf:resource="#Evidence2874" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EGR1 binds CDK5R1 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1281">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1114" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1167">
 <bp:evidence rdf:resource="#Evidence1343" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HRH3 binds pitosilant</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2498">
 <bp:evidence rdf:resource="#Evidence2873" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NGF- and MAPK-dependent EGR1, EGR2 and EGR4 expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1280">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1113" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1166">
 <bp:evidence rdf:resource="#Evidence1342" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HRH2 binds HRH2 antagonists</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2497">
 <bp:evidence rdf:resource="#Evidence2872" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EGR1 binds the TPH1 promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1165">
 <bp:evidence rdf:resource="#Evidence1341" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HRH3 binds Hist</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2496">
 <bp:evidence rdf:resource="#Evidence2871" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EGR1 binds the TF gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction350">
 <bp:evidence rdf:resource="#Evidence406" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOB:GTP recruits DIAPH1 or DIAPH3 to endosomes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction352">
 <bp:evidence rdf:resource="#Evidence408" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FMNL2 binds RHOC:GTP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction351">
 <bp:evidence rdf:resource="#Evidence407" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDC42:GTP:FMNL2 binds Profilin:G-actin</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence335">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction314">
 <bp:evidence rdf:resource="#Evidence359" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S311,S406 KSR1:MARK3 binds YWHAB dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence336">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction313">
 <bp:evidence rdf:resource="#Evidence358" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PP2A dephosphorylates KSR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1249">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1082" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence337">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction316">
 <bp:evidence rdf:resource="#Evidence361" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of RAF</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1248">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1081" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence338">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction315">
 <bp:evidence rdf:resource="#Evidence360" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MRAS:SHOC2:PPP1CC dephosphorylates inactive RAFs</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1247">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1080" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence331">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction310">
 <bp:evidence rdf:resource="#Evidence355" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PP2A dephosphorylates inactive RAFs</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2578">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2246" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence332">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2579">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2247" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence333">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction312">
 <bp:evidence rdf:resource="#Evidence357" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">YWHAB dimer dissociates from KSR1:MARK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence334">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction311">
 <bp:evidence rdf:resource="#Evidence356" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Raf dimer inhibitors bind RAF heterodimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1242">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1076" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1153">
 <bp:evidence rdf:resource="#Evidence1326" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GNRHR2 binds GNRH1,2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2574">
 <bp:stepProcess rdf:resource="#Catalysis695" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2242" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2484">
 <bp:evidence rdf:resource="#Evidence2859" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyrG-CDK5R1,2 bind CDK5</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1241">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1075" />
 <bp:stepProcess rdf:resource="#Catalysis379" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1152">
 <bp:evidence rdf:resource="#Evidence1325" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Follicle-stimulating hormone receptor can bind FSH</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2575">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2243" />
 <bp:stepProcess rdf:resource="#Catalysis696" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2483">
 <bp:evidence rdf:resource="#Evidence2858" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">VGF gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1240">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1074" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1151">
 <bp:evidence rdf:resource="#Evidence1324" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GNRHR binds GNRH1,2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2576">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2244" />
 <bp:stepProcess rdf:resource="#Catalysis697" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2482">
 <bp:evidence rdf:resource="#Evidence2857" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TF gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence330">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1150">
 <bp:evidence rdf:resource="#Evidence1323" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Thyroid-stimulating hormone receptor can bind TSH, Thyrostimulin</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2577">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2245" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2481">
 <bp:evidence rdf:resource="#Evidence2856" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EGR-dependent NAB2 gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction318">
 <bp:evidence rdf:resource="#Evidence364" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MAPKs translocate into the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1246">
 <bp:stepProcess rdf:resource="#Pathway168" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2570">
 <bp:stepProcess rdf:resource="#Catalysis693" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2238" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2480">
 <bp:evidence rdf:resource="#Evidence2855" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AP-1 binds ARC gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction317">
 <bp:evidence rdf:resource="#Evidence363" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PEA15 binds MAPK monomers and dimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1245">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1079" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2571">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2239" />
 <bp:stepProcess rdf:resource="#Catalysis694" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1244">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1078" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2572">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2240" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction319">
 <bp:evidence rdf:resource="#Evidence365" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cytosolic DUSPs dephosphorylate MAPKs</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1243">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1077" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2573">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2241" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1159">
 <bp:evidence rdf:resource="#Evidence1334" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HTR1 and 5A receptors can bind serotonin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1158">
 <bp:evidence rdf:resource="#Evidence1333" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HTR1A binds HTR1A agonists</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2580">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2248" />
 <bp:stepProcess rdf:resource="#Catalysis698" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2489">
 <bp:evidence rdf:resource="#Evidence2864" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REST binds the VGF promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis1">
 <bp:controlled rdf:resource="#BiochemicalReaction1" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1157">
 <bp:evidence rdf:resource="#Evidence1332" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">5-HT4, 6 and 7 receptors can bind serotonin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2488">
 <bp:evidence rdf:resource="#Evidence2863" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ARC binds DNM2 and SH3GL3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis2">
 <bp:controlled rdf:resource="#BiochemicalReaction2" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1156">
 <bp:evidence rdf:resource="#Evidence1331" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">5-HT2 receptor can bind serotonin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2487">
 <bp:evidence rdf:resource="#Evidence2862" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TPH1 gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1155">
 <bp:evidence rdf:resource="#Evidence1330" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HTR1A binds HTR1A antagonists</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2486">
 <bp:evidence rdf:resource="#Evidence2861" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EGR1 binds the VGF gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1154">
 <bp:evidence rdf:resource="#Evidence1327" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Luteinizing hormone receptor can bind LH</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2485">
 <bp:evidence rdf:resource="#Evidence2860" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of ID2 and ID4 is repressed by EGR2:NAB</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence339">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence324">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction325">
 <bp:evidence rdf:resource="#Evidence373" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of p-T,Y-MAPK1:p-S,T-MAP2K2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence325">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction324">
 <bp:evidence rdf:resource="#Evidence371" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP2K1 binds MAPK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence326">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction327">
 <bp:evidence rdf:resource="#Evidence375" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP2K2 binds MAPK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1259">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1092" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence327">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction326">
 <bp:evidence rdf:resource="#Evidence374" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP2K2 phosphorylates MAPK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1258">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1091" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence320">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction321">
 <bp:evidence rdf:resource="#Evidence368" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Inactivation of MAP2K1 by CDK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2589">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2256" />
 <bp:stepProcess rdf:resource="#Catalysis704" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence321">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction320">
 <bp:evidence rdf:resource="#Evidence366" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-T,Y MAPKs dimerize</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence322">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction323">
 <bp:evidence rdf:resource="#Evidence370" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP2K1 phosphorylates MAPK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence323">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction322">
 <bp:evidence rdf:resource="#Evidence369" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of p-T,Y-MAPK3:MAP2K1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1253">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1086" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1142">
 <bp:evidence rdf:resource="#Evidence1314" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The UDP/CysLT (P2Y17) receptor can bind UTP</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2585">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2252" />
 <bp:stepProcess rdf:resource="#Catalysis702" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2473">
 <bp:evidence rdf:resource="#Evidence2848" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EGR binds ARC gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1252">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1085" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1141">
 <bp:evidence rdf:resource="#Evidence1313" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">P2Y2 receptor binds ATP and UTP</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2586">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2253" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2472">
 <bp:evidence rdf:resource="#Evidence2847" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EGR1, EGR2 bind the RRAD promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1251">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1084" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1140">
 <bp:evidence rdf:resource="#Evidence1312" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">P2RY12 binds ADP</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2587">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2254" />
 <bp:stepProcess rdf:resource="#Catalysis703" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2471">
 <bp:evidence rdf:resource="#Evidence2846" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SGK phosphorylates CREB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1250">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1083" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2588">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2255" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2470">
 <bp:evidence rdf:resource="#Evidence2845" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ID1 and ID3 gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction329">
 <bp:evidence rdf:resource="#Evidence380" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOT1 GEFs activate RHOT1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1257">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1090" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2581">
 <bp:stepProcess rdf:resource="#Pathway334" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction328">
 <bp:evidence rdf:resource="#Evidence376" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear DUSPs dephosphorylate MAPKs</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1256">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1089" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2582">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2249" />
 <bp:stepProcess rdf:resource="#Catalysis699" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1255">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1088" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2583">
 <bp:stepProcess rdf:resource="#Catalysis700" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2250" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1254">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1087" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2584">
 <bp:stepProcess rdf:resource="#Catalysis701" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2251" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1149">
 <bp:evidence rdf:resource="#Evidence1322" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GNRHR binds GNRHR peptide agonists</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1148">
 <bp:evidence rdf:resource="#Evidence1321" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GNRHR binds GNRHR peptide antagonists</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2590">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2257" />
 <bp:stepProcess rdf:resource="#Catalysis705" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2479">
 <bp:evidence rdf:resource="#Evidence2854" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EGR1 binds TRIB1 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1147">
 <bp:evidence rdf:resource="#Evidence1320" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GNRHR binds chemical antagonists</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2591">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2258" />
 <bp:stepProcess rdf:resource="#Catalysis706" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2478">
 <bp:evidence rdf:resource="#Evidence2853" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S133 CREB1, LYL1 and EP300 bind the ID1 and ID3 genes</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1260">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1093" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1146">
 <bp:evidence rdf:resource="#Evidence1318" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HCAR2 binds HCAR2 ligands</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2477">
 <bp:evidence rdf:resource="#Evidence2852" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRIB1 gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1145">
 <bp:evidence rdf:resource="#Evidence1317" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GPR35 binds kynurenic acid</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2476">
 <bp:evidence rdf:resource="#Evidence2851" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EGR1,2,3 bind the NAB2 promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1144">
 <bp:evidence rdf:resource="#Evidence1316" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PAF receptor binds platelet activating factor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2475">
 <bp:evidence rdf:resource="#Evidence2850" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NAB2 and CHD4 bind and repress EGR-mediated RRAD gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1143">
 <bp:evidence rdf:resource="#Evidence1315" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CNRs bind CNR agonists</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2474">
 <bp:evidence rdf:resource="#Evidence2849" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SGK phosphorylates SRF</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction330">
 <bp:evidence rdf:resource="#Evidence381" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOT1 hydrolyzes GTP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence328">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence329">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence313">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1228">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1064" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence314">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction379">
 <bp:evidence rdf:resource="#Evidence436" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PAK1 phosphorylates myosin phosphatase</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1227">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1063" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence315">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1226">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1062" />
 <bp:stepProcess rdf:resource="#Catalysis378" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence316">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1225">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1061" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction376">
 <bp:evidence rdf:resource="#Evidence433" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC1 and CDC42 activate PAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2556">
 <bp:stepProcess rdf:resource="#Pathway332" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence310">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction375">
 <bp:evidence rdf:resource="#Evidence431" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOD:GTP recruits DAIPH2-3 to endosomes</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2557">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2226" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence311">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction378">
 <bp:evidence rdf:resource="#Evidence435" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MYLK (MLCK) phosphorylates MRLCs of the non-muscle myosin II complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep598">
 <bp:stepProcess rdf:resource="#Pathway81" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2558">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2227" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence312">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction377">
 <bp:evidence rdf:resource="#Evidence434" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MYLK (MLCK) Active Calmodulin Binding</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep599">
 <bp:stepProcess rdf:resource="#BiochemicalReaction519" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1229">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1065" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2559">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2228" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1220">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1056" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2552">
 <bp:stepProcess rdf:resource="#Pathway330" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2553">
 <bp:stepProcess rdf:resource="#Pathway331" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2554">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2224" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2555">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2225" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1224">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1060" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1223">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1059" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1222">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1058" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2550">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2222" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1221">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1057" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2551">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2223" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction383">
 <bp:evidence rdf:resource="#Evidence440" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC1 and CDC42 activate PAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep596">
 <bp:stepProcess rdf:resource="#Catalysis207" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction517" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction382">
 <bp:evidence rdf:resource="#Evidence439" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PAK1 phosphorylates LIMK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep597">
 <bp:stepProcess rdf:resource="#Catalysis208" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction518" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction385">
 <bp:evidence rdf:resource="#Evidence442" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FLNA binds PAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep594">
 <bp:stepProcess rdf:resource="#BiochemicalReaction515" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction384">
 <bp:evidence rdf:resource="#Evidence441" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PAK1 or PAK2 phosphorylates MYLK</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep595">
 <bp:stepProcess rdf:resource="#BiochemicalReaction516" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence317">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep592">
 <bp:stepProcess rdf:resource="#Pathway80" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence318">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep593">
 <bp:stepProcess rdf:resource="#BiochemicalReaction514" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence319">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction381">
 <bp:evidence rdf:resource="#Evidence438" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Autophosphorylation of PAK1,2,3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep590">
 <bp:stepProcess rdf:resource="#BiochemicalReaction512" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction380">
 <bp:evidence rdf:resource="#Evidence437" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Myosin phosphatase dephosphorylates myosin regulatory light chain</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep591">
 <bp:stepProcess rdf:resource="#BiochemicalReaction513" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence302">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1239">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1073" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence303">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1238">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1072" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence304">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1237">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1071" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence305">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1236">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1070" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction387">
 <bp:evidence rdf:resource="#Evidence444" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF2 binds PAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep589">
 <bp:stepProcess rdf:resource="#BiochemicalReaction511" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2567">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2236" />
 <bp:stepProcess rdf:resource="#Catalysis691" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction386">
 <bp:evidence rdf:resource="#Evidence443" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC1 and CDC42 activate PAK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2568">
 <bp:stepProcess rdf:resource="#Pathway333" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence300">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction389">
 <bp:evidence rdf:resource="#Evidence446" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PAK1 phosphorylates FLNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep587">
 <bp:stepProcess rdf:resource="#BiochemicalReaction510" />
 <bp:stepProcess rdf:resource="#Catalysis206" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2569">
 <bp:stepProcess rdf:resource="#Catalysis692" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2237" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence301">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction388">
 <bp:evidence rdf:resource="#Evidence445" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PAK2 phosphorylates myosin regulatory light chain (MRLC)</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep588">
 <bp:stepProcess rdf:resource="#Pathway79" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1231">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1066" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2563">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2232" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1230">
 <bp:stepProcess rdf:resource="#Pathway166" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2564">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2233" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2565">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2234" />
 <bp:stepProcess rdf:resource="#Catalysis689" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2566">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2235" />
 <bp:stepProcess rdf:resource="#Catalysis690" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1235">
 <bp:stepProcess rdf:resource="#Pathway167" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1234">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1069" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2560">
 <bp:stepProcess rdf:resource="#Catalysis688" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2229" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1233">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1068" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2561">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2230" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1232">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1067" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2562">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2231" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction394">
 <bp:evidence rdf:resource="#Evidence452" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IQGAPs bind CALM1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep585">
 <bp:stepProcess rdf:resource="#BiochemicalReaction508" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction393">
 <bp:evidence rdf:resource="#Evidence451" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IQGAP1 binds CDH1:CTTNB1:CTTNA1 and MEN1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep586">
 <bp:stepProcess rdf:resource="#BiochemicalReaction509" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction396">
 <bp:evidence rdf:resource="#Evidence455" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KTN1 binds Kinesin-1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep583">
 <bp:stepProcess rdf:resource="#Catalysis205" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction506" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction395">
 <bp:evidence rdf:resource="#Evidence453" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GTP-bound RAC1 and CDC42 bind IQGAPs</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep584">
 <bp:stepProcess rdf:resource="#BiochemicalReaction507" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence306">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction390">
 <bp:evidence rdf:resource="#Evidence447" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PAK phosphorylates cortactin</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep581">
 <bp:stepProcess rdf:resource="#Pathway78" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence307">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep582">
 <bp:stepProcess rdf:resource="#BiochemicalReaction505" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence308">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction392">
 <bp:evidence rdf:resource="#Evidence450" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IQGAPs bind F-actin, which is inhibited by calmodulin</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence309">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction391">
 <bp:evidence rdf:resource="#Evidence449" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IQGAP1 binds CLIP1 and microtubules</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep580">
 <bp:stepProcess rdf:resource="#BiochemicalReaction504" />
 <bp:stepProcess rdf:resource="#Catalysis204" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction358">
 <bp:evidence rdf:resource="#Evidence414" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCAI binds SRF:MKL1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1206">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1044" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2538">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2210" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction357">
 <bp:evidence rdf:resource="#Evidence413" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDC42:GTP recruits DIAPH2-2 to kinetochores</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1205">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1043" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2539">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2211" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1204">
 <bp:stepProcess rdf:resource="#Pathway163" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction359">
 <bp:evidence rdf:resource="#Evidence415" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DIAPH1 binds RHOA:GTP</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1203">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1042" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction354">
 <bp:evidence rdf:resource="#Evidence410" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DAAM1 recruits GTP-bound RHOA</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep578">
 <bp:stepProcess rdf:resource="#BiochemicalReaction502" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2534">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2206" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction353">
 <bp:evidence rdf:resource="#Evidence409" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ppDVL binds DAAM1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep579">
 <bp:stepProcess rdf:resource="#BiochemicalReaction503" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1209">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1046" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2535">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2207" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction356">
 <bp:evidence rdf:resource="#Evidence412" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Profilin:G-actin binds MKL1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep576">
 <bp:stepProcess rdf:resource="#BiochemicalReaction500" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1208">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1045" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2536">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2208" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction355">
 <bp:evidence rdf:resource="#Evidence411" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SRGAP2 stimulates RAC1 GTP-ase activity and ends FMNL1-mediated elongation of actin filaments</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep577">
 <bp:stepProcess rdf:resource="#BiochemicalReaction501" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1207">
 <bp:stepProcess rdf:resource="#Pathway164" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2537">
 <bp:stepProcess rdf:resource="#Catalysis683" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2209" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1197">
 <bp:evidence rdf:resource="#Evidence1378" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HCAR1 binds LACT</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2530">
 <bp:stepProcess rdf:resource="#Catalysis682" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2202" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1196">
 <bp:evidence rdf:resource="#Evidence1377" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HCAR3 binds HCAR3 ligands</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2531">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2203" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1195">
 <bp:evidence rdf:resource="#Evidence1375" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">S1PR1 bind S1P</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2532">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2204" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1194">
 <bp:evidence rdf:resource="#Evidence1374" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">S1PR2-5 bind S1P</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2533">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2205" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1202">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1041" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1193">
 <bp:evidence rdf:resource="#Evidence1373" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">S1PR1 binds S1PR1 agonists</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1201">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1040" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1192">
 <bp:evidence rdf:resource="#Evidence1372" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LRPP4(LRPP1-3,5) hydrolyse LPA</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1200">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1039" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1191">
 <bp:evidence rdf:resource="#Evidence1371" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LPA-binding receptors bind LPA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1190">
 <bp:evidence rdf:resource="#Evidence1369" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GPR143 binds L-Dopa</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1199">
 <bp:evidence rdf:resource="#Evidence1381" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Receptor FFAR2 binds carboxylates</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1198">
 <bp:evidence rdf:resource="#Evidence1379" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HCAR2 binds HCAR2 ligands</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction361">
 <bp:evidence rdf:resource="#Evidence417" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SRF:MKL1 stimulate ITGB1 expression while SCAI inhibits it</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep574">
 <bp:stepProcess rdf:resource="#BiochemicalReaction498" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction360">
 <bp:evidence rdf:resource="#Evidence416" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FMNL1 binds RAC1:GTP</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep575">
 <bp:stepProcess rdf:resource="#BiochemicalReaction499" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction363">
 <bp:evidence rdf:resource="#Evidence419" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MKL1 translocates from cytosol to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep572">
 <bp:stepProcess rdf:resource="#BiochemicalReaction496" />
 <bp:stepProcess rdf:resource="#Catalysis203" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction362">
 <bp:evidence rdf:resource="#Evidence418" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MKL1 binds SRF</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep573">
 <bp:stepProcess rdf:resource="#BiochemicalReaction497" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep570">
 <bp:stepProcess rdf:resource="#Pathway77" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep571">
 <bp:stepProcess rdf:resource="#BiochemicalReaction495" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction369">
 <bp:evidence rdf:resource="#Evidence425" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC1:GTP:FMNL1 binds profilin:G-actin</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1217">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1053" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2549">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2221" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction368">
 <bp:evidence rdf:resource="#Evidence424" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FMNL2 binds CDC42:GTP</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1216">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1052" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep569">
 <bp:stepProcess rdf:resource="#BiochemicalReaction494" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1215">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1051" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1214">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1050" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction365">
 <bp:evidence rdf:resource="#Evidence421" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AURKB phosphorylates DIAPH2-2 at kinetochores</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep567">
 <bp:stepProcess rdf:resource="#BiochemicalReaction492" />
 <bp:stepProcess rdf:resource="#Catalysis201" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2545">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2217" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction364">
 <bp:evidence rdf:resource="#Evidence420" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SRGAP2 binds RAC1:GTP:FMNL1:profilin:G-actin</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep568">
 <bp:stepProcess rdf:resource="#BiochemicalReaction493" />
 <bp:stepProcess rdf:resource="#Catalysis202" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2546">
 <bp:stepProcess rdf:resource="#Catalysis686" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2218" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction367">
 <bp:evidence rdf:resource="#Evidence423" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SRF:MKL1 binds ITGB1 Gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep565">
 <bp:stepProcess rdf:resource="#BiochemicalReaction490" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1219">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1055" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2547">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2219" />
 <bp:stepProcess rdf:resource="#Catalysis687" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction366">
 <bp:evidence rdf:resource="#Evidence422" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOA:GTP:DIAPH1 binds EVL and sequesters profilin:G-actin from MKL1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep566">
 <bp:stepProcess rdf:resource="#BiochemicalReaction491" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1218">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1054" />
 <bp:stepProcess rdf:resource="#Catalysis377" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2548">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2220" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1186">
 <bp:evidence rdf:resource="#Evidence1365" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHRM4 binds CHRM4 antagonists</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2541">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2213" />
 <bp:stepProcess rdf:resource="#Catalysis685" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1185">
 <bp:evidence rdf:resource="#Evidence1364" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHRM2 binds CHRM2 antagonists</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2542">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2214" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1184">
 <bp:evidence rdf:resource="#Evidence1362" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&#945;2-agonists bind ADRA2A,B,C</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2543">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2215" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1183">
 <bp:evidence rdf:resource="#Evidence1361" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ADRA2A,B,C bind ADR,NAd</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2544">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2216" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1213">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1049" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1182">
 <bp:evidence rdf:resource="#Evidence1360" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ADRA1A,B,D bind ADR,NAd</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1212">
 <bp:stepProcess rdf:resource="#Pathway165" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1181">
 <bp:evidence rdf:resource="#Evidence1359" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&#946;1,2-agonists bind ADRB1,2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1211">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1048" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1180">
 <bp:evidence rdf:resource="#Evidence1358" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ADRB1 bind ADR,NAd</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1210">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1047" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2540">
 <bp:stepProcess rdf:resource="#Catalysis684" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2212" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1189">
 <bp:evidence rdf:resource="#Evidence1368" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHRM1,3,5 bind CHRM1,3,5 antagonists</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1188">
 <bp:evidence rdf:resource="#Evidence1367" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHRM2,4 bind acetylcholine</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1187">
 <bp:evidence rdf:resource="#Evidence1366" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHRM1,3,5 bind acetylcholine</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction372">
 <bp:evidence rdf:resource="#Evidence428" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FMNL3 binds G-actin</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep563">
 <bp:stepProcess rdf:resource="#BiochemicalReaction488" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction371">
 <bp:evidence rdf:resource="#Evidence427" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Kinetochore capture of astral microtubules is positively regulated by CDC42:GTP:p-S196-DIAPH2-2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep564">
 <bp:stepProcess rdf:resource="#BiochemicalReaction489" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction374">
 <bp:evidence rdf:resource="#Evidence430" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Association of profilin with monomeric actin</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep561">
 <bp:stepProcess rdf:resource="#BiochemicalReaction486" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction373">
 <bp:evidence rdf:resource="#Evidence429" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FMNL3 binds RHOC:GTP</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep562">
 <bp:stepProcess rdf:resource="#BiochemicalReaction487" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep560">
 <bp:stepProcess rdf:resource="#Pathway76" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction370">
 <bp:evidence rdf:resource="#Evidence426" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOD:GTP:DIAPH2-3 recruits SRC-1 to endosomes</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep558">
 <bp:stepProcess rdf:resource="#Catalysis200" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction484" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep559">
 <bp:stepProcess rdf:resource="#BiochemicalReaction485" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep556">
 <bp:stepProcess rdf:resource="#BiochemicalReaction482" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep557">
 <bp:stepProcess rdf:resource="#BiochemicalReaction483" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep554">
 <bp:stepProcess rdf:resource="#Catalysis199" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction480" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep555">
 <bp:stepProcess rdf:resource="#BiochemicalReaction481" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2426">
 <bp:evidence rdf:resource="#Evidence2789" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of clathrin-coated vesicle</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2425">
 <bp:evidence rdf:resource="#Evidence2788" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Axonal transport of NGF:Trk complexes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2424">
 <bp:evidence rdf:resource="#Evidence2787" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Endocytosis (internalization) of clathrin-coated vesicle</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2423">
 <bp:evidence rdf:resource="#Evidence2784" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pro-beta-NGF homodimer transits to the golgi apparatus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2422">
 <bp:evidence rdf:resource="#Evidence2783" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pro-beta-NGF dimerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2421">
 <bp:evidence rdf:resource="#Evidence2782" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The signal peptide is excised from beta-NGF pre-pro-precursor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2420">
 <bp:evidence rdf:resource="#Evidence2781" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pro-beta-NGF and mature beta-NGF are secreted</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep552">
 <bp:stepProcess rdf:resource="#BiochemicalReaction479" />
 <bp:stepProcess rdf:resource="#Catalysis198" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep553">
 <bp:stepProcess rdf:resource="#Pathway75" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep550">
 <bp:stepProcess rdf:resource="#BiochemicalReaction477" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep551">
 <bp:stepProcess rdf:resource="#BiochemicalReaction478" />
 <bp:stepProcess rdf:resource="#Catalysis197" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2429">
 <bp:evidence rdf:resource="#Evidence2794" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ADCYAP1(2-742) binds ADCYAP1R1 and NTRK1,2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2428">
 <bp:evidence rdf:resource="#Evidence2793" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTRK1,2 in Ade-Rib:ADORA2A:NTRK1,2 autophosphorylates</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2427">
 <bp:evidence rdf:resource="#Evidence2792" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ade-Rib binds AODORA2A and NTRK1,2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep549">
 <bp:stepProcess rdf:resource="#Pathway74" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep547">
 <bp:stepProcess rdf:resource="#BiochemicalReaction475" />
 <bp:stepProcess rdf:resource="#Catalysis196" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep548">
 <bp:stepProcess rdf:resource="#BiochemicalReaction476" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep545">
 <bp:stepProcess rdf:resource="#BiochemicalReaction473" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep546">
 <bp:stepProcess rdf:resource="#BiochemicalReaction474" />
 <bp:stepProcess rdf:resource="#Catalysis195" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep543">
 <bp:stepProcess rdf:resource="#BiochemicalReaction471" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep544">
 <bp:stepProcess rdf:resource="#BiochemicalReaction472" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2415">
 <bp:evidence rdf:resource="#Evidence2774" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTRK2 phosphorylates FRS3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2414">
 <bp:evidence rdf:resource="#Evidence2773" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTRK2-phosphorylated FRS2 binds PTPN11</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2413">
 <bp:evidence rdf:resource="#Evidence2772" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTRK2 activates RAS signaling through FRS2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2412">
 <bp:evidence rdf:resource="#Evidence2771" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated NTRK2 binds FRS3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2411">
 <bp:evidence rdf:resource="#Evidence2769" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BDNF binds NTRK2 (TRKB)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2410">
 <bp:evidence rdf:resource="#Evidence2768" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BDNF-bound NTRK2 dimers trans-autophosphorylate</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep541">
 <bp:stepProcess rdf:resource="#BiochemicalReaction470" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep542">
 <bp:stepProcess rdf:resource="#Pathway73" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep540">
 <bp:stepProcess rdf:resource="#BiochemicalReaction469" />
 <bp:stepProcess rdf:resource="#Catalysis194" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2419">
 <bp:evidence rdf:resource="#Evidence2780" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Part of pro-beta-NGF is processed to mature beta-NGF</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2418">
 <bp:evidence rdf:resource="#Evidence2777" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTRK2-phosphorylated FRS2 binds GRB2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2417">
 <bp:evidence rdf:resource="#Evidence2776" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTRK2 phosphorylates FRS2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2416">
 <bp:evidence rdf:resource="#Evidence2775" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated NTRK2 binds FRS2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep538">
 <bp:stepProcess rdf:resource="#BiochemicalReaction467" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep539">
 <bp:stepProcess rdf:resource="#BiochemicalReaction468" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep536">
 <bp:stepProcess rdf:resource="#BiochemicalReaction465" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep537">
 <bp:stepProcess rdf:resource="#Catalysis193" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction466" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep534">
 <bp:stepProcess rdf:resource="#BiochemicalReaction464" />
 <bp:stepProcess rdf:resource="#Catalysis192" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep535">
 <bp:stepProcess rdf:resource="#Pathway72" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep532">
 <bp:stepProcess rdf:resource="#BiochemicalReaction462" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep533">
 <bp:stepProcess rdf:resource="#BiochemicalReaction463" />
 <bp:stepProcess rdf:resource="#Catalysis191" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2404">
 <bp:evidence rdf:resource="#Evidence2761" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTRK2 promotes TIAM1 phosphorylation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2403">
 <bp:evidence rdf:resource="#Evidence2760" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTRK2 phosphorylates CDK5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2402">
 <bp:evidence rdf:resource="#Evidence2758" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated PCLG1 dissociates from NTRK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2401">
 <bp:evidence rdf:resource="#Evidence2757" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y817 of p-5Y-NTRK2 recruits PLCG1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2400">
 <bp:evidence rdf:resource="#Evidence2756" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTRK2 phosphorylates PLCG1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep530">
 <bp:stepProcess rdf:resource="#BiochemicalReaction461" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep531">
 <bp:stepProcess rdf:resource="#Pathway71" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2409">
 <bp:evidence rdf:resource="#Evidence2767" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BDNF-bound NTRK2 dimerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2408">
 <bp:evidence rdf:resource="#Evidence2765" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated NTRK2 binds CDK5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2407">
 <bp:evidence rdf:resource="#Evidence2764" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTRK2 binds TIAM1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2406">
 <bp:evidence rdf:resource="#Evidence2763" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTRK2 and CDK5 promote activation of RAC1 by TIAM1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2405">
 <bp:evidence rdf:resource="#Evidence2762" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDK5 phosphorylates NTRK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep527">
 <bp:stepProcess rdf:resource="#BiochemicalReaction458" />
 <bp:stepProcess rdf:resource="#Catalysis190" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep528">
 <bp:stepProcess rdf:resource="#BiochemicalReaction459" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep525">
 <bp:stepProcess rdf:resource="#BiochemicalReaction456" />
 <bp:stepProcess rdf:resource="#Catalysis189" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep526">
 <bp:stepProcess rdf:resource="#BiochemicalReaction457" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep523">
 <bp:stepProcess rdf:resource="#Catalysis188" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction455" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep524">
 <bp:stepProcess rdf:resource="#Pathway70" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep521">
 <bp:stepProcess rdf:resource="#Catalysis187" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction453" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep522">
 <bp:stepProcess rdf:resource="#BiochemicalReaction454" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep529">
 <bp:stepProcess rdf:resource="#BiochemicalReaction460" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep520">
 <bp:stepProcess rdf:resource="#BiochemicalReaction452" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep516">
 <bp:stepProcess rdf:resource="#Pathway68" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep517">
 <bp:stepProcess rdf:resource="#BiochemicalReaction450" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1980">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep514">
 <bp:stepProcess rdf:resource="#BiochemicalReaction449" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1981">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep515">
 <bp:stepProcess rdf:resource="#Pathway67" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1982">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep512">
 <bp:stepProcess rdf:resource="#BiochemicalReaction447" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1983">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep513">
 <bp:stepProcess rdf:resource="#BiochemicalReaction448" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1984">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep510">
 <bp:stepProcess rdf:resource="#BiochemicalReaction445" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1985">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep511">
 <bp:stepProcess rdf:resource="#BiochemicalReaction446" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1986">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1131">
 <bp:evidence rdf:resource="#Evidence1303" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">P2Y9 receptor can bind to LPA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2462">
 <bp:evidence rdf:resource="#Evidence2835" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHC, complexed with TrkA, is tyrosine-phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1130">
 <bp:evidence rdf:resource="#Evidence1302" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">P2RY12 binds P2RY12 antagonists</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2461">
 <bp:evidence rdf:resource="#Evidence2834" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Guanine nucleotide exchange on RAL</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2460">
 <bp:evidence rdf:resource="#Evidence2833" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding and activation of MAP Kinase</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep518">
 <bp:stepProcess rdf:resource="#BiochemicalReaction451" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep519">
 <bp:stepProcess rdf:resource="#Pathway69" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1139">
 <bp:evidence rdf:resource="#Evidence1311" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">P2Y5 receptor can bind to LPA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1138">
 <bp:evidence rdf:resource="#Evidence1310" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">P2Y14 receptor can bind to UDP-glucose</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2469">
 <bp:evidence rdf:resource="#Evidence2844" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EGR1 binds to the EGR1 promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1137">
 <bp:evidence rdf:resource="#Evidence1309" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">P2Y11 receptor can bind to ATP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2468">
 <bp:evidence rdf:resource="#Evidence2843" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ARC gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1136">
 <bp:evidence rdf:resource="#Evidence1308" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">P2Y4 receptor can bind to UTP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2467">
 <bp:evidence rdf:resource="#Evidence2842" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EGR1 and NAB co-repressors bind EGR1 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1135">
 <bp:evidence rdf:resource="#Evidence1307" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">P2Y6 receptor can bind to UDP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2466">
 <bp:evidence rdf:resource="#Evidence2839" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRB2-1:SOS1 binds p-Y-SHC</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1134">
 <bp:evidence rdf:resource="#Evidence1306" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">P2RY1 binds ADP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2465">
 <bp:evidence rdf:resource="#Evidence2838" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRB2-1:SOS1:p-Y-SHC mediated nucleotide exchange of RAS</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1133">
 <bp:evidence rdf:resource="#Evidence1305" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">P2Y10 receptor can bind to LPA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2464">
 <bp:evidence rdf:resource="#Evidence2837" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHC binds to the activated TrkA receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1132">
 <bp:evidence rdf:resource="#Evidence1304" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">P2Y13 binds ADP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2463">
 <bp:evidence rdf:resource="#Evidence2836" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phospho-Shc dissociates from the TrkA receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1987">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1988">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1989">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction303">
 <bp:evidence rdf:resource="#Evidence347" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAS:GTP binds PI3K</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep505">
 <bp:stepProcess rdf:resource="#BiochemicalReaction441" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction302">
 <bp:evidence rdf:resource="#Evidence346" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SPRED dimer binds NF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep506">
 <bp:stepProcess rdf:resource="#BiochemicalReaction442" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction305">
 <bp:evidence rdf:resource="#Evidence350" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&quot;Activator&quot; RAF:YWHAB dimer binds RAS:GTP</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep503">
 <bp:stepProcess rdf:resource="#Catalysis186" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction440" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1970">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction304">
 <bp:evidence rdf:resource="#Evidence348" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAS:GTP binds RAL GDS proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep504">
 <bp:stepProcess rdf:resource="#Pathway65" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1971">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep501">
 <bp:stepProcess rdf:resource="#Catalysis184" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction438" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1972">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep502">
 <bp:stepProcess rdf:resource="#Catalysis185" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction439" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1973">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction301">
 <bp:evidence rdf:resource="#Evidence345" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAS GAPs stimulate RAS GTPase activity</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1974">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction300">
 <bp:evidence rdf:resource="#Evidence344" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAS GAPs bind RAS:GTP</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep500">
 <bp:stepProcess rdf:resource="#BiochemicalReaction437" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1975">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1120">
 <bp:evidence rdf:resource="#Evidence1289" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AVPR1A,2 bind AVPR antagonists</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2451">
 <bp:evidence rdf:resource="#Evidence2822" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">(Frs2)Rap1-GTP binds to and activates B-Raf</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2450">
 <bp:evidence rdf:resource="#Evidence2821" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FRS2 binds to active TrkA receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction307">
 <bp:evidence rdf:resource="#Evidence352" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Inactive RAFs bind YWHAB</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep509">
 <bp:stepProcess rdf:resource="#BiochemicalReaction444" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction306">
 <bp:evidence rdf:resource="#Evidence351" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAS:GTP:&apos;activator&apos; RAF homo/heterodimerizes with other RAF monomers</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction309">
 <bp:evidence rdf:resource="#Evidence354" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">YWHAB dimer dissociates from dephosphorylated RAF</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep507">
 <bp:stepProcess rdf:resource="#BiochemicalReaction443" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction308">
 <bp:evidence rdf:resource="#Evidence353" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MARK3 phosphorylates KSR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep508">
 <bp:stepProcess rdf:resource="#Pathway66" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1128">
 <bp:evidence rdf:resource="#Evidence1299" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">A1 and A3 receptors bind adenosine</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2459">
 <bp:evidence rdf:resource="#Evidence2832" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ral-GDS binds to Ras-GTP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1127">
 <bp:evidence rdf:resource="#Evidence1296" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CMKLR1 binds Resolvin E1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2458">
 <bp:evidence rdf:resource="#Evidence2831" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38 MAPK phosphorylates MAPKAPK2, MAPKAPK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1126">
 <bp:evidence rdf:resource="#Evidence1295" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">OXGR1 binds 2OG</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2457">
 <bp:evidence rdf:resource="#Evidence2830" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SRC-1 autophosphorylates</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1125">
 <bp:evidence rdf:resource="#Evidence1294" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Neuropeptide Y receptors can bind neuropeptide Y-related peptides</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2456">
 <bp:evidence rdf:resource="#Evidence2827" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP2Ks phosphorylate MAPKs downstream of BRAF and NGF</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1124">
 <bp:evidence rdf:resource="#Evidence1293" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AVPR1A,B,2 bind atosiban</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2455">
 <bp:evidence rdf:resource="#Evidence2826" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-FRS2 binds CRKL</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1123">
 <bp:evidence rdf:resource="#Evidence1292" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AVP(20-28) binds AVPR1A,B</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2454">
 <bp:evidence rdf:resource="#Evidence2825" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated BRAF phosphorylates MAP2K dimers downstream of RAP1 and NGF</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1122">
 <bp:evidence rdf:resource="#Evidence1291" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AVP(20-28) binds AVPR2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2453">
 <bp:evidence rdf:resource="#Evidence2824" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated BRAF recruits MAP2Ks and MAPKs to the endosome</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1121">
 <bp:evidence rdf:resource="#Evidence1290" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Oxytocin receptor bind oxytocin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2452">
 <bp:evidence rdf:resource="#Evidence2823" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of phosphorylated MAP2Ks and MAPKs</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1976">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1977">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1978">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1979">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1129">
 <bp:evidence rdf:resource="#Evidence1300" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ADORA2A,B bind Ade-Rib</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1286">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1118" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2440">
 <bp:evidence rdf:resource="#Evidence2810" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Crk&apos;s SH3 domain engages C3G</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1285">
 <bp:stepProcess rdf:resource="#Pathway169" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1284">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1117" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1283">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1116" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1289">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1121" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1288">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1120" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1287">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1119" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1117">
 <bp:evidence rdf:resource="#Evidence1285" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">POMC(138-176) binds MC2R</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2448">
 <bp:evidence rdf:resource="#Evidence2819" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-T,Y MAPK dimers translocate to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1116">
 <bp:evidence rdf:resource="#Evidence1284" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Prolactin-releasing hormone receptor binds PRH</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2447">
 <bp:evidence rdf:resource="#Evidence2818" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FRS2 is phosphorylated by active TrkA receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1115">
 <bp:evidence rdf:resource="#Evidence1283" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Melanocortin receptors bind melanocortins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2446">
 <bp:evidence rdf:resource="#Evidence2817" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BRAF autophosphorylates downstream of RAP1 and NGF</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1114">
 <bp:evidence rdf:resource="#Evidence1282" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The Kiss receptor GPR54 binds kisspeptin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2445">
 <bp:evidence rdf:resource="#Evidence2816" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">(Frs2)C3G stimulates nucleotide exchange on Rap1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1113">
 <bp:evidence rdf:resource="#Evidence1281" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DARC  is a non-specific receptor for many chemokines</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1293">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1125" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2444">
 <bp:evidence rdf:resource="#Evidence2815" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-FRS2:CRKL binds C3G</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1112">
 <bp:evidence rdf:resource="#Evidence1280" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C5a receptor binds C5a anaphylatoxin</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1292">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1124" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2443">
 <bp:evidence rdf:resource="#Evidence2813" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ARMS:Crk complex binds to active TrkA receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1111">
 <bp:evidence rdf:resource="#Evidence1279" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AGT(34-41) binds to AGTR2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1291">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1123" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2442">
 <bp:evidence rdf:resource="#Evidence2812" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C3G stimulates nucleotide exchange on Rap1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1110">
 <bp:evidence rdf:resource="#Evidence1278" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Somatostatin receptors bind somatostatin and cortistatin</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1290">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1122" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2441">
 <bp:evidence rdf:resource="#Evidence2811" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ARMS is phosphorylated by active TrkA receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1119">
 <bp:evidence rdf:resource="#Evidence1288" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AVPR1A,B bind desmopressin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1118">
 <bp:evidence rdf:resource="#Evidence1287" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AVPR2 bind desmopressin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2449">
 <bp:evidence rdf:resource="#Evidence2820" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-T,Y MAPKs dimerize</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1990">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1991">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1992">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1993">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1994">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1995">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1996">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1997">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1297">
 <bp:stepProcess rdf:resource="#Pathway171" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1296">
 <bp:stepProcess rdf:resource="#Pathway170" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1295">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1127" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1294">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1126" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1299">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1129" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1298">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1128" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1106">
 <bp:evidence rdf:resource="#Evidence1274" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EDNRA, EDNRB bind non-selective ERAs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2437">
 <bp:evidence rdf:resource="#Evidence2805" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RIT/RIN are activated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1105">
 <bp:evidence rdf:resource="#Evidence1273" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EDNRA,EDNRB bind EDNs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2436">
 <bp:evidence rdf:resource="#Evidence2804" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RIT/RIN-GTP binds B-RAF</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1104">
 <bp:evidence rdf:resource="#Evidence1272" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Thyrotropin-releasing hormone receptor binds thyrotropin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2435">
 <bp:evidence rdf:resource="#Evidence2803" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRKA recruits RIT and RIN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1103">
 <bp:evidence rdf:resource="#Evidence1271" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">XK:KEL:Zn2+ cleaves EDN3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2434">
 <bp:evidence rdf:resource="#Evidence2800" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TrkA receptor autophosphorylates</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1102">
 <bp:evidence rdf:resource="#Evidence1270" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Proteinase-activated receptors can bind thrombin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2433">
 <bp:evidence rdf:resource="#Evidence2799" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TrkA receptor internalizes to endosomes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1101">
 <bp:evidence rdf:resource="#Evidence1269" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EDNRA binds selective ERAs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2432">
 <bp:evidence rdf:resource="#Evidence2798" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The bound receptor dimerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1100">
 <bp:evidence rdf:resource="#Evidence1268" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Neuromedin-U receptors bind neuromedins U, S</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2431">
 <bp:evidence rdf:resource="#Evidence2797" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">beta-NGF dimer binds to TrkA receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2430">
 <bp:evidence rdf:resource="#Evidence2795" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTRK1,2 in ADCYAP1(2-742):ADCYAP1R1:NTRK1,2 autophosphorylates</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1998">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1999">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1109">
 <bp:evidence rdf:resource="#Evidence1277" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C3a receptor binds anaphylatoxin C3a</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1108">
 <bp:evidence rdf:resource="#Evidence1276" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Bombesin-like receptors bind bombesin homologues</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2439">
 <bp:evidence rdf:resource="#Evidence2809" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BRAF in Rap1-GTP complex:BRAF complex autophosphorylates</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1107">
 <bp:evidence rdf:resource="#Evidence1275" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Melanin-concentrating hormone receptors bind MCH</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2438">
 <bp:evidence rdf:resource="#Evidence2808" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Rap1-GTP complex binds BRAF complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1943">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1707" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1942">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1706" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1941">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1705" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1940">
 <bp:stepProcess rdf:resource="#Catalysis490" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1704" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1947">
 <bp:stepProcess rdf:resource="#Pathway239" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1946">
 <bp:stepProcess rdf:resource="#Pathway238" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1820">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1945">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1709" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1821">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1944">
 <bp:stepProcess rdf:resource="#Catalysis491" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1708" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1822">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1823">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1824">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1949">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1711" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1825">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1948">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1710" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1826">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1827">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1828">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1829">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1954">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1715" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1953">
 <bp:stepProcess rdf:resource="#Pathway240" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1952">
 <bp:stepProcess rdf:resource="#Catalysis492" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1714" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1951">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1713" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1958">
 <bp:stepProcess rdf:resource="#Catalysis493" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1719" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1957">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1718" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1956">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1717" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1810">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1955">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1716" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1950">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1712" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1819">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1811">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1812">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1813">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1814">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1959">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1720" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1815">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1816">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1817">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1818">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1921">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1688" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1920">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1687" />
 <bp:stepProcess rdf:resource="#Catalysis482" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1840">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1925">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1692" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1841">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1924">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1691" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1842">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1923">
 <bp:stepProcess rdf:resource="#Catalysis483" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1690" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1843">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1922">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1689" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1844">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1929">
 <bp:stepProcess rdf:resource="#Pathway236" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1845">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1928">
 <bp:stepProcess rdf:resource="#Pathway235" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1846">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1927">
 <bp:stepProcess rdf:resource="#Catalysis484" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1694" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1847">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1926">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1693" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1848">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1849">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1932">
 <bp:stepProcess rdf:resource="#Catalysis485" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1696" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1931">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1695" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1930">
 <bp:stepProcess rdf:resource="#Pathway237" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1936">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1700" />
 <bp:stepProcess rdf:resource="#Catalysis487" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1830">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1935">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1699" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1831">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1934">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1698" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1832">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1933">
 <bp:stepProcess rdf:resource="#Catalysis486" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1697" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1833">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1834">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1939">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1703" />
 <bp:stepProcess rdf:resource="#Catalysis489" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1835">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1938">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1702" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1836">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1937">
 <bp:stepProcess rdf:resource="#Catalysis488" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1701" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1837">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1838">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1839">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1903">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1671" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1902">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1670" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1901">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1669" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1900">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1668" />
 <bp:stepProcess rdf:resource="#Catalysis478" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2624">
 <bp:evidence rdf:resource="#Evidence3035" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GALNT3 transfers GalNAc to FGF23</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2623">
 <bp:evidence rdf:resource="#Evidence3034" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Autocatalytic phosphorylation of FGFR3c</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2622">
 <bp:evidence rdf:resource="#Evidence3033" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GalNAc-T178-FGF23(25-251) translocates from Golgi lumen to extracellular region</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2621">
 <bp:evidence rdf:resource="#Evidence3032" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFR3c binds to FGF</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2620">
 <bp:evidence rdf:resource="#Evidence3028" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CBL ubiquitinates FRS2 and FGFR2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1907">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1674" />
 <bp:stepProcess rdf:resource="#Catalysis479" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1906">
 <bp:stepProcess rdf:resource="#Pathway234" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1905">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1673" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1904">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1672" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2629">
 <bp:evidence rdf:resource="#Evidence3043" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PPTN11 dephosphorylates SPRY2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2628">
 <bp:evidence rdf:resource="#Evidence3042" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SPRY2 translocates to the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2627">
 <bp:evidence rdf:resource="#Evidence3041" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SPRY2 binds GRB2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1909">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1676" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2626">
 <bp:evidence rdf:resource="#Evidence3038" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Autocatalytic phosphorylation of FGFR3b</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1908">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1675" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2625">
 <bp:evidence rdf:resource="#Evidence3037" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFR3b binds to FGF</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1910">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1677" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1914">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1681" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1913">
 <bp:stepProcess rdf:resource="#Catalysis481" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1680" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1912">
 <bp:stepProcess rdf:resource="#Catalysis480" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1679" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1911">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1678" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2613">
 <bp:evidence rdf:resource="#Evidence3021" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SPRY2 binds CBL</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2612">
 <bp:evidence rdf:resource="#Evidence3020" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CBL dissociates from ubiquitinated p-SPRY2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2611">
 <bp:evidence rdf:resource="#Evidence3019" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">B-RAF dissociates from S111/S120 p-SPRY2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2610">
 <bp:evidence rdf:resource="#Evidence3018" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SRC phosphorylates SPRY2 on Y55 and Y227</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1918">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1685" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1917">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1684" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1916">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1683" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2619">
 <bp:evidence rdf:resource="#Evidence3027" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated ERK1/2 threonine-phosphorylates FGFR2-associated FRS2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1915">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1682" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2618">
 <bp:evidence rdf:resource="#Evidence3026" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-CBL:GRB2 binds p-FRS2:activated FGFR2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2617">
 <bp:evidence rdf:resource="#Evidence3025" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SPRY2 is phosphorylated by phosphorylated MNK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2616">
 <bp:evidence rdf:resource="#Evidence3024" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SPRY2 is serine phosphorylated in response to MAPK activation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2615">
 <bp:evidence rdf:resource="#Evidence3023" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated SPRY2 is ubiquitinated by CBL</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1919">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1686" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2614">
 <bp:evidence rdf:resource="#Evidence3022" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PPA2A dephosphorylates SPRY2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1808">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2602">
 <bp:evidence rdf:resource="#Evidence3007" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Autocatalytic phosphorylation of FGFR2b</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1809">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2601">
 <bp:evidence rdf:resource="#Evidence3004" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ESRP1 and 2 bind FGFR2 pre-mRNA to promote FGFR2b maturation and expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2600">
 <bp:evidence rdf:resource="#Evidence3003" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTB and hnRNPA1 bind FGFR2 pre-mRNA to repress IIIb splicing and promote formation of FGFR2c mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1800">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1801">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2609">
 <bp:evidence rdf:resource="#Evidence3017" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PPTN11 dephosphorylates SPRY2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1802">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2608">
 <bp:evidence rdf:resource="#Evidence3016" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SPRY2 translocates to the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1803">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2607">
 <bp:evidence rdf:resource="#Evidence3015" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SPRY2 binds GRB2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1804">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2606">
 <bp:evidence rdf:resource="#Evidence3012" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFR2c binds to FGF</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1805">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2605">
 <bp:evidence rdf:resource="#Evidence3011" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Autocatalytic phosphorylation of FGFR2c</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1806">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2604">
 <bp:evidence rdf:resource="#Evidence3009" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFBPs bind FGFs</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1807">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2603">
 <bp:evidence rdf:resource="#Evidence3008" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFR2b binds to FGF</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence298">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis309">
 <bp:controlled rdf:resource="#BiochemicalReaction883" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence299">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis308">
 <bp:controlled rdf:resource="#BiochemicalReaction882" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence294">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis305">
 <bp:controlled rdf:resource="#BiochemicalReaction879" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence295">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis304">
 <bp:controlled rdf:resource="#BiochemicalReaction877" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence296">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis307">
 <bp:controlled rdf:resource="#BiochemicalReaction881" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence297">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis306">
 <bp:controlled rdf:resource="#BiochemicalReaction880" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence290">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis301">
 <bp:controlled rdf:resource="#BiochemicalReaction871" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence291">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis300">
 <bp:controlled rdf:resource="#BiochemicalReaction867" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence292">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis303">
 <bp:controlled rdf:resource="#BiochemicalReaction876" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence293">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis302">
 <bp:controlled rdf:resource="#BiochemicalReaction875" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis310">
 <bp:controlled rdf:resource="#BiochemicalReaction884" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence287">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence288">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis319">
 <bp:controlled rdf:resource="#BiochemicalReaction904" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence289">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence283">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis316">
 <bp:controlled rdf:resource="#BiochemicalReaction894" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence284">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis315">
 <bp:controlled rdf:resource="#BiochemicalReaction892" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence285">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis318">
 <bp:controlled rdf:resource="#BiochemicalReaction901" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence286">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis317">
 <bp:controlled rdf:resource="#BiochemicalReaction900" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis312">
 <bp:controlled rdf:resource="#BiochemicalReaction887" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence280">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis311">
 <bp:controlled rdf:resource="#BiochemicalReaction886" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence281">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis314">
 <bp:controlled rdf:resource="#BiochemicalReaction890" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence282">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis313">
 <bp:controlled rdf:resource="#BiochemicalReaction889" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis321">
 <bp:controlled rdf:resource="#BiochemicalReaction907" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis320">
 <bp:controlled rdf:resource="#BiochemicalReaction905" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1987">
 <bp:stepProcess rdf:resource="#Pathway242" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1986">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1746" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1985">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1745" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1984">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1744" />
 <bp:stepProcess rdf:resource="#Catalysis500" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence276">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence277">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence278">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1989">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1748" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence279">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1988">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1747" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence272">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence273">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence274">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence275">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1983">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1743" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1982">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1742" />
 <bp:stepProcess rdf:resource="#Catalysis499" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence270">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1981">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1741" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence271">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1980">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1740" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence269">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1998">
 <bp:stepProcess rdf:resource="#Catalysis502" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1756" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1997">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1755" />
 <bp:stepProcess rdf:resource="#Catalysis501" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1996">
 <bp:stepProcess rdf:resource="#Pathway243" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1995">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1754" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence265">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence266">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence267">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence268">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1999">
 <bp:stepProcess rdf:resource="#Catalysis503" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1757" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence261">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1990">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1749" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence262">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence263">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence264">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1994">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1753" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1993">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1752" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1992">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1751" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence260">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1991">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1750" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence258">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1965">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1726" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence259">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1964">
 <bp:stepProcess rdf:resource="#Catalysis495" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1725" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1963">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1724" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1962">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1723" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence254">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1969">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1730" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence255">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1968">
 <bp:stepProcess rdf:resource="#Catalysis496" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1729" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence256">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1967">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1728" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence257">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1966">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1727" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence250">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence251">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence252">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence253">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1961">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1722" />
 <bp:stepProcess rdf:resource="#Catalysis494" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1960">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1721" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence247">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1976">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1736" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence248">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1975">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1735" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence249">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1974">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1734" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1973">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1733" />
 <bp:stepProcess rdf:resource="#Catalysis497" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence243">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence244">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1979">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1739" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence245">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1978">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1738" />
 <bp:stepProcess rdf:resource="#Catalysis498" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence246">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1977">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1737" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence240">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence241">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence242">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1972">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1732" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1971">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1731" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1970">
 <bp:stepProcess rdf:resource="#Pathway241" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence236">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction699">
 <bp:evidence rdf:resource="#Evidence810" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WLS:WNT complex is internalized for maturation into exosomes</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence237">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction698">
 <bp:evidence rdf:resource="#Evidence809" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Retromer recycles WLS to the Golgi</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence238">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence239">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence232">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction695">
 <bp:evidence rdf:resource="#Evidence806" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WLS dissociates from retromer</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence233">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction694">
 <bp:evidence rdf:resource="#Evidence805" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PORCN palmitoleoylates N-glycosyl WNTs</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence234">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction697">
 <bp:evidence rdf:resource="#Evidence808" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WNTs are secreted in exosomes</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence235">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction696">
 <bp:evidence rdf:resource="#Evidence807" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WNT ligands traffic to the Golgi</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1296">
 <bp:evidence rdf:resource="#Evidence1489" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of RIAM to plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis249">
 <bp:controlled rdf:resource="#BiochemicalReaction651" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1295">
 <bp:evidence rdf:resource="#Evidence1488" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Integrin alpha IIb beta3 T779 phosphorylation blocks SHC binding</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence230">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1294">
 <bp:evidence rdf:resource="#Evidence1487" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SYK activation by SRC</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence231">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1293">
 <bp:evidence rdf:resource="#Evidence1486" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHC1 bound to integrin alphaIIb beta3 is phosphorylated somehow</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis246">
 <bp:controlled rdf:resource="#BiochemicalReaction644" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1292">
 <bp:evidence rdf:resource="#Evidence1485" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated integrin alphaIIb beta3 binds SHC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis245">
 <bp:controlled rdf:resource="#BiochemicalReaction641" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1291">
 <bp:evidence rdf:resource="#Evidence1484" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SYK binds to integrin alphaIIb beta3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis248">
 <bp:controlled rdf:resource="#BiochemicalReaction648" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1290">
 <bp:evidence rdf:resource="#Evidence1483" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of BCAR1 by SRC-PTK2 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis247">
 <bp:controlled rdf:resource="#BiochemicalReaction645" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis253">
 <bp:controlled rdf:resource="#BiochemicalReaction661" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis252">
 <bp:controlled rdf:resource="#BiochemicalReaction660" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis255">
 <bp:controlled rdf:resource="#BiochemicalReaction668" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis254">
 <bp:controlled rdf:resource="#BiochemicalReaction667" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1299">
 <bp:evidence rdf:resource="#Evidence1492" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Clustering of Integrin alphaIIb beta3 complexes</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis251">
 <bp:controlled rdf:resource="#BiochemicalReaction659" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1298">
 <bp:evidence rdf:resource="#Evidence1491" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of pPTK2 by SRC</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis250">
 <bp:controlled rdf:resource="#BiochemicalReaction654" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1297">
 <bp:evidence rdf:resource="#Evidence1490" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Release of CSK from SRC</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence225">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence226">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence227">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence228">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence221">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence222">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence223">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence224">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1285">
 <bp:evidence rdf:resource="#Evidence1476" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WWTR1 (TAZ) binds ZO-1 (TJP1)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1284">
 <bp:evidence rdf:resource="#Evidence1475" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WWTR1 (TAZ) binds ZO-2 (TJP2)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1283">
 <bp:evidence rdf:resource="#Evidence1474" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">YWHAB (14-3-3 beta/alpha) dimer binds phosphorylated YAP1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence220">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1282">
 <bp:evidence rdf:resource="#Evidence1473" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">YAP1 binds ZO-2 (TJP2)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis257">
 <bp:controlled rdf:resource="#BiochemicalReaction670" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1281">
 <bp:evidence rdf:resource="#Evidence1472" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of YAP by LATS2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis256">
 <bp:controlled rdf:resource="#BiochemicalReaction669" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1280">
 <bp:evidence rdf:resource="#Evidence1471" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of WWTR1 (TAZ) by LATS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis259">
 <bp:controlled rdf:resource="#BiochemicalReaction673" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis258">
 <bp:controlled rdf:resource="#BiochemicalReaction671" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis264">
 <bp:controlled rdf:resource="#BiochemicalReaction722" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis263">
 <bp:controlled rdf:resource="#BiochemicalReaction707" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis266">
 <bp:controlled rdf:resource="#BiochemicalReaction724" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis265">
 <bp:controlled rdf:resource="#BiochemicalReaction723" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis260">
 <bp:controlled rdf:resource="#BiochemicalReaction675" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1289">
 <bp:evidence rdf:resource="#Evidence1482" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of BCAR1 to PTK2 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1288">
 <bp:evidence rdf:resource="#Evidence1481" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Crk binding to p130cas</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis262">
 <bp:controlled rdf:resource="#BiochemicalReaction694" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1287">
 <bp:evidence rdf:resource="#Evidence1479" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHC1 dissociates from integrin alphaIIb beta3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis261">
 <bp:controlled rdf:resource="#BiochemicalReaction680" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1286">
 <bp:evidence rdf:resource="#Evidence1478" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of integrin alphaIIb beta3 with Fibrinogen</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence229">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence214">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction677">
 <bp:evidence rdf:resource="#Evidence786" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of beta-catenin from Axin and association of beta catenin with phospho-(20 aa) APC in the detruction complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence215">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction676">
 <bp:evidence rdf:resource="#Evidence785" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Assembly of the destruction complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence216">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction679">
 <bp:evidence rdf:resource="#Evidence788" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of AMER1 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence217">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction678">
 <bp:evidence rdf:resource="#Evidence787" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of AXIN1 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence210">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction673">
 <bp:evidence rdf:resource="#Evidence782" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Degradation of ubiquitinated beta catenin by the proteasome</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence211">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction672">
 <bp:evidence rdf:resource="#Evidence781" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Association of beta-catenin with the destruction complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence212">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction675">
 <bp:evidence rdf:resource="#Evidence784" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AXIN is phosphorylated in the destruction complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence213">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction674">
 <bp:evidence rdf:resource="#Evidence783" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Multi-ubiquitination of phospho-beta-catenin by RBX1:SCF(beta-TrCP1)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1274">
 <bp:evidence rdf:resource="#Evidence1465" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of YAP by LATS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1273">
 <bp:evidence rdf:resource="#Evidence1464" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DVL2 binds phosphorylated WWTR1 (TAZ)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1272">
 <bp:evidence rdf:resource="#Evidence1463" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of STK4 (MST1) and SAV1 by STK4</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis89">
 <bp:controlled rdf:resource="#BiochemicalReaction192" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1271">
 <bp:evidence rdf:resource="#Evidence1462" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AMOT proteins bind WWTR1 (TAZ)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis88">
 <bp:controlled rdf:resource="#BiochemicalReaction190" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis268">
 <bp:controlled rdf:resource="#BiochemicalReaction733" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1270">
 <bp:evidence rdf:resource="#Evidence1461" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KIBRA (WWC1) binds LATS proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis87">
 <bp:controlled rdf:resource="#BiochemicalReaction187" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis267">
 <bp:controlled rdf:resource="#BiochemicalReaction729" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis86">
 <bp:controlled rdf:resource="#BiochemicalReaction186" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis85">
 <bp:controlled rdf:resource="#BiochemicalReaction185" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis269">
 <bp:controlled rdf:resource="#BiochemicalReaction734" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis84">
 <bp:controlled rdf:resource="#BiochemicalReaction184" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis275">
 <bp:controlled rdf:resource="#BiochemicalReaction785" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis83">
 <bp:controlled rdf:resource="#BiochemicalReaction182" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis274">
 <bp:controlled rdf:resource="#BiochemicalReaction770" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis82">
 <bp:controlled rdf:resource="#BiochemicalReaction178" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis277">
 <bp:controlled rdf:resource="#BiochemicalReaction787" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis81">
 <bp:controlled rdf:resource="#BiochemicalReaction177" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis276">
 <bp:controlled rdf:resource="#BiochemicalReaction786" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1279">
 <bp:evidence rdf:resource="#Evidence1470" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">YWHAE (14-3-3 epsilon) dimer binds phosphorylated WWTR1 (TAZ)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis80">
 <bp:controlled rdf:resource="#BiochemicalReaction175" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis271">
 <bp:controlled rdf:resource="#BiochemicalReaction740" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1278">
 <bp:evidence rdf:resource="#Evidence1469" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of LATS1 and 2 by p-STK3 (p-MST2)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis270">
 <bp:controlled rdf:resource="#BiochemicalReaction738" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1277">
 <bp:evidence rdf:resource="#Evidence1468" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of STK3 (MST2) and SAV1 by STK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis273">
 <bp:controlled rdf:resource="#BiochemicalReaction751" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1276">
 <bp:evidence rdf:resource="#Evidence1467" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of WWTR1 (TAZ) by LATS2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis272">
 <bp:controlled rdf:resource="#BiochemicalReaction748" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1275">
 <bp:evidence rdf:resource="#Evidence1466" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AMOT proteins bind YAP1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction680">
 <bp:evidence rdf:resource="#Evidence789" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">APC is K63-polyubiquitinated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction682">
 <bp:evidence rdf:resource="#Evidence792" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transcription of canonical WNT targets is repressed by the TLE:HDAC and TCF/CTBP complexes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction681">
 <bp:evidence rdf:resource="#Evidence790" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ZRANB1 binds APC</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence218">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence219">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence203">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction688">
 <bp:evidence rdf:resource="#Evidence798" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLE forms non-functional complexes with AES</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence204">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction687">
 <bp:evidence rdf:resource="#Evidence797" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TCF7L2/TCF7L1 bind CTBP1 to repress WNT target genes</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence205">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence206">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction689">
 <bp:evidence rdf:resource="#Evidence800" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WLS binds WNT ligands in the Golgi</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction684">
 <bp:evidence rdf:resource="#Evidence794" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLE recruits HDAC1 to WNT promoters</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence200">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction683">
 <bp:evidence rdf:resource="#Evidence793" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLE oligomerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence201">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction686">
 <bp:evidence rdf:resource="#Evidence796" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLE tetramers bind TCF/LEF at WNT promoters</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence202">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction685">
 <bp:evidence rdf:resource="#Evidence795" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TCF/LEF binds WNT promoters</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1263">
 <bp:evidence rdf:resource="#Evidence1454" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of LATS1 and 2 by p-STK4 (p-MST1)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2594">
 <bp:evidence rdf:resource="#Evidence2996" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of PIK3 regulatory alpha subunit to GRB2:GAB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1262">
 <bp:evidence rdf:resource="#Evidence1453" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MOB1A proteins associate with LATS proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2593">
 <bp:evidence rdf:resource="#Evidence2995" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR2:p-FRS2:p-PPTN11 binds GRB2:GAB1:PI3KR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1261">
 <bp:evidence rdf:resource="#Evidence1452" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of MOB1A and B by p-STK4 (p-MST1)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2592">
 <bp:evidence rdf:resource="#Evidence2994" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFR2-associated PI3K phosphorylates PIP2 to PIP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1260">
 <bp:evidence rdf:resource="#Evidence1451" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cleavage of p-STK4 (p-MST1) by caspase 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2591">
 <bp:evidence rdf:resource="#Evidence2993" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFR2- and PTPN11- associated PI3K phosphorylates PIP2 to PIP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis99">
 <bp:controlled rdf:resource="#BiochemicalReaction218" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis279">
 <bp:controlled rdf:resource="#BiochemicalReaction795" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2590">
 <bp:evidence rdf:resource="#Evidence2991" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR2:pFRS binds GRB2:SOS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis98">
 <bp:controlled rdf:resource="#BiochemicalReaction216" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis278">
 <bp:controlled rdf:resource="#BiochemicalReaction792" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis97">
 <bp:controlled rdf:resource="#BiochemicalReaction207" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis96">
 <bp:controlled rdf:resource="#BiochemicalReaction204" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis95">
 <bp:controlled rdf:resource="#BiochemicalReaction203" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis286">
 <bp:controlled rdf:resource="#BiochemicalReaction817" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis94">
 <bp:controlled rdf:resource="#BiochemicalReaction201" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis285">
 <bp:controlled rdf:resource="#BiochemicalReaction813" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis93">
 <bp:controlled rdf:resource="#BiochemicalReaction199" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis288">
 <bp:controlled rdf:resource="#BiochemicalReaction830" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1269">
 <bp:evidence rdf:resource="#Evidence1460" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of MOB1A and B by p-STK4(MST1)/N</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis92">
 <bp:controlled rdf:resource="#BiochemicalReaction197" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis287">
 <bp:controlled rdf:resource="#BiochemicalReaction821" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1268">
 <bp:evidence rdf:resource="#Evidence1459" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of WWTR1 (TAZ) to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2599">
 <bp:evidence rdf:resource="#Evidence3002" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFR2c-specific alternative splicing produces FGFR2c transcript</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis91">
 <bp:controlled rdf:resource="#BiochemicalReaction195" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis282">
 <bp:controlled rdf:resource="#BiochemicalReaction800" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1267">
 <bp:evidence rdf:resource="#Evidence1458" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of LATS1 and 2 by p-STK3 (MST2)/N</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2598">
 <bp:evidence rdf:resource="#Evidence3001" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFR2b-specific alternative splicing produces FGFR2b transcript</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis90">
 <bp:controlled rdf:resource="#BiochemicalReaction193" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis281">
 <bp:controlled rdf:resource="#BiochemicalReaction799" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1266">
 <bp:evidence rdf:resource="#Evidence1457" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of YAP1 to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2597">
 <bp:evidence rdf:resource="#Evidence2999" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR2:p-FRS2:GRB2:GAB1:PI3KR1 binds PIK3CA</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis284">
 <bp:controlled rdf:resource="#BiochemicalReaction811" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1265">
 <bp:evidence rdf:resource="#Evidence1456" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of MOB1A and B by p-STK3(MST2)/N</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2596">
 <bp:evidence rdf:resource="#Evidence2998" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR2:p-FRS2 binds GRB2:GAB1:PIK3R1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis283">
 <bp:controlled rdf:resource="#BiochemicalReaction807" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1264">
 <bp:evidence rdf:resource="#Evidence1455" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of LATS1 and 2 by p-STK4(MST1)/N</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2595">
 <bp:evidence rdf:resource="#Evidence2997" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR2:p-FRS2:p-PPTN11:GRB2:GAB1:PIK3R1 binds PIK3CA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction691">
 <bp:evidence rdf:resource="#Evidence802" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">secretion of WNT ligands</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction690">
 <bp:evidence rdf:resource="#Evidence801" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">N-linked glycosylation of WNTs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction693">
 <bp:evidence rdf:resource="#Evidence804" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WLS is endocytosed to the early endosome</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis280">
 <bp:controlled rdf:resource="#BiochemicalReaction796" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction692">
 <bp:evidence rdf:resource="#Evidence803" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WNT ligands traffic to the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence207">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence208">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence209">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis209">
 <bp:controlled rdf:resource="#BiochemicalReaction524" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis206">
 <bp:controlled rdf:resource="#BiochemicalReaction510" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis205">
 <bp:controlled rdf:resource="#BiochemicalReaction506" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis208">
 <bp:controlled rdf:resource="#BiochemicalReaction518" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis207">
 <bp:controlled rdf:resource="#BiochemicalReaction517" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis202">
 <bp:controlled rdf:resource="#BiochemicalReaction493" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis201">
 <bp:controlled rdf:resource="#BiochemicalReaction492" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis204">
 <bp:controlled rdf:resource="#BiochemicalReaction504" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis203">
 <bp:controlled rdf:resource="#BiochemicalReaction496" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis211">
 <bp:controlled rdf:resource="#BiochemicalReaction530" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis210">
 <bp:controlled rdf:resource="#BiochemicalReaction527" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis217">
 <bp:controlled rdf:resource="#BiochemicalReaction564" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis216">
 <bp:controlled rdf:resource="#BiochemicalReaction549" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis219">
 <bp:controlled rdf:resource="#BiochemicalReaction567" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis218">
 <bp:controlled rdf:resource="#BiochemicalReaction565" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis213">
 <bp:controlled rdf:resource="#BiochemicalReaction535" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis212">
 <bp:controlled rdf:resource="#BiochemicalReaction533" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis215">
 <bp:controlled rdf:resource="#BiochemicalReaction547" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis214">
 <bp:controlled rdf:resource="#BiochemicalReaction542" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis220">
 <bp:controlled rdf:resource="#BiochemicalReaction569" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis222">
 <bp:controlled rdf:resource="#BiochemicalReaction573" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis221">
 <bp:controlled rdf:resource="#BiochemicalReaction572" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis228">
 <bp:controlled rdf:resource="#BiochemicalReaction585" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis227">
 <bp:controlled rdf:resource="#BiochemicalReaction584" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis229">
 <bp:controlled rdf:resource="#BiochemicalReaction586" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis224">
 <bp:controlled rdf:resource="#BiochemicalReaction578" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis223">
 <bp:controlled rdf:resource="#BiochemicalReaction577" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis226">
 <bp:controlled rdf:resource="#BiochemicalReaction582" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis225">
 <bp:controlled rdf:resource="#BiochemicalReaction579" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis231">
 <bp:controlled rdf:resource="#BiochemicalReaction589" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis230">
 <bp:controlled rdf:resource="#BiochemicalReaction587" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis233">
 <bp:controlled rdf:resource="#BiochemicalReaction600" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis232">
 <bp:controlled rdf:resource="#BiochemicalReaction597" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis239">
 <bp:controlled rdf:resource="#BiochemicalReaction619" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis238">
 <bp:controlled rdf:resource="#BiochemicalReaction615" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis235">
 <bp:controlled rdf:resource="#BiochemicalReaction612" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis234">
 <bp:controlled rdf:resource="#BiochemicalReaction610" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis237">
 <bp:controlled rdf:resource="#BiochemicalReaction614" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis236">
 <bp:controlled rdf:resource="#BiochemicalReaction613" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis242">
 <bp:controlled rdf:resource="#BiochemicalReaction636" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis241">
 <bp:controlled rdf:resource="#BiochemicalReaction632" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis244">
 <bp:controlled rdf:resource="#BiochemicalReaction639" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis243">
 <bp:controlled rdf:resource="#BiochemicalReaction637" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis240">
 <bp:controlled rdf:resource="#BiochemicalReaction624" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction611">
 <bp:evidence rdf:resource="#Evidence712" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated DVL recruits PIP5K1B to the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction610">
 <bp:evidence rdf:resource="#Evidence711" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DVL-associated PIP5K1B phosphorylates PI4P to PI(4,5)P2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction613">
 <bp:evidence rdf:resource="#Evidence714" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CSNK2-mediated phosphorylation of DVL</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction612">
 <bp:evidence rdf:resource="#Evidence713" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WNT signaling stimulates CSNK1-dependent phosphorylation of DVL</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis29">
 <bp:controlled rdf:resource="#BiochemicalReaction76" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis28">
 <bp:controlled rdf:resource="#BiochemicalReaction75" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis27">
 <bp:controlled rdf:resource="#BiochemicalReaction74" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis26">
 <bp:controlled rdf:resource="#BiochemicalReaction73" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction619">
 <bp:evidence rdf:resource="#Evidence723" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DVL2 is phosphorylated by PKC</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis25">
 <bp:controlled rdf:resource="#BiochemicalReaction72" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction618">
 <bp:evidence rdf:resource="#Evidence722" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-DVL2 recruits AP-2 and beta-arrestin 2 to promote clathrin-mediated endocytosis</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis24">
 <bp:controlled rdf:resource="#BiochemicalReaction71" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis23">
 <bp:controlled rdf:resource="#BiochemicalReaction70" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis22">
 <bp:controlled rdf:resource="#BiochemicalReaction69" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction615">
 <bp:evidence rdf:resource="#Evidence718" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">VANGL2 is phosphorylated in response to WNT5A</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis21">
 <bp:controlled rdf:resource="#BiochemicalReaction68" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction614">
 <bp:evidence rdf:resource="#Evidence715" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP34 deubiquitinates AXIN1,AXIN2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis20">
 <bp:controlled rdf:resource="#BiochemicalReaction67" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction617">
 <bp:evidence rdf:resource="#Evidence720" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DAAM1 recruits PFN1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction616">
 <bp:evidence rdf:resource="#Evidence719" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WNT5A binds ROR2 and VANGL2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1216">
 <bp:evidence rdf:resource="#Evidence1401" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EP1 receptor can bind PGE2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2547">
 <bp:evidence rdf:resource="#Evidence2936" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR1 binds FRS3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1215">
 <bp:evidence rdf:resource="#Evidence1400" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP receptor can bind thromboxane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2546">
 <bp:evidence rdf:resource="#Evidence2935" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR1:p-FRS phosphorylates PPTN11</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1214">
 <bp:evidence rdf:resource="#Evidence1399" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTGFR binds PGF2a</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2545">
 <bp:evidence rdf:resource="#Evidence2934" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR1:p-FRS:GRB2:SOS1 activates RAS nucleotide exchange</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1213">
 <bp:evidence rdf:resource="#Evidence1398" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EP3 receptor can bind PGE2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2544">
 <bp:evidence rdf:resource="#Evidence2933" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR1:p-FRS bind to PPTN11</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1212">
 <bp:evidence rdf:resource="#Evidence1397" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DP1 receptor can bind PGD2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2543">
 <bp:evidence rdf:resource="#Evidence2932" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR1 binds FRS2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1211">
 <bp:evidence rdf:resource="#Evidence1396" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DP2 receptor can bind PGD2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2542">
 <bp:evidence rdf:resource="#Evidence2931" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR1:p-FRS:p-PTPN11 activates RAS nucleotide exchange</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1210">
 <bp:evidence rdf:resource="#Evidence1394" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Oxoeicosanoid receptor can bind oxoeicosanoid</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2541">
 <bp:evidence rdf:resource="#Evidence2929" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR1 phosphorylates SHC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2540">
 <bp:evidence rdf:resource="#Evidence2928" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR1:p-SHC1 binds GRB2:SOS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1219">
 <bp:evidence rdf:resource="#Evidence1404" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTGFR binds PTGFR agonists</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1218">
 <bp:evidence rdf:resource="#Evidence1403" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EP2 and EP4 receptors can bind PGE2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2549">
 <bp:evidence rdf:resource="#Evidence2938" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR1 phosphorylates FRS2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1217">
 <bp:evidence rdf:resource="#Evidence1402" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IP receptor can bind prostacyclin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2548">
 <bp:evidence rdf:resource="#Evidence2937" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR1:p-FRS binds GRB2:SOS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction622">
 <bp:evidence rdf:resource="#Evidence726" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WNT5A:FZD4 is endocytosed</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1891">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction621">
 <bp:evidence rdf:resource="#Evidence725" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WNT5A binds FZD4</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1892">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction624">
 <bp:evidence rdf:resource="#Evidence728" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WNT-dependent phosphorylation of DVL</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1893">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction623">
 <bp:evidence rdf:resource="#Evidence727" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ppDVL recruits RAC</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1894">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1895">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1896">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis39">
 <bp:controlled rdf:resource="#BiochemicalReaction89" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction620">
 <bp:evidence rdf:resource="#Evidence724" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WNT5A-FZD4 recruits DVL2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1897">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis38">
 <bp:controlled rdf:resource="#BiochemicalReaction88" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1898">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis37">
 <bp:controlled rdf:resource="#BiochemicalReaction87" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis36">
 <bp:controlled rdf:resource="#BiochemicalReaction85" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction629">
 <bp:evidence rdf:resource="#Evidence734" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DAAM1 recruits GTP-bound RHOA</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis35">
 <bp:controlled rdf:resource="#BiochemicalReaction84" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis34">
 <bp:controlled rdf:resource="#BiochemicalReaction83" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis33">
 <bp:controlled rdf:resource="#BiochemicalReaction82" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction626">
 <bp:evidence rdf:resource="#Evidence731" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WNT5A binds FZD and ROR receptors</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis32">
 <bp:controlled rdf:resource="#BiochemicalReaction81" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction625">
 <bp:evidence rdf:resource="#Evidence729" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DVL is recruited to the receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis31">
 <bp:controlled rdf:resource="#BiochemicalReaction78" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction628">
 <bp:evidence rdf:resource="#Evidence733" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RYK binds WNT5A and VANGL2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis30">
 <bp:controlled rdf:resource="#BiochemicalReaction77" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction627">
 <bp:evidence rdf:resource="#Evidence732" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FZD2, FZD5 and ROR2 are internalized in a WNT5A and clathrin-dependent manner</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1890">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1205">
 <bp:evidence rdf:resource="#Evidence1389" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">UDP/CysLT receptor can bind cysteinyl leukotrienes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2536">
 <bp:evidence rdf:resource="#Evidence2923" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR1:p-FRS2:p-PPTN11:GRB2:GAB1:PIK3R1 binds PIK3CA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1204">
 <bp:evidence rdf:resource="#Evidence1386" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GPR183 binds 7alpha,25-dihydroxycholesterol</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2535">
 <bp:evidence rdf:resource="#Evidence2922" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFR1- and PTPN11- associated PI3K phosphorylates PIP2 to PIP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1203">
 <bp:evidence rdf:resource="#Evidence1385" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GPR31 is a receptor for 12(S)-HETE</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2534">
 <bp:evidence rdf:resource="#Evidence2921" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFR1-associated PI3K phosphorylates PIP2 to PIP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1202">
 <bp:evidence rdf:resource="#Evidence1384" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Receptor FFAR3 binds carboxylates</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2533">
 <bp:evidence rdf:resource="#Evidence2920" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR1:p-FRS2:p-PPTN11 binds GRB2:GAB1:PI3KR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1201">
 <bp:evidence rdf:resource="#Evidence1383" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GPR120 is a receptor for unsaturated long-chain free fatty acids</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2532">
 <bp:evidence rdf:resource="#Evidence2919" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR1:p-FRS2 binds GRB2:GAB1:PIK3R1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1200">
 <bp:evidence rdf:resource="#Evidence1382" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Receptor FFAR1 binds free fatty acids</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2531">
 <bp:evidence rdf:resource="#Evidence2918" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of PIK3 regulatory alpha subunit to GRB2:GAB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2530">
 <bp:evidence rdf:resource="#Evidence2917" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR1:p-FRS2:GRB2:GAB1:PI3KR1 binds PIK3CA</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1899">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1209">
 <bp:evidence rdf:resource="#Evidence1393" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BLT receptors can bind LTB4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1208">
 <bp:evidence rdf:resource="#Evidence1392" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CYSLTR1 binds CYSLTR1 antagonists</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2539">
 <bp:evidence rdf:resource="#Evidence2927" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR1 binds SHC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1207">
 <bp:evidence rdf:resource="#Evidence1391" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CYSLT2 binds LTC4,LTD4,LTE4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2538">
 <bp:evidence rdf:resource="#Evidence2926" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR1:p-SHC1:GRB2:SOS1 activates RAS nucleotide exchange</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1206">
 <bp:evidence rdf:resource="#Evidence1390" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CYSLTR1 binds LTC4,LTD4,LTE4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2537">
 <bp:evidence rdf:resource="#Evidence2924" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR1 binds FLRT1,2,3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2525">
 <bp:evidence rdf:resource="#Evidence2907" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active PLCG1 dissociates from TrkA receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2524">
 <bp:evidence rdf:resource="#Evidence2906" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of PLCG1 to active TrkA receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2523">
 <bp:evidence rdf:resource="#Evidence2904" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK5 translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2522">
 <bp:evidence rdf:resource="#Evidence2903" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK5 is activated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2521">
 <bp:evidence rdf:resource="#Evidence2901" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT3 activation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2520">
 <bp:evidence rdf:resource="#Evidence2899" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active TRKA binds IRS1/2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2529">
 <bp:evidence rdf:resource="#Evidence2915" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR1 binds PLCG1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2528">
 <bp:evidence rdf:resource="#Evidence2914" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR1 phosphorylates PLCG1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2527">
 <bp:evidence rdf:resource="#Evidence2913" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-4Y-PLCG1 dissociates from activated FGFR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2526">
 <bp:evidence rdf:resource="#Evidence2908" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TrkA phosphorylates PLCG1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction600">
 <bp:evidence rdf:resource="#Evidence699" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SET1 complex trimethylates H3K4 at the MYC gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction602">
 <bp:evidence rdf:resource="#Evidence702" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TCF/LEF:CTNNB1 promote transcription of AXIN2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction601">
 <bp:evidence rdf:resource="#Evidence700" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Beta-catenin recruits CBP/p300</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis19">
 <bp:controlled rdf:resource="#BiochemicalReaction64" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis18">
 <bp:controlled rdf:resource="#BiochemicalReaction63" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis17">
 <bp:controlled rdf:resource="#BiochemicalReaction62" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis16">
 <bp:controlled rdf:resource="#BiochemicalReaction61" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis15">
 <bp:controlled rdf:resource="#BiochemicalReaction58" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction608">
 <bp:evidence rdf:resource="#Evidence708" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Beta-catenin:TCF associates with BCL9 and PYGO</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis14">
 <bp:controlled rdf:resource="#BiochemicalReaction57" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction607">
 <bp:evidence rdf:resource="#Evidence707" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Beta-catenin recruits SMARCA4</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis13">
 <bp:controlled rdf:resource="#BiochemicalReaction56" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis12">
 <bp:controlled rdf:resource="#BiochemicalReaction54" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction609">
 <bp:evidence rdf:resource="#Evidence709" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Beta-catenin displaces TLE:HDAC1 from TCF/LEF</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis11">
 <bp:controlled rdf:resource="#BiochemicalReaction53" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction604">
 <bp:evidence rdf:resource="#Evidence704" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TCF/LEF:CTNNB1 bind the AXIN2 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis10">
 <bp:controlled rdf:resource="#BiochemicalReaction52" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction603">
 <bp:evidence rdf:resource="#Evidence703" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TCF7L1/TCF7L2/LEF1:CTNNB1 promote transcription of the MYC gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction606">
 <bp:evidence rdf:resource="#Evidence706" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Beta-catenin recruits TRRAP/KAT5 HAT components</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction605">
 <bp:evidence rdf:resource="#Evidence705" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TCF7L1/TCF7L2/LEF1:CTNNB1 bind the MYC gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2514">
 <bp:evidence rdf:resource="#Evidence2892" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2513">
 <bp:evidence rdf:resource="#Evidence2891" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 activates ELK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2512">
 <bp:evidence rdf:resource="#Evidence2890" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2/5 activate RSK1/2/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2511">
 <bp:evidence rdf:resource="#Evidence2889" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK5 activates the transcription factor MEF2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2510">
 <bp:evidence rdf:resource="#Evidence2888" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2519">
 <bp:evidence rdf:resource="#Evidence2898" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRKA phosphorylates IRS</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2518">
 <bp:evidence rdf:resource="#Evidence2897" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PIP3 binds to RhoA and activates it</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2517">
 <bp:evidence rdf:resource="#Evidence2896" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active IRS recruits PI3K to the plasma membrane and activates it</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2516">
 <bp:evidence rdf:resource="#Evidence2895" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI3K produces PIP3 and other phosphatidyl inositides</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2515">
 <bp:evidence rdf:resource="#Evidence2893" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction655">
 <bp:evidence rdf:resource="#Evidence762" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transcription of canonical WNT targets is negatively regulated by NLK-dependent phosphorylation of TCF/LEF</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction654">
 <bp:evidence rdf:resource="#Evidence761" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of MAP3K7 in response to WNT</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction657">
 <bp:evidence rdf:resource="#Evidence764" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of NFATC1:CaN:CaM to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1860">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction656">
 <bp:evidence rdf:resource="#Evidence763" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-92b binds 3&apos;UTR of NLK mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1861">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction651">
 <bp:evidence rdf:resource="#Evidence758" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Calcineurin binds and dephosphorylates NFAT1 in response to WNT/Ca2+ signaling</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1862">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction650">
 <bp:evidence rdf:resource="#Evidence757" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Gbeta:gamma activation of PLC beta</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1863">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction653">
 <bp:evidence rdf:resource="#Evidence760" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation and activation of PKC alpha in response to WNT signaling</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1864">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction652">
 <bp:evidence rdf:resource="#Evidence759" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TCF/LEF:CTNNB1 bind canonical WNT target promoters</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1865">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1252">
 <bp:evidence rdf:resource="#Evidence1442" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CALCA(83-119) binds CALCA antibodies</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2583">
 <bp:evidence rdf:resource="#Evidence2984" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR2:p-FRS2:GRB2:SOS1 activates RAS nucleotide exchange</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis69">
 <bp:controlled rdf:resource="#BiochemicalReaction148" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1251">
 <bp:evidence rdf:resource="#Evidence1441" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CALCR binds erenumab</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2582">
 <bp:evidence rdf:resource="#Evidence2983" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR2 binds FRS3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis68">
 <bp:controlled rdf:resource="#BiochemicalReaction147" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1250">
 <bp:evidence rdf:resource="#Evidence1440" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AMY1-3 bind pramlintide</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2581">
 <bp:evidence rdf:resource="#Evidence2981" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR2 phosphorylates PLCG1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis67">
 <bp:controlled rdf:resource="#BiochemicalReaction146" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2580">
 <bp:evidence rdf:resource="#Evidence2980" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR2 binds PLCG1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis66">
 <bp:controlled rdf:resource="#BiochemicalReaction141" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction659">
 <bp:evidence rdf:resource="#Evidence766" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLK phosphorylates TCF/LEF</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis65">
 <bp:controlled rdf:resource="#BiochemicalReaction140" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction658">
 <bp:evidence rdf:resource="#Evidence765" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLK translocates to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis289">
 <bp:controlled rdf:resource="#BiochemicalReaction832" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis64">
 <bp:controlled rdf:resource="#BiochemicalReaction139" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis63">
 <bp:controlled rdf:resource="#BiochemicalReaction138" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis62">
 <bp:controlled rdf:resource="#BiochemicalReaction137" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis297">
 <bp:controlled rdf:resource="#BiochemicalReaction863" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis61">
 <bp:controlled rdf:resource="#BiochemicalReaction136" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis296">
 <bp:controlled rdf:resource="#BiochemicalReaction861" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1259">
 <bp:evidence rdf:resource="#Evidence1450" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of YAP1:ZO-2 (TJP2) to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis60">
 <bp:controlled rdf:resource="#BiochemicalReaction135" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis299">
 <bp:controlled rdf:resource="#BiochemicalReaction866" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1258">
 <bp:evidence rdf:resource="#Evidence1449" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NPHP4 protein binds LATS proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2589">
 <bp:evidence rdf:resource="#Evidence2990" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR2:p-FRS bind to PPTN11</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis298">
 <bp:controlled rdf:resource="#BiochemicalReaction864" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1257">
 <bp:evidence rdf:resource="#Evidence1448" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cleavage of p-STK3 (p-MST2) by caspase 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2588">
 <bp:evidence rdf:resource="#Evidence2989" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR2 binds FRS2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis293">
 <bp:controlled rdf:resource="#BiochemicalReaction845" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1256">
 <bp:evidence rdf:resource="#Evidence1447" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of MOB1A and B by p-STK3 (p-MST2)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2587">
 <bp:evidence rdf:resource="#Evidence2988" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR2 phosphorylates PPTN11</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis292">
 <bp:controlled rdf:resource="#BiochemicalReaction842" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1255">
 <bp:evidence rdf:resource="#Evidence1445" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The adrenomedullin receptor can bind adrenomedullin and intermedin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2586">
 <bp:evidence rdf:resource="#Evidence2987" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR2:p-FRS:p-PTPN11 activates RAS nucleotide exchange</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis295">
 <bp:controlled rdf:resource="#BiochemicalReaction858" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1254">
 <bp:evidence rdf:resource="#Evidence1444" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CALCA(83-119) binds CALCR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2585">
 <bp:evidence rdf:resource="#Evidence2986" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR2 phosphorylates FRS2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis294">
 <bp:controlled rdf:resource="#BiochemicalReaction856" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1253">
 <bp:evidence rdf:resource="#Evidence1443" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CALCR binds gepants</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2584">
 <bp:evidence rdf:resource="#Evidence2985" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR2 phosphorylates FRS3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1866">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1867">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction660">
 <bp:evidence rdf:resource="#Evidence767" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PLC beta-mediated PIP2 hydrolysis</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis291">
 <bp:controlled rdf:resource="#BiochemicalReaction840" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1868">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis290">
 <bp:controlled rdf:resource="#BiochemicalReaction835" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1869">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction666">
 <bp:evidence rdf:resource="#Evidence774" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Association of beta-catenin with the RBX1:SCF(beta-TrCP1) ubiquitin ligase complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction665">
 <bp:evidence rdf:resource="#Evidence772" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLK mRNA translation controlled by miR-92b</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction668">
 <bp:evidence rdf:resource="#Evidence777" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of phospho-(Ser45 ) at Thr 41 by GSK-3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction667">
 <bp:evidence rdf:resource="#Evidence776" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of phospho-(Ser45,Thr41,Ser37) at Ser33 by GSK-3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1850">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction662">
 <bp:evidence rdf:resource="#Evidence769" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WNT5A and WNT11 bind FZD receptors to initiate Ca2+ signaling</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1851">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction661">
 <bp:evidence rdf:resource="#Evidence768" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WNT:FZD complex promotes G-protein nucleotide exchange</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1852">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction664">
 <bp:evidence rdf:resource="#Evidence771" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FZD recruits trimeric G-proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1853">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction663">
 <bp:evidence rdf:resource="#Evidence770" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G-protein subunits dissociate from WNT:FZD complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1854">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1241">
 <bp:evidence rdf:resource="#Evidence1430" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GHRH receptor binds GHRH</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2572">
 <bp:evidence rdf:resource="#Evidence2967" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Autocatalytic phosphorylation of Klotho-bound FGFR1c</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1240">
 <bp:evidence rdf:resource="#Evidence1429" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The PACAP receptor binds PACAP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2571">
 <bp:evidence rdf:resource="#Evidence2966" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFR1c binds to Klotho-bound FGF23</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis79">
 <bp:controlled rdf:resource="#BiochemicalReaction172" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2570">
 <bp:evidence rdf:resource="#Evidence2964" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFR1c binds to FGF</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis78">
 <bp:controlled rdf:resource="#BiochemicalReaction170" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis77">
 <bp:controlled rdf:resource="#BiochemicalReaction168" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis76">
 <bp:controlled rdf:resource="#BiochemicalReaction167" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction669">
 <bp:evidence rdf:resource="#Evidence778" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of beta-catenin at Ser45 by CK1 alpha</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis75">
 <bp:controlled rdf:resource="#BiochemicalReaction163" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis74">
 <bp:controlled rdf:resource="#BiochemicalReaction162" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis73">
 <bp:controlled rdf:resource="#BiochemicalReaction159" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1249">
 <bp:evidence rdf:resource="#Evidence1439" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CGRP receptor can bind calcitonin gene-related peptides</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis72">
 <bp:controlled rdf:resource="#BiochemicalReaction158" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1248">
 <bp:evidence rdf:resource="#Evidence1438" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AMY1-3 bind IAPP(34-70)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2579">
 <bp:evidence rdf:resource="#Evidence2979" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-4Y-PLCG1 dissociates from activated FGFR2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis71">
 <bp:controlled rdf:resource="#BiochemicalReaction152" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1247">
 <bp:evidence rdf:resource="#Evidence1436" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Patched binds Smoothened</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2578">
 <bp:evidence rdf:resource="#Evidence2977" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR2:p-SHC1 binds GRB2:SOS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis70">
 <bp:controlled rdf:resource="#BiochemicalReaction150" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1246">
 <bp:evidence rdf:resource="#Evidence1435" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EGF-TM7 receptors bind chondroitin sulphate</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2577">
 <bp:evidence rdf:resource="#Evidence2976" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR2 phosphorylates SHC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1245">
 <bp:evidence rdf:resource="#Evidence1434" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CRHBP binds CRH</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2576">
 <bp:evidence rdf:resource="#Evidence2975" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR2 binds SHC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1244">
 <bp:evidence rdf:resource="#Evidence1433" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CRHR2-2 binds CRH,UCN,UCN2,UCN3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2575">
 <bp:evidence rdf:resource="#Evidence2974" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR2:p-SHC1:GRB2:SOS1 activates RAS nucleotide exchange</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1243">
 <bp:evidence rdf:resource="#Evidence1432" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD97 binds CD55</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2574">
 <bp:evidence rdf:resource="#Evidence2970" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFR1b binds to FGF</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1242">
 <bp:evidence rdf:resource="#Evidence1431" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GIP receptor binds gastric inhibitory peptide</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2573">
 <bp:evidence rdf:resource="#Evidence2969" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Autocatalytic phosphorylation of FGFR1b</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1855">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1856">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction671">
 <bp:evidence rdf:resource="#Evidence780" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of APC component of the destruction complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1857">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction670">
 <bp:evidence rdf:resource="#Evidence779" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of phospho- (Ser45, Thr41) beta-catenin  at Ser37 by GSK-3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1858">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1859">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction633">
 <bp:evidence rdf:resource="#Evidence739" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCRIB is required for asymmetric membrane localization of VANGL2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1880">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction632">
 <bp:evidence rdf:resource="#Evidence738" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DVL2 is phosphorylated after WNT5A binding to FZD</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1881">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction635">
 <bp:evidence rdf:resource="#Evidence741" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WNT5A binding to FZD promotes PRICKLE1 degradation</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1882">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction634">
 <bp:evidence rdf:resource="#Evidence740" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">VANGL2 is required for asymmetric membrane localization of FZD3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1883">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1884">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1885">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction631">
 <bp:evidence rdf:resource="#Evidence736" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WNTs bind the FZD receptor to initiate PCP pathway</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1886">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis49">
 <bp:controlled rdf:resource="#BiochemicalReaction112" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction630">
 <bp:evidence rdf:resource="#Evidence735" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ppDVL binds DAAM1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1887">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis48">
 <bp:controlled rdf:resource="#BiochemicalReaction109" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1230">
 <bp:evidence rdf:resource="#Evidence1417" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CASR binds CASR agonists</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2561">
 <bp:evidence rdf:resource="#Evidence2953" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated SPRY2 is ubiquitinated by CBL</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis47">
 <bp:controlled rdf:resource="#BiochemicalReaction105" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2560">
 <bp:evidence rdf:resource="#Evidence2952" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PPA2A dephosphorylates SPRY2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis46">
 <bp:controlled rdf:resource="#BiochemicalReaction103" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis45">
 <bp:controlled rdf:resource="#BiochemicalReaction102" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis44">
 <bp:controlled rdf:resource="#BiochemicalReaction99" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction637">
 <bp:evidence rdf:resource="#Evidence743" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRICKLE1 is degraded by the proteasome</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis43">
 <bp:controlled rdf:resource="#BiochemicalReaction98" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction636">
 <bp:evidence rdf:resource="#Evidence742" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMURF1/2 ubiquitinates PRICKLE1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis42">
 <bp:controlled rdf:resource="#BiochemicalReaction94" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction639">
 <bp:evidence rdf:resource="#Evidence746" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of CaM and CAMK2 autophosphorylation</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis41">
 <bp:controlled rdf:resource="#BiochemicalReaction93" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction638">
 <bp:evidence rdf:resource="#Evidence744" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMURF1/2 are recruited to the DVL2:PARD6A complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis40">
 <bp:controlled rdf:resource="#BiochemicalReaction91" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1238">
 <bp:evidence rdf:resource="#Evidence1427" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Glucagon binds to Glucagon receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2569">
 <bp:evidence rdf:resource="#Evidence2963" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KAL1 binds HS</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1237">
 <bp:evidence rdf:resource="#Evidence1426" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Secretin receptor binds secretin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2568">
 <bp:evidence rdf:resource="#Evidence2962" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Autocatalytic phosphorylation of FGFR1c</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1236">
 <bp:evidence rdf:resource="#Evidence1425" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Glucagon-like receptor 2 binds GLP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2567">
 <bp:evidence rdf:resource="#Evidence2959" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KAL1 binds FGFR1c</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1235">
 <bp:evidence rdf:resource="#Evidence1424" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">VIP receptors bind VIP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2566">
 <bp:evidence rdf:resource="#Evidence2958" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated ERK1/2 threonine-phosphorylates FGFR1-associated FRS2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1234">
 <bp:evidence rdf:resource="#Evidence1422" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CRHR1,CRHR2-1 binds CRH,UCN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2565">
 <bp:evidence rdf:resource="#Evidence2957" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CBL ubiquitinates FRS2 and FGFR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1233">
 <bp:evidence rdf:resource="#Evidence1421" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Parathyroid hormone receptor can bind parathyroid hormone</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2564">
 <bp:evidence rdf:resource="#Evidence2956" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-CBL:GRB2 binds p-FRS2:activated FGFR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1232">
 <bp:evidence rdf:resource="#Evidence1420" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Frizzled receptors bind Wnts</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2563">
 <bp:evidence rdf:resource="#Evidence2955" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SPRY2 is phosphorylated by phosphorylated MNK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1231">
 <bp:evidence rdf:resource="#Evidence1418" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CASR binds Ca2+</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2562">
 <bp:evidence rdf:resource="#Evidence2954" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SPRY2 is serine phosphorylated in response to MAPK activation</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1888">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1889">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1239">
 <bp:evidence rdf:resource="#Evidence1428" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GLP1R binds GLP1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction644">
 <bp:evidence rdf:resource="#Evidence751" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Autophosphorylation and activation of CAMK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction643">
 <bp:evidence rdf:resource="#Evidence750" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G alpha t2 binds and activates PDE6</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1870">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction646">
 <bp:evidence rdf:resource="#Evidence753" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of Calcineurin</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1871">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction645">
 <bp:evidence rdf:resource="#Evidence752" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of NLK</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1872">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction640">
 <bp:evidence rdf:resource="#Evidence747" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active calmodulin binds CAMK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1873">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1874">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction642">
 <bp:evidence rdf:resource="#Evidence749" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CAMK2 binds MAP3K7</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1875">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction641">
 <bp:evidence rdf:resource="#Evidence748" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PDE6 hydrolyses cGMP to GMP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1876">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis59">
 <bp:controlled rdf:resource="#BiochemicalReaction132" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2550">
 <bp:evidence rdf:resource="#Evidence2939" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR1 phosphorylates FRS3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis58">
 <bp:controlled rdf:resource="#BiochemicalReaction128" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis57">
 <bp:controlled rdf:resource="#BiochemicalReaction127" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis56">
 <bp:controlled rdf:resource="#BiochemicalReaction126" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis55">
 <bp:controlled rdf:resource="#BiochemicalReaction124" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction648">
 <bp:evidence rdf:resource="#Evidence755" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Decreasing cGMP concentration promotes intracellular Ca2+ release in response to WNT</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis54">
 <bp:controlled rdf:resource="#BiochemicalReaction123" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction647">
 <bp:evidence rdf:resource="#Evidence754" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IP3 binds to the IP3 receptor, opening the endoplasmic reticulum Ca2+ channel</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis53">
 <bp:controlled rdf:resource="#BiochemicalReaction122" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis52">
 <bp:controlled rdf:resource="#BiochemicalReaction118" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction649">
 <bp:evidence rdf:resource="#Evidence756" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRKG is activated by binding to high levels of cGMP in the absence of WNT signaling</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis51">
 <bp:controlled rdf:resource="#BiochemicalReaction117" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1227">
 <bp:evidence rdf:resource="#Evidence1414" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GABAB heterodimeric receptor binds GABA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2558">
 <bp:evidence rdf:resource="#Evidence2950" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CBL dissociates from ubiquitinated p-SPRY2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis50">
 <bp:controlled rdf:resource="#BiochemicalReaction114" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1226">
 <bp:evidence rdf:resource="#Evidence1413" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">T1R1/T1R3 dimer is the umami taste receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2557">
 <bp:evidence rdf:resource="#Evidence2949" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">B-RAF dissociates from S111/S120 p-SPRY2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1225">
 <bp:evidence rdf:resource="#Evidence1412" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">T1R2/T1R3 dimer is a sweet taste receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2556">
 <bp:evidence rdf:resource="#Evidence2948" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SRC phosphorylates SPRY2 on Y55 and Y227</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1224">
 <bp:evidence rdf:resource="#Evidence1411" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">T2Rs bind bitter-tasting compounds</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2555">
 <bp:evidence rdf:resource="#Evidence2947" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PPTN11 dephosphorylates SPRY2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1223">
 <bp:evidence rdf:resource="#Evidence1409" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GPR4, GPR65, GPR132 and OGR1 are pH sensing receptors</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2554">
 <bp:evidence rdf:resource="#Evidence2946" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SPRY2 translocates to the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1222">
 <bp:evidence rdf:resource="#Evidence1408" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Melanospin is stimulated by light</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2553">
 <bp:evidence rdf:resource="#Evidence2945" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SPRY2 binds GRB2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1221">
 <bp:evidence rdf:resource="#Evidence1407" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Light stimulates opsin receptors</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2552">
 <bp:evidence rdf:resource="#Evidence2942" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFRL1 binds SPRED1/2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1220">
 <bp:evidence rdf:resource="#Evidence1405" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Zinc is an agonist of GPR39</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2551">
 <bp:evidence rdf:resource="#Evidence2941" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFRL1 dimer binds FGFs</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1877">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1878">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1879">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1229">
 <bp:evidence rdf:resource="#Evidence1416" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GPRC6A can bind L-alpha amino acids and calcium</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1228">
 <bp:evidence rdf:resource="#Evidence1415" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Metabotropic glutamate receptors bind glutamate</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2559">
 <bp:evidence rdf:resource="#Evidence2951" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SPRY2 binds CBL</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1822">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1598" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1821">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1597" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1820">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1596" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1826">
 <bp:stepProcess rdf:resource="#Catalysis463" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1602" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1825">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1601" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1824">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1600" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1700">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1823">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1599" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1709">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2701">
 <bp:evidence rdf:resource="#Evidence3130" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Autocatalytic phosphorylation of BetaKlotho-bound FGFR4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2700">
 <bp:evidence rdf:resource="#Evidence3127" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR4 phosphorylates PLCG1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1701">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2709">
 <bp:evidence rdf:resource="#Evidence3139" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated LEPR Binds STAT5</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1702">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1829">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1604" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2708">
 <bp:evidence rdf:resource="#Evidence3138" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated LEPR Binds SOCS3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1703">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1828">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1603" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2707">
 <bp:evidence rdf:resource="#Evidence3137" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT5 dimers translocate to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1704">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1827">
 <bp:stepProcess rdf:resource="#Pathway226" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2706">
 <bp:evidence rdf:resource="#Evidence3136" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK2 Phosphoryates STAT3 in Response to Leptin</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1705">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2705">
 <bp:evidence rdf:resource="#Evidence3135" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-STAT5 dimerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1706">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2704">
 <bp:evidence rdf:resource="#Evidence3133" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Autocatalytic phosphorylation of FGFR4</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1707">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2703">
 <bp:evidence rdf:resource="#Evidence3132" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFR4 binds to FGF</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1708">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2702">
 <bp:evidence rdf:resource="#Evidence3131" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFR4 binds HS:KLB:FGF19</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1833">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1608" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1832">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1607" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1831">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1606" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1830">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1605" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1837">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1612" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1836">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1611" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1835">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1610" />
 <bp:stepProcess rdf:resource="#Catalysis464" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1834">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1609" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1839">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1614" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1838">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1613" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1800">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1580" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1804">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1584" />
 <bp:stepProcess rdf:resource="#Catalysis458" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1720">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1803">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1583" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1721">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1802">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1582" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1722">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1801">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1581" />
 <bp:stepProcess rdf:resource="#Catalysis457" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1723">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1808">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1587" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1724">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1807">
 <bp:stepProcess rdf:resource="#Pathway222" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1725">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1806">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1586" />
 <bp:stepProcess rdf:resource="#Catalysis459" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1726">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1805">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1585" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1727">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1728">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1729">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1809">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1588" />
 <bp:stepProcess rdf:resource="#Catalysis460" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1811">
 <bp:stepProcess rdf:resource="#Pathway224" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1810">
 <bp:stepProcess rdf:resource="#Pathway223" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1815">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1591" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1814">
 <bp:stepProcess rdf:resource="#Pathway225" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1710">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1813">
 <bp:stepProcess rdf:resource="#Catalysis462" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1590" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1711">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1812">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1589" />
 <bp:stepProcess rdf:resource="#Catalysis461" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1712">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1819">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1595" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1713">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1818">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1594" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1714">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1817">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1593" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1715">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1816">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1592" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1716">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1717">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1718">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1719">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1414">
 <bp:evidence rdf:resource="#Evidence1623" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SUMO-CRABP2:atRA translocates from cytosol to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1413">
 <bp:evidence rdf:resource="#Evidence1622" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RXRA:PPARD binds FABP5:atRA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1412">
 <bp:evidence rdf:resource="#Evidence1621" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SUMO-CRABP2 binds atRA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1411">
 <bp:evidence rdf:resource="#Evidence1620" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PDK isozymes phosphorylate PDHC subunit E1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1410">
 <bp:evidence rdf:resource="#Evidence1619" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAR:RXR binds SUMO-CRABP2:atRA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1419">
 <bp:evidence rdf:resource="#Evidence1630" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Histone acetyltransferases are recruited to the TFF1 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1418">
 <bp:evidence rdf:resource="#Evidence1629" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-26A and B bind to the 3&apos;UTR of the GREB1 mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1417">
 <bp:evidence rdf:resource="#Evidence1628" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CARM1 binds TBP:TFIIA:DDX5:ESR1:estrogen:TFF1 gene </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1416">
 <bp:evidence rdf:resource="#Evidence1626" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ESTG binds ESR2:chaperone complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1415">
 <bp:evidence rdf:resource="#Evidence1624" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FABP5:atRA translocates from cytosol to nucleoplasm</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1403">
 <bp:evidence rdf:resource="#Evidence1612" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ALDH8A1 oxidises 9cRAL to 9cRA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1402">
 <bp:evidence rdf:resource="#Evidence1611" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ADH1A,1C,4 oxidise atROL to atRAL in vitro</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1401">
 <bp:evidence rdf:resource="#Evidence1610" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RDH10,16,DHRS9,RDHE2 oxidise atROL to atRAL</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1400">
 <bp:evidence rdf:resource="#Evidence1609" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ALDHs oxidise atRAL to atRA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1409">
 <bp:evidence rdf:resource="#Evidence1618" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FABP5 binds atRA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1408">
 <bp:evidence rdf:resource="#Evidence1617" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SUMO-CRABP2 dissociates from atRA:RAR:RXR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1407">
 <bp:evidence rdf:resource="#Evidence1616" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RDH5,RDH11 oxidise 11cROL to 11cRAL</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1406">
 <bp:evidence rdf:resource="#Evidence1615" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CYP26C1 4-hydroxylates 9cRA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1405">
 <bp:evidence rdf:resource="#Evidence1614" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKR1C3 reduces atRAL to atROL</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1404">
 <bp:evidence rdf:resource="#Evidence1613" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CRABP1 binds atRA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2723">
 <bp:evidence rdf:resource="#Evidence3153" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK2 Phosphorylates IRS in Response to Leptin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2722">
 <bp:evidence rdf:resource="#Evidence3152" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK2 Phosphorylates LEPR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2721">
 <bp:evidence rdf:resource="#Evidence3151" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK2 Phosphorylates STAT5 in Response to Leptin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2720">
 <bp:evidence rdf:resource="#Evidence3150" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK2 Autophosphorylates in Response to Leptin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2712">
 <bp:evidence rdf:resource="#Evidence3142" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated STAT3 Forms Dimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2711">
 <bp:evidence rdf:resource="#Evidence3141" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated LEP:LEPR:JAK2:SH2B1 Binds IRS1/2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2710">
 <bp:evidence rdf:resource="#Evidence3140" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated LEP:LEPR:JAK2 Binds SH2B1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2719">
 <bp:evidence rdf:resource="#Evidence3149" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Leptin Binds Leptin Receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2718">
 <bp:evidence rdf:resource="#Evidence3148" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated STAT3 Dissociates from Leptin Receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2717">
 <bp:evidence rdf:resource="#Evidence3147" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK2 Phosphorylates SHP2 (PTPN11) in Response to Leptin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2716">
 <bp:evidence rdf:resource="#Evidence3146" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated LEPR Binds STAT3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2715">
 <bp:evidence rdf:resource="#Evidence3145" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated STAT3 Dimer Translocates to the Nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2714">
 <bp:evidence rdf:resource="#Evidence3144" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated STAT5 Dissociates from Leptin Receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2713">
 <bp:evidence rdf:resource="#Evidence3143" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated LEPR Binds SHP2 (PTPN11)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence199">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis408">
 <bp:controlled rdf:resource="#BiochemicalReaction1309" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis407">
 <bp:controlled rdf:resource="#BiochemicalReaction1307" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis409">
 <bp:controlled rdf:resource="#BiochemicalReaction1310" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence195">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis404">
 <bp:controlled rdf:resource="#BiochemicalReaction1300" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence196">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis403">
 <bp:controlled rdf:resource="#BiochemicalReaction1298" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence197">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis406">
 <bp:controlled rdf:resource="#BiochemicalReaction1302" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence198">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis405">
 <bp:controlled rdf:resource="#BiochemicalReaction1301" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence191">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis400">
 <bp:controlled rdf:resource="#BiochemicalReaction1290" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence192">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence193">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis402">
 <bp:controlled rdf:resource="#BiochemicalReaction1295" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence194">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis401">
 <bp:controlled rdf:resource="#BiochemicalReaction1294" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence188">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis419">
 <bp:controlled rdf:resource="#BiochemicalReaction1332" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence189">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis418">
 <bp:controlled rdf:resource="#BiochemicalReaction1331" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence184">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis415">
 <bp:controlled rdf:resource="#BiochemicalReaction1327" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence185">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis414">
 <bp:controlled rdf:resource="#BiochemicalReaction1322" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence186">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis417">
 <bp:controlled rdf:resource="#BiochemicalReaction1330" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence187">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis416">
 <bp:controlled rdf:resource="#BiochemicalReaction1329" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence180">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis411">
 <bp:controlled rdf:resource="#BiochemicalReaction1312" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence181">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis410">
 <bp:controlled rdf:resource="#BiochemicalReaction1311" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence182">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis413">
 <bp:controlled rdf:resource="#BiochemicalReaction1320" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence183">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis412">
 <bp:controlled rdf:resource="#BiochemicalReaction1315" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis420">
 <bp:controlled rdf:resource="#BiochemicalReaction1333" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence190">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1888">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1656" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1887">
 <bp:stepProcess rdf:resource="#Pathway233" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1886">
 <bp:stepProcess rdf:resource="#Pathway232" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1885">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1655" />
 <bp:stepProcess rdf:resource="#Catalysis476" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence177">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence178">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis429">
 <bp:controlled rdf:resource="#BiochemicalReaction1406" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence179">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1889">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1657" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence173">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis426">
 <bp:controlled rdf:resource="#BiochemicalReaction1402" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1880">
 <bp:stepProcess rdf:resource="#Pathway231" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence174">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis425">
 <bp:controlled rdf:resource="#BiochemicalReaction1401" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence175">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis428">
 <bp:controlled rdf:resource="#BiochemicalReaction1405" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence176">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis427">
 <bp:controlled rdf:resource="#BiochemicalReaction1403" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis422">
 <bp:controlled rdf:resource="#BiochemicalReaction1398" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1884">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1654" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence170">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis421">
 <bp:controlled rdf:resource="#BiochemicalReaction1397" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1883">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1653" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence171">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis424">
 <bp:controlled rdf:resource="#BiochemicalReaction1400" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1882">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1652" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence172">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis423">
 <bp:controlled rdf:resource="#BiochemicalReaction1399" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1881">
 <bp:stepProcess rdf:resource="#Catalysis475" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1651" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis431">
 <bp:controlled rdf:resource="#BiochemicalReaction1411" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis430">
 <bp:controlled rdf:resource="#BiochemicalReaction1407" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1899">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1667" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1898">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1666" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1897">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1665" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1896">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1664" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence166">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence167">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence168">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence169">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence162">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis437">
 <bp:controlled rdf:resource="#BiochemicalReaction1488" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1891">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1659" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence163">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis436">
 <bp:controlled rdf:resource="#BiochemicalReaction1485" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1890">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1658" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence164">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis439">
 <bp:controlled rdf:resource="#BiochemicalReaction1490" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence165">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis438">
 <bp:controlled rdf:resource="#BiochemicalReaction1489" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis433">
 <bp:controlled rdf:resource="#BiochemicalReaction1463" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1895">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1663" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis432">
 <bp:controlled rdf:resource="#BiochemicalReaction1451" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1894">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1662" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence160">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis435">
 <bp:controlled rdf:resource="#BiochemicalReaction1472" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1893">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1661" />
 <bp:stepProcess rdf:resource="#Catalysis477" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence161">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis434">
 <bp:controlled rdf:resource="#BiochemicalReaction1466" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1892">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1660" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis440">
 <bp:controlled rdf:resource="#BiochemicalReaction1491" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis442">
 <bp:controlled rdf:resource="#BiochemicalReaction1499" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis441">
 <bp:controlled rdf:resource="#BiochemicalReaction1492" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence159">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1866">
 <bp:stepProcess rdf:resource="#Catalysis473" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1638" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1865">
 <bp:stepProcess rdf:resource="#Catalysis472" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1637" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1864">
 <bp:stepProcess rdf:resource="#Catalysis471" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1636" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1863">
 <bp:stepProcess rdf:resource="#Pathway229" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence155">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence156">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1869">
 <bp:stepProcess rdf:resource="#Catalysis474" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1641" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence157">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1868">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1640" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence158">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1867">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1639" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence151">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence152">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence153">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence154">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1862">
 <bp:stepProcess rdf:resource="#Pathway228" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1861">
 <bp:stepProcess rdf:resource="#Catalysis470" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1635" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1860">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1634" />
 <bp:stepProcess rdf:resource="#Catalysis469" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence150">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence148">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1877">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1648" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence149">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1876">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1647" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1875">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1646" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1874">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1645" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence144">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence145">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence146">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1879">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1650" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence147">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1878">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1649" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence140">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence141">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence142">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence143">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1873">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1644" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1872">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1643" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1871">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1642" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1870">
 <bp:stepProcess rdf:resource="#Pathway230" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence137">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1844">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1619" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence138">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1843">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1618" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence139">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1842">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1617" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1841">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1616" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence133">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1848">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1623" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence134">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1847">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1622" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence135">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1846">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1621" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence136">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1845">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1620" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence130">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence131">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence132">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1840">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1615" />
 <bp:stepProcess rdf:resource="#Catalysis465" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1849">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1624" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence126">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1855">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1629" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence127">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1854">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1628" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence128">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1853">
 <bp:stepProcess rdf:resource="#Pathway227" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence129">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1852">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1627" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence122">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1859">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1633" />
 <bp:stepProcess rdf:resource="#Catalysis468" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence123">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1858">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1632" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence124">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1857">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1631" />
 <bp:stepProcess rdf:resource="#Catalysis467" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence125">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1856">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1630" />
 <bp:stepProcess rdf:resource="#Catalysis466" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence120">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence121">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1851">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1626" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1850">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1625" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep5">
 <bp:stepProcess rdf:resource="#Pathway4" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence115">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction578">
 <bp:evidence rdf:resource="#Evidence674" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DVL is ubiquitinated by CUL3:KLHL12:RBX1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep4">
 <bp:stepProcess rdf:resource="#Catalysis2" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence116">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction577">
 <bp:evidence rdf:resource="#Evidence673" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitinated DVL1 is degraded by the proteasome</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep7">
 <bp:stepProcess rdf:resource="#BiochemicalReaction3" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence117">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep6">
 <bp:stepProcess rdf:resource="#Pathway5" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence118">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction579">
 <bp:evidence rdf:resource="#Evidence675" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitinated DVL is degraded by the proteasome</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep9">
 <bp:stepProcess rdf:resource="#Pathway6" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence111">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction574">
 <bp:evidence rdf:resource="#Evidence669" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RSPOs bind LGRs</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep8">
 <bp:stepProcess rdf:resource="#BiochemicalReaction4" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence112">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction573">
 <bp:evidence rdf:resource="#Evidence668" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP8 deubiquitinates FZD to potentiate WNT signaling</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence113">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction576">
 <bp:evidence rdf:resource="#Evidence672" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DACT1 binds DVL2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence114">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction575">
 <bp:evidence rdf:resource="#Evidence670" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FZD recruits DVL to the receptor complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence110">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis367">
 <bp:controlled rdf:resource="#BiochemicalReaction1016" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis366">
 <bp:controlled rdf:resource="#BiochemicalReaction1015" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis369">
 <bp:controlled rdf:resource="#BiochemicalReaction1022" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis368">
 <bp:controlled rdf:resource="#BiochemicalReaction1018" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis374">
 <bp:controlled rdf:resource="#BiochemicalReaction1030" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis373">
 <bp:controlled rdf:resource="#BiochemicalReaction1027" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis376">
 <bp:controlled rdf:resource="#BiochemicalReaction1037" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis375">
 <bp:controlled rdf:resource="#BiochemicalReaction1036" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis370">
 <bp:controlled rdf:resource="#BiochemicalReaction1023" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis372">
 <bp:controlled rdf:resource="#BiochemicalReaction1026" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis371">
 <bp:controlled rdf:resource="#BiochemicalReaction1024" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction581">
 <bp:evidence rdf:resource="#Evidence677" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DVL is bound by the CUL3:KLHL12:RBX1 ubiquitin ligase complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction580">
 <bp:evidence rdf:resource="#Evidence676" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DVL1 is bound by the HECT ubiquitin ligase HECW1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction583">
 <bp:evidence rdf:resource="#Evidence679" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WNT binds to FZD and LRP5/6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction582">
 <bp:evidence rdf:resource="#Evidence678" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DVL1 is ubiquitinated by HECW1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1">
 <bp:stepProcess rdf:resource="#Pathway2" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence119">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep3">
 <bp:stepProcess rdf:resource="#Catalysis1" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2">
 <bp:stepProcess rdf:resource="#Pathway3" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence104">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction589">
 <bp:evidence rdf:resource="#Evidence686" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNF146 ubiquitinates ADP-ribosylated AXIN</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence105">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction588">
 <bp:evidence rdf:resource="#Evidence685" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNF146 binds RibC-AXIN:TNKS complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence106">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence107">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence100">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction585">
 <bp:evidence rdf:resource="#Evidence682" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitinated AXIN is degraded by the proteasome</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence101">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction584">
 <bp:evidence rdf:resource="#Evidence681" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AXIN is ubiquitinated by SMURF2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence102">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction587">
 <bp:evidence rdf:resource="#Evidence684" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tankyrase ADP-ribosylates AXIN</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence103">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction586">
 <bp:evidence rdf:resource="#Evidence683" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ub-RibC-AXIN is degraded by the proteasome</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis378">
 <bp:controlled rdf:resource="#BiochemicalReaction1062" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis377">
 <bp:controlled rdf:resource="#BiochemicalReaction1054" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis379">
 <bp:controlled rdf:resource="#BiochemicalReaction1075" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis385">
 <bp:controlled rdf:resource="#BiochemicalReaction1257" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis384">
 <bp:controlled rdf:resource="#BiochemicalReaction1256" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis387">
 <bp:controlled rdf:resource="#BiochemicalReaction1261" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis386">
 <bp:controlled rdf:resource="#BiochemicalReaction1260" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis381">
 <bp:controlled rdf:resource="#BiochemicalReaction1192" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis380">
 <bp:controlled rdf:resource="#BiochemicalReaction1103" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis383">
 <bp:controlled rdf:resource="#BiochemicalReaction1239" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis382">
 <bp:controlled rdf:resource="#BiochemicalReaction1238" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction592">
 <bp:evidence rdf:resource="#Evidence690" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SOST binds LRP5/6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction591">
 <bp:evidence rdf:resource="#Evidence688" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMURF2 binds AXIN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction594">
 <bp:evidence rdf:resource="#Evidence692" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WIF1 binds WNTs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction593">
 <bp:evidence rdf:resource="#Evidence691" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DKK promotes clathrin-dependent internalization of LRP6</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence108">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence109">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction590">
 <bp:evidence rdf:resource="#Evidence687" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tankyrase binds AXIN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction556">
 <bp:evidence rdf:resource="#Evidence648" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CBY1 binds beta-catenin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction555">
 <bp:evidence rdf:resource="#Evidence647" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">APC promotes disassembly of beta-catenin transactivation complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction558">
 <bp:evidence rdf:resource="#Evidence650" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Beta-catenin translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction557">
 <bp:evidence rdf:resource="#Evidence649" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TCF:Beta-catenin binds SOX proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction552">
 <bp:evidence rdf:resource="#Evidence644" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHD8 binds beta-catenin to negatively regulate WNT-dependent gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction551">
 <bp:evidence rdf:resource="#Evidence643" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">XIAP dissociates from ub-TLE</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction554">
 <bp:evidence rdf:resource="#Evidence646" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CTNNBIP1 binds beta-catenin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction553">
 <bp:evidence rdf:resource="#Evidence645" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">XPO1 binds the beta-catenin:CBY complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1395">
 <bp:evidence rdf:resource="#Evidence1603" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Acitretin binds to RAR:RXR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1394">
 <bp:evidence rdf:resource="#Evidence1601" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of PLIN1 regulated by NR1H2 or NR1H3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1393">
 <bp:evidence rdf:resource="#Evidence1600" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NR1H2,3 binds the PLIN1 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1392">
 <bp:evidence rdf:resource="#Evidence1598" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of PLTP regulated by NR1H2 or NR1H3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis389">
 <bp:controlled rdf:resource="#BiochemicalReaction1264" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1391">
 <bp:evidence rdf:resource="#Evidence1597" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NR1H2 binds ABCA1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction559">
 <bp:evidence rdf:resource="#Evidence652" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DVL binds CCDC88C</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis388">
 <bp:controlled rdf:resource="#BiochemicalReaction1263" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1390">
 <bp:evidence rdf:resource="#Evidence1596" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ABCA1 mRNA is translated</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis396">
 <bp:controlled rdf:resource="#BiochemicalReaction1277" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis395">
 <bp:controlled rdf:resource="#BiochemicalReaction1276" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis398">
 <bp:controlled rdf:resource="#BiochemicalReaction1280" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis397">
 <bp:controlled rdf:resource="#BiochemicalReaction1278" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis392">
 <bp:controlled rdf:resource="#BiochemicalReaction1269" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1399">
 <bp:evidence rdf:resource="#Evidence1608" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CYP26A1,B1,C1 4-hydroxylate atRA</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis391">
 <bp:controlled rdf:resource="#BiochemicalReaction1267" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1398">
 <bp:evidence rdf:resource="#Evidence1607" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RDH13 reduces atRAL to atROL</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis394">
 <bp:controlled rdf:resource="#BiochemicalReaction1274" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1397">
 <bp:evidence rdf:resource="#Evidence1606" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RDH11,14,DHRS3,DRHS4 reduce atRAL to atROL</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis393">
 <bp:controlled rdf:resource="#BiochemicalReaction1272" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1396">
 <bp:evidence rdf:resource="#Evidence1604" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FABP5 dissociates from RXRA:PPARD:atRA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction561">
 <bp:evidence rdf:resource="#Evidence655" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WNT3A stimulates the caveolin-dependent internalization of FZD5:p-LRP6</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis390">
 <bp:controlled rdf:resource="#BiochemicalReaction1265" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction560">
 <bp:evidence rdf:resource="#Evidence653" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CXXC4 binds DVL to prevent AXIN binding</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction567">
 <bp:evidence rdf:resource="#Evidence661" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of LRP5/6 cytoplasmic domain by membrane-associated GSK3beta</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction566">
 <bp:evidence rdf:resource="#Evidence660" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DVL recruits GSK3beta:AXIN1 to the receptor complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction569">
 <bp:evidence rdf:resource="#Evidence664" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ZNRF3 autoubiquitinates to promote its internalization</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction568">
 <bp:evidence rdf:resource="#Evidence662" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Canonical WNT signaling through the atypical receptor RYK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction563">
 <bp:evidence rdf:resource="#Evidence657" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FRAT proteins bind GSK3beta</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction562">
 <bp:evidence rdf:resource="#Evidence656" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Beta-catenin is released from the destruction complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction565">
 <bp:evidence rdf:resource="#Evidence659" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of LRP5/6 cytoplasmic domain by CSNKI</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction564">
 <bp:evidence rdf:resource="#Evidence658" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PP2A dephosphorylates AXIN, APC and CTNNB1 in the destruction complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1384">
 <bp:evidence rdf:resource="#Evidence1590" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NR1H2,3 binds the CETP gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1383">
 <bp:evidence rdf:resource="#Evidence1589" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NR1H2,3 binds the PLTP gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1382">
 <bp:evidence rdf:resource="#Evidence1588" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NCOA1 recruits EP300 to the ABCA1 promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1381">
 <bp:evidence rdf:resource="#Evidence1587" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NR1H3 mRNA is translated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1380">
 <bp:evidence rdf:resource="#Evidence1586" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of APOC2 regulated by NR1H2 or NR1H3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis399">
 <bp:controlled rdf:resource="#BiochemicalReaction1281" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1389">
 <bp:evidence rdf:resource="#Evidence1595" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NR1H2,3 binds the ABCG8 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1388">
 <bp:evidence rdf:resource="#Evidence1594" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NR1H2,3 binds the NR1H3 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1387">
 <bp:evidence rdf:resource="#Evidence1593" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ARL4C mRNA is translated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1386">
 <bp:evidence rdf:resource="#Evidence1592" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NR1H2,3 binds the ARL4C gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1385">
 <bp:evidence rdf:resource="#Evidence1591" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of APOD regulated by NR1H2 or NR1H3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction570">
 <bp:evidence rdf:resource="#Evidence665" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ZNRF3,RNF43 binds the FZD:LRP5/6 receptor complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction572">
 <bp:evidence rdf:resource="#Evidence667" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ZNRF3 ubiquitinates FZD to promote its downregulation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction571">
 <bp:evidence rdf:resource="#Evidence666" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RSPO:LGR binds ZNRF3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis327">
 <bp:controlled rdf:resource="#BiochemicalReaction922" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis326">
 <bp:controlled rdf:resource="#BiochemicalReaction920" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis329">
 <bp:controlled rdf:resource="#BiochemicalReaction924" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis328">
 <bp:controlled rdf:resource="#BiochemicalReaction923" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis323">
 <bp:controlled rdf:resource="#BiochemicalReaction914" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis322">
 <bp:controlled rdf:resource="#BiochemicalReaction911" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis325">
 <bp:controlled rdf:resource="#BiochemicalReaction919" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis324">
 <bp:controlled rdf:resource="#BiochemicalReaction916" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis330">
 <bp:controlled rdf:resource="#BiochemicalReaction925" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis332">
 <bp:controlled rdf:resource="#BiochemicalReaction929" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis331">
 <bp:controlled rdf:resource="#BiochemicalReaction928" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis338">
 <bp:controlled rdf:resource="#BiochemicalReaction939" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis337">
 <bp:controlled rdf:resource="#BiochemicalReaction937" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis339">
 <bp:controlled rdf:resource="#BiochemicalReaction940" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis334">
 <bp:controlled rdf:resource="#BiochemicalReaction932" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis333">
 <bp:controlled rdf:resource="#BiochemicalReaction931" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis336">
 <bp:controlled rdf:resource="#BiochemicalReaction935" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis335">
 <bp:controlled rdf:resource="#BiochemicalReaction934" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis341">
 <bp:controlled rdf:resource="#BiochemicalReaction950" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis340">
 <bp:controlled rdf:resource="#BiochemicalReaction946" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis343">
 <bp:controlled rdf:resource="#BiochemicalReaction956" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis342">
 <bp:controlled rdf:resource="#BiochemicalReaction954" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction599">
 <bp:evidence rdf:resource="#Evidence698" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Beta-catenin recruits CDC73 and LEO1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction596">
 <bp:evidence rdf:resource="#Evidence694" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DKK and KRM bind LRP5/6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction595">
 <bp:evidence rdf:resource="#Evidence693" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">sFRP binds WNT3A and inhibits WNT:FZD binding</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction598">
 <bp:evidence rdf:resource="#Evidence697" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of SET1 methyltransferase complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction597">
 <bp:evidence rdf:resource="#Evidence696" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KAT5 HAT complex acetylates TCF4 gene at histone H4</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis349">
 <bp:controlled rdf:resource="#BiochemicalReaction983" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis348">
 <bp:controlled rdf:resource="#BiochemicalReaction975" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis345">
 <bp:controlled rdf:resource="#BiochemicalReaction961" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis344">
 <bp:controlled rdf:resource="#BiochemicalReaction959" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis347">
 <bp:controlled rdf:resource="#BiochemicalReaction974" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis346">
 <bp:controlled rdf:resource="#BiochemicalReaction970" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis352">
 <bp:controlled rdf:resource="#BiochemicalReaction989" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis351">
 <bp:controlled rdf:resource="#BiochemicalReaction988" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis354">
 <bp:controlled rdf:resource="#BiochemicalReaction991" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis353">
 <bp:controlled rdf:resource="#BiochemicalReaction990" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis350">
 <bp:controlled rdf:resource="#BiochemicalReaction984" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis359">
 <bp:controlled rdf:resource="#BiochemicalReaction1002" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis356">
 <bp:controlled rdf:resource="#BiochemicalReaction999" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis355">
 <bp:controlled rdf:resource="#BiochemicalReaction993" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis358">
 <bp:controlled rdf:resource="#BiochemicalReaction1001" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis357">
 <bp:controlled rdf:resource="#BiochemicalReaction1000" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis363">
 <bp:controlled rdf:resource="#BiochemicalReaction1010" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis362">
 <bp:controlled rdf:resource="#BiochemicalReaction1009" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis365">
 <bp:controlled rdf:resource="#BiochemicalReaction1014" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis364">
 <bp:controlled rdf:resource="#BiochemicalReaction1011" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis361">
 <bp:controlled rdf:resource="#BiochemicalReaction1006" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis360">
 <bp:controlled rdf:resource="#BiochemicalReaction1004" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1781">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1782">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1783">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1784">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1785">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1786">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1787">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1788">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2660">
 <bp:evidence rdf:resource="#Evidence3079" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFR3-associated PI3K phosphorylates PIP2 to PIP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1780">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1337">
 <bp:evidence rdf:resource="#Evidence1539" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NR1H2,3, NRIP1 bind the FASN gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2668">
 <bp:evidence rdf:resource="#Evidence3090" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">B-RAF dissociates from S111/S120 p-SPRY2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1336">
 <bp:evidence rdf:resource="#Evidence1538" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of ANGPTL3 regulated by NR1H2 or NR1H3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2667">
 <bp:evidence rdf:resource="#Evidence3089" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SRC phosphorylates SPRY2 on Y55 and Y227</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1335">
 <bp:evidence rdf:resource="#Evidence1537" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NR1H2,3 binds the ANGPTL3 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2666">
 <bp:evidence rdf:resource="#Evidence3088" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PPTN11 dephosphorylates SPRY2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1334">
 <bp:evidence rdf:resource="#Evidence1533" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EPO:phospho-EPOR:phospho-JAK2:LYN:IRS2 binds PLCgamma</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2665">
 <bp:evidence rdf:resource="#Evidence3087" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SPRY2 translocates to the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1333">
 <bp:evidence rdf:resource="#Evidence1532" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EPOR-associated PLCG hydrolyzes 1-Phosphatidyl-1D-myo-inositol 4,5-bisphosphate</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2664">
 <bp:evidence rdf:resource="#Evidence3086" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SPRY2 binds GRB2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1332">
 <bp:evidence rdf:resource="#Evidence1531" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LYN phosphorylates PLCG1,2 in EPO:phospho-EPOR:phospho-JAK2:LYN:IRS2:PLCG1,2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2663">
 <bp:evidence rdf:resource="#Evidence3082" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFR3- and PTPN11-associated PI3K phosphorylates PIP2 to PIP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1331">
 <bp:evidence rdf:resource="#Evidence1529" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK2 transphosphorylates and is activated in response to Erythropoietin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2662">
 <bp:evidence rdf:resource="#Evidence3081" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR3:p-FRS2:p-PPTN11:GRB2:GAB1:PIK3R1 binds PIK3CA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1330">
 <bp:evidence rdf:resource="#Evidence1528" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK2 phosphorylates GAB1 in EPO:phospho-EPOR:phospho-JAK2:LYN:IRS2:GAB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2661">
 <bp:evidence rdf:resource="#Evidence3080" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR3:p-FRS2:GRB2:GAB1:PI3KR1 binds PIK3CA</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1789">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1339">
 <bp:evidence rdf:resource="#Evidence1541" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of SCD regulated by NR1H2 or NR1H3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1338">
 <bp:evidence rdf:resource="#Evidence1540" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NR1H2 or NR1H3, NRIP1 bind the SCD gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2669">
 <bp:evidence rdf:resource="#Evidence3091" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CBL dissociates from ubiquitinated p-SPRY2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction501">
 <bp:evidence rdf:resource="#Evidence578" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC2 binds effectors at the ER membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1770">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction500">
 <bp:evidence rdf:resource="#Evidence577" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC2 translocates to the ER membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1771">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction503">
 <bp:evidence rdf:resource="#Evidence580" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC2 binds effectors at the phagocytic vesicle membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1772">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction502">
 <bp:evidence rdf:resource="#Evidence579" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC2 translocates to the mitochondrial membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1773">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1774">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1775">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1776">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1777">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction509">
 <bp:evidence rdf:resource="#Evidence587" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDC42 translocates to the endoplasmic reticulum membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction508">
 <bp:evidence rdf:resource="#Evidence586" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDC42 binds effectors at the ER membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction505">
 <bp:evidence rdf:resource="#Evidence583" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDC42 GDIs block activation of CDC42</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction504">
 <bp:evidence rdf:resource="#Evidence581" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC2 GEFs activate RAC2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction507">
 <bp:evidence rdf:resource="#Evidence585" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDC42 binds effectors at the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction506">
 <bp:evidence rdf:resource="#Evidence584" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDC42 GEFs activate CDC42</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1326">
 <bp:evidence rdf:resource="#Evidence1524" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EPO:phospho-EPOR:phospho-JAK2:LYN:phospho-IRS2 binds PI3K</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2657">
 <bp:evidence rdf:resource="#Evidence3076" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR3:p-FRS2 binds GRB2:GAB1:PIK3R1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1325">
 <bp:evidence rdf:resource="#Evidence1523" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EPO:phospho-EPOR:phospho-JAK2:LYN:IRS2 binds GAB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2656">
 <bp:evidence rdf:resource="#Evidence3074" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR3 phosphorylates PPTN11</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1324">
 <bp:evidence rdf:resource="#Evidence1522" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EPO:phospho-EPOR:phospho-JAK2:LYN:IRS2 binds PI3K</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2655">
 <bp:evidence rdf:resource="#Evidence3073" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR3 phosphorylates FRS3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1323">
 <bp:evidence rdf:resource="#Evidence1520" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EPOR binds EPOR agonists</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2654">
 <bp:evidence rdf:resource="#Evidence3072" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR3:p-FRS:p-PTPN11 activates RAS nucleotide exchange</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1322">
 <bp:evidence rdf:resource="#Evidence1519" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phospho-JAK2 phosphorylates EPOR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2653">
 <bp:evidence rdf:resource="#Evidence3071" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR3:pFRS binds GRB2:SOS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1321">
 <bp:evidence rdf:resource="#Evidence1518" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-STAT5 dissociates from EPO:phospho-EPOR:phospho-JAK2:LYN:IRS2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2652">
 <bp:evidence rdf:resource="#Evidence3070" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR3 binds FRS3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1320">
 <bp:evidence rdf:resource="#Evidence1517" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK2 and LYN phosphorylate STAT5 in EPO:phospho-EPOR:phospho-JAK2:LYN:IRS2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2651">
 <bp:evidence rdf:resource="#Evidence3069" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR3:p-FRS2:GRB2:SOS1 activates RAS nucleotide exchange</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2650">
 <bp:evidence rdf:resource="#Evidence3068" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR3 phosphorylates FRS2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1778">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1779">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1329">
 <bp:evidence rdf:resource="#Evidence1527" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EPO:phospho-EPOR:phospho-JAK2:LYN:IRS2 phosphorylates IRS2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1328">
 <bp:evidence rdf:resource="#Evidence1526" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EPO:phospho-EPOR:phospho-JAK2:LYN:IRS2:phospho-GAB1 binds PI3K</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2659">
 <bp:evidence rdf:resource="#Evidence3078" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR3:p-FRS2:p-PPTN11 binds GRB2:GAB1:PI3KR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1327">
 <bp:evidence rdf:resource="#Evidence1525" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EPOR-associated PI3K phosphorylates PIP2 to PIP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2658">
 <bp:evidence rdf:resource="#Evidence3077" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of PIK3 regulatory alpha subunit to GRB2:GAB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1315">
 <bp:evidence rdf:resource="#Evidence1511" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK2 phosphorylates VAV1 in EPO:p-8Y-EPOR:p-12Y-JAK2:LYN:IRS2:p-Y-CRKL:RASGEF1:p-Y-SHC1:GRB2:VAV1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2646">
 <bp:evidence rdf:resource="#Evidence3063" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR3 binds PLCG1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1314">
 <bp:evidence rdf:resource="#Evidence1510" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EPO:phospho-EPOR:phospho-JAK2:LYN:IRS2:phospho-CRKL:RAPGEF1:phospho-SHC1 binds GRB2:VAV1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2645">
 <bp:evidence rdf:resource="#Evidence3062" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR3 phosphorylates PLCG1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1313">
 <bp:evidence rdf:resource="#Evidence1509" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EPO:p-EPOR:p-JAK2:LYN:IRS2 binds CRKL:RAPGEF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2644">
 <bp:evidence rdf:resource="#Evidence3060" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR3:p-SHC1 binds GRB2:SOS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1312">
 <bp:evidence rdf:resource="#Evidence1508" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK2 phosphorylates SHC1 in EPO:p-8Y-EPOR:p-12Y-JAK2:LYN:p-CRKL:RABGEF1:SHC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2643">
 <bp:evidence rdf:resource="#Evidence3059" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR3:p-SHC1:GRB2:SOS1 activates RAS nucleotide exchange</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1311">
 <bp:evidence rdf:resource="#Evidence1507" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LYN phosphorylates CRKL in EPO:p-8Y-EPOR:p-12Y-JAK2:LYN:IRS2:CRKL:RAPGEF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2642">
 <bp:evidence rdf:resource="#Evidence3058" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR3 binds SHC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1310">
 <bp:evidence rdf:resource="#Evidence1506" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EPO:phospho-EPOR:phospho-JAK2:LYN:IRS2:phospho-CRKL:RAPGEF1:GRB2-1:SOS1,phospho-VAV1 mediates exchange of GTP for GDP bound to RAS</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2641">
 <bp:evidence rdf:resource="#Evidence3057" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR3 phosphorylates SHC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2640">
 <bp:evidence rdf:resource="#Evidence3054" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CBL ubiquitinates FRS2 and FGFR3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1319">
 <bp:evidence rdf:resource="#Evidence1516" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EPO:phospho-EPOR:phospho-JAK2:LYN:IRS2 binds STAT5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1318">
 <bp:evidence rdf:resource="#Evidence1514" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EPO binds EPOR:JAK2:LYN:IRS2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2649">
 <bp:evidence rdf:resource="#Evidence3067" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR3 binds FRS2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1317">
 <bp:evidence rdf:resource="#Evidence1513" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EPO:p-8Y-EPOR:p-12Y-JAK2:LYN:IRS2:p-CRKL:RAPGEF1 binds SHC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2648">
 <bp:evidence rdf:resource="#Evidence3066" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR3:p-FRS bind to PPTN11</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1316">
 <bp:evidence rdf:resource="#Evidence1512" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EPO:phospho-EPOR:phospho-JAK2:LYN:IRS2:phospho-CRKL:RAPGEF1:phospho-SHC1 binds GRB2:SOS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2647">
 <bp:evidence rdf:resource="#Evidence3064" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-4Y-PLCG1 dissociates from activated FGFR3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1792">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1793">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1794">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1795">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1796">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1797">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1798">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1799">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1790">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1791">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1304">
 <bp:evidence rdf:resource="#Evidence1497" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of PTK2 to Focal complexes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2635">
 <bp:evidence rdf:resource="#Evidence3049" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated SPRY2 is ubiquitinated by CBL</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1303">
 <bp:evidence rdf:resource="#Evidence1496" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of Talin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2634">
 <bp:evidence rdf:resource="#Evidence3048" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PPA2A dephosphorylates SPRY2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1302">
 <bp:evidence rdf:resource="#Evidence1495" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of Rap1 by membrane-associated GEFs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2633">
 <bp:evidence rdf:resource="#Evidence3047" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SPRY2 binds CBL</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1301">
 <bp:evidence rdf:resource="#Evidence1494" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dephosphorylation of inactive SRC by PTPB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2632">
 <bp:evidence rdf:resource="#Evidence3046" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CBL dissociates from ubiquitinated p-SPRY2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1300">
 <bp:evidence rdf:resource="#Evidence1493" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Autophosphorylation of SRC</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2631">
 <bp:evidence rdf:resource="#Evidence3045" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">B-RAF dissociates from S111/S120 p-SPRY2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2630">
 <bp:evidence rdf:resource="#Evidence3044" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SRC phosphorylates SPRY2 on Y55 and Y227</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1309">
 <bp:evidence rdf:resource="#Evidence1503" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Autophosphorylation of PTK2 at Y397</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1308">
 <bp:evidence rdf:resource="#Evidence1502" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Integrin alphaIIb beta3 activation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2639">
 <bp:evidence rdf:resource="#Evidence3053" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated ERK1/2 threonine-phosphorylates FGFR3-associated FRS2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1307">
 <bp:evidence rdf:resource="#Evidence1501" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of Rap1 by cytosolic GEFs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2638">
 <bp:evidence rdf:resource="#Evidence3052" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-CBL:GRB2 binds p-FRS2:activated FGFR3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1306">
 <bp:evidence rdf:resource="#Evidence1500" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of SOS with GRB2 bound to FADK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2637">
 <bp:evidence rdf:resource="#Evidence3051" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SPRY2 is phosphorylated by phosphorylated MNK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1305">
 <bp:evidence rdf:resource="#Evidence1499" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of GRB2 to p-PTK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2636">
 <bp:evidence rdf:resource="#Evidence3050" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SPRY2 is serine phosphorylated in response to MAPK activation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction534">
 <bp:evidence rdf:resource="#Evidence621" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GDIs block activation of RHOA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction533">
 <bp:evidence rdf:resource="#Evidence620" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOA GAPs stimulate RHOA GTPase activity</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction536">
 <bp:evidence rdf:resource="#Evidence623" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOA binds effectors at the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction535">
 <bp:evidence rdf:resource="#Evidence622" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOA GEFs activate RHOA</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1740">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction530">
 <bp:evidence rdf:resource="#Evidence615" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOC GEFs activate RHOC</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1741">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1742">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction532">
 <bp:evidence rdf:resource="#Evidence618" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RND3 binds GTP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1743">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction531">
 <bp:evidence rdf:resource="#Evidence617" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RND3 binds effectors</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1744">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1373">
 <bp:evidence rdf:resource="#Evidence1579" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of EEPD1 regulated by NR1H2 or NR1H3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1372">
 <bp:evidence rdf:resource="#Evidence1578" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-26 binds to the 3&apos;UTR of the ABCA1 mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1371">
 <bp:evidence rdf:resource="#Evidence1577" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of ABCG1 regulated by NR1H2,3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1370">
 <bp:evidence rdf:resource="#Evidence1576" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of APOC1 regulated by NR1H2 or NR1H3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction538">
 <bp:evidence rdf:resource="#Evidence625" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOA binds effectors at the ER membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction537">
 <bp:evidence rdf:resource="#Evidence624" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOA:GTP translocates to the ER membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction539">
 <bp:evidence rdf:resource="#Evidence627" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RND2 binds effectors</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1379">
 <bp:evidence rdf:resource="#Evidence1585" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-144 binds to the 3&apos;UTR of the ABCA1 mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1378">
 <bp:evidence rdf:resource="#Evidence1584" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NR1H2,3 binds the APOE gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1377">
 <bp:evidence rdf:resource="#Evidence1583" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NR1H2,3 binds the APOD gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1376">
 <bp:evidence rdf:resource="#Evidence1582" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NR1H2,3 binds the APOC2 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1375">
 <bp:evidence rdf:resource="#Evidence1581" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of CETP regulated by NR1H2 or NR1H3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1374">
 <bp:evidence rdf:resource="#Evidence1580" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NCOA1 binds the ABCA1gene:NR1H2,3:RXR:NR1H2,3 ligands complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1745">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1746">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1747">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1748">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1749">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction545">
 <bp:evidence rdf:resource="#Evidence637" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">YWHAZ binds p-CBY:CTNNB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction544">
 <bp:evidence rdf:resource="#Evidence636" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">beta-catenin is replaced by repression complexes at the promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction547">
 <bp:evidence rdf:resource="#Evidence639" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT phosphorylates CBY1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction546">
 <bp:evidence rdf:resource="#Evidence638" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">YWHAZ and XPO1 mediate the nuclear export of beta-catenin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction541">
 <bp:evidence rdf:resource="#Evidence630" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOBTB3 binds ATP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1730">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction540">
 <bp:evidence rdf:resource="#Evidence628" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RND2 binds GTP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1731">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction543">
 <bp:evidence rdf:resource="#Evidence632" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOBTB3 binds interacting proteins at trans-Golgi network</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1732">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction542">
 <bp:evidence rdf:resource="#Evidence631" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOBTB3 hydrolyzes ATP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1733">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1362">
 <bp:evidence rdf:resource="#Evidence1568" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of ABCG5 regulated by NR1H2,3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2693">
 <bp:evidence rdf:resource="#Evidence3119" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR4:p-FRS2:p-PPTN11:GRB2:GAB1:PIK3R1binds PIK3CA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1361">
 <bp:evidence rdf:resource="#Evidence1567" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of APOE regulated by NR1H2 or NR1H3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2692">
 <bp:evidence rdf:resource="#Evidence3118" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFR4- and PTPN11-associated PI3K phosphorylates PIP2 to PIP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1360">
 <bp:evidence rdf:resource="#Evidence1566" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-33 binds to the 3&apos;UTR of the ABCA1 mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2691">
 <bp:evidence rdf:resource="#Evidence3117" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR4:p-FRS2:p-PPTN11 binds GRB2:GAB1:PI3KR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2690">
 <bp:evidence rdf:resource="#Evidence3115" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR4:p-SHC1 binds GRB2:SOS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction549">
 <bp:evidence rdf:resource="#Evidence641" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">XIAP monoubiquinates TLE</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction548">
 <bp:evidence rdf:resource="#Evidence640" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">XIAP binds TLE</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1369">
 <bp:evidence rdf:resource="#Evidence1575" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of ABCG8 regulated by NR1H2 or NR1H3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1368">
 <bp:evidence rdf:resource="#Evidence1574" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-613 binds to the 3&apos;UTR of the NR1H3 mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2699">
 <bp:evidence rdf:resource="#Evidence3126" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR4 binds PLCG1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1367">
 <bp:evidence rdf:resource="#Evidence1573" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NR1H3 gene transcription regulated by NR1H2,3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2698">
 <bp:evidence rdf:resource="#Evidence3125" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-4Y-PLCG1 dissociates from activated FGFR4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1366">
 <bp:evidence rdf:resource="#Evidence1572" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NR1H2,3 binds the ABCG5 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2697">
 <bp:evidence rdf:resource="#Evidence3123" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR4:p-FRS2:GRB2:GAB1:PI3KR1 binds PIK3CA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1365">
 <bp:evidence rdf:resource="#Evidence1571" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NR1H2,3 binds the APOC1 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2696">
 <bp:evidence rdf:resource="#Evidence3122" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR4:p-FRS2 binds GRB2:GAB1:PIK3R1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1364">
 <bp:evidence rdf:resource="#Evidence1570" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NR1H2,3 binds the EEPD1 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2695">
 <bp:evidence rdf:resource="#Evidence3121" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of PIK3 regulatory alpha subunit to GRB2:GAB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1363">
 <bp:evidence rdf:resource="#Evidence1569" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ABCA1 gene transcription regulated by NR1H2 or NR1H3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2694">
 <bp:evidence rdf:resource="#Evidence3120" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFR4-associated PI3K phosphorylates PIP2 to PIP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1734">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1735">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction550">
 <bp:evidence rdf:resource="#Evidence642" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Beta-catenin binds SOX proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1736">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1737">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1738">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1739">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction512">
 <bp:evidence rdf:resource="#Evidence591" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOH binds GTP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction511">
 <bp:evidence rdf:resource="#Evidence590" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOH binds effectors at the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1760">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction514">
 <bp:evidence rdf:resource="#Evidence594" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOQ translocates to the Golgi-associated vesicle membranes</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1761">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction513">
 <bp:evidence rdf:resource="#Evidence592" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GDIs bind RHOH</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1762">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1763">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1764">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction510">
 <bp:evidence rdf:resource="#Evidence588" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDC42 GAPs stimulate CDC42 GTPase activity</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1765">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1766">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1351">
 <bp:evidence rdf:resource="#Evidence1556" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Oxysterol binds to the UGT1A3 gene:NR1H2,3:RXR:NCOR complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2682">
 <bp:evidence rdf:resource="#Evidence3106" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR4:p-FRS:p-PTPN11 activates RAS nucleotide exchange</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction519">
 <bp:evidence rdf:resource="#Evidence600" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOV binds GTP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1350">
 <bp:evidence rdf:resource="#Evidence1555" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NCOA1 binds the UGT1A3 gene:NR1H2,3:RXR:NR1H2,3 ligand complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2681">
 <bp:evidence rdf:resource="#Evidence3105" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR4 phosphorylates PPTN11</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2680">
 <bp:evidence rdf:resource="#Evidence3104" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR4 phosphorylates FRS3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction516">
 <bp:evidence rdf:resource="#Evidence596" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOQ binds effectors at the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction515">
 <bp:evidence rdf:resource="#Evidence595" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOQ binds GOPC:CFTR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction518">
 <bp:evidence rdf:resource="#Evidence598" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOQ GAPs stimulate RHOQ GTPase activity</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction517">
 <bp:evidence rdf:resource="#Evidence597" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOQ GEFs activate RHOQ</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1359">
 <bp:evidence rdf:resource="#Evidence1565" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Oxysterol binds to the ABCA1 gene:NR1H2,3:RXR:NCOR:GPS2:TBL1:HDAC3 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1358">
 <bp:evidence rdf:resource="#Evidence1564" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NR1H2,3 binds the APOC4 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2689">
 <bp:evidence rdf:resource="#Evidence3114" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR4 phosphorylates SHC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1357">
 <bp:evidence rdf:resource="#Evidence1563" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Oxysterol-induced binding of NR1H2,3:RXR to the ABCG1 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2688">
 <bp:evidence rdf:resource="#Evidence3113" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR4:p-SHC1:GRB2:SOS1 activates RAS nucleotide exchange</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1356">
 <bp:evidence rdf:resource="#Evidence1562" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-26 binds to the 3&apos;UTR of the ARL4C mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2687">
 <bp:evidence rdf:resource="#Evidence3112" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR4 binds SHC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1355">
 <bp:evidence rdf:resource="#Evidence1561" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ARL4C gene transcription regulated by NR1H2,3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2686">
 <bp:evidence rdf:resource="#Evidence3110" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR4 binds FRS2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1354">
 <bp:evidence rdf:resource="#Evidence1560" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Co-repressor complex dissociates from the transcription unit of the ABCA1 gene </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2685">
 <bp:evidence rdf:resource="#Evidence3109" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR4:p-FRS2:GRB2:SOS1 activates RAS nucleotide exchange</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1353">
 <bp:evidence rdf:resource="#Evidence1559" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of APOC4 regulated by NR1H2 or NR1H3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2684">
 <bp:evidence rdf:resource="#Evidence3108" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR4 phosphorylates FRS2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1352">
 <bp:evidence rdf:resource="#Evidence1557" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NR1H2,3 binds the FABP6 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2683">
 <bp:evidence rdf:resource="#Evidence3107" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR4:p-FRS bind to PPTN11</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1767">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1768">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1769">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction523">
 <bp:evidence rdf:resource="#Evidence607" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOBTB2 binds interacting proteins at the endosome membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction522">
 <bp:evidence rdf:resource="#Evidence605" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOBTB1 binds interacting proteins at the endosome membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction525">
 <bp:evidence rdf:resource="#Evidence610" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOC translocates to the endoplasmic reticulum membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1750">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction524">
 <bp:evidence rdf:resource="#Evidence608" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOBTB2 binds GTP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1751">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1752">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1753">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction521">
 <bp:evidence rdf:resource="#Evidence604" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOBTB1 binds GTP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1754">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction520">
 <bp:evidence rdf:resource="#Evidence601" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOV binds effectors at the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1755">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1340">
 <bp:evidence rdf:resource="#Evidence1542" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of FASN regulated by NR1H2 or NR1H3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2671">
 <bp:evidence rdf:resource="#Evidence3093" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PPA2A dephosphorylates SPRY2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2670">
 <bp:evidence rdf:resource="#Evidence3092" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SPRY2 binds CBL</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction527">
 <bp:evidence rdf:resource="#Evidence612" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOC GAPs stimulate RHOC GTPase activity</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction526">
 <bp:evidence rdf:resource="#Evidence611" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOC binds effectors at the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction529">
 <bp:evidence rdf:resource="#Evidence614" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GDIs block activation of RHOC</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction528">
 <bp:evidence rdf:resource="#Evidence613" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHOC activates endoplasmic reticulum effectors</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1348">
 <bp:evidence rdf:resource="#Evidence1553" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of UGT1A3 </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2679">
 <bp:evidence rdf:resource="#Evidence3103" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR4 binds FRS3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1347">
 <bp:evidence rdf:resource="#Evidence1552" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of FABP6 regulated by NR1H2,3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2678">
 <bp:evidence rdf:resource="#Evidence3102" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated FGFR4:p-FRS binds GRB2:SOS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1346">
 <bp:evidence rdf:resource="#Evidence1550" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NR1H2,3 binds the MYLIP gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2677">
 <bp:evidence rdf:resource="#Evidence3099" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated ERK1/2 threonine-phosphorylates FGFR4-associated FRS2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1345">
 <bp:evidence rdf:resource="#Evidence1549" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of MYLIP regulated by NR1H2,3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2676">
 <bp:evidence rdf:resource="#Evidence3098" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-CBL:GRB2 binds p-FRS2:activated FGFR4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1344">
 <bp:evidence rdf:resource="#Evidence1547" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NR1H3, NRIP1 bind the PCK1 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2675">
 <bp:evidence rdf:resource="#Evidence3097" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CBL ubiquitinates FRS2 and FGFR4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1343">
 <bp:evidence rdf:resource="#Evidence1546" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of PCK1 regulated by NR1H3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2674">
 <bp:evidence rdf:resource="#Evidence3096" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SPRY2 is phosphorylated by phosphorylated MNK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1342">
 <bp:evidence rdf:resource="#Evidence1544" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of SREBF1 (SREBP1) regulated by NR1H2 or NR1H3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2673">
 <bp:evidence rdf:resource="#Evidence3095" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SPRY2 is serine phosphorylated in response to MAPK activation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1341">
 <bp:evidence rdf:resource="#Evidence1543" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NR1H2 or NR1H3, NRIP1 bind the SREBF1 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2672">
 <bp:evidence rdf:resource="#Evidence3094" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated SPRY2 is ubiquitinated by CBL</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1756">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1757">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1758">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1759">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1349">
 <bp:evidence rdf:resource="#Evidence1554" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Co-repressor complex dissociates from the transcription unit of the UGT1A3 gene </bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1701">
 <bp:stepProcess rdf:resource="#Catalysis439" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1490" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1700">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1489" />
 <bp:stepProcess rdf:resource="#Catalysis438" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1705">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1494" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1704">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1493" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1703">
 <bp:stepProcess rdf:resource="#Catalysis441" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1492" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2910">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1702">
 <bp:stepProcess rdf:resource="#Catalysis440" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1491" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2919">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1709">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1498" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2912">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1708">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1497" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2911">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1707">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1496" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2914">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1706">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1495" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2913">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2916">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2915">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2918">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2917">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1712">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1501" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1711">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1500" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1710">
 <bp:stepProcess rdf:resource="#Catalysis442" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1499" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1716">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1504" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1715">
 <bp:stepProcess rdf:resource="#Pathway213" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1714">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1503" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1713">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1502" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2909">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2908">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2901">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1719">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1507" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2900">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1718">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1506" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2903">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1717">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1505" />
 <bp:stepProcess rdf:resource="#Catalysis443" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2902">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2905">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2904">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2907">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2906">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2930">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1600">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2932">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1601">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2931">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1602">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2934">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1603">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2933">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1604">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2936">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1605">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2935">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1606">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2938">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1607">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2937">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1608">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1609">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2939">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2921">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2920">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway4">
 <bp:pathwayOrder rdf:resource="#PathwayStep6" />
 <bp:pathwayOrder rdf:resource="#PathwayStep37" />
 <bp:pathwayOrder rdf:resource="#PathwayStep32" />
 <bp:pathwayOrder rdf:resource="#PathwayStep53" />
 <bp:pathwayComponent rdf:resource="#Pathway5" />
 <bp:pathwayComponent rdf:resource="#Pathway7" />
 <bp:pathwayComponent rdf:resource="#Pathway8" />
 <bp:pathwayComponent rdf:resource="#Pathway9" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence6" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTEN Regulation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTEN is regulated at the level of gene transcription, mRNA translation, localization and protein stability. Transcription of the PTEN gene is regulated at multiple levels. Epigenetic repression involves the recruitment of Mi-2/NuRD upon SALL4 binding to the PTEN promoter (Yang et al. 2008, Lu et al. 2009) or EVI1-mediated recruitment of the polycomb repressor complex (PRC) to the PTEN promoter (Song et al. 2009, Yoshimi et al. 2011). Transcriptional regulation is also elicited by negative regulators, including NR2E1:ATN1 (atrophin-1) complex, JUN (c-Jun), SNAIL and SLUG (Zhang et al. 2006, Vasudevan et al. 2007, Escriva et al. 2008, Uygur et al. 2015) and positive regulators such as TP53 (p53), MAF1, ATF2, EGR1 or PPARG (Stambolic et al. 2001, Virolle et al. 2001, Patel et al. 2001, Shen et al. 2006, Li et al. 2016). MicroRNAs miR-26A1, miR-26A2, miR-22, miR-25, miR-302, miR-214, miR-17-5p, miR-19 and miR-205 bind PTEN mRNA and inhibit its translation into protein. These microRNAs are altered in cancer and can account for changes in PTEN levels (Meng et al. 2007, Xiao et al. 2008, Yang et al. 2008, Huse et al. 2009, Kim et al. 2010, Poliseno, Salmena, Riccardi et al. 2010, Cai et al. 2013). In addition, coding and non-coding RNAs can prevent microRNAs from binding to PTEN mRNA. These RNAs are termed competing endogenous RNAs or ceRNAs. Transcripts of the pseudogene PTENP1 and mRNAs transcribed from SERINC1, VAPA and CNOT6L genes exhibit this activity (Poliseno, Salmena, Zhang et al. 2010, Tay et al. 2011, Tay et al. 2014). PTEN can translocate from the cytosol to the nucleus after undergoing monoubiquitination. PTEN&apos;s ability to localize to the nucleus contributes to its tumor suppressive role (Trotman et al. 2007). The ubiquitin protease USP7 (HAUSP) targets monoubiquitinated PTEN in the nucleus, resulting in PTEN deubiquitination and nuclear exclusion. PML, via an unknown mechanism that involves USP7- and PML-interacting protein DAXX, inhibits USP7-mediated deubiquitination of PTEN, thus promoting PTEN nuclear localization. Disruption of PML function in acute promyelocytic leukemia, through a chromosomal translocation that results in expression of a fusion protein PML-RARA, leads to aberrant PTEN localization (Song et al. 2008). Several ubiquitin ligases, including NEDD4, WWP2, STUB1 (CHIP), RNF146, XIAP and MKRN1, polyubiquitinate PTEN and target it for proteasome-mediated degradation (Wang et al. 2007, Van Themsche et al. 2009, Ahmed et al. 2011, Maddika et al. 2011, Lee et al. 2015, Li et al. 2015). The ubiquitin proteases USP13 and OTUD3, frequently down-regulated in breast cancer, remove polyubiquitin chains from PTEN, thus preventing its degradation and increasing its half-life (Zhang et al. 2013, Yuan et al. 2015). The catalytic activity of PTEN is negatively regulated by PREX2 binding (Fine et al. 2009, Hodakoski et al. 2014) and TRIM27-mediated ubiquitination (Lee et al. 2013), most likely through altered PTEN conformation. In addition to ubiquitination, PTEN also undergoes SUMOylation (Gonzalez-Santamaria et al. 2012, Da Silva Ferrada et al. 2013, Lang et al. 2015, Leslie et al. 2016). SUMOylation of the C2 domain of PTEN may regulate PTEN association with the plasma membrane (Shenoy et al. 2012) as well as nuclear localization of PTEN (Bassi et al. 2013, Collaud et al. 2016). PIASx-alpha, a splicing isorom of E3 SUMO-protein ligase PIAS2 has been implicated in PTEN SUMOylation (Wang et al. 2014). SUMOylation of PTEN may be regulated by activated AKT (Lin et al. 2016). Reactions describing PTEN SUMOylation will be annotated when mechanistic details become available. Phosphorylation affects the stability and activity of PTEN. FRK tyrosine kinase (RAK) phosphorylates PTEN on tyrosine residue Y336, which increases PTEN half-life by inhibiting NEDD4-mediated polyubiquitination and subsequent degradation of PTEN. FRK-mediated phosphorylation also increases PTEN enzymatic activity (Yim et al. 2009). Casein kinase II (CK2) constitutively phosphorylates the C-terminal tail of PTEN on serine and threonine residues S370, S380, T382, T383 and S385. CK2-mediated phosphorylation increases PTEN protein stability (Torres and Pulido 2001) but results in ~30% reduction in PTEN lipid phosphatase activity (Miller et al. 2002). PTEN localization and activity are affected by acetylation of its lysine residues (Okumura et al. 2006, Ikenoue et al. 2008, Meng et al. 2016). PTEN can undergo oxidation, which affects its function, but the mechanism is poorly understood (Tan et al. 2015, Shen et al. 2015, Verrastro et al. 2016).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway5">
 <bp:pathwayOrder rdf:resource="#PathwayStep7" />
 <bp:pathwayOrder rdf:resource="#PathwayStep9" />
 <bp:pathwayOrder rdf:resource="#PathwayStep27" />
 <bp:pathwayOrder rdf:resource="#PathwayStep8" />
 <bp:pathwayOrder rdf:resource="#PathwayStep26" />
 <bp:pathwayOrder rdf:resource="#PathwayStep29" />
 <bp:pathwayOrder rdf:resource="#PathwayStep28" />
 <bp:pathwayOrder rdf:resource="#PathwayStep23" />
 <bp:pathwayOrder rdf:resource="#PathwayStep22" />
 <bp:pathwayOrder rdf:resource="#PathwayStep25" />
 <bp:pathwayOrder rdf:resource="#PathwayStep24" />
 <bp:pathwayOrder rdf:resource="#PathwayStep30" />
 <bp:pathwayOrder rdf:resource="#PathwayStep21" />
 <bp:pathwayOrder rdf:resource="#PathwayStep31" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction20" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction19" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction18" />
 <bp:pathwayComponent rdf:resource="#Pathway6" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction22" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction21" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction24" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction23" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction26" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction25" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction4" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction17" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction3" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction16" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence7" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of PTEN mRNA translation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MicroRNAs miR-17, miR-19a, miR-19b, miR-20a, miR-20b, miR-21, miR-22, miR-25, miR 26A1, miR 26A2, miR-93, miR-106a, miR-106b, miR 205, and miR 214 and bind PTEN mRNA and inhibit its translation into protein. These microRNAs are altered in cancer and can account for changes in PTEN levels. There is evidence that PTEN mRNA translation is also inhibited by other microRNAs, such as miR-302 and miR-26B, and these microRNAs will be annotated when additional experimental details become available (Meng et al. 2007, Xiao et al. 2008, Yang et al. 2008, Huse et al. 2009, Kim et al. 2010, Poliseno, Salmena, Riccardi et al. 2010, Zhang et al. 2010, Tay et al. 2011, Qu et al. 2012, Cai et al. 2013). In addition, coding and non coding RNAs can prevent microRNAs from binding to PTEN mRNA. These RNAs are termed competing endogenous RNAs or ceRNAs. Transcripts of the pseudogene PTENP1 and mRNAs transcribed from SERINC1, VAPA and CNOT6L genes exhibit this activity (Poliseno, Salmena, Zhang et al. 2010, Tay et al. 2011, Tay et al. 2014).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway6">
 <bp:pathwayOrder rdf:resource="#PathwayStep19" />
 <bp:pathwayOrder rdf:resource="#PathwayStep16" />
 <bp:pathwayOrder rdf:resource="#PathwayStep15" />
 <bp:pathwayOrder rdf:resource="#PathwayStep18" />
 <bp:pathwayOrder rdf:resource="#PathwayStep17" />
 <bp:pathwayOrder rdf:resource="#PathwayStep12" />
 <bp:pathwayOrder rdf:resource="#PathwayStep11" />
 <bp:pathwayOrder rdf:resource="#PathwayStep14" />
 <bp:pathwayOrder rdf:resource="#PathwayStep13" />
 <bp:pathwayOrder rdf:resource="#PathwayStep10" />
 <bp:pathwayOrder rdf:resource="#PathwayStep20" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction9" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction6" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction11" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction5" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction10" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction8" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction13" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction7" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction12" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction15" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction14" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence10" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Competing endogenous RNAs (ceRNAs) regulate PTEN translation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Coding and non-coding RNAs can prevent microRNAs from binding to PTEN mRNA. These RNAs are termed competing endogenous RNAs or ceRNAs. Transcripts of the pseudogene PTENP1 and mRNAs transcribed from SERINC1, VAPA and CNOT6L genes exhibit this activity (Poliseno et al. 2010, Tay et al. 2011, Tay et al. 2014). SERINC1 mRNA will be annotated in this context when additional experimental details become available.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway7">
 <bp:pathwayOrder rdf:resource="#PathwayStep34" />
 <bp:pathwayOrder rdf:resource="#PathwayStep33" />
 <bp:pathwayOrder rdf:resource="#PathwayStep36" />
 <bp:pathwayOrder rdf:resource="#PathwayStep35" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction29" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction30" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction28" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction27" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence33" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of PTEN localization</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">When monoubiquitinated by E3 ubiquitin ligases XIAP and NEDD4, PTEN translocates from the cytosol to the nucleus (Trotman et al. 2007, Van Themsche et al. 2009). USP7 (HAUSP)-mediated deubiquitination of monoubiquitinated nuclear PTEN promotes relocalization of PTEN to the cytosol (Song et al. 2008).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway1">
 <bp:pathwayOrder rdf:resource="#PathwayStep1503" />
 <bp:pathwayOrder rdf:resource="#PathwayStep979" />
 <bp:pathwayOrder rdf:resource="#PathwayStep811" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1743" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1445" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1533" />
 <bp:pathwayOrder rdf:resource="#PathwayStep139" />
 <bp:pathwayOrder rdf:resource="#PathwayStep236" />
 <bp:pathwayOrder rdf:resource="#PathwayStep632" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1476" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2165" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3133" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2023" />
 <bp:pathwayOrder rdf:resource="#PathwayStep376" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1928" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1" />
 <bp:pathwayOrder rdf:resource="#PathwayStep172" />
 <bp:pathwayComponent rdf:resource="#Pathway25" />
 <bp:pathwayComponent rdf:resource="#Pathway36" />
 <bp:pathwayComponent rdf:resource="#Pathway129" />
 <bp:pathwayComponent rdf:resource="#Pathway49" />
 <bp:pathwayComponent rdf:resource="#Pathway21" />
 <bp:pathwayComponent rdf:resource="#Pathway195" />
 <bp:pathwayComponent rdf:resource="#Pathway90" />
 <bp:pathwayComponent rdf:resource="#Pathway191" />
 <bp:pathwayComponent rdf:resource="#Pathway2" />
 <bp:pathwayComponent rdf:resource="#Pathway192" />
 <bp:pathwayComponent rdf:resource="#Pathway269" />
 <bp:pathwayComponent rdf:resource="#Pathway235" />
 <bp:pathwayComponent rdf:resource="#Pathway246" />
 <bp:pathwayComponent rdf:resource="#Pathway215" />
 <bp:pathwayComponent rdf:resource="#Pathway430" />
 <bp:pathwayComponent rdf:resource="#Pathway112" />
 <bp:pathwayComponent rdf:resource="#Pathway200" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signal Transduction</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signal transduction is a process in which extracellular signals elicit changes in cell state and activity. Transmembrane receptors sense changes in the cellular environment by binding ligands, such as hormones and growth factors, or reacting to other types of stimuli, such as light. Stimulation of transmembrane receptors leads to their conformational change which propagates the signal to the intracellular environment by activating downstream signaling cascades. Depending on the cellular context, this may impact cellular proliferation, differentiation, and survival. On the organism level, signal transduction regulates overall growth and behavior. Receptor tyrosine kinases (RTKs) transmit extracellular signals by phosphorylating their protein partners on conserved tyrosine residues.  Some of the best studied RTKs are EGFR (reviewed in Avraham and Yarden, 2011), FGFR (reviewed in Eswarakumar et al, 2005), insulin receptor (reviewed in Saltiel and Kahn, 2001), NGF (reviewed in Reichardt, 2006), PDGF (reviewed in Andrae et al, 2008) and VEGF (reviewed in Xie et al, 2004).  RTKs frequently activate downstream signaling through RAF/MAP kinases (reviewed in McKay and Morrison, 2007 and Wellbrock et al 2004), AKT (reviewed in Manning and Cantley, 2007) and PLC- gamma (reviewed in Patterson et al, 2005), which ultimately results in changes in gene expression and cellular metabolism.   Receptor serine/threonine kinases of the TGF-beta family, such as TGF-beta receptors (reviewed in Kang et al. 2009) and BMP receptors (reviewed in Miyazono et al. 2009), transmit extracellular signals by phosphorylating regulatory SMAD proteins on conserved serine and threonine residues. This leads to formation of complexes of regulatory SMADs and SMAD4, which translocate to the nucleus where they act as transcription factors.   WNT receptors transmit their signal through beta-catenin. In the absence of ligand, beta-catenin is constitutively degraded in a ubiquitin-dependent manner. WNT receptor stimulation releases beta-catenin from the destruction complex, allowing it to translocate to the nucleus where it acts as a transcriptional regulator (reviewed in MacDonald et al, 2009 and Angers and Moon, 2009).  WNT receptors were originally classified as G-protein coupled receptors (GPCRs).  Although they are structurally related, GPCRs primarily transmit their signals through G-proteins, which are trimers of alpha, beta and gamma subunits. When a GPCR is activated, it acts as a guanine nucleotide exchange factor, catalyzing GDP to GTP exchange on the G-alpha subunit of the G protein and its dissociation from the gamma-beta heterodimer.  The G-alpha subunit regulates the activity of adenylate cyclase, while the gamma-beta heterodimer can activate AKT and PLC signaling (reviewed in Rosenbaum et al. 2009, Oldham and Hamm 2008, Ritter and Hall 2009).  NOTCH receptors are activated by transmembrane ligands expressed on neighboring cells, which results in cleavage of NOTCH receptor and release of its intracellular domain. NOTCH intracellular domain translocates to the nucleus where it acts as a transcription factor (reviewed in Kopan and Ilagan, 2009).  Integrins are activated by extracellular matrix components, such as fibronectin and collagen, leading to conformational change and clustering of integrins on the cell surface.  This results in activation of integrin-linked kinase and other cytosolic kinases and, in co-operation with RTK signaling, regulates survival, proliferation and cell shape and adhesion (reviewed in Hehlgans et al, 2007) .   Besides inducing changes in gene expression and cellular metabolism, extracellular signals that trigger the activation of Rho GTP-ases can trigger changes in the organization of cytoskeleton, thereby regulating cell polarity and cell-cell junctions (reviewed in Citi et al, 2011).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway2">
 <bp:pathwayOrder rdf:resource="#PathwayStep103" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2" />
 <bp:pathwayComponent rdf:resource="#Pathway14" />
 <bp:pathwayComponent rdf:resource="#Pathway3" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Intracellular signaling by second messengers</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Second messengers are generated within the cell as a downstream step in signal transduction cascades initiated by the interaction of an external stimulus with a  cell surface receptor.  Common second messengers include DAG,  cAMP, cGMP, IP3, Ca2+ and phosphatidylinositols (reviewed in Kang et al, 2015; Raker et al, 2016; Li and Marshall, 2015; Pinto et al, 2015; Ahmad et al, 2015).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway3">
 <bp:pathwayOrder rdf:resource="#PathwayStep5" />
 <bp:pathwayOrder rdf:resource="#PathwayStep4" />
 <bp:pathwayOrder rdf:resource="#PathwayStep67" />
 <bp:pathwayOrder rdf:resource="#PathwayStep89" />
 <bp:pathwayOrder rdf:resource="#PathwayStep88" />
 <bp:pathwayOrder rdf:resource="#PathwayStep69" />
 <bp:pathwayOrder rdf:resource="#PathwayStep68" />
 <bp:pathwayOrder rdf:resource="#PathwayStep74" />
 <bp:pathwayOrder rdf:resource="#PathwayStep76" />
 <bp:pathwayOrder rdf:resource="#PathwayStep87" />
 <bp:pathwayOrder rdf:resource="#PathwayStep75" />
 <bp:pathwayOrder rdf:resource="#PathwayStep86" />
 <bp:pathwayOrder rdf:resource="#PathwayStep91" />
 <bp:pathwayOrder rdf:resource="#PathwayStep90" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction80" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction60" />
 <bp:pathwayComponent rdf:resource="#Pathway12" />
 <bp:pathwayComponent rdf:resource="#Pathway11" />
 <bp:pathwayComponent rdf:resource="#Pathway10" />
 <bp:pathwayComponent rdf:resource="#Pathway4" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction66" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction77" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction65" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction76" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction79" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction78" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction59" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence3" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PIP3 activates AKT signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by AKT is one of the key outcomes of receptor tyrosine kinase (RTK) activation. AKT is activated by the cellular second messenger PIP3, a phospholipid that is generated by PI3K. In ustimulated cells, PI3K class IA enzymes reside in the cytosol as inactive heterodimers composed of p85 regulatory subunit and p110 catalytic subunit. In this complex, p85 stabilizes p110 while inhibiting its catalytic activity. Upon binding of extracellular ligands to RTKs, receptors dimerize and undergo autophosphorylation. The regulatory subunit of PI3K, p85, is recruited to phosphorylated cytosolic RTK domains either directly or indirectly, through adaptor proteins, leading to a conformational change in the PI3K IA heterodimer that relieves inhibition of the p110 catalytic subunit. Activated PI3K IA phosphorylates PIP2, converting it to PIP3; this reaction is negatively regulated by PTEN phosphatase. PIP3 recruits AKT to the plasma membrane, allowing TORC2 to phosphorylate a conserved serine residue of AKT. Phosphorylation of this serine induces a conformation change in AKT, exposing a conserved threonine residue that is then phosphorylated by PDPK1 (PDK1). Phosphorylation of both the threonine and the serine residue is required to fully activate AKT. The active AKT then dissociates from PIP3 and phosphorylates a number of cytosolic and nuclear proteins that play important roles in cell survival and metabolism. For a recent review of AKT signaling, please refer to Manning and Cantley, 2007. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence2923">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2922">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2925">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2924">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2927">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2926">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2929">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2928">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction811">
 <bp:evidence rdf:resource="#Evidence937" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated type I receptor phosphorylates SMAD2/3 directly</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction810">
 <bp:evidence rdf:resource="#Evidence936" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">An anchoring protein, ZFYVE9 (SARA), recruits SMAD2/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction817">
 <bp:evidence rdf:resource="#Evidence944" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PP1 dephosphorylates TGFBR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction816">
 <bp:evidence rdf:resource="#Evidence942" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated SMAD2 and SMAD3 form a complex with SMAD4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction819">
 <bp:evidence rdf:resource="#Evidence946" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NEDD4L ubiquitin ligase binds SMAD7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction818">
 <bp:evidence rdf:resource="#Evidence945" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMAD7:NEDD4L complex translocates to the cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction813">
 <bp:evidence rdf:resource="#Evidence939" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TGFBR2 phosphorylates TGFBR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction812">
 <bp:evidence rdf:resource="#Evidence938" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Latent TGF-beta-3 binds integrins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction815">
 <bp:evidence rdf:resource="#Evidence941" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TGFBR2 recruits TGFBR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction814">
 <bp:evidence rdf:resource="#Evidence940" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Latent TGF-beta-1 binds integrins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1535">
 <bp:evidence rdf:resource="#Evidence1752" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitination of DLL/JAG ligands upon binding to NOTCH2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1534">
 <bp:evidence rdf:resource="#Evidence1751" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DLL4 binds NOTCH2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1533">
 <bp:evidence rdf:resource="#Evidence1750" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NEXT2 is cleaved to produce NICD2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1532">
 <bp:evidence rdf:resource="#Evidence1749" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Gamma-secretase cleaves CNTN1:NOTCH2 to release NICD2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1531">
 <bp:evidence rdf:resource="#Evidence1748" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAG1 binds NOTCH2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1530">
 <bp:evidence rdf:resource="#Evidence1747" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAG2 binds NOTCH2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1539">
 <bp:evidence rdf:resource="#Evidence1756" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH2 binds DLL/JAG ligand in cis</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1538">
 <bp:evidence rdf:resource="#Evidence1755" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH2 binds CNTN1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1537">
 <bp:evidence rdf:resource="#Evidence1754" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NICD2 traffics to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1536">
 <bp:evidence rdf:resource="#Evidence1753" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DLL1 binds NOTCH2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction820">
 <bp:evidence rdf:resource="#Evidence947" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STRAP stabilizes interaction of activated TGF-beta receptor complex with SMAD7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction822">
 <bp:evidence rdf:resource="#Evidence949" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">I-SMAD competes with SMAD2/3 for type I receptor (TGFBR1)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction821">
 <bp:evidence rdf:resource="#Evidence948" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STUB1 (CHIP) ubiquitinates SMAD3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction828">
 <bp:evidence rdf:resource="#Evidence955" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMURF2 binds SMAD2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction827">
 <bp:evidence rdf:resource="#Evidence954" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Degradation of ubiquitinated SMAD3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction829">
 <bp:evidence rdf:resource="#Evidence956" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMAD7 binds to SMURF2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction824">
 <bp:evidence rdf:resource="#Evidence951" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMAD3 binds STUB1 (CHIP)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction823">
 <bp:evidence rdf:resource="#Evidence950" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMAD7 binds to SMURF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction826">
 <bp:evidence rdf:resource="#Evidence953" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMAD7:SMURF1 complex binds XPO1 (CRM1)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction825">
 <bp:evidence rdf:resource="#Evidence952" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMAD7 recruits GADD34:PP1 to phosphorylated TGFBR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1524">
 <bp:evidence rdf:resource="#Evidence1738" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SRF and ELK1 bind the FOS gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1523">
 <bp:evidence rdf:resource="#Evidence1737" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDKN1B is phosphorylated in response to estrogen</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1522">
 <bp:evidence rdf:resource="#Evidence1736" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 activates ELK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1521">
 <bp:evidence rdf:resource="#Evidence1735" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ESR1-dependent CCND1 expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1520">
 <bp:evidence rdf:resource="#Evidence1734" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">E2-mediated FOS gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1529">
 <bp:evidence rdf:resource="#Evidence1743" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">27-hydroxysterol binds ESR1, ESR2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1528">
 <bp:evidence rdf:resource="#Evidence1742" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ESR1 binds ESR1 antagonists</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1527">
 <bp:evidence rdf:resource="#Evidence1741" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ESTG binding induces ESR depalmitoylation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1526">
 <bp:evidence rdf:resource="#Evidence1740" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PalmS-ESRs:CAVs translocate to plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1525">
 <bp:evidence rdf:resource="#Evidence1739" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT phosphorylates CREB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1513">
 <bp:evidence rdf:resource="#Evidence1726" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK2 autophosphorylates downstream of EGFR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1512">
 <bp:evidence rdf:resource="#Evidence1725" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Estrogen stimulates dimerization of plasma membrane estrogen receptors</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1511">
 <bp:evidence rdf:resource="#Evidence1724" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ZDHHC7, ZDHHC21 palmitoylate ESR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1510">
 <bp:evidence rdf:resource="#Evidence1723" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK2 binds activated EGFR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1519">
 <bp:evidence rdf:resource="#Evidence1733" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S10 CDKN1B translocates to the cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1518">
 <bp:evidence rdf:resource="#Evidence1732" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT phosphorylates FOXO3 downstream of ESR1 and EGFR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1517">
 <bp:evidence rdf:resource="#Evidence1731" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerization of p-S133-CREB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1516">
 <bp:evidence rdf:resource="#Evidence1730" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BCL gene expression downstream of ESR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1515">
 <bp:evidence rdf:resource="#Evidence1729" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT-phosphorylated FOXO3 translocates to cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1514">
 <bp:evidence rdf:resource="#Evidence1728" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S133 CREB1 dimer binds the CCND1 promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction800">
 <bp:evidence rdf:resource="#Evidence925" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRIM33 monoubiquitinates SMAD4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction806">
 <bp:evidence rdf:resource="#Evidence932" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CBL binds TGFBR2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction805">
 <bp:evidence rdf:resource="#Evidence931" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LTBP1, LTBP3 bind TGF-Beta</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction808">
 <bp:evidence rdf:resource="#Evidence934" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimeric TGF-beta-1 binds to the receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction807">
 <bp:evidence rdf:resource="#Evidence933" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CBL neddylates TGFBR2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction802">
 <bp:evidence rdf:resource="#Evidence928" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LTBP4 binds TGF-Beta-1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction801">
 <bp:evidence rdf:resource="#Evidence926" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WWTR1:SMAD stimulates transcription of SMAD7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction804">
 <bp:evidence rdf:resource="#Evidence930" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Fibrillin-1 binds latent TGF-beta</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction803">
 <bp:evidence rdf:resource="#Evidence929" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated SMAD2/3 dissociates from TGFBR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1502">
 <bp:evidence rdf:resource="#Evidence1714" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Membrane estrogen receptors bind SRC</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1501">
 <bp:evidence rdf:resource="#Evidence1713" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HSBP1 oligomer binds ESRs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1500">
 <bp:evidence rdf:resource="#Evidence1712" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTK2 is recruited to methylated ESR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction809">
 <bp:evidence rdf:resource="#Evidence935" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Secretion and activation of the latent large complex of TGF-beta-1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1509">
 <bp:evidence rdf:resource="#Evidence1722" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRKCZ stimulates RAS nucleotide exchange in response to estrogen</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1508">
 <bp:evidence rdf:resource="#Evidence1721" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRKCZ autophosphorylates downstream of estrogen stimulation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1507">
 <bp:evidence rdf:resource="#Evidence1720" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRKCZ recruits RAS in response to estrogen stimulation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1506">
 <bp:evidence rdf:resource="#Evidence1719" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ESR1- and PRCKZ-dependent MAPK1 translocation to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1505">
 <bp:evidence rdf:resource="#Evidence1718" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PDPK1 activates PRKCZ</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1504">
 <bp:evidence rdf:resource="#Evidence1717" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PDPK1 binds PRKCZ</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1503">
 <bp:evidence rdf:resource="#Evidence1715" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI3K binds membrane-associated estrogen receptors</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1789">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1570" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1788">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1569" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1787">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1568" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1786">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1567" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis529">
 <bp:controlled rdf:resource="#BiochemicalReaction1814" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis528">
 <bp:controlled rdf:resource="#BiochemicalReaction1813" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1781">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1562" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis525">
 <bp:controlled rdf:resource="#BiochemicalReaction1808" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1780">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1561" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis524">
 <bp:controlled rdf:resource="#BiochemicalReaction1804" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis527">
 <bp:controlled rdf:resource="#BiochemicalReaction1811" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis526">
 <bp:controlled rdf:resource="#BiochemicalReaction1810" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1785">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1566" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis521">
 <bp:controlled rdf:resource="#BiochemicalReaction1792" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1784">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1565" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis520">
 <bp:controlled rdf:resource="#BiochemicalReaction1788" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1783">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1564" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis523">
 <bp:controlled rdf:resource="#BiochemicalReaction1802" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1782">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1563" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis522">
 <bp:controlled rdf:resource="#BiochemicalReaction1799" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis530">
 <bp:controlled rdf:resource="#BiochemicalReaction1824" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1799">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1579" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1798">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1578" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1797">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1577" />
 <bp:stepProcess rdf:resource="#Catalysis456" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis539">
 <bp:controlled rdf:resource="#BiochemicalReaction1852" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1792">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1573" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis536">
 <bp:controlled rdf:resource="#BiochemicalReaction1844" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1791">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1572" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis535">
 <bp:controlled rdf:resource="#BiochemicalReaction1842" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1790">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1571" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis538">
 <bp:controlled rdf:resource="#BiochemicalReaction1846" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis537">
 <bp:controlled rdf:resource="#BiochemicalReaction1845" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1796">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1576" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis532">
 <bp:controlled rdf:resource="#BiochemicalReaction1828" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1795">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1575" />
 <bp:stepProcess rdf:resource="#Catalysis455" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis531">
 <bp:controlled rdf:resource="#BiochemicalReaction1827" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1794">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1574" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis534">
 <bp:controlled rdf:resource="#BiochemicalReaction1838" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1793">
 <bp:stepProcess rdf:resource="#Pathway221" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis533">
 <bp:controlled rdf:resource="#BiochemicalReaction1837" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis541">
 <bp:controlled rdf:resource="#BiochemicalReaction1855" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis540">
 <bp:controlled rdf:resource="#BiochemicalReaction1854" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1767">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1550" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1766">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1549" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1765">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1548" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1764">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1547" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1769">
 <bp:stepProcess rdf:resource="#Pathway219" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1768">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1551" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis547">
 <bp:controlled rdf:resource="#BiochemicalReaction1868" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis546">
 <bp:controlled rdf:resource="#BiochemicalReaction1867" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis549">
 <bp:controlled rdf:resource="#BiochemicalReaction1870" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis548">
 <bp:controlled rdf:resource="#BiochemicalReaction1869" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1763">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1546" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis543">
 <bp:controlled rdf:resource="#BiochemicalReaction1861" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1762">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1545" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis542">
 <bp:controlled rdf:resource="#BiochemicalReaction1856" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1761">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1544" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis545">
 <bp:controlled rdf:resource="#BiochemicalReaction1863" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1760">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1543" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis544">
 <bp:controlled rdf:resource="#BiochemicalReaction1862" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis550">
 <bp:controlled rdf:resource="#BiochemicalReaction1871" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis552">
 <bp:controlled rdf:resource="#BiochemicalReaction1876" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis551">
 <bp:controlled rdf:resource="#BiochemicalReaction1874" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1778">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1559" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1777">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1558" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1776">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1557" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1775">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1556" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1779">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1560" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1770">
 <bp:stepProcess rdf:resource="#Pathway220" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis558">
 <bp:controlled rdf:resource="#BiochemicalReaction1915" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis557">
 <bp:controlled rdf:resource="#BiochemicalReaction1911" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis559">
 <bp:controlled rdf:resource="#BiochemicalReaction1916" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1774">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1555" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis554">
 <bp:controlled rdf:resource="#BiochemicalReaction1903" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1773">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1554" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis553">
 <bp:controlled rdf:resource="#BiochemicalReaction1886" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1772">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1553" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis556">
 <bp:controlled rdf:resource="#BiochemicalReaction1907" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1771">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1552" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis555">
 <bp:controlled rdf:resource="#BiochemicalReaction1906" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis561">
 <bp:controlled rdf:resource="#BiochemicalReaction1925" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis560">
 <bp:controlled rdf:resource="#BiochemicalReaction1921" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis563">
 <bp:controlled rdf:resource="#BiochemicalReaction1930" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis562">
 <bp:controlled rdf:resource="#BiochemicalReaction1926" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1745">
 <bp:stepProcess rdf:resource="#Pathway217" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1744">
 <bp:stepProcess rdf:resource="#Pathway216" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1743">
 <bp:stepProcess rdf:resource="#Pathway215" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1742">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1529" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1749">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1533" />
 <bp:stepProcess rdf:resource="#Catalysis452" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1748">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1532" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1747">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1531" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1746">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1530" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1741">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1528" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1740">
 <bp:stepProcess rdf:resource="#Catalysis451" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1527" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1756">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1540" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1755">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1539" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1754">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1538" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1753">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1537" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1759">
 <bp:stepProcess rdf:resource="#Pathway218" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1758">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1542" />
 <bp:stepProcess rdf:resource="#Catalysis454" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1757">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1541" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1752">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1536" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1751">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1535" />
 <bp:stepProcess rdf:resource="#Catalysis453" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1750">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1534" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1723">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1511" />
 <bp:stepProcess rdf:resource="#Catalysis445" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1722">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1510" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1721">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1509" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1720">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1508" />
 <bp:stepProcess rdf:resource="#Catalysis444" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1727">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1514" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis507">
 <bp:controlled rdf:resource="#BiochemicalReaction1766" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1726">
 <bp:stepProcess rdf:resource="#Pathway214" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis506">
 <bp:controlled rdf:resource="#BiochemicalReaction1761" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1725">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1513" />
 <bp:stepProcess rdf:resource="#Catalysis446" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis509">
 <bp:controlled rdf:resource="#BiochemicalReaction1768" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1724">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1512" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis508">
 <bp:controlled rdf:resource="#BiochemicalReaction1767" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis503">
 <bp:controlled rdf:resource="#BiochemicalReaction1757" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis502">
 <bp:controlled rdf:resource="#BiochemicalReaction1756" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis505">
 <bp:controlled rdf:resource="#BiochemicalReaction1759" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis504">
 <bp:controlled rdf:resource="#BiochemicalReaction1758" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis501">
 <bp:controlled rdf:resource="#BiochemicalReaction1755" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis500">
 <bp:controlled rdf:resource="#BiochemicalReaction1744" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1729">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1516" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1728">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1515" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1734">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1521" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1733">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1520" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1732">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1519" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1731">
 <bp:stepProcess rdf:resource="#Catalysis447" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1518" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1738">
 <bp:stepProcess rdf:resource="#Catalysis450" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1525" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis518">
 <bp:controlled rdf:resource="#BiochemicalReaction1783" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1737">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1524" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis517">
 <bp:controlled rdf:resource="#BiochemicalReaction1780" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1736">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1523" />
 <bp:stepProcess rdf:resource="#Catalysis449" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1735">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1522" />
 <bp:stepProcess rdf:resource="#Catalysis448" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis519">
 <bp:controlled rdf:resource="#BiochemicalReaction1786" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis514">
 <bp:controlled rdf:resource="#BiochemicalReaction1774" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis513">
 <bp:controlled rdf:resource="#BiochemicalReaction1773" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis516">
 <bp:controlled rdf:resource="#BiochemicalReaction1776" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis515">
 <bp:controlled rdf:resource="#BiochemicalReaction1775" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1730">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1517" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis510">
 <bp:controlled rdf:resource="#BiochemicalReaction1769" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis512">
 <bp:controlled rdf:resource="#BiochemicalReaction1771" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis511">
 <bp:controlled rdf:resource="#BiochemicalReaction1770" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1739">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1526" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis488">
 <bp:controlled rdf:resource="#BiochemicalReaction1701" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis487">
 <bp:controlled rdf:resource="#BiochemicalReaction1700" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis489">
 <bp:controlled rdf:resource="#BiochemicalReaction1703" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis495">
 <bp:controlled rdf:resource="#BiochemicalReaction1725" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis494">
 <bp:controlled rdf:resource="#BiochemicalReaction1722" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis497">
 <bp:controlled rdf:resource="#BiochemicalReaction1733" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis496">
 <bp:controlled rdf:resource="#BiochemicalReaction1729" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis491">
 <bp:controlled rdf:resource="#BiochemicalReaction1708" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis490">
 <bp:controlled rdf:resource="#BiochemicalReaction1704" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis493">
 <bp:controlled rdf:resource="#BiochemicalReaction1719" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis492">
 <bp:controlled rdf:resource="#BiochemicalReaction1714" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis499">
 <bp:controlled rdf:resource="#BiochemicalReaction1742" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis498">
 <bp:controlled rdf:resource="#BiochemicalReaction1738" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis448">
 <bp:controlled rdf:resource="#BiochemicalReaction1522" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis447">
 <bp:controlled rdf:resource="#BiochemicalReaction1518" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis449">
 <bp:controlled rdf:resource="#BiochemicalReaction1523" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis444">
 <bp:controlled rdf:resource="#BiochemicalReaction1508" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis443">
 <bp:controlled rdf:resource="#BiochemicalReaction1505" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis446">
 <bp:controlled rdf:resource="#BiochemicalReaction1513" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis445">
 <bp:controlled rdf:resource="#BiochemicalReaction1511" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis451">
 <bp:controlled rdf:resource="#BiochemicalReaction1527" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis450">
 <bp:controlled rdf:resource="#BiochemicalReaction1525" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis453">
 <bp:controlled rdf:resource="#BiochemicalReaction1535" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis452">
 <bp:controlled rdf:resource="#BiochemicalReaction1533" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1693">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1694">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1695">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1696">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1697">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1698">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1699">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis459">
 <bp:controlled rdf:resource="#BiochemicalReaction1586" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis458">
 <bp:controlled rdf:resource="#BiochemicalReaction1584" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis455">
 <bp:controlled rdf:resource="#BiochemicalReaction1575" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1690">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis454">
 <bp:controlled rdf:resource="#BiochemicalReaction1542" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1691">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis457">
 <bp:controlled rdf:resource="#BiochemicalReaction1581" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1692">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis456">
 <bp:controlled rdf:resource="#BiochemicalReaction1577" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis462">
 <bp:controlled rdf:resource="#BiochemicalReaction1590" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis461">
 <bp:controlled rdf:resource="#BiochemicalReaction1589" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis464">
 <bp:controlled rdf:resource="#BiochemicalReaction1610" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis463">
 <bp:controlled rdf:resource="#BiochemicalReaction1602" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis460">
 <bp:controlled rdf:resource="#BiochemicalReaction1588" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis469">
 <bp:controlled rdf:resource="#BiochemicalReaction1634" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis466">
 <bp:controlled rdf:resource="#BiochemicalReaction1630" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis465">
 <bp:controlled rdf:resource="#BiochemicalReaction1615" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis468">
 <bp:controlled rdf:resource="#BiochemicalReaction1633" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis467">
 <bp:controlled rdf:resource="#BiochemicalReaction1631" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis473">
 <bp:controlled rdf:resource="#BiochemicalReaction1638" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis472">
 <bp:controlled rdf:resource="#BiochemicalReaction1637" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis475">
 <bp:controlled rdf:resource="#BiochemicalReaction1651" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis474">
 <bp:controlled rdf:resource="#BiochemicalReaction1641" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis471">
 <bp:controlled rdf:resource="#BiochemicalReaction1636" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis470">
 <bp:controlled rdf:resource="#BiochemicalReaction1635" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis477">
 <bp:controlled rdf:resource="#BiochemicalReaction1661" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis476">
 <bp:controlled rdf:resource="#BiochemicalReaction1655" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis479">
 <bp:controlled rdf:resource="#BiochemicalReaction1674" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis478">
 <bp:controlled rdf:resource="#BiochemicalReaction1668" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis484">
 <bp:controlled rdf:resource="#BiochemicalReaction1694" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis483">
 <bp:controlled rdf:resource="#BiochemicalReaction1690" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis486">
 <bp:controlled rdf:resource="#BiochemicalReaction1697" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis485">
 <bp:controlled rdf:resource="#BiochemicalReaction1696" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis480">
 <bp:controlled rdf:resource="#BiochemicalReaction1679" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis482">
 <bp:controlled rdf:resource="#BiochemicalReaction1687" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis481">
 <bp:controlled rdf:resource="#BiochemicalReaction1680" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction853">
 <bp:evidence rdf:resource="#Evidence984" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The Ligand:GPCR:Gz complex dissociates</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1660">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2992">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction852">
 <bp:evidence rdf:resource="#Evidence983" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G-alpha(z):PKC dissociates to give phosphorylated G alpha (z)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1661">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2991">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction855">
 <bp:evidence rdf:resource="#Evidence986" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Liganded Gz-activating GPCRs bind inactive heterotrimeric G-protein Gz</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1662">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2994">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction854">
 <bp:evidence rdf:resource="#Evidence985" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active G alpha (z) binds RGS proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1663">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2993">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1664">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2996">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1665">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2995">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction851">
 <bp:evidence rdf:resource="#Evidence979" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Disassembly of tight junctions</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1666">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2998">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction850">
 <bp:evidence rdf:resource="#Evidence978" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TGFBR2 phosphorylates TGFBR1 and PARD6A</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1667">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2997">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1450">
 <bp:evidence rdf:resource="#Evidence1661" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NCOA3 recruits EP300 to ESR1:estrogen:TFGA gene:NCOA3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction857">
 <bp:evidence rdf:resource="#Evidence988" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G alpha (z):RGS complex dissociates to give inactive G alpha (z)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction856">
 <bp:evidence rdf:resource="#Evidence987" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G alpha (z) in G alpha (z):RGS complex is inactivated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction859">
 <bp:evidence rdf:resource="#Evidence990" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Inactive G alpha (z) reassociates with G beta:gamma</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2990">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction858">
 <bp:evidence rdf:resource="#Evidence989" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKC phosphorylates G alpha (z)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1458">
 <bp:evidence rdf:resource="#Evidence1669" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KCTD6 gene expression is stimulated by RUNX1 and ESR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1457">
 <bp:evidence rdf:resource="#Evidence1668" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 and ESR1 bind the GPAM gene enhancer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1456">
 <bp:evidence rdf:resource="#Evidence1667" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GPAM gene expression is stimulated by RUNX1 and ESR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1455">
 <bp:evidence rdf:resource="#Evidence1666" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TGFA gene expression is stimulated by the CITED1:EP300:ESR1:estrogen</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1454">
 <bp:evidence rdf:resource="#Evidence1665" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NR5A2, ZNF217 and NCOA3 bind GREB1 promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1453">
 <bp:evidence rdf:resource="#Evidence1664" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXA1 and GATA3 bind to CCND1 promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1452">
 <bp:evidence rdf:resource="#Evidence1663" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KDM1A is recruited to MYC and BCL2 genes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1451">
 <bp:evidence rdf:resource="#Evidence1662" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KDM1A demethylates H3 on MYC and BCL genes in response to estrogen</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1668">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1669">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2999">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1459">
 <bp:evidence rdf:resource="#Evidence1670" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 and ESR1 bind the KCTD6 gene enhancer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction864">
 <bp:evidence rdf:resource="#Evidence995" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G alpha (z) auto-inactivates by hydrolysing GTP to GDP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2981">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction863">
 <bp:evidence rdf:resource="#Evidence994" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Adenylate cyclase converts ATP to 3&apos;,5&apos;-cyclic AMP (cAMP) and pyrophosphate</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1650">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2980">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction866">
 <bp:evidence rdf:resource="#Evidence998" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Adenylate cyclase converts ATP to 3&apos;,5&apos;-cyclic AMP (cAMP) and pyrophosphate</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1651">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2983">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction865">
 <bp:evidence rdf:resource="#Evidence997" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G protein alpha (i)-SRC complex dissociates to G protein alpha (i) and Active SRC</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1652">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2982">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction860">
 <bp:evidence rdf:resource="#Evidence991" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKC binds active G alpha (z)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1653">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2985">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1654">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2984">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction862">
 <bp:evidence rdf:resource="#Evidence993" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G alpha (z) inhibits adenylate cyclase</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1655">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2987">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction861">
 <bp:evidence rdf:resource="#Evidence992" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Liganded Gz-activating GPCR acts as a GEF for Gz</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1656">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2986">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction868">
 <bp:evidence rdf:resource="#Evidence1000" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The Ligand:GPCR:Gi complex dissociates</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction867">
 <bp:evidence rdf:resource="#Evidence999" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Opsins binds G alpha-t</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction869">
 <bp:evidence rdf:resource="#Evidence1001" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active G alpha (i)&#8211;i1/i2/i3 binds RGS proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1447">
 <bp:evidence rdf:resource="#Evidence1658" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Estrogen-responsive MYC gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1446">
 <bp:evidence rdf:resource="#Evidence1657" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ESR1 binds to TFF1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1445">
 <bp:evidence rdf:resource="#Evidence1656" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NCOA3 binds ESR1:estrogen:TFGA gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1444">
 <bp:evidence rdf:resource="#Evidence1655" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ESR1:ESTG and EP300 are recruited to TFF3 promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1443">
 <bp:evidence rdf:resource="#Evidence1654" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Estrogen-responsive MYB gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1442">
 <bp:evidence rdf:resource="#Evidence1653" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DDX5 binds ESR1:estrogen:TFF1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1441">
 <bp:evidence rdf:resource="#Evidence1652" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Estrogen-responsive TFF3 gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1440">
 <bp:evidence rdf:resource="#Evidence1651" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NCOA1 binds ESR1:estrogen:TGFA gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1657">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2989">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1658">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2988">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1659">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1449">
 <bp:evidence rdf:resource="#Evidence1660" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ESR1:ESTG, JUND:FOSB and Cohesin Complex bind distal enhancer elements in MYC gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1448">
 <bp:evidence rdf:resource="#Evidence1659" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ESR1:ESTG bind the EBAG9 5&apos; region</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction831">
 <bp:evidence rdf:resource="#Evidence958" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMAD7:SMURF2 complex translocates to the cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1682">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction830">
 <bp:evidence rdf:resource="#Evidence957" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMURF2 ubiquitinates SMAD2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1683">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction833">
 <bp:evidence rdf:resource="#Evidence960" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Degradation of ubiquitinated SMAD2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1684">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction832">
 <bp:evidence rdf:resource="#Evidence959" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMAD7:SMURF1 complex is exported to the cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1685">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1686">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1687">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1688">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1689">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction839">
 <bp:evidence rdf:resource="#Evidence966" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Degradation of TGF-beta receptor complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction838">
 <bp:evidence rdf:resource="#Evidence965" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MTMR4 binds phosphorylated SMAD2/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction835">
 <bp:evidence rdf:resource="#Evidence962" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MTMR4 dephosphorylates SMAD2/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction834">
 <bp:evidence rdf:resource="#Evidence961" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMAD7:SMURF complex binds to phosphorylated TGFBR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction837">
 <bp:evidence rdf:resource="#Evidence964" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STRAP binds phosphorylated TGF-beta receptor complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1680">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction836">
 <bp:evidence rdf:resource="#Evidence963" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BAMBI interferes with the interaction of type I receptor with type II receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1681">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1436">
 <bp:evidence rdf:resource="#Evidence1647" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NCOA1 recruits EP300 to TGFA promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1435">
 <bp:evidence rdf:resource="#Evidence1646" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EP300 is recruited to MYC and BCL2 genes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1434">
 <bp:evidence rdf:resource="#Evidence1645" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ESR1 binds to TGFA gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1433">
 <bp:evidence rdf:resource="#Evidence1644" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Estrogen-responsive EBAG9 gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1432">
 <bp:evidence rdf:resource="#Evidence1643" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KPNA2 translation is negatively regulated by miR-26A and B</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1431">
 <bp:evidence rdf:resource="#Evidence1642" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ESR1 binds the AXIN1 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1430">
 <bp:evidence rdf:resource="#Evidence1641" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Estrogen-responsive CTSD expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1439">
 <bp:evidence rdf:resource="#Evidence1650" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Overexpressed HIST1H2AC and ESR1:ESTG bind MYC and BCL2 genes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1438">
 <bp:evidence rdf:resource="#Evidence1649" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CITED1 and EP300 bind ESR1:estrogen:TGFA gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1437">
 <bp:evidence rdf:resource="#Evidence1648" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 binds ESR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction842">
 <bp:evidence rdf:resource="#Evidence969" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMURFs/NEDD4L ubiquitinate phosphorylated TGFBR1 and SMAD7</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1671">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction841">
 <bp:evidence rdf:resource="#Evidence968" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PMEPA1 sequesters phosphorylated SMAD2/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1672">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction844">
 <bp:evidence rdf:resource="#Evidence971" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PMEPA1 sequesters unphosphorylated SMAD2/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1673">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction843">
 <bp:evidence rdf:resource="#Evidence970" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">UCHL5 binds SMAD7 in complex with ubiquitinated TGFBR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1674">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1675">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1676">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction840">
 <bp:evidence rdf:resource="#Evidence967" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">UCHL5, USP15 deubiquitinate TGFBR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1677">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1678">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction849">
 <bp:evidence rdf:resource="#Evidence977" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMURF1 binds phosphorylated PARD6A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction846">
 <bp:evidence rdf:resource="#Evidence974" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TGFBR1 is recruited to tight junctions by PARD6A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction845">
 <bp:evidence rdf:resource="#Evidence972" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Latent TGF-beta-1 is cleaved by FURIN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction848">
 <bp:evidence rdf:resource="#Evidence976" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TGFBR2 is recruited to tight junctions after TGF-beta stimulation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction847">
 <bp:evidence rdf:resource="#Evidence975" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMURF1 ubiquitinates RHOA</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1670">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1425">
 <bp:evidence rdf:resource="#Evidence1636" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Estrogen-responsive KPNA2 gene transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1424">
 <bp:evidence rdf:resource="#Evidence1635" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ESR1:ESTG and KDM4B bind H3K9me3 target gene enhancers</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1423">
 <bp:evidence rdf:resource="#Evidence1634" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-26A and B bind to the 3&apos;UTR of the KPNA2 mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1422">
 <bp:evidence rdf:resource="#Evidence1633" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Estrogen-responsive TFF1 gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1421">
 <bp:evidence rdf:resource="#Evidence1632" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRMT1 binds TBP:TFIIA:DDX5:ESR1:estrogen:TFF1 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1420">
 <bp:evidence rdf:resource="#Evidence1631" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 and ESR1 bind the AXIN1 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1679">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1429">
 <bp:evidence rdf:resource="#Evidence1640" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GREB1 translation is negatively regulated by miR-26A and B</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1428">
 <bp:evidence rdf:resource="#Evidence1639" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TBP and TFIIA bind TATA box on  ESR1:estrogen bound TFF1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1427">
 <bp:evidence rdf:resource="#Evidence1638" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Estrogen-responsive KDM4B gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1426">
 <bp:evidence rdf:resource="#Evidence1637" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXA1 and GATA3 bind TFF genes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction897">
 <bp:evidence rdf:resource="#Evidence1038" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRK2 binds CALM1:4Ca2+</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction896">
 <bp:evidence rdf:resource="#Evidence1034" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of PLC beta-1/4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction899">
 <bp:evidence rdf:resource="#Evidence1041" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CaMKK binds activated calmodulin in the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2950">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction898">
 <bp:evidence rdf:resource="#Evidence1040" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Calmodulin-bound CaMKII-gamma enters the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction893">
 <bp:evidence rdf:resource="#Evidence1030" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G alpha (i) inhibits adenylate cyclase</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1620">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2952">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction892">
 <bp:evidence rdf:resource="#Evidence1029" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Adenylate cyclase increases the GTPase activity of Gi alpha</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1621">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2951">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction895">
 <bp:evidence rdf:resource="#Evidence1032" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of the Gi alpha:G olf complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1622">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2954">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction894">
 <bp:evidence rdf:resource="#Evidence1031" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Adenylate cyclase increases the GTPase activity of G alpha-olf</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1623">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2953">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1494">
 <bp:evidence rdf:resource="#Evidence1706" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ESR binds STRN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1493">
 <bp:evidence rdf:resource="#Evidence1705" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PalmS-ESRs bind CAVs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1492">
 <bp:evidence rdf:resource="#Evidence1704" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SPHK1 phosphorylates sphingosine in response to E2 stimulation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1491">
 <bp:evidence rdf:resource="#Evidence1703" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRMT1 methylates ESRs</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway8">
 <bp:pathwayOrder rdf:resource="#PathwayStep38" />
 <bp:pathwayOrder rdf:resource="#PathwayStep49" />
 <bp:pathwayOrder rdf:resource="#PathwayStep48" />
 <bp:pathwayOrder rdf:resource="#PathwayStep39" />
 <bp:pathwayOrder rdf:resource="#PathwayStep45" />
 <bp:pathwayOrder rdf:resource="#PathwayStep44" />
 <bp:pathwayOrder rdf:resource="#PathwayStep47" />
 <bp:pathwayOrder rdf:resource="#PathwayStep46" />
 <bp:pathwayOrder rdf:resource="#PathwayStep41" />
 <bp:pathwayOrder rdf:resource="#PathwayStep52" />
 <bp:pathwayOrder rdf:resource="#PathwayStep40" />
 <bp:pathwayOrder rdf:resource="#PathwayStep51" />
 <bp:pathwayOrder rdf:resource="#PathwayStep43" />
 <bp:pathwayOrder rdf:resource="#PathwayStep42" />
 <bp:pathwayOrder rdf:resource="#PathwayStep50" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction40" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction31" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction42" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction41" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction33" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction44" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction32" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction43" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction35" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction34" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction45" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction37" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction36" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction39" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction38" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence38" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of PTEN gene transcription</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transcription of the PTEN gene is regulated at multiple levels. Epigenetic repression involves the recruitment of Mi-2/NuRD upon SALL4 binding to the PTEN promoter (Yang et al. 2008, Lu et al. 2009) or EVI1-mediated recruitment of the polycomb repressor complex (PRC) to the PTEN promoter (Song et al. 2009, Yoshimi et al. 2011). Transcriptional regulation is also elicited by negative regulators, including NR2E1:ATN1 (atrophin-1) complex, JUN (c-Jun), SNAIL and SLUG (Zhang et al. 2006, Vasudevan et al. 2007, Escriva et al. 2008, Uygur et al. 2015) and positive regulators such as TP53 (p53), MAF1, ATF2, EGR1 or PPARG (Stambolic et al. 2001, Virolle et al. 2001, Patel et al. 2001, Shen et al. 2006, Li et al. 2016).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1490">
 <bp:evidence rdf:resource="#Evidence1702" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MMPs cleave HB-EGF</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway9">
 <bp:pathwayOrder rdf:resource="#PathwayStep59" />
 <bp:pathwayOrder rdf:resource="#PathwayStep56" />
 <bp:pathwayOrder rdf:resource="#PathwayStep55" />
 <bp:pathwayOrder rdf:resource="#PathwayStep66" />
 <bp:pathwayOrder rdf:resource="#PathwayStep58" />
 <bp:pathwayOrder rdf:resource="#PathwayStep57" />
 <bp:pathwayOrder rdf:resource="#PathwayStep63" />
 <bp:pathwayOrder rdf:resource="#PathwayStep62" />
 <bp:pathwayOrder rdf:resource="#PathwayStep54" />
 <bp:pathwayOrder rdf:resource="#PathwayStep65" />
 <bp:pathwayOrder rdf:resource="#PathwayStep64" />
 <bp:pathwayOrder rdf:resource="#PathwayStep61" />
 <bp:pathwayOrder rdf:resource="#PathwayStep60" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction51" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction50" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction53" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction52" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction55" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction54" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction46" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction57" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction56" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction48" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction47" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction58" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction49" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence54" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of PTEN stability and activity</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTEN protein stability is regulated by ubiquitin ligases, such as NEDD4, WWP2, STUB1 (CHIP), XIAP, MKRN1 and RNF146, which polyubiquitinate PTEN in response to different stimuli and thus target it for proteasome-mediated degradation (Wang et al. 2007, Van Themsche et al. 2009, Maddika et al. 2011, Ahmed et al. 2012, Lee et al. 2015, Li et al. 2015). Several ubiquitin proteases, such as USP13 and OTUD3, can remove polyubiquitin chains from PTEN and rescue it from degradation (Zhang et al. 2013, Yuan et al. 2015). TRIM27 (RFP) is an E3 ubiquitin ligase that polyubiquitinates PTEN on multiple lysines in the C2 domain of PTEN using K27 linkage between ubiquitin molecules. TRIM27 mediated ubiquitination inhibits PTEN lipid phosphatase activity, but does not affect PTEN protein localization or stability (Lee et al. 2013). PTEN phosphorylation by the tyrosine kinase FRK (RAK) inhibits NEDD4 mediated polyubiquitination and subsequent degradation of PTEN, thus increasing PTEN half life. FRK mediated phosphorylation also increases PTEN enzymatic activity (Yim et al. 2009). Casein kinase 2 (CK2) mediated phosphorylation of the C-terminus of PTEN on multiple serine and threonine residues increases PTEN protein stability (Torres and Pulido 2001) but results in ~30% reduction in PTEN lipid phosphatase activity (Miller et al. 2002). PREX2, a RAC1 guanine nucleotide exchange factor (GEF) can binds to PTEN and inhibit its catalytic activity (Fine et al. 2009).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1499">
 <bp:evidence rdf:resource="#Evidence1711" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">eNOS synthesizes NO</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1498">
 <bp:evidence rdf:resource="#Evidence1710" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Estrogen receptor binds IGF1R and SHC1 in response to estrogen</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1497">
 <bp:evidence rdf:resource="#Evidence1709" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G-proteins dissociate from plasma-membrane estrogen receptors</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1496">
 <bp:evidence rdf:resource="#Evidence1708" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Heterotrimeric G protein (i) binds membrane-associated ESRs:ESTG</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1495">
 <bp:evidence rdf:resource="#Evidence1707" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">S1P binds S1PR3 in response to E2 stimulation</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1624">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2956">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1625">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2955">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1626">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2958">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1627">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2957">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1628">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1629">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2959">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2941">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1610">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2940">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1611">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2943">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1612">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2942">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1483">
 <bp:evidence rdf:resource="#Evidence1694" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ESTG translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1482">
 <bp:evidence rdf:resource="#Evidence1693" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GREB1 binds ESR1:ESTG and co-activators</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1481">
 <bp:evidence rdf:resource="#Evidence1692" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ESR1:ESTG binds to proximal and distal regions of the CTSD promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1480">
 <bp:evidence rdf:resource="#Evidence1691" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Estrogen-responsive BCL2 gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1489">
 <bp:evidence rdf:resource="#Evidence1701" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ESR-associated SRC autophosphorylates</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1488">
 <bp:evidence rdf:resource="#Evidence1699" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Estrogen-independent phosphorylation of ESR1 S118 by MAPK1 and MAPK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1487">
 <bp:evidence rdf:resource="#Evidence1698" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ESR1 binds ESR1 agonists</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1486">
 <bp:evidence rdf:resource="#Evidence1697" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ESR dimerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1485">
 <bp:evidence rdf:resource="#Evidence1696" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HSP90-dependent ATP hydrolysis promotes release of ESR:ESTG from chaperone complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1484">
 <bp:evidence rdf:resource="#Evidence1695" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ESTG binds ESR1:chaperone complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1613">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2945">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1614">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2944">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1615">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2947">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1616">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2946">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1617">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2949">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1618">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2948">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1619">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction875">
 <bp:evidence rdf:resource="#Evidence1009" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The receptor:G-protein complex  binds GTP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2970">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction874">
 <bp:evidence rdf:resource="#Evidence1008" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The receptor:G-protein complex releases GDP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction877">
 <bp:evidence rdf:resource="#Evidence1011" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The high affinity receptor complex binds to G-protein</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1640">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2972">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction876">
 <bp:evidence rdf:resource="#Evidence1010" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G-protein alpha subunit is inactivated</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1641">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2971">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction871">
 <bp:evidence rdf:resource="#Evidence1003" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Liganded Gi-activating GPCR acts as a GEF for Gi</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1642">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2974">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction870">
 <bp:evidence rdf:resource="#Evidence1002" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G alpha (i) inhibits adenylate cyclase</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1643">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2973">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction873">
 <bp:evidence rdf:resource="#Evidence1007" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G-protein beta-gamma subunits rebind the alpha-GDP subunit</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1644">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2976">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction872">
 <bp:evidence rdf:resource="#Evidence1006" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The receptor:G-protein complex dissociates</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1645">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2975">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1472">
 <bp:evidence rdf:resource="#Evidence1683" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KDM4B demethylates H3K9me3 on estrogen-responsive target enhancers</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1471">
 <bp:evidence rdf:resource="#Evidence1682" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-26A and B bind to the 3&apos;UTR of the CHD11 mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1470">
 <bp:evidence rdf:resource="#Evidence1681" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB4s80 forms a complex with estrogen receptor ESR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction879">
 <bp:evidence rdf:resource="#Evidence1014" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DARPP-32 is dephosphorylated on Thr75 by PP2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction878">
 <bp:evidence rdf:resource="#Evidence1012" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Opioid binds MOR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1479">
 <bp:evidence rdf:resource="#Evidence1690" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PGR gene expression is stimulated by ERBB4s80:ESR1:estrogen</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1478">
 <bp:evidence rdf:resource="#Evidence1689" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Estrogen-responsive CCND1 gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1477">
 <bp:evidence rdf:resource="#Evidence1688" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HATs and coactivators are recruited to the CTSD gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1476">
 <bp:evidence rdf:resource="#Evidence1687" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB4s80:ESR1 binds PGR gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1475">
 <bp:evidence rdf:resource="#Evidence1686" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Estrogen-responsive GREB1 gene transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1474">
 <bp:evidence rdf:resource="#Evidence1685" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AXIN1 gene expression is inhibited by ESR1 and stimulated by RUNX1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1473">
 <bp:evidence rdf:resource="#Evidence1684" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Estrogen-responsive CHD1 gene transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1646">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2978">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1647">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2977">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction880">
 <bp:evidence rdf:resource="#Evidence1015" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDK5 phosphorylates DARPP-32 on Thr75</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1648">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1649">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2979">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction886">
 <bp:evidence rdf:resource="#Evidence1021" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S54-PDE4B hydrolyses cAMP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction885">
 <bp:evidence rdf:resource="#Evidence1020" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">cAMP binds PKA tetramer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction888">
 <bp:evidence rdf:resource="#Evidence1023" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Inactive catalytic PP2B is activated by the binding of calmodulin</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2961">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction887">
 <bp:evidence rdf:resource="#Evidence1022" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKA phosphorylates PDE4B</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1630">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2960">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction882">
 <bp:evidence rdf:resource="#Evidence1017" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PDE4A,C,D hydrolyse cAMP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1631">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2963">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction881">
 <bp:evidence rdf:resource="#Evidence1016" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DARPP-32 phosphorylated on Thr75 binds to PKA, inhibiting its function</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1632">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2962">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction884">
 <bp:evidence rdf:resource="#Evidence1019" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PPP3 complex dephosphorylates DARPP-32 on Thr34</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1633">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2965">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction883">
 <bp:evidence rdf:resource="#Evidence1018" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKA phosphorylates DARPP-32 on Thr34</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1634">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2964">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1461">
 <bp:evidence rdf:resource="#Evidence1672" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ESR1:ESTG:P-TEFb recruited to paused RNA polymerase II on MYB gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1460">
 <bp:evidence rdf:resource="#Evidence1671" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of AP1 transcriptional activator complexes to CCND1 promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction889">
 <bp:evidence rdf:resource="#Evidence1024" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DARPP-32 phosphorylated on T34 binds to PP1, inhibiting its function</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1469">
 <bp:evidence rdf:resource="#Evidence1680" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CXCL12 gene expression is stimulated by ERBB4s80:ESR1:estrogen</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1468">
 <bp:evidence rdf:resource="#Evidence1679" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ESR1:ESTG binds CXXC5 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1467">
 <bp:evidence rdf:resource="#Evidence1678" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ESR1:ESTG:PGR:P4 bind pioneer factors and coactivators</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1466">
 <bp:evidence rdf:resource="#Evidence1677" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Progesterone stimulation promotes PGR:P4 binding to ESR1:ESTG</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1465">
 <bp:evidence rdf:resource="#Evidence1676" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB4s80:ESR1 binds CXCL12 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1464">
 <bp:evidence rdf:resource="#Evidence1675" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Estrogen-responsive CXXC5 gene expresion</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1463">
 <bp:evidence rdf:resource="#Evidence1674" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-TEFb phosphorylates serine 2 in RNA polymerase II CTD</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1462">
 <bp:evidence rdf:resource="#Evidence1673" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHD1 translation is negatively regulated by miR-26A and B</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1635">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2967">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1636">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2966">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction891">
 <bp:evidence rdf:resource="#Evidence1028" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G alpha-olf:GTP binds to Gi alpha1:GTP:adenylate cyclase complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1637">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2969">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction890">
 <bp:evidence rdf:resource="#Evidence1025" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">cAMP induces dissociation of inactive PKA tetramers</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1638">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2968">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1639">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2912">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2527" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2913">
 <bp:stepProcess rdf:resource="#Catalysis803" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2528" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2914">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2529" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2915">
 <bp:stepProcess rdf:resource="#Pathway387" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2910">
 <bp:stepProcess rdf:resource="#Pathway385" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2911">
 <bp:stepProcess rdf:resource="#Pathway386" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1612">
 <bp:evidence rdf:resource="#Evidence1838" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CCND1:CREBBP binds NOTCH1 promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1611">
 <bp:evidence rdf:resource="#Evidence1837" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translation of NOTCH2NLB mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1610">
 <bp:evidence rdf:resource="#Evidence1836" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ELANE cleaves NOTCH2NLA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1619">
 <bp:evidence rdf:resource="#Evidence1845" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MIR181C microRNA binds 3&apos;UTR of NOTCH4 mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1618">
 <bp:evidence rdf:resource="#Evidence1844" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SIRT6 binds to acetylated histones at NOTCH1 and NOTCH4 gene promoters</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1617">
 <bp:evidence rdf:resource="#Evidence1843" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MIR302A microRNA binds 3&apos;UTR of NOTCH4 mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1616">
 <bp:evidence rdf:resource="#Evidence1842" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds promoters of MIR34 genes</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2916">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2530" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1615">
 <bp:evidence rdf:resource="#Evidence1841" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRKCI phosphorylates ELF3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2917">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2531" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1614">
 <bp:evidence rdf:resource="#Evidence1840" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH1 coactivator complex binds NOTCH3 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2918">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2532" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1613">
 <bp:evidence rdf:resource="#Evidence1839" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">E2F1/3:DP1/2 binds NOTCH1 promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2919">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2533" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2923">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2537" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2924">
 <bp:stepProcess rdf:resource="#Pathway388" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2925">
 <bp:stepProcess rdf:resource="#Catalysis806" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2538" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2926">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2539" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2920">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2534" />
 <bp:stepProcess rdf:resource="#Catalysis804" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2921">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2535" />
 <bp:stepProcess rdf:resource="#Catalysis805" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2922">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2536" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1601">
 <bp:evidence rdf:resource="#Evidence1826" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH1 and NOTCH4 gene transcription is inhibited by SIRT6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1600">
 <bp:evidence rdf:resource="#Evidence1825" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 binds NOTCH4 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1609">
 <bp:evidence rdf:resource="#Evidence1835" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translation of NOTCH2NLA mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1608">
 <bp:evidence rdf:resource="#Evidence1834" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transcription of NOTCH2NLR gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1607">
 <bp:evidence rdf:resource="#Evidence1833" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transcription of NOTCH2NLC gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1606">
 <bp:evidence rdf:resource="#Evidence1832" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transcription of NOTCH2NLB gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1605">
 <bp:evidence rdf:resource="#Evidence1831" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ELANE binds NOTCH2NLA</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2927">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2540" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1604">
 <bp:evidence rdf:resource="#Evidence1830" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transcription of NOTCH2NLA gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2928">
 <bp:stepProcess rdf:resource="#Catalysis807" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2541" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1603">
 <bp:evidence rdf:resource="#Evidence1829" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translation of NOTCH2NLC mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2929">
 <bp:stepProcess rdf:resource="#Pathway389" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1602">
 <bp:evidence rdf:resource="#Evidence1827" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SIRT6 deacetylates histones at NOTCH1 and NOTCH4 gene promoters</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2811">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2810">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2813">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2812">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2815">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2814">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2817">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2816">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2819">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2818">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2901">
 <bp:stepProcess rdf:resource="#Pathway381" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2902">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2522" />
 <bp:stepProcess rdf:resource="#Catalysis801" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2903">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2523" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2904">
 <bp:stepProcess rdf:resource="#Pathway382" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2800">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2900">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2521" />
 <bp:stepProcess rdf:resource="#Catalysis800" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2809">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2802">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2909">
 <bp:stepProcess rdf:resource="#Pathway384" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2801">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2804">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2803">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2806">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2905">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2524" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2805">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2906">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2525" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2808">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2907">
 <bp:stepProcess rdf:resource="#Catalysis802" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2526" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2807">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2908">
 <bp:stepProcess rdf:resource="#Pathway383" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1656">
 <bp:evidence rdf:resource="#Evidence1889" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NBEA translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1655">
 <bp:evidence rdf:resource="#Evidence1886" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Gamma-secretase cleaves NOTCH4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1654">
 <bp:evidence rdf:resource="#Evidence1885" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAG1 binds NOTCH4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1653">
 <bp:evidence rdf:resource="#Evidence1884" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NICD4 traffics to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1652">
 <bp:evidence rdf:resource="#Evidence1883" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DLL4 binds NOTCH4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1651">
 <bp:evidence rdf:resource="#Evidence1882" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ADAM10 cleaves NOTCH4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1650">
 <bp:evidence rdf:resource="#Evidence1880" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH4 binds FLT4 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1659">
 <bp:evidence rdf:resource="#Evidence1892" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH1 stimulates HES1 transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1658">
 <bp:evidence rdf:resource="#Evidence1891" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH1 stimulates HES5 transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1657">
 <bp:evidence rdf:resource="#Evidence1890" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH1 Coactivator Complex binds MYC promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction701">
 <bp:evidence rdf:resource="#Evidence815" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TGFBR3 degradation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction700">
 <bp:evidence rdf:resource="#Evidence811" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Retromer associates with WLS</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction707">
 <bp:evidence rdf:resource="#Evidence821" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TGFBR3 phosphorylation by TGFBR2 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction706">
 <bp:evidence rdf:resource="#Evidence820" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TGFB1,TGFB2 bind TGFBR3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction709">
 <bp:evidence rdf:resource="#Evidence824" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Inhibin-A binding to TGFBR3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction708">
 <bp:evidence rdf:resource="#Evidence822" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TGFBR3 binding to ARRB1/2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BioSource rdf:ID="BioSource1">
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Homo sapiens</bp:name>
</bp:BioSource>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction703">
 <bp:evidence rdf:resource="#Evidence817" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TGFBR3 binding to GIPC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction702">
 <bp:evidence rdf:resource="#Evidence816" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TGFBR3(1-783) binds to TGFB1,TGFB2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction705">
 <bp:evidence rdf:resource="#Evidence819" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TGFBR3 complex binds to TGFBR2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction704">
 <bp:evidence rdf:resource="#Evidence818" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Endocytosis of TGFBR3:ARRB complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1645">
 <bp:evidence rdf:resource="#Evidence1875" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HES1 gene expression is stimulated by NOTCH4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1644">
 <bp:evidence rdf:resource="#Evidence1874" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ACTA2 gene expression is stimulated by NOTCH1, NOTCH2 and NOTCH4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1643">
 <bp:evidence rdf:resource="#Evidence1873" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HEY2 gene expression is stimulated by NOTCH4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1642">
 <bp:evidence rdf:resource="#Evidence1872" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HES5 gene expression is stimulated by NOTCH4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1641">
 <bp:evidence rdf:resource="#Evidence1870" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Proteasome degrades ubiquitinated NICD4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1640">
 <bp:evidence rdf:resource="#Evidence1869" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-4S-NICD4 binds YWHAZ</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1649">
 <bp:evidence rdf:resource="#Evidence1879" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NICD4 binds RBPJ and MAML in the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1648">
 <bp:evidence rdf:resource="#Evidence1878" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HEY1 gene expression is stimulated by NOTCH4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1647">
 <bp:evidence rdf:resource="#Evidence1877" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH4 binds SMAD3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1646">
 <bp:evidence rdf:resource="#Evidence1876" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FLT4 gene expression is stimulated by NOTCH4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1634">
 <bp:evidence rdf:resource="#Evidence1861" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Galactosylation of Pre-NOTCH</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1633">
 <bp:evidence rdf:resource="#Evidence1860" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH precursor cleaved to form mature NOTCH</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1632">
 <bp:evidence rdf:resource="#Evidence1859" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transport of NOTCH precursor to Golgi</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1631">
 <bp:evidence rdf:resource="#Evidence1858" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Fringe-modified Pre-NOTCH is cleaved by FURIN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1630">
 <bp:evidence rdf:resource="#Evidence1857" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Sialylation of Pre-NOTCH</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1639">
 <bp:evidence rdf:resource="#Evidence1868" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NICD4 binds to TACC3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1638">
 <bp:evidence rdf:resource="#Evidence1867" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FBXW7 promotes ubiquitination of p-NICD4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1637">
 <bp:evidence rdf:resource="#Evidence1866" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT1 phosphorylates NOTCH4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1636">
 <bp:evidence rdf:resource="#Evidence1865" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Unknown kinase phosphorylates NICD4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1635">
 <bp:evidence rdf:resource="#Evidence1862" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Glycosylation of Pre-NOTCH by FRINGE</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1623">
 <bp:evidence rdf:resource="#Evidence1849" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MIR150 microRNA binds 3&apos;UTR of NOTCH3 mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1622">
 <bp:evidence rdf:resource="#Evidence1848" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MIR200B/C microRNAs bind NOTCH1 mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1621">
 <bp:evidence rdf:resource="#Evidence1847" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MIR206 microRNA binds 3&apos;UTR of NOTCH3 mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1620">
 <bp:evidence rdf:resource="#Evidence1846" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MIR34 microRNAs bind 3&apos;UTR of NOTCH2 mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1629">
 <bp:evidence rdf:resource="#Evidence1856" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transport of fringe-modified NOTCH to plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1628">
 <bp:evidence rdf:resource="#Evidence1855" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Mature NOTCH heterodimer traffics to the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1627">
 <bp:evidence rdf:resource="#Evidence1853" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH4 gene transcription is inhibited by RUNX1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1626">
 <bp:evidence rdf:resource="#Evidence1852" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ELF3 binds NOTCH3 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1625">
 <bp:evidence rdf:resource="#Evidence1851" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH1 gene transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1624">
 <bp:evidence rdf:resource="#Evidence1850" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MIR449 microRNAs bind 3&apos;UTR of NOTCH1 mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1668">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1458" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1667">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1457" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence9">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1666">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1456" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1665">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1455" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2996">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2595" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis649">
 <bp:controlled rdf:resource="#BiochemicalReaction2115" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2997">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2596" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2998">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2597" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1669">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1459" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2999">
 <bp:stepProcess rdf:resource="#Pathway403" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1660">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1450" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis646">
 <bp:controlled rdf:resource="#BiochemicalReaction2111" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2992">
 <bp:stepProcess rdf:resource="#Catalysis829" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2591" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis645">
 <bp:controlled rdf:resource="#BiochemicalReaction2105" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2993">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2592" />
 <bp:stepProcess rdf:resource="#Catalysis830" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis648">
 <bp:controlled rdf:resource="#BiochemicalReaction2113" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2994">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2593" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis647">
 <bp:controlled rdf:resource="#BiochemicalReaction2112" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2995">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2594" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1664">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1454" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis642">
 <bp:controlled rdf:resource="#BiochemicalReaction2097" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1663">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1453" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis641">
 <bp:controlled rdf:resource="#BiochemicalReaction2091" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1662">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1452" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis644">
 <bp:controlled rdf:resource="#BiochemicalReaction2104" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2990">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2590" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1661">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1451" />
 <bp:stepProcess rdf:resource="#Catalysis432" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis643">
 <bp:controlled rdf:resource="#BiochemicalReaction2100" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2991">
 <bp:stepProcess rdf:resource="#Pathway402" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis651">
 <bp:controlled rdf:resource="#BiochemicalReaction2120" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis650">
 <bp:controlled rdf:resource="#BiochemicalReaction2119" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence3">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence4">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence7">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence8">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence5">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence6">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1679">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1469" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1678">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1468" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1677">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1467" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1676">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1466" />
 <bp:stepProcess rdf:resource="#Catalysis434" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1671">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1461" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis657">
 <bp:controlled rdf:resource="#BiochemicalReaction2136" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1670">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1460" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis656">
 <bp:controlled rdf:resource="#BiochemicalReaction2135" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis659">
 <bp:controlled rdf:resource="#BiochemicalReaction2142" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis658">
 <bp:controlled rdf:resource="#BiochemicalReaction2139" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1675">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1465" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis653">
 <bp:controlled rdf:resource="#BiochemicalReaction2127" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1674">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1464" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis652">
 <bp:controlled rdf:resource="#BiochemicalReaction2121" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1673">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1463" />
 <bp:stepProcess rdf:resource="#Catalysis433" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis655">
 <bp:controlled rdf:resource="#BiochemicalReaction2133" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1672">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1462" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis654">
 <bp:controlled rdf:resource="#BiochemicalReaction2130" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis660">
 <bp:controlled rdf:resource="#BiochemicalReaction2143" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis662">
 <bp:controlled rdf:resource="#BiochemicalReaction2151" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis661">
 <bp:controlled rdf:resource="#BiochemicalReaction2146" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1646">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1436" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2978">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2579" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1645">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1435" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2979">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2580" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1644">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1434" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1643">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1433" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2974">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2576" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1649">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1439" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2975">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2577" />
 <bp:stepProcess rdf:resource="#Catalysis823" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1648">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1438" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2976">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2578" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1647">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1437" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2977">
 <bp:stepProcess rdf:resource="#Pathway400" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis668">
 <bp:controlled rdf:resource="#BiochemicalReaction2162" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2970">
 <bp:stepProcess rdf:resource="#Pathway397" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis667">
 <bp:controlled rdf:resource="#BiochemicalReaction2159" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2971">
 <bp:stepProcess rdf:resource="#Pathway398" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2972">
 <bp:stepProcess rdf:resource="#Pathway399" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis669">
 <bp:controlled rdf:resource="#BiochemicalReaction2166" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2973">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2575" />
 <bp:stepProcess rdf:resource="#Catalysis822" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1642">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1432" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis664">
 <bp:controlled rdf:resource="#BiochemicalReaction2155" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1641">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1431" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis663">
 <bp:controlled rdf:resource="#BiochemicalReaction2153" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1640">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1430" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis666">
 <bp:controlled rdf:resource="#BiochemicalReaction2158" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis665">
 <bp:controlled rdf:resource="#BiochemicalReaction2157" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis671">
 <bp:controlled rdf:resource="#BiochemicalReaction2174" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis670">
 <bp:controlled rdf:resource="#BiochemicalReaction2171" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis673">
 <bp:controlled rdf:resource="#BiochemicalReaction2177" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis672">
 <bp:controlled rdf:resource="#BiochemicalReaction2175" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1657">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1447" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2989">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2589" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1656">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1446" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1655">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1445" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1654">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1444" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2985">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2585" />
 <bp:stepProcess rdf:resource="#Catalysis827" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2986">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2586" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1659">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1449" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2987">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2587" />
 <bp:stepProcess rdf:resource="#Catalysis828" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1658">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1448" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2988">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2588" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis679">
 <bp:controlled rdf:resource="#BiochemicalReaction2196" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2981">
 <bp:stepProcess rdf:resource="#Pathway401" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis678">
 <bp:controlled rdf:resource="#BiochemicalReaction2193" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2982">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2582" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2983">
 <bp:stepProcess rdf:resource="#Catalysis825" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2583" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2984">
 <bp:stepProcess rdf:resource="#Catalysis826" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2584" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1653">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1443" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis675">
 <bp:controlled rdf:resource="#BiochemicalReaction2179" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1652">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1442" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis674">
 <bp:controlled rdf:resource="#BiochemicalReaction2178" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1651">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1441" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis677">
 <bp:controlled rdf:resource="#BiochemicalReaction2187" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1650">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1440" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis676">
 <bp:controlled rdf:resource="#BiochemicalReaction2186" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2980">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2581" />
 <bp:stepProcess rdf:resource="#Catalysis824" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis682">
 <bp:controlled rdf:resource="#BiochemicalReaction2202" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis681">
 <bp:controlled rdf:resource="#BiochemicalReaction2198" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis684">
 <bp:controlled rdf:resource="#BiochemicalReaction2212" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis683">
 <bp:controlled rdf:resource="#BiochemicalReaction2209" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis680">
 <bp:controlled rdf:resource="#BiochemicalReaction2197" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1624">
 <bp:stepProcess rdf:resource="#Pathway210" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2956">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2565" />
 <bp:stepProcess rdf:resource="#Catalysis817" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1623">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1415" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis609">
 <bp:controlled rdf:resource="#BiochemicalReaction2026" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2957">
 <bp:stepProcess rdf:resource="#Catalysis818" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2566" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1622">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1414" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2958">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2567" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1621">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1413" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2959">
 <bp:stepProcess rdf:resource="#Pathway393" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1628">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1418" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis606">
 <bp:controlled rdf:resource="#BiochemicalReaction2021" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2952">
 <bp:stepProcess rdf:resource="#Catalysis815" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2561" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1627">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1417" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis605">
 <bp:controlled rdf:resource="#BiochemicalReaction2019" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2953">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2562" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1626">
 <bp:stepProcess rdf:resource="#Pathway211" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis608">
 <bp:controlled rdf:resource="#BiochemicalReaction2023" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2954">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2563" />
 <bp:stepProcess rdf:resource="#Catalysis816" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1625">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1416" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis607">
 <bp:controlled rdf:resource="#BiochemicalReaction2022" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2955">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2564" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis602">
 <bp:controlled rdf:resource="#BiochemicalReaction2007" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis601">
 <bp:controlled rdf:resource="#BiochemicalReaction2004" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis604">
 <bp:controlled rdf:resource="#BiochemicalReaction2012" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2950">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2559" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis603">
 <bp:controlled rdf:resource="#BiochemicalReaction2010" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2951">
 <bp:stepProcess rdf:resource="#Catalysis814" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2560" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1620">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1412" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis600">
 <bp:controlled rdf:resource="#BiochemicalReaction2002" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1629">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1419" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1635">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1425" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2967">
 <bp:stepProcess rdf:resource="#Pathway396" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1634">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1424" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2968">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2573" />
 <bp:stepProcess rdf:resource="#Catalysis821" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1633">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1423" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2969">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2574" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1632">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1422" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1639">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1429" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis617">
 <bp:controlled rdf:resource="#BiochemicalReaction2046" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2963">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2570" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1638">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1428" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis616">
 <bp:controlled rdf:resource="#BiochemicalReaction2042" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2964">
 <bp:stepProcess rdf:resource="#Pathway395" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1637">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1427" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis619">
 <bp:controlled rdf:resource="#BiochemicalReaction2048" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2965">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2571" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1636">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1426" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis618">
 <bp:controlled rdf:resource="#BiochemicalReaction2047" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2966">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2572" />
 <bp:stepProcess rdf:resource="#Catalysis820" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis613">
 <bp:controlled rdf:resource="#BiochemicalReaction2035" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis612">
 <bp:controlled rdf:resource="#BiochemicalReaction2034" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2960">
 <bp:stepProcess rdf:resource="#Pathway394" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis615">
 <bp:controlled rdf:resource="#BiochemicalReaction2041" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2961">
 <bp:stepProcess rdf:resource="#Catalysis819" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2568" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis614">
 <bp:controlled rdf:resource="#BiochemicalReaction2040" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2962">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2569" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1631">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1421" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1630">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1420" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis611">
 <bp:controlled rdf:resource="#BiochemicalReaction2032" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis610">
 <bp:controlled rdf:resource="#BiochemicalReaction2028" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1602">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1395" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2934">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2546" />
 <bp:stepProcess rdf:resource="#Catalysis809" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1601">
 <bp:stepProcess rdf:resource="#Pathway208" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2935">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2547" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1600">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1394" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2936">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2548" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2937">
 <bp:stepProcess rdf:resource="#Catalysis810" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2549" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1606">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1398" />
 <bp:stepProcess rdf:resource="#Catalysis422" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis628">
 <bp:controlled rdf:resource="#BiochemicalReaction2065" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2930">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2542" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1605">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1397" />
 <bp:stepProcess rdf:resource="#Catalysis421" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis627">
 <bp:controlled rdf:resource="#BiochemicalReaction2064" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2931">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2543" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1604">
 <bp:stepProcess rdf:resource="#Pathway209" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2932">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2544" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1603">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1396" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis629">
 <bp:controlled rdf:resource="#BiochemicalReaction2071" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2933">
 <bp:stepProcess rdf:resource="#Catalysis808" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2545" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis624">
 <bp:controlled rdf:resource="#BiochemicalReaction2058" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis623">
 <bp:controlled rdf:resource="#BiochemicalReaction2057" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis626">
 <bp:controlled rdf:resource="#BiochemicalReaction2063" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis625">
 <bp:controlled rdf:resource="#BiochemicalReaction2060" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis620">
 <bp:controlled rdf:resource="#BiochemicalReaction2050" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis622">
 <bp:controlled rdf:resource="#BiochemicalReaction2054" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis621">
 <bp:controlled rdf:resource="#BiochemicalReaction2052" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1609">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1401" />
 <bp:stepProcess rdf:resource="#Catalysis425" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1608">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1400" />
 <bp:stepProcess rdf:resource="#Catalysis424" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1607">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1399" />
 <bp:stepProcess rdf:resource="#Catalysis423" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2938">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2550" />
 <bp:stepProcess rdf:resource="#Catalysis811" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2939">
 <bp:stepProcess rdf:resource="#Pathway390" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1613">
 <bp:stepProcess rdf:resource="#Catalysis428" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1405" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2945">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2554" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1612">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1404" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2946">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2555" />
 <bp:stepProcess rdf:resource="#Catalysis812" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1611">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1403" />
 <bp:stepProcess rdf:resource="#Catalysis427" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2947">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2556" />
 <bp:stepProcess rdf:resource="#Catalysis813" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1610">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1402" />
 <bp:stepProcess rdf:resource="#Catalysis426" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2948">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2557" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1617">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1409" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis639">
 <bp:controlled rdf:resource="#BiochemicalReaction2088" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2941">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2552" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1616">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1408" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis638">
 <bp:controlled rdf:resource="#BiochemicalReaction2087" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2942">
 <bp:stepProcess rdf:resource="#Pathway391" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1615">
 <bp:stepProcess rdf:resource="#Catalysis430" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1407" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2943">
 <bp:stepProcess rdf:resource="#Pathway392" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1614">
 <bp:stepProcess rdf:resource="#Catalysis429" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1406" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2944">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2553" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis635">
 <bp:controlled rdf:resource="#BiochemicalReaction2081" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis634">
 <bp:controlled rdf:resource="#BiochemicalReaction2080" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis637">
 <bp:controlled rdf:resource="#BiochemicalReaction2084" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis636">
 <bp:controlled rdf:resource="#BiochemicalReaction2082" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2940">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2551" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis631">
 <bp:controlled rdf:resource="#BiochemicalReaction2074" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis630">
 <bp:controlled rdf:resource="#BiochemicalReaction2072" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis633">
 <bp:controlled rdf:resource="#BiochemicalReaction2079" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis632">
 <bp:controlled rdf:resource="#BiochemicalReaction2075" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis640">
 <bp:controlled rdf:resource="#BiochemicalReaction2090" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1619">
 <bp:stepProcess rdf:resource="#Catalysis431" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1411" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1618">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1410" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2949">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2558" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep158">
 <bp:stepProcess rdf:resource="#Catalysis61" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction136" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep159">
 <bp:stepProcess rdf:resource="#Catalysis62" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction137" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep156">
 <bp:stepProcess rdf:resource="#BiochemicalReaction134" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep157">
 <bp:stepProcess rdf:resource="#Catalysis60" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction135" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep154">
 <bp:stepProcess rdf:resource="#BiochemicalReaction133" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep155">
 <bp:stepProcess rdf:resource="#Pathway23" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep152">
 <bp:stepProcess rdf:resource="#BiochemicalReaction131" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep153">
 <bp:stepProcess rdf:resource="#Catalysis59" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction132" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep150">
 <bp:stepProcess rdf:resource="#BiochemicalReaction129" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep151">
 <bp:stepProcess rdf:resource="#BiochemicalReaction130" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep149">
 <bp:stepProcess rdf:resource="#BiochemicalReaction128" />
 <bp:stepProcess rdf:resource="#Catalysis58" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway427">
 <bp:pathwayOrder rdf:resource="#PathwayStep3124" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3125" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3126" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2700" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2699" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2698" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence3124" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phospholipase C-mediated cascade; FGFR4</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phospholipase C-gamma (PLC-gamma) is a substrate of the fibroblast growth factor receptor (FGFR) and other receptors with tyrosine kinase activity. It is known that the src homology region 2 (SH2 domain) of PLC-gamma and of other signaling molecules (such as GTPase-activating protein and phosphatidylinositol 3-kinase-associated p85) direct their binding toward autophosphorylated tyrosine residues of the FGFR. Recruitment of PLC-gamma results in its phosphorylation and activation by the receptor.  Activated PLC-gamma hydrolyzes phosphatidyl inositol[4,5] P2 to form the second messengers diacylglycerol (DAG) and Ins [1,4,5]P3, which stimulate calcium release and activation of calcium/calmodulin dependent kinases. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway426">
 <bp:pathwayOrder rdf:resource="#PathwayStep3117" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3118" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3119" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3116" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3120" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3121" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3122" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2697" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2696" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2695" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2694" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2693" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2692" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2691" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence3116" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI-3K cascade:FGFR4</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The ability of growth factors to protect from apoptosis is primarily due to the activation of the AKT survival pathway. P-I-3-kinase dependent activation of PDK leads to the activation of AKT which in turn affects the activity or expression of pro-apoptotic factors, which contribute to protection from apoptosis. AKT activation also blocks the activity of GSK-3b which could lead to additional antiapoptotic signals.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep147">
 <bp:stepProcess rdf:resource="#BiochemicalReaction126" />
 <bp:stepProcess rdf:resource="#Catalysis56" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway429">
 <bp:pathwayOrder rdf:resource="#PathwayStep3130" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3129" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2701" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2702" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence3129" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">betaKlotho-mediated ligand binding</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGF21 and FGF19 require betaKlotho for efficient signaling through FGFR1c and FGFR3c.  betaKlotho does not interact with &apos;b&apos; receptor isoforms, and only weakly with FGFR2c.  In addition, FGF19, but not FGF21, signals through FGFR4 in a betaKlotho-dependent fashion</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep148">
 <bp:stepProcess rdf:resource="#BiochemicalReaction127" />
 <bp:stepProcess rdf:resource="#Catalysis57" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway428">
 <bp:pathwayOrder rdf:resource="#PathwayStep3128" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3131" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3132" />
 <bp:pathwayComponent rdf:resource="#Pathway429" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2704" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2703" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence3128" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFR4 ligand binding and activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFR4 is expressed mainly in mature skeletal muscle, and disruption of FGFR4 signaling interrupts limb muscle formation in vertebrates.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep145">
 <bp:stepProcess rdf:resource="#BiochemicalReaction124" />
 <bp:stepProcess rdf:resource="#Catalysis55" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep146">
 <bp:stepProcess rdf:resource="#BiochemicalReaction125" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep143">
 <bp:stepProcess rdf:resource="#BiochemicalReaction122" />
 <bp:stepProcess rdf:resource="#Catalysis53" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep144">
 <bp:stepProcess rdf:resource="#BiochemicalReaction123" />
 <bp:stepProcess rdf:resource="#Catalysis54" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep141">
 <bp:stepProcess rdf:resource="#Pathway22" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway430">
 <bp:pathwayOrder rdf:resource="#PathwayStep3139" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3135" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3146" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3136" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3147" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3137" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3148" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3138" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3149" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3142" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3143" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3144" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3134" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3145" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3150" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3140" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3151" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3141" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3152" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2712" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2723" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2711" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2722" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2710" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2721" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2720" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2709" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2708" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2719" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2707" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2718" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2706" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2717" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2705" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2716" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2715" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2714" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2713" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence3134" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by Leptin</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Leptin (LEP, OB, OBS), a circulating adipokine, and its receptor LEPR (DB, OBR) control food intake and energy balance and are implicated in obesity-related diseases (recently reviewed in Amitani et al. 2013, Dunmore and Brown 2013, Cottrell and Mercer 2012, La Cava 2012, Marroqui et al. 2012, Paz-Filho et al. 2012, Denver et al. 2011, Lee 2011, Marino et al. 2011, Morton and Schwartz 2011, Scherer and Buettner 2011, Shan and Yeo 2011, Wauman and Tavernier 2011, Dardeno et al. 2010, Bjorbaek 2009, Morris and Rui 2009, Myers et al. 2008), including cancer (Guo et al. 2012), inflammation (Newman and Gonzalez-Perez 2013, Iikuni et al. 2008), and angiogenesis (Gonzalez-Perez et al. 2013). The identification of spontaneous mutations in the leptin gene (ob or LEP) and the leptin receptor gene (Ob-R, db or LEPR) genes in mice opened up a new field in obesity research. Leptin was discovered as the product of the gene affected by the ob (obesity) mutation, which causes obesity in mice. Likewise LEPR is the product of the gene affected by the db (diabetic) mutation. Leptin binding to LEPR induces canonical (JAK2/STATs; MAPK/ERK 1/2, PI-3K/AKT) and non-canonical signaling pathways (PKC, JNK, p38 MAPK and AMPK) in diverse cell types. The binding of leptin to the long isoform of LEPR (OB-Rl) initiates a phosphorylation cascade that results in transcriptional activation of target genes by STAT5 and STAT3 and activation of the PI3K pathway(not shown here), the MAPK/ERK pathway, and the mTOR/S6K pathway. Shorter LEPR isoforms with truncated intracellular domains are unable to activate the STAT pathway, but can transduce signals by way of activation of JAK2, IRS-1 or ERKs, including MAPKs. LEPR is constitutively bound to the JAK2 kinase. Binding of LEP to LEPR causes a conformational change in LEPR that activates JAK2 autophosphorylation followed by phosphorylation of LEPR by JAK2. Phosphorylated LEPR binds STAT3, STAT5, and SHP2 which are then phosphorylated by JAK2. Phosphorylated JAK2 binds SH2B1 which then binds IRS1/2, resulting in phosphorylation of IRS1/2 by JAK2. Phosphorylated STAT3 and STAT5 dimerize and translocate to the nucleus where they activate transcription of target genes (Jovanovic et al. 2010). SHP2 activates the MAPK pathway. IRS1/2 activate the PI3K/AKT pathway which may be the activator of mTOR/S6K. Several isoforms of LEPR have been identified (reviewed in Gorska et al. 2010). The long isoform (LEPRb, OBRb) is expressed in the hypothalamus and all types of immune cells. It is the only isoform known to fully activate signaling pathways in response to leptin. Shorter isoforms (LEPRa, LEPRc, LEPRd, and a soluble isoform LEPRe) are able to interact with JAK kinases and activate other pathways, however their roles in energy homeostasis are not fully characterized. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep142">
 <bp:stepProcess rdf:resource="#BiochemicalReaction121" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep140">
 <bp:stepProcess rdf:resource="#BiochemicalReaction120" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction798">
 <bp:evidence rdf:resource="#Evidence923" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ATP1B4 binds SNW1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction797">
 <bp:evidence rdf:resource="#Evidence922" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Degradation of ubiquitinated SKI/SKIL</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway419">
 <bp:pathwayOrder rdf:resource="#PathwayStep3075" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3080" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3081" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3076" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3077" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3078" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3079" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2657" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2663" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2662" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2661" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2660" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2659" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2658" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence3075" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI-3K cascade:FGFR3</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The ability of growth factors to protect from apoptosis is primarily due to the activation of the AKT survival pathway. P-I-3-kinase dependent activation of PDK leads to the activation of AKT which in turn affects the activity or expression of pro-apoptotic factors, which contribute to protection from apoptosis. AKT activation also blocks the activity of GSK-3b which could lead to additional antiapoptotic signals.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction799">
 <bp:evidence rdf:resource="#Evidence924" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK1 and MAPK3 phosphorylate SMAD2 and SMAD3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep138">
 <bp:stepProcess rdf:resource="#BiochemicalReaction119" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction794">
 <bp:evidence rdf:resource="#Evidence919" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMURF2 binds SMAD3 phosphorylated in the linker region</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway416">
 <bp:pathwayOrder rdf:resource="#PathwayStep3058" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3059" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3056" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3057" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2644" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2643" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2642" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2641" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence3056" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHC-mediated cascade:FGFR3</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The exact role of SHC1 in FGFR signaling remains unclear.   Numerous studies have shown that the p46 and p52 isoforms of SHC1 are phosphorylated in response to FGF stimulation, but direct interaction with the receptor has not been demonstrated. Co-precipitation of p46 and p52 with the FGFR2 IIIc receptor has been reported, but this interaction is thought to be indirect, possibly mediated by SRC.  Consistent with this, co-precipitation of SHC1 and FGFR1 IIIc is seen in mammalian cells expressing v-SRC.  The p66 isoform of SHC1 has also been co-precipitated with FGFR3, but this occurs independently of receptor stimulation, and the p66 isoform not been shown to undergo FGF-dependent phosphorylation.  SHC1 has been shown to associate with GRB2 and SOS1 in response to FGF stimulation, suggesting that the recruitment of SHC1 may contribute to activation of the MAPK cascade downstream of FGFR.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep139">
 <bp:stepProcess rdf:resource="#Pathway21" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction793">
 <bp:evidence rdf:resource="#Evidence918" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SKI/SKIL binds SMAD complex, suppressing TGF-beta signaling</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway415">
 <bp:pathwayOrder rdf:resource="#PathwayStep3074" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3064" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3060" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3055" />
 <bp:pathwayComponent rdf:resource="#Pathway419" />
 <bp:pathwayComponent rdf:resource="#Pathway416" />
 <bp:pathwayComponent rdf:resource="#Pathway418" />
 <bp:pathwayComponent rdf:resource="#Pathway417" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence3055" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Downstream signaling of activated FGFR3</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling via FGFRs is mediated via direct recruitment of signaling proteins that bind to tyrosine auto-phosphorylation sites on the activated receptor and via closely linked docking proteins that become tyrosine phosphorylated in response to FGF-stimulation and form a complex with additional complement of signaling proteins.   The activation loop in the catalytic domain of FGFR maintains the PTK domain in an inactive or low activity state. The activation-loop of FGFR1, for instance, contains two tyrosine residues that must be autophosphorylated for maintaining the catalytic domain in an active state. In the autoinhibited configuration, a kinase invariant proline residue at the C-terminal end of the activation loop interferes with substrate binding while allowing access to ATP in the nucleotide binding site. In addition to the catalytic PTK core, the cytoplasmic domain of FGFR contains several regulatory sequences. The juxtamembrane domain of FGFRs is considerably longer than that of other receptor tyrosine kinases. This region contains a highly conserved sequence that serves as a binding site for the phosphotyrosine binding (PTB) domain of FRS2. A variety of signaling proteins are phosphorylated in response to FGF stimulation, including Shc, phospholipase-C gamma and FRS2 leading to stimulation of intracellular signaling pathways that control cell proliferation, cell differentiation, cell migration, cell survival and cell shape.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep136">
 <bp:stepProcess rdf:resource="#Catalysis51" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction117" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction796">
 <bp:evidence rdf:resource="#Evidence921" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMURF2 monoubiquitinates SMAD3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway418">
 <bp:pathwayOrder rdf:resource="#PathwayStep3072" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3073" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3070" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3071" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3069" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3065" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3066" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3067" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3068" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2656" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2655" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2654" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2653" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2652" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2651" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2650" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2649" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2648" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence3065" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FRS-mediated FGFR3 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The FRS family of scaffolding adaptor proteins has two members, FRS2 (also known as FRS2 alpha) and FRS3 (also known as FRS2beta or SNT-2).  Activation of FGFR tyrosine kinase allows FRS proteins to become phosphorylated on tyrosine residues and then bind to the adaptor GRB2 and the tyrosine phosphatase PPTN11/SHP2.  Subsequently, PPTN11 activates the RAS-MAP kinase pathway and GRB2 activates the RAS-MAP kinase , PI-3-kinase and ubiquitinations/degradation pathways by binding to SOS, GAB1 and CBL, respectively, via the SH3 domains of GRB2.  FRS2 acts as a central mediator in FGF signaling mainly because it induces sustained levels of activation of ERK with ubiquitous expression.   </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep137">
 <bp:stepProcess rdf:resource="#BiochemicalReaction118" />
 <bp:stepProcess rdf:resource="#Catalysis52" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction795">
 <bp:evidence rdf:resource="#Evidence920" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitin-dependent degradation of the SMAD complex terminates TGF-beta signaling</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway417">
 <bp:pathwayOrder rdf:resource="#PathwayStep3061" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3062" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3063" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2646" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2645" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2647" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence3061" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phospholipase C-mediated cascade; FGFR3</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phospholipase C-gamma (PLC-gamma) is a substrate of the fibroblast growth factor receptor (FGFR) and other receptors with tyrosine kinase activity. It is known that the src homology region 2 (SH2 domain) of PLC-gamma and of other signaling molecules (such as GTPase-activating protein and phosphatidylinositol 3-kinase-associated p85) direct their binding toward autophosphorylated tyrosine residues of the FGFR. Recruitment of PLC-gamma results in its phosphorylation and activation by the receptor.  Activated PLC-gamma hydrolyzes phosphatidyl inositol[4,5] P2 to form the second messengers diacylglycerol (DAG) and Ins [1,4,5]P3, which stimulate calcium release and activation of calcium/calmodulin dependent kinases. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep134">
 <bp:stepProcess rdf:resource="#Pathway20" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway423">
 <bp:pathwayOrder rdf:resource="#PathwayStep3115" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3110" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3100" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3123" />
 <bp:pathwayComponent rdf:resource="#Pathway427" />
 <bp:pathwayComponent rdf:resource="#Pathway426" />
 <bp:pathwayComponent rdf:resource="#Pathway425" />
 <bp:pathwayComponent rdf:resource="#Pathway424" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence3100" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Downstream signaling of activated FGFR4</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling via FGFRs is mediated via direct recruitment of signaling proteins that bind to tyrosine auto-phosphorylation sites on the activated receptor and via closely linked docking proteins that become tyrosine phosphorylated in response to FGF-stimulation and form a complex with additional complement of signaling proteins.   The activation loop in the catalytic domain of FGFR maintains the PTK domain in an inactive or low activity state. The activation-loop of FGFR1, for instance, contains two tyrosine residues that must be autophosphorylated for maintaining the catalytic domain in an active state. In the autoinhibited configuration, a kinase invariant proline residue at the C-terminal end of the activation loop interferes with substrate binding while allowing access to ATP in the nucleotide binding site. In addition to the catalytic PTK core, the cytoplasmic domain of FGFR contains several regulatory sequences. The juxtamembrane domain of FGFRs is considerably longer than that of other receptor tyrosine kinases. This region contains a highly conserved sequence that serves as a binding site for the phosphotyrosine binding (PTB) domain of FRS2. A variety of signaling proteins are phosphorylated in response to FGF stimulation, including Shc, phospholipase-C gamma and FRS2 leading to stimulation of intracellular signaling pathways that control cell proliferation, cell differentiation, cell migration, cell survival and cell shape.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep135">
 <bp:stepProcess rdf:resource="#BiochemicalReaction116" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway422">
 <bp:pathwayOrder rdf:resource="#PathwayStep3094" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3095" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3085" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3086" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3090" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3091" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3092" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3093" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3087" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3088" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3089" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2668" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2667" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2666" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2665" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2664" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2674" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2673" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2672" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2671" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2670" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2669" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence3085" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Spry regulation of FGF signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Sprouty was initially characterized as a negative regulator of  FGFR signaling in Drosophila. Human cells contain four genes encoding Sprouty proteins, of which Spry2 is the best studied and most widely expressed.  Spry proteins modulate the duration and extent of signaling through the MAPK cascade after FGF stimulation, although the mechanism appears to depend on the particular biological context.  Some studies have suggested that Sprouty binds to GRB2 and interferes with the recruitment of GRB2-SOS1 to the receptor, while others have shown that Sprouty interferes with the MAPK cascade at the level of RAF activation.  In addition to modulating the MAPK pathway in response to FGF stimulation, Sprouty itself appears to be subject to complex post-translational modification that regulates its activity and stability.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep132">
 <bp:stepProcess rdf:resource="#Catalysis50" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction114" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway425">
 <bp:pathwayOrder rdf:resource="#PathwayStep3113" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3114" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3111" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3112" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2689" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2688" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2687" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2690" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence3111" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHC-mediated cascade:FGFR4</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The exact role of SHC1 in FGFR signaling remains unclear.   Numerous studies have shown that the p46 and p52 isoforms of SHC1 are phosphorylated in response to FGF stimulation, but direct interaction with the receptor has not been demonstrated. Co-precipitation of p46 and p52 with the FGFR2 IIIc receptor has been reported, but this interaction is thought to be indirect, possibly mediated by SRC.  Consistent with this, co-precipitation of SHC1 and FGFR1 IIIc is seen in mammalian cells expressing v-SRC.  The p66 isoform of SHC1 has also been co-precipitated with FGFR3, but this occurs independently of receptor stimulation, and the p66 isoform not been shown to undergo FGF-dependent phosphorylation.  SHC1 has been shown to associate with GRB2 and SOS1 in response to FGF stimulation, suggesting that the recruitment of SHC1 may contribute to activation of the MAPK cascade downstream of FGFR.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep133">
 <bp:stepProcess rdf:resource="#BiochemicalReaction115" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway424">
 <bp:pathwayOrder rdf:resource="#PathwayStep3106" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3107" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3108" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3109" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3102" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3103" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3104" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3105" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3101" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2679" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2678" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2686" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2685" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2684" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2683" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2682" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2681" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2680" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence3101" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FRS-mediated FGFR4 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The FRS family of scaffolding adaptor proteins has two members, FRS2 (also known as FRS2 alpha) and FRS3 (also known as FRS2beta or SNT-2).  Activation of FGFR tyrosine kinase allows FRS proteins to become phosphorylated on tyrosine residues and then bind to the adaptor GRB2 and the tyrosine phosphatase PPTN11/SHP2.  Subsequently, PPTN11 activates the RAS-MAP kinase pathway and GRB2 activates the RAS-MAP kinase , PI-3-kinase and ubiquitinations/degradation pathways by binding to SOS, GAB1 and CBL, respectively, via the SH3 domains of GRB2.  FRS2 acts as a central mediator in FGF signaling mainly because it induces sustained levels of activation of ERK with ubiquitous expression.   </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep130">
 <bp:stepProcess rdf:resource="#BiochemicalReaction112" />
 <bp:stepProcess rdf:resource="#Catalysis49" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep131">
 <bp:stepProcess rdf:resource="#BiochemicalReaction113" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway421">
 <bp:pathwayOrder rdf:resource="#PathwayStep3084" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3096" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3097" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3098" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2677" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2676" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2675" />
 <bp:pathwayComponent rdf:resource="#Pathway422" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence3084" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Negative regulation of FGFR4 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Once activated, the FGFR signaling pathway is regulated by numerous negative feedback mechanisms.  These include downregulation of receptors through CBL-mediated ubiquitination and endocytosis, ERK-mediated inhibition of FRS2-tyrosine phosphorylation and the attenuation of ERK signaling through the action of dual-specificity phosphatases, IL17RD/SEF, Sprouty and Spred proteins.  A number of these inhibitors are themselves transcriptional targets of the activated FGFR pathway.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway420">
 <bp:pathwayOrder rdf:resource="#PathwayStep3083" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3127" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3099" />
 <bp:pathwayComponent rdf:resource="#Pathway428" />
 <bp:pathwayComponent rdf:resource="#Pathway423" />
 <bp:pathwayComponent rdf:resource="#Pathway421" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence3083" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by FGFR4</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The 22 members of the fibroblast growth factor (FGF) family of growth factors mediate their cellular responses by binding to and activating the different isoforms encoded by the four receptor tyrosine kinases (RTKs) designated FGFR1, FGFR2, FGFR3 and FGFR4. These receptors are key regulators of several developmental processes in which cell fate and differentiation to various tissue lineages are determined. Unlike other growth factors, FGFs act in concert with heparin or heparan sulfate proteoglycan (HSPG) to activate FGFRs and to induce the pleiotropic responses that lead to the variety of cellular responses induced by this large family of growth factors. An alternative, FGF-independent, source of FGFR activation originates from the interaction with cell adhesion molecules, typically in the context of interactions on neural cell membranes and is crucial for neuronal survival and development.  Upon ligand binding, receptor dimers are formed and their intrinsic tyrosine kinase is activated causing phosphorylation of multiple tyrosine residues on the receptors. These then serve as docking sites for the recruitment of SH2 (src homology-2) or PTB (phosphotyrosine binding) domains of adaptors, docking proteins or signaling enzymes. Signaling complexes are assembled and recruited to the active receptors resulting in a cascade of phosphorylation events.  This leads to stimulation of intracellular signaling pathways that control cell proliferation, cell differentiation, cell migration, cell survival and cell shape, depending on the cell type or stage of maturation. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway409">
 <bp:pathwayOrder rdf:resource="#PathwayStep3029" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3038" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3054" />
 <bp:pathwayComponent rdf:resource="#Pathway415" />
 <bp:pathwayComponent rdf:resource="#Pathway413" />
 <bp:pathwayComponent rdf:resource="#Pathway410" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence3029" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signaling by FGFR3</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The 22 members of the fibroblast growth factor (FGF) family of growth factors mediate their cellular responses by binding to and activating the different isoforms encoded by the four receptor tyrosine kinases (RTKs) designated FGFR1, FGFR2, FGFR3 and FGFR4. These receptors are key regulators of several developmental processes in which cell fate and differentiation to various tissue lineages are determined. Unlike other growth factors, FGFs act in concert with heparin or heparan sulfate proteoglycan (HSPG) to activate FGFRs and to induce the pleiotropic responses that lead to the variety of cellular responses induced by this large family of growth factors. An alternative, FGF-independent, source of FGFR activation originates from the interaction with cell adhesion molecules, typically in the context of interactions on neural cell membranes and is crucial for neuronal survival and development.  Upon ligand binding, receptor dimers are formed and their intrinsic tyrosine kinase is activated causing phosphorylation of multiple tyrosine residues on the receptors. These then serve as docking sites for the recruitment of SH2 (src homology-2) or PTB (phosphotyrosine binding) domains of adaptors, docking proteins or signaling enzymes. Signaling complexes are assembled and recruited to the active receptors resulting in a cascade of phosphorylation events.  This leads to stimulation of intracellular signaling pathways that control cell proliferation, cell differentiation, cell migration, cell survival and cell shape, depending on the cell type or stage of maturation. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway408">
 <bp:pathwayOrder rdf:resource="#PathwayStep3020" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3018" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3019" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3014" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3015" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3016" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3017" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3021" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3022" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3023" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3024" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2613" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2612" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2611" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2610" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2609" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2608" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2607" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2617" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2616" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2615" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2614" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence3014" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Spry regulation of FGF signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Sprouty was initially characterized as a negative regulator of  FGFR signaling in Drosophila. Human cells contain four genes encoding Sprouty proteins, of which Spry2 is the best studied and most widely expressed.  Spry proteins modulate the duration and extent of signaling through the MAPK cascade after FGF stimulation, although the mechanism appears to depend on the particular biological context.  Some studies have suggested that Sprouty binds to GRB2 and interferes with the recruitment of GRB2-SOS1 to the receptor, while others have shown that Sprouty interferes with the MAPK cascade at the level of RAF activation.  In addition to modulating the MAPK pathway in response to FGF stimulation, Sprouty itself appears to be subject to complex post-translational modification that regulates its activity and stability.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep129">
 <bp:stepProcess rdf:resource="#BiochemicalReaction111" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep127">
 <bp:stepProcess rdf:resource="#BiochemicalReaction110" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway405">
 <bp:pathwayOrder rdf:resource="#PathwayStep3007" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3008" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3006" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2602" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2604" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2603" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence3006" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFR2b ligand binding and activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">This pathway depicts the binding of an experimentally-verified range of ligands to FGFR2b. While binding affinities may vary considerably within this set, the ligands listed have been established to bring about receptor activation at their reported physiological concentrations.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep128">
 <bp:stepProcess rdf:resource="#Pathway19" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway404">
 <bp:pathwayOrder rdf:resource="#PathwayStep3009" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3005" />
 <bp:pathwayComponent rdf:resource="#Pathway405" />
 <bp:pathwayComponent rdf:resource="#Pathway406" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence3005" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFR2 ligand binding and activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dominant mutations in the fibroblast growth factor receptor 2 (FGFR2) gene have been identified as causes of four phenotypically distinct craniosynostosis syndromes, including Crouzon, Jackson- Weiss, Pfeiffer, and Apert syndromes. FGFR2 binds a number of different FGFs preferentially, as illustrated in this pathway.  FGFR is probably activated by NCAM very differently from the way by which it is activated by FGFs, reflecting the different conditions for NCAM-FGFR and FGF-FGFR interactions. The affinity of FGF for FGFR is approximately  10e6 times higher than that of NCAM for FGFR. Moreover, in the brain NCAM is constantly present on the cell surface at a much higher (micromolar) concentration than FGFs, which only appear transiently in the extracellular environment in the nanomolar range.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep125">
 <bp:stepProcess rdf:resource="#Pathway18" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway407">
 <bp:pathwayOrder rdf:resource="#PathwayStep3025" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3026" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3027" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3013" />
 <bp:pathwayComponent rdf:resource="#Pathway408" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2620" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2619" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2618" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence3013" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Negative regulation of FGFR2 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Once activated, the FGFR signaling pathway is regulated by numerous negative feedback mechanisms.  These include downregulation of receptors through CBL-mediated ubiquitination and endocytosis, ERK-mediated inhibition of FRS2-tyrosine phosphorylation and the attenuation of ERK signaling through the action of dual-specificity phosphatases, IL17RD/SEF, Sprouty and Spred proteins.  A number of these inhibitors are themselves transcriptional targets of the activated FGFR pathway.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep126">
 <bp:stepProcess rdf:resource="#Catalysis48" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction109" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway406">
 <bp:pathwayOrder rdf:resource="#PathwayStep3010" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3011" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2606" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2605" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence3010" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFR2c ligand binding and activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">This pathway depicts the binding of an experimentally-verified range of ligands to FGFR2c. While binding affinities may vary considerably within this set, the ligands listed have been established to bring about receptor activation at their reported physiological concentrations.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep123">
 <bp:stepProcess rdf:resource="#BiochemicalReaction107" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway412">
 <bp:pathwayOrder rdf:resource="#PathwayStep3036" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3037" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2626" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2625" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence3036" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFR3b ligand binding and activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">This pathway depicts the binding of an experimentally-verified range of ligands to FGFR3b. While binding affinities may vary considerably within this set, the ligands listed have been established to bring about receptor activation at their reported physiological concentrations.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep124">
 <bp:stepProcess rdf:resource="#BiochemicalReaction108" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway411">
 <bp:pathwayOrder rdf:resource="#PathwayStep3031" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3032" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3033" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3034" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2624" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2623" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2622" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2621" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence3031" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFR3c ligand binding and activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">This pathway depicts the binding of an experimentally-verified range of ligands to FGFR3c. While binding affinities may vary considerably within this set, the ligands listed have been established to bring about receptor activation at their reported physiological concentrations.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep121">
 <bp:stepProcess rdf:resource="#BiochemicalReaction105" />
 <bp:stepProcess rdf:resource="#Catalysis47" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway414">
 <bp:pathwayOrder rdf:resource="#PathwayStep3050" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3040" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3041" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3042" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3047" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3048" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3049" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3043" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3044" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3045" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3046" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2635" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2634" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2633" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2632" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2631" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2630" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2629" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2628" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2627" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2637" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2636" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence3040" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Spry regulation of FGF signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Sprouty was initially characterized as a negative regulator of  FGFR signaling in Drosophila. Human cells contain four genes encoding Sprouty proteins, of which Spry2 is the best studied and most widely expressed.  Spry proteins modulate the duration and extent of signaling through the MAPK cascade after FGF stimulation, although the mechanism appears to depend on the particular biological context.  Some studies have suggested that Sprouty binds to GRB2 and interferes with the recruitment of GRB2-SOS1 to the receptor, while others have shown that Sprouty interferes with the MAPK cascade at the level of RAF activation.  In addition to modulating the MAPK pathway in response to FGF stimulation, Sprouty itself appears to be subject to complex post-translational modification that regulates its activity and stability.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep122">
 <bp:stepProcess rdf:resource="#BiochemicalReaction106" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway413">
 <bp:pathwayOrder rdf:resource="#PathwayStep3051" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3052" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3053" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3039" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2640" />
 <bp:pathwayComponent rdf:resource="#Pathway414" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2639" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2638" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence3039" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Negative regulation of FGFR3 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Once activated, the FGFR signaling pathway is regulated by numerous negative feedback mechanisms.  These include downregulation of receptors through CBL-mediated ubiquitination and endocytosis, ERK-mediated inhibition of FRS2-tyrosine phosphorylation and the attenuation of ERK signaling through the action of dual-specificity phosphatases, IL17RD/SEF, Sprouty and Spred proteins.  A number of these inhibitors are themselves transcriptional targets of the activated FGFR pathway.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep120">
 <bp:stepProcess rdf:resource="#BiochemicalReaction104" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway410">
 <bp:pathwayOrder rdf:resource="#PathwayStep3030" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3035" />
 <bp:pathwayComponent rdf:resource="#Pathway412" />
 <bp:pathwayComponent rdf:resource="#Pathway411" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence3030" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFR3 ligand binding and activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFR3 is a receptor tyrosine kinase of the FGF receptor family, known to have a negative regulatory effect on long bone growth. Somatically, some of the same activating mutations are associated with hypochondroplasia, multiple myeloma, and cervical and vesical carcinoma.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1583">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1584">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep118">
 <bp:stepProcess rdf:resource="#BiochemicalReaction102" />
 <bp:stepProcess rdf:resource="#Catalysis45" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1585">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep119">
 <bp:stepProcess rdf:resource="#BiochemicalReaction103" />
 <bp:stepProcess rdf:resource="#Catalysis46" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1586">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep116">
 <bp:stepProcess rdf:resource="#BiochemicalReaction100" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1587">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep117">
 <bp:stepProcess rdf:resource="#BiochemicalReaction101" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1588">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep114">
 <bp:stepProcess rdf:resource="#BiochemicalReaction98" />
 <bp:stepProcess rdf:resource="#Catalysis43" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1589">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep115">
 <bp:stepProcess rdf:resource="#BiochemicalReaction99" />
 <bp:stepProcess rdf:resource="#Catalysis44" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis569">
 <bp:controlled rdf:resource="#BiochemicalReaction1939" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis568">
 <bp:controlled rdf:resource="#BiochemicalReaction1938" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis565">
 <bp:controlled rdf:resource="#BiochemicalReaction1934" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1580">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis564">
 <bp:controlled rdf:resource="#BiochemicalReaction1931" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1581">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis567">
 <bp:controlled rdf:resource="#BiochemicalReaction1937" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1582">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis566">
 <bp:controlled rdf:resource="#BiochemicalReaction1936" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis572">
 <bp:controlled rdf:resource="#BiochemicalReaction1945" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis571">
 <bp:controlled rdf:resource="#BiochemicalReaction1943" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis574">
 <bp:controlled rdf:resource="#BiochemicalReaction1949" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis573">
 <bp:controlled rdf:resource="#BiochemicalReaction1948" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis570">
 <bp:controlled rdf:resource="#BiochemicalReaction1942" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep112">
 <bp:stepProcess rdf:resource="#BiochemicalReaction96" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep113">
 <bp:stepProcess rdf:resource="#BiochemicalReaction97" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep110">
 <bp:stepProcess rdf:resource="#BiochemicalReaction95" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep111">
 <bp:stepProcess rdf:resource="#Pathway17" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep109">
 <bp:stepProcess rdf:resource="#Pathway16" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1572">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1573">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep107">
 <bp:stepProcess rdf:resource="#BiochemicalReaction94" />
 <bp:stepProcess rdf:resource="#Catalysis42" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1574">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep108">
 <bp:stepProcess rdf:resource="#Pathway15" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1575">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep105">
 <bp:stepProcess rdf:resource="#BiochemicalReaction92" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1576">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep106">
 <bp:stepProcess rdf:resource="#BiochemicalReaction93" />
 <bp:stepProcess rdf:resource="#Catalysis41" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1577">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep103">
 <bp:stepProcess rdf:resource="#Pathway14" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1578">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep104">
 <bp:stepProcess rdf:resource="#BiochemicalReaction91" />
 <bp:stepProcess rdf:resource="#Catalysis40" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1579">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis579">
 <bp:controlled rdf:resource="#BiochemicalReaction1963" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis576">
 <bp:controlled rdf:resource="#BiochemicalReaction1955" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis575">
 <bp:controlled rdf:resource="#BiochemicalReaction1951" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1570">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis578">
 <bp:controlled rdf:resource="#BiochemicalReaction1962" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1571">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis577">
 <bp:controlled rdf:resource="#BiochemicalReaction1960" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis583">
 <bp:controlled rdf:resource="#BiochemicalReaction1970" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis582">
 <bp:controlled rdf:resource="#BiochemicalReaction1969" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis585">
 <bp:controlled rdf:resource="#BiochemicalReaction1973" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis584">
 <bp:controlled rdf:resource="#BiochemicalReaction1971" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis581">
 <bp:controlled rdf:resource="#BiochemicalReaction1965" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis580">
 <bp:controlled rdf:resource="#BiochemicalReaction1964" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep101">
 <bp:stepProcess rdf:resource="#Catalysis39" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction89" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep102">
 <bp:stepProcess rdf:resource="#BiochemicalReaction90" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep100">
 <bp:stepProcess rdf:resource="#Catalysis38" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction88" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1689">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1479" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1688">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1478" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1687">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1477" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1682">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1472" />
 <bp:stepProcess rdf:resource="#Catalysis435" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1681">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1471" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1680">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1470" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1686">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1476" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis587">
 <bp:controlled rdf:resource="#BiochemicalReaction1981" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1685">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1475" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis586">
 <bp:controlled rdf:resource="#BiochemicalReaction1974" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1684">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1474" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis589">
 <bp:controlled rdf:resource="#BiochemicalReaction1983" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1683">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1473" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis588">
 <bp:controlled rdf:resource="#BiochemicalReaction1982" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis594">
 <bp:controlled rdf:resource="#BiochemicalReaction1993" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis593">
 <bp:controlled rdf:resource="#BiochemicalReaction1991" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis596">
 <bp:controlled rdf:resource="#BiochemicalReaction1995" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis595">
 <bp:controlled rdf:resource="#BiochemicalReaction1994" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis590">
 <bp:controlled rdf:resource="#BiochemicalReaction1985" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis592">
 <bp:controlled rdf:resource="#BiochemicalReaction1989" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis591">
 <bp:controlled rdf:resource="#BiochemicalReaction1986" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1594">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1595">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1596">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1699">
 <bp:stepProcess rdf:resource="#Pathway212" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1597">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1698">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1488" />
 <bp:stepProcess rdf:resource="#Catalysis437" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1598">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1599">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1693">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1483" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1692">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1482" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1691">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1481" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1690">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1480" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1590">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1697">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1487" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis598">
 <bp:controlled rdf:resource="#BiochemicalReaction2000" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1591">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1696">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1486" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis597">
 <bp:controlled rdf:resource="#BiochemicalReaction1998" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1592">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1695">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1485" />
 <bp:stepProcess rdf:resource="#Catalysis436" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1593">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1694">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1484" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis599">
 <bp:controlled rdf:resource="#BiochemicalReaction2001" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction732">
 <bp:evidence rdf:resource="#Evidence852" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The SMAD2/3:SMAD4 complex transfers to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2871">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction731">
 <bp:evidence rdf:resource="#Evidence851" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activin A,AB,B binds Activin Receptor ACVR2A,B:ACVR1B</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1540">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2870">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction734">
 <bp:evidence rdf:resource="#Evidence855" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Type II receptor phosphorylates type I receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1541">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2873">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction733">
 <bp:evidence rdf:resource="#Evidence853" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of SMAD2,3 by Activin:Activin Receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1542">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2872">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1543">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2875">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1544">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2874">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction730">
 <bp:evidence rdf:resource="#Evidence850" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activin AB,B binds Activin Receptor ACVR2A,B:ACVR1C</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1545">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2877">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1546">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2876">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1571">
 <bp:evidence rdf:resource="#Evidence1791" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DLGAP5 gene transcription is stimulated by NOTCH3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction739">
 <bp:evidence rdf:resource="#Evidence860" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ACVRL1 binds BMP9,BMP10</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1570">
 <bp:evidence rdf:resource="#Evidence1790" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PLXND1 gene expression is stimulated by NOTCH1,NOTCH3 coactivator complexes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction736">
 <bp:evidence rdf:resource="#Evidence857" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">I-Smad competes with Co-Smad for R-Smad1/5/8</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction735">
 <bp:evidence rdf:resource="#Evidence856" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">I-Smad competes with R-Smad1/5/8 for type I receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction738">
 <bp:evidence rdf:resource="#Evidence859" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitin-dependent degradation controls basal levels of R-Smad1/5/8</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction737">
 <bp:evidence rdf:resource="#Evidence858" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The phospho-R-Smad1/5/8:Co-Smad transfers to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1579">
 <bp:evidence rdf:resource="#Evidence1800" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NICD3 traffics to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1578">
 <bp:evidence rdf:resource="#Evidence1799" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NICD3 binds to TACC3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1577">
 <bp:evidence rdf:resource="#Evidence1798" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NEXT3 is cleaved to produce NICD3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1576">
 <bp:evidence rdf:resource="#Evidence1797" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH3 binds WWP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1575">
 <bp:evidence rdf:resource="#Evidence1796" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WWP2 ubiquitinates NOTCH3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1574">
 <bp:evidence rdf:resource="#Evidence1795" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH3 binds DLL1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1573">
 <bp:evidence rdf:resource="#Evidence1793" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH3 coactivator complex binds WWC1 (Kibra) gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1572">
 <bp:evidence rdf:resource="#Evidence1792" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH1,NOTCH3 coactivator complex binds PLXND1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1547">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2879">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1548">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2878">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1549">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction743">
 <bp:evidence rdf:resource="#Evidence864" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AMHR2 binds AMH</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2860">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction742">
 <bp:evidence rdf:resource="#Evidence863" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phospho-R-Smad1/5/8 forms a complex with Co-Smad</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction745">
 <bp:evidence rdf:resource="#Evidence866" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of a heteromeric BMP receptor complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1530">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2862">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction744">
 <bp:evidence rdf:resource="#Evidence865" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phospho-R-Smad1/5/8 dissociates from the receptor complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1531">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2861">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1532">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2864">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1533">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2863">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction741">
 <bp:evidence rdf:resource="#Evidence862" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SKI complexes with the Smad complex, suppressing BMP2 signalling</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1534">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2866">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction740">
 <bp:evidence rdf:resource="#Evidence861" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated type I receptor phosphorylates R-Smad1/5/8 directly</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1535">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2865">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1560">
 <bp:evidence rdf:resource="#Evidence1780" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NICD3 binds RBPJ and MAML in the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction747">
 <bp:evidence rdf:resource="#Evidence868" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BMP2 binds to the receptor complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction746">
 <bp:evidence rdf:resource="#Evidence867" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The ligand trap binds the ligand BMP2, blocking BMP signalling</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction749">
 <bp:evidence rdf:resource="#Evidence870" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">An anchoring protein, Endofin, recruits R-Smad1/5/8</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction748">
 <bp:evidence rdf:resource="#Evidence869" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitin-dependent degradation of the Smad complex terminates BMP2 signalling</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1568">
 <bp:evidence rdf:resource="#Evidence1788" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FABP7 gene expression is positively regulated by NOTCH1 and NOTCH3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1567">
 <bp:evidence rdf:resource="#Evidence1787" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH3 coactivator complex binds DLGAP5 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1566">
 <bp:evidence rdf:resource="#Evidence1786" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HES5 gene expression is stimulated by NOTCH3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1565">
 <bp:evidence rdf:resource="#Evidence1785" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IK1 binds the PTCRA gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1564">
 <bp:evidence rdf:resource="#Evidence1784" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PBX1 gene expression is stimulated by NOTCH3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1563">
 <bp:evidence rdf:resource="#Evidence1783" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WWC1 (Kibra) gene expression is stimulated by NOTCH3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1562">
 <bp:evidence rdf:resource="#Evidence1782" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HEY2 gene expression is positively regulated by NOTCH3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1561">
 <bp:evidence rdf:resource="#Evidence1781" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTCRA gene expression is stimulated by NOTCH3 and inhibited by IK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1536">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2868">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1537">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2867">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1538">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1539">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2869">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1569">
 <bp:evidence rdf:resource="#Evidence1789" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH3 coactivator complex and STAT1 bind HES1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction710">
 <bp:evidence rdf:resource="#Evidence825" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">InhibinA-TGFBR3 binding to ACVR2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1561">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2893">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1562">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2892">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction712">
 <bp:evidence rdf:resource="#Evidence828" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MIR23B microRNA binds 3&apos;UTR of TGFBR3 mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1563">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2895">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction711">
 <bp:evidence rdf:resource="#Evidence827" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of MyoD to TGFBR3 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1564">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2894">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1565">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2897">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1566">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2896">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1567">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2899">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1568">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2898">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction718">
 <bp:evidence rdf:resource="#Evidence834" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TGFBR3 translation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction717">
 <bp:evidence rdf:resource="#Evidence833" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of SP1 to TGFBR3 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction719">
 <bp:evidence rdf:resource="#Evidence836" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TGFBR3 binding to FGF2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction714">
 <bp:evidence rdf:resource="#Evidence830" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TGFBR3 transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction713">
 <bp:evidence rdf:resource="#Evidence829" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MIR27B microRNA binds 3&apos;UTR of TGFBR3 mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction716">
 <bp:evidence rdf:resource="#Evidence832" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MIR-Let7-a1 microRNA binds 3&apos;UTR of TGFBR3 mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2891">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction715">
 <bp:evidence rdf:resource="#Evidence831" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of ATRA to TGFBR3 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1560">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2890">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1557">
 <bp:evidence rdf:resource="#Evidence1777" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HEY1 gene expression is positively regulated by NOTCH3 and STAT1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1556">
 <bp:evidence rdf:resource="#Evidence1776" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HEYL gene expression is stimulated by NOTCH3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1555">
 <bp:evidence rdf:resource="#Evidence1775" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH3 coactivator complex binds HES1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1554">
 <bp:evidence rdf:resource="#Evidence1774" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH3 coactivator complex binds the PTCRA gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1553">
 <bp:evidence rdf:resource="#Evidence1773" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH3 coactivator complex binds HEYL gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1552">
 <bp:evidence rdf:resource="#Evidence1772" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT1 binds HEY1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1551">
 <bp:evidence rdf:resource="#Evidence1769" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH2 coactivator complex binds HES1 promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1550">
 <bp:evidence rdf:resource="#Evidence1768" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NICD2 binds RBPJ and MAML in the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1569">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1559">
 <bp:evidence rdf:resource="#Evidence1779" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HES1 gene expression is stimulated by NOTCH3 and STAT1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1558">
 <bp:evidence rdf:resource="#Evidence1778" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH3 coactivator complex binds PBX1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction721">
 <bp:evidence rdf:resource="#Evidence839" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TGFBR3 translocation to plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1550">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2882">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction720">
 <bp:evidence rdf:resource="#Evidence837" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGF2:TGFBR3 binding to GIPC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1551">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2881">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction723">
 <bp:evidence rdf:resource="#Evidence841" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TGFBR3_mem cleavage by MMPs</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1552">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2884">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction722">
 <bp:evidence rdf:resource="#Evidence840" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TGFBR3(784-851) degradation</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1553">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2883">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1554">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2886">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1555">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2885">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1556">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2888">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1557">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2887">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction729">
 <bp:evidence rdf:resource="#Evidence849" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ACVR2A,B (ActRIIA,B) phosphorylates ACVR1C (ActRIC, ALK7) in response to Activin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction728">
 <bp:evidence rdf:resource="#Evidence848" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated SMAD2 and SMAD3 form a complex with SMAD4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction725">
 <bp:evidence rdf:resource="#Evidence845" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FSTL3 binds Activin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction724">
 <bp:evidence rdf:resource="#Evidence843" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ACVR2A,B (ActRIIA,B) phosphorylates ACVR1B (ActRIB, ALK4) in response to Activin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction727">
 <bp:evidence rdf:resource="#Evidence847" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phospho R-SMAD(SMAD2,3):CO-SMAD(SMAD4):FOXH1 binds Activin Response Element</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2880">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction726">
 <bp:evidence rdf:resource="#Evidence846" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Follistatin (FST) binds Activin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1546">
 <bp:evidence rdf:resource="#Evidence1764" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH2 coactivator complex binds HES5 promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1545">
 <bp:evidence rdf:resource="#Evidence1763" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH2 coactivator complex binds FCER2 promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1544">
 <bp:evidence rdf:resource="#Evidence1762" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH2 stimulates transcription of HES5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1543">
 <bp:evidence rdf:resource="#Evidence1761" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH2 coactivator complex and phosphorylated CREB1 bind GZMB promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1542">
 <bp:evidence rdf:resource="#Evidence1759" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH2-ligand complex is cleaved to produce NEXT2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1541">
 <bp:evidence rdf:resource="#Evidence1758" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH2 binds MDK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1540">
 <bp:evidence rdf:resource="#Evidence1757" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH2NLB, (NOTCH2NLA, NOTCH2NLC) bind DLL1, (DLL4, JAG1, JAG2)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1558">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1559">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2889">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1549">
 <bp:evidence rdf:resource="#Evidence1767" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH2 stimulates transcription of FCER2 (CD23A)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1548">
 <bp:evidence rdf:resource="#Evidence1766" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH2 stimulates GZMB transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1547">
 <bp:evidence rdf:resource="#Evidence1765" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH2 stimulates HES1 transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction776">
 <bp:evidence rdf:resource="#Evidence901" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP9X (FAM) binds to ubiquitinated SMAD4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction775">
 <bp:evidence rdf:resource="#Evidence900" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitinated SMAD4 translocates from the nucleus to the cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction778">
 <bp:evidence rdf:resource="#Evidence903" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRIM33 (Ectodermin) binds SMAD heterotrimer in the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction777">
 <bp:evidence rdf:resource="#Evidence902" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT1 stimulates SMAD7 gene transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction772">
 <bp:evidence rdf:resource="#Evidence896" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMAD2/3:SMAD4 complex positively regulates JUNB transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2831">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction771">
 <bp:evidence rdf:resource="#Evidence895" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WWTR1:SMAD stimulates transcription of SERPINE1 while TGIF:SMAD and SMAD7 inhibit it</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1500">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2830">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction774">
 <bp:evidence rdf:resource="#Evidence898" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Degradation of Ub-SMAD7</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1501">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2833">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction773">
 <bp:evidence rdf:resource="#Evidence897" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated SMAD2 and SMAD3 form a complex with SMAD4</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1502">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2832">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction779">
 <bp:evidence rdf:resource="#Evidence904" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NEDD4L binds phosphorylated linker region of SMAD2/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1503">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2835">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway401">
 <bp:pathwayOrder rdf:resource="#PathwayStep2989" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2985" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2986" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2987" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2988" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2982" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2983" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2984" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2990" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2589" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2588" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2587" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2586" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2585" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2584" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2583" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2582" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2590" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2982" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FRS-mediated FGFR2 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The FRS family of scaffolding adaptor proteins has two members, FRS2 (also known as FRS2 alpha) and FRS3 (also known as FRS2beta or SNT-2).  Activation of FGFR tyrosine kinase allows FRS proteins to become phosphorylated on tyrosine residues and then bind to the adaptor GRB2 and the tyrosine phosphatase PPTN11/SHP2.  Subsequently, PPTN11 activates the RAS-MAP kinase pathway and GRB2 activates the RAS-MAP kinase , PI-3-kinase and ubiquitinations/degradation pathways by binding to SOS, GAB1 and CBL, respectively, via the SH3 domains of GRB2.  FRS2 acts as a central mediator in FGF signaling mainly because it induces sustained levels of activation of ERK with ubiquitous expression.   </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1504">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2834">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway400">
 <bp:pathwayOrder rdf:resource="#PathwayStep2978" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2979" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2980" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2579" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2581" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2580" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2978" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phospholipase C-mediated cascade; FGFR2</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phospholipase C-gamma (PLC-gamma) is a substrate of the fibroblast growth factor receptor (FGFR) and other receptors with tyrosine kinase activity. It is known that the src homology region 2 (SH2 domain) of PLC-gamma and of other signaling molecules (such as GTPase-activating protein and phosphatidylinositol 3-kinase-associated p85) direct their binding toward autophosphorylated tyrosine residues of the FGFR. Recruitment of PLC-gamma results in its phosphorylation and activation by the receptor.  Activated PLC-gamma hydrolyzes phosphatidyl inositol[4,5] P2 to form the second messengers diacylglycerol (DAG) and Ins [1,4,5]P3, which stimulate calcium release and activation of calcium/calmodulin dependent kinases. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction781">
 <bp:evidence rdf:resource="#Evidence906" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMAD7 binds SERPINE1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1505">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2837">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway403">
 <bp:pathwayOrder rdf:resource="#PathwayStep3003" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3000" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3001" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3002" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2601" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2600" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2599" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2598" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence3000" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FGFR2 alternative splicing</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Alternative splicing of the FGFR2 nascent mRNA generates an epithelial specific isoform (FGFR2 IIIb) and a mesenchymal specific isoform (FGFR2 IIIc).  The inclusion of exon 8 in FGFR2 IIIb or exon 9 in FGFR2 IIIc alters the C-terminal half of the D3 loop of the receptor and is responsible for the different ligand-binding specificities of the two isoforms (reviewed in Eswarakumar et al, 2005).  In recent years, a number of cis- and trans-acting elements have been identified that regulate the alternative splicing event. Exon IIIb repression is mediated by the presence of weak splice sites flanking the exon, an exonic silencing sequence (ESS) within the IIIb exon and both intronic silencing sequences (ISS) upstream and downstream (Carstens et al, 2000; Del Gatto and Breathnach, 1995; Del Gatto et al, 1996; Wagner et al 2005; Wagner and Garcia-Blanco, 2001).  Binding of hnRNPA1, PTB1, SR family proteins and other factors to these elements represses the IIIb exon and promotes FGFR2 IIIc expression in mesenchymal cells (Del Gatto-Konczak et al, 1999; Carstens et al, 2000; Wagner et al, 2005; Wagner and Garcia-Blanco, 2001; Wagner and Garcia-Blanco, 2002).  In epithelial cells, recruitment of epithelial specific factors shifts the splicing events to favour inclusion of exon 8.  ESPN1 and ESPN2 are epithelial-specific factors that bind to an ISE/ISS-3 (intronic splicing enhancer/intronic splicing silencer-3) region within intron 8 to promote FGFR2 IIIb-specific splicing (Warzecha et al, 2009). A complex of RBFOX2, hnRNPH1 and hnRNPF also contribute to epithelial-specific splicing by competing for binding to a site that is occupied by the SR proteins ASF/SF2 in mesenchymal cells (Baraniak et al, 2006; Mauger et al, 2008).  Other proteins and sequences have also been identified that appear to contribute to the regulated expression of FGFR2b and FGFR2c, but the full details of the alternative splicing event remain to be worked out (Muh et al, 2002; Newman et al, 2006; Del Gatto et al, 2000; Hovhannisyan and Carstens, 2007).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction780">
 <bp:evidence rdf:resource="#Evidence905" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TGIF recruits HDAC1 to SMAD2/3:SMAD4 heterotrimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1506">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2836">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway402">
 <bp:pathwayOrder rdf:resource="#PathwayStep2996" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2997" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2998" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2992" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2993" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2994" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2995" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2597" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2596" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2595" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2594" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2593" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2592" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2591" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2992" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI-3K cascade:FGFR2</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The ability of growth factors to protect from apoptosis is primarily due to the activation of the AKT survival pathway. P-I-3-kinase dependent activation of PDK leads to the activation of AKT which in turn affects the activity or expression of pro-apoptotic factors, which contribute to protection from apoptosis. AKT activation also blocks the activity of GSK-3b which could lead to additional antiapoptotic signals.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1507">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2839">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1508">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2838">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1509">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction787">
 <bp:evidence rdf:resource="#Evidence912" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PPM1A dephosphorylates nuclear SMAD2/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction786">
 <bp:evidence rdf:resource="#Evidence911" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PARP1 ADP-ribosylates SMAD3 and SMAD4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction789">
 <bp:evidence rdf:resource="#Evidence914" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WWTR1:p-2S-SMAD2,3:SMAD4 binds SMAD7 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction788">
 <bp:evidence rdf:resource="#Evidence913" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PPM1A protein phosphatase binds phosphorylated SMAD2/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction783">
 <bp:evidence rdf:resource="#Evidence908" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Degradation of SMAD2/3:SMAD4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2820">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction782">
 <bp:evidence rdf:resource="#Evidence907" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMAD2/3 activation induces binding of RNF111/SMURF2 to SKI/SKIL</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction785">
 <bp:evidence rdf:resource="#Evidence910" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitination of SKI/SKIL by RNF111/SMURF2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2822">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction784">
 <bp:evidence rdf:resource="#Evidence909" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NEDD4L ubiquitinates SMAD2/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2821">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction790">
 <bp:evidence rdf:resource="#Evidence915" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dephosphorylated SMAD2/3 translocates to the cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2824">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2823">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction792">
 <bp:evidence rdf:resource="#Evidence917" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP9X (FAM) deubiquitinates SMAD4</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2826">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction791">
 <bp:evidence rdf:resource="#Evidence916" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PARP1 binds SMAD2/3:SMAD4 heterotrimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2825">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2828">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2827">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2829">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction754">
 <bp:evidence rdf:resource="#Evidence878" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMAD2/3:SMAD4:SP1 complex stimulates transcription of CDKN2B</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction753">
 <bp:evidence rdf:resource="#Evidence877" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WWTR1 binds SMAD2/3:SMAD4 heterotrimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction756">
 <bp:evidence rdf:resource="#Evidence880" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FURIN gene transcription is stimulated by SMAD2/SMAD3:SMAD4</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2851">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction755">
 <bp:evidence rdf:resource="#Evidence879" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-2S-SMAD2,3:SMAD4:SP1 binds CDKN2B gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1520">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2850">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction750">
 <bp:evidence rdf:resource="#Evidence871" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">I-Smad binds to type I receptor, preventing Smad1/5/8 from being activated</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1521">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2853">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1522">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2852">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction752">
 <bp:evidence rdf:resource="#Evidence876" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-2S-SMAD3:p-2S-SMAD3:SMAD4 forms a complex with SP1 and EP300 at the COL1A2 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1523">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2855">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction751">
 <bp:evidence rdf:resource="#Evidence875" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNF111 ubiquitinates SMAD7</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1524">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2854">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1593">
 <bp:evidence rdf:resource="#Evidence1818" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH3 gene transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1592">
 <bp:evidence rdf:resource="#Evidence1817" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH1 mRNA translation controlled by miRNAs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1591">
 <bp:evidence rdf:resource="#Evidence1816" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH2 mRNA translation controlled by miRNAs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1590">
 <bp:evidence rdf:resource="#Evidence1814" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Fucosylation of Pre-NOTCH by POFUT1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction758">
 <bp:evidence rdf:resource="#Evidence882" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">YBX1 binds COL1A2 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction757">
 <bp:evidence rdf:resource="#Evidence881" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WWTR1:p-2S-SMAD2,3:SMAD4 binds SERPINE1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction759">
 <bp:evidence rdf:resource="#Evidence883" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-2S-SMAD2,3:SMAD4:RBL1:E2F4,5:DP1,2 binds MYC gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1599">
 <bp:evidence rdf:resource="#Evidence1824" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH4 gene transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1598">
 <bp:evidence rdf:resource="#Evidence1823" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p53 positively regulates transcription of MIR34 microRNAs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1597">
 <bp:evidence rdf:resource="#Evidence1822" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH2 gene transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1596">
 <bp:evidence rdf:resource="#Evidence1821" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH4 mRNA translation controlled by miRNAs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1595">
 <bp:evidence rdf:resource="#Evidence1820" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH3 mRNA translation controlled by miRNAs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1594">
 <bp:evidence rdf:resource="#Evidence1819" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MIR34 microRNAs bind 3&apos;UTR of NOTCH1 mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1525">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2857">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1526">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2856">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1527">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2859">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1528">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2858">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1529">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction765">
 <bp:evidence rdf:resource="#Evidence889" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WWTR1:SMAD translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction764">
 <bp:evidence rdf:resource="#Evidence888" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MEN1 binds SMAD2/3:SMAD4 heterotrimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction767">
 <bp:evidence rdf:resource="#Evidence891" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">COL1A2 gene expression is stimulated by p-2S-SMAD3:p-2S-SMAD3:SMAD4</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2840">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction766">
 <bp:evidence rdf:resource="#Evidence890" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-2S-SMAD2,3:SMAD4 binds JUNB gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction761">
 <bp:evidence rdf:resource="#Evidence885" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FURIN translocates to the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1510">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2842">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction760">
 <bp:evidence rdf:resource="#Evidence884" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMAD2/3:SMAD4 heterotrimer binds SP1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1511">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2841">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction763">
 <bp:evidence rdf:resource="#Evidence887" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNF111 binds SMAD7</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1512">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2844">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction762">
 <bp:evidence rdf:resource="#Evidence886" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The SMAD2/3:SMAD4 complex transfers to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1513">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2843">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1582">
 <bp:evidence rdf:resource="#Evidence1803" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH3 binds DLL4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1581">
 <bp:evidence rdf:resource="#Evidence1802" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH3-ligand complex is cleaved to produce NEXT3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1580">
 <bp:evidence rdf:resource="#Evidence1801" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH3 binds JAG1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction769">
 <bp:evidence rdf:resource="#Evidence893" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMAD2/3:SMAD4 heterotrimer forms a complex with RBL1, E2F4/5 and DP1/2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction768">
 <bp:evidence rdf:resource="#Evidence892" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MYC trancscription is negatively regulated by SMAD2/3:SMAD4:RBL1:E2F4/5:DP1/2 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1589">
 <bp:evidence rdf:resource="#Evidence1813" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Glucosylation of Pre-NOTCH by POGLUT1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1588">
 <bp:evidence rdf:resource="#Evidence1810" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Gamma-secretase cleaves YBX1:NOTCH3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1587">
 <bp:evidence rdf:resource="#Evidence1809" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH3 binds YBX1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1586">
 <bp:evidence rdf:resource="#Evidence1807" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitination of DLL/JAG ligands upon binding to NOTCH3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1585">
 <bp:evidence rdf:resource="#Evidence1806" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH3 binds activated EGFR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1584">
 <bp:evidence rdf:resource="#Evidence1805" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EGFR phosphorylates NOTCH3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1583">
 <bp:evidence rdf:resource="#Evidence1804" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH3 binds JAG2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1514">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2846">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1515">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2845">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction770">
 <bp:evidence rdf:resource="#Evidence894" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of SMAD2 and SMAD3 linker regions by CDK8 or CDK9</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1516">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2848">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1517">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2847">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1518">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1519">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2849">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1733">
 <bp:evidence rdf:resource="#Evidence1974" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CSNK1A1 phosphorylates SMO dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1732">
 <bp:evidence rdf:resource="#Evidence1973" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMO dimer binds ARRB and KIF3A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1731">
 <bp:evidence rdf:resource="#Evidence1972" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EFCAB7:IQCE binds EVC2:EVC</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1730">
 <bp:evidence rdf:resource="#Evidence1970" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMURF1/2 dissociates from ub-PTCH1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1739">
 <bp:evidence rdf:resource="#Evidence1980" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EVC2:EVC binds p-SMO</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1738">
 <bp:evidence rdf:resource="#Evidence1979" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ADRBK1 phosphorylates SMO dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1737">
 <bp:evidence rdf:resource="#Evidence1978" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CSNK1A1 and ADRBK1 dissociate from p-SMO dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1736">
 <bp:evidence rdf:resource="#Evidence1977" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ADRBK1 binds phosphorylated SMO dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1735">
 <bp:evidence rdf:resource="#Evidence1976" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMO translocates to the cilium</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1734">
 <bp:evidence rdf:resource="#Evidence1975" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CSNK1A1 binds SMO dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction91">
 <bp:evidence rdf:resource="#Evidence105" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IP3R:I(1,4,5)P3 tetramer transports Ca2+ from ER lumen to cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction90">
 <bp:evidence rdf:resource="#Evidence103" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">THEM4 (CTMP) and/or TRIB3 inhibit AKT phosphorylation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction93">
 <bp:evidence rdf:resource="#Evidence107" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active PLCG1 hydrolyses PIP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction92">
 <bp:evidence rdf:resource="#Evidence106" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IP3 binds to the IP3 receptor, opening the endoplasmic reticulum Ca2+ channel</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction95">
 <bp:evidence rdf:resource="#Evidence111" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRK2 binds CALM1:4Ca2+</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction94">
 <bp:evidence rdf:resource="#Evidence108" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DAG stimulates protein kinase C-delta</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction97">
 <bp:evidence rdf:resource="#Evidence114" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CaMKK binds activated calmodulin in the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction96">
 <bp:evidence rdf:resource="#Evidence113" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Calmodulin-bound CaMKII-gamma enters the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1722">
 <bp:evidence rdf:resource="#Evidence1962" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ULK3 phosphorylates GLI</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1721">
 <bp:evidence rdf:resource="#Evidence1961" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">phosphorylated GLI proteins bind SPOP:CUL3:RBX1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1720">
 <bp:evidence rdf:resource="#Evidence1960" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NUMB binds ITCH</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction99">
 <bp:evidence rdf:resource="#Evidence116" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CaMKK autophosphorylates in the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction98">
 <bp:evidence rdf:resource="#Evidence115" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CaMKII autophosphorylates</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1729">
 <bp:evidence rdf:resource="#Evidence1969" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NUMB:ITCH ubiquitinates GLI1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1728">
 <bp:evidence rdf:resource="#Evidence1968" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTCH is internalized</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1727">
 <bp:evidence rdf:resource="#Evidence1967" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GLI proteins bind CDC73</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1726">
 <bp:evidence rdf:resource="#Evidence1966" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMURF1/2 bind PTCH1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1725">
 <bp:evidence rdf:resource="#Evidence1965" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GLI proteins are phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1724">
 <bp:evidence rdf:resource="#Evidence1964" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GLI proteins bind SUFU</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1723">
 <bp:evidence rdf:resource="#Evidence1963" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GLI translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction80">
 <bp:evidence rdf:resource="#Evidence91" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction82">
 <bp:evidence rdf:resource="#Evidence94" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PHLPP dephosphorylates S473 in AKT</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction81">
 <bp:evidence rdf:resource="#Evidence93" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTEN dephosphorylates PIP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction84">
 <bp:evidence rdf:resource="#Evidence97" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Inhibition of PP2A activity by phosphorylation of the catalytic subunit at tyrosine Y307</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction83">
 <bp:evidence rdf:resource="#Evidence96" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI3K phosphorylates PIP2 to PIP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction86">
 <bp:evidence rdf:resource="#Evidence99" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IER3 recruits MAPKs to PP2A-B56-beta,gamma</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction85">
 <bp:evidence rdf:resource="#Evidence98" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT1 dephosphorylation by PP2A-B56-beta,gamma</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1709">
 <bp:evidence rdf:resource="#Evidence1946" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">P4HB forms mixed disulphides with Hh precursors</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1711">
 <bp:evidence rdf:resource="#Evidence1950" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GLI proteins bind PTCH1 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1710">
 <bp:evidence rdf:resource="#Evidence1949" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GLI1 binds HHIP gene, PTCH2 gene and BOC gene promoters</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction88">
 <bp:evidence rdf:resource="#Evidence101" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKs phosphorylate PP2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1719">
 <bp:evidence rdf:resource="#Evidence1959" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GLI2,3 are degraded by the proteasome</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction87">
 <bp:evidence rdf:resource="#Evidence100" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI5P is phosphorylated to PI(4,5)P2 by PIP4K2 dimers at the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1718">
 <bp:evidence rdf:resource="#Evidence1958" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hh-Npp binds BOC:PTCH1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1717">
 <bp:evidence rdf:resource="#Evidence1957" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hh-Npp binds CDON and PTCH</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction89">
 <bp:evidence rdf:resource="#Evidence102" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI4P is phosphorylated to PI(4,5)P2 by PIP5K1A-C at the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1716">
 <bp:evidence rdf:resource="#Evidence1956" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hh-Npp binds GAS1 and PTCH</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1715">
 <bp:evidence rdf:resource="#Evidence1955" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HHIP binds Hedgehog</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1714">
 <bp:evidence rdf:resource="#Evidence1953" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMURF1/2 ubiquitinates PTCH1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1713">
 <bp:evidence rdf:resource="#Evidence1952" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GLI proteins bind GLI1 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1712">
 <bp:evidence rdf:resource="#Evidence1951" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hh-dependent expression of GLI1 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction71">
 <bp:evidence rdf:resource="#Evidence82" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT phosphorylates p21Cip1 and p27Kip1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction70">
 <bp:evidence rdf:resource="#Evidence81" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT phosphorylates BAD</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction73">
 <bp:evidence rdf:resource="#Evidence84" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT phosphorylates TSC2, inhibiting it</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction72">
 <bp:evidence rdf:resource="#Evidence83" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT phosphorylates MDM2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction75">
 <bp:evidence rdf:resource="#Evidence86" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT phosphorylates GSK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction74">
 <bp:evidence rdf:resource="#Evidence85" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT phosphorylates IKKalpha</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1700">
 <bp:evidence rdf:resource="#Evidence1937" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SYVN1 ubiquitinates Hh C-terminal fragments</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction77">
 <bp:evidence rdf:resource="#Evidence88" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TORC2 (mTOR) phosphorylates AKT at S473</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1708">
 <bp:evidence rdf:resource="#Evidence1945" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hh C-terminal fragments are degraded by the proteasome</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction76">
 <bp:evidence rdf:resource="#Evidence87" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI3K phosphorylates PIP2 to PIP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1707">
 <bp:evidence rdf:resource="#Evidence1944" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Glycosylation of Hh</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction79">
 <bp:evidence rdf:resource="#Evidence90" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PIP3 recruits AKT to the membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1706">
 <bp:evidence rdf:resource="#Evidence1943" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hh-Np traffics to the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction78">
 <bp:evidence rdf:resource="#Evidence89" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PDPK1 phosphorylates SGK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1705">
 <bp:evidence rdf:resource="#Evidence1942" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C-terminal Hh fragments are bound by lectins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1704">
 <bp:evidence rdf:resource="#Evidence1941" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Autoproteolytic cleavage of Hh precursors</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1703">
 <bp:evidence rdf:resource="#Evidence1940" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HHAT palmitoylates Hh N-terminal fragment</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1702">
 <bp:evidence rdf:resource="#Evidence1939" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C-terminal Hh fragments are recruited to SEL1:SYVN1 at the ER membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1701">
 <bp:evidence rdf:resource="#Evidence1938" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">VCP-catalyzed ATP hydrolysis promotes the translocation of Hh-C into the cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction60">
 <bp:evidence rdf:resource="#Evidence69" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PDPK1 binds PIP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction62">
 <bp:evidence rdf:resource="#Evidence72" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT can phosphorylate NR4A1 (NUR77)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction61">
 <bp:evidence rdf:resource="#Evidence71" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT can phosphorylate RSK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction64">
 <bp:evidence rdf:resource="#Evidence74" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT phosphorylates FOXO transcription factors</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction63">
 <bp:evidence rdf:resource="#Evidence73" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT phosphorylates CREB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1777">
 <bp:evidence rdf:resource="#Evidence2022" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GLI3R binds the PTCH1 promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1776">
 <bp:evidence rdf:resource="#Evidence2021" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKA phosphorylates GLI1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1775">
 <bp:evidence rdf:resource="#Evidence2020" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF(beta-TrCP) ubiquitinates p-GLI1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1774">
 <bp:evidence rdf:resource="#Evidence2019" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GLI1 is degraded by the proteasome after ubiquitination by beta-TrCP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1773">
 <bp:evidence rdf:resource="#Evidence2018" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NUMB:ITCH bind and ubiquitnate GLI1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1772">
 <bp:evidence rdf:resource="#Evidence2017" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NUMB binds ITCH</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1771">
 <bp:evidence rdf:resource="#Evidence2016" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GLI1 is degraded by the proteasome after ubiquitination by ITCH</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1770">
 <bp:evidence rdf:resource="#Evidence2014" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GLI2 is degraded by the proteasome</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction66">
 <bp:evidence rdf:resource="#Evidence76" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC1,RAC2,RHOG activate PI3K</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction65">
 <bp:evidence rdf:resource="#Evidence75" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PIP3 recruits PDPK1 to the membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction68">
 <bp:evidence rdf:resource="#Evidence79" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT phosphorylates MKRN1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction67">
 <bp:evidence rdf:resource="#Evidence78" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT phosphorylates caspase-9</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction69">
 <bp:evidence rdf:resource="#Evidence80" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT phosphorylates AKT1S1 (PRAS40)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1779">
 <bp:evidence rdf:resource="#Evidence2027" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The p75NTR C-terminal fragment enters endosomes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1778">
 <bp:evidence rdf:resource="#Evidence2023" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">cAMP dissociates PKA, promoting GLI processing</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction51">
 <bp:evidence rdf:resource="#Evidence60" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MKRN1 polyubiquitinates PTEN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction50">
 <bp:evidence rdf:resource="#Evidence59" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRIM27 binds PTEN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction53">
 <bp:evidence rdf:resource="#Evidence62" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNF146 polyubiquitinates PARylated PTEN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction52">
 <bp:evidence rdf:resource="#Evidence61" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FRK phosphorylates PTEN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1766">
 <bp:evidence rdf:resource="#Evidence2010" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GSK3 phosphorylates p-GLI2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1765">
 <bp:evidence rdf:resource="#Evidence2008" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of PTCH1 is repressed by GLI3R in the absence of Hh signaling</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1764">
 <bp:evidence rdf:resource="#Evidence2007" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TULP3 is required for GPR161 localization in the cilium</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1763">
 <bp:evidence rdf:resource="#Evidence2006" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of GLI2 is repressed by GLI3R in the absence of Hh signaling</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1762">
 <bp:evidence rdf:resource="#Evidence2005" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of GLI1 is repressed by GLI3R in the absence of Hh signaling</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1761">
 <bp:evidence rdf:resource="#Evidence2004" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GPR161 promotes cAMP production in a G alpha(s)-dependent manner</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1760">
 <bp:evidence rdf:resource="#Evidence2003" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The IFT-A complex recruits TULP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction55">
 <bp:evidence rdf:resource="#Evidence64" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTEN binds FRK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction54">
 <bp:evidence rdf:resource="#Evidence63" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TNKS and TNKS2 PARylate PTEN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction57">
 <bp:evidence rdf:resource="#Evidence66" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRIM27 polyubiquitinates PTEN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction56">
 <bp:evidence rdf:resource="#Evidence65" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Casein kinase II phosphorylates PTEN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction59">
 <bp:evidence rdf:resource="#Evidence68" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT binds PDPK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction58">
 <bp:evidence rdf:resource="#Evidence67" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP13 and OTUD3 deubiquitinate PTEN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1769">
 <bp:evidence rdf:resource="#Evidence2013" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKA phosphorylates GLI2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1768">
 <bp:evidence rdf:resource="#Evidence2012" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CK1 phosphorylates p-GLI2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1767">
 <bp:evidence rdf:resource="#Evidence2011" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF(beta-TrCP) ubiquitinates p-GLI2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction40">
 <bp:evidence rdf:resource="#Evidence48" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SALL4 recruits NuRD to PTEN gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction42">
 <bp:evidence rdf:resource="#Evidence50" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">mTORC1 phosphorylates MAF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction41">
 <bp:evidence rdf:resource="#Evidence49" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAF1 binds the PTEN gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1755">
 <bp:evidence rdf:resource="#Evidence1998" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF(beta-TrCP) ubiquitinates p-GLI3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1754">
 <bp:evidence rdf:resource="#Evidence1996" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GLI3R translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1753">
 <bp:evidence rdf:resource="#Evidence1995" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GLI3R binds the GLI1 promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1752">
 <bp:evidence rdf:resource="#Evidence1994" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GLI proteins bind SUFU</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1751">
 <bp:evidence rdf:resource="#Evidence1993" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GLI3R binds the GLI2 promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1750">
 <bp:evidence rdf:resource="#Evidence1992" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KIF7 is recruited to the ciliary tip through interaction with axonemal microtubules</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction44">
 <bp:evidence rdf:resource="#Evidence52" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SALL4 binds the PTEN gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction43">
 <bp:evidence rdf:resource="#Evidence51" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SNAI1,SNAI2 bind the PTEN gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction46">
 <bp:evidence rdf:resource="#Evidence55" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT phosphorylates MKRN1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction45">
 <bp:evidence rdf:resource="#Evidence53" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the PTEN promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction48">
 <bp:evidence rdf:resource="#Evidence57" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Proteasome degrades polyubiquitinated PTEN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1759">
 <bp:evidence rdf:resource="#Evidence2002" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKA phosphorylates GLI3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction47">
 <bp:evidence rdf:resource="#Evidence56" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NEDD4, WWP2, CHIP and XIAP polyubiquitinate PTEN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1758">
 <bp:evidence rdf:resource="#Evidence2001" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CK1 phosphorylates p-GLI3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1757">
 <bp:evidence rdf:resource="#Evidence2000" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GLI3 is partially degraded by the proteasome to yield the GLI3 repressor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction49">
 <bp:evidence rdf:resource="#Evidence58" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PREX2 binds PTEN and inhibits it</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1756">
 <bp:evidence rdf:resource="#Evidence1999" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GSK3 phosphorylates p-GLI3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction31">
 <bp:evidence rdf:resource="#Evidence39" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTEN gene transcription is stimulated by TP53, EGR1, PPARG, ATF2, MAF1, and inhibited by NR2E1, SALL4, MECOM, SNAI1, SNAI2, JUN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction30">
 <bp:evidence rdf:resource="#Evidence37" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Deubiquitinated PTEN translocates to the cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1744">
 <bp:evidence rdf:resource="#Evidence1985" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SPOP:CUL3:RBX1 ubiquitinates GLI2,3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1743">
 <bp:evidence rdf:resource="#Evidence1984" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GLI:SUFU dissociates</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1742">
 <bp:evidence rdf:resource="#Evidence1983" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ub-GLI is degraded by the proteasome</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1741">
 <bp:evidence rdf:resource="#Evidence1982" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ULK3:SUFU dissociates</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1740">
 <bp:evidence rdf:resource="#Evidence1981" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GPR161 is internalized</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction33">
 <bp:evidence rdf:resource="#Evidence41" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAF1 translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction32">
 <bp:evidence rdf:resource="#Evidence40" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECOM (EVI1) recruits polycomb repressor complexes (PRCs) to the PTEN gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction35">
 <bp:evidence rdf:resource="#Evidence43" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-T69,T71-ATF2 binds PTEN gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction34">
 <bp:evidence rdf:resource="#Evidence42" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NR2E1 associated with transcription repressors binds PTEN promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1749">
 <bp:evidence rdf:resource="#Evidence1991" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The intraflagellar transport B (IFT-B) complex is required for the transit of GLI:SUFU complexes to the ciliary tip</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction37">
 <bp:evidence rdf:resource="#Evidence45" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JUN binds the PTEN gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1748">
 <bp:evidence rdf:resource="#Evidence1990" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The intraflagellar transport A (IFT-A) complex is required for the transit of GLI:SUFU complexes to the ciliary base</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction36">
 <bp:evidence rdf:resource="#Evidence44" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EGR1 binds the PTEN gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1747">
 <bp:evidence rdf:resource="#Evidence1989" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTCH1 inhibits accumulation of SMO in the primary cilium in the absence of Hh signal</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction39">
 <bp:evidence rdf:resource="#Evidence47" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECOM (EVI1) binds the PTEN gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1746">
 <bp:evidence rdf:resource="#Evidence1987" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NUMB:ITCH binds GLI1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction38">
 <bp:evidence rdf:resource="#Evidence46" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated PPARG binds PTEN gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1745">
 <bp:evidence rdf:resource="#Evidence1986" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GLI:SUFU translocates to the ciliary tip in response to Hh signaling</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction20">
 <bp:evidence rdf:resource="#Evidence26" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-17 microRNA binds PTEN mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction29">
 <bp:evidence rdf:resource="#Evidence36" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTEN undergoes monoubiquitination</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction22">
 <bp:evidence rdf:resource="#Evidence28" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-20 microRNAs bind PTEN mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction21">
 <bp:evidence rdf:resource="#Evidence27" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-21 nonendonucleolytic RISC binds PTEN mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction24">
 <bp:evidence rdf:resource="#Evidence30" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-26A microRNAs bind PTEN mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction23">
 <bp:evidence rdf:resource="#Evidence29" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-205 microRNA binds PTEN mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction26">
 <bp:evidence rdf:resource="#Evidence32" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-19a microRNA binds PTEN mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction25">
 <bp:evidence rdf:resource="#Evidence31" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-214 microRNA binds PTEN mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction28">
 <bp:evidence rdf:resource="#Evidence35" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Monoubiquitinated PTEN translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction27">
 <bp:evidence rdf:resource="#Evidence34" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP7 deubiquitinates monoubiquitinated PTEN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction19">
 <bp:evidence rdf:resource="#Evidence25" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-106 microRNAs bind PTEN mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction18">
 <bp:evidence rdf:resource="#Evidence24" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-19b microRNA binds PTEN mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction11">
 <bp:evidence rdf:resource="#Evidence17" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-20 microRNAs bind VAPA mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction10">
 <bp:evidence rdf:resource="#Evidence16" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-20 microRNAs bind CNOT6L mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction13">
 <bp:evidence rdf:resource="#Evidence19" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-106a,(miR106b) microRNA binds CNOT6L mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction12">
 <bp:evidence rdf:resource="#Evidence18" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTENP1 mRNA binds miR-19b RISC</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction15">
 <bp:evidence rdf:resource="#Evidence21" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTENP1 mRNA binds miR-20 RISC</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction14">
 <bp:evidence rdf:resource="#Evidence20" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-19a microRNA binds CNOT6L mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction17">
 <bp:evidence rdf:resource="#Evidence23" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-25 microRNA binds PTEN mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction16">
 <bp:evidence rdf:resource="#Evidence22" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-22 microRNA binds PTEN mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1495">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1496">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1497">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1498">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1499">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2006">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1764" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2007">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1765" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2008">
 <bp:stepProcess rdf:resource="#Pathway244" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2009">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1766" />
 <bp:stepProcess rdf:resource="#Catalysis507" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2002">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1760" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2003">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1761" />
 <bp:stepProcess rdf:resource="#Catalysis506" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2004">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1762" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1490">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2005">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1763" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1491">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1492">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1493">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2000">
 <bp:stepProcess rdf:resource="#Catalysis504" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1758" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1494">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2001">
 <bp:stepProcess rdf:resource="#Catalysis505" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1759" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1462">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2794">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1463">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2793">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1464">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2796">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1465">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2795">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1466">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2798">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1467">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2797">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1468">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1469">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2799">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2790">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1460">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2792">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1461">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2791">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1451">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2783">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1452">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2782">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1453">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2785">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1454">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2784">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1455">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2787">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1456">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2786">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1457">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2789">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1458">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2788">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2781">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1450">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2780">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1459">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1484">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1485">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1486">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1487">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1488">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1489">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1480">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1481">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1482">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1483">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1473">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1474">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1475">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1476">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1477">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1478">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1479">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1470">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1471">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1472">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2750">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1420">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2752">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1421">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2751">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1422">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2754">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1423">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2753">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1424">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2756">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1425">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2755">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1692">
 <bp:evidence rdf:resource="#Evidence1926" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH1 binds DLK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2079">
 <bp:stepProcess rdf:resource="#Pathway260" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1691">
 <bp:evidence rdf:resource="#Evidence1925" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH1 binds DLL1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1690">
 <bp:evidence rdf:resource="#Evidence1924" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ITCH ubiquitinates DTX</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2075">
 <bp:stepProcess rdf:resource="#Pathway258" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2076">
 <bp:stepProcess rdf:resource="#Pathway259" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2077">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1819" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2078">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1820" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2082">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1823" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1699">
 <bp:evidence rdf:resource="#Evidence1936" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hh-Np binds SCUBE2 in the extracellular region to promote long-range signalling</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2083">
 <bp:stepProcess rdf:resource="#Catalysis530" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1824" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1698">
 <bp:evidence rdf:resource="#Evidence1935" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hh-Np binds to DISP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2084">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1825" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1697">
 <bp:evidence rdf:resource="#Evidence1934" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTUM releases Hh-Np:GPC5 from the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2085">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1826" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1696">
 <bp:evidence rdf:resource="#Evidence1933" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hh-Np is cleaved by ADAM17 to promote ligand shedding</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1695">
 <bp:evidence rdf:resource="#Evidence1932" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hh-Np binds GPC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1694">
 <bp:evidence rdf:resource="#Evidence1928" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitination of NOTCH1 by ITCH in the absence of ligand</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2080">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1821" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1693">
 <bp:evidence rdf:resource="#Evidence1927" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH1 associates with negative regulators NUMB and ITCH</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2081">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1822" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1426">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2758">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1427">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2757">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1428">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1429">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2759">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2741">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1410">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2740">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1411">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2743">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1412">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2742">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1413">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2745">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1414">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2744">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1681">
 <bp:evidence rdf:resource="#Evidence1915" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cleavage of DNER:NOTCH1 complex releases NICD1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1680">
 <bp:evidence rdf:resource="#Evidence1914" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NEXT1 is cleaved to produce NICD1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2086">
 <bp:stepProcess rdf:resource="#Pathway261" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2087">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1827" />
 <bp:stepProcess rdf:resource="#Catalysis531" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2088">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1828" />
 <bp:stepProcess rdf:resource="#Catalysis532" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2089">
 <bp:stepProcess rdf:resource="#Pathway262" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1689">
 <bp:evidence rdf:resource="#Evidence1923" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH1 binds DLL4</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2093">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1832" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1688">
 <bp:evidence rdf:resource="#Evidence1922" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH1 binds DLL/JAG ligand in cis</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2094">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1833" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1687">
 <bp:evidence rdf:resource="#Evidence1921" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitination of DLL/JAG ligands upon binding to NOTCH1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2095">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1834" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1686">
 <bp:evidence rdf:resource="#Evidence1920" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH1 binds JAG1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2096">
 <bp:stepProcess rdf:resource="#Pathway263" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1685">
 <bp:evidence rdf:resource="#Evidence1919" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH1 binds DNER</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1684">
 <bp:evidence rdf:resource="#Evidence1918" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cleavage of CNTN1:NOTCH1 complex releases NICD1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2090">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1829" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1683">
 <bp:evidence rdf:resource="#Evidence1917" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH1 binds JAG2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2091">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1830" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1682">
 <bp:evidence rdf:resource="#Evidence1916" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Contactin-1 (CNTN1) binds NOTCH1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2092">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1831" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1415">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2747">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1416">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2746">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1417">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2749">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1418">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2748">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1419">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1440">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2772">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1441">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2771">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1442">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2774">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1443">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2773">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1444">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2776">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1445">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2775">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1446">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2778">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1447">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2777">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1670">
 <bp:evidence rdf:resource="#Evidence1903" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated NICD1 binds FBXW7</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2057">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1803" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2058">
 <bp:stepProcess rdf:resource="#Catalysis524" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1804" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2059">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1805" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2053">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1800" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2054">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1801" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2055">
 <bp:stepProcess rdf:resource="#Pathway255" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2770">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2056">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1802" />
 <bp:stepProcess rdf:resource="#Catalysis523" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1678">
 <bp:evidence rdf:resource="#Evidence1912" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DTX recruits beta-arrestin (ARRB) to NOTCH</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2060">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1806" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1677">
 <bp:evidence rdf:resource="#Evidence1911" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DTX binds NOTCH1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2061">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1807" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1676">
 <bp:evidence rdf:resource="#Evidence1910" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NICD1 traffics to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2062">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1808" />
 <bp:stepProcess rdf:resource="#Catalysis525" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1675">
 <bp:evidence rdf:resource="#Evidence1909" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ITCH binds DTX</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2063">
 <bp:stepProcess rdf:resource="#Pathway256" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1674">
 <bp:evidence rdf:resource="#Evidence1908" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Complex of NOTCH1 with its ligand is cleaved to produce NEXT1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1673">
 <bp:evidence rdf:resource="#Evidence1906" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH1 stimulates HEY transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1672">
 <bp:evidence rdf:resource="#Evidence1905" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH1 Coactivator Complex binds promoters of HEY genes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1671">
 <bp:evidence rdf:resource="#Evidence1904" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH1 stimulates MYC transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1448">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1449">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2779">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1679">
 <bp:evidence rdf:resource="#Evidence1913" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ARRB mediates NOTCH1 ubiquitination</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2761">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1430">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2760">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1431">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2763">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1432">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2762">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1433">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2765">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1434">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2764">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1435">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2767">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1436">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2766">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2068">
 <bp:stepProcess rdf:resource="#Catalysis528" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1813" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2069">
 <bp:stepProcess rdf:resource="#Catalysis529" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1814" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2064">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1809" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2065">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1810" />
 <bp:stepProcess rdf:resource="#Catalysis526" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2066">
 <bp:stepProcess rdf:resource="#Catalysis527" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1811" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2067">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1812" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1667">
 <bp:evidence rdf:resource="#Evidence1900" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HES1 binds TLE</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2071">
 <bp:stepProcess rdf:resource="#Pathway257" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1666">
 <bp:evidence rdf:resource="#Evidence1899" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NICD1 displaces co-repressor complex from RBPJ (CSL)</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2072">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1816" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1665">
 <bp:evidence rdf:resource="#Evidence1898" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH1 Coactivator Complex binds HES5 promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2073">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1817" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1664">
 <bp:evidence rdf:resource="#Evidence1897" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH1 Coactivator Complex binds HES1 promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2074">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1818" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1663">
 <bp:evidence rdf:resource="#Evidence1896" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NICD1 in complex with RBPJ (CSL) recruits MAML</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1662">
 <bp:evidence rdf:resource="#Evidence1895" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAML in complex with NICD1 recruits CDK8</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1661">
 <bp:evidence rdf:resource="#Evidence1894" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitination of NICD1 by FBWX7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1660">
 <bp:evidence rdf:resource="#Evidence1893" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NICD1 binds HIF1A</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2070">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1815" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1437">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2769">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1438">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2768">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1439">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1669">
 <bp:evidence rdf:resource="#Evidence1902" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NBEA binds NICD1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1668">
 <bp:evidence rdf:resource="#Evidence1901" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NICD1 is phosphorylated by CDK8</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2039">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1789" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2710">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2712">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2711">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2035">
 <bp:stepProcess rdf:resource="#Pathway251" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2036">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1786" />
 <bp:stepProcess rdf:resource="#Catalysis519" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2037">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1787" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2038">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1788" />
 <bp:stepProcess rdf:resource="#Catalysis520" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2031">
 <bp:stepProcess rdf:resource="#Pathway249" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2032">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1784" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2033">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1785" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2034">
 <bp:stepProcess rdf:resource="#Pathway250" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2040">
 <bp:stepProcess rdf:resource="#Pathway252" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2041">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1790" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2714">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2713">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2716">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2715">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2718">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2717">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2719">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2701">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2700">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2046">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1795" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2047">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1796" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2048">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1797" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2049">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1798" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2042">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1791" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2043">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1792" />
 <bp:stepProcess rdf:resource="#Catalysis521" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2044">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1793" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2045">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1794" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2050">
 <bp:stepProcess rdf:resource="#Pathway253" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2051">
 <bp:stepProcess rdf:resource="#Pathway254" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2052">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1799" />
 <bp:stepProcess rdf:resource="#Catalysis522" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2703">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2702">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2705">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2704">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2707">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2706">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2709">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2708">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2730">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1400">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2017">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1773" />
 <bp:stepProcess rdf:resource="#Catalysis513" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2732">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1401">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2018">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1774" />
 <bp:stepProcess rdf:resource="#Catalysis514" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2731">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1402">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2019">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1775" />
 <bp:stepProcess rdf:resource="#Catalysis515" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2734">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1403">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2733">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2013">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1770" />
 <bp:stepProcess rdf:resource="#Catalysis511" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2014">
 <bp:stepProcess rdf:resource="#Pathway245" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2015">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1771" />
 <bp:stepProcess rdf:resource="#Catalysis512" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2016">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1772" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2010">
 <bp:stepProcess rdf:resource="#Catalysis508" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1767" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2011">
 <bp:stepProcess rdf:resource="#Catalysis509" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1768" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2012">
 <bp:stepProcess rdf:resource="#Catalysis510" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1769" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1404">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2736">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1405">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2735">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1406">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2738">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1407">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2737">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1408">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1409">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2739">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2028">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1781" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2721">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2029">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1782" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2720">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2723">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2722">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2024">
 <bp:stepProcess rdf:resource="#Pathway247" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2025">
 <bp:stepProcess rdf:resource="#Pathway248" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2026">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1779" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2027">
 <bp:stepProcess rdf:resource="#Catalysis517" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1780" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2020">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1776" />
 <bp:stepProcess rdf:resource="#Catalysis516" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2021">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1777" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2022">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1778" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2023">
 <bp:stepProcess rdf:resource="#Pathway246" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2030">
 <bp:stepProcess rdf:resource="#Catalysis518" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1783" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2725">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2724">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2727">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2726">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2729">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2728">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1854">
 <bp:evidence rdf:resource="#Evidence2118" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHUK, IKBKB phosphorylate CYLD at S418</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1853">
 <bp:evidence rdf:resource="#Evidence2117" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TBK1, IKBKE binds Met1-polyUb within the TNFR1 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1852">
 <bp:evidence rdf:resource="#Evidence2116" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RIPK1 is cleaved by CASP8</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1851">
 <bp:evidence rdf:resource="#Evidence2115" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FLIP(L) and procaspase-8 form heterodimer in TNF signaling</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1850">
 <bp:evidence rdf:resource="#Evidence2114" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LUBAC ubiquitinates CFLAR at K351, K353</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1859">
 <bp:evidence rdf:resource="#Evidence2123" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MIB2 binds CFLAR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1858">
 <bp:evidence rdf:resource="#Evidence2122" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TNF-&#945;:TNFR1 binds DENN/MADD</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1857">
 <bp:evidence rdf:resource="#Evidence2121" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LUBAC binds OTULIN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1856">
 <bp:evidence rdf:resource="#Evidence2120" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LUBAC ubiquitinates RIPK1 at K627</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1855">
 <bp:evidence rdf:resource="#Evidence2119" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKAPK2 phosphorylates RIPK1 at S320</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction905">
 <bp:evidence rdf:resource="#Evidence1047" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CaMK4 phosphorylates CREB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction904">
 <bp:evidence rdf:resource="#Evidence1046" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CAMK4 autophosphorylates</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction907">
 <bp:evidence rdf:resource="#Evidence1049" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CaMKK phosphorylates CAMK4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction906">
 <bp:evidence rdf:resource="#Evidence1048" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Calmodulin binds CAMK4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction901">
 <bp:evidence rdf:resource="#Evidence1043" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CaMKK autophosphorylates in the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction900">
 <bp:evidence rdf:resource="#Evidence1042" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CaMKII autophosphorylates</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction903">
 <bp:evidence rdf:resource="#Evidence1045" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerization of p-S133-CREB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction902">
 <bp:evidence rdf:resource="#Evidence1044" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CAMK4 enters the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1843">
 <bp:evidence rdf:resource="#Evidence2107" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GNB2L1 binds IKKA:IKKB:NEMO</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1842">
 <bp:evidence rdf:resource="#Evidence2106" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MIB2 ubiquitinates CYLD at K338, K530</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1841">
 <bp:evidence rdf:resource="#Evidence2105" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SPATA2 links CYLD to LUBAC</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1840">
 <bp:evidence rdf:resource="#Evidence2104" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">OPTN binds polyUb-RIPK1 within the TNFR1 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction909">
 <bp:evidence rdf:resource="#Evidence1051" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CaMKII binds activated calmodulin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction908">
 <bp:evidence rdf:resource="#Evidence1050" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CAMK4 binds KPNA2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1849">
 <bp:evidence rdf:resource="#Evidence2113" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Viral inhibitor of caspase-8 activation (UL36) binds caspase-8</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1848">
 <bp:evidence rdf:resource="#Evidence2112" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CYLD:SPATA2:LUBAC binds TNFR1 signaling complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1847">
 <bp:evidence rdf:resource="#Evidence2111" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LUBAC binds CFLAR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1846">
 <bp:evidence rdf:resource="#Evidence2110" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CYLD hydrolyses M1polyUb on RIPK1 within the TNFR1 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1845">
 <bp:evidence rdf:resource="#Evidence2109" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MIB2 ubiquitinates CFLAR </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1844">
 <bp:evidence rdf:resource="#Evidence2108" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SPATA2:CYLD-bound LUBAC ubiquitinates RIPK1 at K627 within the TNFR1 signaling complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Provenance rdf:ID="Provenance1">
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Reactome</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.reactome.org</bp:comment>
</bp:Provenance>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1832">
 <bp:evidence rdf:resource="#Evidence2094" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAIL:TRAIL-Receptor2 Trimer:FADD complex binds procaspase-10</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1831">
 <bp:evidence rdf:resource="#Evidence2093" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAIL binds TRAIL receptors</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1830">
 <bp:evidence rdf:resource="#Evidence2092" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAIL receptor-4 binds TRAIL receptor-1 or TRAIL receptor-2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1839">
 <bp:evidence rdf:resource="#Evidence2103" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RIPK1 binds STUB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1838">
 <bp:evidence rdf:resource="#Evidence2102" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RIPK1 is cleaved by CASP8:FLIP(L)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1837">
 <bp:evidence rdf:resource="#Evidence2101" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">K63polyUb-RIPK1 is deubiquitinated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1836">
 <bp:evidence rdf:resource="#Evidence2100" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MIB2 binds CYLD</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1835">
 <bp:evidence rdf:resource="#Evidence2099" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Caspase-8 and FLIP(L) processing at TNFR signaling complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1834">
 <bp:evidence rdf:resource="#Evidence2096" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Trimerization of TRAIL:TRAIL receptor complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1833">
 <bp:evidence rdf:resource="#Evidence2095" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAIL:TRAIL receptor trimers bind FADD</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1819">
 <bp:evidence rdf:resource="#Evidence2078" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NGF binding to p75NTR inactivates RHOA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1821">
 <bp:evidence rdf:resource="#Evidence2081" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p75NTR:NgR complex interacts with the axonal inhibitor LINGO1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1820">
 <bp:evidence rdf:resource="#Evidence2079" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p75NTR and RHOA-GDI interact</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1829">
 <bp:evidence rdf:resource="#Evidence2091" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAIL:TRAIL Receptor Trimer:FADD complex binds procaspase-8</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1828">
 <bp:evidence rdf:resource="#Evidence2089" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Production of ceramide which can activate JNK and other targets</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1827">
 <bp:evidence rdf:resource="#Evidence2088" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Sphingomyelinase is activated by the NGF:p75NTR complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1826">
 <bp:evidence rdf:resource="#Evidence2086" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The p75NTR:NgR:MDGI binds RHOA-GDI</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1825">
 <bp:evidence rdf:resource="#Evidence2085" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The p75NTR:NgR:MDGI complex reduces RHOA-GDI activity, displacing RHOA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1824">
 <bp:evidence rdf:resource="#Evidence2084" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RhoA is activated by nucleotide exchange and inhibits axonal growth</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1823">
 <bp:evidence rdf:resource="#Evidence2083" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Myelin components can interact with p75NTR:NgR:LINGO1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1822">
 <bp:evidence rdf:resource="#Evidence2082" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p75NTR interacts with the NOGO receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction930">
 <bp:evidence rdf:resource="#Evidence1077" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The G alpha-olf:GDP:Adenylate cyclase complex dissociates</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction932">
 <bp:evidence rdf:resource="#Evidence1079" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Galpha-olf:GTP binds to adenylate cyclase and activates it</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction931">
 <bp:evidence rdf:resource="#Evidence1078" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Adenylate cyclase converts ATP into cyclic AMP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction938">
 <bp:evidence rdf:resource="#Evidence1085" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G alpha (i):RGS dissociates to inactive G alpha (i)&#8211;i1/i2/i3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1890">
 <bp:evidence rdf:resource="#Evidence2157" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRADD:TRAF2:RIP1:FADD binds pro-caspase 8  </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction937">
 <bp:evidence rdf:resource="#Evidence1084" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Opsins act as GEFs for G alpha-t</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction939">
 <bp:evidence rdf:resource="#Evidence1086" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G-alpha(t):G-beta-gamma:Opsins complex dissociates to active G-alpha(t)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction934">
 <bp:evidence rdf:resource="#Evidence1081" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G alpha (i)&#8211;i1/i2/i3 in G (i):RGS complex is inactivated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction933">
 <bp:evidence rdf:resource="#Evidence1080" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Opioid dissociates from MOR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction936">
 <bp:evidence rdf:resource="#Evidence1083" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Inactive G alpha (i) reassociates with G beta:gamma</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction935">
 <bp:evidence rdf:resource="#Evidence1082" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G alpha (i) auto-inactivates by hydrolysing GTP to GDP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1898">
 <bp:evidence rdf:resource="#Evidence2168" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRB2 is indirectly recruited to p-KIT through SHP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1897">
 <bp:evidence rdf:resource="#Evidence2165" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FasL:Fas binds FADD</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1896">
 <bp:evidence rdf:resource="#Evidence2164" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FASL:FAS Receptor Trimer:FADD complex binds pro-Caspase-8</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1895">
 <bp:evidence rdf:resource="#Evidence2163" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Trimerization of the FASL:FAS receptor complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1894">
 <bp:evidence rdf:resource="#Evidence2162" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FASL:FAS Receptor Trimer:FADD complex binds procaspase-10</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1893">
 <bp:evidence rdf:resource="#Evidence2161" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FASL binds FAS Receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1892">
 <bp:evidence rdf:resource="#Evidence2159" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Membrane-anchored TNF-&#945; binds TNFR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1891">
 <bp:evidence rdf:resource="#Evidence2158" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRADD:TRAF2:RIP1 binds FADD</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1899">
 <bp:evidence rdf:resource="#Evidence2170" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of CBL to KIT</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction941">
 <bp:evidence rdf:resource="#Evidence1088" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Liganded Gi-activating GPCRs bind inactive heterotrimeric G-protein Gi</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction940">
 <bp:evidence rdf:resource="#Evidence1087" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G protein alpha (i)-SRC complex catalyzes SRC to p-Y419-SRC</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction943">
 <bp:evidence rdf:resource="#Evidence1091" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The Ligand:GPCR:G12/13 complex dissociates</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction942">
 <bp:evidence rdf:resource="#Evidence1089" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G alpha (i):GTP binds SRC</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction949">
 <bp:evidence rdf:resource="#Evidence1097" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LARG binds plexin B1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction948">
 <bp:evidence rdf:resource="#Evidence1096" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ROCK activation by RHO</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction945">
 <bp:evidence rdf:resource="#Evidence1093" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ROCK1,2 bind ROCKi</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction944">
 <bp:evidence rdf:resource="#Evidence1092" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G alpha (12)-BTK complex dissociates to Active BTK and G alpha (12)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction947">
 <bp:evidence rdf:resource="#Evidence1095" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LARG activation by G alpha 12/13</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction946">
 <bp:evidence rdf:resource="#Evidence1094" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G alpha (12/13) auto-inactivates by hydrolysing GTP to GDP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1887">
 <bp:evidence rdf:resource="#Evidence2153" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Soluble TNF-&#945; binds TNFR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1886">
 <bp:evidence rdf:resource="#Evidence2152" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TNF-&#945; is cleaved by ADAM17 (TACE)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1885">
 <bp:evidence rdf:resource="#Evidence2151" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TNF:TNFR1 binds TRADD, TRAF2 and RIPK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1884">
 <bp:evidence rdf:resource="#Evidence2150" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TNF-alpha inhibitors bind to soluble TNF trimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1883">
 <bp:evidence rdf:resource="#Evidence2149" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TNF-&#945;:TNFR1:NSMAF:GNB2L1 associates with SMPD2,3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1882">
 <bp:evidence rdf:resource="#Evidence2148" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TNF-&#945;:TNFR1:NSMAF binds GNB2L1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1881">
 <bp:evidence rdf:resource="#Evidence2147" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TNF-&#945;:TNFR1 binds NSMAF</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1880">
 <bp:evidence rdf:resource="#Evidence2145" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TNF:TNFR1:TRADD:TRAF2:RIPK1 binds LUBAC</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1889">
 <bp:evidence rdf:resource="#Evidence2156" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRADD:TRAF2:RIP1 dissociates from TNF-&#945;:TNFR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1888">
 <bp:evidence rdf:resource="#Evidence2154" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TNF-alpha inhibitors bind to TNF(1-233) trimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction910">
 <bp:evidence rdf:resource="#Evidence1052" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated calmodulin dissociates from CaMKII-gamma</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction916">
 <bp:evidence rdf:resource="#Evidence1060" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">cAMP induces dissociation of inactive PKA tetramers</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction915">
 <bp:evidence rdf:resource="#Evidence1059" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">cAMP binds PKA tetramer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction918">
 <bp:evidence rdf:resource="#Evidence1063" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Calmodulin activates Cam-PDE 1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction917">
 <bp:evidence rdf:resource="#Evidence1061" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKA catalytic subunit translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction912">
 <bp:evidence rdf:resource="#Evidence1055" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerization of p-S133-CREB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction911">
 <bp:evidence rdf:resource="#Evidence1054" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKA phosphorylates CREB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction914">
 <bp:evidence rdf:resource="#Evidence1058" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Adenylate cyclase produces cAMP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction913">
 <bp:evidence rdf:resource="#Evidence1057" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NBEA binds PRKAR2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1876">
 <bp:evidence rdf:resource="#Evidence2141" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BIRC(cIAP1/2) ubiquitinates RIPK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1875">
 <bp:evidence rdf:resource="#Evidence2139" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">OPTN recruits CYLD to the TNFR1 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1874">
 <bp:evidence rdf:resource="#Evidence2138" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SPPL2a/b cleaves TNF(1-76)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1873">
 <bp:evidence rdf:resource="#Evidence2137" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CLIP3 and CYLD bind TNF signaling complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1872">
 <bp:evidence rdf:resource="#Evidence2136" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF1 binds TRAF2 within TNFR1 signaling complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction919">
 <bp:evidence rdf:resource="#Evidence1064" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">cAMP hydrolysis by Cam-PDE 1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1871">
 <bp:evidence rdf:resource="#Evidence2135" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ULK1 phosphorylates RIPK1 at S357</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1870">
 <bp:evidence rdf:resource="#Evidence2134" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STUB1 ubiquitinates RIPK1 at K571, K604, K627</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1879">
 <bp:evidence rdf:resource="#Evidence2144" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TNF:TNFR1:TRADD:TRAF2:K63polyUb-RIPK1:BIRC2,3:LUBAC recruits IKKA:IKBKB:IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1878">
 <bp:evidence rdf:resource="#Evidence2143" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TNF:TNFR1:TRADD:TRAF2:RIPK1 recruits BIRC2/3 (cIAP1/2)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1877">
 <bp:evidence rdf:resource="#Evidence2142" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TNF:TNFR1:TRADD:TRAF2:K63polyUb-RIPK1:BIRC2/3:LUBAC recruits TAK1 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction921">
 <bp:evidence rdf:resource="#Evidence1066" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Calcium binds calmodulin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction920">
 <bp:evidence rdf:resource="#Evidence1065" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKC phosphorylates GRK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction927">
 <bp:evidence rdf:resource="#Evidence1073" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IP3 binds to the IP3 receptor, opening the endoplasmic reticulum Ca2+ channel</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction926">
 <bp:evidence rdf:resource="#Evidence1072" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Inactivation of PLC beta</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction929">
 <bp:evidence rdf:resource="#Evidence1076" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Adenylaye cyclase increases the GTPase activity of G alpha-olf</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction928">
 <bp:evidence rdf:resource="#Evidence1074" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IP3R:I(1,4,5)P3 tetramer transports Ca2+ from ER lumen to cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction923">
 <bp:evidence rdf:resource="#Evidence1069" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PLA2G4A (cPLA2) hydrolyzes phosphatidylcholine</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction922">
 <bp:evidence rdf:resource="#Evidence1068" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of cPLA2 by ERK-2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction925">
 <bp:evidence rdf:resource="#Evidence1071" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PIP2 hydrolysis</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction924">
 <bp:evidence rdf:resource="#Evidence1070" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phospho-cPLA2 translocates to membranes when intracellular calcium levels increase</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1865">
 <bp:evidence rdf:resource="#Evidence2129" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TAX1BP1:TNFAIP3(A20) binds RIPK1-containing complexes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1864">
 <bp:evidence rdf:resource="#Evidence2128" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MIB2 binds RIPK1 within TNF-&#945;:TNFR1:TRADD:RIPK1:TRAF2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1863">
 <bp:evidence rdf:resource="#Evidence2127" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TNFAIP3 (A20) ubiquitinates RIPK1 with K48-linked Ub chains </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1862">
 <bp:evidence rdf:resource="#Evidence2126" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF1 is cleaved by caspases</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1861">
 <bp:evidence rdf:resource="#Evidence2125" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TBK1, IKBKE phosphorylate RIPK1 at T189</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1860">
 <bp:evidence rdf:resource="#Evidence2124" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">OPTN binds CASP8</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1869">
 <bp:evidence rdf:resource="#Evidence2133" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHUK, IKBKB phosphorylate RIPK1 at S25</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1868">
 <bp:evidence rdf:resource="#Evidence2132" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MIB2 ubiquitinates RIPK1 at K377, K604, K634</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1867">
 <bp:evidence rdf:resource="#Evidence2131" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CYLD hydrolyses K63polyUb on RIPK1 within the TNFR1 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1866">
 <bp:evidence rdf:resource="#Evidence2130" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Viral serpin blocks caspase-8 activity</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1809">
 <bp:evidence rdf:resource="#Evidence2065" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NRIF binds to p75NTR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1808">
 <bp:evidence rdf:resource="#Evidence2063" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JNK phosphorylates BIM, BAD and other targets</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1810">
 <bp:evidence rdf:resource="#Evidence2066" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 polyubiquitinates NRIF</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1818">
 <bp:evidence rdf:resource="#Evidence2075" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRDM4 inhibits cyclin E transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1817">
 <bp:evidence rdf:resource="#Evidence2074" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRDM4 (SC1) binds to p75NTR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1816">
 <bp:evidence rdf:resource="#Evidence2073" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRDM4 translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1815">
 <bp:evidence rdf:resource="#Evidence2071" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Polyubiquitinated NRIF migrates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1814">
 <bp:evidence rdf:resource="#Evidence2070" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Polyubiquitinated NRIF binds to p62 (Sequestosome)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1813">
 <bp:evidence rdf:resource="#Evidence2069" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NRIF and TRAF6 may activate JNK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1812">
 <bp:evidence rdf:resource="#Evidence2068" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binds to p75NTR:NRIF</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1811">
 <bp:evidence rdf:resource="#Evidence2067" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">gamma-secretase cleaves p75NTR, releasing NRIF and TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1297">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1298">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1299">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1290">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1291">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1292">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1293">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1294">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1295">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1296">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1807">
 <bp:evidence rdf:resource="#Evidence2062" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active JNK moves to the nucleus and phosphorylates different transcription factors</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1806">
 <bp:evidence rdf:resource="#Evidence2061" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GTP-bound RAC contributes to JNK activation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1805">
 <bp:evidence rdf:resource="#Evidence2060" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NGF:p75NTR complex binds to NRAGE</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1804">
 <bp:evidence rdf:resource="#Evidence2059" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p75NTR indirectly activates RAC and Cdc42 via a guanyl-nucleotide exchange factor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1803">
 <bp:evidence rdf:resource="#Evidence2058" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NRAGE sequesters CHE1 in the cytoplasm</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1802">
 <bp:evidence rdf:resource="#Evidence2057" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NRAGE activates JNK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1801">
 <bp:evidence rdf:resource="#Evidence2055" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p75NTR binds to NADE</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1800">
 <bp:evidence rdf:resource="#Evidence2054" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">14-3-3epsilon attentuates NADE-related apoptosis</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1385">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1386">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1387">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1388">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1389">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1380">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1381">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1382">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1383">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1384">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1374">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1375">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1376">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1377">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1378">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1379">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1370">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1371">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1372">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1373">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1396">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1397">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1398">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1399">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1390">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1391">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1392">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1393">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1394">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1395">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1341">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2673">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1342">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2672">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1343">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2675">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1344">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2674">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1345">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2677">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1346">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2676">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1347">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2679">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1348">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2678">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2671">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1340">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2670">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1349">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1330">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2662">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1331">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2661">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1332">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2664">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1333">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2663">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1334">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2666">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1335">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2665">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1336">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2668">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1337">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2667">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2660">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1338">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1339">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2669">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1363">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2695">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1364">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2694">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1365">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2697">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1366">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2696">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1367">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2699">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1368">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2698">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1369">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2691">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1360">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2690">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1361">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2693">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1362">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2692">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1352">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2684">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1353">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2683">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1354">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2686">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1355">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2685">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1356">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2688">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1357">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2687">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1358">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1359">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2689">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2680">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1350">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2682">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1351">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2681">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction974">
 <bp:evidence rdf:resource="#Evidence1128" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G alpha (q) in G (q):RGS complex is inactivated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction973">
 <bp:evidence rdf:resource="#Evidence1127" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G alpha (q) inhibits PI3K alpha</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction976">
 <bp:evidence rdf:resource="#Evidence1130" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRK2 sequesters activated Gq</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2631">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction975">
 <bp:evidence rdf:resource="#Evidence1129" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PLC-beta hydrolyses PIP2 to DAG and IP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1300">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2630">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction970">
 <bp:evidence rdf:resource="#Evidence1123" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDC42 in GNB/GNG:PAK1:ARHGEF6:CDC42 is activated</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1301">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2633">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1302">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2632">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction972">
 <bp:evidence rdf:resource="#Evidence1125" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDC42 binds GNB/GNG:PAK1:ARHGEF6 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1303">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2635">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction971">
 <bp:evidence rdf:resource="#Evidence1124" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PAK1 binds ARHGEF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1304">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2634">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction978">
 <bp:evidence rdf:resource="#Evidence1132" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G alpha (q):RGS dissociates to inactive G alpha (q)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction977">
 <bp:evidence rdf:resource="#Evidence1131" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Liganded Gq-activating GPCRs bind inactive heterotrimeric Gq</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction979">
 <bp:evidence rdf:resource="#Evidence1133" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The Ligand:GPCR:Gq complex dissociates</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1305">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2637">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1306">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2636">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1307">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2639">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1308">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2638">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1309">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction985">
 <bp:evidence rdf:resource="#Evidence1140" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Calcium and Diacylglycerol activate CalDAG-GEFs (RasGRPs)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction984">
 <bp:evidence rdf:resource="#Evidence1139" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IP3R tetramer:I(1,4,5)P3:4xCa2+ transports Ca2+ from platelet dense tubular system to cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction987">
 <bp:evidence rdf:resource="#Evidence1142" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of IP3 to IP3 receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2620">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction986">
 <bp:evidence rdf:resource="#Evidence1141" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DAG activation of TRPC channels</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction981">
 <bp:evidence rdf:resource="#Evidence1135" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PLC beta is activated by G alpha (q)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2622">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction980">
 <bp:evidence rdf:resource="#Evidence1134" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active G alpha (q) binds RGS proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2621">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction983">
 <bp:evidence rdf:resource="#Evidence1137" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Liganded Gq/11-activating GPCRs act as GEFs for Gq/11</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2624">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction982">
 <bp:evidence rdf:resource="#Evidence1136" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G alpha (q) binds to Trio family RhoGEFs</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2623">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction989">
 <bp:evidence rdf:resource="#Evidence1145" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">2-AG hydrolysis to arachidonate by MAGL</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction988">
 <bp:evidence rdf:resource="#Evidence1143" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DAG kinase produces phosphatidic acid from DAG</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2626">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2625">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction990">
 <bp:evidence rdf:resource="#Evidence1146" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ABHD6,12 hydrolyse 3AG</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2628">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2627">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2629">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction952">
 <bp:evidence rdf:resource="#Evidence1100" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G alpha (13) activates Rho guanine nucleotide exchange factor 1 (p115-RhoGEF)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2651">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction951">
 <bp:evidence rdf:resource="#Evidence1099" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Inactive G alpha (12/13) reassociates with G beta:gamma</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1320">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2650">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction954">
 <bp:evidence rdf:resource="#Evidence1102" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GEFs activate RhoA,B,C</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1321">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2653">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction953">
 <bp:evidence rdf:resource="#Evidence1101" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Liganded G12/13-activating GPCRs bind inactive heterotrimeric G-protein G12/13</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1322">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2652">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1323">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2655">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1324">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2654">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction950">
 <bp:evidence rdf:resource="#Evidence1098" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p115-RhoGEF activation of RHOA</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1325">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2657">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1326">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2656">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1791">
 <bp:evidence rdf:resource="#Evidence2043" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK interacts with TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction959">
 <bp:evidence rdf:resource="#Evidence1109" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PLC beta-mediated PIP2 hydrolysis</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1790">
 <bp:evidence rdf:resource="#Evidence2042" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 is auto-ubiquitinated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction956">
 <bp:evidence rdf:resource="#Evidence1104" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Liganded G12/13-activating GPCR acts as a GEF for G12/13</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction955">
 <bp:evidence rdf:resource="#Evidence1103" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G alpha (12) binds BTK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction958">
 <bp:evidence rdf:resource="#Evidence1108" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Gbeta:gamma activation of PLC beta</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction957">
 <bp:evidence rdf:resource="#Evidence1105" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BTK in G alpha (12)-BTK complex is activated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1799">
 <bp:evidence rdf:resource="#Evidence2053" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p75NTR:NADE promotes caspase2/3 activation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1798">
 <bp:evidence rdf:resource="#Evidence2050" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MYD88 dissociates</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1797">
 <bp:evidence rdf:resource="#Evidence2049" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p75NTR interacts with IRAK:MYD88</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1796">
 <bp:evidence rdf:resource="#Evidence2048" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p62 recruits an atypical PKC</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1795">
 <bp:evidence rdf:resource="#Evidence2047" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p75NTR interacts with RIP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1794">
 <bp:evidence rdf:resource="#Evidence2046" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKK-beta is recruited</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1793">
 <bp:evidence rdf:resource="#Evidence2045" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p62 is recruited and forms a complex with TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1792">
 <bp:evidence rdf:resource="#Evidence2044" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK is activated</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1327">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2659">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1328">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2658">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1329">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction963">
 <bp:evidence rdf:resource="#Evidence1114" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Gbeta:gamma recruits PI3K gamma</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2640">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction962">
 <bp:evidence rdf:resource="#Evidence1113" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PIP3 binds to RhoA and activates it</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction965">
 <bp:evidence rdf:resource="#Evidence1117" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BTK in PIP3:BTK:G beta-gamma complex is activated</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1310">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2642">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction964">
 <bp:evidence rdf:resource="#Evidence1116" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G beta-gamma complex and PIP3 recruit BTK to membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1311">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2641">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1312">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2644">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1313">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2643">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction961">
 <bp:evidence rdf:resource="#Evidence1112" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G beta:gamma activated PI3Kgamma converts PIP2 to PIP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1314">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2646">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction960">
 <bp:evidence rdf:resource="#Evidence1111" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PIP3 recruits PDK1 and AKT to the membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1315">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2645">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1780">
 <bp:evidence rdf:resource="#Evidence2028" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">alpha-secretase cleaves the p75NTR extracellular domain</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction967">
 <bp:evidence rdf:resource="#Evidence1120" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active PAK1 and Active CDC42 dissociates from GNB/GNG:PAK1:ARHGEF6:CDC42 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction966">
 <bp:evidence rdf:resource="#Evidence1118" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PIP3:BTK:G beta-gamma complex dissociates to Active BTK, PIP3 and G beta-gamma complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction969">
 <bp:evidence rdf:resource="#Evidence1122" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PAK1:ARHGEF6 complex binds G-protein beta-gamma complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction968">
 <bp:evidence rdf:resource="#Evidence1121" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PAK1 in GNB/GNG:PAK1:ARHGEF6:Active CDC42 is activated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1788">
 <bp:evidence rdf:resource="#Evidence2039" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKKbeta is activated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1787">
 <bp:evidence rdf:resource="#Evidence2038" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kB migrates to the nucleus and turns on transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1786">
 <bp:evidence rdf:resource="#Evidence2037" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKKbeta phosphorylates IkB causing NF-kB to dissociate</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1785">
 <bp:evidence rdf:resource="#Evidence2034" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NGF homodimer binds to p75NTR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1784">
 <bp:evidence rdf:resource="#Evidence2033" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of pro-NGF to p75NTR:sortilin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1783">
 <bp:evidence rdf:resource="#Evidence2031" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">gamma-secretase cleaves the p75NTR transmembrane domain</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1782">
 <bp:evidence rdf:resource="#Evidence2030" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Part of the ICD migrates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1781">
 <bp:evidence rdf:resource="#Evidence2029" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p75NTR ICD signals to NF-kB</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1316">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2648">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1317">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2647">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1318">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1319">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2649">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1789">
 <bp:evidence rdf:resource="#Evidence2040" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IkB is ubiquitinated and degraded</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction996">
 <bp:evidence rdf:resource="#Evidence1152" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRK5 sequesters activated Gq</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction995">
 <bp:evidence rdf:resource="#Evidence1151" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BTK in active Gq-BTK complex is activated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction998">
 <bp:evidence rdf:resource="#Evidence1154" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Gq-BTK complex dissociates to Active BTK and Gq</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction997">
 <bp:evidence rdf:resource="#Evidence1153" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Inactive G alpha (q) reassociates with G beta:gamma</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction992">
 <bp:evidence rdf:resource="#Evidence1148" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of Protein Kinase C novel isoforms</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2611">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction991">
 <bp:evidence rdf:resource="#Evidence1147" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DAG is metabolized by DAGL to 2-AG</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2610">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction994">
 <bp:evidence rdf:resource="#Evidence1150" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active Gq binds BTK</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2613">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction993">
 <bp:evidence rdf:resource="#Evidence1149" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G alpha (q) auto-inactivates by hydrolysing GTP to GDP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2612">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction999">
 <bp:evidence rdf:resource="#Evidence1156" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2/5 activate RSK1/2/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2615">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2614">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2617">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2616">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2619">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2618">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2600">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2602">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2601">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2604">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2603">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2606">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2605">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2608">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2607">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2609">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1975">
 <bp:evidence rdf:resource="#Evidence2254" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB2 forms heterodimers with ligand-activated ERBB receptors: EGFR, ERBB3 and ERBB4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1974">
 <bp:evidence rdf:resource="#Evidence2253" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHIP (STUB1) mediates ubiquitination of ERBB2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1973">
 <bp:evidence rdf:resource="#Evidence2252" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CUL5 mediates ubiquitination of ERBB2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1972">
 <bp:evidence rdf:resource="#Evidence2251" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MATK (CSK homologous kinase) binds phosphorylated ERBB2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1971">
 <bp:evidence rdf:resource="#Evidence2250" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Self-ubiquitination of RNF41</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1970">
 <bp:evidence rdf:resource="#Evidence2249" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNF41 ubiquitinates ERBB3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1979">
 <bp:evidence rdf:resource="#Evidence2260" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB3 binds neuregulins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1978">
 <bp:evidence rdf:resource="#Evidence2259" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated ERBB2 heterodimers bind MEMO1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1977">
 <bp:evidence rdf:resource="#Evidence2258" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MEMO1 binds RHOA:GTP:DIAPH1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1976">
 <bp:evidence rdf:resource="#Evidence2256" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRB7 binds phosphorylated heterodimer of ERBB2 and ERBB3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1964">
 <bp:evidence rdf:resource="#Evidence2243" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Deubiquitination of RNF41 by P-USP8</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1963">
 <bp:evidence rdf:resource="#Evidence2241" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTPN18 dephosphorylates ERBB2 at Y1196, Y1112 and Y1248</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1962">
 <bp:evidence rdf:resource="#Evidence2240" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTPN12 dephosphorylates ERBB2 on tyrosine Y1248</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1961">
 <bp:evidence rdf:resource="#Evidence2239" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTPN18 binds ERBB2:EGFR heterodimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1960">
 <bp:evidence rdf:resource="#Evidence2237" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PLCG1 phosphorylation by p-EGFR:p-ERBB2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1969">
 <bp:evidence rdf:resource="#Evidence2248" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of USP8 by P-AKT</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1968">
 <bp:evidence rdf:resource="#Evidence2247" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB3 binds RNF41 ubiquitin ligase</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1967">
 <bp:evidence rdf:resource="#Evidence2246" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitinated RNF41 binds P-USP8</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1966">
 <bp:evidence rdf:resource="#Evidence2245" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNF41 binds neuregulin-activated ERBB3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1965">
 <bp:evidence rdf:resource="#Evidence2244" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNF41 ubiquitinates activated ERBB3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1953">
 <bp:evidence rdf:resource="#Evidence2228" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of PI3K to GRB2:GAB1 in complex with phosphorylated heterodimer of ERBB2 and EGFR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1952">
 <bp:evidence rdf:resource="#Evidence2227" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of PI3K to p-ERBB2:p-ERBB4 CYT-1 heterodimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1951">
 <bp:evidence rdf:resource="#Evidence2226" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PIP2 to PIP3 conversion by PI3K bound to phosphorylated heterodimer of ERBB2 and ERBB3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1950">
 <bp:evidence rdf:resource="#Evidence2225" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of PI3K to ERBB2:p-ERBB3 heterodimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1959">
 <bp:evidence rdf:resource="#Evidence2236" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PLCG1 binds to p-ERBB2:p-EGFR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1958">
 <bp:evidence rdf:resource="#Evidence2234" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB2 binds trastuzumab</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1957">
 <bp:evidence rdf:resource="#Evidence2233" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB2 binds TKIs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1956">
 <bp:evidence rdf:resource="#Evidence2232" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB2 binds pertuzumab</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1955">
 <bp:evidence rdf:resource="#Evidence2230" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PIP2 to PIP3 conversion by PI3K bound to phosphorylated heterodimer of ERBB2 and ERBB4 CYT1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1954">
 <bp:evidence rdf:resource="#Evidence2229" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of GRB2:GAB1 to p-ERBB2:p-EGFR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1942">
 <bp:evidence rdf:resource="#Evidence2215" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAS guanyl-nucleotide exchange mediated by SOS1 in complex with GRB2 and phosphorylated EGFR:ERBB2 heterodimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1941">
 <bp:evidence rdf:resource="#Evidence2214" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRB2:SOS1 complex binds phosphorylated ERBB4:ERBB2 heterodimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1940">
 <bp:evidence rdf:resource="#Evidence2213" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRB2:SOS1 complex binds phosphorylated EGFR:ERBB2 heterodimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1949">
 <bp:evidence rdf:resource="#Evidence2224" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PIP2 to PIP3 conversion by PI3K bound to GRB2:GAB1 in complex with phosphorylated heterodimer of ERBB2 and EGFR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1948">
 <bp:evidence rdf:resource="#Evidence2222" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAS guanyl-nucleotide exchange mediated by SOS1 in complex with GRB2 and p-SHC1:Phosphorylated ERBB2 heterodimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1947">
 <bp:evidence rdf:resource="#Evidence2221" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHC1 binds PTPN12</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1946">
 <bp:evidence rdf:resource="#Evidence2220" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHC1 binds phosphorylated ERBB2 heterodimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1945">
 <bp:evidence rdf:resource="#Evidence2219" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated PKC phosphorylates SHC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1944">
 <bp:evidence rdf:resource="#Evidence2218" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of GRB2:SOS1 to p-SHC1 in complex with phosphorylated ERBB2 heterodimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1943">
 <bp:evidence rdf:resource="#Evidence2217" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHC1 phosphorylation by ERBB2 heterodimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep3087">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2666" />
 <bp:stepProcess rdf:resource="#Catalysis859" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3088">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2667" />
 <bp:stepProcess rdf:resource="#Catalysis860" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3089">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2668" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3094">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2673" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3095">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2674" />
 <bp:stepProcess rdf:resource="#Catalysis863" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3096">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2675" />
 <bp:stepProcess rdf:resource="#Catalysis864" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3097">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2676" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3090">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2669" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3091">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2670" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3092">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2671" />
 <bp:stepProcess rdf:resource="#Catalysis861" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3093">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2672" />
 <bp:stepProcess rdf:resource="#Catalysis862" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3098">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2677" />
 <bp:stepProcess rdf:resource="#Catalysis865" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3099">
 <bp:stepProcess rdf:resource="#Pathway423" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3069">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2652" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3065">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2648" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3066">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2649" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3067">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2650" />
 <bp:stepProcess rdf:resource="#Catalysis853" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3068">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2651" />
 <bp:stepProcess rdf:resource="#Catalysis854" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1997">
 <bp:evidence rdf:resource="#Evidence2288" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PDPK1 binds PIP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep3072">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2655" />
 <bp:stepProcess rdf:resource="#Catalysis855" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1996">
 <bp:evidence rdf:resource="#Evidence2287" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT2 binds PIP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep3073">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2656" />
 <bp:stepProcess rdf:resource="#Catalysis856" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1995">
 <bp:evidence rdf:resource="#Evidence2286" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PDPK1 phosphorylates AKT2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep3074">
 <bp:stepProcess rdf:resource="#Pathway419" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1994">
 <bp:evidence rdf:resource="#Evidence2284" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-T309,S474-AKT2:PIP3 phosphorylates PDE3B</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep3075">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2657" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1993">
 <bp:evidence rdf:resource="#Evidence2283" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S295-PDE3B hydrolyses cAMP to AMP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1992">
 <bp:evidence rdf:resource="#Evidence2279" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRB2-1:SOS1 binds p-IRS1,p-IRS2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1991">
 <bp:evidence rdf:resource="#Evidence2278" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRB2:SOS1:p-Y-IRS1,p-Y-IRS2 mediated nucleotide exchange of RAS</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep3070">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2653" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1990">
 <bp:evidence rdf:resource="#Evidence2274" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Insulin binds the insulin receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep3071">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2654" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1999">
 <bp:evidence rdf:resource="#Evidence2290" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y-IRS1,p-Y-IRS2 bind PI3K</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1998">
 <bp:evidence rdf:resource="#Evidence2289" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI3K-containing complexes phosphorylate PIP2 to PIP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep3076">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2658" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3077">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2659" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3078">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2660" />
 <bp:stepProcess rdf:resource="#Catalysis857" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3079">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2661" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1986">
 <bp:evidence rdf:resource="#Evidence2270" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Insulin degradation</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep3083">
 <bp:stepProcess rdf:resource="#Pathway421" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1985">
 <bp:evidence rdf:resource="#Evidence2269" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Insulin receptor de-phosphorylation</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep3084">
 <bp:stepProcess rdf:resource="#Pathway422" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1984">
 <bp:evidence rdf:resource="#Evidence2268" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Re-integration of insulin receptor into plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep3085">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2664" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1983">
 <bp:evidence rdf:resource="#Evidence2266" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Autophosphorylation of insulin receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep3086">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2665" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1982">
 <bp:evidence rdf:resource="#Evidence2264" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SRC family kinases phosphorylate ERBB2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1981">
 <bp:evidence rdf:resource="#Evidence2263" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERBB2 promotes PTK6 autophosphorylation</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep3080">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2662" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1980">
 <bp:evidence rdf:resource="#Evidence2262" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated ERBB2 binds PTK6 (BRK)</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep3081">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2663" />
 <bp:stepProcess rdf:resource="#Catalysis858" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3082">
 <bp:stepProcess rdf:resource="#Pathway420" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1989">
 <bp:evidence rdf:resource="#Evidence2273" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Endosome acidification</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1988">
 <bp:evidence rdf:resource="#Evidence2272" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ATP6AP1 binds V-ATPase</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1987">
 <bp:evidence rdf:resource="#Evidence2271" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of insulin from insulin receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1187">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1188">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1189">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1929">
 <bp:evidence rdf:resource="#Evidence2200" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerization of STATs</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1180">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1181">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1182">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1183">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1184">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1185">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1186">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1931">
 <bp:evidence rdf:resource="#Evidence2202" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of STATs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1930">
 <bp:evidence rdf:resource="#Evidence2201" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of p-KIT on Y900 by Src kinases</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1939">
 <bp:evidence rdf:resource="#Evidence2212" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAS guanyl nucleotide exchange mediated by SOS1 bound to GRB2 in complex with phosphorylated ERBB4:ERBB2 heterodimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1938">
 <bp:evidence rdf:resource="#Evidence2210" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Trans-autophosphorylation of ERBB2 heterodimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1937">
 <bp:evidence rdf:resource="#Evidence2209" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Trans-autophosphorylation of p-Y877-ERBB2 heterodimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1936">
 <bp:evidence rdf:resource="#Evidence2207" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Synthesis of PIP3 from PIP2 by PI3K</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1935">
 <bp:evidence rdf:resource="#Evidence2206" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAK2 binds to p-KIT</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1934">
 <bp:evidence rdf:resource="#Evidence2205" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of GAB2 by SFKs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1933">
 <bp:evidence rdf:resource="#Evidence2204" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHP2 interacts with p-KIT</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1932">
 <bp:evidence rdf:resource="#Evidence2203" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Indirect recruitment of GAB2 to p-KIT</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1176">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1177">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1178">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1179">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1919">
 <bp:evidence rdf:resource="#Evidence2190" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KIT binds type I TKIs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1918">
 <bp:evidence rdf:resource="#Evidence2189" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of Src family kinases with p-KIT</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1170">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1171">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1172">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1173">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1174">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1175">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1920">
 <bp:evidence rdf:resource="#Evidence2191" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTP-RO interacts with p-c-Kit complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1928">
 <bp:evidence rdf:resource="#Evidence2199" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerization of KIT upon SCF binding</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1927">
 <bp:evidence rdf:resource="#Evidence2198" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Disassociation and translocation of STATs to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1926">
 <bp:evidence rdf:resource="#Evidence2197" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of RAS by p-KIT bound SOS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1925">
 <bp:evidence rdf:resource="#Evidence2196" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Autophosphorylation of KIT</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1924">
 <bp:evidence rdf:resource="#Evidence2195" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerization of sSCF</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1923">
 <bp:evidence rdf:resource="#Evidence2194" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of STATs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1922">
 <bp:evidence rdf:resource="#Evidence2193" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRB2:SOS interacts with p-KIT</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1921">
 <bp:evidence rdf:resource="#Evidence2192" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of JAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1909">
 <bp:evidence rdf:resource="#Evidence2180" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of other adapter proteins with p-KIT</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1908">
 <bp:evidence rdf:resource="#Evidence2179" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Indirect recruitment of PI3K to KIT via p(Y)-GAB2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1907">
 <bp:evidence rdf:resource="#Evidence2178" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of SHP2 by SFKs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1917">
 <bp:evidence rdf:resource="#Evidence2188" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of other tyrosine kinases with p-KIT</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1916">
 <bp:evidence rdf:resource="#Evidence2187" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation and activation of VAV1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1915">
 <bp:evidence rdf:resource="#Evidence2186" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of RAC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1914">
 <bp:evidence rdf:resource="#Evidence2185" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KIT binds type II TKIs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1913">
 <bp:evidence rdf:resource="#Evidence2184" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Direct recruitment of PI3K to p-KIT</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1912">
 <bp:evidence rdf:resource="#Evidence2183" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KIT binds ripretinib</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1911">
 <bp:evidence rdf:resource="#Evidence2182" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Processing of SCF isoform 1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1910">
 <bp:evidence rdf:resource="#Evidence2181" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of KIT and sSCF</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1198">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1199">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1190">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1191">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1192">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1193">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1194">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1195">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1196">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1197">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1906">
 <bp:evidence rdf:resource="#Evidence2177" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKC alpha interacts with and phosphorylates KIT</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1905">
 <bp:evidence rdf:resource="#Evidence2176" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of APS and p-KIT</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1904">
 <bp:evidence rdf:resource="#Evidence2175" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SOCS1 as a regulator of KIT signaling</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1903">
 <bp:evidence rdf:resource="#Evidence2174" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of APS</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1902">
 <bp:evidence rdf:resource="#Evidence2173" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LNK binds to p-KIT and inhibit downstream signaling</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1901">
 <bp:evidence rdf:resource="#Evidence2172" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of SHP1 and KIT</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1900">
 <bp:evidence rdf:resource="#Evidence2171" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Downregulation of c-Kit signaling by SOCS6</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1264">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2596">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1265">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2595">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1266">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2598">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1267">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2597">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1268">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1269">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2599">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2590">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1260">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2592">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1261">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2591">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1262">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2594">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1263">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2593">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1253">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2585">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1254">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2584">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1255">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2587">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1256">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2586">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1257">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2589">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1258">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2588">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1259">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2581">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1250">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2580">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1251">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2583">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1252">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2582">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1286">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1287">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1288">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1289">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1280">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1281">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1282">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1283">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1284">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1285">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1275">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1276">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1277">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1278">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1279">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1270">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1271">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1272">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1273">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1274">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1220">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2552">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1221">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2551">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1222">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2554">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1223">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2553">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1224">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2556">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1225">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2555">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1226">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2558">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1227">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2557">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2550">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1228">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1229">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2559">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2541">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1210">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2540">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1211">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2543">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1212">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2542">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1213">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2545">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1214">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2544">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1215">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2547">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1216">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2546">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1217">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2549">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1218">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2548">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1219">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1242">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2574">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1243">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2573">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1244">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2576">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1245">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2575">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1246">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2578">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1247">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2577">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1248">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1249">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2579">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2570">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1240">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2572">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1241">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2571">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction9">
 <bp:evidence rdf:resource="#Evidence15" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-106 microRNAs bind VAPA mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction6">
 <bp:evidence rdf:resource="#Evidence12" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-17 microRNA binds VAPA mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction5">
 <bp:evidence rdf:resource="#Evidence11" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-17 microRNA binds CNOT6L mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction8">
 <bp:evidence rdf:resource="#Evidence14" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-19a microRNA binds VAPA mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction7">
 <bp:evidence rdf:resource="#Evidence13" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-19b microRNA binds CNOT6L mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2">
 <bp:evidence rdf:resource="#Evidence5" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TORC2 complex phosphorylates SGK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1">
 <bp:evidence rdf:resource="#Evidence4" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PDPK1 phosphorylates AKT at T308</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction4">
 <bp:evidence rdf:resource="#Evidence9" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTEN mRNA translation is negatively regulated by microRNAs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction3">
 <bp:evidence rdf:resource="#Evidence8" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-93 microRNA binds PTEN mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1231">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2563">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1232">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2562">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1233">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2565">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1234">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2564">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1235">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2567">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1236">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2566">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1237">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2569">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1238">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2568">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2561">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1230">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2560">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1239">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2510">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2512">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2511">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2514">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2513">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2516">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2515">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2518">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2517">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2519">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2501">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2500">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2503">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2502">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2505">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2504">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2507">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2506">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2509">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2508">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2530">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1200">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2532">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1201">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2531">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1202">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2534">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1203">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2533">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1204">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2536">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1205">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2535">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep3146">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2717" />
 <bp:stepProcess rdf:resource="#Catalysis878" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3147">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2718" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3148">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2719" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3149">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2720" />
 <bp:stepProcess rdf:resource="#Catalysis879" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3142">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2713" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3143">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2714" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3144">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2715" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3145">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2716" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3150">
 <bp:stepProcess rdf:resource="#Catalysis880" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2721" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3151">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2722" />
 <bp:stepProcess rdf:resource="#Catalysis881" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3152">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2723" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1206">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2538">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1207">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2537">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1208">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1209">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2539">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2521">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2520">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2523">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2522">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2525">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2524">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2527">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2526">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2529">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2528">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep3128">
 <bp:stepProcess rdf:resource="#Pathway429" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3129">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2701" />
 <bp:stepProcess rdf:resource="#Catalysis875" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3124">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2698" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3125">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2699" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3126">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2700" />
 <bp:stepProcess rdf:resource="#Catalysis874" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3127">
 <bp:stepProcess rdf:resource="#Pathway428" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3120">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2695" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3121">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2696" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3122">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2697" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3123">
 <bp:stepProcess rdf:resource="#Pathway427" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3130">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2702" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3139">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2710" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3135">
 <bp:stepProcess rdf:resource="#Catalysis877" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2706" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3136">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2707" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3137">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2708" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3138">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2709" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3131">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2703" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3132">
 <bp:stepProcess rdf:resource="#Catalysis876" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2704" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3133">
 <bp:stepProcess rdf:resource="#Pathway430" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3134">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2705" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3140">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2711" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3141">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2712" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3106">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2683" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3107">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2684" />
 <bp:stepProcess rdf:resource="#Catalysis868" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3108">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2685" />
 <bp:stepProcess rdf:resource="#Catalysis869" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3109">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2686" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3102">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2679" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3103">
 <bp:stepProcess rdf:resource="#Catalysis866" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2680" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3104">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2681" />
 <bp:stepProcess rdf:resource="#Catalysis867" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3105">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2682" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3100">
 <bp:stepProcess rdf:resource="#Pathway424" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3101">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2678" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3117">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2692" />
 <bp:stepProcess rdf:resource="#Catalysis872" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3118">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2693" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3119">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2694" />
 <bp:stepProcess rdf:resource="#Catalysis873" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3113">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2689" />
 <bp:stepProcess rdf:resource="#Catalysis871" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3114">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2690" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3115">
 <bp:stepProcess rdf:resource="#Pathway426" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3116">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2691" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3110">
 <bp:stepProcess rdf:resource="#Pathway425" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3111">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2687" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3112">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2688" />
 <bp:stepProcess rdf:resource="#Catalysis870" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1099">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1091">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1092">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1093">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1094">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1095">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1096">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1097">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1098">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis200">
 <bp:controlled rdf:resource="#BiochemicalReaction484" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1066">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2398">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1067">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2397">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1068">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1069">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2399">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2390">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1060">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2392">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1061">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2391">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1062">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2394">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1063">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2393">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1064">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2396">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1065">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2395">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1055">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2387">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1056">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2386">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1057">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2389">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1058">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2388">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1059">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2381">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1050">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2380">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1051">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2383">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1052">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2382">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1053">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2385">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1054">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2384">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1088">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1089">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1080">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1081">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1082">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1083">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1084">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1085">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1086">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1087">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1090">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1077">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1078">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1079">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1070">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1071">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1072">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1073">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1074">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1075">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1076">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1143">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2475">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1144">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2474">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1145">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2477">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1146">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2476">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1147">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2479">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1148">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2478">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1149">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis129">
 <bp:controlled rdf:resource="#BiochemicalReaction286" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis128">
 <bp:controlled rdf:resource="#BiochemicalReaction285" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis125">
 <bp:controlled rdf:resource="#BiochemicalReaction277" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence2471">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis124">
 <bp:controlled rdf:resource="#BiochemicalReaction276" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1140">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2470">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis127">
 <bp:controlled rdf:resource="#BiochemicalReaction279" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1141">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2473">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis126">
 <bp:controlled rdf:resource="#BiochemicalReaction278" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1142">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2472">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis132">
 <bp:controlled rdf:resource="#BiochemicalReaction297" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis131">
 <bp:controlled rdf:resource="#BiochemicalReaction295" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis134">
 <bp:controlled rdf:resource="#BiochemicalReaction299" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis133">
 <bp:controlled rdf:resource="#BiochemicalReaction298" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis130">
 <bp:controlled rdf:resource="#BiochemicalReaction289" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1132">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2464">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1133">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2463">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1134">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2466">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1135">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2465">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1136">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2468">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1137">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2467">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1138">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1139">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2469">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis139">
 <bp:controlled rdf:resource="#BiochemicalReaction315" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis136">
 <bp:controlled rdf:resource="#BiochemicalReaction308" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence2460">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis135">
 <bp:controlled rdf:resource="#BiochemicalReaction301" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis138">
 <bp:controlled rdf:resource="#BiochemicalReaction313" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1130">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2462">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis137">
 <bp:controlled rdf:resource="#BiochemicalReaction310" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1131">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2461">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis143">
 <bp:controlled rdf:resource="#BiochemicalReaction323" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis142">
 <bp:controlled rdf:resource="#BiochemicalReaction321" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis145">
 <bp:controlled rdf:resource="#BiochemicalReaction328" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis144">
 <bp:controlled rdf:resource="#BiochemicalReaction326" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis141">
 <bp:controlled rdf:resource="#BiochemicalReaction319" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis140">
 <bp:controlled rdf:resource="#BiochemicalReaction316" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1165">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2497">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1166">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2496">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1167">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2499">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1168">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2498">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1169">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2491">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1160">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2490">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis147">
 <bp:controlled rdf:resource="#BiochemicalReaction330" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1161">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2493">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis146">
 <bp:controlled rdf:resource="#BiochemicalReaction329" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1162">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2492">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis149">
 <bp:controlled rdf:resource="#BiochemicalReaction334" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1163">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2495">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis148">
 <bp:controlled rdf:resource="#BiochemicalReaction332" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1164">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2494">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis154">
 <bp:controlled rdf:resource="#BiochemicalReaction342" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis153">
 <bp:controlled rdf:resource="#BiochemicalReaction341" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis156">
 <bp:controlled rdf:resource="#BiochemicalReaction345" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis155">
 <bp:controlled rdf:resource="#BiochemicalReaction344" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis150">
 <bp:controlled rdf:resource="#BiochemicalReaction335" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis152">
 <bp:controlled rdf:resource="#BiochemicalReaction340" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis151">
 <bp:controlled rdf:resource="#BiochemicalReaction336" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1154">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2486">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1155">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2485">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1156">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2488">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1157">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2487">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1158">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1159">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2489">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2480">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis158">
 <bp:controlled rdf:resource="#BiochemicalReaction347" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1150">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2482">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis157">
 <bp:controlled rdf:resource="#BiochemicalReaction346" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1151">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2481">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1152">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2484">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis159">
 <bp:controlled rdf:resource="#BiochemicalReaction355" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1153">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2483">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis165">
 <bp:controlled rdf:resource="#BiochemicalReaction382" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis164">
 <bp:controlled rdf:resource="#BiochemicalReaction381" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis167">
 <bp:controlled rdf:resource="#BiochemicalReaction388" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis166">
 <bp:controlled rdf:resource="#BiochemicalReaction384" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis161">
 <bp:controlled rdf:resource="#BiochemicalReaction378" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis160">
 <bp:controlled rdf:resource="#BiochemicalReaction365" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis163">
 <bp:controlled rdf:resource="#BiochemicalReaction380" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis162">
 <bp:controlled rdf:resource="#BiochemicalReaction379" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence2431">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1100">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2430">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1101">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2433">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1102">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2432">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1103">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2435">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1104">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2434">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1105">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2437">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1106">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2436">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1107">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2439">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1108">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2438">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1109">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2420">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2422">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2421">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2424">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2423">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2426">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2425">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis101">
 <bp:controlled rdf:resource="#BiochemicalReaction223" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis100">
 <bp:controlled rdf:resource="#BiochemicalReaction220" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence2428">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2427">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2429">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1121">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2453">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1122">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2452">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1123">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2455">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1124">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2454">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1125">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2457">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1126">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2456">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1127">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2459">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1128">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2458">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis107">
 <bp:controlled rdf:resource="#BiochemicalReaction237" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis106">
 <bp:controlled rdf:resource="#BiochemicalReaction236" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis109">
 <bp:controlled rdf:resource="#BiochemicalReaction241" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis108">
 <bp:controlled rdf:resource="#BiochemicalReaction239" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis103">
 <bp:controlled rdf:resource="#BiochemicalReaction228" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis102">
 <bp:controlled rdf:resource="#BiochemicalReaction225" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis105">
 <bp:controlled rdf:resource="#BiochemicalReaction234" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence2451">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis104">
 <bp:controlled rdf:resource="#BiochemicalReaction229" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1120">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2450">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis110">
 <bp:controlled rdf:resource="#BiochemicalReaction245" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis112">
 <bp:controlled rdf:resource="#BiochemicalReaction251" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis111">
 <bp:controlled rdf:resource="#BiochemicalReaction246" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1129">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1110">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2442">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1111">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2441">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1112">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2444">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1113">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2443">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1114">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2446">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1115">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2445">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1116">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2448">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1117">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2447">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis118">
 <bp:controlled rdf:resource="#BiochemicalReaction263" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis117">
 <bp:controlled rdf:resource="#BiochemicalReaction262" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis119">
 <bp:controlled rdf:resource="#BiochemicalReaction265" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis114">
 <bp:controlled rdf:resource="#BiochemicalReaction256" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis113">
 <bp:controlled rdf:resource="#BiochemicalReaction255" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis116">
 <bp:controlled rdf:resource="#BiochemicalReaction261" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence2440">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis115">
 <bp:controlled rdf:resource="#BiochemicalReaction259" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis121">
 <bp:controlled rdf:resource="#BiochemicalReaction267" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis120">
 <bp:controlled rdf:resource="#BiochemicalReaction266" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis123">
 <bp:controlled rdf:resource="#BiochemicalReaction270" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis122">
 <bp:controlled rdf:resource="#BiochemicalReaction269" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1118">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1119">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2449">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep3047">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2634" />
 <bp:stepProcess rdf:resource="#Catalysis845" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3048">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2635" />
 <bp:stepProcess rdf:resource="#Catalysis846" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3049">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2636" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3043">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2630" />
 <bp:stepProcess rdf:resource="#Catalysis844" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3044">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2631" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3045">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2632" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3046">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2633" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3050">
 <bp:stepProcess rdf:resource="#Catalysis847" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2637" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3051">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2638" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3052">
 <bp:stepProcess rdf:resource="#Catalysis848" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2639" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3053">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2640" />
 <bp:stepProcess rdf:resource="#Catalysis849" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3058">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2643" />
 <bp:stepProcess rdf:resource="#Catalysis851" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3059">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2644" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3054">
 <bp:stepProcess rdf:resource="#Pathway415" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3055">
 <bp:stepProcess rdf:resource="#Pathway416" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3056">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2641" />
 <bp:stepProcess rdf:resource="#Catalysis850" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3057">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2642" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3061">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2645" />
 <bp:stepProcess rdf:resource="#Catalysis852" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3062">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2646" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3063">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2647" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3064">
 <bp:stepProcess rdf:resource="#Pathway418" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3060">
 <bp:stepProcess rdf:resource="#Pathway417" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2411">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2410">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2413">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep3029">
 <bp:stepProcess rdf:resource="#Pathway410" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2412">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2415">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2414">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep3025">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2618" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3026">
 <bp:stepProcess rdf:resource="#Catalysis838" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2619" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3027">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2620" />
 <bp:stepProcess rdf:resource="#Catalysis839" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3028">
 <bp:stepProcess rdf:resource="#Pathway409" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3021">
 <bp:stepProcess rdf:resource="#Catalysis835" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2614" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3022">
 <bp:stepProcess rdf:resource="#Catalysis836" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2615" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3023">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2616" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3024">
 <bp:stepProcess rdf:resource="#Catalysis837" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2617" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3030">
 <bp:stepProcess rdf:resource="#Pathway411" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3031">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2621" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2417">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2416">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2419">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2418">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2400">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2402">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2401">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2404">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2403">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep3036">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2625" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3037">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2626" />
 <bp:stepProcess rdf:resource="#Catalysis842" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3038">
 <bp:stepProcess rdf:resource="#Pathway413" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3039">
 <bp:stepProcess rdf:resource="#Pathway414" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3032">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2622" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3033">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2623" />
 <bp:stepProcess rdf:resource="#Catalysis840" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3034">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2624" />
 <bp:stepProcess rdf:resource="#Catalysis841" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3035">
 <bp:stepProcess rdf:resource="#Pathway412" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3040">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2627" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3041">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2628" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3042">
 <bp:stepProcess rdf:resource="#Catalysis843" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2629" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2406">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2405">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2408">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2407">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2409">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep3007">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2603" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3008">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2604" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3009">
 <bp:stepProcess rdf:resource="#Pathway406" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3003">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2601" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3004">
 <bp:stepProcess rdf:resource="#Pathway404" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3005">
 <bp:stepProcess rdf:resource="#Pathway405" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3006">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2602" />
 <bp:stepProcess rdf:resource="#Catalysis831" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis169">
 <bp:controlled rdf:resource="#BiochemicalReaction390" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis168">
 <bp:controlled rdf:resource="#BiochemicalReaction389" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep3000">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2598" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3001">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2599" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3002">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2600" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis176">
 <bp:controlled rdf:resource="#BiochemicalReaction408" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis175">
 <bp:controlled rdf:resource="#BiochemicalReaction406" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis178">
 <bp:controlled rdf:resource="#BiochemicalReaction410" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis177">
 <bp:controlled rdf:resource="#BiochemicalReaction409" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis172">
 <bp:controlled rdf:resource="#BiochemicalReaction401" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis171">
 <bp:controlled rdf:resource="#BiochemicalReaction400" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis174">
 <bp:controlled rdf:resource="#BiochemicalReaction404" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis173">
 <bp:controlled rdf:resource="#BiochemicalReaction402" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis170">
 <bp:controlled rdf:resource="#BiochemicalReaction399" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep3018">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2611" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3019">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2612" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3014">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2607" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3015">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2608" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3016">
 <bp:stepProcess rdf:resource="#Catalysis833" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2609" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3017">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2610" />
 <bp:stepProcess rdf:resource="#Catalysis834" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3010">
 <bp:stepProcess rdf:resource="#Catalysis832" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2605" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis179">
 <bp:controlled rdf:resource="#BiochemicalReaction415" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep3011">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2606" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3012">
 <bp:stepProcess rdf:resource="#Pathway407" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3013">
 <bp:stepProcess rdf:resource="#Pathway408" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis187">
 <bp:controlled rdf:resource="#BiochemicalReaction453" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis186">
 <bp:controlled rdf:resource="#BiochemicalReaction440" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis189">
 <bp:controlled rdf:resource="#BiochemicalReaction456" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis188">
 <bp:controlled rdf:resource="#BiochemicalReaction455" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep3020">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2613" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis183">
 <bp:controlled rdf:resource="#BiochemicalReaction427" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis182">
 <bp:controlled rdf:resource="#BiochemicalReaction422" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis185">
 <bp:controlled rdf:resource="#BiochemicalReaction439" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis184">
 <bp:controlled rdf:resource="#BiochemicalReaction438" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis181">
 <bp:controlled rdf:resource="#BiochemicalReaction418" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis180">
 <bp:controlled rdf:resource="#BiochemicalReaction416" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis198">
 <bp:controlled rdf:resource="#BiochemicalReaction479" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis197">
 <bp:controlled rdf:resource="#BiochemicalReaction478" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis199">
 <bp:controlled rdf:resource="#BiochemicalReaction480" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis194">
 <bp:controlled rdf:resource="#BiochemicalReaction469" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis193">
 <bp:controlled rdf:resource="#BiochemicalReaction466" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis196">
 <bp:controlled rdf:resource="#BiochemicalReaction475" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis195">
 <bp:controlled rdf:resource="#BiochemicalReaction474" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis190">
 <bp:controlled rdf:resource="#BiochemicalReaction458" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis192">
 <bp:controlled rdf:resource="#BiochemicalReaction464" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis191">
 <bp:controlled rdf:resource="#BiochemicalReaction463" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep2406">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2096" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2407">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2097" />
 <bp:stepProcess rdf:resource="#Catalysis642" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2408">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2098" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2409">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2099" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2402">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2092" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2403">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2093" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2404">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2094" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2405">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2095" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2400">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2091" />
 <bp:stepProcess rdf:resource="#Catalysis641" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2401">
 <bp:stepProcess rdf:resource="#Pathway311" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2277">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2276">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2279">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2278">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2271">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2270">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2273">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2272">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2275">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2274">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2266">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2265">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2268">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2267">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2269">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2260">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2262">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2261">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2264">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2263">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2299">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2298">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2291">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2290">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2293">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2292">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2295">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2294">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2297">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2296">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2288">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2287">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2289">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2280">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2282">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2281">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2284">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2283">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2286">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2285">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence24">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1022">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2354">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence23">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1023">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2353">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence22">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1024">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1149">
 <bp:stepProcess rdf:resource="#BiochemicalReaction994" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2356">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence21">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1025">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1148">
 <bp:stepProcess rdf:resource="#BiochemicalReaction993" />
 <bp:stepProcess rdf:resource="#Catalysis355" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2355">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence28">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1026">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2358">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2479">
 <bp:stepProcess rdf:resource="#Pathway323" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence27">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1027">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2357">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence26">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1028">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence25">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1029">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2359">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1143">
 <bp:stepProcess rdf:resource="#Pathway156" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2475">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2154" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1142">
 <bp:stepProcess rdf:resource="#Catalysis351" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction988" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2476">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2155" />
 <bp:stepProcess rdf:resource="#Catalysis664" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1141">
 <bp:stepProcess rdf:resource="#BiochemicalReaction987" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2477">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2156" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1140">
 <bp:stepProcess rdf:resource="#BiochemicalReaction986" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2478">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2157" />
 <bp:stepProcess rdf:resource="#Catalysis665" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence20">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1147">
 <bp:stepProcess rdf:resource="#BiochemicalReaction992" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2350">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2471">
 <bp:stepProcess rdf:resource="#Catalysis662" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2151" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1146">
 <bp:stepProcess rdf:resource="#Catalysis354" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction991" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2472">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2152" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1020">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1145">
 <bp:stepProcess rdf:resource="#Catalysis353" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction990" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2352">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2473">
 <bp:stepProcess rdf:resource="#Pathway322" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1021">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1144">
 <bp:stepProcess rdf:resource="#Catalysis352" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction989" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2351">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2474">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2153" />
 <bp:stepProcess rdf:resource="#Catalysis663" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2480">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2158" />
 <bp:stepProcess rdf:resource="#Catalysis666" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2481">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2159" />
 <bp:stepProcess rdf:resource="#Catalysis667" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1150">
 <bp:stepProcess rdf:resource="#BiochemicalReaction995" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence29">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence35">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1011">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2343">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence34">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1012">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2342">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence33">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1013">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2345">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence32">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1014">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1159">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1002" />
 <bp:stepProcess rdf:resource="#Catalysis359" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2344">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence39">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1015">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2347">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence38">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1016">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2346">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence37">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1017">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2349">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence36">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1018">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2348">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1154">
 <bp:stepProcess rdf:resource="#Pathway157" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2486">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2164" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1153">
 <bp:stepProcess rdf:resource="#BiochemicalReaction998" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2487">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2165" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1152">
 <bp:stepProcess rdf:resource="#BiochemicalReaction997" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2488">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2166" />
 <bp:stepProcess rdf:resource="#Catalysis669" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1151">
 <bp:stepProcess rdf:resource="#BiochemicalReaction996" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2489">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2167" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence31">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1158">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1001" />
 <bp:stepProcess rdf:resource="#Catalysis358" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2482">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2160" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence30">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1157">
 <bp:stepProcess rdf:resource="#Pathway158" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2483">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2161" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1156">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1000" />
 <bp:stepProcess rdf:resource="#Catalysis357" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2341">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2484">
 <bp:stepProcess rdf:resource="#Catalysis668" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2162" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1010">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1155">
 <bp:stepProcess rdf:resource="#Catalysis356" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction999" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2340">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2485">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2163" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2490">
 <bp:stepProcess rdf:resource="#Pathway324" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2491">
 <bp:stepProcess rdf:resource="#Pathway325" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2492">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2168" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1161">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1004" />
 <bp:stepProcess rdf:resource="#Catalysis360" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1160">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1003" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1019">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence46">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1044">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1129">
 <bp:stepProcess rdf:resource="#BiochemicalReaction976" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2376">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence45">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1045">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1128">
 <bp:stepProcess rdf:resource="#BiochemicalReaction975" />
 <bp:stepProcess rdf:resource="#Catalysis348" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2375">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence44">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1046">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1127">
 <bp:stepProcess rdf:resource="#BiochemicalReaction974" />
 <bp:stepProcess rdf:resource="#Catalysis347" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2378">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence43">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1047">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1126">
 <bp:stepProcess rdf:resource="#BiochemicalReaction973" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2377">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1048">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2457">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2140" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence49">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1049">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2379">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2458">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2141" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence48">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2459">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2142" />
 <bp:stepProcess rdf:resource="#Catalysis659" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence47">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1121">
 <bp:stepProcess rdf:resource="#BiochemicalReaction969" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2453">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2137" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1120">
 <bp:stepProcess rdf:resource="#BiochemicalReaction968" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2454">
 <bp:stepProcess rdf:resource="#Pathway318" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2370">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2455">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2138" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2456">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2139" />
 <bp:stepProcess rdf:resource="#Catalysis658" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence42">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1040">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1125">
 <bp:stepProcess rdf:resource="#Pathway154" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2372">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence41">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1041">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1124">
 <bp:stepProcess rdf:resource="#BiochemicalReaction972" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2371">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2450">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2134" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence40">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1042">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1123">
 <bp:stepProcess rdf:resource="#BiochemicalReaction971" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2374">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2451">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2135" />
 <bp:stepProcess rdf:resource="#Catalysis656" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1043">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1122">
 <bp:stepProcess rdf:resource="#BiochemicalReaction970" />
 <bp:stepProcess rdf:resource="#Catalysis346" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2373">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2452">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2136" />
 <bp:stepProcess rdf:resource="#Catalysis657" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence57">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1033">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2365">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence56">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1034">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1139">
 <bp:stepProcess rdf:resource="#BiochemicalReaction985" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2364">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence55">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1035">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1138">
 <bp:stepProcess rdf:resource="#BiochemicalReaction984" />
 <bp:stepProcess rdf:resource="#Catalysis350" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2367">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence54">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1036">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1137">
 <bp:stepProcess rdf:resource="#Pathway155" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2366">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1037">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2369">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2468">
 <bp:stepProcess rdf:resource="#Pathway321" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1038">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2368">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2469">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2149" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence59">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1039">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence58">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1132">
 <bp:stepProcess rdf:resource="#BiochemicalReaction979" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2464">
 <bp:stepProcess rdf:resource="#Catalysis661" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2146" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1131">
 <bp:stepProcess rdf:resource="#BiochemicalReaction978" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2465">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2147" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1130">
 <bp:stepProcess rdf:resource="#BiochemicalReaction977" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2466">
 <bp:stepProcess rdf:resource="#Pathway320" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2467">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2148" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence53">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1136">
 <bp:stepProcess rdf:resource="#BiochemicalReaction983" />
 <bp:stepProcess rdf:resource="#Catalysis349" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2361">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2460">
 <bp:stepProcess rdf:resource="#Pathway319" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence52">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1030">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1135">
 <bp:stepProcess rdf:resource="#BiochemicalReaction982" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2360">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2461">
 <bp:stepProcess rdf:resource="#Catalysis660" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2143" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence51">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1031">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1134">
 <bp:stepProcess rdf:resource="#BiochemicalReaction981" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2363">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2462">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2144" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence50">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1032">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1133">
 <bp:stepProcess rdf:resource="#BiochemicalReaction980" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2362">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2463">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2145" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2470">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2150" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1107">
 <bp:stepProcess rdf:resource="#BiochemicalReaction958" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2310">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2439">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2127" />
 <bp:stepProcess rdf:resource="#Catalysis653" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1106">
 <bp:stepProcess rdf:resource="#Pathway150" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1105">
 <bp:stepProcess rdf:resource="#Pathway149" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2312">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1104">
 <bp:stepProcess rdf:resource="#BiochemicalReaction957" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2311">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2314">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2435">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2124" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2313">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2436">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2125" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1109">
 <bp:stepProcess rdf:resource="#Pathway151" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2316">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2437">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2126" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1108">
 <bp:stepProcess rdf:resource="#BiochemicalReaction959" />
 <bp:stepProcess rdf:resource="#Catalysis344" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2315">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2438">
 <bp:stepProcess rdf:resource="#Pathway313" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2431">
 <bp:stepProcess rdf:resource="#Catalysis651" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2120" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2432">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2121" />
 <bp:stepProcess rdf:resource="#Catalysis652" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2433">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2122" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2434">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2123" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1103">
 <bp:stepProcess rdf:resource="#Catalysis343" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction956" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1102">
 <bp:stepProcess rdf:resource="#BiochemicalReaction955" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1101">
 <bp:stepProcess rdf:resource="#BiochemicalReaction954" />
 <bp:stepProcess rdf:resource="#Catalysis342" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1100">
 <bp:stepProcess rdf:resource="#BiochemicalReaction953" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2430">
 <bp:stepProcess rdf:resource="#Catalysis650" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2119" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2318">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2317">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2319">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1118">
 <bp:stepProcess rdf:resource="#Pathway153" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1117">
 <bp:stepProcess rdf:resource="#BiochemicalReaction966" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1116">
 <bp:stepProcess rdf:resource="#BiochemicalReaction965" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2301">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1115">
 <bp:stepProcess rdf:resource="#BiochemicalReaction964" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2300">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2303">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2446">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2131" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2302">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2447">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2132" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2305">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2448">
 <bp:stepProcess rdf:resource="#Pathway317" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1119">
 <bp:stepProcess rdf:resource="#BiochemicalReaction967" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2304">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2449">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2133" />
 <bp:stepProcess rdf:resource="#Catalysis655" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1110">
 <bp:stepProcess rdf:resource="#BiochemicalReaction960" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2442">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2130" />
 <bp:stepProcess rdf:resource="#Catalysis654" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2443">
 <bp:stepProcess rdf:resource="#Pathway314" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2444">
 <bp:stepProcess rdf:resource="#Pathway315" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2445">
 <bp:stepProcess rdf:resource="#Pathway316" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1114">
 <bp:stepProcess rdf:resource="#Pathway152" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1113">
 <bp:stepProcess rdf:resource="#BiochemicalReaction963" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1112">
 <bp:stepProcess rdf:resource="#BiochemicalReaction962" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2440">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2128" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1111">
 <bp:stepProcess rdf:resource="#BiochemicalReaction961" />
 <bp:stepProcess rdf:resource="#Catalysis345" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2441">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2129" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2307">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2306">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2309">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2308">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1000">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2332">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2417">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2107" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1001">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2331">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2418">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2108" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1002">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2334">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2419">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2109" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1003">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2333">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep699">
 <bp:stepProcess rdf:resource="#BiochemicalReaction601" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1004">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2336">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2413">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2103" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1005">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2335">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2414">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2104" />
 <bp:stepProcess rdf:resource="#Catalysis644" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep697">
 <bp:stepProcess rdf:resource="#BiochemicalReaction599" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1006">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2338">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2415">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2105" />
 <bp:stepProcess rdf:resource="#Catalysis645" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep698">
 <bp:stepProcess rdf:resource="#BiochemicalReaction600" />
 <bp:stepProcess rdf:resource="#Catalysis233" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1007">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2337">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2416">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2106" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2410">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2100" />
 <bp:stepProcess rdf:resource="#Catalysis643" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2411">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2101" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2412">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2102" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2330">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep695">
 <bp:stepProcess rdf:resource="#Catalysis232" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction597" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1008">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep696">
 <bp:stepProcess rdf:resource="#BiochemicalReaction598" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1009">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2339">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep693">
 <bp:stepProcess rdf:resource="#BiochemicalReaction596" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep694">
 <bp:stepProcess rdf:resource="#Pathway99" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep691">
 <bp:stepProcess rdf:resource="#BiochemicalReaction594" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep692">
 <bp:stepProcess rdf:resource="#BiochemicalReaction595" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep690">
 <bp:stepProcess rdf:resource="#BiochemicalReaction593" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence13">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2321">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2428">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2117" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence12">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2320">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2429">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2118" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence11">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2323">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence10">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2322">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence17">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep688">
 <bp:stepProcess rdf:resource="#Pathway98" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2325">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2424">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2114" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence16">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep689">
 <bp:stepProcess rdf:resource="#BiochemicalReaction592" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2324">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2425">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2115" />
 <bp:stepProcess rdf:resource="#Catalysis649" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence15">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep686">
 <bp:stepProcess rdf:resource="#BiochemicalReaction590" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2327">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2426">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2116" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence14">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep687">
 <bp:stepProcess rdf:resource="#BiochemicalReaction591" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2326">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2427">
 <bp:stepProcess rdf:resource="#Pathway312" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2420">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2110" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2421">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2111" />
 <bp:stepProcess rdf:resource="#Catalysis646" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2422">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2112" />
 <bp:stepProcess rdf:resource="#Catalysis647" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2423">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2113" />
 <bp:stepProcess rdf:resource="#Catalysis648" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep684">
 <bp:stepProcess rdf:resource="#BiochemicalReaction588" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2329">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep685">
 <bp:stepProcess rdf:resource="#BiochemicalReaction589" />
 <bp:stepProcess rdf:resource="#Catalysis231" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2328">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence19">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep682">
 <bp:stepProcess rdf:resource="#BiochemicalReaction586" />
 <bp:stepProcess rdf:resource="#Catalysis229" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence18">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep683">
 <bp:stepProcess rdf:resource="#Catalysis230" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction587" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep680">
 <bp:stepProcess rdf:resource="#BiochemicalReaction584" />
 <bp:stepProcess rdf:resource="#Catalysis227" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep681">
 <bp:stepProcess rdf:resource="#BiochemicalReaction585" />
 <bp:stepProcess rdf:resource="#Catalysis228" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep679">
 <bp:stepProcess rdf:resource="#Pathway97" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep677">
 <bp:stepProcess rdf:resource="#BiochemicalReaction582" />
 <bp:stepProcess rdf:resource="#Catalysis226" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep678">
 <bp:stepProcess rdf:resource="#BiochemicalReaction583" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep675">
 <bp:stepProcess rdf:resource="#BiochemicalReaction580" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep676">
 <bp:stepProcess rdf:resource="#BiochemicalReaction581" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep673">
 <bp:stepProcess rdf:resource="#BiochemicalReaction578" />
 <bp:stepProcess rdf:resource="#Catalysis224" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep674">
 <bp:stepProcess rdf:resource="#BiochemicalReaction579" />
 <bp:stepProcess rdf:resource="#Catalysis225" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep671">
 <bp:stepProcess rdf:resource="#BiochemicalReaction576" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep672">
 <bp:stepProcess rdf:resource="#BiochemicalReaction577" />
 <bp:stepProcess rdf:resource="#Catalysis223" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep670">
 <bp:stepProcess rdf:resource="#Pathway96" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep668">
 <bp:stepProcess rdf:resource="#BiochemicalReaction574" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep669">
 <bp:stepProcess rdf:resource="#BiochemicalReaction575" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep666">
 <bp:stepProcess rdf:resource="#Catalysis221" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction572" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep667">
 <bp:stepProcess rdf:resource="#Catalysis222" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction573" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep664">
 <bp:stepProcess rdf:resource="#BiochemicalReaction570" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep665">
 <bp:stepProcess rdf:resource="#BiochemicalReaction571" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep662">
 <bp:stepProcess rdf:resource="#Pathway95" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep663">
 <bp:stepProcess rdf:resource="#Catalysis220" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction569" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep660">
 <bp:stepProcess rdf:resource="#BiochemicalReaction567" />
 <bp:stepProcess rdf:resource="#Catalysis219" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep661">
 <bp:stepProcess rdf:resource="#BiochemicalReaction568" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep659">
 <bp:stepProcess rdf:resource="#BiochemicalReaction566" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep657">
 <bp:stepProcess rdf:resource="#BiochemicalReaction564" />
 <bp:stepProcess rdf:resource="#Catalysis217" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep658">
 <bp:stepProcess rdf:resource="#BiochemicalReaction565" />
 <bp:stepProcess rdf:resource="#Catalysis218" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep655">
 <bp:stepProcess rdf:resource="#BiochemicalReaction562" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep656">
 <bp:stepProcess rdf:resource="#BiochemicalReaction563" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep653">
 <bp:stepProcess rdf:resource="#Pathway94" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep654">
 <bp:stepProcess rdf:resource="#BiochemicalReaction561" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep651">
 <bp:stepProcess rdf:resource="#BiochemicalReaction559" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep652">
 <bp:stepProcess rdf:resource="#BiochemicalReaction560" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep650">
 <bp:stepProcess rdf:resource="#Pathway93" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep648">
 <bp:stepProcess rdf:resource="#BiochemicalReaction557" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep649">
 <bp:stepProcess rdf:resource="#BiochemicalReaction558" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep646">
 <bp:stepProcess rdf:resource="#BiochemicalReaction555" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep647">
 <bp:stepProcess rdf:resource="#BiochemicalReaction556" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep644">
 <bp:stepProcess rdf:resource="#BiochemicalReaction553" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep645">
 <bp:stepProcess rdf:resource="#BiochemicalReaction554" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep642">
 <bp:stepProcess rdf:resource="#BiochemicalReaction551" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep643">
 <bp:stepProcess rdf:resource="#BiochemicalReaction552" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep640">
 <bp:stepProcess rdf:resource="#Catalysis216" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction549" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep641">
 <bp:stepProcess rdf:resource="#BiochemicalReaction550" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep637">
 <bp:stepProcess rdf:resource="#BiochemicalReaction546" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep638">
 <bp:stepProcess rdf:resource="#BiochemicalReaction547" />
 <bp:stepProcess rdf:resource="#Catalysis215" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep635">
 <bp:stepProcess rdf:resource="#BiochemicalReaction544" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep636">
 <bp:stepProcess rdf:resource="#BiochemicalReaction545" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep633">
 <bp:stepProcess rdf:resource="#Pathway91" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep634">
 <bp:stepProcess rdf:resource="#Pathway92" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep631">
 <bp:stepProcess rdf:resource="#BiochemicalReaction543" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep632">
 <bp:stepProcess rdf:resource="#Pathway90" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1187">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1028" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1186">
 <bp:stepProcess rdf:resource="#Catalysis373" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1027" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1185">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1026" />
 <bp:stepProcess rdf:resource="#Catalysis372" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1184">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1025" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep639">
 <bp:stepProcess rdf:resource="#BiochemicalReaction548" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1189">
 <bp:stepProcess rdf:resource="#Catalysis374" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1030" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1188">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1029" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1190">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1031" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1194">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1035" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1193">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1034" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1192">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1033" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1191">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1032" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep630">
 <bp:stepProcess rdf:resource="#BiochemicalReaction542" />
 <bp:stepProcess rdf:resource="#Catalysis214" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep626">
 <bp:stepProcess rdf:resource="#BiochemicalReaction539" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep627">
 <bp:stepProcess rdf:resource="#BiochemicalReaction540" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep624">
 <bp:stepProcess rdf:resource="#BiochemicalReaction538" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep625">
 <bp:stepProcess rdf:resource="#Pathway88" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep622">
 <bp:stepProcess rdf:resource="#BiochemicalReaction536" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep623">
 <bp:stepProcess rdf:resource="#BiochemicalReaction537" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep620">
 <bp:stepProcess rdf:resource="#BiochemicalReaction534" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep621">
 <bp:stepProcess rdf:resource="#BiochemicalReaction535" />
 <bp:stepProcess rdf:resource="#Catalysis213" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1198">
 <bp:stepProcess rdf:resource="#Pathway162" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1197">
 <bp:stepProcess rdf:resource="#Pathway161" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1196">
 <bp:stepProcess rdf:resource="#Catalysis376" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1037" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1195">
 <bp:stepProcess rdf:resource="#Catalysis375" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1036" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep628">
 <bp:stepProcess rdf:resource="#Pathway89" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep629">
 <bp:stepProcess rdf:resource="#BiochemicalReaction541" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1199">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1038" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep615">
 <bp:stepProcess rdf:resource="#Pathway86" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep616">
 <bp:stepProcess rdf:resource="#BiochemicalReaction531" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep613">
 <bp:stepProcess rdf:resource="#BiochemicalReaction529" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep614">
 <bp:stepProcess rdf:resource="#Catalysis211" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction530" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep611">
 <bp:stepProcess rdf:resource="#Catalysis210" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction527" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep612">
 <bp:stepProcess rdf:resource="#BiochemicalReaction528" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep610">
 <bp:stepProcess rdf:resource="#BiochemicalReaction526" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1165">
 <bp:stepProcess rdf:resource="#Pathway159" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2497">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2173" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1164">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1007" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2498">
 <bp:stepProcess rdf:resource="#Catalysis671" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2174" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1163">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1006" />
 <bp:stepProcess rdf:resource="#Catalysis361" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2499">
 <bp:stepProcess rdf:resource="#Catalysis672" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2175" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1162">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1005" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep619">
 <bp:stepProcess rdf:resource="#BiochemicalReaction533" />
 <bp:stepProcess rdf:resource="#Catalysis212" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1169">
 <bp:stepProcess rdf:resource="#Catalysis364" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1011" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2493">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2169" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1168">
 <bp:stepProcess rdf:resource="#Catalysis363" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1010" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2494">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2170" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep617">
 <bp:stepProcess rdf:resource="#BiochemicalReaction532" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1167">
 <bp:stepProcess rdf:resource="#Catalysis362" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1009" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2495">
 <bp:stepProcess rdf:resource="#Catalysis670" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2171" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep618">
 <bp:stepProcess rdf:resource="#Pathway87" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1166">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1008" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2496">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2172" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1172">
 <bp:stepProcess rdf:resource="#Catalysis365" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1014" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1171">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1013" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1170">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1012" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep604">
 <bp:stepProcess rdf:resource="#BiochemicalReaction522" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep605">
 <bp:stepProcess rdf:resource="#Pathway84" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep602">
 <bp:stepProcess rdf:resource="#Pathway83" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep603">
 <bp:stepProcess rdf:resource="#BiochemicalReaction521" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep600">
 <bp:stepProcess rdf:resource="#BiochemicalReaction520" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep601">
 <bp:stepProcess rdf:resource="#Pathway82" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1176">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1017" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1175">
 <bp:stepProcess rdf:resource="#Pathway160" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1174">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1016" />
 <bp:stepProcess rdf:resource="#Catalysis367" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1173">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1015" />
 <bp:stepProcess rdf:resource="#Catalysis366" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep608">
 <bp:stepProcess rdf:resource="#Pathway85" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep609">
 <bp:stepProcess rdf:resource="#BiochemicalReaction525" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1179">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1020" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep606">
 <bp:stepProcess rdf:resource="#BiochemicalReaction523" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1178">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1019" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep607">
 <bp:stepProcess rdf:resource="#BiochemicalReaction524" />
 <bp:stepProcess rdf:resource="#Catalysis209" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1177">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1018" />
 <bp:stepProcess rdf:resource="#Catalysis368" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1183">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1024" />
 <bp:stepProcess rdf:resource="#Catalysis371" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1182">
 <bp:stepProcess rdf:resource="#Catalysis370" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1023" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1181">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1022" />
 <bp:stepProcess rdf:resource="#Catalysis369" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1180">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1021" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep714">
 <bp:stepProcess rdf:resource="#BiochemicalReaction614" />
 <bp:stepProcess rdf:resource="#Catalysis237" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep715">
 <bp:stepProcess rdf:resource="#Pathway102" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep712">
 <bp:stepProcess rdf:resource="#BiochemicalReaction612" />
 <bp:stepProcess rdf:resource="#Catalysis235" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep713">
 <bp:stepProcess rdf:resource="#BiochemicalReaction613" />
 <bp:stepProcess rdf:resource="#Catalysis236" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep710">
 <bp:stepProcess rdf:resource="#BiochemicalReaction610" />
 <bp:stepProcess rdf:resource="#Catalysis234" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep711">
 <bp:stepProcess rdf:resource="#BiochemicalReaction611" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep718">
 <bp:stepProcess rdf:resource="#BiochemicalReaction616" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep719">
 <bp:stepProcess rdf:resource="#BiochemicalReaction617" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep716">
 <bp:stepProcess rdf:resource="#Pathway103" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep717">
 <bp:stepProcess rdf:resource="#Catalysis238" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction615" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep703">
 <bp:stepProcess rdf:resource="#BiochemicalReaction604" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep704">
 <bp:stepProcess rdf:resource="#BiochemicalReaction605" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep701">
 <bp:stepProcess rdf:resource="#BiochemicalReaction602" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep702">
 <bp:stepProcess rdf:resource="#BiochemicalReaction603" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep700">
 <bp:stepProcess rdf:resource="#Pathway100" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep709">
 <bp:stepProcess rdf:resource="#Pathway101" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep707">
 <bp:stepProcess rdf:resource="#BiochemicalReaction608" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep708">
 <bp:stepProcess rdf:resource="#BiochemicalReaction609" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep705">
 <bp:stepProcess rdf:resource="#BiochemicalReaction606" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep706">
 <bp:stepProcess rdf:resource="#BiochemicalReaction607" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2199">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2192">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2191">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2194">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2193">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2196">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2195">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2198">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2197">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2189">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2188">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2181">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2180">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2183">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2182">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2185">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2184">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2187">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2186">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2190">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence68">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2156">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence67">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2155">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence66">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2158">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence65">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2157">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2159">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence69">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence60">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2150">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence64">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2152">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence63">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2151">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence62">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2154">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence61">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2153">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence79">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2145">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence78">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2144">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence77">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2147">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence76">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2146">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2149">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2148">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence71">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence70">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence75">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2141">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence74">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2140">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence73">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2143">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence72">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2142">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2178">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence89">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2177">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence88">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence87">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2179">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence82">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2170">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence81">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence80">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2172">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2171">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence86">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2174">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence85">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2173">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence84">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2176">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence83">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2175">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2167">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2166">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence99">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2169">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence98">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2168">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence93">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence92">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence91">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2161">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence90">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2160">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence97">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2163">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence96">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2162">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence95">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2165">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence94">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2164">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2233">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1029">
 <bp:stepProcess rdf:resource="#BiochemicalReaction893" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2232">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1028">
 <bp:stepProcess rdf:resource="#BiochemicalReaction892" />
 <bp:stepProcess rdf:resource="#Catalysis315" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2235">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1027">
 <bp:stepProcess rdf:resource="#BiochemicalReaction891" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2234">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2237">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2358">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2052" />
 <bp:stepProcess rdf:resource="#Catalysis621" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2236">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2359">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2053" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2239">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2238">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1022">
 <bp:stepProcess rdf:resource="#BiochemicalReaction888" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2354">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2048" />
 <bp:stepProcess rdf:resource="#Catalysis619" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1021">
 <bp:stepProcess rdf:resource="#BiochemicalReaction887" />
 <bp:stepProcess rdf:resource="#Catalysis312" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2355">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2049" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1020">
 <bp:stepProcess rdf:resource="#BiochemicalReaction886" />
 <bp:stepProcess rdf:resource="#Catalysis311" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2356">
 <bp:stepProcess rdf:resource="#Catalysis620" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2050" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2357">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2051" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1026">
 <bp:stepProcess rdf:resource="#Pathway137" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2350">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2045" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1025">
 <bp:stepProcess rdf:resource="#Pathway136" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2351">
 <bp:stepProcess rdf:resource="#Catalysis617" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2046" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1024">
 <bp:stepProcess rdf:resource="#BiochemicalReaction890" />
 <bp:stepProcess rdf:resource="#Catalysis314" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2231">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2352">
 <bp:stepProcess rdf:resource="#Pathway307" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1023">
 <bp:stepProcess rdf:resource="#BiochemicalReaction889" />
 <bp:stepProcess rdf:resource="#Catalysis313" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2230">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2353">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2047" />
 <bp:stepProcess rdf:resource="#Catalysis618" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2360">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2054" />
 <bp:stepProcess rdf:resource="#Catalysis622" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2222">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2221">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1039">
 <bp:stepProcess rdf:resource="#BiochemicalReaction898" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2224">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1038">
 <bp:stepProcess rdf:resource="#Pathway142" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2223">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2226">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2369">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2062" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2225">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2228">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2227">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1033">
 <bp:stepProcess rdf:resource="#BiochemicalReaction896" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2365">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2059" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1032">
 <bp:stepProcess rdf:resource="#Pathway138" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2366">
 <bp:stepProcess rdf:resource="#Pathway308" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1031">
 <bp:stepProcess rdf:resource="#BiochemicalReaction895" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2367">
 <bp:stepProcess rdf:resource="#Catalysis625" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2060" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1030">
 <bp:stepProcess rdf:resource="#BiochemicalReaction894" />
 <bp:stepProcess rdf:resource="#Catalysis316" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2368">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2061" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1037">
 <bp:stepProcess rdf:resource="#BiochemicalReaction897" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2361">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2055" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1036">
 <bp:stepProcess rdf:resource="#Pathway141" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2362">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2056" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1035">
 <bp:stepProcess rdf:resource="#Pathway140" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2220">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2363">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2057" />
 <bp:stepProcess rdf:resource="#Catalysis623" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1034">
 <bp:stepProcess rdf:resource="#Pathway139" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2364">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2058" />
 <bp:stepProcess rdf:resource="#Catalysis624" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2370">
 <bp:stepProcess rdf:resource="#Catalysis626" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2063" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2371">
 <bp:stepProcess rdf:resource="#Catalysis627" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2064" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1040">
 <bp:stepProcess rdf:resource="#BiochemicalReaction899" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2229">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1008">
 <bp:stepProcess rdf:resource="#BiochemicalReaction875" />
 <bp:stepProcess rdf:resource="#Catalysis302" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2255">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1007">
 <bp:stepProcess rdf:resource="#BiochemicalReaction874" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2254">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1006">
 <bp:stepProcess rdf:resource="#BiochemicalReaction873" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2257">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1005">
 <bp:stepProcess rdf:resource="#BiochemicalReaction872" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2256">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2259">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2336">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2034" />
 <bp:stepProcess rdf:resource="#Catalysis612" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2258">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2337">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2035" />
 <bp:stepProcess rdf:resource="#Catalysis613" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2338">
 <bp:stepProcess rdf:resource="#Pathway304" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1009">
 <bp:stepProcess rdf:resource="#BiochemicalReaction876" />
 <bp:stepProcess rdf:resource="#Catalysis303" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2339">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2036" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1000">
 <bp:stepProcess rdf:resource="#BiochemicalReaction869" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2332">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2030" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2333">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2031" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2334">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2032" />
 <bp:stepProcess rdf:resource="#Catalysis611" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2335">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2033" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1004">
 <bp:stepProcess rdf:resource="#Pathway134" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2251">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1003">
 <bp:stepProcess rdf:resource="#Pathway133" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2250">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1002">
 <bp:stepProcess rdf:resource="#BiochemicalReaction871" />
 <bp:stepProcess rdf:resource="#Catalysis301" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2253">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2330">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2029" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1001">
 <bp:stepProcess rdf:resource="#BiochemicalReaction870" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2252">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2331">
 <bp:stepProcess rdf:resource="#Pathway303" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1019">
 <bp:stepProcess rdf:resource="#BiochemicalReaction885" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2244">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1018">
 <bp:stepProcess rdf:resource="#Catalysis310" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction884" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2243">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1017">
 <bp:stepProcess rdf:resource="#Catalysis309" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction883" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2246">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1016">
 <bp:stepProcess rdf:resource="#BiochemicalReaction882" />
 <bp:stepProcess rdf:resource="#Catalysis308" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2245">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2248">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2347">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2043" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2247">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2348">
 <bp:stepProcess rdf:resource="#Pathway306" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2349">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2044" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2249">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1011">
 <bp:stepProcess rdf:resource="#BiochemicalReaction878" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2343">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2039" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1010">
 <bp:stepProcess rdf:resource="#BiochemicalReaction877" />
 <bp:stepProcess rdf:resource="#Catalysis304" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2344">
 <bp:stepProcess rdf:resource="#Catalysis614" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2040" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2345">
 <bp:stepProcess rdf:resource="#Catalysis615" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2041" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2346">
 <bp:stepProcess rdf:resource="#Catalysis616" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2042" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1015">
 <bp:stepProcess rdf:resource="#BiochemicalReaction881" />
 <bp:stepProcess rdf:resource="#Catalysis307" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2240">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1014">
 <bp:stepProcess rdf:resource="#BiochemicalReaction880" />
 <bp:stepProcess rdf:resource="#Catalysis306" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2340">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2037" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1013">
 <bp:stepProcess rdf:resource="#Catalysis305" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction879" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2242">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2341">
 <bp:stepProcess rdf:resource="#Pathway305" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1012">
 <bp:stepProcess rdf:resource="#Pathway135" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2241">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2342">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2038" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2318">
 <bp:stepProcess rdf:resource="#Pathway299" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2319">
 <bp:stepProcess rdf:resource="#Pathway300" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2314">
 <bp:stepProcess rdf:resource="#Pathway297" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2315">
 <bp:stepProcess rdf:resource="#Pathway298" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2316">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2019" />
 <bp:stepProcess rdf:resource="#Catalysis605" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2317">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2020" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2310">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2017" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2311">
 <bp:stepProcess rdf:resource="#Pathway295" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2312">
 <bp:stepProcess rdf:resource="#Pathway296" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2313">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2018" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2329">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2028" />
 <bp:stepProcess rdf:resource="#Catalysis610" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2325">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2024" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2326">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2025" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2327">
 <bp:stepProcess rdf:resource="#Catalysis609" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2026" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2328">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2027" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2321">
 <bp:stepProcess rdf:resource="#Catalysis606" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2021" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2322">
 <bp:stepProcess rdf:resource="#Catalysis607" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2022" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2323">
 <bp:stepProcess rdf:resource="#Pathway302" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2324">
 <bp:stepProcess rdf:resource="#Catalysis608" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2023" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2320">
 <bp:stepProcess rdf:resource="#Pathway301" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2211">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2210">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2213">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2212">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2215">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2214">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2217">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2216">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2219">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2218">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2200">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2307">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2015" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2308">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2016" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2202">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2309">
 <bp:stepProcess rdf:resource="#Pathway294" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2201">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2204">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2303">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2011" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2203">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2304">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2012" />
 <bp:stepProcess rdf:resource="#Catalysis604" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2206">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2305">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2013" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2205">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2306">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2014" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2300">
 <bp:stepProcess rdf:resource="#Pathway293" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2301">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2009" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2302">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2010" />
 <bp:stepProcess rdf:resource="#Catalysis603" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2208">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2207">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2209">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence995">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence996">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence997">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence998">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep798">
 <bp:stepProcess rdf:resource="#Pathway111" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence991">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep799">
 <bp:stepProcess rdf:resource="#BiochemicalReaction689" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence992">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep796">
 <bp:stepProcess rdf:resource="#BiochemicalReaction687" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence993">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep797">
 <bp:stepProcess rdf:resource="#BiochemicalReaction688" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence994">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence990">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep794">
 <bp:stepProcess rdf:resource="#BiochemicalReaction685" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep795">
 <bp:stepProcess rdf:resource="#BiochemicalReaction686" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep792">
 <bp:stepProcess rdf:resource="#BiochemicalReaction683" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep793">
 <bp:stepProcess rdf:resource="#BiochemicalReaction684" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep790">
 <bp:stepProcess rdf:resource="#Pathway110" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence999">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep791">
 <bp:stepProcess rdf:resource="#BiochemicalReaction682" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence984">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence985">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep789">
 <bp:stepProcess rdf:resource="#BiochemicalReaction681" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence986">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence987">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep787">
 <bp:stepProcess rdf:resource="#BiochemicalReaction679" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence980">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep788">
 <bp:stepProcess rdf:resource="#Catalysis261" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction680" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence981">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep785">
 <bp:stepProcess rdf:resource="#BiochemicalReaction677" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence982">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep786">
 <bp:stepProcess rdf:resource="#BiochemicalReaction678" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence983">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep783">
 <bp:stepProcess rdf:resource="#Catalysis260" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction675" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep784">
 <bp:stepProcess rdf:resource="#BiochemicalReaction676" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep781">
 <bp:stepProcess rdf:resource="#BiochemicalReaction673" />
 <bp:stepProcess rdf:resource="#Catalysis259" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep782">
 <bp:stepProcess rdf:resource="#BiochemicalReaction674" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence988">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep780">
 <bp:stepProcess rdf:resource="#BiochemicalReaction672" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence989">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence973">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence974">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep778">
 <bp:stepProcess rdf:resource="#BiochemicalReaction670" />
 <bp:stepProcess rdf:resource="#Catalysis257" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence975">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep779">
 <bp:stepProcess rdf:resource="#BiochemicalReaction671" />
 <bp:stepProcess rdf:resource="#Catalysis258" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence976">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep776">
 <bp:stepProcess rdf:resource="#BiochemicalReaction668" />
 <bp:stepProcess rdf:resource="#Catalysis255" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep777">
 <bp:stepProcess rdf:resource="#BiochemicalReaction669" />
 <bp:stepProcess rdf:resource="#Catalysis256" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence970">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep774">
 <bp:stepProcess rdf:resource="#Pathway109" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence971">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep775">
 <bp:stepProcess rdf:resource="#BiochemicalReaction667" />
 <bp:stepProcess rdf:resource="#Catalysis254" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence972">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1088">
 <bp:stepProcess rdf:resource="#BiochemicalReaction942" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1087">
 <bp:stepProcess rdf:resource="#BiochemicalReaction941" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1086">
 <bp:stepProcess rdf:resource="#BiochemicalReaction940" />
 <bp:stepProcess rdf:resource="#Catalysis339" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1085">
 <bp:stepProcess rdf:resource="#Catalysis338" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction939" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1089">
 <bp:stepProcess rdf:resource="#Pathway148" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1091">
 <bp:stepProcess rdf:resource="#BiochemicalReaction944" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1090">
 <bp:stepProcess rdf:resource="#BiochemicalReaction943" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1095">
 <bp:stepProcess rdf:resource="#BiochemicalReaction948" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1094">
 <bp:stepProcess rdf:resource="#BiochemicalReaction947" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1093">
 <bp:stepProcess rdf:resource="#Catalysis340" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction946" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1092">
 <bp:stepProcess rdf:resource="#BiochemicalReaction945" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep772">
 <bp:stepProcess rdf:resource="#Pathway108" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep773">
 <bp:stepProcess rdf:resource="#BiochemicalReaction666" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep770">
 <bp:stepProcess rdf:resource="#BiochemicalReaction664" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep771">
 <bp:stepProcess rdf:resource="#BiochemicalReaction665" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence977">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence978">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence979">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep769">
 <bp:stepProcess rdf:resource="#BiochemicalReaction663" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence962">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence963">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep767">
 <bp:stepProcess rdf:resource="#Catalysis253" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction661" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence964">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep768">
 <bp:stepProcess rdf:resource="#BiochemicalReaction662" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence965">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep765">
 <bp:stepProcess rdf:resource="#Catalysis251" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction659" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep766">
 <bp:stepProcess rdf:resource="#Catalysis252" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction660" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep763">
 <bp:stepProcess rdf:resource="#BiochemicalReaction657" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence960">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep764">
 <bp:stepProcess rdf:resource="#BiochemicalReaction658" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence961">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1099">
 <bp:stepProcess rdf:resource="#BiochemicalReaction952" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1098">
 <bp:stepProcess rdf:resource="#BiochemicalReaction951" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1097">
 <bp:stepProcess rdf:resource="#Catalysis341" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction950" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1096">
 <bp:stepProcess rdf:resource="#BiochemicalReaction949" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep761">
 <bp:stepProcess rdf:resource="#BiochemicalReaction655" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep762">
 <bp:stepProcess rdf:resource="#BiochemicalReaction656" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep760">
 <bp:stepProcess rdf:resource="#BiochemicalReaction654" />
 <bp:stepProcess rdf:resource="#Catalysis250" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence966">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence967">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence968">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence969">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep758">
 <bp:stepProcess rdf:resource="#BiochemicalReaction652" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence951">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep759">
 <bp:stepProcess rdf:resource="#BiochemicalReaction653" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence952">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep756">
 <bp:stepProcess rdf:resource="#BiochemicalReaction650" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence953">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep757">
 <bp:stepProcess rdf:resource="#BiochemicalReaction651" />
 <bp:stepProcess rdf:resource="#Catalysis249" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence954">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep754">
 <bp:stepProcess rdf:resource="#BiochemicalReaction648" />
 <bp:stepProcess rdf:resource="#Catalysis248" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep755">
 <bp:stepProcess rdf:resource="#BiochemicalReaction649" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep752">
 <bp:stepProcess rdf:resource="#BiochemicalReaction646" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep753">
 <bp:stepProcess rdf:resource="#BiochemicalReaction647" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence950">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1066">
 <bp:stepProcess rdf:resource="#Pathway146" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2398">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2089" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1065">
 <bp:stepProcess rdf:resource="#BiochemicalReaction921" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2399">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2090" />
 <bp:stepProcess rdf:resource="#Catalysis640" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1064">
 <bp:stepProcess rdf:resource="#BiochemicalReaction920" />
 <bp:stepProcess rdf:resource="#Catalysis326" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1063">
 <bp:stepProcess rdf:resource="#BiochemicalReaction919" />
 <bp:stepProcess rdf:resource="#Catalysis325" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2394">
 <bp:stepProcess rdf:resource="#Pathway310" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1069">
 <bp:stepProcess rdf:resource="#Catalysis329" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction924" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2395">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2086" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1068">
 <bp:stepProcess rdf:resource="#Catalysis328" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction923" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2396">
 <bp:stepProcess rdf:resource="#Catalysis638" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2087" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1067">
 <bp:stepProcess rdf:resource="#Catalysis327" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction922" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2397">
 <bp:stepProcess rdf:resource="#Catalysis639" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2088" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1073">
 <bp:stepProcess rdf:resource="#Catalysis331" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction928" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1072">
 <bp:stepProcess rdf:resource="#BiochemicalReaction927" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1071">
 <bp:stepProcess rdf:resource="#BiochemicalReaction926" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1070">
 <bp:stepProcess rdf:resource="#Catalysis330" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction925" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep750">
 <bp:stepProcess rdf:resource="#BiochemicalReaction644" />
 <bp:stepProcess rdf:resource="#Catalysis246" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence959">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep751">
 <bp:stepProcess rdf:resource="#BiochemicalReaction645" />
 <bp:stepProcess rdf:resource="#Catalysis247" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence955">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence956">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence957">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence958">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep747">
 <bp:stepProcess rdf:resource="#BiochemicalReaction641" />
 <bp:stepProcess rdf:resource="#Catalysis245" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence940">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep748">
 <bp:stepProcess rdf:resource="#BiochemicalReaction642" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence941">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep745">
 <bp:stepProcess rdf:resource="#Catalysis244" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction639" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence942">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep746">
 <bp:stepProcess rdf:resource="#BiochemicalReaction640" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence943">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep743">
 <bp:stepProcess rdf:resource="#BiochemicalReaction638" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep744">
 <bp:stepProcess rdf:resource="#Pathway107" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep741">
 <bp:stepProcess rdf:resource="#Catalysis242" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction636" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep742">
 <bp:stepProcess rdf:resource="#Catalysis243" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction637" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1077">
 <bp:stepProcess rdf:resource="#BiochemicalReaction931" />
 <bp:stepProcess rdf:resource="#Catalysis333" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1076">
 <bp:stepProcess rdf:resource="#BiochemicalReaction930" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1075">
 <bp:stepProcess rdf:resource="#Catalysis332" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction929" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1074">
 <bp:stepProcess rdf:resource="#Pathway147" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep749">
 <bp:stepProcess rdf:resource="#BiochemicalReaction643" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1079">
 <bp:stepProcess rdf:resource="#BiochemicalReaction933" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1078">
 <bp:stepProcess rdf:resource="#BiochemicalReaction932" />
 <bp:stepProcess rdf:resource="#Catalysis334" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1080">
 <bp:stepProcess rdf:resource="#BiochemicalReaction934" />
 <bp:stepProcess rdf:resource="#Catalysis335" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1084">
 <bp:stepProcess rdf:resource="#BiochemicalReaction938" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1083">
 <bp:stepProcess rdf:resource="#BiochemicalReaction937" />
 <bp:stepProcess rdf:resource="#Catalysis337" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1082">
 <bp:stepProcess rdf:resource="#BiochemicalReaction936" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1081">
 <bp:stepProcess rdf:resource="#Catalysis336" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction935" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence948">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep740">
 <bp:stepProcess rdf:resource="#BiochemicalReaction635" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence949">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence944">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence945">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence946">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence947">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep736">
 <bp:stepProcess rdf:resource="#Pathway106" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep737">
 <bp:stepProcess rdf:resource="#BiochemicalReaction632" />
 <bp:stepProcess rdf:resource="#Catalysis241" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence930">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep734">
 <bp:stepProcess rdf:resource="#BiochemicalReaction630" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence931">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep735">
 <bp:stepProcess rdf:resource="#BiochemicalReaction631" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence932">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1049">
 <bp:stepProcess rdf:resource="#BiochemicalReaction908" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep732">
 <bp:stepProcess rdf:resource="#BiochemicalReaction628" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep733">
 <bp:stepProcess rdf:resource="#BiochemicalReaction629" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep730">
 <bp:stepProcess rdf:resource="#BiochemicalReaction626" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep731">
 <bp:stepProcess rdf:resource="#BiochemicalReaction627" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1044">
 <bp:stepProcess rdf:resource="#BiochemicalReaction903" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2376">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2069" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1043">
 <bp:stepProcess rdf:resource="#BiochemicalReaction902" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2377">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2070" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1042">
 <bp:stepProcess rdf:resource="#Catalysis318" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction901" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2378">
 <bp:stepProcess rdf:resource="#Catalysis629" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2071" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1041">
 <bp:stepProcess rdf:resource="#Catalysis317" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction900" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2379">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2072" />
 <bp:stepProcess rdf:resource="#Catalysis630" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1048">
 <bp:stepProcess rdf:resource="#Catalysis321" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction907" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2372">
 <bp:stepProcess rdf:resource="#Catalysis628" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2065" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1047">
 <bp:stepProcess rdf:resource="#BiochemicalReaction906" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2373">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2066" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep738">
 <bp:stepProcess rdf:resource="#BiochemicalReaction633" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1046">
 <bp:stepProcess rdf:resource="#Catalysis320" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction905" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2374">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2067" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep739">
 <bp:stepProcess rdf:resource="#BiochemicalReaction634" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1045">
 <bp:stepProcess rdf:resource="#Catalysis319" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction904" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2375">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2068" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2380">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2073" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2381">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2074" />
 <bp:stepProcess rdf:resource="#Catalysis631" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2382">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2075" />
 <bp:stepProcess rdf:resource="#Catalysis632" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1051">
 <bp:stepProcess rdf:resource="#BiochemicalReaction910" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1050">
 <bp:stepProcess rdf:resource="#BiochemicalReaction909" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence937">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence938">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence939">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence933">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence934">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence935">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence936">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep725">
 <bp:stepProcess rdf:resource="#BiochemicalReaction622" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep726">
 <bp:stepProcess rdf:resource="#BiochemicalReaction623" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep723">
 <bp:stepProcess rdf:resource="#BiochemicalReaction620" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence920">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep724">
 <bp:stepProcess rdf:resource="#BiochemicalReaction621" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence921">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep721">
 <bp:stepProcess rdf:resource="#BiochemicalReaction618" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep722">
 <bp:stepProcess rdf:resource="#BiochemicalReaction619" />
 <bp:stepProcess rdf:resource="#Catalysis239" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep720">
 <bp:stepProcess rdf:resource="#Pathway104" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1055">
 <bp:stepProcess rdf:resource="#Pathway144" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2387">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2080" />
 <bp:stepProcess rdf:resource="#Catalysis634" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1054">
 <bp:stepProcess rdf:resource="#BiochemicalReaction912" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2388">
 <bp:stepProcess rdf:resource="#Catalysis635" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2081" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1053">
 <bp:stepProcess rdf:resource="#BiochemicalReaction911" />
 <bp:stepProcess rdf:resource="#Catalysis322" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2389">
 <bp:stepProcess rdf:resource="#Catalysis636" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2082" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1052">
 <bp:stepProcess rdf:resource="#Pathway143" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep729">
 <bp:stepProcess rdf:resource="#Pathway105" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1059">
 <bp:stepProcess rdf:resource="#BiochemicalReaction916" />
 <bp:stepProcess rdf:resource="#Catalysis324" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2383">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2076" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1058">
 <bp:stepProcess rdf:resource="#BiochemicalReaction915" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2384">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2077" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep727">
 <bp:stepProcess rdf:resource="#BiochemicalReaction624" />
 <bp:stepProcess rdf:resource="#Catalysis240" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1057">
 <bp:stepProcess rdf:resource="#Catalysis323" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction914" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2385">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2078" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep728">
 <bp:stepProcess rdf:resource="#BiochemicalReaction625" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1056">
 <bp:stepProcess rdf:resource="#BiochemicalReaction913" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2386">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2079" />
 <bp:stepProcess rdf:resource="#Catalysis633" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2390">
 <bp:stepProcess rdf:resource="#Pathway309" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2391">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2083" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2392">
 <bp:stepProcess rdf:resource="#Catalysis637" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction2084" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2393">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2085" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1062">
 <bp:stepProcess rdf:resource="#BiochemicalReaction918" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1061">
 <bp:stepProcess rdf:resource="#Pathway145" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1060">
 <bp:stepProcess rdf:resource="#BiochemicalReaction917" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence926">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence927">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence928">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence929">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence922">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence923">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence924">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence925">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep835">
 <bp:stepProcess rdf:resource="#BiochemicalReaction719" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep836">
 <bp:stepProcess rdf:resource="#BiochemicalReaction720" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep833">
 <bp:stepProcess rdf:resource="#BiochemicalReaction718" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep834">
 <bp:stepProcess rdf:resource="#Pathway117" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence910">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep831">
 <bp:stepProcess rdf:resource="#BiochemicalReaction716" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep832">
 <bp:stepProcess rdf:resource="#BiochemicalReaction717" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep830">
 <bp:stepProcess rdf:resource="#BiochemicalReaction715" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep839">
 <bp:stepProcess rdf:resource="#Catalysis264" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction722" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep837">
 <bp:stepProcess rdf:resource="#Pathway118" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep838">
 <bp:stepProcess rdf:resource="#BiochemicalReaction721" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence919">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence915">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence916">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence917">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence918">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence911">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence912">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence913">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence914">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep824">
 <bp:stepProcess rdf:resource="#BiochemicalReaction710" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep825">
 <bp:stepProcess rdf:resource="#Pathway116" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep822">
 <bp:stepProcess rdf:resource="#Pathway115" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep823">
 <bp:stepProcess rdf:resource="#BiochemicalReaction709" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep820">
 <bp:stepProcess rdf:resource="#Catalysis263" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction707" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep821">
 <bp:stepProcess rdf:resource="#BiochemicalReaction708" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep828">
 <bp:stepProcess rdf:resource="#BiochemicalReaction713" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep829">
 <bp:stepProcess rdf:resource="#BiochemicalReaction714" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep826">
 <bp:stepProcess rdf:resource="#BiochemicalReaction711" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep827">
 <bp:stepProcess rdf:resource="#BiochemicalReaction712" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence908">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence909">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence904">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence905">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence906">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence907">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence900">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence901">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence902">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence903">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep813">
 <bp:stepProcess rdf:resource="#Pathway114" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep814">
 <bp:stepProcess rdf:resource="#BiochemicalReaction701" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep811">
 <bp:stepProcess rdf:resource="#Pathway112" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep812">
 <bp:stepProcess rdf:resource="#Pathway113" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep810">
 <bp:stepProcess rdf:resource="#BiochemicalReaction700" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep819">
 <bp:stepProcess rdf:resource="#BiochemicalReaction706" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep817">
 <bp:stepProcess rdf:resource="#BiochemicalReaction704" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep818">
 <bp:stepProcess rdf:resource="#BiochemicalReaction705" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep815">
 <bp:stepProcess rdf:resource="#BiochemicalReaction702" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep816">
 <bp:stepProcess rdf:resource="#BiochemicalReaction703" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep802">
 <bp:stepProcess rdf:resource="#BiochemicalReaction692" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep803">
 <bp:stepProcess rdf:resource="#BiochemicalReaction693" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep800">
 <bp:stepProcess rdf:resource="#BiochemicalReaction690" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep801">
 <bp:stepProcess rdf:resource="#BiochemicalReaction691" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep808">
 <bp:stepProcess rdf:resource="#BiochemicalReaction698" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep809">
 <bp:stepProcess rdf:resource="#BiochemicalReaction699" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep806">
 <bp:stepProcess rdf:resource="#BiochemicalReaction696" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep807">
 <bp:stepProcess rdf:resource="#BiochemicalReaction697" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep804">
 <bp:stepProcess rdf:resource="#BiochemicalReaction694" />
 <bp:stepProcess rdf:resource="#Catalysis262" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep805">
 <bp:stepProcess rdf:resource="#BiochemicalReaction695" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2079">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2078">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2071">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2070">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2073">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2072">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2075">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2074">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2077">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2076">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2080">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2068">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2067">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2069">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2060">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2062">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2061">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2064">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2063">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2066">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2065">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2093">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2092">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2095">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2094">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2097">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2096">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2099">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2098">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2089">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2082">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2081">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2084">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2083">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2086">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2085">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2088">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2087">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2091">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2090">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2035">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2034">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2037">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2036">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2039">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2038">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep89">
 <bp:stepProcess rdf:resource="#BiochemicalReaction79" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep88">
 <bp:stepProcess rdf:resource="#BiochemicalReaction78" />
 <bp:stepProcess rdf:resource="#Catalysis31" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep85">
 <bp:stepProcess rdf:resource="#BiochemicalReaction75" />
 <bp:stepProcess rdf:resource="#Catalysis28" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2031">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep84">
 <bp:stepProcess rdf:resource="#BiochemicalReaction74" />
 <bp:stepProcess rdf:resource="#Catalysis27" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2030">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep87">
 <bp:stepProcess rdf:resource="#BiochemicalReaction77" />
 <bp:stepProcess rdf:resource="#Catalysis30" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2033">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep86">
 <bp:stepProcess rdf:resource="#Catalysis29" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction76" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2032">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep92">
 <bp:stepProcess rdf:resource="#BiochemicalReaction81" />
 <bp:stepProcess rdf:resource="#Catalysis32" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep91">
 <bp:stepProcess rdf:resource="#Pathway12" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep94">
 <bp:stepProcess rdf:resource="#Pathway13" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep93">
 <bp:stepProcess rdf:resource="#BiochemicalReaction82" />
 <bp:stepProcess rdf:resource="#Catalysis33" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep90">
 <bp:stepProcess rdf:resource="#BiochemicalReaction80" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2024">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2023">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2026">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2025">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2028">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2027">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2029">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep78">
 <bp:stepProcess rdf:resource="#BiochemicalReaction68" />
 <bp:stepProcess rdf:resource="#Catalysis21" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep77">
 <bp:stepProcess rdf:resource="#BiochemicalReaction67" />
 <bp:stepProcess rdf:resource="#Catalysis20" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep79">
 <bp:stepProcess rdf:resource="#Catalysis22" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction69" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep74">
 <bp:stepProcess rdf:resource="#BiochemicalReaction65" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2020">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep73">
 <bp:stepProcess rdf:resource="#Catalysis19" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction64" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep76">
 <bp:stepProcess rdf:resource="#Pathway11" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2022">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep75">
 <bp:stepProcess rdf:resource="#BiochemicalReaction66" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2021">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep81">
 <bp:stepProcess rdf:resource="#BiochemicalReaction71" />
 <bp:stepProcess rdf:resource="#Catalysis24" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep80">
 <bp:stepProcess rdf:resource="#BiochemicalReaction70" />
 <bp:stepProcess rdf:resource="#Catalysis23" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep83">
 <bp:stepProcess rdf:resource="#BiochemicalReaction73" />
 <bp:stepProcess rdf:resource="#Catalysis26" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep82">
 <bp:stepProcess rdf:resource="#BiochemicalReaction72" />
 <bp:stepProcess rdf:resource="#Catalysis25" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2057">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2056">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2059">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2058">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2051">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2050">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2053">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2052">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2055">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2054">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2046">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2045">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2048">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2047">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2049">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep99">
 <bp:stepProcess rdf:resource="#Catalysis37" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction87" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2040">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep96">
 <bp:stepProcess rdf:resource="#BiochemicalReaction84" />
 <bp:stepProcess rdf:resource="#Catalysis35" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2042">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep95">
 <bp:stepProcess rdf:resource="#BiochemicalReaction83" />
 <bp:stepProcess rdf:resource="#Catalysis34" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2041">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep98">
 <bp:stepProcess rdf:resource="#BiochemicalReaction86" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2044">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep97">
 <bp:stepProcess rdf:resource="#BiochemicalReaction85" />
 <bp:stepProcess rdf:resource="#Catalysis36" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2043">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2112">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2111">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2114">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2113">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep49">
 <bp:stepProcess rdf:resource="#BiochemicalReaction42" />
 <bp:stepProcess rdf:resource="#Catalysis5" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2116">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2237">
 <bp:stepProcess rdf:resource="#Pathway278" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep48">
 <bp:stepProcess rdf:resource="#BiochemicalReaction41" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2115">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2238">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1961" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2118">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2239">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1962" />
 <bp:stepProcess rdf:resource="#Catalysis578" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2117">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep45">
 <bp:stepProcess rdf:resource="#BiochemicalReaction38" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2233">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1958" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep44">
 <bp:stepProcess rdf:resource="#BiochemicalReaction37" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2234">
 <bp:stepProcess rdf:resource="#Pathway277" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep47">
 <bp:stepProcess rdf:resource="#BiochemicalReaction40" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2235">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1959" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep46">
 <bp:stepProcess rdf:resource="#BiochemicalReaction39" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2236">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1960" />
 <bp:stepProcess rdf:resource="#Catalysis577" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep41">
 <bp:stepProcess rdf:resource="#BiochemicalReaction34" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep40">
 <bp:stepProcess rdf:resource="#BiochemicalReaction33" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2230">
 <bp:stepProcess rdf:resource="#Pathway276" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep43">
 <bp:stepProcess rdf:resource="#BiochemicalReaction36" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2110">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2231">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1956" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep42">
 <bp:stepProcess rdf:resource="#BiochemicalReaction35" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2232">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1957" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep50">
 <bp:stepProcess rdf:resource="#BiochemicalReaction43" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2119">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2101">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2100">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2103">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2102">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep38">
 <bp:stepProcess rdf:resource="#BiochemicalReaction31" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2105">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2248">
 <bp:stepProcess rdf:resource="#Catalysis583" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1970" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep37">
 <bp:stepProcess rdf:resource="#Pathway8" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2104">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2249">
 <bp:stepProcess rdf:resource="#Catalysis584" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1971" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2107">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep39">
 <bp:stepProcess rdf:resource="#BiochemicalReaction32" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2106">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep34">
 <bp:stepProcess rdf:resource="#BiochemicalReaction28" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2244">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1966" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep33">
 <bp:stepProcess rdf:resource="#Catalysis3" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction27" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2245">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1967" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep36">
 <bp:stepProcess rdf:resource="#BiochemicalReaction30" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2246">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1968" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep35">
 <bp:stepProcess rdf:resource="#BiochemicalReaction29" />
 <bp:stepProcess rdf:resource="#Catalysis4" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2247">
 <bp:stepProcess rdf:resource="#Catalysis582" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1969" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep30">
 <bp:stepProcess rdf:resource="#BiochemicalReaction25" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2240">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1963" />
 <bp:stepProcess rdf:resource="#Catalysis579" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2241">
 <bp:stepProcess rdf:resource="#Pathway279" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep32">
 <bp:stepProcess rdf:resource="#Pathway7" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2242">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1964" />
 <bp:stepProcess rdf:resource="#Catalysis580" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep31">
 <bp:stepProcess rdf:resource="#BiochemicalReaction26" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2243">
 <bp:stepProcess rdf:resource="#Catalysis581" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1965" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2250">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1972" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2109">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2108">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2134">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2219">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1946" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2133">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2136">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2135">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2138">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2215">
 <bp:stepProcess rdf:resource="#Pathway274" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2137">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2216">
 <bp:stepProcess rdf:resource="#Catalysis571" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1943" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2217">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1944" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2139">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2218">
 <bp:stepProcess rdf:resource="#Catalysis572" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1945" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep67">
 <bp:stepProcess rdf:resource="#BiochemicalReaction59" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2211">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1939" />
 <bp:stepProcess rdf:resource="#Catalysis569" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep66">
 <bp:stepProcess rdf:resource="#Catalysis15" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction58" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2212">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1940" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep69">
 <bp:stepProcess rdf:resource="#Pathway10" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2213">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1941" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep68">
 <bp:stepProcess rdf:resource="#BiochemicalReaction60" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2214">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1942" />
 <bp:stepProcess rdf:resource="#Catalysis570" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep63">
 <bp:stepProcess rdf:resource="#BiochemicalReaction55" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2130">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep62">
 <bp:stepProcess rdf:resource="#BiochemicalReaction54" />
 <bp:stepProcess rdf:resource="#Catalysis12" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep65">
 <bp:stepProcess rdf:resource="#Catalysis14" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction57" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2132">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep64">
 <bp:stepProcess rdf:resource="#Catalysis13" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction56" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2131">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2210">
 <bp:stepProcess rdf:resource="#Pathway273" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep70">
 <bp:stepProcess rdf:resource="#BiochemicalReaction61" />
 <bp:stepProcess rdf:resource="#Catalysis16" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep72">
 <bp:stepProcess rdf:resource="#Catalysis18" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction63" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep71">
 <bp:stepProcess rdf:resource="#BiochemicalReaction62" />
 <bp:stepProcess rdf:resource="#Catalysis17" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2123">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2122">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2125">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2124">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2127">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2226">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1952" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep59">
 <bp:stepProcess rdf:resource="#BiochemicalReaction51" />
 <bp:stepProcess rdf:resource="#Catalysis9" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2126">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2227">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1953" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2129">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2228">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1954" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2128">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2229">
 <bp:stepProcess rdf:resource="#Catalysis576" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1955" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep56">
 <bp:stepProcess rdf:resource="#BiochemicalReaction48" />
 <bp:stepProcess rdf:resource="#Catalysis8" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2222">
 <bp:stepProcess rdf:resource="#Pathway275" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep55">
 <bp:stepProcess rdf:resource="#BiochemicalReaction47" />
 <bp:stepProcess rdf:resource="#Catalysis7" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2223">
 <bp:stepProcess rdf:resource="#Catalysis574" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1949" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep58">
 <bp:stepProcess rdf:resource="#BiochemicalReaction50" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2224">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1950" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep57">
 <bp:stepProcess rdf:resource="#BiochemicalReaction49" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2225">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1951" />
 <bp:stepProcess rdf:resource="#Catalysis575" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep52">
 <bp:stepProcess rdf:resource="#BiochemicalReaction45" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep51">
 <bp:stepProcess rdf:resource="#BiochemicalReaction44" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep54">
 <bp:stepProcess rdf:resource="#Catalysis6" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction46" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2121">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2220">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1947" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep53">
 <bp:stepProcess rdf:resource="#Pathway9" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2120">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2221">
 <bp:stepProcess rdf:resource="#Catalysis573" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1948" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep61">
 <bp:stepProcess rdf:resource="#BiochemicalReaction53" />
 <bp:stepProcess rdf:resource="#Catalysis11" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep60">
 <bp:stepProcess rdf:resource="#BiochemicalReaction52" />
 <bp:stepProcess rdf:resource="#Catalysis10" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2208">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1937" />
 <bp:stepProcess rdf:resource="#Catalysis567" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2209">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1938" />
 <bp:stepProcess rdf:resource="#Catalysis568" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2204">
 <bp:stepProcess rdf:resource="#Catalysis565" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1934" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2205">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1935" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2206">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1936" />
 <bp:stepProcess rdf:resource="#Catalysis566" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2207">
 <bp:stepProcess rdf:resource="#Pathway272" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2200">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1930" />
 <bp:stepProcess rdf:resource="#Catalysis563" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2201">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1931" />
 <bp:stepProcess rdf:resource="#Catalysis564" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2202">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1932" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2203">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1933" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence896">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence897">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence898">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence899">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep27">
 <bp:stepProcess rdf:resource="#BiochemicalReaction22" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence892">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep26">
 <bp:stepProcess rdf:resource="#BiochemicalReaction21" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence893">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep29">
 <bp:stepProcess rdf:resource="#BiochemicalReaction24" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence894">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep28">
 <bp:stepProcess rdf:resource="#BiochemicalReaction23" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence895">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep23">
 <bp:stepProcess rdf:resource="#BiochemicalReaction18" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep22">
 <bp:stepProcess rdf:resource="#BiochemicalReaction17" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep25">
 <bp:stepProcess rdf:resource="#BiochemicalReaction20" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence890">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep24">
 <bp:stepProcess rdf:resource="#BiochemicalReaction19" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence891">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep21">
 <bp:stepProcess rdf:resource="#BiochemicalReaction16" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep20">
 <bp:stepProcess rdf:resource="#BiochemicalReaction15" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence885">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep19">
 <bp:stepProcess rdf:resource="#BiochemicalReaction14" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence886">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence887">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence888">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep16">
 <bp:stepProcess rdf:resource="#BiochemicalReaction11" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence881">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep15">
 <bp:stepProcess rdf:resource="#BiochemicalReaction10" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence882">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep18">
 <bp:stepProcess rdf:resource="#BiochemicalReaction13" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence883">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep17">
 <bp:stepProcess rdf:resource="#BiochemicalReaction12" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence884">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep12">
 <bp:stepProcess rdf:resource="#BiochemicalReaction7" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep11">
 <bp:stepProcess rdf:resource="#BiochemicalReaction6" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep14">
 <bp:stepProcess rdf:resource="#BiochemicalReaction9" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep13">
 <bp:stepProcess rdf:resource="#BiochemicalReaction8" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence880">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep10">
 <bp:stepProcess rdf:resource="#BiochemicalReaction5" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence889">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence874">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence875">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence876">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence877">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence870">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence871">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence872">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence873">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence878">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence879">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence863">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence864">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence865">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence866">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence860">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence861">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence862">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence867">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence868">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence869">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence852">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence853">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence854">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep899">
 <bp:stepProcess rdf:resource="#BiochemicalReaction775" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence855">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep897">
 <bp:stepProcess rdf:resource="#BiochemicalReaction774" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep898">
 <bp:stepProcess rdf:resource="#Pathway125" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence850">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep895">
 <bp:stepProcess rdf:resource="#BiochemicalReaction772" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence851">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep896">
 <bp:stepProcess rdf:resource="#BiochemicalReaction773" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2299">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2008" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2295">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2004" />
 <bp:stepProcess rdf:resource="#Catalysis601" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2296">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2005" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2297">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2006" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2298">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2007" />
 <bp:stepProcess rdf:resource="#Catalysis602" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep893">
 <bp:stepProcess rdf:resource="#Catalysis274" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction770" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep894">
 <bp:stepProcess rdf:resource="#BiochemicalReaction771" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep891">
 <bp:stepProcess rdf:resource="#BiochemicalReaction768" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep892">
 <bp:stepProcess rdf:resource="#BiochemicalReaction769" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence856">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence857">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep890">
 <bp:stepProcess rdf:resource="#BiochemicalReaction767" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence858">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence859">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence841">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence842">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence843">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep888">
 <bp:stepProcess rdf:resource="#BiochemicalReaction765" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence844">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep889">
 <bp:stepProcess rdf:resource="#BiochemicalReaction766" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep886">
 <bp:stepProcess rdf:resource="#BiochemicalReaction763" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep887">
 <bp:stepProcess rdf:resource="#BiochemicalReaction764" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep884">
 <bp:stepProcess rdf:resource="#BiochemicalReaction761" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence840">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep885">
 <bp:stepProcess rdf:resource="#BiochemicalReaction762" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence849">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep882">
 <bp:stepProcess rdf:resource="#BiochemicalReaction759" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep883">
 <bp:stepProcess rdf:resource="#BiochemicalReaction760" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep880">
 <bp:stepProcess rdf:resource="#BiochemicalReaction757" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep881">
 <bp:stepProcess rdf:resource="#BiochemicalReaction758" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence845">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence846">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence847">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence848">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence830">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep879">
 <bp:stepProcess rdf:resource="#BiochemicalReaction756" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence831">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence832">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep877">
 <bp:stepProcess rdf:resource="#BiochemicalReaction754" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence833">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep878">
 <bp:stepProcess rdf:resource="#BiochemicalReaction755" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep875">
 <bp:stepProcess rdf:resource="#BiochemicalReaction752" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep876">
 <bp:stepProcess rdf:resource="#BiochemicalReaction753" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep873">
 <bp:stepProcess rdf:resource="#Pathway124" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep874">
 <bp:stepProcess rdf:resource="#Catalysis273" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction751" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2277">
 <bp:stepProcess rdf:resource="#Catalysis593" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1991" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2278">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1992" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2279">
 <bp:stepProcess rdf:resource="#Pathway288" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2273">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1990" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2274">
 <bp:stepProcess rdf:resource="#Pathway285" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2275">
 <bp:stepProcess rdf:resource="#Pathway286" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2276">
 <bp:stepProcess rdf:resource="#Pathway287" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2280">
 <bp:stepProcess rdf:resource="#Pathway289" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2281">
 <bp:stepProcess rdf:resource="#Pathway290" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2282">
 <bp:stepProcess rdf:resource="#Catalysis594" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1993" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2283">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1994" />
 <bp:stepProcess rdf:resource="#Catalysis595" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence838">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep871">
 <bp:stepProcess rdf:resource="#Pathway122" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence839">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep872">
 <bp:stepProcess rdf:resource="#Pathway123" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep870">
 <bp:stepProcess rdf:resource="#BiochemicalReaction750" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence834">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence835">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence836">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence837">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep868">
 <bp:stepProcess rdf:resource="#Catalysis272" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction748" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence820">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep869">
 <bp:stepProcess rdf:resource="#BiochemicalReaction749" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence821">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep866">
 <bp:stepProcess rdf:resource="#BiochemicalReaction746" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence822">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep867">
 <bp:stepProcess rdf:resource="#BiochemicalReaction747" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep864">
 <bp:stepProcess rdf:resource="#BiochemicalReaction744" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep865">
 <bp:stepProcess rdf:resource="#BiochemicalReaction745" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep862">
 <bp:stepProcess rdf:resource="#BiochemicalReaction742" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep863">
 <bp:stepProcess rdf:resource="#BiochemicalReaction743" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2288">
 <bp:stepProcess rdf:resource="#Catalysis597" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1998" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2289">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1999" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2284">
 <bp:stepProcess rdf:resource="#Pathway291" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2285">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1995" />
 <bp:stepProcess rdf:resource="#Catalysis596" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2286">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1996" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2287">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1997" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2291">
 <bp:stepProcess rdf:resource="#Pathway292" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2292">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2001" />
 <bp:stepProcess rdf:resource="#Catalysis599" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2293">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2002" />
 <bp:stepProcess rdf:resource="#Catalysis600" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2294">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2003" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2290">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2000" />
 <bp:stepProcess rdf:resource="#Catalysis598" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence827">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep860">
 <bp:stepProcess rdf:resource="#Catalysis271" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction740" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence828">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep861">
 <bp:stepProcess rdf:resource="#BiochemicalReaction741" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence829">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence823">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence824">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence825">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence826">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep857">
 <bp:stepProcess rdf:resource="#BiochemicalReaction737" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep858">
 <bp:stepProcess rdf:resource="#Catalysis270" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction738" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence810">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep855">
 <bp:stepProcess rdf:resource="#BiochemicalReaction735" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence811">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep856">
 <bp:stepProcess rdf:resource="#BiochemicalReaction736" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep853">
 <bp:stepProcess rdf:resource="#Pathway121" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2259">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1979" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep854">
 <bp:stepProcess rdf:resource="#BiochemicalReaction734" />
 <bp:stepProcess rdf:resource="#Catalysis269" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep851">
 <bp:stepProcess rdf:resource="#BiochemicalReaction732" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep852">
 <bp:stepProcess rdf:resource="#BiochemicalReaction733" />
 <bp:stepProcess rdf:resource="#Catalysis268" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2255">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1976" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2256">
 <bp:stepProcess rdf:resource="#Pathway281" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2257">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1977" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2258">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1978" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2251">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1973" />
 <bp:stepProcess rdf:resource="#Catalysis585" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2252">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1974" />
 <bp:stepProcess rdf:resource="#Catalysis586" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep859">
 <bp:stepProcess rdf:resource="#BiochemicalReaction739" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2253">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1975" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2254">
 <bp:stepProcess rdf:resource="#Pathway280" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2260">
 <bp:stepProcess rdf:resource="#Pathway282" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2261">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1980" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence816">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence817">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep850">
 <bp:stepProcess rdf:resource="#BiochemicalReaction731" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence818">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence819">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence812">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence813">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence814">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence815">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep846">
 <bp:stepProcess rdf:resource="#BiochemicalReaction727" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep847">
 <bp:stepProcess rdf:resource="#BiochemicalReaction728" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep844">
 <bp:stepProcess rdf:resource="#BiochemicalReaction725" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence800">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep845">
 <bp:stepProcess rdf:resource="#BiochemicalReaction726" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep842">
 <bp:stepProcess rdf:resource="#Catalysis266" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction724" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep843">
 <bp:stepProcess rdf:resource="#Pathway120" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep840">
 <bp:stepProcess rdf:resource="#BiochemicalReaction723" />
 <bp:stepProcess rdf:resource="#Catalysis265" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep841">
 <bp:stepProcess rdf:resource="#Pathway119" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2266">
 <bp:stepProcess rdf:resource="#Pathway284" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2267">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1984" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2268">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1985" />
 <bp:stepProcess rdf:resource="#Catalysis590" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2269">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1986" />
 <bp:stepProcess rdf:resource="#Catalysis591" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2262">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1981" />
 <bp:stepProcess rdf:resource="#Catalysis587" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2263">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1982" />
 <bp:stepProcess rdf:resource="#Catalysis588" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep848">
 <bp:stepProcess rdf:resource="#BiochemicalReaction729" />
 <bp:stepProcess rdf:resource="#Catalysis267" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2264">
 <bp:stepProcess rdf:resource="#Pathway283" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep849">
 <bp:stepProcess rdf:resource="#BiochemicalReaction730" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2265">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1983" />
 <bp:stepProcess rdf:resource="#Catalysis589" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2270">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1987" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2271">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1988" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2272">
 <bp:stepProcess rdf:resource="#Catalysis592" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1989" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence809">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence805">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence806">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence807">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence808">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence801">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence802">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence803">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence804">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep956">
 <bp:stepProcess rdf:resource="#BiochemicalReaction830" />
 <bp:stepProcess rdf:resource="#Catalysis288" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep957">
 <bp:stepProcess rdf:resource="#BiochemicalReaction831" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep954">
 <bp:stepProcess rdf:resource="#BiochemicalReaction828" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep955">
 <bp:stepProcess rdf:resource="#BiochemicalReaction829" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep952">
 <bp:stepProcess rdf:resource="#BiochemicalReaction826" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep953">
 <bp:stepProcess rdf:resource="#BiochemicalReaction827" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep950">
 <bp:stepProcess rdf:resource="#BiochemicalReaction824" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep951">
 <bp:stepProcess rdf:resource="#BiochemicalReaction825" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep958">
 <bp:stepProcess rdf:resource="#BiochemicalReaction832" />
 <bp:stepProcess rdf:resource="#Catalysis289" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep959">
 <bp:stepProcess rdf:resource="#BiochemicalReaction833" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep945">
 <bp:stepProcess rdf:resource="#BiochemicalReaction819" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep946">
 <bp:stepProcess rdf:resource="#BiochemicalReaction820" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep943">
 <bp:stepProcess rdf:resource="#Catalysis286" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction817" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep944">
 <bp:stepProcess rdf:resource="#BiochemicalReaction818" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep941">
 <bp:stepProcess rdf:resource="#BiochemicalReaction816" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep942">
 <bp:stepProcess rdf:resource="#Pathway127" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep940">
 <bp:stepProcess rdf:resource="#BiochemicalReaction815" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep949">
 <bp:stepProcess rdf:resource="#BiochemicalReaction823" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep947">
 <bp:stepProcess rdf:resource="#BiochemicalReaction821" />
 <bp:stepProcess rdf:resource="#Catalysis287" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep948">
 <bp:stepProcess rdf:resource="#BiochemicalReaction822" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep934">
 <bp:stepProcess rdf:resource="#BiochemicalReaction809" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep935">
 <bp:stepProcess rdf:resource="#BiochemicalReaction810" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep932">
 <bp:stepProcess rdf:resource="#Catalysis283" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction807" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep933">
 <bp:stepProcess rdf:resource="#BiochemicalReaction808" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep930">
 <bp:stepProcess rdf:resource="#BiochemicalReaction805" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep931">
 <bp:stepProcess rdf:resource="#BiochemicalReaction806" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep938">
 <bp:stepProcess rdf:resource="#Catalysis285" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction813" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep939">
 <bp:stepProcess rdf:resource="#BiochemicalReaction814" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep936">
 <bp:stepProcess rdf:resource="#BiochemicalReaction811" />
 <bp:stepProcess rdf:resource="#Catalysis284" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep937">
 <bp:stepProcess rdf:resource="#BiochemicalReaction812" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep923">
 <bp:stepProcess rdf:resource="#BiochemicalReaction799" />
 <bp:stepProcess rdf:resource="#Catalysis281" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep924">
 <bp:stepProcess rdf:resource="#BiochemicalReaction800" />
 <bp:stepProcess rdf:resource="#Catalysis282" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep921">
 <bp:stepProcess rdf:resource="#BiochemicalReaction797" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep922">
 <bp:stepProcess rdf:resource="#BiochemicalReaction798" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep920">
 <bp:stepProcess rdf:resource="#BiochemicalReaction796" />
 <bp:stepProcess rdf:resource="#Catalysis280" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep929">
 <bp:stepProcess rdf:resource="#BiochemicalReaction804" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep927">
 <bp:stepProcess rdf:resource="#BiochemicalReaction802" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep928">
 <bp:stepProcess rdf:resource="#BiochemicalReaction803" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep925">
 <bp:stepProcess rdf:resource="#BiochemicalReaction801" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep926">
 <bp:stepProcess rdf:resource="#Pathway126" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep912">
 <bp:stepProcess rdf:resource="#BiochemicalReaction788" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep913">
 <bp:stepProcess rdf:resource="#BiochemicalReaction789" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep910">
 <bp:stepProcess rdf:resource="#BiochemicalReaction786" />
 <bp:stepProcess rdf:resource="#Catalysis276" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep911">
 <bp:stepProcess rdf:resource="#BiochemicalReaction787" />
 <bp:stepProcess rdf:resource="#Catalysis277" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep918">
 <bp:stepProcess rdf:resource="#BiochemicalReaction794" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep919">
 <bp:stepProcess rdf:resource="#BiochemicalReaction795" />
 <bp:stepProcess rdf:resource="#Catalysis279" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep916">
 <bp:stepProcess rdf:resource="#BiochemicalReaction792" />
 <bp:stepProcess rdf:resource="#Catalysis278" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep917">
 <bp:stepProcess rdf:resource="#BiochemicalReaction793" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep914">
 <bp:stepProcess rdf:resource="#BiochemicalReaction790" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep915">
 <bp:stepProcess rdf:resource="#BiochemicalReaction791" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep901">
 <bp:stepProcess rdf:resource="#BiochemicalReaction777" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep902">
 <bp:stepProcess rdf:resource="#BiochemicalReaction778" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep900">
 <bp:stepProcess rdf:resource="#BiochemicalReaction776" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep909">
 <bp:stepProcess rdf:resource="#Catalysis275" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction785" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep907">
 <bp:stepProcess rdf:resource="#BiochemicalReaction783" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep908">
 <bp:stepProcess rdf:resource="#BiochemicalReaction784" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep905">
 <bp:stepProcess rdf:resource="#BiochemicalReaction781" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep906">
 <bp:stepProcess rdf:resource="#BiochemicalReaction782" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep903">
 <bp:stepProcess rdf:resource="#BiochemicalReaction779" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep904">
 <bp:stepProcess rdf:resource="#BiochemicalReaction780" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2097">
 <bp:stepProcess rdf:resource="#Pathway264" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2098">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1835" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2099">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1836" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2091">
 <bp:evidence rdf:resource="#Evidence2401" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Extracellular processing of novel PDGFs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2090">
 <bp:evidence rdf:resource="#Evidence2400" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTPN12 dephosphorylates PDGFRB at Y1021</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2099">
 <bp:evidence rdf:resource="#Evidence2410" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GAP binds to PDGF-beta receptors only</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2098">
 <bp:evidence rdf:resource="#Evidence2409" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT binds to the active receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2097">
 <bp:evidence rdf:resource="#Evidence2408" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of Src</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2096">
 <bp:evidence rdf:resource="#Evidence2407" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRB2:SOS1 complex binds to the active receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2095">
 <bp:evidence rdf:resource="#Evidence2406" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Grb7 binds to the active PDGF receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2094">
 <bp:evidence rdf:resource="#Evidence2405" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p130Cas and C3G bind PDGFR bound Crk</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2093">
 <bp:evidence rdf:resource="#Evidence2404" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SH2 domain of Src binds to the active receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2092">
 <bp:evidence rdf:resource="#Evidence2403" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated PLC gamma dissociates from the PDGF receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2080">
 <bp:evidence rdf:resource="#Evidence2388" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of CBL (EGFR:CBL)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2088">
 <bp:evidence rdf:resource="#Evidence2398" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PDGF-AA clevage by Furin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2087">
 <bp:evidence rdf:resource="#Evidence2397" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Autophosphorylation of PDGF beta receptors</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2086">
 <bp:evidence rdf:resource="#Evidence2396" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of PDGF from ER to Golgi</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2085">
 <bp:evidence rdf:resource="#Evidence2394" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phospholipase C-gamma1 binds to the activated EGF receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2084">
 <bp:evidence rdf:resource="#Evidence2393" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EGFR activates PLC-gamma1 by phosphorylation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2083">
 <bp:evidence rdf:resource="#Evidence2392" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active PLC-gamma1 dissociates from EGFR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2082">
 <bp:evidence rdf:resource="#Evidence2390" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EGFR autophosphorylation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2081">
 <bp:evidence rdf:resource="#Evidence2389" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitination of stimulated EGFR (CBL:GRB2)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2089">
 <bp:evidence rdf:resource="#Evidence2399" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PDGF binds to extracellular matrix proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2077">
 <bp:evidence rdf:resource="#Evidence2385" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Beta-Pix:CDC42:GTP binds CBL in EGF:p-6Y-EGFR:CBL:CIN85</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2076">
 <bp:evidence rdf:resource="#Evidence2384" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDC42:GTP binds CBL:Beta-Pix</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2075">
 <bp:evidence rdf:resource="#Evidence2383" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitination of stimulated EGFR (CBL)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2074">
 <bp:evidence rdf:resource="#Evidence2382" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CBL binds and ubiquitinates phosphorylated Sprouty</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2073">
 <bp:evidence rdf:resource="#Evidence2381" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Assembly of EGFR complex in clathrin-coated vesicles</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2072">
 <bp:evidence rdf:resource="#Evidence2380" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of CBL (EGFR:GRB2:CBL)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2071">
 <bp:evidence rdf:resource="#Evidence2379" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CBL escapes CDC42-mediated inhibition by down-regulating the adaptor molecule Beta-Pix</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2070">
 <bp:evidence rdf:resource="#Evidence2378" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Sprouty lures CBL away from EGFR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2079">
 <bp:evidence rdf:resource="#Evidence2387" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTPN12 dephosphorylates EGFR at Y1172 (Y1148)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2078">
 <bp:evidence rdf:resource="#Evidence2386" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Localization of CBL:GRB2 to the membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2116">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1853" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2117">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1854" />
 <bp:stepProcess rdf:resource="#Catalysis540" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2118">
 <bp:stepProcess rdf:resource="#Catalysis541" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1855" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2119">
 <bp:stepProcess rdf:resource="#Catalysis542" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1856" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2112">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1849" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2022">
 <bp:evidence rdf:resource="#Evidence2323" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-T309,S474-AKT2:PIP3 phosphorylates PDE3B</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2113">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1850" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2021">
 <bp:evidence rdf:resource="#Evidence2322" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S295-PDE3B hydrolyses cAMP to AMP</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2114">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1851" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2020">
 <bp:evidence rdf:resource="#Evidence2318" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRB2-1:SOS1 binds p-IRS1,p-IRS2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2115">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1852" />
 <bp:stepProcess rdf:resource="#Catalysis539" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2110">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1847" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2111">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1848" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2029">
 <bp:evidence rdf:resource="#Evidence2331" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IGF1,2:p-Y1161,1165,1166-IGF1R binds IRS1,4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2028">
 <bp:evidence rdf:resource="#Evidence2330" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IGF1,2:p-Y1161,1165,1166-IGF1R phosphorylates IRS1,2,4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2027">
 <bp:evidence rdf:resource="#Evidence2329" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y-IRS1,p-Y-IRS2 bind PI3K</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2026">
 <bp:evidence rdf:resource="#Evidence2328" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI3K-containing complexes phosphorylate PIP2 to PIP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2025">
 <bp:evidence rdf:resource="#Evidence2327" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PDPK1 binds PIP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2024">
 <bp:evidence rdf:resource="#Evidence2326" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT2 binds PIP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2023">
 <bp:evidence rdf:resource="#Evidence2325" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PDPK1 phosphorylates AKT2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2127">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1864" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2128">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1865" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2129">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1866" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2123">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1860" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2011">
 <bp:evidence rdf:resource="#Evidence2304" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of IRS to insulin receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2124">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1861" />
 <bp:stepProcess rdf:resource="#Catalysis543" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2010">
 <bp:evidence rdf:resource="#Evidence2303" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of IRS</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep2125">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1862" />
 <bp:stepProcess rdf:resource="#Catalysis544" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2126">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1863" />
 <bp:stepProcess rdf:resource="#Catalysis545" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2120">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1857" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2121">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1858" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2122">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1859" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2019">
 <bp:evidence rdf:resource="#Evidence2317" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRB2:SOS1:p-Y-IRS1,p-Y-IRS2 mediated nucleotide exchange of RAS</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2018">
 <bp:evidence rdf:resource="#Evidence2314" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IGF1,2:p-Y1161,1165,1166-IGF1R binds IRS2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2017">
 <bp:evidence rdf:resource="#Evidence2311" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IGF1,2 binds IGF1R</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2016">
 <bp:evidence rdf:resource="#Evidence2309" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Internalisation of the insulin receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2015">
 <bp:evidence rdf:resource="#Evidence2308" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRB2-1 binds SOS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2014">
 <bp:evidence rdf:resource="#Evidence2307" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of SHC1 to insulin receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2013">
 <bp:evidence rdf:resource="#Evidence2306" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of p-Y427-SHC1 from insulin receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2012">
 <bp:evidence rdf:resource="#Evidence2305" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of SHC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2013">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2012">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2015">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2014">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2017">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2016">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2019">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2018">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2000">
 <bp:evidence rdf:resource="#Evidence2291" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRB2:SOS:p-Y427-SHC1 mediated nucleotide exchange of RAS</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2011">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2010">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2008">
 <bp:evidence rdf:resource="#Evidence2300" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRB2-1:SOS1 binds p-Y427-SHC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2007">
 <bp:evidence rdf:resource="#Evidence2299" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dephosphorylation of p-Y-IRS1,p-Y-IRS2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2006">
 <bp:evidence rdf:resource="#Evidence2298" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of Grb10 to the insulin receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2005">
 <bp:evidence rdf:resource="#Evidence2297" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRB2-1:p-4S-SOS1:p-Y427-SHC1 dissociates</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2004">
 <bp:evidence rdf:resource="#Evidence2296" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">De-phosphorylation of p-Y427-SHC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2003">
 <bp:evidence rdf:resource="#Evidence2295" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRB2:p-4S-SOS1:p-Y-IRS1,p-Y-IRS2 dissociates</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2002">
 <bp:evidence rdf:resource="#Evidence2294" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK3,(MAPK1) phosphorylates GRB2-1:SOS1:p-Y-IRS1,p-Y-IRS2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2001">
 <bp:evidence rdf:resource="#Evidence2293" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK3,(MAPK1) phosphorylates GRB2-1:SOS1:p-Y427-SHC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2009">
 <bp:evidence rdf:resource="#Evidence2302" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of IRS-P from insulin receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence2002">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2109">
 <bp:stepProcess rdf:resource="#Catalysis538" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1846" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2001">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2004">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2003">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2006">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2105">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1842" />
 <bp:stepProcess rdf:resource="#Catalysis535" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2005">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2106">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1843" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2008">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2107">
 <bp:stepProcess rdf:resource="#Catalysis536" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1844" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2007">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2108">
 <bp:stepProcess rdf:resource="#Catalysis537" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1845" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2101">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1838" />
 <bp:stepProcess rdf:resource="#Catalysis534" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2102">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1839" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2103">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1840" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2104">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1841" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2000">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2100">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1837" />
 <bp:stepProcess rdf:resource="#Catalysis533" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2009">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence797">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence798">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence799">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence793">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence794">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence795">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence796">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2066">
 <bp:evidence rdf:resource="#Evidence2374" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CIN85 dissociates from EGF:p-6Y-EGFR:CBL:Beta-Pix:CDC42:GTP:CIN85</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence790">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2065">
 <bp:evidence rdf:resource="#Evidence2373" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CBL ubiquitinates Sprouty</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence791">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2064">
 <bp:evidence rdf:resource="#Evidence2372" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CBL-mediated ubiquitination of CIN85</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence792">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2063">
 <bp:evidence rdf:resource="#Evidence2371" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EGFR phosphorylates EPS15</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2062">
 <bp:evidence rdf:resource="#Evidence2370" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EGFR binds EPS15, EPN1, EPS15L1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2061">
 <bp:evidence rdf:resource="#Evidence2369" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EGFR non-clathrin mediated endocytosis</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2060">
 <bp:evidence rdf:resource="#Evidence2368" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTPN3 dephosphorylates EPS15</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2069">
 <bp:evidence rdf:resource="#Evidence2377" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CBL binds to GRB2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2068">
 <bp:evidence rdf:resource="#Evidence2376" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of CBL to EGFR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2067">
 <bp:evidence rdf:resource="#Evidence2375" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Sprouty sequesters CBL away from active EGFR</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence786">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence787">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence788">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence789">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence782">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence783">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence784">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence785">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2055">
 <bp:evidence rdf:resource="#Evidence2362" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GAB1 binds phosphatidylinositol-3,4,5-trisphosphate</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2054">
 <bp:evidence rdf:resource="#Evidence2361" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GAB1 phosphorylation by EGFR kinase</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence780">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2053">
 <bp:evidence rdf:resource="#Evidence2360" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRB2:GAB1 binds to phosphorylated EGFR</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence781">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2052">
 <bp:evidence rdf:resource="#Evidence2359" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dephosphorylation of Gab1 by SHP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2051">
 <bp:evidence rdf:resource="#Evidence2358" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI3K binds to EGF:EGFR:GRB2:GAB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2050">
 <bp:evidence rdf:resource="#Evidence2357" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dephosphorylation of PAG by SHP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2059">
 <bp:evidence rdf:resource="#Evidence2366" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FAM83B, (FAM83A, FAM83D) bind EGFR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2058">
 <bp:evidence rdf:resource="#Evidence2365" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pro-EGF is cleaved to form mature EGF</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2057">
 <bp:evidence rdf:resource="#Evidence2364" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHP2 dephosphorylates Tyr 992 on EGFR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2056">
 <bp:evidence rdf:resource="#Evidence2363" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of SHP2 through the binding to phospho-Gab1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence775">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence776">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence777">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence778">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence771">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence772">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence773">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence774">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2044">
 <bp:evidence rdf:resource="#Evidence2350" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRB2:SOS1 complex binds to EGF:EGFR complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2043">
 <bp:evidence rdf:resource="#Evidence2348" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EGFR binds EGF ligand</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2042">
 <bp:evidence rdf:resource="#Evidence2347" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of EGFR by SRC kinase</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence770">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2041">
 <bp:evidence rdf:resource="#Evidence2346" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHC1 phosphorylation by phosphorylated EGFR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2040">
 <bp:evidence rdf:resource="#Evidence2345" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SOS1-mediated nucleotide exchange of RAS (EGF:EGFR:SHC1:GRB2:SOS1)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2049">
 <bp:evidence rdf:resource="#Evidence2356" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of GRB2 to GAB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2048">
 <bp:evidence rdf:resource="#Evidence2355" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Sustained activation of SRC kinase by SHP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2047">
 <bp:evidence rdf:resource="#Evidence2354" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI3K converts phosphatidylinositol-4,5-bisphosphate (PIP2) to phosphatidylinositol-3,4,5-trisphosphate (PIP3)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2046">
 <bp:evidence rdf:resource="#Evidence2352" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SOS1-mediated nucleotide exchange of RAS (EGF:EGFR:GRB2:SOS1)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2045">
 <bp:evidence rdf:resource="#Evidence2351" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRB2-1 binds SOS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence779">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence764">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence765">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence766">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence767">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence760">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence761">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence762">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence763">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2033">
 <bp:evidence rdf:resource="#Evidence2336" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IGF1,2:p-Y1161,1165,1166-IGF1R binds SHC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2032">
 <bp:evidence rdf:resource="#Evidence2335" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRB2-1:SOS1:p-3Y-SHC1 mediated nucleotide exchange of RAS</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2031">
 <bp:evidence rdf:resource="#Evidence2334" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-3Y-SHC1 dissociates from IGF1R</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2030">
 <bp:evidence rdf:resource="#Evidence2333" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRB2-1:SOS1 binds p-3Y-SHC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2039">
 <bp:evidence rdf:resource="#Evidence2344" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SHC1 binds to the phosphorylated EGF receptor:ligand complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2038">
 <bp:evidence rdf:resource="#Evidence2343" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRB2:SOS1 binds to phosphorylated SHC1 in complex with EGFR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2037">
 <bp:evidence rdf:resource="#Evidence2341" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EGFR dimerization</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2036">
 <bp:evidence rdf:resource="#Evidence2340" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AAMP binds EGFR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2035">
 <bp:evidence rdf:resource="#Evidence2338" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IGF1,2:IGF1R autophosphorylates</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2034">
 <bp:evidence rdf:resource="#Evidence2337" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IGF1R phosphorylates SHC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence768">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence769">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence753">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence754">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence755">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence756">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence750">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence751">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence752">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2196">
 <bp:stepProcess rdf:resource="#Catalysis562" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1926" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2197">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1927" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2198">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1928" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2199">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1929" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence757">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence758">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence759">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence742">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence743">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence744">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence745">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence740">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence741">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence746">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence747">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence748">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence749">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence731">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence732">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence733">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence734">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence730">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2178">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1908" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2179">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1909" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2174">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1904" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2175">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1905" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2176">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1906" />
 <bp:stepProcess rdf:resource="#Catalysis555" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2177">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1907" />
 <bp:stepProcess rdf:resource="#Catalysis556" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2181">
 <bp:stepProcess rdf:resource="#Catalysis557" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1911" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2182">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1912" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2183">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1913" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2184">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1914" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2180">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1910" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence739">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence735">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence736">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence737">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence738">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence720">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence721">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence722">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence723">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep2189">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1919" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2185">
 <bp:stepProcess rdf:resource="#Catalysis558" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1915" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2186">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1916" />
 <bp:stepProcess rdf:resource="#Catalysis559" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2187">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1917" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2188">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1918" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2192">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1922" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2193">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1923" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2194">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1924" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2195">
 <bp:stepProcess rdf:resource="#Catalysis561" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1925" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2190">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1920" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2191">
 <bp:stepProcess rdf:resource="#Catalysis560" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1921" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence728">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence729">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence724">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence725">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence726">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence727">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence710">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence711">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep998">
 <bp:stepProcess rdf:resource="#BiochemicalReaction867" />
 <bp:stepProcess rdf:resource="#Catalysis300" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence712">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep999">
 <bp:stepProcess rdf:resource="#BiochemicalReaction868" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep996">
 <bp:stepProcess rdf:resource="#BiochemicalReaction865" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep997">
 <bp:stepProcess rdf:resource="#BiochemicalReaction866" />
 <bp:stepProcess rdf:resource="#Catalysis299" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep994">
 <bp:stepProcess rdf:resource="#BiochemicalReaction864" />
 <bp:stepProcess rdf:resource="#Catalysis298" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep995">
 <bp:stepProcess rdf:resource="#Pathway132" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2156">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1890" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2157">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1891" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2158">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1892" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2159">
 <bp:stepProcess rdf:resource="#Pathway268" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2152">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1887" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2153">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1888" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2154">
 <bp:stepProcess rdf:resource="#Pathway267" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2155">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1889" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2160">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1893" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2161">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1894" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2162">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1895" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence717">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep992">
 <bp:stepProcess rdf:resource="#BiochemicalReaction862" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence718">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep993">
 <bp:stepProcess rdf:resource="#Catalysis297" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction863" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence719">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep990">
 <bp:stepProcess rdf:resource="#BiochemicalReaction860" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep991">
 <bp:stepProcess rdf:resource="#Catalysis296" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction861" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence713">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence714">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence715">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence716">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep989">
 <bp:stepProcess rdf:resource="#BiochemicalReaction859" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence700">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep987">
 <bp:stepProcess rdf:resource="#BiochemicalReaction857" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence701">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep988">
 <bp:stepProcess rdf:resource="#Catalysis295" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction858" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep985">
 <bp:stepProcess rdf:resource="#BiochemicalReaction855" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep986">
 <bp:stepProcess rdf:resource="#Catalysis294" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction856" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep983">
 <bp:stepProcess rdf:resource="#BiochemicalReaction853" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep984">
 <bp:stepProcess rdf:resource="#BiochemicalReaction854" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2167">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1898" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2168">
 <bp:stepProcess rdf:resource="#Pathway271" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2169">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1899" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2163">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1896" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2164">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1897" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2165">
 <bp:stepProcess rdf:resource="#Pathway269" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2166">
 <bp:stepProcess rdf:resource="#Pathway270" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2170">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1900" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2171">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1901" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2172">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1902" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2173">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1903" />
 <bp:stepProcess rdf:resource="#Catalysis554" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence706">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep981">
 <bp:stepProcess rdf:resource="#Pathway131" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence707">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep982">
 <bp:stepProcess rdf:resource="#BiochemicalReaction852" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence708">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence709">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep980">
 <bp:stepProcess rdf:resource="#Pathway130" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence702">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence703">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence704">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence705">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep978">
 <bp:stepProcess rdf:resource="#BiochemicalReaction851" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep979">
 <bp:stepProcess rdf:resource="#Pathway129" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep976">
 <bp:stepProcess rdf:resource="#BiochemicalReaction849" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep977">
 <bp:stepProcess rdf:resource="#BiochemicalReaction850" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep974">
 <bp:stepProcess rdf:resource="#BiochemicalReaction847" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2138">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1875" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep975">
 <bp:stepProcess rdf:resource="#BiochemicalReaction848" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2139">
 <bp:stepProcess rdf:resource="#Pathway265" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep972">
 <bp:stepProcess rdf:resource="#Pathway128" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep973">
 <bp:stepProcess rdf:resource="#BiochemicalReaction846" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2134">
 <bp:stepProcess rdf:resource="#Catalysis550" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1871" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2135">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1872" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2136">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1873" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2137">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1874" />
 <bp:stepProcess rdf:resource="#Catalysis551" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2130">
 <bp:stepProcess rdf:resource="#Catalysis546" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1867" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2131">
 <bp:stepProcess rdf:resource="#Catalysis547" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1868" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2132">
 <bp:stepProcess rdf:resource="#Catalysis548" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1869" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2133">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1870" />
 <bp:stepProcess rdf:resource="#Catalysis549" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2140">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1876" />
 <bp:stepProcess rdf:resource="#Catalysis552" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep970">
 <bp:stepProcess rdf:resource="#BiochemicalReaction844" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep971">
 <bp:stepProcess rdf:resource="#Catalysis293" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction845" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep967">
 <bp:stepProcess rdf:resource="#BiochemicalReaction841" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep968">
 <bp:stepProcess rdf:resource="#BiochemicalReaction842" />
 <bp:stepProcess rdf:resource="#Catalysis292" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep965">
 <bp:stepProcess rdf:resource="#BiochemicalReaction839" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep966">
 <bp:stepProcess rdf:resource="#BiochemicalReaction840" />
 <bp:stepProcess rdf:resource="#Catalysis291" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep963">
 <bp:stepProcess rdf:resource="#BiochemicalReaction837" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2149">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1884" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep964">
 <bp:stepProcess rdf:resource="#BiochemicalReaction838" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep961">
 <bp:stepProcess rdf:resource="#Catalysis290" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction835" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep962">
 <bp:stepProcess rdf:resource="#BiochemicalReaction836" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2145">
 <bp:stepProcess rdf:resource="#Pathway266" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2146">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1881" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2147">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1882" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2148">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1883" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2141">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1877" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2142">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1878" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep969">
 <bp:stepProcess rdf:resource="#BiochemicalReaction843" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2143">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1879" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2144">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1880" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2150">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1885" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2151">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1886" />
 <bp:stepProcess rdf:resource="#Catalysis553" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep960">
 <bp:stepProcess rdf:resource="#BiochemicalReaction834" />
</bp:PathwayStep>
</rdf:RDF>